Generated by All in One SEO v4.9.2, this is an llms.txt file, used by LLMs to index the site.

# ABSA International

The Association for Biosafety and Biosecurity

## Sitemaps

- [XML Sitemap](https://absa.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [2025 Award Recipients: Honor Awards, Recognition Awards, Promotional Awards Winners](https://absa.org/award-recipients-honor-awards-recognition-awards-promotional-awards-winners-2/) - Award Recipients: Honor Awards, Recognition Awards, Promotional Awards Winners
- [CDC Import Permit Program Transition & Training: New Electronic Permitting System](https://absa.org/cdc-import-permit-program-transition-training-new-electronic-permitting-system/) - The CDC Import Permit Program (IPP) will soon be launching a new electronic permitting system, BioPermit, for those wishing to obtain permits in order to import infectious biological materials that could cause disease in humans. BioPermit will replace the current system, eIPP, as the centralized location for obtaining import permits and sharing information with IPP. The new
- [Need Credentialing Maintenance (CM) Points?](https://absa.org/need-credentialing-maintenance-cm-points/) - Are you nearing the end of your 5-year credentialing cycle or just starting your journey? Either way, here’s a quick guide to earning the Credentialing Maintenance (CM) points needed to maintain your ABSA credential (RBP or CBSP). To re-credential, you need 40 CM points over 5 years — that’s roughly 320 hours of biosafety/biosecurity service
- [Biosafety Cabinet Selection - New BSC Type](https://absa.org/nsf49-update/) - Do you know how to select an appropriate biosafety cabinet (BSC) Type and install it? A biosafety officer or qualified safety professional who has training and field experience that includes methods used to control biohazards and knowledge of the design, application, and testing of biosafety cabinets should approve purchases of biosafety cabinets (BSCs) after consultation with the user, architect, engineer, and facility manager.
- [Building a Biosafety and Biosecurity Relationship with the iGEM and DIY Communities](https://absa.org/building-a-biosafety-and-biosecurity-relationship-with-the-igem-and-diy-communities/)
- [Mary Ann Liebert, Inc. to Publish <em>Applied Biosafety</em>](https://absa.org/mary-ann-liebert-inc-to-publish-applied-biosafety/) - For Immediate Release Contact: Kathryn Ryan, Mary Ann Liebert, Inc., publishers, 914-740-2100, kryan@liebertpub.com Mary Ann Liebert, Inc. to Publish Applied Biosafety New Rochelle, NY, July 29, 2020—ABSA International has awarded the contract to publish their journal, Applied Biosafety: Journal of ABSA International, to Mary Ann Liebert, Inc., publishers, effective 2021. The Journal adds a dynamic
- [Zika virus; What is the Risk Assesment](https://absa.org/zika-virus-ra/) - Zika virus is a new and emerging pathogen that is impacting many people across the Americas. With the increased drive for an effective treatment, Zika virus research will be increasing in many laboratories. The biosafety risk assessment will be important to guide safe work practices when tackling this new agent.
- [NIOSH to Celebrate N95 Day with Webinar and Social Media Campaign](https://absa.org/n95day/) - 9/5 is N95 day! Do you wear a respirator at work? NIOSH is promoting proper respirator use on #N95Day this year. Follow @NIOSH_NPPTL and @NIOSH on twitter
- [EHS at ASU Launches Eye Promise Safety Glasses Campaign](https://absa.org/ehs-at-asu-launches-eye-promise-safety-glasses-campaign/) - Environmental Health and Safety has launched the Eye Promise campaign to raise awareness for wearing appropriate eye protection. The campaign asks university students, faculty and staff to promise to wear their safety glasses whenever they are in areas working with hazardous materials or physical hazards. Whether an individual works with wood in a shop, uses
- [National Inventory for Poliovirus Containment (NIPC) survey](https://absa.org/national-inventory-for-poliovirus-containment-nipc-survey/) - The US National Authority for Containment of Poliovirus (NAC) at the Centers for Disease Control and Prevention, Center for Preparedness and Response has recently launched the National Inventory for Poliovirus Containment: Minimizing Risk of Poliovirus Release from Laboratories in the United States, as part of the WHO Global Action Plan (GAP III). In compliance with
- [Applications are now open for CDC’s Laboratory Leadership Service (LLS)](https://absa.org/applications-are-now-open-for-cdcs-laboratory-leadership-service-lls/) - Applications are now open for CDC’s Laboratory Leadership Service (LLS). LLS provides training for laboratory scientists with an emphasis on safety, quality, and leadership. LLS is intended to prepare laboratory leaders to protect the public’s health, safety, and security. LLS fellows enhance their leadership and critical thinking skills to provide rapid, strategic, and effective solutions
- [New Affiliates](https://absa.org/new-affiliates/) - The Affiliate Relations Committee is proud to welcome two new affiliate members! Northern California Biological Safety Association (Norcal Biosafety) includes members in Northern California, Oregon, Washington, and Idaho helping to promote the study, evaluation, and control of biohazards in the workplace and in the environment. Swiss Biosafety Network (SBNeT) is open to all biosafety and
- [COVID-19 Joint Statement from ABSA International and APHL](https://absa.org/covid-19-joint-statement-from-absa-international-and-aphl/) - March 26, 2020 Dear APHL and ABSA International Members and Partners, As leaders of APHL and ABSA International, we deeply appreciate the valuable work of our members and partners during this critical response to coronavirus disease (COVID-19). Both professions, in most cases working together, are fighting to keep our workplaces and communities safe during the
- [MEMBERS: Join us at ABSA International Communities!](https://absa.org/members-look-for-your-invite-to-absa-international-communities/) - ABSA International’s new Howspace members-only engagement platform ABSA International Communities a dynamic space designed to foster collaboration, meaningful discussions, and impactful networking opportunities. Our mission at ABSA International has always been to promote biosafety and biosecurity worldwide. By leveraging this cutting-edge digital platform, we aim to provide a seamless environment where members like you can:
- [Prion Toolbox: For Navigating the Challenging Field of Misfolded Proteins](https://absa.org/prion-toolbox-for-navigating-the-challenging-field-of-misfolded-proteins/) - Prions are misfolded proteins that defy conventional biology and are not well understood. Prions consist of proteins, lack nucleic acids, and are challenging to work with. Human prion diseases are transmissible, progressive, and cause fatal neurodegenerative disorders. Despite rare occurrences (1-2 persons per million), prions pose considerable public health threat due to lack of pre-mortem
- [Recent Updates to the EIDC Toolboxes January 2022](https://absa.org/recent-updates-to-the-eidc-toolboxes-january-2022/) - The ABSA International Emerging Infectious Diseases Committee (EIDC) continues to update the toolboxes for salient infectious diseases and other relevant topics such as antimicrobial resistance. The latest updates include the following: SARS-CoV-2/COVID-19 Toolbox updates feature resources related to minimizing transmission of SARS CoV-2 from free-range animals to humans, recent peer-reviewed publications on SARS CoV-2 variants,
- [COVID-19 Joint Statement from ABSA International and CABS](https://absa.org/covid-19-joint-statement-from-absa-international-and-cabs/)
- [Ebola, one year later](https://absa.org/ebola-one-year-later/) - One year ago the largest Ebola outbreak began in March of 2014 the public Health authorities of Guinea reported an outbreak of Ebola. Now, in April 2015, more than 25,000 suspected cases of Ebola have occurred. This outbreak, while centered in Western Africa, has touched the lives of many around the world. Unfortunately, case counts are still rising and people are still dying from the disease.
- [Human Salmonella Typhimurium Infections Linked to Exposure to Clinical and Teaching Microbiology Laboratories](https://absa.org/cdc_report_salmonella-lais/) - CDC reported on 7/19/17, that there was another multi-state outbreak linked to clinical, commercial and college microbiology teaching laboratories.
- [COVID-19 Joint Statement from ABSA International and AIHA](https://absa.org/covid-19-joint-statement-from-absa-international-and-aiha/) - March 24, 2020 Dear AIHA and ABSA International Members and Friends, As leaders of AIHA and ABSA International, we would like to jointly show our appreciation for our members during this tenuous time and the critical work they do for the global community. Both professions, in most cases working jointly together, are keeping our workplaces
- [ABSA in the News: Embrace experimentation in biosecurity governance](https://absa.org/embrace-experimentation-in-biosecurity-governance/) - Embrace experimentation in biosecurity governance Sam Weiss Evans, Jacob Beal, Kavita Berger, Diederik A. Bleijs, Alessia Cagnetti, Francesca Ceroni, Gerald L. Epstein, Natàlia Garcia-Reyero, David R. Gillum, Graeme Harkess, Nathan J. Hillson, Petra A. M. Hogervorst, Jacob L. Jordan, Geneviève Lacroix, Rebecca Moritz, Seán S. ÓhÉigeartaigh, Megan J. Palmer and Mark W. J. van Passel
- [ABSA's Top-5 Biorisk Management Resources](https://absa.org/absas-top-5-biorisk-management-resources/) - Medical laboratory professionals are recognized at the end of April in the United States. We want to recognize here this group of unsung heroes during the COVID-19 pandemic. Marian Downing, Shoolah Escott, and Michael Marsico will present a poster during the upcoming virtual APHL 2021 Conference showcasing Biorisk Management tips and tools offered by ABSA
- [Looking for Waterborne Diseases or Fungal Diseases resources to conduct your risk assessments?](https://absa.org/looking-for-waterborne-diseases-or-fungal-diseases-resources-to-conduct-your-risk-assessments/) - The ABSA Emerging Infectious Diseases Committee (EIDC) collated resources that will help the biosafety professional conduct risk assessments for waterborne diseases and fungal diseases. The CDC says “every year, waterborne disease causes 7 million illnesses and $3 billion in healthcare costs in the US”. The Waterborne Diseases toolbox (https://absa.org/topic/waterborne/) include resources for the US and
- [Applied Biosafety invites you to submit your manuscript for online publication](https://absa.org/applied-biosafety-invites-you-to-submit-your-manuscript-for-online-publication/)
- [COVID-19 Joint Statement from ABSA International and AALAS](https://absa.org/covid-19-joint-statement-from-absa-international-and-aalas/) - April 16, 2020 Dear AALAS and ABSA International Members and Partners, As leaders of AALAS and ABSA International, we deeply appreciate the valuable work of our members and partners during this critical response to coronavirus disease (COVID-19). Both professions, in most cases working together, are fighting to keep our workplaces and communities safe during the
- [Biosecurity Commentary: Hacking a Lab's Pathogen Containment System; should this experiment have been published?](https://absa.org/biosecurity-commentary-hacking-a-labs-pathogen-containment-system-should-this-experiment-have-been-published/) - A recent article by a group of cyber-physical security experts at University of California Irvine (UCI) highlighted a potential vulnerability in negative pressure containment rooms. https://dl.acm.org/doi/10.1145/3548606.3560643 A commentary about this article was authored by George Poste and David Gillum at Arizona State University asking the question: “Should this research have been published?” https://thebulletin.org/2023/01/researchers-hacked-a-labs-pathogen-containment-system-was-it-a-good-idea-to-publish-the-results/#post-heading The authors
- [Updated  ABSA LAI Database include ZIKV, Macacine alphaherpesvirus 1, SARS CoV-2, and Shiga Toxin](https://absa.org/updated-absa-lai-database-include-zikv-macacine-alphaherpesvirus-1-sars-cov-2-and-shiga-toxin/) - The ABSA International Laboratory-Acquired Infection (LAI) Database has posted new entries for the following pathogens or toxins. You can search partial terms using the asterisk (*), AND, OR: 2013- Shiga Toxin from Escherichia coli O157:H7: mixing six E. coli O157:H7 strains in a soil-biochar blend Unknown time- Zika Virus; Injection of a highly concentrated live ZIKV strain into
- [Building Safety Bridges](https://absa.org/building-safety-bridges/) - It is easy for groups within institutions to fall victim to a “silo” operational approach, between handling day-to-day operations and unplanned challenges. The danger in this is obvious when safety is isolated as a group few know about and only turn to when there is an occupational exposure. Building bridges between safety professionals and other
- [A Recap of Biosafety and Biosecurity Month](https://absa.org/a-recap-of-biosafety-and-biosecurity-month/) - Thank you to everyone who participated in the 2021 Biosafety and Biosecurity Month in October. Putting a spotlight on Biosafety and Biosecurity at our institutions is an excellent way to foster a culture of biosafety and biosecurity. Did you know that Biosafety and Biosecurity Month began as a “National Biosafety Stewardship Month”, sponsored by the
- [Reporting all biosafety errors could improve labs worldwide – and increase public trust in biological research](https://absa.org/reporting-all-biosafety-errors-could-improve-labs-worldwide-and-increase-public-trust-in-biological-research/) - David Gillum, Kathleen Vogel, Rebecca Moritz The origin of SARS-CoV-2 remains a mystery. One theory is that the coronavirus that causes COVID-19 was transmitted from animals to humans – a fairly common occurrence. Another is that it came from a laboratory accident – a more infrequent circumstance. Around the world, scientists conduct many kinds of
- [Have you read the CDC/NIH BMBL-6 yet? The ABSA International Summary of Changes and the Side-by-Side Comparison will help focus your reading.](https://absa.org/have-you-read-the-cdc-nih-bmbl-6-yet-the-absa-international-summary-of-changes-and-the-side-by-side-comparison-will-help-focus-your-reading/) - The ABSA International Technical and Regulatory Review Committee compiled a Summary of Changes and a Side-by-Side Comparison to the 6th edition of the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL-6) released in November of 2020. The BMBL-6 continues to be, since the first edition in 1984, an advisory document. Consequently, words such as "must" and "should" have been
- [Recent Updates to the SARS-CoV-2 COVID-19 Toolbox by the EIDC](https://absa.org/recent-updates-to-the-sars-cov-2-covid-19-toolbox-by-the-eidc/) - In March 2020, the Emerging Infectious Diseases Committee (EIDC, then a task force) spearheaded the compilation of scientific and non-scientific resources into the SARS-CoV-2 COVID-19 Toolbox. Since then, the Committee has been busy adding resources, updating guidance provided primarily by US CDC and OSHA, and the WHO. But we don’t stop there, members of the EIDC
- [The State Press: Behind the quick turnaround of ASU's COVID-19 test](https://absa.org/the-state-press-behind-the-quick-turnaround-of-asus-covid-19-test/)
- [New COVID-19 Resource: Brochure available on planning events during a pandemic](https://absa.org/new-covid-19-resource-brochure-available-on-planning-events-during-a-pandemic/) - ABSA International is pleased to provide a brochure to assist organizations with providing a safe and healthy environment during periods when infectious diseases are of concern, such as the current COVID-19 pandemic. The information included serves as a guide for organizations to plan activities involving community members, volunteers, or others where personal interaction is slated
- [Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic](https://absa.org/decontamination-and-reuse-of-n95-respirators-with-hydrogen-peroxide-vapor-to-address-worldwide-personal-protective-equipment-shortages-during-the-sars-cov-2-covid-19-pandemic/) - Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic (PDF April 2020) Antony Schwartz et al. Duke University, Applied Biosafety: Journal of ABSA International This manuscript has been accepted to Applied Biosafety, publication forthcoming. This is a peer reviewed preprint and once
- [ABSA in the News: Q&A: Coronavirus and COVID-19 Basics](https://absa.org/absa-in-the-news-qa-coronavirus-and-covid-19-basics/) - Lumpen radio host Jamie Trecker interviews biosafety officer Allen Helm The following is an edited transcript of an interview with bacteriologist Allen Helm, a senior biosafety officer in the Office of Research Safety at the University of Chicago, about the novel coronavirus that causes COVID-19, conducted by host Jamie Trecker. The interview aired on March
- [ABSA in the News: Behind the scenes in the biosafety office](https://absa.org/absa-in-the-news-behind-the-scenes-in-the-biosafety-office/) - CAREER FEATURE 04 March 2020 Behind the scenes in the biosafety office It’s never a dull day for those tasked with keeping biological research safe for all. David Gillum received a flood of phone calls in January, after his university announced that someone in the campus community had been diagnosed with the COVID-19 coronavirus.
- [ABSA in the News: Coronavirus Travel Advice: How to Minimize Exposure While Traveling, Including at Airports, on Planes and Cruises](https://absa.org/absa-in-the-news-coronavirus-travel-advice-how-to-minimize-exposure-while-traveling-including-at-airports-on-planes-and-cruises/) - ABSA in the News: Coronavirus Travel Advice: How to Minimize Exposure While Traveling, Including at Airports, on Planes and Cruises The executive director of ABSA International (The Association for Biosafety and Biosecurity), Ed Stygar, also told Newsweek: "When traveling, you are always going to be at risk for exposure to a variety of infectious agents,
- [COVID-19 Information](https://absa.org/osha-coronavirus-information/) - ABSA International COVID-19 Information Page What is the 2019 novel coronavirus? The 2019 Novel Coronavirus, or SARS-CoV-2, is a new respiratory virus that was first identified in Wuhan, Hubei Province, in China. The disease caused by SARS-CoV-2 is called coronavirus disease 2019, or COVID-19, which presents as a pneumonic syndrome. Many of the earlier
- [Dr. Michael Pentella Interviews](https://absa.org/dr-michael-pentella-interview/) - Michael A. Pentella, Ph.D., M.S., SM(ASCP), CIC, D(ABMM) Clinical Professor at the University of Iowa, College of Public Health Director of the Iowa State Hygienic Laboratory Arnold G. Wedum Memorial Lecture Award speaker at the 62nd Annual Biosafety and Biosecurity Conference Biosafety in Clinical Laboratories Part I Part II
- [Dr Robert Emery Interview](https://absa.org/dr-robert-emery-interview/) - Interview with Robert Emery, DrPH, CBSP University of Texas Health Science Center at Houston, Houston, TX Invited speaker at the 62nd Annual Biosafety and Biosecurity Conference Making Your Biosafety Message Stick!
- [ABSA Council Members Promote Biosecurity Engagement](https://absa.org/absa-council-members-promote-biosecurity-engagement/) - On May, 2, 2019, ABSA Council Members Rebecca Moritz and Patricia de la Rosa and President-Elect David Gillum attended a meeting at Georgetown University to discuss opportunities for improving biosecurity oversight of research activities, including Dual Use Research and Gain of Function experiments. The half-day meeting was designed to encourage and promote biosecurity collaborations with
- [ABSA International’s 1<sup>st</sup> Biosecurity Symposium](https://absa.org/absa-internationals-1st-biosecurity-symposium/) - ABSA International’s 1st Biosecurity Symposium biosecuritysymposium.org When: May 12-15, 2020 Where: Minneapolis, MN Why is ABSA getting involved in holding this symposium and creating a credential? ABSA International is “The Association for Biosafety and Biosecurity.” As science becomes more interdisciplinary, recognizing and defining the synergistic roles of biosafety and biosecurity have never been more paramount.
- [Biosafety and Infectious Disease Training Intitative at UTHealth](https://absa.org/infectious-disease-training/) - The University of Texas Health Science Center at Houston School of Public health received a $100,000 grant from the National Institute of Environmental Health Sciences (NIEHS) to create a Biosafety and Infectious Disease Training Initiative.
- [Dual Use Research of Concern, Robert Ellis, CBSP - Interviews from the 2017 ABSA International Conference](https://absa.org/duel-use-research-of-concern-robert-ellis-cbsp/) - Robert Ellis discusses the positive and negatives aspects of Dual Use Research of Concern at the 59th Annual Biosafety Conference in Albuquerque, NM, October, 2017.
- [Biosafety Culture Within an Organization, David A. Casavant CFM LEED AP - Interviews from the 2017 ABSA International Conference](https://absa.org/biosafety-culture-within-an-organization-david-a-casavant-cfm-leed-ap-interviews-from-the-2017-absa-international-conference/) - David Casavant talks about creating a biosafety culture within an organization at the 59th Annual Biosafety Conference in Albuquerque, NM, October, 2017. He shares that “…to encourage management to make safety a part of the organization.... find out what motivates them.” And discusses insurance case studies that show a $5-6 return on investment for every dollar spent on safety.
- [Researcher's Perspective on Biosafety, Hazel Barton, PhD - Interviews from the 2017 ABSA International Conference](https://absa.org/researchers-perspective-on-biosafety-hazel-barton-phd-interviews-from-the-2017-absa-international-conference/) - Hazel Barton, a cave biologist, talks about the relationship between researchers and biosafety professionals at the 59th Annual Biosafety Conference in Albuquerque, NM, October, 2017. She states that biosafety professionals “are trying to help you with your research.”
- [The "New and Improved" Select Agent Program](https://absa.org/new-sap/) - The Federal Select Agent Program (FSAP) has recently gone through major changes in their processes and interactions with registered entities. One major change of note, is the new relationship emerging between the FSAP and ABSA.
- [MERS Not New to Camels](https://absa.org/mers-camels/) - MERS virus continues to be a puzzle that scientists are racing to put together. The latest piece of the MERS puzzle is camels and it dates back for 20 years. MERS virus has now been confirmed in 189 people, 82 of which died from the disease.

## Pages

- [ABSA International: The Association for Biosafety and Biosecurity](https://absa.org/) - ABSA International (ABSA) serves the growing needs of biosafety and biosecurity professionals throughout the world.
- [Awards](https://absa.org/awards/) - Biosafety Honor Awards Recipients Also, see the: Biosafety and Biosecurity Promotional Awards Arnold G. Wedum Distinguished Achievement Award In recognition of outstanding work that provided greater knowledge in the field of biosafety, the Arnold G. Wedum Distinguished Achievement Award was established in 1976. The Arnold G. Wedum Distinguished Achievement Award is given to a current ABSA member
- [Find an Affiliate](https://absa.org/find-affiliates/) - Find an Affiliate UC BSO WGSEBSASBASBNetSB3PBSANEBSANBSAMDBBAPHABSAMABSAMABioNJBSAIBSAGeBSAFRaBSAEBSA ABSA Partner ChABSACaBSACABS|ACSBBASBioNETBACACBACACAZBAA-PBAAMEXBIOABSANZAfBSA (Africa) African Biological Safety Association (AfBSA) Contact: afbsa@afbsa.org (New Zealand & Australia) Association of Biosafety for Australia and New Zealand (ABSANZ) Contact: admin@absanz.org.au (Mexico) Asociación Mexicana de Bioseguridad A.C. (AMEXBio) Contact: presidente@amexbio.org (Asia) Asia Pacific Biological Safety Association (A-PBA) Contact: secretariat@a-pba.org (Arizona) Arizona Biosafety Alliance (AZBA)
- [Affiliates / Partners](https://absa.org/affiliates/) - Affiliates / Partners ABSA Affiliate and Partner Benefits Affiliate logo and point of contact information posted to our website Access to ABSA members in multiple affiliate regions Networking resources Listserv discussions for affiliate leaders on sharing resources Affiliate trainings and events posted to our website Automatic approval for Credentialing Maintenance (CM) points for professional development
- [Registered Biosafety Professional (RBP)](https://absa.org/rbp/) - Registered Biological Safety Professional (RBP) A Registered Biological Safety Professional (RBP) is a biosafety practitioner with documented university education or specialized training in biological safety disciplines. To qualify for the RBP credential, applicants must have successfully completed one accredited, 3-credit course titled “Microbiology” or “Molecular Biology.” RBPs demonstrate foundational knowledge of infectious agents, biological hazards,
- [Professional Credentials in Biosafety](https://absa.org/credentials/) - Professional Credentials in Biosafety As research in fields such as recombinant and synthetic nucleic acid (r/sNA) technology and infectious diseases has progressed, the need for specialized oversight has become increasingly crucial. Historically, biosafety oversight was often assigned to senior research scientists with microbiological expertise or safety professionals lacking biological backgrounds. However, as the landscape of
- [test test test test](https://absa.org/test/)
- [President](https://absa.org/president/) - President It’s a true honor to step into this role as President of ABSA International and continue the incredible work and accomplishments of those who came before me. From my first ABSA International Conference to today, what has always stood out is our community — a global family united by collaboration, integrity, and a shared purpose:
- [Recordings from Past Webinars, Conferences, Symposia](https://absa.org/recordings/) - Recordings from Past Webinars, Conferences, Symposia Recordings of past webinars, conference, and symposia will be available for purchase for a limited time after their initial offering dates. Recorded webinar participants will receive their course information within 10 business days of registration. Participants will have 60 days to complete the course on the ABSA International Training
- [Credentialing Maintenance Points Application Process](https://absa.org/cma/) - Application for Credentialing Maintenance Points
- [Credentialing Maintenance Program](https://absa.org/cmp/) - Credentialing Maintenance Program A Credentialing Maintenance (CM) Program has been implemented in order to ensure that RBPs and CBSPs maintain their professional qualifications. The CM Program requires RBPs and CBSPs participate in professional development activities in addition to biological safety activities encountered through their daily job function. RBPs and CBSPs must meet the requirements of
- [Portal - ABSA International](https://absa.org/portal-2/) - ABSA Portal Welcome to the ABSA Portal. Choose below where you would like to go. Add your event to the Biosafety Calendar Login to the ABSA.org website: manage your Biosafety Calendar events access your Workflow Dashboard If you are logged in and a current member of ABSA International: Member Documents Free online access to Applied
- [Teams & Committees](https://absa.org/teams-committees-2/)
- [Council](https://absa.org/council/) - Council President Anne-Sophie Brocard, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM) President-Elect Betsy Matos, PhD, CBSP(ABSA) Past President Sherry Bohn, PhD, MSL, CBSP(ABSA) Secretary Joshua Turse, PhD, CBSP(ABSA) Treasurer James Henry, RBP(ABSA) Councilor Rachel Gamble, DrPH, RBP(ABSA), CBSP(ABSA) Councilor Brandon Hatcher, PhD, RBP(ABSA), CBSP(ABSA) Councilor Harbourt, David, RBP(ABSA), CBSP(ABSA) Councilor Corrie Ntiforo, RBP(ABSA) All ABSA Councilors (2010 to
- [Certified Biological Safety Professional (CBSP)](https://absa.org/cbsp/) - Certified Biological Safety Professional (CBSP) A Certified Biological Safety Professional (CBSP) is an experienced biosafety practitioner with a documented foundation in microbiology and demonstrated responsibility for managing or overseeing a biosafety program. CBSPs are internationally recognized for their expertise, professionalism, and ongoing commitment to advancing biosafety. To qualify for the CBSP credential, applicants must have
- [ABSA Call to Action: NIH Biosafety Oversight](https://absa.org/cta-nih-biosafety-oversight/) - ABSA International Call to Action: Help Shape the Future of NIH Oversight As you are likely aware, NIH launched a landmark initiative to modernize and strengthen biosafety oversight — and ABSA International has been invited to contribute directly to this process. Being included as a partner in this national conversation underscores the critical importance of
- [Office Staff](https://absa.org/office-staff/) - Office Staff ABSA Executive Director Edward J. Stygar, III, MBA, CAE ed@absaoffice.org Deputy Director Julie Savage julie@absaoffice.org Director of Marketing and Publications Karen Savage karen@absaoffice.org Accountant Lena Razin lena@absaoffice.org Director of Education Kari DeServi, MEd kariann@absaoffice.org Credentialing Administrator Michelle Gehrke michelle@absaoffice.org Member Services Brenda Rivera-Alcozer brenda@absaoffice.org Assistant Director of Meetings and Education Colleen Thomas colleen@absaoffice.org
- [Blog Submission](https://absa.org/blog-submission/) - If you are interested in submitting a blog post to our site, please complete the form below and we will contact you soon. Thanks! An ABSA member or a person sponsored by an ABSA Member, can earn 0.125 CM points for authoring each blog post. In a 5-year certification cycle, an individual may earn up
- [Applied Biosafety: Journal of ABSA International (APB)](https://absa.org/apb/) - Applied Biosafety: Journal of ABSA International (APB) Applied Biosafety: Journal of ABSA International (APB) is a peer-reviewed, scientific journal committed to promoting global biosafety awareness and best practices to prevent occupational exposures and adverse environmental impacts related to biohazardous releases. Using original articles, reviews, letters to the editors, and commentaries, the Journal provides a forum for
- [Biosafety](https://absa.org/biosafety/) - Biosafety What is Biosafety? The concept of Biological Safety (or biosafety) has paralleled the development of the science of microbiology and its extension into new and related areas including tissue culture, recombinant DNA, animal studies, molecular biology, synthetic biology, and biotechnology. The knowledge and skill gained by microbiologists necessary to isolate, manipulate, and propagate pathogenic
- [Membership](https://absa.org/membership/) - Membership ALL Memberships run the calendar year from January 1 to December 31. ABSA International is committed to its members through: Annual Biosafety and Biosecurity Conference Discounted fees for all ABSA International Events and products; Including the Annual Biosafety and Biosecurity Conference, professional development courses, the Biosecurity Symposium and online courses. Mentorship and networking
- [History of ABSA International](https://absa.org/history/) - History of ABSA International ABSA International (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. However, the discipline of biosafety has a much longer past. For a fascinating look at the history (and pre-history) of ABSA, please refer to these articles
- [Teams & Committees](https://absa.org/teams-committees/) - Teams & Committees The individuals listed on this page are all volunteers. Please direct all correspondence through the ABSA International office. Get Involved! We all have unique talents, and ABSA has many opportunities for its members to become involved. Please consider getting involved! Becoming a member of one of our committees. Get Involved! ★ These
- [Quarterly Committee Report](https://absa.org/qcr/) - You must be logged in as a MEMBER to use this form.
- [Biosafety & Biosecurity Month](https://absa.org/biosafety-biosecurity-month/) - ABSA International Biosafety and Biosecurity Month ABSA International is proud to announce the 12th anniversary of Biosafety and Biosecurity Month in October 2025. Use this month to shine the spotlight on training ideas, stewardship and engagement, how to foster positive relationships within the research community, or supporting responsible and ethical research through our profession. 2025
- [BRM Connect](https://absa.org/brmconnect/) - What is BRM Connect ABSA International is piloting a coaching program – BioRisk Management Connect (BRM Connect). It aims to facilitate relationships between biosafety/biosecurity practitioners of varying experience and expertise levels. What Can BRM Connect Offer You? If you are… new to the biosafety/biosecurity profession, member of ABSA International or an affiliate ABSA International’s BRM
- [ABSA International Elections](https://absa.org/elections/) - 2025 ABSA International Election Results ABSA International’s annual election requires the participation of many members: those who nominate potential candidates, those who choose to become candidates, and those who vote. ABSA International appreciates all of our volunteers, members, and their contributions to ABSA and the field of biosafety and biosecurity! The 2025 election results are
- [Share a Resource](https://absa.org/share-resource/) - Share a Resource Have a resource you are willing to share here? Our goal is to provide training tools, templates, and resources to biosafety professionals. These can be placed on the public site for full access or on the members-only area for access only by ABSA members. Your content will be reviewed prior to posting.
- [Suggest a Resource](https://absa.org/suggest-resource/) - Suggest a Resource What resources would you find useful here? Our goal is to provide training tools, templates, and resources to biosafety professionals. The Tools and Resources Committee will gather suggestions and look into what resources are currently available as well as make recommendations for development of appropriate tools.
- [ABSA International Blog](https://absa.org/blog/) - ABSA International Blog Jan 72026 CDC Import Permit Program Transition & Training: New Electronic Permitting System ABSA International2026-01-08T06:52:22-06:00January 7th, 2026| The CDC Import Permit Program (IPP) will soon be launching a new electronic permitting system, BioPermit, for those wishing to obtain permits in order to import infectious biological materials that could cause disease in humans. BioPermit
- [Position Statements, Reviews & Comments](https://absa.org/policy/) - Position Statements, Reviews & Comments Statement on NIH’s Announcement of the Biosafety Modernization Initiative – Response by ABSA International President Sherry Bohn to the NIH’s Office of Science Policy’s announcement regarding the Biosafety Modernization Initiative. The Critical Role of NIOSH in Advancing Workplace Safety and Economic Competitiveness, a letter written by the Intersociety Forum to
- [Statement on NIH’s Announcement of the Biosafety Modernization Initiative (9/9/2025)](https://absa.org/090925-statement-on-nihs-announcement-of-the-biosafety-modernization-initiative/) - 9/9/2025 Statement ABSA International – Statement on NIH’s Announcement of the Biosafety Modernization Initiative ABSA International to Collaborate with NIH on the Biosafety Modernization Initiative. ABSA International President Sherry Bohn responded to the NIH’s Office of Science Policy’s announcement regarding the Biosafety Modernization Initiative, stating: “As the leading global organization dedicated to advancing biosafety and
- [Biosafety Resources: Emerging Infectious Diseases Toolboxes](https://absa.org/toolboxes/) - EIDC Toolboxes The EIDC has compiled information for these toolboxes from organizations, government agencies, and news outlets and works to keep them current and relevant. Anthrax Toolbox Antibiotic / Antimicrobial Resistance (AR/AMR) Toolbox Fungi Toolbox Influenza Virus Toolbox MMR (Measles/Mumps/Rubella) Toolbox Parasites Toolbox Poliovirus Toolbox Pox Viruses Toolbox Prion Diseases Toolbox SARS-CoV-2/COVID-19 Toolbox Viral Hemorrhagic
- [Who We Are](https://absa.org/about/) - Who We Are ABSA International, the Association for Biosafety and Biosecurity, is a non-profit professional membership organization that is dedicated to serving the needs of biosafety and biosecurity professionals throughout the world. ABSA International accomplishes these goals by: Annual Biosafety and Biosecurity Conference Discounted fees for all ABSA International events and products including the Annual
- [Biosafety & Biosecurity Month](https://absa.org/biosafety-biosecurity-month-2/) - ABSA International Biosafety and Biosecurity Month ABSA International is proud to announce the 11th anniversary of Biosafety and Biosecurity Month in October 2024. Use this month to shine the spotlight on training ideas, stewardship and engagement, how to foster positive relationships within the research community, or supporting responsible and ethical research through our profession. 2024
- [Nomination Form: Arnold G. Wedum Distinguished Achievement Award](https://absa.org/awardnom-agw/) - Nomination Form: Arnold G. Wedum Distinguished Achievement Award Arnold G. Wedum is revered as the person most responsible for creating the biosafety profession. He was a caring and wonderful mentor for many of the early leaders of ABSA. His traits of determination and persistence served biosafety well. He was a brilliant man whose knowledge of
- [Nomination Form: John H. Richardson Special Recognition Award](https://absa.org/awardnom-jhr/) - Nomination Form: John H. Richardson Special Recognition Award John H. Richardson was an early mentor and teacher of biological safety. He has been a prolific author of many biosafety articles as well as a contributing author to many of our recognized guides to biosafety. The John H. Richardson Special Recognition Award was developed for, and
- [Nomination Form: Everett Hanel, Jr. Presidential Award](https://absa.org/awardnom-eh/) - Nomination Form: Everett Hanel, Jr. Presidential Award Everett Hanel, Jr was a member of Dr. Wedum’s safety group at Fort Detrick. Following his tenure there, he became the Director of the Health & Safety group at the National Cancer Institute in Frederick, MD. His efforts were central in the development and perpetuation of the Biological
- [Nomination Form: Diane Fleming Leadership Award](https://absa.org/awardnom-df/) - Nomination Form: Diane Fleming Leadership Award Diane Fleming served as mentor to many people interested in the field of biosafety. Her biosafety career began when she was selected to be trained as an Institutional Biosafety Officer. Diane was a student in the first NIH sponsored course on “Control of Biohazards in the Research Laboratory”, and taught and
- [Professional Development](https://absa.org/professional-development/) - Professional Development opportunities for training and continuing education credits About the webinars from ABSA International Do you wonder what types of online courses ABSA offers? Login to ABSA International’s Professional Development Training Site Also Available: Recordings from Past Webinars, Conferences, Symposia Upcoming Webinars 14. Plant & Insect Permit Pathways: Navigating the Regulatory Maze from MTA
- [ABSA Learning Verification Opportunities](https://absa.org/absa-lvo/) - ABSA Learning Verification Opportunities The Certification Maintenance Board has pre-approved the use of various ABSA publications as a means of acquiring credentialing maintenance points for the completion of a quiz. These are online educational opportunities that can be accessed via your computer at your leisure. This program is available to ABSA MEMBERS ONLY Become a
- [Biosafety Resources: Biosafety Links](https://absa.org/links/) - Biosafety Links Share/Suggest a ResourceQuestions, Comments, Suggestions? Leave Feedback. Rumor Management Snopes.com FactCheck.org Pertinent Government Agency Alerts 2019 US Global Health Security Strategy(PDF 333KB) NIOSH Needlestick Alert NIOSH Latex Safety Alert NIOSH Animal Asthma Alert ABSA/OSHA Fact Sheets General Microbiology Fact Sheet(PDF 3.5MB) Select Agent Disease Fact Sheet(PDF 430KB) Zoonotic Fact Sheet(PDF 533KB) Principles of
- [ABSA Update - March 2012](https://absa.org/update-1203/) - ABSA Update – March 2012 ABSA Orlando 2012 The 55th Annual Biosafety and Biosecurity Conference will be in Orlando, FL, October 18-24, 2012. Meetings and Exhibits will be at the Hilton Bonnet Creek Resort and the banquet will be at Sea World. The Call for Papers is available at www.absaconference.org. The deadline is April 13.
- [ABSA Update - December 2011](https://absa.org/update-1112/) - ABSA Update – December 2011 ABSA Orlando 2012 The 55th Annual Biosafety and Biosecurity Conference will be in Orlando, FL, October 18-24, 2012. Meetings and Exhibits will be at the Hilton Bonnet Creek Resort and the banquet will be at Sea World. The Call for Papers and Proposals will open shortly. A notice will be
- [ABSA Update - September 2013](https://absa.org/update-1309/) - ABSA Update – September, 2013 ABSA Kansas City 2013 The 56th Annual Biosafety and Biosecurity Conference will be in Kansas City, Missouri, October 17-23, 2013. Meetings and Exhibits will be at the Sheraton Crown Center. More information and hotel registration is available at www.absaconference.org. Exhibit and Sponsor opportunities for 2013 are also available. We are
- [Discussion Groups](https://absa.org/groups/) - ABSA International Communities ABSA International’s new Howspace members-only engagement platform, a dynamic space designed to foster collaboration, meaningful discussions, and impactful networking opportunities. Site Access and Logging In Access to the ABSA International Communities website is limited to ONLY members of ABSA International. This login link is good for a month. To send a new
- [Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition](https://absa.org/wholbm-4/) - Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR) in collaboration with the International Relations Committee. April 2022 This Summary of Changes is not to be used as a substitute for the WHO Laboratory Biosafety
- [Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition](https://absa.org/wholbm-3/) - Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR) in collaboration with the International Relations Committee. April 2022 This Summary of Changes is not to be used as a substitute for the WHO Laboratory Biosafety
- [Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition](https://absa.org/wholbm-2/) - Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR) in collaboration with the International Relations Committee. April 2022 This Summary of Changes is not to be used as a substitute for the WHO Laboratory Biosafety
- [Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition](https://absa.org/wholbm/) - Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR) in collaboration with the International Relations Committee. April 2022 This Summary of Changes is not to be used as a substitute for the WHO Laboratory Biosafety
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Appendix I-N](https://absa.org/bmbl-8/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Appendix C-H](https://absa.org/bmbl-7/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Appendix A-B](https://absa.org/bmbl-6/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Section 8f-8h](https://absa.org/bmbl-5/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Section 8b-8e](https://absa.org/bmbl-4/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Section 8a](https://absa.org/bmbl-3/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Section 5-7](https://absa.org/bmbl-2/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) - Section 1-4](https://absa.org/bmbl/) - Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) This Summary of Changes was prepared by the ABSA International Technical and Regulatory Review Committee (TRR). May 2021 This Summary of Changes is not to be used as a substitute for the CDC/NIH BMBL-6 edition. Download CDC/NIH Biosafety in Microbiological and
- [ABSA Update - July 2015](https://absa.org/update-1507/) - ABSA Update – July, 2015 ABSA Council President: Marian Downing Hello ABSA Members, The year is flying by! The ABSA Council, office, teams, and committees have been very busy during these past 3 months. ABSA Council requested the NIH NBBTP (National Biosafety and Biocontainment Program) Fellows to consider taking on 3 projects. I am excited
- [ABSA Update - March 2015](https://absa.org/update-1503/) - ABSA Update – March, 2015 ABSA Council President: Marian Downing Dear ABSA Colleagues, I hope that 2015 has been good to you so far! The ABSA Office, Committees, and Teams have been very busy in the last few months. ABSA served as the managing partner for the USDA ARS (Agriculture Research Service) 3rd International Biosafety
- [ABSA Update - August 2014](https://absa.org/update-1408/) - ABSA Update – August, 2014 ABSA Council PRESIDENT: PAUL MEECHAN PRESIDENT-ELECT: MARIAN DOWNING TREASURER: CAROL MCGHAN SECRETARY: MELISSA MORLAND PAST PRESIDENT: BARBARA FOX NELLIS COUNCIL: SCOTT ALDERMAN ROBERT HECKERT JULIE JOHNSON DEE ZIMMERMAN Hello ABSA Colleagues! Hello ABSA Colleagues-The last quarter has been a very busy for most of us. The revelations concerning potential anthrax
- [ABSA Update - January 2014](https://absa.org/update-1401/) - ABSA Update – January, 2014 ABSA Council President: Paul Meechan Hello ABSA Colleagues! It's been a busy start to the 2014 Council year. Council has been engaged with the International Standards Organization (ISO) as they work to determine the fate of the Laboratory Biorisk Management document (CWA 15793). ABSA Council has applied to be a
- [ABSA Update - June 2016](https://absa.org/update-1606/)
- [ABSA International Elections](https://absa.org/elections-nom/) - Call for Nominees for 2025 ABSA Election The 2025 Nominating Committee has begun the process of identifying candidates for this year’s ABSA International Council and Nominating Committee elections. Deadline: March 31, 2025. Open positions for 2025 include: President-Elect, Treasurer, Councilor (2 positions), and Nominating Committee (4 positions). All people being nominated must be current 2025
- [ABSA Advanced Biosafety Training Series](https://absa.org/abts/) - ABSA Advanced Biosafety Training Series A CBSP Online Review Course A on-demand learning opportunity The Advanced Biosafety Training Series is an intermediate to advanced online offering, designed for those studying for the CBSP (Certified Biological Safety Professional) exam, as well as those biological safety professionals who are interested in advanced training. Each module will cover
- [Basic Disinfection](https://absa.org/basic-disinfection/) - Basic Disinfection An on-demand distance learning opportunity Basic Disinfection is an on-demand virtual training introducing the essential elements of disinfection for laboratory and research environments. Basic Disinfection is comprised of four modules: Chemical Disinfection, Physical Disinfection, Hand Hygiene, and Volume Disinfection. Chemical Disinfection covers basic terminology, the pros and cons of various chemical agents used
- [Basic Biosafety On-demand Module](https://absa.org/basic-biosafety-module/) - Basic Biosafety On-demand Module Basic Biosafety is an on-demand module designed to provide guidance on the basic principles and practices of biological safety for biosafety professionals, biosafety officers, and other professionals involved in workplace safety in laboratories and facilities throughout the world. The module contains 5 sections: Defining the Biosafety Profession Basic Risk Assessment Hazard
- [Biosafety Cabinet Basics](https://absa.org/biosafety-cabinet-basics/) - Biosafety Cabinet Basics A self-paced learning opportunity Biosafety Cabinet Basics is an on-demand virtual course introducing the essential elements of use and selecting the correct cabinet. This course will first go over the typical applications that use biosafety cabinets (BSC). The course will then go over each class and type of cabinet and their basic
- [Anthology of Biosafety Series](https://absa.org/anthology-of-biosafety/) - Anthology of Biosafety The Anthology of Biosafety is a 14-book series published between 1999 and 2015 addressing biosafety in different settings. Only members of ABSA International have access to download the PDFs on this page. Members will need to be logged in. Anthology of Biosafety I: Perspectives on Laboratory Design Contents: Management of Biosafety –
- [Working at Animal Biosafety Level 1](https://absa.org/absl1vid/)
- [Working at Animal Biosafety Level 2](https://absa.org/absl2vid/)
- [Working at Animal Biosafety Level 3](https://absa.org/absl3vid/)
- [Overview of Risk Assessment and Risk Management in Laboratory Animal Biosafety](https://absa.org/abs-riskassess/)
- [Working with Livestock in a BSL-3 Facility](https://absa.org/absl3livestockra/)
- [Livestock Behavior and Handling in a BSL-3 Facility](https://absa.org/absl3livestock/)
- [Cattle Handling at a BSL-3 Facility](https://absa.org/absl3cattle/)
- [Handling Sheep and Goats at a BSL-3 Facility](https://absa.org/absl3sheepgoats/)
- [Swine Handling at a BSL-3 Facility](https://absa.org/absl3swine/)
- [Biosafety Resources: Animal Biosafety Videos](https://absa.org/absl/) - Animal Biosafety Videos Working Safety in Animal Biosafety level 1, 2, or 3 The following videos describe the procedures animal handlers should follow when Working Safety in Animal Biosafety level 1, 2, or 3. Each video provides guidance on a wide range of topics including donning and doffing personal protective equipment, decontamination of work
- [Biosafety Resources: Introduction to Biosafety Biosafety Curriculum for Undergraduate and Graduate Students](https://absa.org/intro/) - Introduction to Biosafety Biosafety Curriculum for Undergraduate and Graduate Students Are your students prepared to work safely in the laboratory? Research laboratories are unique environments that present specific risks and challenges. Many undergraduates, and even graduate students, lack rigorous instruction in biological safety. They don’t understand the risk present in the laboratory or how to
- [Biosafety Resources: Viral Vector Tools](https://absa.org/viral-vectors/) - VIRAL VECTOR TOOLS Last Updated on September 15, 2025 Share/Suggest a ResourceQuestions, Comments, Suggestions? Leave Feedback. Viral Vector Hazard Identification Tool Beta test version of the viral vector hazard identification tool. Designed for use by biosafety professionals and scientific personnel, this tool provides prompts for the users to collect a variety of information that is
- [E-Com Committee design suggestion-4](https://absa.org/e-com-4/) - ABSA International The Association for Biosafety and Biosecurity Video: Biosafety/Biosecurity Professionals and ABSA International Announcements MEMBERS: Look for your invite to ABSA International Communities, ABSA’s Howspace members-only website—a dynamic space designed to foster collaboration, meaningful discussions, and impactful networking opportunities. (more…) 2025 ABSA Honor Awards Nominations – The Awards Committee requests your help in identifying
- [Member Documents & Resources](https://absa.org/downloads/) - ABSA Members Documents ABSA Documents (4.2 MiB) 7 [29] Council Minutes 10/13/23» 227.1 KiB - 5 hits - December 28, 2023You do not have permission to download this file.ABSA International Council Minutes 10/13/23 Team Leads Orientation 2023-2024 - ABSA International» 1.1 MiB - 6 hits - February 7, 2024You do not have permission to download
- [ABSA Corporate Membership](https://absa.org/corp-mem/) - Benefits of Corporate Membership ABSA International Corporate Logo use on your website and letterhead ABSA International is pleased to offer the Corporate Member Logo to all current Corporate Members of the Association. Please read the Corporate Member Logo Agreement(PDF 259KB) Once the Agreement is received by the ABSA International office, a heavy duty, easel-back placard
- [E-Com Committee design suggestion](https://absa.org/e-com-2/) - Quick Links: New to Biosafety? Membership Affiliates Professional Development Training Webinar Recordings Attend an event Submit an Event ABSA Conference Biosafety Credentials Risk Group Database LAI Database Mark Your Calendars Principles & Practices of Biosafety®, San Diego, CA March 29 - April 3 4th Biosecurity Symposium May 12 - May 13 Principles & Practices of
- [Look & Feel Stylesheet](https://absa.org/look-feel-stylesheet/)
- [Call for Posters: USDA ARS 7th International Biosafety & Biocontainment Hybrid Symposium](https://absa.org/usda-ars-cfp/) - Call for Posters: USDA ARS 8th International Biosafety & Biocontainment Symposium Addressing Agricultural Biorisk February 10-13, 2025Hilton Baltimore Inner HarborBaltimore, Maryland Questions? Problems with this form? Contact us.
- [ABSA Websites Feedback Form](https://absa.org/content/)
- [ABSA Update - March 2016](https://absa.org/update-1603/) - ABSA Update – March, 2016 ABSA International Council President: Melissa Morland Hello ABSA Colleagues! I’m excited to provide you with a brief quarterly update of the activities of your ABSA International Council. The volunteers who comprise the Council have been very busy working on your behalf. I’m providing you some information on major accomplishments or
- [COVID-19 Archive](https://absa.org/covid19archive/) - SARS-CoV-2/COVID-19 TOOLBOX (archived links) Last Updated on September 15, 2025 Fierce Biotech: AstraZeneca’s COVID-19 vaccine enters phase 2/3 clinical trial. May 22, 2020. Novel Coronavirus (2019-nCoV): Situation Report – 7 (27 January 2020) WHO Epidemiological Update – Novel coronavirus (2019-nCoV) (27 January 2020) Novel Coronavirus (2019-nCoV): Situation Report – 5 (25 January 2020) Centers for
- [ABSA Update - August 2012](https://absa.org/update-1208/) - ABSA Update – August 2012 ABSA Orlando 2012 The 55th Annual Biosafety and Biosecurity Conference will be in Orlando, FL, October 18-24, 2012. Meetings and Exhibits will be at the Hilton Bonnet Creek Resort and the banquet will be at Sea World. The Call for Papers is available at www.absaconference.org. The deadline is April 13.
- [ABSA Update - July 2010](https://absa.org/update-1007/) - ABSA Update – July 2010 ABSA COUNCIL President: Ben Fontes What matters to you? This has been the focus of the ABSA Council for our membership and those interested in the profession of Biosafety. Whether it is responding directly to your queries, ideas and suggestions, carrying out the annual duties of the Association as our
- [Nomination Form: The Hashimoto Recognition Award](https://absa.org/awardnom-hash/) - Nomination Form: The Hashimoto Recognition Award Robert Hashimoto had a long history of service and leadership within ABSA. He was a mentor to countless biosafety professionals and a friend to even more. The Hashimoto Recognition Award recognizes outstanding service to an ABSA committee or task force. Nominations must be received by the ABSA Office no
- [Look & Feel Stylesheet](https://absa.org/look-feel-stylesheet-2/)
- [ABSA Update](https://absa.org/update/) - ABSA Update – September 2025 In this issue: President’s ReportLearning Verification Committee (LVC)Bylaws CommitteeTechnical, Regulatory, Legislative Review CommitteePreconference Course Committee (PCC)Advanced Biosafety Training Subcommittee (ABTS)Scientific Program Committee (SPC)Applied Biosafety (APB) Editorial BoardAffiliate Relations CommitteeTraining/Tools and Resources (TTR) CommitteePublic Health Outreach Shared Interest GroupDistance Learning Committee (DLC)Credentialing Evaluation Board (CEB)Exhibitors CommitteeExam Development BoardCongratulations! (RBPs and CBSPs)Credentialing
- [Past Council Members](https://absa.org/past-council/) - ABSA Councilors (2010 to present) Scott Alderman, MS Angela Birnbaum, MPH Heather Blair, MPH Sherry Bohn, PhD, MSL LouAnn Burnett, MS Karen Byers Luis Alberto Ochoa Carrera, MSc Patrick Condreay, PhD Danielle Daniely, PhD, MPH Patricia Delarosa, PhD Marian Downing Robert Ellis, PhD Kelly Flint Benjamin Fontes Lolly Gardiner, MBA David Gillum Miguel Grimaldo, DSc,
- [ANSI/ASSP Z9.14-2020 Standard](https://absa.org/ansi-assp/) - ANSI/ASSP Z9.14-2020 Standard ANSI/ASSP Z9.14-2020 STANDARD Testing and Performance-Verification Methodologies for Biosfety Level 3 (BSL-3) and Animal Biosafety Level 3 (ABSL-3) Ventilation Systems (digital download only) The ANSI/ASSE Z9.14 Standard focuses on performance verification of engineering controls related specifically to ventilation system features of BSL-3/ABSL-3 facilities. ANSI/ASSE Z9.14 uses a risk assessment and performance-based approach
- [Log Out](https://absa.org/logout/)
- [ABSA Portal](https://absa.org/login/)
- [Anthology of Biosafety Series](https://absa.org/aob/) - Anthology of Biosafety Series The Anthology of Biosafety is a 14-book series that addresses biosafety in different settings. I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level 3 VIII: Evolving Issues in Containment IX: Exploring the
- [Principles & Practices of Biosafety® - past courses](https://absa.org/pastppb/) - Past Principles & Practices of Biosafety® Courses
- [Submit a Workflow Form](https://absa.org/submit-a-workflow-form/) - Workflow Dashboard Submit Submit a new form/Create a new application
- [Workflow Inbox](https://absa.org/workflow-inbox/) - Workflow Dashboard Inbox Notifications of tasks that require your attention… PLEASE NOTE: some of the forms on this page may take up to 30 seconds to load and even longer to process your data after you submit it. Please be patient with them.
- [ABSA Update - April 2010](https://absa.org/update-1004/) - ABSA Update – April 2010 ABSA COUNCIL President: Ben Fontes Greetings and happy spring! Spring Council Meeting The Council has selected San Diego as the host site of the 2014 ABSA Conference. The Council spent time at the Spring Council Meeting reviewing and updating the ABSA strategic plan, reviewing the budget, updating each other on
- [ABSA Update - March 2013](https://absa.org/update-1303/) - ABSA Update – March, 2013 ABSA Kansas City 2013 The 56th Annual Biosafety and Biosecurity Conference will be in Kansas City, Missouri, October 17-23, 2013. Meetings and Exhibits will be at the Sheraton Crown Center. More information and hotel registration is available at www.absaconference.org. Exhibit and Sponsor opportunities for 2013 are also available. We are
- [ABSA Update - July 2011](https://absa.org/update-1107/) - ABSA Update – July 2011 ABSA Anaheim 2011 Registration and PreConference Courses are now online! The 2011 ABSA Conference will be in Anaheim from October 27 to November 2, 2011 at the Anaheim Marriott. The conference progam should be online in mid-July. ABSA Council President: Karen Byers ABSA Council had a very productive meeting
- [ABSA Update - April 2011](https://absa.org/update-1104/) - ABSA Update – April 2011 ABSA Anaheim 2011 The 2011 ABSA Conference will be in Anaheim from October 27 to November 2, 2011 at the Anaheim Marriott. Click here for hotel reservations and preliminary information. ABSA Council President: Karen Byers Council President: Karen Byers, MS, RBP, CBSP President-Elect: LouAnn Burnett, MS, CBSP Treasurer: Ros
- [ABSA Update - January 2010](https://absa.org/update-1001/) - ABSA Update – January 2010 ABSA COUNCIL President: Ben Fontes Greetings Colleagues: I’m excited to provide you with a brief quarterly update of the activities of your ABSA Council. Although it has only been three months since departing with information overload at what was a sensational annual conference, the volunteers who comprise the Council have
- [ABSA Update - December 2010](https://absa.org/update-1012/) - ABSA Update – December 2010 ABSA Denver Conference We would like to thank the hundreds of volunteers that contributed to the success of the ABSA Annual Conference in Denver! We hope that everyone enjoyed the courses, presentations, exhibits, and networking. We posted some of the conference presentations, and videos of the President's Address and Griffin
- [ABSA Update - July 2009](https://absa.org/update-0907/) - ABSA Update – July 2009 PROFESSIONAL DEVELOPMENT TEAM Team Leader: Michelle McKinney This has been an exciting quarter for the ABSA Professional Development Team (PDT). There are numerous training opportunities being planned and offered, and discussions within the PDT committees to expand on ABSA's distance learning program to meet the needs of members who now
- [Privacy Policy](https://absa.org/privacy-policy/) - ABSA INTERNATIONAL PRIVACY POLICY The American Biological Safety Association, Inc., (ABSA) dba ABSA International, is a non-profit 501 (C)(6) registered in Illinois. ABSA recognizes the importance of protecting personal information and the individual’s right to privacy. ABSA is dedicated to maintaining high standards of confidentiality regarding the information provided to us by members and other
- [A History of the American Biological Safety Association Part III: Safety Conferences 1978-1987](https://absa.org/about/hist03/) - A History of the American Biological Safety Association: Part I | Part II | Part III A History of the American Biological Safety Association Part III: Safety Conferences 1978-1987 Richard H. Kruse and Manuel S. Barbeito MEDI, Inc., Lexington, Kentucky USDA (Retired), Frederick, Maryland INTRODUCTION The biological safety conferences continue to grow in attendance and
- [Professional Development Activities](https://absa.org/biopdalist/) - If you have problems using the list below you can find the same list on the my.ABSA.org site here.
- [A History of the American Biological Safety Association Part I: The First 10 Biological Safety Conferences 1955-1965](https://absa.org/about/hist01/) - A History of the American Biological Safety Association: Part I | Part II | Part III A History of the American Biological Safety Association Part I: The First 10 Biological Safety Conferences 1955-1965 Manuel S. Barbeito and Richard H. Kruse USDA, Retired, Past President of ABSA, Frederick, Maryland President, MEDI, Inc., Lexington, Kentucky On April
- [A History of the American Biological Safety Association Part II: Safety Conferences 1966-1977](https://absa.org/about/hist02/) - A History of the American Biological Safety Association: Part I | Part II | Part III A History of the American Biological Safety Association Part II: Safety Conferences 1966-1977 Richard H. Kruse and Manuel S. Barbeito MEDI, Inc., Lexington, Kentucky USDA (Retired), Frederick, Maryland The first decade of biological safety conferences (Barbeito, 1997) were, to
- [Search](https://absa.org/search/) - Search for:
- [Publications](https://absa.org/publications/) - Publications Applied Biosafety: Journal of ABSA International Applied Biosafety: Journal of ABSA International (APB) is a peer-reviewed, scientific journal committed to promoting global biosafety awareness and best practices to prevent occupational exposures and adverse environmental impacts related to biohazardous releases. Using original articles, reviews, letters to the editors, and commentaries, the Journal provides a forum
- [Workflow Status](https://absa.org/workflow-status/) - Workflow Dashboard Status Check on the status of your submitted forms/applications.
- [my.ABSA.org HELP DESK](https://absa.org/myabsahelp/) - NOTE: my.ABSA.org website has a separate login system from ABSA's other websites. This form is for help with the my.ABSA.org website. If you need assistance with other ABSA websites, please use the main contact form. ABSA International 1200 Allanson Road Mundelein, IL 60060-3808 Phone: 847-949-1517, or 866-425-1385 (toll free) Fax: 847-566-4580 E-mail: info@absa.org
- [Get Involved!](https://absa.org/get-involved/)
- [Advertise in the ABSA International Biosafety Buyer's Guide](https://absa.org/bbg/) - Advertise in the ABSA International Biosafety Buyer’s Guide back to the Biosafety Buyer’s Guide ABSA International created the Biosafety Buyer’s Guide to connect ABSA International partners with ABSA International members and biosafety professionals. The Biosafety Buyer’s Guide features biosafety related companies, services, and consultants. The Biosafety Buyer’s Guide offers biosafety professionals easy access to ABSA
- [Biosafety Resources - Feedback](https://absa.org/biosafety-resources-feedback/) - ABSA International 1200 Allanson Road Mundelein, IL 60060-3808 Phone: 847-949-1517, or 866-425-1385 (toll free) Fax: 847-566-4580 E-mail: info@absa.org
- [Job Dashboard](https://absa.org/job-dashboard/)
- [Contact ABSA International](https://absa.org/contact/) - ABSA International 1200 Allanson Road Mundelein, IL 60060-3808 Phone: 847-949-1517, or 866-425-1385 (toll free) Fax: 847-566-4580 E-mail: info@absa.org
- [Admin](https://absa.org/admin/)
- [Post a Job](https://absa.org/post-a-job/)
- [Lost Password](https://absa.org/lostpassword/)
- [Register](https://absa.org/register/)
- [Reset Password](https://absa.org/resetpass/)
- [Risk Group Database - Feedback](https://absa.org/rgfeedback/) - ABSA International 1200 Allanson Road Mundelein, IL 60060-3808 Phone: 847-949-1517, or 866-425-1385 (toll free) Fax: 847-566-4580 E-mail: info@absa.org

## Posts

- [WP Router Placeholder Page](https://absa.org/WP_Router/wp-router-placeholder-page/)

## News

- [Public Health Outreach Shared Interest Group](https://absa.org/news/2025-01-public-health-shared-interest-group-ph-sig/) - Lead: Shoolah Escott Co-Lead: Crystal Fortune The SIG’s poster titled “Ergonomic, Green and ADA Considerations for Renovation and Construction” was presented at ABSA’s 67th Annual Biosafety and Biosecurity Conference in Phoenix. The authors were: Drew Fayram, Merrick; Robert Glaser, NYS PHL; Crystal Fortune, MT PHL; Michael Marsico, APHL; Marian Downing, Consultant; and Shoolah Escott, Biosafety
- [Public Health Outreach Shared Interest Group](https://absa.org/news/2025-07-public-health-shared-interest-group-ph-sig/) - Lead: Shoolah Escott Vice-Lead: Crystal Fortune The SIG’s poster, “Ergonomic, Green and ADA Considerations for Renovation and Construction,” was presented at the Association of Public Health Laboratories (APHL) Annual meeting in Portland, OR. The authors were Drew Fayram, Merrick; Robert Glaser, NYS PHL; Crystal Fortune, MT PHL; Michael Marsico, APHL; Marian Downing, Consultant; and Shoolah
- [Public Health Outreach Shared Interest Group](https://absa.org/news/2025-09-public-health-shared-interest-group-ph-sig/) - Lead: Shoolah Escott Vice-Lead: Crystal Fortune Welcome to Eric Lundquist, Minnesota Public Health Laboratory, the newest member of the SIG!! The SIG’s poster, “Ergonomic, Green and ADA Considerations for Renovation and Construction,” was presented at the Association of Public Health Laboratories (APHL) Annual meeting in Portland, OR, last May. The authors were Drew Fayram, Merrick;
- [Scientific Program Committee (SPC)](https://absa.org/news/2025-09-scientific-program-committee-spc/) - Chair: Colleen Kovacsics Vice-Chairs: Susan Vleck and Sunny Hoffman The Scientific Program Committee (SPC) is pleased to share that the program for the 68th Annual Biosafety and Biosecurity Hybrid Conference has been finalized and can be found on the conference website at absaconference.org. The program includes keynote and invited speakers across each day and the
- [President’s Report](https://absa.org/news/2025-09-presidents-report/) - The Council has been diligently working to enhance oversight and transparency within our organization. For example, we have developed a comprehensive code of conduct for ABSA members and established a reimbursement policy for those traveling on ABSA business. These measures are designed to uphold the highest standards of professionalism and accountability. Additionally, a dedicated task
- [Learning Verification Committee (LVC)](https://absa.org/news/2025-09-learning-verification-committee-lvc/) - Chair: Niki Drazenovich Vice-Chair: Dana Buckley ABSA members currently have 17 quizzes available online for CM points and an additional quiz in development covering volume 29 of the Applied Biosafety Journal. These quizzes are low cost and can be located on the website at https://absa.org/online-education/.
- [Bylaws Committee](https://absa.org/news/2025-09-bylaws-committee/) - Chair: Amy Ryan Vice-Chair: David Cavallaro The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. One P&P was reviewed since the last report. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office will
- [Technical, Regulatory, Legislative Review Committee](https://absa.org/news/2025-09-technical-regulatory-legislative-review-committee/) - Chair: Karon L. Floyd Vice Chair: Hongliang “Hong” Yang The Technical, Regulatory, and Legislative Review Committee (RTLR) Chaired by Karon L. Floyd and Co-Chaired by Hongliang “Hong” Yang would like to welcome you to Fall. As you know our committee is the result of two committees merging. They have similar goals and functions, and we
- [Preconference Course Committee (PCC)](https://absa.org/news/2025-09-preconference-course-committee-pcc/) - Chairs: Geoffrey K. Phillips and Raymond Scheetz The PCC is actively engaged in preparing for the October conference. We are excited to offer 20 in-person and 10 virtual professional development courses for this year’s conference. The offerings cover a range of topics from traditional biosafety management and operations to the advancing interest in cybersecurity and
- [Advanced Biosafety Training Subcommittee (ABTS)](https://absa.org/news/2025-09-advanced-biosafety-training-subcommittee-abts/) - Chairs: Daniel Eisenman and Shalaka Kotkar The ABTS training modules were overhauled as much of the content was several years (likely 1-3 decades) old. Audio was recorded for the updated slides. The committee updated the associated quizzes and is currently working on reviewing supplementary materials.
- [Applied Biosafety (APB) Editorial Board](https://absa.org/news/2025-09-applied-biosafety-apb-editorial-board/) - Coeditors-in-Chief: Barbara Johnson and Karen Byers Associate Editors: David Gillum and Scott Patlovich The journal editors are soliciting manuscripts for two Special Issues, one to be published in 2026 and the other to be published in 2027. The call for papers for the Special Issue (Volume 31, 2026), “Risk Minimization Strategies: National and International Biosafety
- [Affiliate Relations Committee](https://absa.org/news/2025-09-affiliate-relations-committee/) - Chairs: Parimala Arokiaraj and Lia Vizzotti The Affiliates Committee remains committed to fostering meaningful connections with organizations that align with our vision and can contribute to ABSA International’s mission. Recently, we had the opportunity to meet with several of our international affiliate leaders, marking an encouraging step forward in strengthening these important relationships. We view
- [Training/Tools and Resources (TTR) Committee](https://absa.org/news/2025-09-training-tools-and-resources-ttr-committee/) - Chair: Will Pinard Vice Chair: Kelly Kim We have several exciting announcements for this newsletter. First, we are pleased to welcome Kelly Kim as our new Vice Chair! Kelly has been an active and engaged member of the committee, and we look forward to her continued contributions in this leadership role. Historically, this committee has
- [Distance Learning Committee (DLC)](https://absa.org/news/2025-09-distance-learning-committee-dlc/) - Chairs: Eric Lewis, Ericka Pearce, Endah Sulistijo, and Nicole Drumhiller The Distance Learning Committee has completed nine webinars for ABSA International members, reaching over 470 participants as of August 15, 2025. Additional webinars are scheduled for 2025, covering topics such as Arthropod Biosafety as well as an introductory course on Artificial Intelligence (AI) for biosafety
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2025-09-credentialing-evaluation-board-ceb/) - Chair: John Henneman We are excited to announce that Michele Howard has been appointed as the new Vice Chair of the CEB. Michelle brings extensive expertise and a proven commitment to the biosafety profession, and we look forward to her continued influence and contributions. In July, the CEB reviewed a total of 18 RBP (Registered
- [Exhibitors Committee](https://absa.org/news/2025-09-exhibitors-committee/) - Chair: Steve Sebastian The 68th Annual Biosafety and Biosecurity Hybrid Conference will be October 24-29, 2025, in Raleigh, North Carolina. E-blast solicitations are sent every 1.5 weeks to promote exhibiting and sponsorship opportunities at the conference. To date, we have 54 exhibitors and 11 sponsors—AABC Testing and Certification (Gold); AirClean Systems (Gold); SciSure (Gold); ABC
- [Exam Development Board](https://absa.org/news/2025-09-exam-development-board/) - Chair: Joe Kozlovac Vice-Chair: David Harbourt The Exam Development Board remains steadfast in its commitment to upholding the integrity and rigor of the Certified Biological Safety Professional (CBSP) credential. Board members diligently engage in the development of new examination questions and the systematic review of existing items to ensure they function as intended and accurately
- [Congratulations! (RBPs and CBSPs)](https://absa.org/news/2025-09-congratulations-rbps-and-cbsps/) - Congratulations! ABSA proudly welcomes the newest members of the credentialed biosafety professional community, who have earned the Registered Biosafety Professional (RBP) and/or Certified Biological Safety Professional (CBSP) designation! These individuals demonstrate the education, experience, and commitment required to uphold current knowledge in alignment with emerging developments in biological safety. Albrecht, Randy, RBP, CBSP(ABSA) Gaisser, Richard,
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2025-09-credentialing-maintenance-board-cmb/) - Chairs: Heidi Page and Kim DiGiandomenico This year, the CMB randomly selected 4 of 39 CM worksheets for audit, all of which passed the review. Additionally, the Board has refreshed and updated our FAQ to ensure it remains a useful, accurate resource for the community. The revised version, approved by the Board in August, will
- [Public Relations and Marketing (PRM)](https://absa.org/news/2025-09-public-relations-and-marketing-prm/) - Chair: Robin Tobias Vice-Chair: Daniela Didier The Public Relations and Marketing Committee (PRM) has been busy working on Biosafety and Biosecurity Month projects as an opportunity for our community to recognize, reflect, promote, and advocate for biosafety and biosecurity in research and healthcare. The goal for October 2025 is to highlight the importance of biosafety
- [Biosafety and Biosecurity Training Course® (BBTC)](https://absa.org/news/2025-09-biosafety-and-biosecurity-training-course-bbtc/) - Chair: Bob Ellis The 21st BBTC was held August 4-8, 2025, in Fort Collins, CO. This course is intended for those biosafety professionals in the middle to expert level of the profession. There were 6 speakers and 5 topics for the Animal sessions (1.5 days); 9 topics and 8 speakers for the General sessions (2
- [Awards Committee](https://absa.org/news/2025-09-awards-committee/) - Chair: James Baugh The Awards Committee has made the selection for the Richard Knudsen Publication Award for presentation at the 68th Annual Biosafety and Biosecurity Conference in Raleigh, NC. We have also submitted our recommendations for the 2025 honor awards. Thanks to all who submitted nominations. It was a tough decision with a great pool
- [Member Resources Committee (MRC)](https://absa.org/news/2025-09-member-resources-committee-mrc/) - Chair: Dee Zimmerman Vice-Chair: Kalpana Patel The Member Resources Committee (MRC) has updated the committee’s policy and procedures for this year, reviewed and updated both the ABSA International Emeritus application and the listing for Areas of Expertise. The MRC reaches out to new ABSA members to welcome them. We are looking forward to meeting new
- [Emerging Infectious Disease Committee (EIDC)](https://absa.org/news/2025-09-emerging-infectious-disease-committee-eidc/) - Chairs: Marian Downing and Susan Harper The EIDC posts updates and new resources for most Toolboxes as new information becomes available. A new Toolbox “Other Emerging Pathogens” and “MMR” were recently created as RSV reemerged as a heightened risk when circulating with Human Metapneumovirus and measles outbreaks have been documented in several states. Discussions about
- [BSAT Community Advocate Committee (BSAT CAC)](https://absa.org/news/2025-09-bsat-community-advocate-committee-bsat-cac/) - Lead: Kelly Flint Vice-Lead: Leo Njongmeta Two meetings held in April and June during which the following documents were reviewed: BSAT Practices and Procedures OSHA Guidance Document Fact Sheet Discussions also focused on moving forward with BSAT CAC, especially given the CDC FSAP Program will no longer be involved. The ABSA Office sent out a
- [Historical Committee](https://absa.org/news/2025-09-historical-committee-2/) - Chair: John Balog Vice Chair: Bob Hawley The Historical Committee wishes to inform the members that no items were submitted for consideration to be added to the Biosafety Special Collection (ABSA Biosafety Archive) at the USDA National Agricultural Library, (NAL) in Beltsville, MD. The ABSA website contains images of some archived materials. The archived materials
- [Lab-Acquired Infections (LAI) Database](https://absa.org/news/2025-09-lab-acquired-infections-lai-database/) - Chair: Karen Byers Help Us Keep Our Databases Current! The Risk Group and Lab-Acquired Infections databases are continuously updated as new references are identified in the literature and PubMed. These resources are vital to the biosafety community, and we rely on your expertise to keep them accurate and comprehensive. ABSA members: If you come across
- [Biosecurity Symposium Steering Committee (BSSC)](https://absa.org/news/2025-09-biosecurity-symposium-steering-committee-bssc/) - Chair: Enitra Jones Sprouse Vice-Chairs: Ryan Burnette and Mary Turlington-Powell Preparations for the 4th Biosecurity Virtual Symposium are well underway! The Call for Professional Development Course Proposals and Platform/Poster Abstracts are now open until October 1, 2025—we encourage you to submit your biosecurity abstracts. The Steering Committee is diligently finalizing an exciting roster of invited
- [E-Communications](https://absa.org/news/2025-09-e-communications/) - Chair: Matt Anderson Vice-Chairs: James Pharr and Amanda Haley The E-Communications committee has been busy finishing edits to the ABSA webpage to make the design language and theme that was rolled out earlier this year consistent across all pages on the website. We have also corrected or removed several dead links to resources on the
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2025-09-webinars-recordings-on-demand-modules/) - 2025 Webinars: • Virus-based Gene Transfer Vectors - September 11 & 18 • 1V. A Helpful Guide to Becoming a Well-Rounded Biosafety Professional - September 12 • 2V. Program Management Fundamentals for the Biosafety Professional - September 19 • 3V Introduction to the Science and Biosafety of Cell and Gene Therapy Clinical Trials - September
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2025-09-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [ABSA International Membership Site](https://absa.org/news/2025-09-absa-international-membership-site/) - Through MemberClicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase ABSA
- [Job Board](https://absa.org/news/2025-09-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance their career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Anthology of Biosafety](https://absa.org/news/2025-09-anthology-of-biosafety/) - The Anthology of Biosafety series is now available at no cost to ABSA members! The 14-book series published between 1999 and 2015 addresses biosafety in different settings: I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level
- [ABSA International Inclusion Statement](https://absa.org/news/2025-09-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Code of Conduct for Members](https://absa.org/news/2025-09-code-of-conduct-for-members/) - ABSA International is committed to providing an environment that encourages the free expression and the exchange of scientific ideas and promotes respectful treatment for all participants. All members are expected to treat others with respect and consideration and follow ABSA International policies. ABSA International prohibits and will not tolerate any form of harassment or bullying.
- [President’s Report](https://absa.org/news/2025-07-presidents-report/) - Greetings ABSA Members! ABSA's Continued Growth and Success ABSA International continues to thrive with over 1,900 members and growing engagement across all sectors. Our Phoenix conference was a tremendous success with 834 attendees, featuring an exceptional scientific program and robust discussions around emerging biosafety and biosecurity challenges. The USDA-ARS symposium in February was also an
- [Applied Biosafety (APB) Editorial Board](https://absa.org/news/2025-07-applied-biosafety-apb-editorial-board/) - Coeditors-in-Chief: Barbara Johnson, and Karen Byers Associate Editors: David Gillum and Scott Patlovich In recognition of Applied Biosafety’s 30th anniversary (Volume 30, Number 2) will feature an expanded Special Issue on Biosafety and Biosecurity for Pathogens with Enhanced Pandemic Potential (PEPP) and Dual-Use Research of Concern (DURC) that focuses on the various issues and increased
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2025-07-credentialing-maintenance-board-cmb/) - Vice Chairs: Heidi Page and Kim DiGiandomenico The CMB reviewed 45 worksheets for the 2020-2024 cycle year. Of these, two applicants failed recertification (lack of points); two were granted an extension to obtain 40 points by June 2025. CM worksheets were randomly selected for audit and are in the process of being evaluated. The CMB
- [Emerging Infectious Disease Committee (EIDC)](https://absa.org/news/2025-07-advanced-biosafety-training-subcommittee-abts/) - Chairs: Marian Downing and Susan Harper The EIDC posts updates and new resources for most Toolboxes as new information becomes available. A new Toolbox “Other Emerging Pathogens” was created as RSV re-emerged as a heightened risk when circulating with Human Metapneumovirus and measles outbreaks have been documented in several states. Thank you, Ami Patel, for
- [Advanced Biosafety Training Subcommittee (ABTS)](https://absa.org/news/advanced-biosafety-training-subcommittee-abts/) - Chairs: Daniel Eisenman and Shalaka Kotkar ABTS completely overhauled the training slides and recorded audio for the slides. ABTS is reviewing the pre- and post-test questions. If time allows, we will evaluate the practice test questions and answers provided to students as supplementary study materials.
- [Finance Committee](https://absa.org/news/2025-07-lfinance-committee/) - Treasurer: Heather Blair Vice-Chair: Andrea Vogel The Finance Committee is responsible for conducting thorough reviews of the monthly financial statements to ensure adherence to the approved budget allocations. The Finance Committee Chair is the current ABSA Treasurer, Heather Blair, and the Finance Committee Vice Chair is Andrea Vogel. This term, the committee has updated the
- [Learning Verification Committee (LVC)](https://absa.org/news/2025-07-learning-verification-committee-lvc/) - Chair: Niki Drazenovich Vice-Chair: Dana Buckley ABSA members currently have 16 quizzes available online for CM points and an additional quiz in development covering Volume 26 of the Applied Biosafety Journal. These quizzes are low-cost and can be located on the website at https://absa.org/online-education/.
- [Lab-Acquired Infections (LAI) Database](https://absa.org/news/2025-07-lab-acquired-infections-lai-database/) - Chair: Karen Byers The LAI Database has new entries including Zika Virus, Burkholderia pseudomallei, Brucella sp, Prions, and LCMV. Please send any publications including lab-acquired infections or accidental pathogen escape from laboratory settings (APELS) to karen_byers@dfci.harvard.edu
- [E-Communications](https://absa.org/news/2025-07-e-communications/) - Chair: Matt Anderson Vice-Chairs: James Pharr and Amanda Haley The E-Communications committee completed a visual revamp and menu reorganization of the ABSA.org website. This revamp created additional methods for navigating to popular areas of the website with buttons on the homepage and changed the color scheme from green and orange tones to more vibrant blues
- [Distance Learning Committee (DLC)](https://absa.org/news/2025-07-distance-learning-committee-dlc/) - Chair: Eric Lewis Vice-Chairs: Ericka Pearce and Endah Sulistijo The DLC continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. As of May 2025, we have completed four courses, reaching over 300 participants. One of the webinars launched earlier this year, titled “Navigating Your Career: Strategies for Success
- [Public Relations and Marketing (PRM)](https://absa.org/news/2025-07-public-relations-and-marketing-prm/) - Chair: Robin Tobias Vice-Chair: Daniela Didier The PRM Committee has been busy working on projects for Biosafety and Biosecurity Month as an opportunity for our community to recognize, reflect, promote, and advocate for biosafety and biosecurity in research and healthcare. The goal for October 2025 is to highlight the importance of biosafety and biosecurity and
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2025-07-credentialing-evaluation-board-ceb/) - Chair: John Henneman The CEB convened multiple times in March and April to thoroughly and fairly review all Certified Biological Safety Professional (CBSP) applications. Of the 26 applications submitted, 18 were approved. Additionally, the Board continues to review Registered Biosafety Professional (RBP) applications monthly. Out of 39 recent RBP applicants, 28 were successfully credentialed. We
- [Affiliate Relations Committee](https://absa.org/news/2025-07-baffiliate-relations-committee/) - Chairs: Parimala Arokiaraj and Lia Vizzotti The Affiliate Relations Committee remains committed to fostering meaningful connections with organizations that align with our vision and can contribute to ABSA International’s mission. Recently, we had the opportunity to meet with several of our international affiliate leaders, making an encouraging step forward in strengthening these important relationships. We
- [Bylaws Committee](https://absa.org/news/2025-07-bylaws-committee/) - Chairs: Amy Ryan and David Cavallaro The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. Four P&Ps have been reviewed since the last report. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office
- [Biosecurity Symposium Steering Committee (BSSC)](https://absa.org/news/2025-07-biosecurity-symposium-steering-committee-bssc/) - Chair: Enitra Jones Sprouse Vice-Chairs: Ryan Burnette and Mary Turlington-Powell We would like to express our sincere appreciation to Dr. Cristine C. Lawson, the former Chair, and former committee members for their unwavering support and contributions in making the 3rd International Biosecurity Virtual Symposium, held 7-8 May 2024, a resounding success. Preparations for the 4th
- [Scientific Program Committee (SPC)](https://absa.org/news/2025-07-scientific-program-committee-spc/) - Chair: Colleen Kovacsics Vice-Chairs: Sunny Hoffman and Susan Vleck The SPC is pleased to share that the ABSA community came out strong again this year, submitting over 100 abstracts for consideration. SPC has been working diligently and collaboratively to score and select platform and poster presentations for this year’s conference in Raleigh, NC. We are
- [Exhibitors Committee](https://absa.org/news/2025-07-exhibitors-committee/) - Chair: Steve Sebastian The 68th Annual Biosafety and Biosecurity Hybrid Conference will be October 24-29, 2025, in Raleigh, North Carolina. E-blast solicitations are sent every 1.5 weeks to promote exhibiting and sponsorship opportunities at the conference. To date, we have 22 exhibitors and 6 sponsors—AABC Testing and Certification (Gold); AirClean Systems (Gold); SciShield (Gold); ABC
- [Preconference Course Committee (PCC)](https://absa.org/news/2025-07-preconference-course-committee-pcc/) - Chairs: Geoffrey K. Phillips and Raymond Scheetz The PCC has been busy getting ready for the October conference. The committee reviewed 37 course proposals. On April 28, the PCC held a decision call to discuss the proposals and make recommendations for the Professional Development Program. The committee accepted 20 courses for in-person and 8 courses
- [BRM Connect Taskforce](https://absa.org/news/2025-07-brm-connect-taskforce/) - Lead: Maya Nair Vice Lead: Noman Siddiqi BRM Connect Task Force met in February, March, and May. The members had robust discussions about how to advertise the program and recruit mentees and mentors for the program. Members approved the program flyer, and the ABSA Office invited the web team to the committee meeting and outlined
- [Historical Committee](https://absa.org/news/2025-07-historical-committee/) - Chair: John Balog Vice Chair: Bob Hawley The Historical Committee wishes to inform the members that no items were submitted for consideration to be added to the Biosafety Special Collection (ABSA Biosafety Archive) at the USDA National Agricultural Library (NAL) in Beltsville, MD. The archived materials are available for viewing by the public by appointment
- [Technical, Regulatory, Legislative Review Committee](https://absa.org/news/2025-07-technical-regulatory-legislative-review-committee/) - Chair: Karon L. Floyd Vice Chair: Hongliang "Hong” Yang The Legislative Committee has merged with the Regulatory and Technical Review Committee to form the new Technical, Regulatory, and Legislative Review Committee. The new committee charter and P&Ps have been approved by the ABSA Council, and we are off and running. The committee is open to
- [Principles & Practices of Biosafety (PPB®)](https://absa.org/news/2025-07-principles-practices-of-biosafety-ppb/) - Chairs: Pat Condreay and Paul Jennette PPB held its second of three 2025 sessions this past May in Omaha. The third session will be in Pittsburgh in July where the instructors will convene to have their annual curriculum development workshop.
- [Biosafety and Biosecurity Training Course (BBTC®)](https://absa.org/news/2025-07-biosafety-and-biosecurity-training-course-bbtc/) - Chair: Bob Ellis The BBTC is scheduled for August 4-8, 2025. All speakers for all sessions are on board. This course is intended for those biosafety professionals in the middle to expert level of the profession. Disciplines represented include biosafety, biosecurity, laboratory designers, laboratory management, program managers, vivarium management, maintenance and engineering. The BBTC is
- [Exam Development Board](https://absa.org/news/2025-07-exam-development-board/) - Chair: Joe Kozlovac Vice-Chair: David Harbourt We have reviewed questions related to the NIH guideline changes/updates and incorporated changes where appropriate. The board is currently reviewing questions for quality and appropriateness for the upcoming CBSP exam. We would like to thank departing board member Dr. Julie Johnson from Kansas State University for her service on
- [Member Resources Committee (MRC)](https://absa.org/news/2025-07-member-resources-committee-mrc/) - Chair: Dee Zimmerman Vice-Chair: Kalpana Patel The Member Resources Committee (MRC) has updated the committee’s policy and procedures for this year, reviewed and updated both the ABSA International Emeritus application and the listing for Areas of Expertise. The MRC is currently looking for mentors that would be interested in supporting ABSA student members. If you
- [2025 Local Arrangements Committee (LAC)](https://absa.org/news/2025-07-2025-local-arrangements-committee-lac/) - Chair: Scott Alderman The Local Arrangements Committee (LAC) is thrilled to announce that planning is well underway for the 68th Annual ABSA International Conference in beautiful Raleigh, North Carolina! We are incredibly excited to welcome our colleagues to our state known for its rich scientific community, warm hospitality, and unique blend of innovation and Southern
- [Training Tools and Resources (TTR) Committee](https://absa.org/news/2025-07-training-tools-and-resources-ttr-committee/) - Chair: Will Pinard The TTR Committee plays a vital role in identifying, evaluating, and curating tools and resources that support biosafety professionals globally. These resources are made accessible through a dedicated section on the ABSA website, which features a searchable interface with filters for keywords, resource origin, and type. TTR employs a structured review and
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2025-07-webinars-recordings-on-demand-modules/) - 2025 Webinars: 05. Concepts of Virology 06. Large-scale Biosafety 07. Molecular Biology 101 08. Virus-based Gene Transfer Vectors 09. Introduction to Biosafety in the Clinical Setting 11. Field Biosafety: Protecting Researchers and Communities in Wildlife Disease Investigations Recordings Available for Limited Time: 67th Annual Biosafety and Biosecurity Hybrid Conference​ USDA ARS 8th International Biosafety & Biocontainment
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2025-01-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Job Board](https://absa.org/news/2025-01-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance their career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Anthology of Biosafety](https://absa.org/news/2025-01-anthology-of-biosafety/) - The Anthology of Biosafety series is now available at no cost to ABSA members! The 14-book series published between 1999 and 2015 addresses biosafety in different settings: I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level
- [ABSA International Inclusion Statement](https://absa.org/news/2025-01-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Biosafety and Biosecurity Training Course (BBTC®)](https://absa.org/news/2025-01-biosafety-and-biosecurity-training-course-bbtc/) - Chair: Bob Ellis The BBTC® will be held August 4-8, at the Hilton Fort Collins in Fort Collins, CO. Please see the BBTC home page announcements for the BBTC description and registration information.
- [President’s Report](https://absa.org/news/2025-01-presidents-report/) - Dear Colleagues, I am truly honored and excited to serve as ABSA International’s President! I acknowledge the faith our members have placed in me, and I am committed to working with the Council, Team Leads, Committee Chairs and Members, and the dedicated ABSA Membership to support biosafety and biosecurity professionals across the globe. I also
- [Learning Verification Committee (LVC)](https://absa.org/news/2025-01-learning-verification-committee-lvc/) - Chair: Niki Drazenovich Vice-Chair: Dana Buckley ABSA members currently have 11 quizzes available online for CM points and additional quizzes in development covering 2 Applied Biosafety Journals, 2 Anthology books (VIII and VIX), and the Bradford University-Preventing Biological Threats book. These quizzes are low-cost and can be located on the website at https://absa.org/online-education/.
- [Bylaws Committee](https://absa.org/news/2025-01-bylaws-committee/) - Co-Chairs: Amy Ryan and David Cavallaro The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. Two P&Ps were reviewed since the last report. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office will
- [Preconference Course Committee (PCC)](https://absa.org/news/2025-01-preconference-course-committee-pcc/) - Co-Chairs: Geoffrey K. Phillips and Ray Scheetz The PCC has completed a successful offering of courses at the 2024 ABSA International Conference in Phoenix, Arizona. Twenty-two in-person courses were offered as well as 8 virtual courses. All were well attended and received. An after-action review was conducted onsite by the facilitators. Facilitators assigned to each
- [Scientific Program Committee (SPC)](https://absa.org/news/2025-01-scientific-program-committee-spc/) - Chair: AJ Troiano Vice-Chairs: Colleen Kovacsics and Susan Vleck The Scientific Program Committee is excited to begin preparations for the next conference. Reflecting on the 67th Annual Biosafety and Biosecurity Conference in Phoenix, AZ, we had 53 speakers across keynotes, invited speakers, platform presentations, and the highly anticipated return of dual-track sessions. This robust schedule
- [Distance Learning Committee (DLC)](https://absa.org/news/2025-01-distance-learning-committee-dlc/) - Chairs: Eric Lewis, Endah Sulistijo, Ericka Pearce, and Rhonda O’Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. As of December 16, 2024, 18 courses have been completed, reaching over 1,100 participants. We have exciting webinars scheduled for 2025. Topics for webinars under
- [Public Relations and Marketing (PRM)](https://absa.org/news/2025-01-public-relations-and-marketing-prm/) - Chair: Robin Tobias Vice-Chair: Daniela Didier The Public Relations and Marketing Committee has been actively partnering with the ABSA Public Relations Firm and will continue applying information learned through this collaboration to the existing Media Toolkit project in progress. We continue to work on Biosafety and Biosecurity Month as an opportunity for our community to
- [Applied Biosafety (APB) Editorial Board](https://absa.org/news/2025-01-applied-biosafety-apb-editorial-board/) - Coeditors-in-Chief: Barbara Johnson and Karen Byers Applied Biosafety has received over 20 manuscripts in response to the call for papers for the Special Issue, “Biosafety and Biosecurity for Potential Pandemic Pathogens (PPPs) and Dual-Use Research of Concern (DURC).” Manuscripts include reviews, brief reviews, original research articles, and commentaries. A celebratory expanded issue containing all the
- [Advanced Biosafety Training Subcommittee (ABTS)](https://absa.org/news/2025-01-advanced-biosafety-training-subcommittee-abts/) - Chairs: Dan Eisenman and Shalaka Kotkar The goal of the group is to review the survey results received following the updates and review the assessment questions to ensure the materials and questions are aligned.
- [Technical Review, Legislative and Regulatory Committee (TRLR)](https://absa.org/news/2025-01-technical-review-legislative-and-regulatory-committee-trlr/) - Chairs: Esmeralda Meyer and Karon Floyd During this period, the ABSA Council approved the merging of the TRR and the Legislative Committee into the Technical Review, Legislative and Regulatory Committee (TRLR). The Vice-Chairs of both subcommittees, Karon Floyd and Esmeralda Meyer worked with the Technical Team Leads and the ABSA International office to draft the
- [Emerging Infectious Disease Committee (EIDC)](https://absa.org/news/2025-01-emerging-infectious-disease-committee-eidc/) - Chairs: Marian Downing and Susan Harper The EIDC posted updates and new resources for most Toolboxes as new information becomes available. During this quarter, the EIDC contributed to the discussions initiated by the ABSA Council on the maintenance and update of the Risk Group Database. The main references of this database were updated before the
- [Principles & Practices of Biosafety (PPB ®)](https://absa.org/news/2025-01-principles-practices-of-biosafety-ppb/) - Chairs: Pat Condreay and Paul Jennette There will be three sessions of PPB® in 2025, in March, May, and July. The March session is filled, and the other sessions are filling quickly.
- [Member Resources Committee (MRC)](https://absa.org/news/2025-01-member-resources-committee-mrc/) - Chairs: Dee Zimmerman Vice-Chair: Kalpana Patel Member Resources Committee (MRC) welcomes Kalpana Patel as Vice-Chair of the MRC. Betsy Weirich has stepped down as Vice-Chair to pursue travels and enjoy retirement, we thank Betsy for sharing her expertise over the last two years with the ABSA membership through the MRC. The ABSA International Phoenix New
- [E-Communications Committee](https://absa.org/news/2025-01-e-communications-committee/) - Chair: Matt Anderson Vice-Chairs: Amanda Haley and James Pharr The E-communications Committee would like to thank all the ABSA Conference attendees who stopped by the selfie booth in the Exhibitor Hall and took pictures with friends and colleagues and shared them on social media. We had our best involvement yet from members and vendors and
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2025-01-credentialing-maintenance-board-cmb/) - Chair: Rhonda O’Keefe The CMB welcomes new members, Mark Campbell and David Burcin and says farewell to our past Chair, Hallie Hoskins. The CMB develops the continuing education criteria necessary for Certified Biological Safety Professionals (CBSP[ABSA]s) and Registered Biosafety Professionals (RBP[ABSA]s) to maintain their certification and administers the recertification process. The criteria for serving on
- [Training Tools/Resources Committee (TTR)](https://absa.org/news/2025-01-training-tools-resources-committee-ttr/) - Chair: Will Pinard TTR collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These resources are collated on the ABSA website featuring a search function, keywords, the origin, and the type of resources. The committee uses evaluation and review methods for new incoming resources that
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2025-01-credentialing-evaluation-board-ceb/) - Chairs: Paul Meechan and John Henneman The CEB continues to meet monthly to review applications for certification as Registered Biosafety Professionals (RBP) and Certified Biological Safety Professionals (CBSP). As a reminder, February 1, 2025, is the deadline for submitting CBSP exam applications.
- [APHL Partner Update](https://absa.org/news/2025-01-aphl-partner-update/) - Submitted by: Marian Downing APHL is preparing to post an RFP (Request for Proposals) for their new “Microcredential” program. This program has the goal to develop and enhance a pipeline for those seeking to further their knowledge, skills, abilities, and careers in biological safety and biosecurity and to strengthen overall laboratory systems by providing trainings
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2025-01-webinars-recordings-on-demand-modules/) - Available for Purchase for a Limited Time: 67th Annual Biosafety and Biosecurity Hybrid Conference 3rd International Biosecurity Virtual Symposium 24PDC7V. Intro to the Science and Biosafety of Cell and Gene Therapy Clinical Trials 24PDC1V. Plant and Arthropod Biosafety Basics 24PDC2V. Infectious Substance Shipping Program Management 24PDC6V. Disposal of Animal Carcasses 18. Gain-of-Function Research and PEPP
- [Biosafety and Biosecurity Internship – Central Asia and Caucasus](https://absa.org/news/aff-bacac/) - Biosafety Association for Central Asia and Caucasus (BACAC) is offering an internship for undergraduate or graduate students interested in gaining practical experience in public health, biosecurity and biosafety, international security, public policy, public administration as well as in conducting their own research project in the region. Interns participate in a variety of activities that support
- [Learning Verification Committee](https://absa.org/news/2018-05-learning-verification-committee/) - Co-chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee has completed review of the University of Bradford's book titled "Preventing Biological Threats: What You Can Do" and Anthology XIV: Sustainability and questions have been created to generate online quizzes. ABSA members currently have 8 quizzes available online for CM points. These quizzes are low
- [Learning Verification Committee (LVC)](https://absa.org/news/2018-12-learning-verification-committee-lvc/) - Co-chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee has completed review of the University of Bradford's book titled "Preventing Biological Threats: What You Can Do" and Anthology XIV: Sustainability and questions have been submitted to ABSA to generate on-line quizzes. The committee will review Anthology XIII: Animal Production and Protection-Challenges, Risks, and Best
- [Learning Verification Committee (LVC)](https://absa.org/news/2019-08-learning-verification-committee-lvc/) - Co-chairs: Niki Drazenovich and Matthew Fischer The LVC has completed review of the Applied Biosafety Journal (Volume 22). Questions have been submitted to the committee for review before sending to ABSA International office to generate the online quizzes. The committee will review Volumes 23 and 24 of the Applied Biosafety Journal. ABSA members currently have
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2024-09-webinars-recordings-on-demand-modules/) - Available for Purchase for a Limited Time: 66th Annual Biosafety and Biosecurity Conference​ 3rd International Biosecurity Virtual Symposium​ 06. Working with Highly Pathogenic Avian Influenza Virus (HPAIV)​ 08. Concepts of Virology ​ 17. Export Compliance for the Biosafety Professional​ 14. APHIS 101 for the Arthropod Research World​ 16. Gain-of-Function Research: Biosafety vs. Biosecurity​ 13. Animal
- [2023 Omaha Local Arrangements Committee](https://absa.org/news/2023-09-2023-omaha-local-arrangements-committee/) - Chair: Matt Anderson The Local Arrangements Committee for Omaha 2023 has been finalizing arrangements for the Conference and we cannot wait to welcome you to Omaha and share all that the city and surrounding area has to offer! The conference hotels and conventions center are located in the up and coming North Downtown neighborhood and
- [Local Arrangement Committee (LAC)](https://absa.org/news/2018-09-lac/) - Co-chairs: Sylvie Blondell and Shelley Jones The USS Yorktown aircraft carrier has been selected as the banquet venue and the LAC is reaching-out to potential local bands for entertainment. The LAC is actively investigating ideas for the conference speakers' and attendees' gifts. Shuttle service has been secured between the Charleston Convention Center and downtown Charleston
- [ABSA International's Promotional Videos and YouTube Channel](https://absa.org/news/2018-09-youtube/) - Thanks to the Public Relations Committee, ABSA has new promotional videos for ABSA and our conference. The videos can be found at http://www.absa.org and on ABSA International's YouTube channel at https://youtu.be/xAQPZxMvqRY. Also on ABSA's YouTube channel are video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Biosafety Buyer's Guide](https://absa.org/news/2018-09-bbg/) - ABSA International launched the Biosafety Buyer's Guide in early 2014 at https://biosafetybuyersguide.org/. March 1 marked the beginning of the Guide's 5th successful year. The Guide lists companies and consultants that provide biosafety-related products and services. Over the past 4-1/2 years, we have had much success with many visits to the ads and listings. The most
- [Distance Learning Committee (DLC)](https://absa.org/news/2018-09-dlc/) - Co-chairs: Kathleen Kennedy, Lisa Burley, and Rhonda O'Keefe The committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. The DLC has 7 webinars scheduled with more courses under development. Scheduled webinars cover topics including biosecurity, public relations, and occupational health. A new course currently under development will
- [Anthology XIV: Sustainability](https://absa.org/news/2018-09-anth14/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [ARS Symposium](https://absa.org/news/2018-09-ars/) - The USDA ARS 5th International Biosafety & Biocontainment Symposium: Biorisk and Facility Challenges in Agriculture will be February 11-14, 2019 at the Hilton Baltimore in Baltimore, Maryland. Topics include: Managing Risks; Governance Updates; Facilities; Disease Agents; Arthropod-borne Disease and Pests. There will be valuable presymposium courses and 2-1/2 days of scientific presentations. Exhibits showcasing the latest
- [Learning Verification Committee](https://absa.org/news/2018-09-lv/) - Co-chairs: Niki Drazenovich and Matthew Fischer The committee has almost completed review of Anthology XIV: Sustainability and most questions have been submitted to ABSA International to generate online quizzes, waiting for one committee member to complete his questions. The committee will review Anthology XIII: Animal Production and Protection-Challenges, Risks, and Best Practices next with a target
- [ABSA Owned Courses](https://absa.org/news/2018-09-aoc/) - Basic & Advanced Risk Assessment Co-chairs: Brandon Hatcher and Chad Austin The instructors for the Risk Assessment courses have revised course materials and are preparing to deliver the Basic Risk Assessment course at the upcoming ABSA International Conference in Charleston. They continue to improve the Advanced Risk Assessment course content in light of attendee feedback.
- [ABSA International Membership Site](https://absa.org/news/2018-09-absaweb/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [Biosafety Buyer's Guide](https://absa.org/news/2017-02-bbg/) - ABSA launched the Biosafety Buyer's Guide in early 2014 at http://biosafetybuyersguide.org. As we enter the fourth year, the Guide has had much success with many visits to the ads and listings. The guide lists companies and consultants that provide biosafety-related products and services. For more information, contact Karen Savage at karen@absaoffice.org.
- [Credentialing Maintenance Board](https://absa.org/news/2017-02-ceb-2/) - Chairs: Susan Cook, CBSP and Thomas Leonard, PhD, CBSP During the ABSA International Annual Conference in Grapevine, Texas, the Credentialing Evaluation Board (CEB) and Credentialing Maintenance Board (CMB) held a joint information and Q&A session to discuss the credentialing program. Several of the CEB and CMB members were present to field questions. The session
- [Awards Committee](https://absa.org/news/2017-02-awards/) - Chairs: Janet Peterson, CBSP and Jeffrey Potts, MPH, CBSP The Awards Committee is looking forward to a productive year. This year each of the awards will have its own nomination form which will reflect the specific criteria for that award. We'd like to take this opportunity to encourage all ABSA International members to consider
- [E-Communications Committee](https://absa.org/news/2017-02-e-communications/) - Chairs: Matt Anderson, PhD and Sarah Ziegler, PhD The committee focused on a few areas of the new website to redesign (change layout and format) that have the most traffic and then work on the other areas once the new site is up and running. The plan is to focus on the front page,
- [Technical & Regulatory Review Committee](https://absa.org/news/2016-10-trr/) - Co-Chairs: Eric Steelman and Yolanda Arriaga The Technical and Regulatory Review Committee (TRR) frequently reviews technical and regulatory documents and determines which documents need a deeper review and comment by the committee. In some cases, a technical review is determined to not be warranted based on further analysis or if other ABSA groups are involved.
- [Journal Board](https://absa.org/news/2016-10-journal/) - Applied Biosafety Coeditors-in-Chief: Karen Byers and Barbara Johnson SAGE Publishing is on-track with the publication schedule. SAGE is assisting with Indexing starting now through 2017 (we hope to get feedback in 6 months). If you would like to propose an article to the journal, please visit https://mc.manuscriptcentral.com/apb.
- [Finance Committee](https://absa.org/news/2025-01-finance-committee/) - Treasurer: Heather Blair Vice-Chair: Andrea Vogel The Finance Committee is the checks and balances of the budget. Every month the committee reviews and compares the month and year financial summary report to the previous month and year’s financial summary report to make sure ABSA International is staying in line with the approved budget for the
- [ABSA International Membership Site](https://absa.org/news/2025-01-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase
- [Public Health Outreach Shared Interest Group](https://absa.org/news/2024-09-public-health-outreach-shared-interest-group/) - Lead: Shoolah Escott Co-Lead: Crystal Fortune The SIG has conducted two renovation webinars this year. The first was held January 19 and was attended by approximately 400 people. Shoolah Escott was the moderator and featured Robin Tobias, Lisa Wallace, Anna Liddicoat, and Miguel Grimaldo as speakers. The second was held on February 29 and featured
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2024-09-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or link to it from
- [ABSA International Membership Site](https://absa.org/news/2024-09-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase ABSA
- [Job Board](https://absa.org/news/2024-09-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance their career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [The Anthology of Biosafety](https://absa.org/news/2024-09-the-anthology-of-biosafety/) - The Anthology of Biosafety series is now available at no cost to ABSA members! The 14-book series published between 1999 and 2015 addresses biosafety in different settings: I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level
- [ABSA International Inclusion Statement](https://absa.org/news/2024-06-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Applied Biosafety (APB) Editorial Board](https://absa.org/news/2024-09-applied-biosafety-apb-editorial-board/) - Coeditors-in-Chief: Barbara Johnson and Karen Byers Applied Biosafety (Volume 29, Number 2) is the first of a 2-part special issue series focusing the growing availability of customizable nucleic acid sequences and genomes from commercial sources, which has been recently printed and delivered. The second volume of this special issue is currently being proofed for printing and
- [Exhibitors Committee](https://absa.org/news/2024-09-exhibitors-committee/) - Chair: William Peters The 67th Annual Biosafety and Biosecurity Hybrid Conference will be November 1-6, 2024, in Phoenix, Arizona. We started promoting exhibits earlier than usual this year. E-blast solicitations are being sent every week promoting exhibiting and sponsoring at the conference. To date, we have 44 exhibitors and nine sponsors—Miltenyi Biotec (Gold); Sitero (Gold);
- [Preconference Course Committee (PCC)](https://absa.org/news/2024-09-preconference-course-committee-pcc/) - Co-Chairs: Geoffrey K. Phillips and Ray Scheetz The PCC completed the 2024 ABSA Call for Course Proposal reviews in May. The PCC was grateful to have a number of new course topics to choose from for the professional development courses offerings. Facilitators from the PCC have been assigned courses and are assisting with all the
- [E-Communications Committee](https://absa.org/news/2024-09-e-communications-committee/) - Chair: Matt Anderson Co-Chairs: Amanda Haley and James Pharr The E-comm Committee has been working to finalize the refresh of the ABSA International website home page and hopes to have the page updated by the end of September. We hope the membership and the public will find the changes make it easier to find what
- [Biosafety and Biosecurity Training Course® (BBTC)](https://absa.org/news/2024-09-biosafety-and-biosecurity-training-course-bbtc/) - Chair: Bob Ellis The BBTC was held in August in Fort Collins, CO to a full house of 60 participants. The next offering will be held August 4-8, 2025. The course director for the BBTC reminds everyone that attendees have the opportunity to learn about many aspects of biosafety and biosecurity—with general applications as well
- [Biosecurity Symposium Steering Committee](https://absa.org/news/2024-09-biosecurity-symposium-steering-committee/) - Chair: Cristine C. Lawson Co-Chairs: Enitra Jones Sprouse and Ryan Burnette The Steering Committee delivered a successful 3rd International Biosecurity Virtual Symposium and has reviewed all feedback received from the symposium survey. The committee is pleased to report that over 85% of attendees rated their overall experience good/excellent. Planning for the 4th International Biosecurity Virtual
- [2024 Local Arrangements Committee (LAC)](https://absa.org/news/2024-09-2024-local-arrangements-committee-lac/) - Chair: Sepideh S. Hockley The 2024 Local Arrangements Committee has been working on the final details to make the ABSA International Conference in Phoenix, Arizona an informative and enjoyable experience for all our attendees. The conference will be held at the luxurious JW Marriott Desert Ridge Resort and Spa and is within walking distance of
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2024-09-credentialing-maintenance-board-cmb/) - Chair: Hallie Hoskins Co-Chair: Rhonda O’Keefe The Board is pleased to welcome two new members as we had to say goodbye to a few that have truly created an impact in the credentialing community. The CMB is continually working on finding free to low-cost training to help with maintaining CM points. The new Excel-formatted CM
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2024-09-credentialing-evaluation-board-ceb/) - Chair: Paul Meechan Co-Chair: John Henneman The CEB continues to meet monthly to review RBP and CBSP applications. Also, based on a task force recommendation made to Council, a change in the service requirements for RBP and CBSP credentialing will take place starting on July 1, 2025. Any application not completed prior to that date
- [Learning Verification Committee (LVC)](https://absa.org/news/2024-09-learning-verification-committee-lvc/) - Chair: Niki Drazenovich Co-Chair: Matt Fischer ABSA members currently have 11 quizzes available online for CM points and additional quizzes in development covering two Applied Biosafety Journals, two Anthologies (VIII and VIX), and the Bradford University-Preventing Biological Threats book. These quizzes are low cost and can be located on the website at https://absa.org/online-education/.
- [Distance Learning Committee (DLC)](https://absa.org/news/2024-09-distance-learning-committee-dlc/) - Chairs: Eric Lewis, Endah Sulistijo, Ericka Pearce, and Rhonda O’Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing courses for ABSA International members’ professional growth. As of August 16, 16 courses have been completed reaching over 1,100 participants. The remaining course scheduled for mid-September is Virus-based Gene Transfer Vectors. Topics
- [Exam Development Board (EDB)](https://absa.org/news/2024-09-exam-development-board-edb/) - Chair: Joseph Kozlovac Co-Chair: David Harbourt The Board recently met with a statistician to review the CBSP exam analysis and determine a pass/fail percentage. This year had 16 individuals that sat for the exam and of those, nine have received the CBSP designation. The Exam Development Board (EDB) will continue to work at maintaining the
- [Public Relations and Marketing (PRM)](https://absa.org/news/2024-09-public-relations-and-marketing-prm/) - Chair: Robin Tobias Co-Chair: Daniela Didier PRM has been actively partnering with the ABSA Public Relations Firm and has applied the information learned through this collaboration to the existing Media Toolkit Project in progress. We continue to work on Biosafety and Biosecurity Month as an opportunity for our community to recognize, reflect, promote, and advocate
- [Member Resources Committee (MRC)](https://absa.org/news/2024-09-member-resources-committee-mrc/) - Chairs: Dee Zimmerman and Betsy Weirich The Member Resources Committee (MRC) has instituted the New Member Outreach Program, a personal communication between the new member and the MRC volunteers. The purpose is to welcome them to ABSA International and provide a point of contact for questions and chats. Our hope is that this will encourage
- [Historical Committee](https://absa.org/news/2024-09-historical-committee/) - Chair: John Balog Co-Chair: Bob Hawley The Historical Committee has not received any items to be evaluated for inclusion in the NAL Collection of the ABSA Biosafety archive in the past 12 months. The Policy and Procedures in review. Please contact the Historical Committee c/o the ABSA Office with questions about the National Agricultural Library
- [Emerging Infectious Disease Committee (EIDC)](https://absa.org/news/2024-09-emerging-infectious-disease-committee-eidc/) - Chairs: Esmeralda Meyer and Marian Downing The EIDC posted updates and new resources for the Influenza toolbox and Viral Hemorrhagic Fever as new information becomes available. During this quarter, Ami Patel led the assembly of the Prion toolbox and Betsy Gilman-Duane continued to nurture the revival of the ABSA-OSHA collaboration. We request your feedback on
- [Legislative Affairs/Regulatory & Technical Review Committee (TRR)](https://absa.org/news/2024-09-legislative-affairs-regulatory-technical-review-committee-trr/) - Co-Chairs: Esmeralda Meyer and Karon Floyd The TRR and Legislative Committee chairs continue to work with the leads for the Regulatory and Technical Affairs Team to finalize the merger of these two ABSA committees. A new set of P&Ps have been generated and await the final approval of the ABSA Council. Stay tuned for more
- [Affiliate Relations Committee](https://absa.org/news/2024-09-affiliate-relations-committee/) - Co-Chairs: Lia Vizzotti and Parimala Arokiaraj The Affiliate Relations Committee has been actively scouting for fresh candidates to join our network. If you, as an ABSA International member, know of any biosafety associations in your region, we encourage you to nominate them! Here’s the website if you are seeking more information about the affiliate program at ABSA.
- [Training Tools/Resources Committee (TTR)](https://absa.org/news/2024-09-training-tools-resources-committee-ttr/) - Chair: Maya Nair Co-Chair: Will Pinard TTR members reviewed the following resources this quarter. Agent Information Sheets developed by Boston and Emory University’s for 50 agents and resources submitted from Advancing Veterinary Diagnostic Laboratory Science (AAVLD) on PPE in BSL-3/ABSL-3 Laboratories. These approved resources are posted to the TTR page on the website.
- [Scientific Program Committee (SPC)](https://absa.org/news/2024-09-scientific-program-committee-spc/) - Chair: AJ Troiano Co-Chairs: Colleen Kovacsics and Susan Vleck The SPC continued to work into the summer to finalize the conference agenda for November, which we are proud to showcase: Four keynote speakers with the addition of another local invited speaker thanks to the help of the Local Arrangements Committee Concurrent sessions on Tuesday afternoon
- [Advanced Biosafety Training Subcommittee (ABTS)](https://absa.org/news/2024-09-advanced-biosafety-training-subcommittee-abts/) - Chairs: Dan Eisenman and Shalaka Kotkar The training slides were updated, and the audio has been recorded. The 2024 goal is to evaluate post-test questions as well as any questions that have been submitted by students for the course.
- [Principles & Practices of Biosafety® (PPB)](https://absa.org/news/2024-09-principles-practices-of-biosafety-ppb/) - Co-Leads: Pat Condreay and Carrie Smith The summer offering of PPB was held in Denver, Colorado in July. There will be three offerings in 2025 (Alexandria, Virginia in March; Omaha, Nebraska in May; and Pittsburgh, Pennsylvania in July) to accommodate additional students. Registration is closed for Alexandria, but open for Omaha and Pittsburgh. Please visit https://absa-ppb.org/.
- [Bylaws Committee](https://absa.org/news/2024-09-bylaws-committee/) - Co-Chairs: Amy Ryan and David Cavallaro The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office will forward the changes to the committee for review
- [President’s Report](https://absa.org/news/2024-09-presidents-report/) - Dear Biosafety and Biosecurity Community, The final quarter of 2024 is quickly approaching, and I am excited to share a few of ABSA International’s significant accomplishments and ongoing efforts that continue to advance our mission of promoting biosafety and biosecurity worldwide. Last year we celebrated a successful 66th Annual Biosafety and Biosecurity Hybrid Conference with
- [The Anthology of Biosafety series](https://absa.org/news/2024-06-the-anthology-of-biosafety-series/) - The Anthology of Biosafety series is now available at no cost to ABSA members! The 14-book series published between 1999 and 2015 addresses biosafety in different settings: I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level 3
- [Job Board](https://absa.org/news/2024-06-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance their career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [ABSA International Membership Site](https://absa.org/news/2024-06-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2024-06-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2024-06-webinars-recordings-on-demand-modules/) - Recordings Available for Purchase for a Limited Time: 66th Annual Biosafety and Biosecurity Hybrid Conference Available until: October 13, 2024 3rd International Biosecurity Virtual Symposium Available Until: November 7, 2024 12. PR & Communication Essentials for Biosafety Professionals Available Until: June 28, 2024 04. Battling Professional Burnout by Taking Control of your Biosafety Career Available
- [Exam Development Board](https://absa.org/news/2024-06-exam-development-board/) - Chair: Joseph Kozlovac Co-Chair: David Harbourt The Exam Development Board currently evaluated a draft of the CBSP exam for dissemination in June. The Board thoroughly reviews every question for clarity and grammatical issues along with verifying correct answers and potential discrepancies. The Exam Development Board has met monthly during the year to discuss new and
- [E-Communications Committee](https://absa.org/news/2024-06-e-communications-committee/) - Chair: Matt Anderson The E-Communications Committee has been busy working on an overhaul of the ABSA website homepage to facilitate better and easier navigation of the site. We hope to have the new homepage rolled out by the end of the summer. This includes a revamp of the navigation menus and the addition of “Button”
- [Member Resources Committee](https://absa.org/news/2024-06-member-resources-committee/) - Chairs: Dee Zimmerman and Betsy Weirich The Member Resources Committee is currently working on an outreach process to provide new members with a point of contact to engage and facilitate access to ABSA resources, as well as a friendly face at the annual conference. The list of recommended courses for incoming biosafety professionals is being
- [Affiliate Relations Committee](https://absa.org/news/2024-06-affiliate-relations-committee/) - Co-Chairs: Lia Vizzotti and Parimala Arokiaraj We have been actively scouting for fresh candidates to join our network. If you, as an ABSA International member, know of any biosafety associations in your region, we encourage you to nominate them!
- [Biosecurity Symposium Steering Committee](https://absa.org/news/2024-06-biosecurity-symposium-steering-committee/) - Chair: Cristine C. Lawson Co-chairs: Ryan Burnette and Enitra Jones Sprouse This past year the Biosecurity Symposium Steering Committee supported ABSA on final development and review of the Biosecurity Symposium Program Guide and Policies & Procedures (P&Ps), and participated on several discussions to ensure the Biosecurity Symposium continues to be relevant and current, while occurring
- [Legislative Affairs/Regulatory & Technical Review Committee](https://absa.org/news/2024-06-legislative-affairs-regulatory-technical-review-committee/) - Co-Chairs: Esmeralda Meyer and Karon Floyd The Legislative Affairs Committee and the Regulatory and Technical Review Committee have merged together. The new committee is co-chaired by Esmeralda Meyer and Karon Floyd. The co-chairs are still reviewing and modifying the committee charters, roles, and responsibilities. We are looking forward to the new year with excitement and
- [Public Health Outreach Shared Interest Group](https://absa.org/news/2024-06-public-health-outreach-shared-interest-group/) - Lead: Shoolah Escott Co-Lead: Crystal Fortune The Public Health Outreach Shared Interest Group has had a busy start to 2024. Shoolah Escott has started the year as lead with Crystal Fortune as co-lead, but the group was also very fortunate to have Marian Downing stay on as a well-seasoned member and advisor. So far this
- [Distance Learning Committee](https://absa.org/news/2024-06-distance-learning-committee/) - Chair: Eric Lewis Co-Chairs: Endah Sulistijo, Ericka Pearce, and Rhonda O’Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. As of May 14, 2024, 7 courses have been completed reaching over 600 participants. Ten additional webinars are already on the schedule for later
- [Emerging Infectious Disease Committee](https://absa.org/news/2024-06-emerging-infectious-disease-committee/) - Chairs: Esmeralda Meyer and Marian Downing The Emerging Infectious Disease Committee welcomed three members in 2024; Joanna Spinato, Brett Haltiwanger, and Kristie Yeakle. New toolboxes have been created for Prions and Parasites, be sure to check them out. The committee continues to update the toolboxes monthly and recently added new resources to the Influenza and
- [Advanced Biosafety Training Subcommittee](https://absa.org/news/2024-06-advanced-biosafety-training-subcommittee/) - Chairs: Dan Eisenman and Shalaka Kotkar The Advanced Biosafety Training slides have been completely overhauled. In 2023 the audio was recorded for the updated slides. The 2024 goal is to evaluate post course assessment questions as well as any questions that have been submitted by students for the course.
- [Training Tools/Resources Committee](https://absa.org/news/2024-06-training-tools-resources-committee/) - Chair: Maya Nair Co-Chair: Will Pinard Training Tools/Resources Committee met in January, February, and April. The members reviewed and approved the following resources during this period: Agent Information Sheets developed by Boston and Emory Universities Total Information Sheets for 50 agents Terminology and definitions for Basic Lab Biosafety ABSA/APHL - IBC Membership for Laboratory Personnel
- [BRM Connect Task Force](https://absa.org/news/2024-06-brm-connect-task-force/) - Lead: Maya Nair Vice Lead: Noman Siddiqi BRM Connect Taskforce met in January, March, and April. The members had robust discussions about how a project-based mentoring program could be successfully implemented given the diversity of ABSA members from various locations, institutions, sectors and with diverse kinds of expertise. Based on these discussions, the BRM Connect
- [Bylaws Committee](https://absa.org/news/2024-06-bylaws-committee/) - Chair: Amy Ryan The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. Three P&Ps were reviewed during the past quarter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International office. The office will forward the changes
- [Biological Select Agent and Toxin Community Advocate Committee](https://absa.org/news/2024-06-biological-select-agent-and-toxin-community-advocate-committee/) - Co-Chairs: Kelly Flint and Anthony R. Sambol The Biological Select Agent and Toxin Community Advocate Committee is in a rebuilding phase. The committee is working on planning webinars for the 2024 calendar year and looking to add to its membership. The main requirement of membership is being part of a Select Agent program (i.e., current
- [Credentialing Evaluation Board](https://absa.org/news/2024-06-credentialing-evaluation-board/) - Chair: Paul Meechan Co-Chair: John Henneman The Credentialing Evaluation Board has met at least monthly, completing the applications to sit for the Certified Biological Safety Professional (CBSP) examination earlier this spring. The Board also added Michele Howard as a new member and wishes to thank Colleen Driskill for her dedicated service to the Board over
- [Scientific Program Committee](https://absa.org/news/2024-06-scientific-program-committee/) - Chair: AJ Troiano Co-Chairs: Colleen Kovacsics and Susan Vleck The Scientific Program Committee is in full swing as we enter the summer months, with another impactful and diverse program agenda anticipated for 2024! Our annual 2-hour abstract submission call occurs in late May, and we look forward to finalizing the conference agenda and sharing the
- [Principles & Practices of Biosafety® (PPB)](https://absa.org/news/2024-06-principles-practices-of-biosafety-ppb/) - Co-Leads: Pat Condreay and Carrie Smith The spring offering of PPB was held in San Diego in March. The summer offering, with our annual curriculum workshop, will be held in Denver at the beginning of July. To address the large list of people interested in attending the class, there will be a third offering of
- [Learning Verification Committee](https://absa.org/news/2024-06-learning-verification-committee/) - Chair: Niki Drazenovich Co-Chair: Matt Fischer ABSA members currently have 11 quizzes available online for CM points and additional quizzes in development covering 2 Applied Biosafety Journals, 2 Anthology books (VIII and VIX) and the Bradford University-Preventing Biological Threats book. These quizzes are low cost and can be located on the website at absa.org/online-education/.
- [Preconference Course Committee](https://absa.org/news/2024-06-preconference-course-committee/) - Co-Chairs: Geoff Phillips and Ray Scheetz The Preconference Course Committee recently added two new members. We are excited by the additions of these talented individuals. Both members are enthusiastic and looking forward to contributing to the organization. The professional development course submissions were reviewed by committee members in mid-May. The committee chose a wide variety
- [Exhibitors Committee](https://absa.org/news/2024-06-exhibitors-committee/) - Chair: William Peters The 67th Annual Biosafety and Biosecurity Hybrid Conference will be held from November 1-6, 2024, in Phoenix, Arizona. We started promoting exhibits earlier than usual this year. E-blasts solicitations being sent every 1.5 weeks. To date, we have 34 exhibitors and 9 sponsors—Miltenyi Biotec (Gold); Sitero (Gold); BioSAFE Engineering (Silver); ABC Actini
- [<em>Applied Biosafety</em> Editorial Board](https://absa.org/news/2024-06-applied-biosafety-editorial-board/) - Coeditors-in-Chief: Barbara Johnson and Karen Byers Applied Biosafety successfully solicited an exceptional number of high-quality manuscript submissions for the forthcoming Special Issue on Biosafety and Biosecurity for Synthetic Genomics. We are pleased to report that the Special Issue will be featured over two full volumes (Volume 29, Number 2 and Volume 29, Number 3). In
- [2024 Local Arrangements Committee – Phoenix](https://absa.org/news/2024-06-2024-local-arrangements-committee-phoenix/) - Chair: Sepideh S. Hockley The 2024 Local Arrangements Committee has been working to finalize plans to make the ABSA International Conference in Phoenix, Arizona a positive and enjoyable experience for all our attendees. The conference will be held at the luxurious JW Marriott Desert Ridge Resort and Spa and is within walking distance of Desert
- [President’s Report](https://absa.org/news/2024-06-presidents-report/) - Dear Biosafety and Biosecurity Community, Welcome to the 2024 spring ABSA President’s Report! As we embark on this exciting season, I am thrilled to share the progress and ongoing projects from our esteemed ABSA International committees, working groups, and task forces. The dedication and commitment of each of our Council members, team leads, volunteers, and
- [Exhibitors Advisory Committee](https://absa.org/news/2016-10-conf-exhib/) - Chair: Brandon Rosendahl ABSA International would like to thank all of the sponsors and exhibiting companies participating at the the annual conference in Grapevine! We appreciate your support! Go to the following link for a list of sponsors and exhibitors https://absaconference.org/exhibitors-sponsors/.
- [Accreditation Board](https://absa.org/news/2016-10-accred/) - Chair: Chris Thompson The Accreditation Board recently met and re-elected Co-Chairs for all their committees. We continue to be hopeful that with the recent fee structure reduction, we will be garnering further attention for the accreditation of facilities nationwide. We are also exploring opening the accreditation process to those international partners that are seeking accreditation.
- [President's Report](https://absa.org/news/2017-09-presidents-report/) - Maureen O'Leary, PhD, CBSP Dear ABSA International Colleagues, The ABSA International Conference, which will be held October 13-18 in Albuquerque, New Mexico, is rapidly approaching. We have an excellent line-up of speakers, courses, and posters as well as many additional exciting sessions to attend while at the meeting. On Sunday, October 15 from 1:00-4:00 pm
- [ARS Symposium](https://absa.org/news/2017-12-ars-symposium/) - The next ARS Symposium will be February 4-7, 2019 at the Hilton Baltimore in Baltimore, Maryland. Topics include: Biorisk Management Challenges in a One Health World; Arthropods; High Pathogen Avian Influenza; Laboratory Assessment Programs and Tools; and Risk Assessment. There will be valuable presymposium courses and 2-1/2 days of scientific presentations. Exhibits showcasing the latest
- [ARS Symposium](https://absa.org/news/2018-05-ars-symposium/) - The USDA ARS 5th International Biosafety & Biocontainment Symposium: Biorisk and Facility Challenges in Agriculture will be February 11-14, 2019 at the Hilton Baltimore in Baltimore, Maryland. Topics include: Managing Risks; Governance Updates; Facilities; Disease Agents; Arthropod-borne Disease and Pests. There will be valuable presymposium courses and 2-1/2 days of scientific presentations. Exhibits showcasing the
- [ARS 2019 Symposium](https://absa.org/news/2018-12-ars-2019-symposium/) - The USDA ARS 5th International Biosafety & Biocontainment Symposium: Biorisk and Facility Challenges in Agriculture will be February 11-14, 2019 at the Hilton Baltimore in Baltimore, Maryland. Topics include: Managing Risks; Governance Updates; Facilities; Disease Agents; Arthropod-borne Disease and Pests. There will be valuable presymposium courses and 2-1/2 days of scientific presentations. Exhibits showcasing the
- [President's Report](https://absa.org/news/2018-12-presidents-report/) - Domenica (Dee) Zimmerman Dear ABSA International Colleagues, The first quarter of the ABSA International calendar has been a busy one for Council. The annual conference in Charleston was a resounding success even as we watched high wind and rain weather impact areas surrounding Charleston. At the same time, the ABSA International office received notification that
- [USDA ARS 6th International Biosafety and Biosecurity Symposium: Emerging Biorisk Challenges in Agriculture](https://absa.org/news/2020-09-usda-ars-6th-international-biosafety-and-biosecurity-symposium-emerging-biorisk-challenges-in-agriculture/) - Chair: Joe Kozlovac The symposium will be held at the Renaissance Baltimore Harborplace Hotel, February 1-4, 2021. Some of the presentations will address African Swine Fever, On Farm Biosecurity Practices, the Impact of COVID-19 on Food and Agriculture. Pre-symposium courses covering Biocontainment Challenges for High-Containment, Occupational Health, and Managing Research Safety During Pandemic Conditions will
- [Scientific Program Committee (SPC)](https://absa.org/news/2017-12-scientific-program-committee-spc/) - Co-chairs: Betsy Matos, Jessica McCormick-Ell, and Claudia Gentry-Weeks The SPC reviewed the conference survey and discussed such during a conference call this month. SPC is accepting suggestions for the four Keynote Speakers for 2018 ABSA International Conference. Submissions of abstracts for platform and poster presentations will begin in January 2018 until March 2018. ABSA 2017
- [ABSA 2017 Conference Presentations and Recordings Now Available!](https://absa.org/news/2018-05-absa-2017-conference-presentations-and-recordings-now-available/) - ABSA International would like to thank all of our volunteers, members, and colleagues for another successful conference in Albuquerque, New Mexico. The presentations are free, but there is a fee for the recordings. Please e-mail info@absa.org if you have any questions or need assistance.
- [Preconference Course Committee (PCC)](https://absa.org/news/2019-08-preconference-course-committee-pcc/) - Co-chairs: Heather Blair and Antony Schwartz The co-chairs have assigned at least one facilitator to each Professional Development Course. The facilitator(s) will be reviewing the course materials to ensure the material is consistent with the ABSA International professional development standards and level indicated for the course.
- [Local Arrangements Committee (LAC)](https://absa.org/news/2018-05-local-arrangements-lac/) - Co-chairs: Sylvie Blondell and Shelley Jones The USS Yorktown aircraft carrier has been selected as the banquet venue and the LAC is reaching-out to potential local bands for entertainment. The LAC is actively investigating ideas for the conference speakers' and attendees' gifts. Shuttle service has been secured between the Charleston Convention Center and downtown Charleston
- [Obituary: Jonathan Young Richmond](https://absa.org/news/2018-09-obituary-jonathan-young-richmond/) - Jonathan Young Richmond February 10, 1941 - June 27, 2018 Dr. Jonathan Young Richmond, 77 of Southport, passed away on June 27, 2018. Dr. Richmond was born February 10, 1941 in Norwalk, Connecticut, the son of the late Allen P. Richmond, Jr. and Adele Ketzinger Richmond. Dr. Richmond received both Bachelor of Arts and Master
- [Journal Board](https://absa.org/news/2020-06-journal-board/) - Chairs: Karen Byers, Barbara Johnson, Scott Patlovich Applied Biosafety has received several submissions regarding SARS-CoV-2 and the editors, reviewers, and SAGE staff have worked to publish accepted submissions on Online-First in record time (some within one week of submission). Applied Biosafety is examining the possibility of having a Special Section in one issue in 2020
- [Scientific Program Committee (SPC)](https://absa.org/news/2020-02-scientific-program-committee-spc/) - Chair: Jessica McCormick-Ell Co-chairs: Claudia Gentry-Weeks and AJ Troiano The Scientific Program Committee (SPC) is well underway at planning the 2020 conference. Thank you to all of you who attended and helped to make the 2019 conference a success! The SPC has reviewed the conference survey and is currently discussing keynote speakers and sending names
- [Journal Board](https://absa.org/news/2019-08-journal-board/) - Coeditors-in-Chief: Karen B. Byers and Barbara Johnson Associate Editor: David Gillum Applied Biosafety is on track to publish Volume 24, Number 3 in September. Contents will include a Guest Editorial from the National Academies of Science, a Letter to the Editor on the 2019 Biosafety and Biosecurity Month, and a review article on gene therapy.
- [E-Communications Committee](https://absa.org/news/2022-06-e-communications-committee/) - Chair: Matt Anderson We are continuing to work with the Publications committee to publish regular posts to the ABSA International Blog to promote biosafety and highlight the great work many ABSA members are doing every day to keep people safe. If you have something you would like to contribute to the blog, please consider submitting
- [Webinars, Recordings, On-demand](https://absa.org/news/2022-06-webinars-recordings-on-demand/) - In case you missed the 2nd Biosecurity Hybrid Symposium held May 4-6 in Minneapolis, Minnesota, you can register for the recording at a discounted rate until October 4, 2022. ABSA International webinars such as Current Advances in Research, Public Health, and Biosafety Considerations Regarding SARS-CoV-2 or Fundamentals of Microbiology and Infectious Disease are also available for purchase at absa.org/recordings.
- [ABSA-Owned Course Committee](https://absa.org/news/2022-01-absa-owned-course-committee/) - Co-Chairs: Chad Austin and Lisa Benford Biosafety and Biosecurity Training Course (BBTC) Chair: Bob Ellis The Biosafety and Biosecurity Training Course directors are currently planning to offer the course from August 8-12, 2022. Recent additions to course material include preparation for audits and inspections, BSL-2/BSL-3 building design and operations, field investigations biosafety, and many more.
- [Emerging Infectious Disease Consortium](https://absa.org/news/2022-01-emerging-infectious-disease-consortium/) - Chairs: Esmeralda Meyer and Marian Downing The EIDC has updated the toolboxes for SARS-CoV-2/COVID-19, Influenza, Hemorrhagic Fever Virus (including Ebola Virus), Zika Virus, and Antibiotic/Antimicrobial Resistance. We look forward to receiving feedback from the ABSA members to improve the content and organization of the toolboxes. Lastly, the EIDC welcomes Kenneth Shenge as the new member
- [Emerging Infectious Disease  Consortium (EIDC)](https://absa.org/news/2020-09-emerging-infectious-disease-consortium-eidc/) - Leads: Esmeralda Meyer and Marian Downing The Emerging Infectious Diseases Consortium (EIDC) updated the existing webpages for Ebola Virus and Zika Virus. The Emerging Infectious Diseases Toolboxes can be accessed from the ABSA International home page. A new Toolbox is now available to provide updates on the rising threat of the G4 EA Avian-Like Influenza
- [USDA ARS 6th International Biosafety and Biosecurity Symposium: Emerging Biorisk Challenges in Agriculture](https://absa.org/news/2021-01-usda-ars-6th-international-biosafety-and-biosecurity-symposium-emerging-biorisk-challenges-in-agriculture/) - The symposium will be held virtually from February 2-4, 2021. Some of the presentations will address African Swine Fever, On Farm Biosecurity Practices, the Impact of COVID-19 on Food and Agriculture. Professional development courses covering Biocontainment Challenges for High-Containment, Medical Surveillance in Biological Labs, and the Vivarium, and Managing Research Safety During Pandemic Conditions will
- [President's Report](https://absa.org/news/2021-01-presidents-report/) - Melissa Mørland, MS, MBA, RBP, CBSP Dear ABSA Colleagues, I hope this message finds you safe and healthy. While we had hoped to be together in Arizona for our 2020 annual conference, we had a very successful virtual conference and the largest attendance ever with 822 attendees. We also had 651 professional development course attendees.
- [Webinars, Recordings, On-demand](https://absa.org/news/2022-09-webinars-recordings-on-demand/) - In case you missed the 2nd Biosecurity Hybrid Symposium held May 4-6 in Minneapolis, MN, you can register for the recording at a discounted rate until October 4, 2022. ABSA International webinars such as Large-scale Biosafety, Molecular Biology 101, and Q&A Infectious Substance Shipping or Concepts of Virology are also available for purchase at absa.org/recordings.
- [Training Tools and Resources (TTR)](https://absa.org/news/2022-06-training-tools-and-resources-ttr/) - Co-Chairs: Lauriane Quenee and Maya Nair TTR collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These resources are collated on the ABSA website featuring a search function, keywords, the origin, and the type of resources. The committee uses evaluation and review methods for new
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2023-06-webinars-recordings-on-demand-modules/) - There’s still time to purchase the recordings from the USDA ARS 7th International Biosafety & Biocontainment Hybrid Symposium held February 2023 in Baltimore, Maryland. Available until August 1, 2023. Recordings of past webinars, conferences, and symposia will be available for purchase for a limited time after their initial offering dates. Please visit https://absa.org/recordings/ to see
- [Training Tools & Resources for Biosafety Professionals (TTR)](https://absa.org/news/2023-06-training-tools-resources-for-biosafety-professionals-ttr/) - Chair: Maya Nair Co-Chair: Will Pinard The Training Tools & Resources (TTR) Committee has reviewed a new Tri-University Biosafety Training Video developed by Arizona State University, Northern Arizona University, and the University of Arizona. The three Biorisk Management videos are available for viewing on the TTR webpage at https://absa.org/topic/ttr/. Committee members have started reviewing and
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2024-01-webinars-recordings-on-demand-modules/) - Webinars, Recordings, On-demand Modules Available for Purchase: 66th Annual Biosafety and Biosecurity Hybrid Conference Available until: October 13, 2024 Course 6V: Selection and Use of Personal Protective Equipment (PPE) For sale until: January 27, 2024 Course 7V: Laboratory Facility Programming and Design Best Practices For sale until: February 13, 2024 Other Upcoming Opportunities for Professional
- [USDA ARS 4th International Symposium](https://absa.org/news/2016-10-usda-ars/) - SAVE THE DATE! USDA ARS 4th International Symposium: Global Biorisk Challenges - Agriculture and Beyond February 6-9, 2017 Baltimore, Maryland http://arssymposium.absa.org
- [Biological Select Agent and Toxin (BSAT) Community Advocate Committee (CAC)](https://absa.org/news/2024-01-biological-select-agent-and-toxin-bsat-community-advocate-committee-cac/) - Co-Chairs: Kelly Flint and Anthony R. Sambol The BSAT Community Advocate Committee (BSAT CAC) is in a rebuilding phase. Support from the CDC had been re-initiated, and together the committee and CDC are planning webinars for the 2024 calendar year. The BSAT CAC is looking to add to its membership. The main requirement of membership
- [Public Health Outreach Shared Interest Group](https://absa.org/news/2024-01-public-health-outreach-shared-interest-group/) - Lead: Shoolah Escott Co-Lead: Crystal Fortune Shoolah Escott, current Public Health Outreach Shared Interest Group (SIG) Co-Lead, has agreed to take over as the Lead and Crystal Fortune has agreed to become the Co-Lead. Shoolah presented the SIG’s poster titled “Public Health Laboratory Construction & Renovation Helpful Tips” at the Northeast Association for Clinical Microbiology
- [<em>Applied Biosafety</em> Editorial Board](https://absa.org/news/2024-01-applied-biosafety-editorial-board/) - Coeditors-in-Chief: Barbara Johnson and Karen Byers In addition to the typical influx of biosafety and biosecurity related manuscripts being submitted, the Applied Biosafety Editorial Board is working on a special issue of the journal that is focused on Biosafety and Biosecurity for Synthetic Genomics. The Guest Editors for the special issue are Drs. Sarah R.
- [Scientific Program Committee (SPC)](https://absa.org/news/2024-01-scientific-program-committee-spc/) - Chair: AJ Troiano Co-Chairs: Colleen Kovacsics and Susan Vleck The Scientific Program Committee welcomed new members to the committee as we reflected on the 66th Annual Biosafety and Biosecurity Conference in Omaha, Nebraska last October. Working diligently through the conference survey feedback, the responses were overwhelmingly positive with some poignant recommendations for improvement moving into
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2024-01-credentialing-evaluation-board-ceb/) - Chair: Paul Meechan Co-Chair: John Henneman The Credentialing Evaluation Board (CEB) continues to meet monthly to review applications for certification as Registered Biosafety Professionals (RBP) and Certified Biological Safety Professionals (CBSP). As a reminder, February 1, 2024, is the deadline for submitting CBSP exam applications.
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2024-01-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or link
- [Job Board](https://absa.org/news/2024-01-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance their career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [The Anthology of Biosafety series is now available at no cost to ABSA members!](https://absa.org/news/2024-01-the-anthology-of-biosafety-series-is-now-available-at-no-cost-to-absa-members/) - The 14-book series published between 1999 and 2015 addresses biosafety in different settings: I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level 3 VIII: Evolving Issues in Containment IX: Exploring the Performance Envelope for BSL-3 and
- [ABSA International Inclusion Statement](https://absa.org/news/2024-01-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Member Resources Committee (MRC)](https://absa.org/news/2024-01-member-resources-committee-mrc/) - Chairs: Dee Zimmerman and Betsy Weirich Member Resources Committee (MRC) had a productive meeting during the ABSA conference this year. Several ABSA members attended. The MRC facilitates the relationship between members within ABSA International. The MRC supports and enhances biosafety and biosecurity knowledge by providing sustained opportunities for biosafety and biosecurity communication, education, and mentoring.
- [Exam Development Board (EDB)](https://absa.org/news/2024-01-exam-development-board-edb/) - Chair: Joseph Kozlovac Co-Chair: David Harbourt The Exam Development Board continues to make revisions and improvements to the CBSP exam to maintain the integrity of the credential. The Board met multiple times in the past quarter to look for subject areas that require additional questions used to generate the exam. Individual members have submitted new
- [Emerging Infectious Disease Consortium (EIDC)](https://absa.org/news/2024-01-emerging-infectious-disease-consortium-eidc/) - Chairs: Esmeralda Meyer and Marian Downing EIDC Toolboxes (https://absa.org/toolboxes/) continue to be updated monthly with the most recent resources. Below are the new resources added in the second half of 2023: New toolboxes compiling information on recent outbreaks including Other Zoonotic Agents and Parasites The Labroots Video featured during the 2023 ABSA Annual Conference: Introducing
- [Affiliate Relations Committee (ARC)](https://absa.org/news/2024-01-affiliate-relations-committee-arc/) - Co-Chairs: Lia Vizzotti and Parimala Arokiaraj The Affiliates Committee is pleased to announce that the Brazilian Biosafety & Biosecurity Society (SB3) has been approved as an affiliate of our organization. SB3’s commitment to promoting biosafety and biosecurity aligns perfectly with our mission, and we believe that their expertise and contributions will greatly enhance our efforts
- [E-Communications Committee](https://absa.org/news/2024-01-e-communications-committee/) - Chair: Matt Anderson Thank you to everyone who attended the conference in Omaha, Nebraska and took part in the “Selfie Booth.” We heard lots of comments about the stickers and buttons we gave out to those who showed us that they had posted to social media. Some of the feedback we received was about how
- [BRM Connect Task Force](https://absa.org/news/2024-01-brm-connect-task-force/) - Lead: Maya Nair Vice Lead: Noman Siddiqi BRM Connect taskforce met in September, October, and November. Due to the holidays, the December meeting is cancelled. The members had robust discussions about how a project-based mentoring program could be successfully implemented given the diversity of ABSA members from various locations, institutions, sectors and with different kinds
- [Distance Learning Committee (DLC)](https://absa.org/news/2024-01-distance-learning-committee-dlc/) - Chair: Eric Lewis Co-chairs: Rhonda O’Keefe, Ericka Pearce, and Endah Sulistijo The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. As of December 2023, 14 courses have been completed, reaching over 1,200 participants. Webinars scheduled for the coming months include: What is Biosecurity? Why
- [Public Relations and Marketing (PRM)](https://absa.org/news/2024-01-public-relations-and-marketing-prm/) - Chair: Robin Tobias Co-Chair: Daniela Didier The Public Relations and Marketing Committee (PRM) is happy to welcome new members this year as well as a new rotation of Chair and Co-Chair. We are actively involved in partnering with the ABSA public relations firm and plan to apply the information learned through this collaboration to the
- [Legislative Affairs Committee](https://absa.org/news/2024-01-legislative-affairs-committee/) - Chair: Karon Floyd Co-Chair: Brian O’Shea The Legislative Committee has been a little busy this year. We reviewed the request for comments on the Proposed Revisions to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) regarding potential changes to the policies for oversight of Dual Use Research of Concern
- [Training Tools/Resources (TTR) Committee](https://absa.org/news/2024-01-training-tools-resources-ttr-committee/) - Chair: Maya Nair Co-Chair: Will Pinard In October, the TTR met at the conference with 12 members attending. The Strategic Plan was shared and discussed the following points with the committee. How can TTR contribute towards the strategic plan? What are some strategies that can help to bring resources from affiliates to ABSA? Establish guidelines
- [Principles & Practices of Biosafety®](https://absa.org/news/2024-01-principles-practices-of-biosafety/) - Co-Leads: Pat Condreay and Carrie Smith The Spring session of PPB will be held in San Diego, California in March of 2024. The class is sold-out, and a list has been started for the summer 2024 session which will be held in Denver, Colorado. To be added to the notification list for registration opening, please
- [Preconference Course Committee (PCC)](https://absa.org/news/2024-01-preconference-course-committee-pcc/) - Co-Chairs: Geoff Phillips and Ray Scheetz PCC has completed the review of the Preconference Committee comments regarding the 2023 Omaha professional development courses. Logistic considerations for 2024 will include streamlining the course sign-in process, location of instructor tables, and the membership notification regarding the proper electronic devices and plugs used at the conference. The PCC
- [Advanced Biosafety Training Subcommittee (ABTS)](https://absa.org/news/2024-01-advanced-biosafety-training-subcommittee-abts/) - Chairs: Dan Eisenman and Shalaka Kotkar The ABTS modules were completely overhauled in 2022. In 2023, we reviewed the associated quizzes and recorded audio for each of the ABTS modules. Further information about each of the seven (7) modules is available at https://absa.org/online-education/.
- [2024 Local Arrangements Committee—Phoenix](https://absa.org/news/2024-01-2024-local-arrangements-committee-phoenix/) - Chair: Sepideh Hockley The 2024 Local Arrangements Committee for Phoenix has picked up where it left off with plans originally intended for the 2020 Phoenix conference. The conference will be held at the JW Marriott Desert Ridge Resort and Spa and is within walking distance of Desert Ridge Mall bars, restaurants, and shopping. The banquet
- [Bylaws Committee](https://absa.org/news/2024-01-bylaws-committee/) - Chair: Amy Ryan The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. Two P&Ps were reviewed during the past quarter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office will forward the changes
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2024-01-credentialing-maintenance-board-cmb/) - Chair: Hallie Hoskins Co-Chair: Rhonda O’Keefe The Board has finalized an improved CM Worksheet in Excel format, and it is now posted on our webpage. Members may begin using it regardless of their cycle end dates as it is a great record-keeping tool as well. The new form lets you know if you are short
- [Learning Verification Committee](https://absa.org/news/2024-01-learning-verification-committee/) - Chair: Niki Drazenovich Co-Chair: Matt Fischer ABSA members currently have 10 quizzes available online for CM points and additional quizzes in development covering two Anthology Books (VIII and VIX) and the Bradford University-Preventing Biological Threats book. These quizzes are low cost and can be located on the website at https://absa.org/online-education/.
- [Exhibitors Committee](https://absa.org/news/2024-01-exhibitors-committee/) - Chair: William Peters The 66th Annual Biosafety and Biosecurity Hybrid Conference was held from October 13-18, 2023, in Omaha, Nebraska. We had 52 companies exhibiting and 8 sponsors—4 Bronze, 2 Silver, 1 Gold, and 1 Platinum. Onsite exhibit booths were open during the 3-day conference for participants to access and interact with booth personnel. We
- [President’s Report](https://absa.org/news/2024-01-presidents-report/) - Dear Biosafety and Biosecurity Community, I am honored and humbled to serve as President of ABSA International. I look forward to bringing my passion for biosafety and biosecurity, in the same way that you all do, making our profession one of the most important professions in recent years. I share and admire your deep commitment
- [Training Tools/Resources (TTR) Committee](https://absa.org/news/2023-09-training-tools-resources-ttr-committee/) - Chair: Maya Nair Co-Chair: Will Pinard The Training Tools/Resources committee met virtually in May, June, and July 2023. Members continue reviewing resources from various sources. Currently we are reviewing the resources developed by international biosafety professionals who participated in the Twinning Project in collaboration with Sandia National Laboratories. These resources are from different countries representing
- [Principles and Practices of Biosafety® (PPB)](https://absa.org/news/2023-09-principles-and-practices-of-biosafety-ppb/) - Co-Leads: Carrie Smith and Patrick Condreay The summer session of Principles and Practices of Biosafety was held in Pittsburgh, PA in July. The instructors met before the class for our annual curriculum workshop. The spring session will be held in San Diego, CA in March 2024.
- [Legislative Affairs Committee](https://absa.org/news/2023-09-legislative-affairs-committee/) - Chair: Karon Floyd This past year has been a year of changes. After the Legislative Affairs Committee experienced a change in leadership, it was decided to merge the Legislative Affairs Committee with the Technical Review Committee. We found that these two committees had very similar objectives and performed roughly the same duties. Understanding that and
- [BRM Connect Task Force](https://absa.org/news/2023-09-brm-connect-task-force/) - Lead: Maya Nair Vice Lead: Noman Siddiqi BRM Connect TF’s model was approved by the Council and in May 2023 the Council appointed BRM Connect TF to develop an implementation plan for the project-based Mentoring. Task Force members were all agreed to continue serve in the same capacity. BRM Connect TF meeting is in June
- [Public Health Outreach Shared Interest Group](https://absa.org/news/2023-09-public-health-outreach-shared-interest-group/) - Lead: Marian Downing Co-Lead: Shoolah Escott Lisa Wallace (West Virginia Office of Laboratory Services) presented the Public Health Outreach Shared Interest Group’s (SIG) poster titled “Public Health Laboratory Construction & Renovation Helpful Tips” at the APHL Annual Meeting in May. She also did the speed dating session. Both the poster and the speed dating session
- [Preconference Course Committee](https://absa.org/news/2023-09-preconference-course-committee/) - Chair: Kalpana Rengarajan Co-Chairs: Geoffrey Phillips, Raymond Scheetz, and Danielle Daniely PCC completed the review of course proposals in May. The committee selected 19 proposals for in-person courses and seven proposals for virtual courses for the 66th Annual Biosafety and Biosecurity Conference. We had a 100% attendance during the facilitator call and all facilitators have
- [Member Resources Committee (MRC)](https://absa.org/news/2023-09-member-resources-committee-mrc/) - Chairs: Dee Zimmerman and Betsy Weirich The MRC has posted the recommended listing of Preconference and Virtual courses for biosafety professionals entering the profession. MRC is seeking ABSA members that would be interested in mentoring, please email info@absa.org with your information which will be forwarded to the MRC.
- [Public Relations and Marketing Committee (PRM)](https://absa.org/news/2023-09-public-relations-and-marketing-committee-prm/) - Chair: Danielle Rintala Co-Chair: Robin Tobias PRM is working to prepare for Biosafety and Biosecurity Month through finalizing a permanent graphic to represent the month that can be reused annually. Biosafety and Biosecurity Month is recognized in October annually and is an opportunity for our community to recognize, reflect, promote, and advocate for biosafety and biosecurity
- [Affiliate Relations Committee (ARC)](https://absa.org/news/2023-09-affiliate-relations-committee-arc/) - Co-Chairs: Lia Vizzotti and Parimala Arokiaraj Application from the Brazilian Association: We have received an application from the Brazilian Association for affiliation with our organization. The application was reviewed and approved by the committee members. It was carefully evaluated to ensure the affiliates’ mission and goals align with ABSA’s values. Final approval for affiliation will
- [Scientific Program Committee (SPC)](https://absa.org/news/2023-09-scientific-program-committee-spc/) - Chairs: AJ Troiano and Colleen Kovacsics The Scientific Program Committee (SPC) is pleased to share that the agenda for the 66th Annual Biosafety and Biosecurity Hybrid Conference in Omaha, Nebraska is now on the conference website! While this is normally completed by the beginning of the summer, this year we were challenged with nearly triple
- [Emerging Infectious Disease Consortium (EIDC)](https://absa.org/news/2023-09-emerging-infectious-disease-consortium-eidc/) - Chairs: Esmeralda Meyer and Marian Downing EIDC Toolboxes (on ABSA website main page) continue to be updated monthly with the most recent credible resources. Here are additional contributions so far for 2023: Recently added toolboxes include those for Fungi and Waterborne Diseases, and additional resources for parasitic diseases. The EIDC submitted a 2023 Conference proposal entitled A Panel
- [Technical & Regulatory Review (TRR)](https://absa.org/news/2023-09-technical-regulatory-review-trr/) - Chair: Esmeralda Meyer Members of the TRR Committee continue to monitor the Federal Register for instances where proposed regulatory changes are announced. At the request of the ABSA leadership, the TRR prepared a draft document with comments and recommendations to the WHO Biosecurity Guidance in July 2023. Conversations between the Team Leaders for Regulatory & Technical Affairs
- [Biosafety and Biosecurity Training Course® (BBTC)](https://absa.org/news/2023-09-biosafety-and-biosecurity-training-course-bbtc/) - Chair: Bob Ellis The BBTC was held in August in Fort Collins, CO to a full house of 70 participants (11 were international registrants). The next offering will be held August 5-9, 2024. The course director for the BBTC reminds everyone that attendees have the opportunity to learn about many aspects of biosafety and biosecurity—with
- [Exam Development Board (EDB)](https://absa.org/news/2023-09-exam-development-board-edb/) - Chair: Joseph Kozlovac Co-Chair: David Harbourt The Exam Development Board is continually working to maintain the quality of the CBSP exam and the integrity of the credential. The Board met with a statistician post examination in July. There were 28 individuals that sat for the exam this year and of those 19 have been conferred with
- [E-Communications Committee](https://absa.org/news/2023-09-e-communications-committee/) - Chair: Matt Anderson Co-Chair: Tim Sturgis The E-Communications committee has been working diligently on revamping the navigation menus for the ABSA website and should be able to roll out those changes by the end of the year. The next step will involve getting assistance from all committees, task forces and other groups that have content
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2023-09-credentialing-evaluation-board-ceb/) - Chair: Paul Meechan Co-Chair: John Henneman The Board continues to meet monthly to review RBP and CBSP applications. Information on credential criteria for both is posted on the ABSA website. The Board welcomes Rachel Gamble as a new Board member and thanks John Balog for his years of service.
- [Learning Verification Committee](https://absa.org/news/2023-09-learning-verification-committee/) - Chair: Niki Drazenovich Co-Chair: Matt Fischer ABSA members currently have eight quizzes available online for CM points and 11 quizzes in development. These quizzes are low cost and can be located on the website at https://absa.org/online-education/.
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2023-09-credentialing-maintenance-board-cmb/) - Chair: Hallie Hoskins Co-Chair: Rhonda O’Keefe The Board has created an improved Credentialing Maintenance (CM) Worksheet in Excel format, which tallies CM points automatically. This new format is being finalized to ensure consistency in wording and points values with the current worksheet and will be posted online for use shortly. Credential professionals will be able
- [Bylaws Committee](https://absa.org/news/2023-09-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office will forward the changes to the committee for review and
- [Journal - Applied Biosafety](https://absa.org/news/2023-09-journal-applied-biosafety/) - Coeditors-in-Chief: Barbara Johnson and Karen Byers Associate Editors: David Gillum and Scott Patlovich We are pleased to announce that Applied Biosafety (APB) has recently achieved several notable landmarks. First, the journal recently received its first published Journal Impact Factor (JIF) of 1.5. This metric recognizes that the journal is part of a globally recognized, selective database of
- [Exhibitors Committee](https://absa.org/news/2023-09-exhibitors-committee/) - Chair: William Peters Exhibits at the 66th Annual Biosafety and Biosecurity Hybrid Conference will be held October 15-17, 2023, at the CHI Health Center in Omaha, Nebraska. ABSA International encourages your company to participate by exhibiting their products and services and/or sponsoring an event. We have 47 exhibitors and 8 sponsors—4 Bronze, 2 Silver, 1
- [President’s Report](https://absa.org/news/2023-09-presidents-report/) - Dear Biosafety Professionals, I hope you had a wonderful summer. It is hard to believe my time as President is coming to an end. It has gone by in the blink of an eye. As I reflect on this past year, I hope that my contributions have resulted in a better and stronger foundation for
- [Distance Learning Committee (DLC)](https://absa.org/news/2023-09-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Eric Lewis, Ericka Pearce, and Endah Sulistijo The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. As of August 1, 2023, nine courses have been completed, reaching over 680 participants. Webinars scheduled for the coming months include: Techniques and Tools for
- [Webinars, Recordings, On-demand Modules](https://absa.org/news/2023-09-webinars-recordings-on-demand-modules/) - Available for Purchase: Conspiracy Theories, Mis- and Disinformation Available for purchase until: September 28 Large-scale Biosafety Available for purchase until: October 19 Molecular Biology 101 Available for purchase until November 15 PDC1V – Introduction to Biosafety in the Clinical Setting Available for purchase until November 29 Techniques and Tools for Conducting Relevant Literature Reviews Available
- [Publications Committee](https://absa.org/news/2023-09-publications-committee/) - Chair: R. Vilmarie Rodriguez Figueroa Co-Chair: Larry Mendoza The Publications Committee has been busy working on a number of projects. One of which is on the ABSA Blog. The Committee is actively looking for blog submissions to review and post. Those interested can view current and past blogs as well as access the blog submission
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2023-09-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [ABSA International Membership Site](https://absa.org/news/2023-09-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase
- [Anthology of Biosafety](https://absa.org/news/2023-09-anthology-of-biosafety/) - The Anthology of Biosafety is a 14-book series that addresses biosafety in different settings including: I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level 3 VIII: Evolving Issues in Containment IX: Exploring the Performance Envelope for
- [ABSA International Inclusion Statement](https://absa.org/news/2023-09-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Job Board](https://absa.org/news/2023-09-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance their career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Public Relations and Marketing Committee](https://absa.org/news/2023-06-public-relations-and-marketing-committee/) - Chair: Danielle Rintala Co-Chair: Robin Tobias The Public Relations and Marketing Committee has been busy shifting its strategy to focus more on the public relations piece of our group this year. We are exploring training opportunities so we can learn more about public relations. We are working on a media toolkit to help guide biosafety
- [Exhibitors Committee](https://absa.org/news/2023-06-exhibitors-committee/) - Chair: William Peters Exhibits at the 66th Annual Biosafety and Biosecurity Hybrid Conference will be held October 15-17, 2023, at the CHI Health Center in Omaha, Nebraska. ABSA International encourages your company to participate by exhibiting their products and services and/or sponsoring an event. We have twenty-two exhibitors and six sponsors—Advarra (Platinum); Miltenyi Biotec (Gold);
- [Advanced Biosafety Training Series Subcommittee (ABTS)](https://absa.org/news/2023-06-advanced-biosafety-training-series-subcommittee-abts/) - Chairs: Dan Eisenman and Shalaka Kotkar The ABTS modules were completely overhauled in 2022. Our goal for 2023 was to record audio for the ABTS modules, which we originally expected would cost about $2,000. The subcommittee is extremely grateful to Endah Sulistijo who found a way to record the audio at no cost and proceeded
- [Credentialing Maintenance Board](https://absa.org/news/2023-06-credentialing-maintenance-board/) - Chair: Hallie Hoskins Co-Chair: Rhonda O’Keefe The Board is excited to announce a forthcoming improved CM Worksheet! Credentialed professionals will be able to track CM points and submit for their five-year recertification. This new Excel format will allow users to see how they are accumulating points and to make sure they are accumulating the 15
- [Learning Verification Committee](https://absa.org/news/2023-06-learning-verification-committee/) - Chair: Niki Drazenovich Co-Chair: Matt Fischer The Learning Verification Committee has reviewed Applied Biosafety Journals V14 through V23 as well as two Anthologies and a few other resources. ABSA members currently have eight quizzes available online for CM points and nine quizzes are in development. These quizzes are low cost and can be located on
- [Bylaws Committee](https://absa.org/news/2023-06-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The ABSA Office will forward the changes to the committee for
- [Scientific Program Committee (SPC)](https://absa.org/news/2023-06-scientific-program-committee-spc/) - Chairs: AJ Troiano, Daniel Eisenman, and Colleen Kovacsics The Scientific Program Committee (SPC) over the last several months has been well under way planning for the 66th Annual Biosafety and Biosecurity Hybrid Conference come October in Omaha, Nebraska. Working with the support of the Local Arrangements Committee, the SPC pooled together a list of nearly
- [Principles and Practices of Biosafety (PPB)](https://absa.org/news/2023-06-principles-and-practices-of-biosafety-ppb/) - Co-Leads: Carrie Smith and Patrick Condreay The spring session of Principles and Practices of Biosafety was held in Alexandria, VA in March. The summer session, to be held in Pittsburgh, PA in July, is full. The instructors will meet before the summer class for our annual curriculum workshop.
- [Credentialing Evaluation Board](https://absa.org/news/2023-06-credentialing-evaluation-board/) - Chair: Paul Meechan Co-Chair: John Henneman The Credentialing Evaluation Board (CEB) continues to meet at least monthly, completing the applications to sit for the Certified Biological Safety Professional (CBSP) examination earlier this spring. The Board also reviewed application for the Registered Biosafety Professional (RBP) credential on an ongoing basis. The Board would like to remind
- [Public Health Outreach Shared Interest Group](https://absa.org/news/2023-06-public-health-outreach-shared-interest-group/) - Lead: Marian Downing Co-Lead: Shoolah Escott The Public Health Outreach Shared Interest Group (SIG) added the following new members in February: Crystal Fortune (MT PH), Nikki Marlenee (CO State), Susan Harper (NIH), David Hill (NY Wadsworth Center). The recording of the three presentations from the one-hour webinar for the Safety Committee of the American Association
- [Distance Learning Committee (DLC)](https://absa.org/news/2023-06-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Eric Lewis, Ericka Pearce, Endah Sulistijo The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. As of May 1, 2023, four courses have been completed, reaching over 380 participants. Webinars scheduled for the coming months include Concepts of Virology; Conspiracy Theories,
- [Member Resources Committee (MRC)](https://absa.org/news/2023-06-member-resources-committee-mrc/) - Chairs: Dee Zimmerman and Betsy Weirich The MRC replaced the previous Membership and Mentoring Committees. They continue to review the current information on ABSA.org. The review results in updates to the website, making member information more comprehensive and easier to find. The MRC has completed the annual review of “New Member Welcome Letter” that is
- [Technical & Regulatory Review (TRR)](https://absa.org/news/2023-06-technical-regulatory-review-trr/) - Chair: Esmeralda Meyer Members of the TRR Committee continue to monitor the Federal Register for instances where proposed regulatory changes are announced. The TRR and Legislative Affairs Chairs are discussing optimization of the roles and responsibilities assigned to each committee leveraging the ABSA members' expertise. Stay tuned.
- [Preconference Course Committee](https://absa.org/news/2023-06-preconference-course-committee/) - Chair: Kalpana Rengarajan Co-Chairs: Geoffrey Phillips, Raymond Scheetz, and Danielle Daniely PCC started 2023 with a bang. We had a total of 35 Preconference course proposals submitted for the 2023 ABSA conference. We have completed the decision call and selected the courses to be offered. Instructors will be informed about their respective courses by the
- [Legislative Affairs Committee](https://absa.org/news/2023-06-legislative-affairs-committee/) - Chair: Karon Floyd Early in the year, there was a change in leadership. The Chair, Brian O’Shea, stepped down and the Co-Chair, Karon Floyd, assumed responsibilities as the Chair of the Legislative Affairs Committee. Mr. O’Shea agreed to continue to assist the committee. Members of the Legislative Affairs Committee reviewed and provided comments on a
- [E-Communications Committee](https://absa.org/news/2023-06-e-communications-committee/) - Chair: Matt Anderson Co-Chair: Tim Sturgis The E-Communications committee is busy working on updates to the ABSA website to improve navigation and organization of content. As part of the refresh of the website, we want to add more pictures of biosafety professionals doing biosafety activities instead of most of the pictures being of us at
- [2023 Omaha Local Arrangements Committee](https://absa.org/news/2023-06-2023-omaha-local-arrangements-committee/) - Chair: Matt Anderson The Local Arrangements Committee for Omaha 2023 has been working hard for the past year to make the ABSA Conference in Omaha a great experience! The Tuesday night banquet will be held at the historic Durham Museum in downtown Omaha, and we have some fun activities planned for the night including a
- [Journal Board](https://absa.org/news/2023-06-journal-board/) - Co-editors: Karen Byers, Barbara Johnson Associate Editors: David Gillum, Scott Patlovich Applied Biosafety serves the ABSA International commitment to promoting global biosafety by providing a forum for exchanging sound biosafety and biosecurity initiatives by publishing original articles, review articles, letters to the editors, commentaries, and brief reviews. Applied Biosafety is a peer-reviewed scientific journal, and
- [LAI Database Working Group](https://absa.org/news/2023-06-lai-database-working-group/) - Co-Chairs: Karen Byers, Margaret Juergensmeyer, Esmeralda Meyer The LAI Database working group is preparing a campaign to add new entries to this resource. Literature searches are ongoing; soon, we will need volunteers to summarize the relevant information in the database. If interested, please contact the ABSA Office, info@absa.org with LAI Database in the subject line.
- [Biological Select Agent and Toxin (BSAT) Community Advocate Committee (CAC)](https://absa.org/news/2023-06-biological-select-agent-and-toxin-bsat-community-advocate-committee-cac/) - Chair: Kelly Flint Co-chair: Anthony Sambol The BSAT Community Advocate Committee (BSAT CAC) is in a rebuilding phase. This group no longer has a CDC support contract and is looking to redefine itself. At this time, all activities will be supported by ABSA International. The BSAT CAC is looking to add to its membership and
- [Biosecurity Symposium Steering Committee](https://absa.org/news/2023-06-biosecurity-symposium-steering-committee/) - Chair: Cristine C. Lawson Co-chairs: Enitra Jones and Ryan Burnette The steering committee, working with ABSA leadership, has established dates for the 3rd International Biosecurity Virtual Symposium, as well as topics, subtopics, and a timeline for proposal submissions (platform, posters, and courses). The committee is now working on building a roster for the steering committee;
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2023-06-absa-internationals-promotional-videos-and-youtube-channel/) - Many thanks to the Public Relations/Marketing Committee as ABSA International now has promotional videos for our ABSA organization and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel. In addition, , ABSA’s YouTube channel contains video interviews of conference presenters and keynotes. Feel free to share
- [ABSA International Membership Site](https://absa.org/news/2023-01-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase
- [Job Board](https://absa.org/news/2023-01-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Anthology of Biosafety](https://absa.org/news/2023-01-anth/) - The Anthology of Biosafety is a 14-book series that addresses biosafety in different settings including: I: Perspectives on Laboratory Design II: Facility Design Considerations III: Application of Principles IV: Issues in Public Health V: BSL-4 Laboratories VI: Arthropod Borne Diseases VII: Biosafety Level 3 VIII: Evolving Issues in Containment IX: Exploring the Performance Envelope for
- [ABSA International Inclusion Statement](https://absa.org/news/2021-10-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [President’s Report](https://absa.org/news/2023-06-presidents-report/) - Dear Biosafety Professionals, I hope you all are having a good spring. There has been a lot taking place over the past six months and I am sure you have noticed that there has been a lot happening in the biosafety profession. In this newsletter, I share some of the recent happenings at ABSA International.
- [President’s Report](https://absa.org/news/2023-01-presidents-report/) - Dear Biosafety Professionals, I am honored and humbled to serve ABSA International as President for the coming year. I am looking forward to collaborating with the Council, our leaders, and volunteers. There is always a lot of work to be done and it is important we recognize the amount of effort and time our volunteers
- [Exhibitors Committee](https://absa.org/news/2023-01-exhibitors-committee/) - Chair: William Peters The 65th Annual Biosafety and Biosecurity Hybrid Conference was held from October 14-19, 2022, in Milwaukee, Wisconsin. We had 52 companies exhibiting and six sponsors—2 Bronze, 3 Silver, and 1 Platinum. Onsite exhibit booths were welcomed back and open during the 3-day conference for participants to access and interact booth personnel. We
- [Credentialing Evaluation Board](https://absa.org/news/2023-01-credentialing-evaluation-board/) - Chair: Paul Meechan Co-Chair: John Henneman The Credentialing Evaluation Board (CEB) continues to meet at least monthly (frequently more than once per month) to review applications for certification as Registered Biosafety Professionals (RBP) and Certified Biological Safety Professionals (CBSP). This fall, the Board made minor revisions to the CBSP forms for candidates to improve the
- [Bylaws Committee](https://absa.org/news/2023-01-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office will forward the changes to the committee for review
- [Distance Learning Committee (DLC)](https://absa.org/news/2023-01-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Eric Lewis, Ericka Pearce, Endah Sulistijo The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. In 2022, 11 courses were offered, reaching over 560 participants. Webinars scheduled for early 2023 include Updating your Preparedness Toolbox for Future Outbreaks or Pandemics and
- [Principles and Practices of Biosafety (PPB)](https://absa.org/news/2023-01-principles-and-practices-of-biosafety-ppb/) - Co-Chairs: Patrick Condreay and Carrie Smith The next class will be March 12-17, 2023, in Alexandria, Virginia. The summer session will be July 9-14, 2023, in Pittsburgh, Pennsylvania.
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2023-01-credentialing-maintenance-board-cmb/) - Chair: Hallie Hoskins Co-Chair: Rhonda O’Keefe The Credentialing Maintenance Board (CMB) welcomes new member Heidi Page and the transition of new chair Hallie Hoskins beginning in the new year. Su-Hwi Hung-Cunliffe is stepping down after graciously serving our Board for the last 4 years. The Board has had a busy year reviewing 138 CM applications
- [E-Communications Committee](https://absa.org/news/2023-01-e-communications-committee/) - Chair: Matt Anderson Co-Chair: Tim Sturgis The E-Communications Committee sponsored the selfie booth at the ABSA Conference in Milwaukee in October, and it was a big hit with many attendees taking pictures with friends and colleagues. There were many biosafety-themed buttons given out at the conference to those who posted pictures on social media. The
- [Public Health Outreach Special Interest Group](https://absa.org/news/2023-01-public-health-outreach-special-interest-group/) - Lead: Marian Downing Co-Lead: Shoolah Escott The Public Health Outreach Special Interest Group provided a 1-hour webinar for the Safety Committee of AAVLD (American Association of Veterinary Laboratory Diagnosticians) on October 8. There were 33 attendees; this presentation was in conjunction with APHL. The presenters were ABSA members Nicole Marlenee, Stephanie Kutz, and Mylissia Smith,
- [Member Resources Committee (MRC)](https://absa.org/news/2023-01-member-resources-committee-mrc/) - Chairs: Dee Zimmerman, Betsy Weirich The MRC met in October during the ABSA Annual Conference in Milwaukee. The committee reviewed the P&Ps with two new members and discussed the role of the MRC as advocates for the ABSA membership, encompassing both membership and mentoring. As advocates the MRC is available to support members during the
- [ABSA Ambassadors](https://absa.org/news/2023-01-absa-ambassadors/) - Chair: David Harbourt Co-Chair: Marian Downing Karen Byers provided information at the NEBSA Symposium on October 22 about Applied Biosafety’s acceptance into PubMed. She also provided a preconference course on laboratory acquired infections (LAIs) at the November 4 Southern Biosafety Association Symposium.  Nicole Marlenee, Stephanie Kutz, and Mylissia Smith provided a 1-hour webinar for
- [Scientific Program Committee (SPC)](https://absa.org/news/2023-01-scientific-program-committee-spc/) - Chairs: AJ Troiano, Daniel Eisenman and Colleen Kovacsics With the 65th Annual Biosafety and Biosecurity Hybrid Conference in the books, the SPC thoroughly evaluated the conference feedback both through the conference application (Slido) as well as the ABSA survey. It is through these comments, concerns, and general evaluations that the SPC works to continuously improve
- [Emerging Infectious Disease Consortium (EIDC)](https://absa.org/news/2023-01-emerging-infectious-disease-consortium-eidc/) - Chairs: Esmeralda Meyer, Marian Downing The EIDC continues to compile, assess, and post biosafety resources for all Toolboxes. The existing Toolboxes for SARS-CoV-2/COVID-19, Zika, Influenza, Viral Hemorrhagic Fever, Antibiotic/Antimicrobial Resistance, Polio Virus, and Pox Viruses continue to be updated monthly, as new information becomes available. New in January will be a toolbox for Water-borne diseases,
- [Training Tools & Resources for Biosafety Professionals (TTR)](https://absa.org/news/2023-01-training-tools-resources-for-biosafety-professionals-ttr/) - Chair: Maya Nair Co-Chair: Will Pinard The Training Tools/Resources (TTR) Committee met every month virtually and in October, met in person in Milwaukee at the ABSA annual conference. During the October meeting, the Council approved the request to have Will Pinard serve as co-chair. Several resources on biorisk management, NIH resources, and biosecurity links from
- [BRM Connect Task Force](https://absa.org/news/2023-01-brm-connect-task-force/) - Lead: Maya Nair BRM Connect Task Force committee met virtually from June through November. In October, the committee met in-person in conjunction with the ABSA annual conference. Through monthly discussions, the task force has determined that a mentorship program akin to the BRM Connect pilot program is feasible with appropriate guidance and on-going support from
- [Preconference Course Committee](https://absa.org/news/2023-01-preconference-course-committee/) - Chair: Kalpana Rengarajan Co-Chairs: Geoffrey Phillips, Raymond Scheetz, and Danielle Daniely PCC had a very successful year. We had a total of 561 participants who took in-person courses during the conference and 186 participants who took courses virtually. For the entire 65th Annual Conference, a total of 152 international participants attended either in-person or virtually,
- [Legislative Affairs Committee](https://absa.org/news/2023-01-legislative-affairs-committee/) - Co-Chairs: Karon Floyd and Brian O’Shea The Legislative Affairs Committee has been working to monitor proposals for legislation on Capitol Hill that may have a potential impact on biological research and/or research oversight. Most recently, ABSA was asked to review and provide feedback regarding the draft bill from Ted Cruz (R-TX), to require the Director
- [Journal Board](https://absa.org/news/2023-01-journal-board/) - Editors: Karen Byers and Barbara Johnson Associate Editors: Scott Patlovich and David Gillum Applied Biosafety has continued to receive a high volume of quality manuscripts throughout 2022. The final printed issue this year (Volume 27, Number 4, 2022) shipped in December. Based on the topics of recent submissions, we are planning two special themed
- [Education & Curriculum Task Force](https://absa.org/news/2023-01-education-curriculum-task-force/) - Co-Leads: Brandy Nelson and Betsy Weirich The Education and Curriculum Task Force Co-leads (Nelson and Weirich) sent letters to the current membership to determine their level of interest in continuing with the Task Force. Responses indicated that there may be a need for additional members or time commitments from existing members for the ECTF to
- [Technical & Regulatory Review (TRR)](https://absa.org/news/2023-01-technical-regulatory-review-trr/) - Chair: Esmeralda Meyer During the last quarter of 2022, the Technical and Regulatory Review Committee contributed to the ABSA Council request to respond to Senate Bill Legislation to Establish a Repository of Institutional Biosafety Committee Minutes for Federally Funded Research Projects that Involve Potential Pandemic Pathogens, and For Other Purposes (Senator Cruz). Several members of
- [Webinars, Recordings, On-demand](https://absa.org/news/2023-01-webinars-recordings-on-demand/) - There’s still time to purchase the recording of the Scientific Program of the 65th Annual Biosafety and Biosecurity Hybrid Conference held October 2022 in Milwaukee, Wisconsin. Access to the recording will be available online until June 1, 2023. Recordings for the Virtual Professional Development Courses are also available for purchase until March 17, 2023: 1V.
- [ABSA International Membership Site](https://absa.org/news/2022-09-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase ABSA International
- [Job Board](https://absa.org/news/2022-09-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Anthology XIV: Sustainability](https://absa.org/news/2022-09-job-board-2/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information to
- [Technical and Regulatory Review Committee (TRR)](https://absa.org/news/2022-09-technical-and-regulatory-review-committee-trr/) - Chair: David Pawlowski Co-Chair: Esmeralda Meyer This quarter, the TRR committee assisted with ABSA responses to two items. The first item was published in the Federal Register entitled, “Screening Framework Guidance for Providers and Users of Synthetic Nucleic Acids.” As published, this regulation would add a burden to both the producers of synthetic nucleic acids
- [Training Tools and Resources (TTR)](https://absa.org/news/2022-09-training-tools-and-resources-ttr/) - Chair: Chair: Maya Nair Co-Chair: Will Pinard TTR collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These resources are collated on the ABSA website featuring a search function, keywords, the origin, and the type of resources. The committee uses an evaluation and review method
- [Exam Development Board (EDB)](https://absa.org/news/2022-09-exam-development-board-edb/) - Chair: Joseph Kozlovac Co-Chair: Heather Blair The (EDB) has been very busy over the past few months, meeting a total of 9 hours to prepare the 150 question CBSP Exam. The entire EDB reviews every question on the exam and then a final review is conducted by the Chair as a final QC check. This
- [ABSA-Owned Course Committee](https://absa.org/news/2022-09-absa-owned-course-committee/) - Advanced Biosafety Training Series (ABTS) Modules Lead: Daniel Eisenman Co-Lead: Shalaka Kotkar The ABTS modules have been overhauled and are live online. The committee’s focus for 2022 is generating audio narration of the scripted slide notes. Basic Risk Assessment Lead: Rachel Gamble Co-Lead: David Harbourt The Basic Risk Assessment course has transferred leadership and will
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2022-09-credentialing-evaluation-board-ceb/) - Chairs: Paul Meechan Co-Chair: John Henneman The CEB continues to meet at least monthly (frequently more than once per month) to review applications for certification as Registered Biosafety Professionals (RBP). Throughout the spring and summer, the Board continued to make minor revisions to the RBP and CBSP forms for candidates to improve the function of
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2022-09-credentialing-maintenance-board-cmb/) - Chair: Su-Hwi Hung-Cunliffe Co-Chair: Rhonda O’Keefe The CMB has reviewed 59 CM worksheets for the 2017-2021 credentialing cycle and one CM worksheet for extension. Six worksheets were randomly selected for audit and were passed. There were 57 approvals, one pending review, and one failure among the worksheets reviewed. One worksheet was granted a 1-year extension.
- [Preconference Course Committee (PCC)](https://absa.org/news/2022-09-preconference-course-committee-pcc/) - Chair: Kalpana Rengarajan Co-Chairs: Danielle Daniely, Geoffrey Phillips, and Ray Scheetz The PCC will be offering 15 courses in-person at the Annual Conference and five virtual courses with one of the courses occurring in February of 2023. Virtual course offerings start in September. If the membership has any questions or suggestions regarding PCC, please contact
- [Emerging Infectious Disease Committee (EIDC)](https://absa.org/news/2022-09-emerging-infectious-disease-committee-eidc/) - Chairs: Esmeralda Meyer and Marian Downing The EIDC has been busy this summer compiling and assessing biosafety resources for Monkeypox and Polio. The Monkeypox section has been posted on the ABSA EIDC Toolboxes page and it is updated regularly. Biosafety-related resources for Polio were also compiled by the members of the EIDC and made available
- [Distance Learning Committee (DLC)](https://absa.org/news/2022-09-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Eric Lewis, Ericka Pearce, and Endah Sulistijo The DLC continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. Currently in 2022, 12 courses have been scheduled and/or completed, reaching over 500 participants. Webinars under development have a focus on several topics including biosafety in the
- [Membership Resources Committee (MRC)](https://absa.org/news/2022-09-membership-resources-committee-mrc/) - Chairs: Dee Zimmerman and Betsy Weirich The MRC has been reviewing the current information on ABSA.org and my.ABSA.org. The review will result in updates to the websites with information for the MRC. The Membership Resources Committee is a new committee that replaces the previous Membership and Mentoring Committees. The MRC can be found under Groups
- [E-Communications Committee](https://absa.org/news/2022-09-e-communications-committee/) - Chair: Matt Anderson Co-Chair: Tim Sturgis The E-Communications Committee has started a review of the ABSA International website navigation and organization in response to feedback from the membership. This will likely be a lengthy process that will extend into 2023, but the goal is to make it easier for site visitors to find what they
- [Public Health Outreach (PHO) Shared Interest Group (SIG)](https://absa.org/news/2022-09-public-health-outreach-pho-shared-interest-group-sig/) - Leads: Marian Downing and Shoolah Escott Topics have been chosen and speakers are identified for a 1-hour webinar to be presented by the SIG at the AAVLD (American Association of Veterinary Laboratory Diagnosticians) Safety Committee Meeting on October 8 as part of their annual meeting in Minneapolis. A biosafety resource list has been prepared from
- [Awards Committee](https://absa.org/news/2022-09-awards-committee/) - Chairs: Jeff Potts and John Veitch The Awards Committee performed our annual solicitation for Honor Award Nominees from the membership. ABSA now has 4 Honor Awards, and we also select the most relevant article published within the past year in Applied Biosafety. Recipients for 2022 will be recognized at the Honor’s Luncheon this year in
- [Scientific Program Committee (SPC)](https://absa.org/news/2022-09-scientific-program-committee-spc/) - Chairs: AJ Troiano, Cristine Lawson, and Daniel Eisenman The SPC has worked diligently the past few months reviewing poster and platform abstracts for the 65th Annual Biosafety and Biosecurity Hybrid Conference and finalizing the program. This conference cycle, we saw abstract submissions decrease to less than 50% of pre-pandemic years, creating one of our greatest
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2022-09-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Journal Board](https://absa.org/news/2022-09-journal-board/) - Editors: Karen Byers, Barbara Johnson, Scott Patlovich, and David Gillum We are proud to announce that Applied Biosafety (APB) was accepted for indexing in the PubMed Central (PMC), a leading indexing service. This is another milestone in promoting ABSA International as the premier resource for evidence-based biosafety and biosecurity. To gain acceptance into PubMed Central,
- [Bylaws Committee](https://absa.org/news/2022-09-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. One review has been completed since the last newsletter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office
- [Exhibitors Committee](https://absa.org/news/2022-09-exhibitors-committee/) - Chair: William Peters Exhibits at the 65th Annual Biosafety and Biosecurity Hybrid Conference will be open on Sunday, October 16 at 6:30-8:30 pm during the Opening Reception as well as Monday, October 17 and Tuesday, October 18 from 9:00-4:00 pm. The conference and exhibits will be held at the Wisconsin Center in Milwaukee, WI. There are
- [President’s Report](https://absa.org/news/2022-09-presidents-report/) - LouAnn Burnett, CBSP(ABSA) Happy September! The ABSA International team (our office and many, many, many members) are busy preparing for the 65th Annual Biosafety and Biosecurity Hybrid Conference to be held in-person AND virtually from Milwaukee, WI on October 14-19! Early registration closes September 13, so submit your registration in. Four Virtual Professional Development Courses
- [Emerging Infectious Disease Consortium](https://absa.org/news/2022-06-emerging-infectious-disease-consortium/) - Chairs: Esmeralda Meyer and Marian Downing The Emerging Infectious Diseases Committee continues to update the SARS-CoV-2, Zika, Influenza, Hemorrhagic Fever Viruses, and Antimicrobial Resistance toolboxes. The committee is also reviewing documents created during the COVID-19 pandemic to ensure that these reflect current guidance.
- [Journal Board](https://absa.org/news/2022-06-journal-board/) - Editors: Karen Byers, Barbara Johnson, Scott Patlovich, and David Gillum The in-press Applied Biosafety Volume 27, Number 2 presents current research and commentary on a range of critical biosafety topics. Applied Biosafety Volume 27, Number 3 will feature SARS-CoV-2, experiences, responses, and future pandemic preparation. The report from the Applied Biosafety (APB) ONLINE NOW website
- [NextGen SIG](https://absa.org/news/2022-06-nextgen-sig/) - Chairs: Christina Tafoya and Luis Alberto Ochoa Carrera After a hiatus and changes in leadership, new chairs were finalized March 2022. The group is chaired by Christine Tafoya and Louis Alberto Ochoa-Carrera. The group is recruiting members and will be establishing goals and action plans once membership is stabilized.
- [Membership Resources Committee](https://absa.org/news/2022-06-membership-resources-committee/) - Chairs: Dee Zimmerman and Betsy Weirich The Membership Resources Committee (MRC) facilitates the relationship of members within ABSA International. The MRC supports and enhances biosafety and biosecurity knowledge by providing sustained opportunities for biosafety and biosecurity communication, education, and mentoring.
- [Publications Committee](https://absa.org/news/2022-06-publications-committee/) - Chairs: Aparupa Sengupta and R. Vilmarie Rodriguez Figueroa The effective Committee Policies and Procedures (P&P) were distributed and discussed with committee members. The effective version is providing clarity in Committee Scope, Mission, and Responsibilities for roles within the Committee. ABSA blog status is as follows: Blog workflow was completed, and a procedure describing the workflow
- [Technical and Regulatory Review Committee (TRR)](https://absa.org/news/2022-06-technical-and-regulatory-review-committee-trr/) - Chairs: David R. Pawlowski and Esmeralda Meyer The TRR committee has been busy this quarter. Similar to the BMBL (Biosafety in Microbiological & Biomedical Laboratories) 6th edition summary published to the ABSA website, we have completed a summary of the WHO LBM (Laboratory Biosafety Manual) 4th edition and its accompanying monographs in collaboration with the
- [ABSA-Owned Course Committee](https://absa.org/news/2022-06-absa-owned-course-committee/) - Co-Chairs: Chad Austin and Lisa Benford Biosafety and Biosecurity Training Course® (BBTC) Chair: Bob Ellis The course directors for the BBTC are excited for the August 2022 sessions and would like to remind everyone that there is still available space for those who would like to attend and learn about biosafety and biosecurity—with General applications
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2022-01-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [ABSA International Membership Site](https://absa.org/news/2022-01-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase
- [Job Board](https://absa.org/news/2022-01-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Anthology XIV: Sustainability](https://absa.org/news/2022-01-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [Preconference Course Committee](https://absa.org/news/2022-06-preconference-course-committee/) - Kalpana Rengarajan (Chair), Danielle Daniely, Geoffrey Phillips, and Ray Scheetz (Co-Chairs) The Preconference Course Committee (PCC) is off to a good start. Twenty-two abstracts were submitted for the ABSA 2022 Conference. The membership had two meetings including the decision call on selecting the courses to be offered at the conference. There will be over 15
- [Bylaws Committee](https://absa.org/news/2022-06-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. Three reviews have been completed since the last newsletter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office
- [Public Relations and Marketing Committee (PR/M)](https://absa.org/news/2022-06-public-relations-and-marketing-committee-pr-m/) - Chairs: Danielle Rintala and Robin Tobias The Public Relations and Marketing Committee is pleased to announce plans for this year’s Biosafety and Biosecurity Month. We would like to focus on the core components of what October should be used to highlight at their institutions: ethical research, transparency, training, engagement, and stewardship of biosafety and biosecurity.
- [Education and Curriculum Task Force (ECTF)](https://absa.org/news/2022-06-education-and-curriculum-task-force-ectf/) - Leads: Brandy Nelson and Chad Austin The membership of the Education and Curriculum Task Force was joined by Betsy Weirich as Co-Lead. ECTF Co-Leads (Weirich and Nelson) have met regularly since the beginning of 2022 to examine the work of the ECTF to date, align task force goals with other ABSA committees and initiatives, and
- [Scientific Program Committee (SPC)](https://absa.org/news/2022-06-scientific-program-committee-spc/) - Chairs: AJ Troiano, Cristine Lawson, and Daniel Eisenman The 65th Annual Biosafety and Biosecurity Hybrid Conference is scheduled from October 14-19 in Milwaukee, Wisconsin. Over the last several months, the SPC has thoroughly reviewed the feedback from the previous conference and held several meetings discussing potential subject matter areas for the scientific program. The SPC
- [ABSA Ambassadors](https://absa.org/news/2022-06-absa-ambassadors/) - Chairs: David Harbourt and Marian Downing The Ambassadors Committee is currently looking for additional volunteers to join the committee and continue our mission of outreach and awareness of biosafety and ABSA International. The committee is also reviewing the policies and procedures along with updates to presentations used for ABSA outreach.
- [Public Health Outreach (PHO) Shared Interest Group (SIG)](https://absa.org/news/2022-06-public-health-outreach-pho-shared-interest-group-sig/) - Leads: Marian Downing and Shoolah Escott In the spirit of the One Health approach, ABSA/APHL is in active discussions with the American Association of Veterinary Laboratory Diagnosticians (AAVLD) Safety Committee about presenting a biorisk management webinar during their meeting at the October AAVLD conference. An APHL-ABSA mentoring proposal for PH and clinical laboratory biosafety officers
- [ABSA Exam Development Board (EDB)](https://absa.org/news/2022-06-absa-exam-development-board-edb/) - Chairs: Joseph Kozlovac and Heather Blair The Board’s primary role is to maintain the quality and value of the Certified Biological Safety Professional (CBSP) exam as well as the CBSP credential. EDB members have worked thoroughly to assure that examination questions are relevant, understandable, and reasonable. The exam is offered through the month of June each
- [Local Arrangements Committee](https://absa.org/news/2022-06-local-arrangements-committee/) - Chair: Danielle Rintala The Local Arrangements Committee is eager to welcome everyone to Milwaukee, Wisconsin this October for the 65th Annual Biosafety and Biosecurity Hybrid Conference. Milwaukee is a beautiful city with lots to see and do, teeming with restaurants, local shops, and breweries serving up Wisconsin's finest food and drink. Milwaukee is located on
- [Distance Learning Committee (DLC)](https://absa.org/news/2022-06-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Eric Lewis, Ericka Pearce, Endah Sulistijo The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. In 2021, 12 courses were completed reaching 917 participants. Currently in 2022, 11 courses have been scheduled and/or completed, reaching over 390 participants. Topics of upcoming
- [Learning Verification Committee](https://absa.org/news/2022-06-learning-verification-committee/) - Chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee has reviewed Applied Biosafety Journals Volume 23 and Volume 24. ABSA members currently have eight quizzes available online for CM points and nine quizzes in development. These quizzes are low cost and can be located on the website at absa.org/online-education/.
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2022-06-credentialing-maintenance-board-cmb/) - Chairs: Su-Hwi Hung-Cunliffe and Rhonda O’Keefe The Credentialing Maintenance Board (CMB) have reviewed 57 CM worksheets for the 2017-2022 credentialing cycle and two CM worksheet for extension. Six worksheets were randomly selected for audit and four were pass/approved and two are pending for review. There were fifty-six approvals and one failure among the worksheets reviewed.
- [Credentialing Evaluation Board](https://absa.org/news/2022-06-credentialing-evaluation-board/) - Chairs: Paul Meechan and John Henneman The Credentialing Evaluation Board (CEB) continues to meet at least monthly (frequently more than once per month) to review applications for certification as Registered Biosafety Professionals (RBP) as well as prospective candidates for the June 2022 Certified Biosafety Professional (CBSP) examination. Throughout the winter and spring, the Board continued
- [Exhibitors Committee](https://absa.org/news/2022-06-exhibitors-committee/) - Chair: William Peters The 2nd Biosecurity Hybrid Symposium was held from May 3-6 in Minneapolis, Minnesota. Exhibits were in-person for the first time since November 2019. We had six exhibitors and one sponsor. Exhibits at the 65th Annual Biosafety and Biosecurity Hybrid Conference will be open on Sunday, October 16 at 6:30-8:30 pm during the
- [President’s Report](https://absa.org/news/2022-06-presidents-report/) - LouAnn Burnett, CBSP(ABSA) The ongoing pandemic has brought unprecedented attention to biosafety, biosecurity, public health, research with pathogens of pandemic potential, and high biocontainment laboratories. The issues that our profession has grappled with for years have, arguably, never been so visible to the public and under so much scrutiny by elected officials and policymakers. However,
- [ABSA International’s 2nd Biosecurity Symposium](https://absa.org/news/2022-01-absa-internationals-2nd-biosecurity-symposium/) - ABSA International’s 2nd Biosecurity Symposium will be May 3-6, 2022, at the Depot Renaissance Minneapolis Hotel. The hybrid symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on biosecurity governance, implementation,
- [Training Tools and Resources (TTR)](https://absa.org/news/2022-01-training-tools-and-resources-ttr/) - Chair: Lauriane Quenee Training Tools and Resources collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These collated resources are located on the ABSA website. The committee has finalized the organization of existing resources into a searchable database, featuring keywords, the origin, and the type
- [Publications Committee](https://absa.org/news/2022-01-publications-committee/) - Chairs: Aparupa Sengupta and R. Vilmarie Rodriguez Figueroa Publications Committee (PC) continues the commitment towards highlighting ABSA International’s role in the field of Biosafety and Biosecurity by contributing towards the e-platform publications. The PC plans to collaboratively work with the E-communications Committee and Public Relations and Marketing Committee to enhance the global presence of ABSA
- [E-Communications Committee](https://absa.org/news/2022-01-e-communications-committee/) - Chair: Matt Anderson The E-Communications Committee is proud to announce the winners of our ABSA Conference Social Media Contest. Most posts award goes to Kalpana Patel (KPGAGal) on Twitter and Sarah Atwood (@sarahattwood) on LinkedIn. Matthew Stinoski (@matthewstinoski), Katherine Kasper (@KKasper42), the Dittmer Lab (@LabDittmer), and The Baker Company (@TheBakerCo) were also selected as winners
- [Education and Curriculum Task Force (ECTF)](https://absa.org/news/2022-01-education-and-curriculum-task-force-ectf/) - Leads: Brandy Nelson and Chad Austin Members of the Education and Curriculum Task Force have met regularly over the last quarter. ECTF members presented a discussion forum for ABSA members in September 2021. This forum was well attended by ABSA International members and generated excellent feedback. Member input received during this discussion forum will be
- [Public Relations and Marketing Committee (PR/M)](https://absa.org/news/2022-01-public-relations-and-marketing-committee-pr-m/) - Chairs: Danielle Rintala and Robin Tobias Public Relations and Marketing thanks everyone for their participation in Biosafety and Biosecurity Month. We also appreciate feedback about graphics and information provided during October. We invite our community of professionals to share ideas with us to consider for 2022 Biosafety and Biosecurity Month, public relations outreach, and marketing
- [Bylaws Committee](https://absa.org/news/2022-01-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office will forward the changes to the committee for review
- [Preconference Course Committee](https://absa.org/news/2022-01-preconference-course-committee/) - Antony Schwartz (Chair), Heather Blair (Co-Chair) and Angela Ragan (Co-Chair) The Preconference Course Committee (PCC) had a great 2021 conference! Participants were able to attend the virtual professional development courses as well as access the recordings to further their learning. Course recordings offered as part of the 2021 conference are available for viewing until March
- [Public Health Outreach (PHO) Shared Interest Group (SIG)](https://absa.org/news/2022-01-public-health-outreach-pho-shared-interest-group-sig/) - Leads: Marian Downing and Shoolah Escott There was a free joint ABSA/APHL Biosafety Month webinar on November 1, 2021, entitled “Biorisk Management Perspective: Then and Now” which featured Michael Stevenson, Danielle Rintala, and Marian Downing. Discussions are underway with other organizations, such as AAVLD (American Association of Veterinary Laboratory Diagnosticians) regarding outreach in biorisk management.
- [ABSA Ambassadors](https://absa.org/news/2022-01-absa-ambassadors/) - Chairs: David Harbourt, Marian Downing Most volunteer activities continue to be remote, due to the pandemic. Karen Byers presented on HIV research biosafety to the Boston Biosafety Working Group in September. The BSWG forum is organized by the Boston Public Health Commission to foster communication with EMS, fire, police, BL3 lab managers. Karen also met
- [Scientific Program Committee (SPC)](https://absa.org/news/2022-01-scientific-program-committee-spc/) - Chairs: Claudia Gentry-Weeks, AJ Troiano, and Cristine Lawson The 64th Annual Biosafety and Biosecurity Conference was held virtually from October 25-27. There were 17 oral presentations with 4 invited speakers and 3 roundtable sessions, 23 poster presentations, 2 networking sessions and virtual exhibitions. The presentations were designed to encourage participation in the conference and focused
- [Journal Board](https://absa.org/news/2022-01-journal-board/) - Editors: Karen Byers, Barbara Johnson, Scott Patlovich, David Gillum The Applied Biosafety journal (APB) continues to provide peer-reviewed information to serve the biosafety community. From January 1 to September 30, there were 58,864 full downloads. APB is now indexed or abstracted in: Web of Science Emerging Sources Citation Index (ESCI) Scopus Biological Abstracts BIOSIS Previews
- [Distance Learning Committee (DLC)](https://absa.org/news/2022-01-jdistance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Joleen Weese, Eric Lewis The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. Eleven courses have been completed so far in 2020 reaching over 886 participants. Work is currently underway scheduling several webinars for 2022.Webinar topics in the works for 2022
- [Accreditation Committee](https://absa.org/news/2022-01-accreditation-committee/) - Chairs: Bob Ellis and Rebecca Caruso There have been no new facilities accredited by ABSA during this past quarter.
- [Exam Development Board](https://absa.org/news/2022-01-exam-development-board/) - Chairs: Joseph Kozlovac and Heather Blair The Exam Development Board continues to review the current exam pool and develop new questions. We are Happy to announce that Dr. Julie Johnson from Kansas State University will be joining the board. We express our thanks and gratitude to Dr. Mary Delarosa for her years of outstanding service
- [Learning Verification Committee](https://absa.org/news/2022-01-learning-verification-committee/) - Chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee has reviewed Applied Biosafety journals (Volume 23 and Volume 24). ABSA members currently have eight quizzes available online for CM points and nine quizzes in development. These quizzes are low cost and can be located on the website.
- [Technical and Regulatory Review Committee (TRR)](https://absa.org/news/2022-01-technical-and-regulatory-review-committee-trr/) - Chairs: David R. Pawlowski and Esmeralda Meyer The Technical and Regulatory Review has teamed with the International Engagement Committee to review the 4th edition of the WHO Laboratory Biosafety Manual (WHO LBM) using a similar approach to the 6th Edition of the BMBL that was recently published on the ABSA website. Members of the International
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2022-01-credentialing-maintenance-board-cmb/) - Chairs: Su-Hwi Hung-Cunliffe and Rhonda O’Keefe The Credentialing Maintenance Board welcomes new member Sylvie Blondelle. In 2021, the CMB has reviewed 151 CM applications (120 CM apps were approved, and 31 CM apps were denied). The approved CM applications are listed at the ABSA’s Professional Development Activities page. The CMB reminds the credentialing applicants that
- [Credentialing Evaluation Board](https://absa.org/news/2022-01-credentialing-evaluation-board/) - Chairs: Paul Meechan and John Henneman The Credentialing Evaluation Board (CEB) continues to meet at least monthly (frequently more than once per month) to review applications for certification as Registered Biosafety Professionals (RBP). This summer and fall, the Board has taken on the additional tasks of reviewing and updating the information for candidates that has
- [Exhibitors Advisory Committee](https://absa.org/news/2022-01-exhibitors-advisory-committee/) - Chair: William Peters The 64th Annual Biosafety and Biosecurity Virtual Conference was held from October 25-27, 2021. Virtual exhibit booths were open and accessible anytime during the 3-day conference for participants to access and interact. We had twenty-three virtual exhibitors and 10 sponsors (1 Platinum, 7 Silver, and 2 Bronze). For those who attended the
- [President’s Report](https://absa.org/news/2022-01-presidents-report/) - LouAnn Burnett, CBSP(ABSA) Dear ABSA Colleagues, I have been a member of ABSA International for 28 years. Despite my long tenure, I am continually humbled by the collegiality and collaboration of our community and by how much I learn from every interaction. This holds truer in the face of the ongoing COVID-19 pandemic. The inspirational
- [President’s Report](https://absa.org/news/2021-10-presidents-report/) - Melissa Mørland, MS, MBA, RBP(ABSA), CBSP(ABSA) Dear ABSA Colleagues, Since my last message, the increases in COVID cases have caused us to make the difficult decision to move the 64th Annual Biosafety and Biosecurity Conference to fully virtual. I know so many of us were looking forward to networking with our peers again in person;
- [Anthology XIV: Sustainability](https://absa.org/news/2021-10-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [Job Board](https://absa.org/news/2021-10-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [ABSA International Membership Site](https://absa.org/news/2021-absa-international-membership-site/) - Through Member Clicks, not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also purchase
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2021-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has promotional videos for ABSA and our ABSA Conference. The videos can be found on the ABSA website and on ABSA International’s YouTube channel at. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [ABSA International’s 2nd Biosecurity Symposium](https://absa.org/news/2021-absa-internationals-2nd-biosecurity-symposium/) - ABSA International’s 2nd Biosecurity Virtual Symposium will be May 3-6, 2022, at the Depot Renaissance Minneapolis Hotel. The symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on biosecurity governance, implementation,
- [Principles & Practices of Biosafety® (PPB)](https://absa.org/news/2021-10-principles-practices-of-biosafety-ppb/) - Co-Chairs: Patrick Condreay and Carrie Smith The first Principle & Practices of Biosafety Course since Spring 2020 was successfully offered July 18-23 in Pittsburgh for 35 participants. Plans are underway for the next offering in San Antonio March 6-11, 2022. We are planning for a full class of 48 participants, though this is subject to
- [Advanced Biosafety Training Series](https://absa.org/news/2021-10-advanced-biosafety-training-series/) - Co-Chairs: Dan Eisenman and Shalaka Kotkar The Advanced Biosafety Training Series review team is in the process of reviewing and finalizing changes to the previous course material.
- [BSL-3 Operations and Management](https://absa.org/news/2021-10-bsl-3-operations-and-management/) - Co-Chairs: Paul Jennette and Carrie Smith The BSL-3 Operations and Management course has been rescheduled for the 2022 ABSA Conference in Milwaukee, Wisconsin.
- [Basic & Advanced Risk Assessment](https://absa.org/news/2021-10-basic-advanced-risk-assessment/) - Co-Chairs: Chad Austin and Brandon Hatcher The course instructors are planning to offer the Basic Risk Assessment course at the 2022 ABSA Conference in Milwaukee, Wisconsin. The Advanced Risk Assessment course instructors have built upon their successful 2019 content and prepared additional, new, interactive scenarios for the next offering of the course which is scheduled
- [ABSA-Owned Course Committee](https://absa.org/news/2021-10-absa-owned-course-committee/) - Chair: Robert Ellis Co-Chairs: Chad Austin and Lisa Benford
- [E-Communications Committee](https://absa.org/news/2021-10-e-communications-committee/) - Chair: Matt Anderson The E-Communications committee has been busy working with both the Publications and the Public Relations Committees to increase post frequency on the ABSA blog. The goal of this endeavor is to highlight the work of our colleagues in Applied Biosafety and promote the profession. The posts will be available on the ABSA
- [Mentoring Committee](https://absa.org/news/2021-10-mentoring-committee/) - Chair: Althea Treacy The mentoring committee has matched several ABSA members with mentors. They are also continuing to look for more mentors to support the ABSA community.
- [International Engagement Committee (IEC)](https://absa.org/news/2021-10-international-engagement-committee-iec/) - Chair: Eric Cook The IEC is working closely with the TTR committee to do a comparative review of the new WHO edition and highlight changes in the same manner the BMBL editions were evaluated. The IEC continues to work in translating COVID documents into different languages to provide tools for the biosafety community.
- [Education & Curriculum Task Force](https://absa.org/news/2021-10-education-curriculum-task-force/) - Lead: Brandy Nelson Members of the Education and Curriculum Task Force have met regularly over the last quarter. ECTF members have been working to organize and present a discussion forum with ABSA members. Member input received during this discussion forum will be used to guide the future direction of the task force.
- [Public Relations/Marketing Committee (PR/M)](https://absa.org/news/2021-10-public-relations-marketing-committee-pr-m/) - Chairs: Eric Rouse and Danielle Rintala October is Biosafety and Biosecurity Month and runs concurrent with the 64th Annual Conference. The theme for 2021 is “Innovation in Biosafety and Biosecurity.” Spotlight articles highlighting how much Biosafety and Biosecurity has evolved over time from the perspective of some of our highly experienced Biosafety and Biosecurity Professionals
- [Bylaws Committee](https://absa.org/news/2021-10-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees and has completed 1 review since the last newsletter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International office. The office
- [Preconference Course Committee (PCC)](https://absa.org/news/2021-10-preconference-course-committee-pcc/) - Chairs: Antony Schwartz, Angela Ragan, and Heather Blair Since the last update, the Preconference Course Committee (PCC) has been working with the ABSA Education Director to convert all professional development courses from in-person offerings to all virtual offerings due to the annual conference being fully virtual. This includes reaching out to the instructors, rescheduling courses,
- [Affiliate Relations Committee (ARC)](https://absa.org/news/2021-10-affiliate-relations-committee-arc/) - Chairs: Lia Vizzotti and Parimala Arokiaraj The affiliate committee is working with the Ambassador committee to provide information as needed to keep the community informed.
- [Public Health Outreach (PHO) Shared Interest Group (SIG)](https://absa.org/news/2021-10-public-health-outreach-pho-shared-interest-group-sig/) - Leads: Marian Downing and Shoolah Escott The Public Health Outreach (PHO) Special Interest Group put out a call for new members—3 additional members representing PH and clinical interests were chosen. Thanks to all who applied. The SIG is still looking for ways to reach out to Public Health and clinical laboratories via presentations and webinars,
- [ABSA Ambassadors](https://absa.org/news/2021-10-absa-ambassadors/) - Chair: David Harbourt Most volunteer activities continue to be remote, due to the pandemic. In July, Lolly Gardiner gave a 2.5-hour presentation/workshop on the Biosafety Profession to university students for the American Society of Virology. Scott Patlovich is serving on the IBC for Rice University as a community member. He also gave a 1-hour virtual
- [Scientific Program Committee (SPC)](https://absa.org/news/2021-10-scientific-program-committee-spc/) - Chairs: Claudia Gentry-Weeks, AJ Troiano, Cristine Lawson, and Jessica McCormick-Ell The Scientific Program Committee has invited speakers and selected both platform, poster, and roundtable presentations for the upcoming 2021 Virtual Biosafety and Biosecurity Conference. The program has been finalized and can be found on the conference website at absaconference.org. We look forward to an engaging
- [Journal Board](https://absa.org/news/2021-10-journal-board/) - Chairs: Karen B. Byers, Barbara Johnson, David Gillum, and Scott Patlovich In 2021, APB was accepted for indexing in the Web of Science Emerging Sources Citation Index, or ESCI. In addition, Scopus announced that the 2020 cite index for APB articles published in 2017-2019 had risen 83%, from 0.6 in 2019 to 1.1 in 2020.
- [Emerging Infectious Disease Consortium (EIDC)](https://absa.org/news/2021-10-emerging-infectious-disease-consortium-eidc/) - Chairs: Esmeralda Meyer and Marian Downing OSHA published the interim final rule for the Occupational Exposure to COVID-19; Emergency Temporary Standard on June 21,2021. OSHA requested Comments on any aspect of the ETS and whether the ETS should be adopted as a permanent standard by August 20, 2021. The Emerging Infectious Diseases Committee worked with
- [Distance Learning Committee (DLC)](https://absa.org/news/2021-10-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Joleen Weese, and Eric Lewis The Distance Learning Committee (DLC) continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. Nine webinars have been completed so far in 2021 reaching over 740 participants. Planning is currently underway scheduling several webinars for late 2021 and early 2022.
- [Accreditation Board](https://absa.org/news/2021-10-accreditation-board/) - Chair: Christina Thompson The ABSA Accreditation Committee reviewed 1 application in the past quarter. This review included assessment of all the documents (e.g., biosafety manual, IBC minutes, floor plans, occ health plan) provided in the renewal application. The renewal application was approved by the accreditation committee. There were no other accreditation applications reviewed during this
- [Exam Development Board (EDB)](https://absa.org/news/2021-10-exam-development-board-edb/) - The exam development board reviewed and approved the exam questions utilized for this year’s exam which was taken by 22 individuals. Post exam activities included a review of the post-exam statistical analysis of questions relative to performance. The EDB is currently reviewing questions within the exam blueprint and developing questions in areas of the exam
- [Learning Verification Committee (LVC)](https://absa.org/news/2021-10-learning-verification-committee-lvc/) - Chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee is currently reviewing Applied Biosafety Journals (Volume 23 and Volume 24). ABSA members currently have 8 quizzes available online for CM points and 4 quizzes in development. These quizzes are low cost and can be located on the website at absa.org/online-education.
- [Technical and Regulatory Review (TRR) Committee](https://absa.org/news/2021-10-technical-and-regulatory-review-trr-committee/) - Chairs: David R. Pawlowski and Esmeralda Meyer The TRR has teamed with the International Engagement committee to review the 4th edition of the WHO Laboratory Biosafety Manual (WHO LBM) using a similar approach to the 6th Edition of the BMBL that was recently published on the ABSA website (absa.org/bmbl). Members of the International Engagement Committee
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2021-10-credentialing-maintenance-board-cmb/) - Co-Chairs: Su-Hwi Hung-Cunliffe and Rhonda O’Keefe The Credentialing Maintenance Board (CMB) has completed the review for the 2016-2020 credentialing cycle of 53 CM worksheets and 1 CM worksheet for reinstating an RBP credential. Five worksheets were randomly selected for audit and 4 were passed and 1 failed. There were 51 approvals and 3 failures among
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2021-10-credentialing-evaluation-board-ceb/) - Chair: Paul Meechan After much deliberation, the application fee for the RBP be raised to $150. The fee has never increased since the inception of the program. The new fee will go into effect January 1, 2022.
- [Exhibitors Committee](https://absa.org/news/2021-10-exhibitors-committee/) - Chair: William Peters The 64th Annual Biosafety and Biosecurity Virtual Conference will be from October 25-27, 2021. Virtual exhibits at the conference will be open and accessible anytime through the conference for participants to access and interact with your virtual booth icons that are linked to pictures, brochures, and videos along with a live chat
- [Public Relations and Marketing (PR/M) Committee](https://absa.org/news/2020-09-public-relations-and-marketing-pr-m-committee/) - Chairs: Eric Rouse and Danielle Rintala The Public Relations and Marketing (PR/M) Committee hopes that this finds you and your membership/organization safe and healthy during this trying time. Each year, ABSA International sponsors Biosafety and Biosecurity Month to raise awareness about the importance of Biosafety and Biosecurity. To recognize the role biosafety and biosecurity professionals
- [President’s Report](https://absa.org/news/2021-07-presidents-report/) - Melissa Mørland, MS, MBA, RBP(ABSA), CBSP(ABSA) Dear ABSA Colleagues, There finally seems to be light at the end of the tunnel, and with lower COVID-19 positivity rates and increased vaccinations, we are able to resume more in-person activities. Networking with colleagues and attending a conference in real-life without logging onto a computer are some of
- [ABSA International Inclusion Statement](https://absa.org/news/2021-01-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Job Board](https://absa.org/news/2021-01-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Anthology XIV: Sustainability](https://absa.org/news/2021-07-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [ABSA International Membership Site](https://absa.org/news/2021-07-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2021-07-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has new promotional videos for ABSA and our ABSA Conference. The videos can be found at absa.org and on ABSA International’s YouTube channel. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or link to
- [Biosafety and Biosecurity Training Course (BBTC)](https://absa.org/news/2021-07-biosafety-and-biosecurity-training-course-bbtc/) - The first ABSA offering of the Biosafety and Biosecurity Training Course (BBTC) is scheduled for August 2-6, 2021. The course is modular in design and attendees can choose to attend some or all the modules. The Animal Session module is scheduled for August 2-3, 2021 and includes considerations for both small animal research and large
- [Public Relations/Marketing Committee (PR/M)](https://absa.org/news/2021-07-public-relations-marketing-committee-pr-m/) - Chairs: Eric Rouse and Danielle Rintala The PR/M is working on all the logistics of the 2021 Biosafety and Biosecurity Month. The theme for 2021 is “Innovation in Biosafety and Biosecurity”. Additional information about the biosafety and biosecurity month activities will be forthcoming.
- [Bylaws Committee](https://absa.org/news/2021-07-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA Office. The office will forward the changes to the committee for review and
- [Preconference Course Committee (PCC)](https://absa.org/news/2021-07-preconference-course-committee-pcc/) - Chairs: Antony Schwartz, Angela Ragan, and Heather Blair The PCC has reviewed the professional development course proposals and finalized the slate of virtual and in-person courses for this year’s annual conference! We started with a healthy number of course proposal submissions across various new and interesting topics. All members reviewed the courses, discussed their choices,
- [Affiliate Relations Committee (ARC)](https://absa.org/news/2021-07-affiliate-relations-committee-arc/) - Chairs: Lia Vizzotti and Parimala Arokiaraj The Affiliate Relations Committee (ARC) is represented by 14 members who are engaged in biosafety work in hospitals, biomedical research, government, academia, and consulting. 2020 was unusually quiet due to the pandemic. The group of members offered COVID 19 assistance through ABSA to reach out to members worldwide where
- [Public Health Outreach (PHO) SIG](https://absa.org/news/2021-07-public-health-outreach-pho-sig/) - Leads: Marian Downing and Shoolah Escott The Public Health Outreach (PHO) Task Force presented a poster at the 2021 APHL virtual meeting, entitled “Biorisk Management Quick Tips and Tools.” ABSA members will participate in a webinar, hosted by APHL, that is planned for July 2021 on the topic of implementation of the ISO 35001:2019 Biorisk
- [ABSA Ambassadors](https://absa.org/news/2021-07-absa-ambassadors/) - Chairs: David Harbourt and Marian Downing Outreach opportunities for speakers have dwindled during the pandemic, but some members were able to spread the word about ABSA and the field of Biosafety/Biosecurity. Scott Patlovich serves as a Community Member on the Rice University IBC. Marian Downing serves as a Community Member on the UTMB (University of
- [Scientific Program Committee (SPC)](https://absa.org/news/2021-07-scientific-program-committee-spc/) - Chairs: Claudia Gentry-Weeks, AJ Troiano, Cristine Lawson, and Jessica McCormick-Ell The Scientific Program Committee (SPC) has completed reviewing submitted abstracts and has recruited the keynote speakers for the upcoming 2021 Conference in Raleigh, North Carolina. Seventy-seven abstracts were received for consideration. Notifications to speakers were sent out towards end of June. We look forward to
- [Journal Board](https://absa.org/news/2021-07-journal-board/) - Chairs: Karen B. Byers, Barbara Johnson, David Gillum, and Scott Patlovich Applied Biosafety (Volume 26, Number 2) has been finalized and mailed to subscribers this month. This special themed issue features several papers utilizing different decontamination methods for various respiratory protection devices. Other manuscripts within this issue include a paper on testing breathing air filters
- [Emerging Infectious Disease Consortium (EIDC)](https://absa.org/news/2021-07-emerging-infectious-disease-consortium-eidc/) - Chairs: Esmeralda Meyer and Marian Downing During the first semester of 2021, the SARS-CoV-2/COVID-19 toolbox was redesigned based on the feedback provided by the users. The EIDC also updated the document “Considerations for Handling Potential SARS-CoV-2 Samples” to include handling of synthetic nucleic acids and viral vectors associated with the COVID-19 vaccines (the Spanish and
- [Distance Learning Committee (DLC)](https://absa.org/news/2021-07-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Joleen Weese, and Eric Lewis The Distance Learning Committee (DLC) continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. Six courses have been completed so far in 2021 reaching over 592 participants. Planning is currently underway for additional webinars in 2021. Webinar topics that are
- [Accreditation Board](https://absa.org/news/2021-07-accreditation-board/) - Chair: Chris Thompson The Accreditation Board met virtually to discuss updating our documents to revise references based on BMBL 6th edition, the new WHO manual, and the ISO standard 35001:2019. The BSL-2 checklist has been updated. The Standards document and BSL-3 checklist will be updated in the near future.
- [CBSP Exam Development Board (EDB)](https://absa.org/news/2021-07-cbsp-exam-development-board-edb/) - Chair: Joseph Kozlovac The CBSP Exam Development Board has completed its review and update of the exam pool questions to ensure conformance with the CDC/NIH BMBL 6th and the WHO Laboratory Biosafety Manual, 4th edition. The Board reviewed the questions that will be utilized in the upcoming CBSP exam. Additionally, the Board has contributed to
- [Learning Verification Committee (LVC)](https://absa.org/news/2021-07-learning-verification-committee-lvc/) - Chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee (LVC) has completed review of the Applied Biosafety journal (Volume 22) and questions have been submitted to the LVC committee for review before sending to ABSA Office to generate the online quizzes. ABSA members currently have 8 quizzes available online for CM points and 4
- [Technical and Regulatory Review (TRR) Committee](https://absa.org/news/2021-07-technical-and-regulatory-review-trr-committee/) - Chairs: David R. Pawlowski and Esmeralda Meyer The ABSA Technical and Regulatory Review (TRR) Committee has published the “Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6)” that can be found at https://absa.org/bmbl/. Along with the summary is a side-by-side comparison of editions 5 and 6 published as a downloadable
- [Nominating Committee](https://absa.org/news/2021-07-nominating-committee/) - Chair: David Gillum The Nominating Committee has completed the selection of nominees for the 2021 ballot. The Chair of the Nominating Committee, David Gillum, would like to thank Meghan Seltzer, Paul Meechan, Esmeralda Meyer, and Kalpana Rengarajan for their work in selecting tremendous candidates this year. Thank you to the ABSA Office, especially Kari DeServi
- [Awards Committee](https://absa.org/news/2021-07-awards-committee/) - Chairs: Jeff Potts and John Veitch The Awards Committee is pleased to announce the new Diane Fleming Leadership Award. The Diane Fleming Leadership Award is presented to a current ABSA International member who exemplifies leadership within ABSA International and the biosafety and biosecurity profession. The award will recognize excellence demonstrated through mentoring safety professionals, building
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2021-07-credentialing-maintenance-board-cmb/) - Chairs: Su-Hwi Hung-Cunliffe and Krista Murray The Credentialing Maintenance Board (CMB) have completed the review of 53 CM worksheets for the 2016-2020 credentialing cycle and one CM worksheet for reinstating RBP. There were 52 approvals and two failures among the 54 worksheets reviewed. Five worksheets were randomly selected for audit and three were passed and
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2021-07-credentialing-evaluation-board-ceb/) - Chair: Paul Meechan The Credentialing Evaluation Board has continually reviewed applications for the Registered Biosafety Professional (RBP) credential and applications from those interested in sitting for the CBSP Exam. 68 applications have been reviewed since the beginning of the year. After much deliberation, the Board has also recommended the application fee for the RBP be
- [Exhibitors Committee](https://absa.org/news/2021-07-exhibitors-committee/) - Chair: William Peters Exhibits at the 64th Annual Biosafety and Biosecurity Conference will be open on Sunday, October 24 from 6:30-8:30 pm during the Opening Reception as well as Monday, October 25 and Tuesday, October 26 from 9:00-4:00 pm. The conference and exhibits will be held at the Raleigh Convention Center in Raleigh, North Carolina.
- [ABSA International Membership Site](https://absa.org/news/2021-01-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members’ Directory; you can update your contact information under the “My Information” link; view events you have registered for under “My Events”; access your educational credits under the “My Professional Development” link; and print a copy of past invoices under “My Transactions.” You can also
- [Anthology XIV: Sustainability](https://absa.org/news/2021-01-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2021-01-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has new promotional videos for ABSA and our ABSA Conference. The videos can be found at absa.org and on ABSA’s YouTube channel. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or link to it
- [ABSA Affiliate Relations Committee (ARC)](https://absa.org/news/2021-01-absa-affiliate-relations-committee-arc/) - Chairs: Lia Vizzotti and Parimala Arokiaraj The ABSA Affiliate Relations Committee (ARC) is unusual in that it only has work to do when another group requests to be affiliated with ABSA. The Affiliate group has collaborated with the International Engagement Committee to have the COVID ABSA trifold translated.
- [Mentoring Committee](https://absa.org/news/2021-01-mentoring-committee/) - Chairs: Althea Treacy and Rebecca Moritz The Mentoring Committee continues to work on the forum, creating a space where people can ask questions and get them answered by a biosafety professional.
- [Membership Committee](https://absa.org/news/2021-01-membership-committee/) - Chairs: Malissa Mayer-Diaz and Kelly Flint The Membership Committee continues to work with the ABSA International Office and Council to ensure the new members of ABSA are given the support they need. New Emeritus Membership applications are being accepted and processed as needed. We look forward to working with the International Engagement Committee to create
- [Public Relations /Marketing Committee (PR/M)](https://absa.org/news/2021-01-public-relations-marketing-committee-pr-m/) - Chairs: Eric Rouse and Danielle Rintala The Public Relations/Marketing Committee (PR/M) would like to thank everyone for a successful annual conference and all the effort put into Biosafety and Biosecurity Month 2020, “The Role of Biosafety and Biosecurity in Mitigating Emerging Risk.” We know this year has been challenging for everyone both personally and professionally;
- [Biosecurity Credentialing Task Force](https://absa.org/news/2021-01-biosecurity-credentialing-task-force/) - Leads: LouAnn Burnett and Patrick Condreay The Biosecurity Credential Task Force continues to craft a framework for a Biosecurity credential and hopes to submit a proposal to Council early in 2021.
- [Technical & Regulatory Review (TRR)](https://absa.org/news/2021-01-technical-regulatory-review-trr/) - Chairs: David Pawlowski and Esmeralda Meyer The World Health Organization (WHO) requested that ABSA International provide feedback on Annex 2 titled “Biorisk management standard for poliovirus-essential facilities holding wild poliovirus materials” and Annex 3 titled “Annex 3 Biorisk management standard for poliovirus-essential facilities holding only OPV/Sabin poliovirus materials (no WPV)” of the Global Action Plan
- [E-communications Committee (ECC)](https://absa.org/news/2021-01-e-communications-committee-ecc/) - Chair: Matthew Anderson The E-communications Committee (ECC) sponsored a social media contest during the professional development courses taught virtually in October and during the 63rd Annual Biosafety and Biosecurity Virtual Conference. We created ABSA-branded cloth face-coverings as prizes for best and most tweets. There were not nearly as many participants as we had hoped would
- [Preconference Course Committee (PCC)](https://absa.org/news/2021-01-preconference-course-committee-pcc/) - Chairs: Heather Blair, Antony Schwartz, and Angela Ragan The Preconference Course Committee (PCC) and the ABSA Office worked closely together to provide 12 virtual Professional Development courses for the ABSA International Community. We had a total of 661 participants attend or register for at least one Professional Development Course. The virtual format allowed for increased
- [Publications Committee](https://absa.org/news/2021-01-publications-committee/) - Chairs: Aparupa Sengupta and R. Vilmarie Rodriguez Figueroa The Publications Committee continues to meet monthly, make progress, and continue to move forward on standing items. Recently, the committee met with ABSA’s Executive Director, Ed Stygar, to explore the possibility of expanding the role of the committee to influence the Biosafety-Security society worldwide on the current
- [Expanding ABSA’s Influence Task Force (EAI)](https://absa.org/news/2021-01-expanding-absas-influence-task-force-eai/) - Leads: Chad Austin and Lolly Gardiner Members of the Expanding ABSA’s Influence Task Force (EAI) received some helpful feedback on their poster at the 63rd Annual Biosafety and Biosecurity Virtual Conference describing the results of the community needs survey. The Task Force is looking forward to developing a new page on the ABSA website to
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2021-01-credentialing-maintenance-board-cmb/) - Chairs: Su-Hwi Hung-Cunliffe and Rhonda O’Keefe The Credentialing Maintenance Board (CMB) have reviewed 179 online Credentialing Maintenance (CM) application submissions and approved 142 applications for CM points in 2020. The online CM applications can be completed by logging in to ABSA portal at absa.org. The status for all the CM applications can now be tracked
- [Emerging Infectious Disease Consortium (EIDC)](https://absa.org/news/2021-01-emerging-infectious-disease-consortium-eidc-2/) - Chairs: Esmeralda Meyer and Marian Downing The Emerging Infectious Disease Consortium (EIDC) released the resource for the community titled COVID-19 and Your Community—How to plan an event during a pandemic in early September 2020. EIDC frequently reviews the web traffic to the Toolbox and surveys the potential readership to determine areas for improvement and enhancement.
- [Public Health Outreach (PHO) Task Force](https://absa.org/news/2021-01-public-health-outreach-pho-task-force/) - Leads: Marian Downing and Shoolah Escott The Public Health Outreach (PHO) Task Force presented a poster at the 2020 APHL virtual meeting, titled “Next Stop Biosafety! Engaging all Levels.” ABSA and APHL presented a joint webinar for October Biosafety/Biosecurity Month: “Navigating and Mitigating Laboratory Risks during COVID-19.” Eric Rouse presented as part of the panel.
- [ABSA Ambassadors](https://absa.org/news/2021-01-absa-ambassadors/) - Chair: Marian Downing Opportunities for ABSA Ambassadors have been limited again this quarter, as many speaker meetings have been cancelled/postponed. Betsy Gilman Duane and Marian Downing presented a webinar for the Massachusetts Non-Profit Network on October 20 entitled “Covid-19 Safety for Non-Profits,” sponsored by S4NP (Safety for Non-Profits). Barb Owen and Kalpana Rengarajan have represented
- [Education Curriculum Task Force](https://absa.org/news/2021-01-education-curriculum-task-force/) - Leads: Brandy Nelson and Chad Austin The Education Curriculum Task Force is looking forward to a new year full of new opportunities and has ambitions to continue their previous work as soon as feasible.
- [International Engagement Committee (IEC)](https://absa.org/news/2021-01-international-engagement-committee-iec/) - Chairs: Eric Cook and Anne-Sophie Brocard This year the International Engagement Committee (IEC) developed and implemented a mentoring program for the ABSA International membership called Biorisk Management Connect (BRM Connect). It was piloted at the 63rd Annual Biosafety and Biosecurity Virtual Conference. The project team members conducted an orientation for the newly selected mentors and
- [Local Arrangements Committee (LAC)](https://absa.org/news/2021-01-local-arrangements-committee-lac/) - Chair: Scott Alderman The LAC has been busy planning for the 2021 ABSA Conference in Raleigh, NC. The banquet will be held at the North Carolina Museum of Natural Sciences which is a short walk from the convention center. We are looking forward to seeing everyone in person for a great conference.
- [Scientific Program Committee (SPC)](https://absa.org/news/2021-01-scientific-program-committee-spc/) - Jessica McCormick-Ell, Claudia Gentry-Weeks, and AJ Troiano The Scientific Program Committee (SPC) hopes all attendees enjoyed the virtual conference. It was a new platform, but we heard that attendees enjoyed the engaging question and answer sessions and the networking rooms at the end of the day. Our thanks to all of you for attending and
- [Awards Committee](https://absa.org/news/2021-01-awards-committee/) - Chairs: Jeffrey Potts and John Veitch The Awards Committee was able to make two wonderful selections for Honor Awards this year. We would like to announce that Bob Ellis is the 2020 Wedum Award recipient and Barb Owen is the Hanel Award recipient. Both are longtime ABSA International members and have contributed in major ways
- [Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC)](https://absa.org/news/2021-01-biological-select-agent-and-toxins-community-advocate-committee-bsat-cac/) - Chairs: Angela Birnbaum and Eric Jeppesen The Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC) hosted two webinars in July and August covering panel topics. The committee hosted the Select Agent Users Workshop in two separate components, one focusing on a “Regulatory Section” and the other Focusing on a “User Section” held on
- [Journal Board](https://absa.org/news/2021-01-journal-board/) - Chairs: Karen Byers, Barbara Johnson, and Scott Patlovich Applied Biosafety (Volume 25, Number 4) has been mailed to subscribers and contains a special section on Gene Therapy. The papers contain information on safeguards for using viral vector systems in human gene therapy, guidance on biosafety for large-scale gene therapy manufacture, and risk mitigation when using
- [Advanced Biosafety Training Series (ABTS)](https://absa.org/news/2021-01-advanced-biosafety-training-series-abts/) - The Advanced Biosafety Training Series (ABTS) instructors and subject matter experts continue to finalize content and suggestions for updates to achieve a successful migration to the Learning Management System.
- [Basic Risk Assessment & Advanced Risk Assessment](https://absa.org/news/2021-01-basic-risk-assessment-advanced-risk-assessment/) - The instructors for the Basic Risk Assessment course needed to experiment somewhat with the new remote delivery options for the offering at the 63rd Annual Biosafety and Biosecurity Conference; and with the participation of course attendees, were able to hone-in on a successful strategy for course delivery. They look forward the attendee feedback so that
- [BSL-3 Operations and Management](https://absa.org/news/2021-01-bsl-3-operations-and-management/) - The BSL3 Operations and Management course is planning to be offered at the 64th Annual Biosafety and Biosecurity Conference and will incorporate updates based on suggestions and feedback from the 2019 offering.
- [Biosafety and Biosecurity Training Course (BBTC)](https://absa.org/news/2021-01-biosafety-and-biosecurity-training-course-bbtc/) - The first ABSA offering of the Biosafety and Biosecurity Training Course (BBTC) is scheduled for August 2-6, 2021. The course is modular in design and attendees can choose to attend some or all the modules. The Animal Session module is scheduled for August 2-3, 2021 and includes considerations for both small animal research and large
- [Learning Verification Committee (LVC)](https://absa.org/news/2021-01-learning-verification-committee-lvc/) - Chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee (LVC) has completed its review of the Applied Biosafety Journal V22 and questions have been submitted to the LVC committee for review before sending to ABSA office to generate the online quizzes. ABSA members currently have eight quizzes available online for CM points and 4
- [Exam Development Board (EDB)](https://absa.org/news/2021-01-exam-development-board-edb/) - Chair: Joseph Kozlovac The Exam Development Board (EDB) has their regularly monthly meetings, and the International Certified Biological Safety Professional (CBSP) Task Force has worked on determining the market for an international credential.
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2021-01-credentialing-evaluation-board-ceb/) - Chairs: Paul Meechan and Krista Murray The Credentialing Evaluation Board (CEB) continues to review Registered Biosafety Professional (RBP) candidates monthly and has started to receive applications for Certified Biological Safety Professional (CBSP) candidates applying to take the 2021 CBSP examination. Interested CSBP exam candidates will need to have their applications in by February 1, 2021.
- [Training Tools and Resources (TTR)](https://absa.org/news/2021-01-training-tools-and-resources-ttr/) - Co-chairs: Eric Cook and Lauriane Quenee Training Tools and Resources (TTR) collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These resources are collated on the ABSA website. The committee has refined evaluations and reviewed methods for making the information and resources easier to find
- [Bylaws Committee](https://absa.org/news/2021-01-bylaws-committee/) - Co-chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. One review has been completed since the last newsletter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The office
- [Exhibitors Committee](https://absa.org/news/2021-01-exhibitors-committee/) - Chair: William Peters The 63rd Annual Biosafety and Biosecurity Virtual Conference was held November 4-6, 2020. There were 22 virtual exhibitors accessible throughout the conference for participants to gain exhibitor information. There were 3 Silver sponsors and 1 Bronze sponsor. Conference participants’ response to the virtual exhibits was excellent and it was a learning experience
- [Principles and Practices of Biosafety (PPB)](https://absa.org/news/2021-01-principles-and-practices-of-biosafety-ppb/) - Chairs: Patrick Condreay and Carrie Smith Due to meeting restrictions in the state of California, the March 2021 Principles and Practices of Biosafety (PPB) course has been cancelled. Future offerings are available for PPB in Pittsburgh (July 2021) and PPB in San Antonio (March 2022). For event listing, please visit our site at: absa.org/events/category/absa-sponsored/ppb/
- [Distance Learning Committee (DLC)](https://absa.org/news/2021-01-distance-learning-committee-dlc/) - Chairs: Rhonda O’Keefe, Joleen Weese, and Eric Lewis The Distance Learning Committee (DLC) continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. Fourteen courses have been completed in 2020 reaching over 1620 participants. Planning is currently underway to schedule several webinars for 2021. Webinar topics in the works
- [ABSA International’s 1st Biosecurity Symposium](https://absa.org/news/2021-01-absa-internationals-1st-biosecurity-symposium/) - The 1st offering will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on biosecurity governance, implementation, personnel reliability, bioeconomy, biosecurity in DIYbio communities, biosecurity training, cyberbiosecurity, and interactive discussions on lessons learned
- [Winners of the 63rd Annual Biosafety & Biosecurity Conference Poster Awards](https://absa.org/news/2021-01-winners-of-the-63rd-annual-biosafety-biosecurity-conference-poster-awards/) - Category: Scientific PLASTIC RAZOR BLADES AS AN ENGINEERED-SAFE SHARP ALTERNATIVE: A SURVEY OF SHARPS INJURIES FROM 2016-2018 AT THE NATIONAL INSTITUTES OF HEALTH Haley DeMers, Jaymie Brooks Dumproff, Veronique Bonhomme Simingalam, National Institutes of Health, Bethesda, MD Category: Informational NEED FOR VIRAL VECTOR RISK ASSESSMENT SUPPORT AMONG ABSA INTERNATIONAL MEMBERSHIP: RESULTS OF THE TASK FORCE
- [ABSA International Inclusion Statement](https://absa.org/news/2020-09-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Job Board](https://absa.org/news/2020-09-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Journal Board](https://absa.org/news/2020-09-journal-board/) - Editors: Karen B. Byers, Barbara Johnson, and Scott Patlovich ABSA International has signed a contract with Mary Ann Liebert to publish Applied Biosafety. The Editors are engaged in regular conference calls and e-mails with the new publisher to ensure a smooth transition of the journal and are very pleased with the level of professionalism and
- [ABSA Affiliate Relations Committee (ARC)](https://absa.org/news/2020-09-absa-affiliate-relations-committee-arc/) - Chairs: Lia Vizzotti and Parimala Arokiaraj The ABSA Affiliate Relations Committee (ARC) is unusual in that it only has work to do when another group requests to be affiliated with ABSA. While they did have one tentative request from an international group, that group has not responded recently. They are ready to assist as soon
- [Principles and Practices of Biosafety (PPB)](https://absa.org/news/2020-09-principles-and-practices-of-biosafety-ppb/) - Chairs: Patrick Condreay and Carrie Smith The Portland class that was to have taken place in July has been postponed until December 2020. The next offerings will be: March 14-19, 2021 in San Diego, CA and July 18-23, 2021 in Pittsburgh, PA. Watch the ABSA website for additional information.
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2020-09-credentialing-maintenance-board-cmb/) - Chairs: Su-Hwi Hung-Cunliffe and Rhonda O'Keefe The Credentialing Maintenance Board (CMB) has completed the review of 32 re-credentialing applications for the 2014-2018 cycle and one extension application for the 2014-2019 cycle. The CMB has audited three randomly chosen applicants to verify their re-credentialing worksheet submission. 100% of these applicants received re-certification. Among the recertified, there
- [Accreditation Board](https://absa.org/news/2020-09-accreditation-board/) - The Accreditation Board has been reviewing and updating the Policies & Procedures for all the Accreditation committees.
- [Biosecurity Credentialing Task Force](https://absa.org/news/2020-09-biosecurity-credentialing-task-force/) - Leads: LouAnn Burnett and Patrick Condreay The Task Force is working to determine the scope and framework of a biosecurity credential based on the RBP credential model.
- [ABSA Ambassadors](https://absa.org/news/2020-09-absa-ambassadors/) - Chair: Marian Downing Many ABSA Ambassadors continue to self-isolate this quarter. Virtual activities included a Bloodborne Pathogen/COVID-19 session for Ronald McDonald volunteers given by Chris Thompson, and a session entitled "Lessons Learned in the Effluent Decontamination Selection Process" by David Harbourt for a joint ChABSA/AIHA meeting in March. Bob Ellis participated in 3 webinars for
- [ABSA International's Promotional Videos and YouTube Channel](https://absa.org/news/2020-09-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has new promotional videos for ABSA and our ABSA Conference. The videos can be found at https://absa.org/ and on ABSA International's YouTube channel at https://youtu.be/xAQPZxMvqRY. Also, ABSA's YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Membership Committee](https://absa.org/news/2020-09-membership-committee/) - Chairs: Malissa Mayer-Diaz and Kelly Flint The Membership Committee has been working with International Engagement Committee (IEC) on a buddy system for the conference, but those plans are rapidly changing due to the conference now being online only. They have approved multiple emeritus members.
- [Education and Curriculum Task Force](https://absa.org/news/2020-09-education-and-curriculum-task-force/) - Leads: Brandy Nelson and Chad Austin Members of the Education and Curriculum Task Force have been unable to meet due to the COVID-19 pandemic. They will meet soon to discuss the Task Force activities and next steps.
- [Distance Learning Committee (DLC)](https://absa.org/news/2020-09-distance-learning-committee-dlc/) - Chairs: Kathleen Kennedy, Rhonda O'Keefe, and Joleen Weese The Distance Learning Committee (DLC) continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. Twelve courses have been completed so far in 2020 reaching over 1,500 participants. A new course titled "Making Biosafety Accessible during the COVID-19 Pandemic" will be
- [Learning Verification Committee (LVC)](https://absa.org/news/2020-09-learning-verification-committee-lvc/) - Chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee (LVC) has completed review of the Applied Biosafety Journal V22 and questions have been submitted to the LVC committee for review before sending to ABSA office to generate the online quizzes. ABSA members currently have 8 quizzes available online for CM points and 4 quizzes
- [Anthology XIV: Sustainability](https://absa.org/news/2020-09-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [ABSA International's  1st Biosecurity Symposium](https://absa.org/news/2020-09-absa-internationals-1st-biosecurity-symposium/) - ABSA International's 1st Biosecurity Symposium The 1st offering will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on biosecurity governance, implementation, personnel reliability, bioeconomy, biosecurity in DIYbio communities, biosecurity training, cyberbiosecurity, and
- [Preconference Course Committee](https://absa.org/news/2020-09-preconference-course-committee/) - Chairs: Heather Blair, Antony Schwartz, and Angela Ragan The Professional Development Courses are finalized and will be ready for registrations on the ABSA Conference website (absaconference.org). There will be 12 courses available during the month of October. The courses will be a mix of 4-, 6-, and 8-hour lengths.
- [Publications Committee](https://absa.org/news/2020-09-publications-committee/) - Chairs: Aparupa Sengupta and R. Vilmarie Rodriguez Figueroa Publications Committee continues to meet monthly. Recently, the committee has discussed the fantastic citations and additional to the LAI database. Committee members continue to add to the ideas for submission to the Applied Biosafety Journal, including COVID-19 various aspects but not just limited to that. The committee
- [ABSA International Membership Site](https://absa.org/news/2020-09-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [Scientific Program Committee (SPC)](https://absa.org/news/2020-09-scientific-program-committee-spc/) - Chairs: Jessica McCormick-Ell, Claudia Gentry-Weeks, and AJ Troiano The Scientific Program Committee (SPC) has finalized the abstracts that are accepted for platform and poster presentations. We are pivoting and working with the office staff to ensure the use of the virtual platform will provide a great conference experience. The invited speakers have confirmed their availability
- [ABSA International 2020 Conference](https://absa.org/news/2020-09-absa-international-2020-conference/) - ABSA International 63rd Annual Biosafety and Biosecurity Virtual Conference November 4-6, 2020 Registration is open! Virtual Conference Highlights Conference Presentations and Professional Development Courses will be recorded, so you can view it later if you miss an event. Discounts for 2 or more from the same institution will be offered as well as a 10% discount on Professional Development
- [Bylaws Committee](https://absa.org/news/2020-09-bylaws-committee/) - Chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of the various teams and committees. Two reviews have been completed since the last newsletter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office. The
- [E-communications Committee](https://absa.org/news/2020-09-e-communications-committee/) - Chairs: Sarah Ziegler and Matthew Anderson The E-communications Committee has been busy planning for the 2020 ABSA Virtual Conference. We are still planning to have a contest for active social media posting during the conference minus the "Sick Art" selfies and plan to have ABSA-branded cloth face-masks as prizes as well as some of the
- [Awards Committee](https://absa.org/news/2020-09-awards-committee/) - Chairs: Jeffrey Potts and John Veitch The Awards Committee released the call for nominations for the 2020 Honor Awards over the summer. The committee will be busy reviewing submitted nominees for selection in September. They have also been working with ABSA Council to develop a new Honor Award that will be revealed at the annual
- [Biosafety Career Entry and Professional Development Task Force](https://absa.org/news/2020-09-biosafety-career-entry-and-professional-development-task-force/) - Leads: Meghan Seltzer, Rebecca Moritz, and Sherry Bohn The Biosafety Career Entry and Professional Development Task Force is working on sharing its findings and recommendations with the relevant committees. In the coming year, members of the Task Force are working on two primary initiatives: developing recommendations to improve credentialing resources on the website and developing
- [International Engagement Committee (IEC)](https://absa.org/news/2020-09-international-engagement-committee-iec/) - Chairs: Eric Cook and Anne-Sophie Brocard The International Engagement Committee (IEC) is working hard to enhance the upcoming virtual 63rd ABSA Conference. They are looking at a variety of ideas to encourage international attendees to come to the ABSA Conference virtually and trying to pair up ABSA members who speak languages other than English with
- [Nominating Committee](https://absa.org/news/2020-09-nominating-committee/) - Chair: Dee Zimmerman Thank you to all the ABSA members who voted in the 2020 election. Results of the election will be released in September.
- [Technical & Regulatory Review Committee](https://absa.org/news/2020-09-technical-regulatory-review-committee/) - Chairs: David Pawlowski and Esmeralda Meyer The Technical & Regulatory Review (TRR) committee continues to monitor the Federal Register for meetings and publications affecting the Biosafety community. The TRR leadership team is actively planning for the teams' review and response to the anticipated publication of the 6th edition of the BMBL.
- [Advanced Biosafety Training Series](https://absa.org/news/2020-09-advanced-biosafety-training-series/) - Chair: Dan Eisenman and Shalaka Kotkar The course directors, instructors, and subject matter experts continue to review the previous course content and provide updates and improvements. The team is very excited that they are almost done with their initial revisions and look forward to the next phase which is to record new audio to match
- [BSAT Community Advocate Committee](https://absa.org/news/2020-09-bsat-community-advocate-committee/) - Chairs: Angela Birnbaum and Eric Jeppesen The BSAT Community Advocate Committee (CAC) hosted webinars covering the topics of Personnel Suitability on July 22, 2020 and Virtual Inspections--The 5W's on August 20, 2020. The committee is also working on the coordination and agenda for the upcoming Select Agent Users Workshop. Dates and agenda will be finalized
- [Biosafety and Biosecurity Training Course (BBTC)](https://absa.org/news/2020-09-biosafety-and-biosecurity-training-course-bbtc/) - Chair: Robert Ellis The Biosafety and Biocontainment Training Course is currently planned for August 2021. Please visit https://absa.org/event/absa-bbtc-fort-collins/ for more information.
- [Expanding ABSA's Influence Task Force](https://absa.org/news/2020-09-expanding-absas-influence-task-force/) - Leads: Chad Austin and Lolly Gardiner Expanding ABSA's Influence Task Force is preparing a poster for presentation at the upcoming 63rd Annual Biosafety and Biosecurity Virtual Conference that will summarize the results of the community needs survey. We are also pursuing the previously mentioned updates to the ABSA International website to add tools for risk
- [Basic & Advanced Risk Assessment](https://absa.org/news/2020-09-basic-advanced-risk-assessment/) - Chairs: Brandon Hatcher and Chad Austin Instructors are planning to deliver the Basic Risk Assessment course using the remote delivery options that ABSA is making available for professional development courses this year. The instructors are working to make sure the content can be effectively delivered using the new venue and are planning to record didactic
- [Training Tools and Resources (TTR)](https://absa.org/news/2020-09-training-tools-and-resources-ttr/) - Chairs: Eric Cook and Lauriane Quenee Training Tools and Resources (TTR) collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These resources are collated on the ABSA website. The committee continues to work on evaluation and review methods for making the information and resources are
- [Mentoring Committee](https://absa.org/news/2020-09-mentoring-committee/) - Chairs: Althea Treacy and Sarah Ziegler The Mentoring Committee continues to work on the forum, creating a space where people can ask questions and get them answered by a biosafety professional.
- [Public Health Outreach (PHO) Task Force](https://absa.org/news/2020-09-public-health-outreach-pho-task-force/) - Leads: Marian Downing and Shoolah Escott The PHO Task Force submitted an abstract for the 2020 APHL meeting, titled "Next Stop Biosafety! Engaging all Levels." The poster was accepted and will now be part of the virtual APHL 2020 meeting, which will run September 22 - October 15. Shoolah Escott will record a 2-minute presentation
- [Exhibitors Committee](https://absa.org/news/2020-09-exhibitors-committee/) - Chair: William Peters The 63rd Annual Biosafety and Biosecurity Virtual Conference will be from November 4-6, 2020. Virtual exhibits at the conference will be open and accessible anytime through the conference for participants to access and interact with your virtual booth icons that are linked to pictures, brochures, and videos along with a live chat
- [Local Arrangements Committee (LAC)](https://absa.org/news/2020-09-local-arrangements-committee-lac/) - Chair: Shelley Jones The Local Arrangements Committee (LAC) is disappointed that we will not be welcoming you to the Phoenix for the 2020 Conference; the good news is we are way ahead of schedule for planning the 2024 Conference. Our focus for preparing for this year's conference has shifted and the only remaining task is
- [President's Report](https://absa.org/news/2020-09-presidents-report/) - David Gillum, MS, RBP(ABSA) Dear Biosafety Professionals, 2020 has certainly presented us with numerous surprises and challenges, but also some unique opportunities as biosafety professionals. With the discovery of the new coronavirus, SARS-CoV-2, and the disease it causes, we have been compelled to adapt our working and living environments. The use of face coverings in
- [Principles and Practices of Biosafety (PPB)](https://absa.org/news/2020-06-principles-and-practices-of-biosafety-ppb/) - Chairs: Patrick Condreay, Carrie Smith The next Principles & Practices of Biosafety course has been rescheduled for December 6-11, 2020 in Portland, OR and the roster is currently full. Public health efforts to slow the spread of COVID-19 are being monitored closely to ensure the health and safety of instructors and participants. Updates can be
- [New Emerging Technologies and Disease Working Group](https://absa.org/news/2018-05-new-emerging-technologies-and-disease-working-group/) - Co-chairs: David Gillum and Rebecca Moritz Currently, members of the New Emerging Technologies and Disease Working Group have at least 9 manuscripts in various stages of development. Some topics of discussion for manuscripts include dual use research of concern, working with public health authorities, microbiome research, infection control in research, management of high-containment programs, genome
- [New and Emerging Technologies and Diseases (NETD) Task Force](https://absa.org/news/2018-09-netd/) - Co-chairs: David Gillum and Rebecca Moritz The New and Emerging Technologies and Diseases (NETD) Task Force has been very busy identifying high-profile topics for potential publication in Applied Biosafety. Several papers that were initiated by the NETD have been accepted and published in the journal and several more are on the way. A few of the
- [ABSA Ambassadors Task Force](https://absa.org/news/2017-02-ambassadors/) - Lead: Marian Downing, RBP, CBSP The ABSA International Ambassadors Task Force (Rob Heckert, Dee Zimmerman, Rich Rebar, and Marian Downing) has drafted a report form and outreach letter for potential ambassadors. The program is expected to launch in the first quarter of 2017.
- [ABSA Ambassadors](https://absa.org/news/2018-05-absa-ambassadors/) - Lead: Marian Downing The ABSA Ambassadors have given a variety of presentations to a wide range of audiences (see Ambassador Committee efforts below). Recently, they gave a webinar titled "Practical Disinfection Guidance for the Clinical Laboratory" in conjunction with the Public Health Preparedness and Response Program. Marian Downing will be presenting a poster on ABSA
- [ABSA Ambassadors](https://absa.org/news/2020-02-absa-ambassadors/) - Chair: Marian Downing The ABSA Ambassadors continue to spread the word about ABSA and the Biosafety profession. Meghan Seltzer gave an ABSA Update at the ChABSA Annual Symposium in June, and Marian Downing gave an ABSA Update at the Fall Southern Biosafety Association meeting in November. Karen Byers spoke about Laboratory Acquired Infections at the
- [ABSA Ambassadors](https://absa.org/news/2020-06-absa-ambassadors/) - Chair: Marian Downing Many ABSA Ambassadors were self-isolating this quarter. Anthony Schwartz gave an ABSA Update and covered 2019 Conference Highlights at the CaBSA meeting in February. Krista Murray gave an ABSA International/Biosafety overview at the February University of Delaware "Emergency Animal Management Course."
- [ABSA Affiliate Relations Committee (ARC)](https://absa.org/news/2020-06-absa-affiliate-relations-committee-arc/) - Chairs: Lia Vizzotti, Parimala Arokiaraj 2019 was interesting for the committee as the following affiliates were reviewed: Approved, Northern California ABSA Approved, Swiss Biosafety Network Our annual meeting at the 62nd ABSA Conference in Birmingham was well attended by representatives from the following affiliates NEBSA, FRABSA, Southern Biosafety Association, Canada, AMEXBIO, LBIONET, NORCAL, MID ATLANTIC,
- [ABSA Affiliate Relations Committee (ARC)](https://absa.org/news/2020-02-absa-affiliate-relations-committee-arc/) - Co-chairs: Lia Vizzotti and Parimala Arokiaraj ABSA Affiliate Relations Committee (ARC) is represented by 14 members who are engaged in biosafety work in hospitals, biomedical research, government, academia and consulting. 2019 was interesting for the committee as the following affiliates were reviewed: Approved, Northern California ABSA Approved, Swiss Biosafety Network In review with ABSA Council,
- [Biosecurity Credential Task Force](https://absa.org/news/biosecurity-credential-task-force/) - Leads: Barbara Owen and David Gillum In the second quarter of 2017, an ABSA International membership survey was created to assess members biosecurity needs. Survey data confirmed members are interested in biosecurity becoming an area of focus across ABSA International's program areas. The survey also supported instituting a biosecurity credential. As a result of the
- [Biosecurity Task Force 2.0](https://absa.org/news/2018-05-biosecurity-task-force-2-0/) - Leads: Barbara Owen and David Gillum The ABSA International Biosecurity Task Force 2.0 has created 4 subcommittees to assist in determining the feasibility, scope, and resources needed for creating a biosecurity credential. These subcommittees include: 1) Defining the Biosecurity Credential, Subcommittee Leads-Jessica McCormick-Ell and Ben Perman; 2) Criteria Needed to Evaluate and Award a Biosecurity
- [Biosecurity Task Force 2.0](https://absa.org/news/2018-12-biosecurity-task-force-2-0/) - Leads: David Gillum and Barbara Owen The Biosecurity Task Force and respective subcommittees held multiple teleconferences to establish the path forward and framework for offering a Biosecurity Credential through ABSA International, determine the resources needed to support credentialing (new training, classes, publications, etc.), and define the marketing strategy to launch this new biosecurity credential. To
- [Biosecurity Task Force 2.0](https://absa.org/news/2019-04-biosecurity-task-force-2-0/) - Leads: Barbara Owen and David Gillum The Biosecurity Task Force completed and submitted a proposal to ABSA regarding the initiation and launching of a biosecurity credential. The proposal outlined (1) how the credential would be defined, (2) criteria needed to evaluate and award the credential, (3) Resources needed to support he credentialing process, and (4)
- [ABSA Memorial](https://absa.org/news/2017-12-absa-memorial/) - Jack Keene passed away on Oct. 23, 2016. He was president of ABSA from 1999-2000 and had contributions to ABSA and biosafety through his teaching, mentorship, and sharing his knowledge. Jack was always willing to help and served on many ABSA committee's and task forces. Jack wrote the "Ask the Expert" column for ABSA's Journal,
- [Local Arrangements Committee](https://absa.org/news/2017-02-local-arrangements/) - Chair: Jen Gaudioso, PhD The Local Arrangements Committee has secured the venue for the Tuesday banquet and is now focusing on catering the event as well as entertainment. The LAC has also initiated a search for gifts to be distributed to speakers and attendees. Members of the LAC are reaching out to local vendors
- [Public Relations and Marketing (PR/M)](https://absa.org/news/2020-06-public-relations-and-marketing-pr-m/) - Chairs: Eric Rouse, Danielle Rintala The Public Relations and Marketing Committee hopes this finds everyone in our ABSA family well and safe. We are in a time like no other and must adapt to best serve both our membership and the biosafety and biosecurity community at large. We are pleased to announce that the Council
- [ABSA International's Promotional Videos and YouTube Channel](https://absa.org/news/2020-06-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has new promotional videos for ABSA and our ABSA Conference. The videos can be found at https://absa.org/ and on ABSA International's YouTube channel at https://youtu.be/xAQPZxMvqRY. Also, ABSA's YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Biosafety Buyer's Guide](https://absa.org/news/2020-06-biosafety-buyers-guide/) - ABSA International launched the Biosafety Buyer's Guide in early 2014 at https://biosafetybuyersguide.org/. We have had much success with many visits to the ads and listings over the past 6 years. The Guide lists companies and consultants that provide biosafety-related products and services. The most recent quarter shows the average monthly unique visitors are 2,933. The
- [Distance Learning Committee (DLC)](https://absa.org/news/2020-06-distance-learning-committee-dlc/) - Chairs: Kathleen Kennedy, Rhonda O'Keefe, Joleen Weese The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. Seven courses have been completed so far in 2020 reaching over 1250 participants. "Nanomaterials and Biosafety 101" will be offered on June 3, 2020. The DLC is working
- [Learning Verification Committee (LVC)](https://absa.org/news/2020-06-learning-verification-committee-lvc/) - Chairs: Niki Drazenovich, Matthew Fischer The Learning Verification Committee (LVC) continues to generate online quizzes. These quizzes are low-cost and can be located on the website at https://absa.org/online-education/.
- [Anthology XIV: Sustainability](https://absa.org/news/2020-06-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [ABSA International's  1st Biosecurity Symposium](https://absa.org/news/2020-06-absa-internationals-1st-biosecurity-symposium/) - ABSA International's 1st Biosecurity Symposium will be held at The Renaissance Depot Hotel in Minneapolis, Minnesota from April 20-23, 2021. The symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on
- [Preconference Course Committee (PCC)](https://absa.org/news/2020-06-preconference-course-committee-pcc/) - Chairs: Heather Blair, Antony Schwartz, Angela Ragan The Preconference Course Committee met Wednesday April 29th and finalized the Professional Development Course Program for the 63rd Annual Biosafety and Biosecurity Conference in Phoenix, Arizona. There will be one less day of professional development courses this year to accommodate limited travel funding/opportunities. The Professional Development Courses will
- [Publications Committee (PC)](https://absa.org/news/2020-06-publications-committee-pc/) - Chairs: Aparupa Sengupta, R. Vilmarie Rodriguez Figueroa Publications committee continues to meet regularly (monthly). Committee members are working towards getting collaborations on new publications related to COVID-19. There were discussions on collaboration with 'award nomination committees' to go over the award for best publications. The committee continues to brainstorm with members to make strategies to
- [ABSA International Membership Site](https://absa.org/news/2020-06-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [Scientific Program Committee (SPC)](https://absa.org/news/2020-06-scientific-program-committee-spc/) - Chairs: Jessica McCormick-Ell Claudia Gentry-Weeks, AJ Troiano The Scientific Program Committee is currently reviewing submitted abstracts for the upcoming 2020 Conference in Phoenix, AZ. This year 93 submissions were received for consideration. Notifications to speakers will go out in mid-June. Additionally, Council has approved the keynote speakers for conference. We look forward to seeing everyone
- [ABSA International 2020 Conference](https://absa.org/news/2020-06-absa-international-2020-conference/) - The 63rd Annual Biosafety and Biosecurity Conference will be held at the JW Marriott Phoenix Desert Ridge in Phoenix, Arizona from October 31-November 5. There will be 3 full days of intensive professional development courses to educate and inspire; 3 full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial
- [Job Board](https://absa.org/news/2020-06-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [ABSA International Inclusion Statement](https://absa.org/news/2020-06-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Biosecurity Credentialing Task Force](https://absa.org/news/2020-06-biosecurity-credentialing-task-force/) - Chairs: LouAnn Burnett, Patrick Condreay The Biosecurity Credentialing Task Force held its kick-off meeting in March. In the next quarter, the Task Force will be reviewing ABSA and other security industry credentialing processes, determining the scope and framework for the credential, and beginning to develop notional criteria to populate the framework. A finalized framework and
- [Nominating Committee](https://absa.org/news/2020-06-nominating-committee/) - Chair: Dee Zimmerman The Nominating Committee is in the process of contacting potential nominees for the 2020 election. Please look for the ABSA International Election ballot in your email on August 1, 2020.
- [Finance Committee](https://absa.org/news/2020-06-finance-committee/) - Chair: Lolly Gardiner The Finance Committee has been working with the ABSA International Office on managing the impacts of the Covid-19 pandemic to the current budget. The ABSA International Office has received a Paycheck Protection Program (PPP) Loan which is designed to provide a direct incentive for small businesses to keep their workers on the
- [ABSA Exam Development Board](https://absa.org/news/2020-06-absa-exam-development-board/) - Chair: Joseph Kozlovac The Board members have worked diligently to assure that examination questions are relevant, understandable, and reasonable. The Board's primary role is to maintain the quality and value of the exam as well as the CBSP credential. To meet those ends, the Board conducted a review of the exam blueprint and determined areas
- [Advanced Biosafety Training Series](https://absa.org/news/2020-06-advanced-biosafety-training-series/) - Chair: Chad Austin The Advanced Biosafety Training Series instructors continue to process content for migration to the new Learning Management System. New members have been brought on board to expedite the review process.
- [Biosafety and Biosecurity Training Course (BBTC)](https://absa.org/news/2020-06-biosafety-and-biosecurity-training-course-bbtc/) - Chair: Robert Ellis This is the first year that ABSA International and the Biosafety and Biosecurity Training Course are joining forces to offer the course and both groups are excited to share in the challenges and the rewards. The course is planned to be held in-person in Fort Collins, Colorado from August 9-14, 2020. The
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2020-06-credentialing-evaluation-board-ceb/) - Chairs: Paul Meechan and Donald Wang The CEB has continued to meet monthly to review applications for the RBP and CBSP credentials. The Board completed reviews for candidates for the 2020 CBSP exam, which may be extended to accommodate the coronavirus restrictions on people and businesses. Additionally, the Board has agreed to a second meeting
- [Expanding ABSA's Influence (EAI) Task Force](https://absa.org/news/2020-06-expanding-absas-influence-eai-task-force/) - Leads: Chad Austin, Lolly Gardiner The Expanding ABSA's Influence Task Force thanks the ABSA community for responding to the Viral Vectors needs survey and wants to provide a quick update on their progress in developing tools to address the community's needs. The EAI TF has analyzed the survey results and identified simple, practical tools that
- [BSL-3 Operations and Management](https://absa.org/news/2020-06-bsl-3-operations-and-management/) - Chairs: Paul Jennette, Carrie Smith The BSL-3 Operations and Management course was presented at the 62nd Annual Biosafety and Biosecurity Conference in Birmingham, Alabama. Instructors Paul Jennette and Carrie Smith successfully engaged the 43-student class and encouraged the students to ask a lot of questions. The instructors have identified a number of improvements to make
- [Basic & Advanced Risk Assessment](https://absa.org/news/2020-06-basic-advanced-risk-assessment/) - Chairs: Brandon Hatcher, Chad Austin The course instructors are revising course content to ensure the course remains a timely and useful resource for participants at the 63rd Annual Biosafety and Biosecurity Conference in Phoenix, Arizona in November. Currently, instructors plan to expand content on agricultural biosafety and biosecurity and are discussing other content areas to
- [Mentoring Committee](https://absa.org/news/2020-06-mentoring-committee/) - Chairs: Althea Treacy, Sarah Ziegler The Mentoring Committee is still working on adapting a forum for use for ABSA members only. It is live, but still in testing phase. They are working with the International Engagement Committee on a "buddy program" to encourage networking among new members/conference attendees, with a focus on partnering people who
- [Public Health Outreach (PHO) Task Force](https://absa.org/news/2020-06-public-health-outreach-pho-task-force/) - Leads: Marian Downing, Shoolah Escott The Public Health Outreach Task Force was created to increase ABSA International's efforts in the development of Biosafety and Biosecurity programs in Public Health and clinical laboratories. Over the last several years, ABSA and Association of Public Health Laboratories (APHL) have cooperated on Special Interest Group meetings, joint webinars, the
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2020-06-credentialing-maintenance-board-cmb/) - Chairs: Su-Hwi Hung-Cunliffe, Rhonda O'Keefe The Credentialing Maintenance Board has completed the review of 28 re-credentialing applications for the 2015-2019 cycle and one extension application for the 2014-2019 cycle. There are 13 RBP(ABSA), 8 CBSP(ABSA), and 8 RBP(ABSA)/CBSP(ABSA) among these re-credentialing applications. To complete this cycle of recredentialing review, the CMB has audited three randomly
- [International Engagement Committee (IEC)](https://absa.org/news/2020-06-international-engagement-committee-iec/) - Chairs: Eric Cook, Anne-Sophie Brocard The International Engagement Committee has been very busy reaching out to various ABSA International members to help with translating the materials in the Covid-19 Toolbox. They have also been gathering links and information from other sites and making it available to the international community. In addition, they are working to
- [Emerging Infectious Disease Consortium (EIDC)](https://absa.org/news/2020-06-emerging-infectious-disease-consortium-eidc/) - Leads: Esmeralda Meyer, Marian Downing The Emerging Infectious Disease Consortium continues to collate the weekly website updates for the ABSA International SARS-CoV2/COVID-19 toolbox https://absa.org/covid19toolbox/. Since mid-March, the committee has generated 14 documents in the areas of SARS-CoV-2/COVID-19 disinfection, personal protective equipment, laboratory/research, and shipping. Finalized documents are forwarded to the ABSA Office for formatting and
- [Exhibitors Committee](https://absa.org/news/2020-06-exhibitors-committee/) - Chair: William Peters The 63rd Annual Biosafety and Biosecurity Conference at the JW Marriott Phoenix Desert Ridge in Phoenix, Arizona will begin Sunday, November 1, 2020 to Thursday, November 5, 2020. Exhibits at the conference will be open on Monday, November 2 at 6:30-8:30 pm during the Opening Reception as well as Tuesday, November 3
- [Local Arrangements Committee (LAC)](https://absa.org/news/2020-06-local-arrangements-committee-lac/) - Chair: Shelley Jones The Local Arrangements Committee and ABSA Office have been finalizing details for the banquet at Desert Foothills on Wednesday, November 4, 2020. We have also been continuing to explore ideas for speaker and attendee gifts.
- [President's Report](https://absa.org/news/2020-06-presidents-report/) - David Gillum, MS, RBP(ABSA) Dear Biosafety Professionals, Several months ago, the world changed. The COVID-19 pandemic entered our daily lives causing countless disruptions. The pandemic hit pretty early in Arizona with the first case recorded in the state on January 26, 2020, which was the fifth case in the United States. Since then, my team
- [Bylaws Committee](https://absa.org/news/2020-02-bylaws-committee/) - Co-chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. One review has been completed since the last newsletter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International office. The office
- [Preconference Course Committee (PCC)](https://absa.org/news/2020-02-preconference-course-committee-pcc/) - Chair: Heather Blair Co-chairs: Antony Schwartz and Angela Ragan The Preconference Course Committee (PCC) has added a second Co-Chair to the committee, Angela Ragan. The PCC is also reviewing the course evaluations from 2019 and are collecting information and data to help in the decision making for the 2020 course offerings. The call for course
- [ABSA International's  1st Biosecurity Symposium](https://absa.org/news/2020-02-absa-internationals-1st-biosecurity-symposium/) - ABSA International's 1st Biosecurity Symposium will be held at The Renaissance Depot Hotel in Minneapolis, Minnesota from May 12-15, 2020. The symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on
- [Learning Verification Committee (LVC)](https://absa.org/news/2020-02-learning-verification-committee-lvc/) - Chair: Niki Drazenovich Co-chair: Matthew Fischer The Learning Verification Committee (LVC) has completed review of the Applied Biosafety journal Volume 22 and questions have been submitted to the LVC committee for review before sending to ABSA International office to generate the online quizzes. The committee has started review of Applied Biosafety journals Volume 23 and
- [Distance Learning Committee (DLC)](https://absa.org/news/2020-02-distance-learning-committee-dlc/) - Chair: Kathleen Kennedy Co-chairs: Rhonda O'Keefe and Joleen Weese The Distance Learning Committee (DLC) continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. Three core courses are on the 2020 calendar and open for registration including Q&A Infectious Substance Shipping (February 7), Fundamentals of Microbiology (March 5 and
- [Biosafety Buyer's Guide](https://absa.org/news/2020-02-biosafety-buyers-guide/) - ABSA International launched the Biosafety Buyer's Guide in early 2014. We have had much success with many visits to the ads and listings over the past 6 years. The guide lists companies and consultants that provide biosafety-related products and services. The most recent quarter shows the average monthly unique visitors are 3,575. The average monthly
- [ABSA International's Promotional Videos and YouTube Channel](https://absa.org/news/2020-02-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations/Marketing Committee, ABSA has new promotional videos for ABSA and our ABSA Conference. The videos can be found at https://absa.org/ and on ABSA International's YouTube channel at https://youtu.be/xAQPZxMvqRY. Also, ABSA's YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Public Relations and Marketing Committee (PR/M)](https://absa.org/news/2020-02-public-relations-and-marketing-committee-pr-m/) - Chair: Eric Rouse Co-chair: Danielle Rintala The Public Relations and Marketing Committee would like to thank everyone for their efforts in making Biosafety and Biosecurity Month 2019 a success. From hosting events at your institutions, to contributing materials and interviews, we could not have accomplished so much without your support. At the 2019 conference in
- [Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC)](https://absa.org/news/2020-02-biological-select-agent-and-toxins-community-advocate-committee-bsat-cac/) - Chair: Angela Birnbaum Co-chair: Eric Jeppesen The Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC) hosted the Annual SRA Users Workshop in Birmingham Alabama on November 21, 2019. The workshop had attendance from ROs, AROS, SRA cleared persons and scientists. Topics at the meeting included an open discussion with directors Dr. Sam Edwin
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2020-02-credentialing-maintenance-board-cmb/) - Chairs: Su-Hwi Hung-Cunliffe Co-chair: Rhonda O'Keefe The Credentialing Maintenance Board (CMB) thanks Deborah Newby for her services of the board and as a Co-Chair for many years. The CMB welcome new Co-Chair Rhonda O'Keefe. The CMB develops the continuing education criteria necessary for Certified Biological Safety Professionals (CBSP[ABSA]s) and Registered Biosafety Professionals (RBP[ABSA]s) to maintain
- [Principles & Practices of Biosafety (PPB)](https://absa.org/news/2020-02-principles-practices-of-biosafety-ppb/) - Course Directors: Pat Condreay and Carrie Smith The next Principles & Practices of Biosafety (PPB) course will be held July 19-24 in Portland, Oregon. Expansion of the class size to 48 students during the last offering was successful, so we are continuing with the larger class size to reach more students. We will be debuting
- [Legislative Affairs Committee](https://absa.org/news/2020-02-legislative-affairs-committee/) - Chair: Brian O'Shea Co-chair: Karon Floyd The Legislative Affairs Committee recently reviewed H.R. 4373 (ENGINEERING BIOLOGY RESEARCH AND DEVELOPMENT ACT OF 2019) and provided feedback and advice to ABSA Council as to potential areas of opportunity and influence for ABSA International. A letter on behalf of ABSA International and the Legislative Affairs Committee was sent
- [Journal Board](https://absa.org/news/2020-02-journal-board/) - Coeditors-in-Chief: Karen B. Byers and Barbara Johnson Associate Editors: David Gillum and Scott Patlovich The journal is on schedule for publication of Volume 25 Issue 1. The Editors have 6 confirmations from authors for a Special Themed Issue on gene editing, gene therapy, gene drives, and aspects of synthetic biology scheduled for Volume 25 Issue
- [Biosafety Career Entry and Professional Development Task Force](https://absa.org/news/2020-02-biosafety-career-entry-and-professional-development-task-force/) - Lead: Meghan Seltzer Vice-leads: Sherry Bohn and Rebecca Moritz The Biosafety Career Entry and Professional Development Task Force was formed to identify and create resources to: promote biosafety as a career; have a clear roadmap of ways to enter the profession and earn a credential; maintain credentials in a cost-effective manner; and develop key leadership
- [Public Health Outreach Task Force](https://absa.org/news/2020-02-public-health-outreach-task-force/) - Lead: Marian Downing Vice-lead: Shoolah Escott The Public Health Outreach Task Force was created to increase ABSA International's efforts in the development of Biosafety and Biosecurity programs in Public Health and clinical laboratories. Over the last several years, ABSA and APHL (Association of Public Health Laboratories) have cooperated on Special Interest Group meetings, joint webinars,
- [ABSA International Inclusion Statement](https://absa.org/news/2020-02-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [ABSA International 2020 Conference](https://absa.org/news/2020-02-absa-international-2020-conference/) - The 63rd Annual Biosafety and Biosecurity Conference will be held at the JW Marriott Phoenix Desert Ridge in Phoenix, Arizona from October 31-November 5. There will be 3 full days of intensive professional development courses to educate and inspire; 3 full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial
- [ABSA International Membership Site](https://absa.org/news/2020-02-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [E-Communications Committee](https://absa.org/news/2020-02-e-communications-committee/) - Chair: Sarah Ziegler Co-chair: Matthew Anderson The E-Communications Committee sponsored the Selfie Booth at the ABSA conference again this year. There appeared to be more participation than last year with regards to posts on social media. We offered special biosafety pins this year as a reward for posting to social media. Thanks to all who
- [Membership Committee](https://absa.org/news/2020-02-membership-committee/) - Chair: Malissa Mayer-Diaz Co-chair: Kelly Flint The Membership Committee has added new members and continues to work with the ABSA International Office and Council to ensure the new members of ABSA are given the support they need. The Committee is working with the International Engagement committee to create Conference Buddies to help new members (both
- [Mentoring Committee](https://absa.org/news/2020-02-mentoring-committee/) - Chair: Althea Treacy Co-chair: Sarah Ziegler The Mentoring Committee is working on creating a new forum where people can post a specific biosafety or biosecurity question and have it answered by an acknowledged biosafety/biosecurity professional. It will not be like the Listserve, but instead will have target posts to get more subject matter expert input
- [Advanced Risk Assessment](https://absa.org/news/2020-02-advanced-risk-assessment/) - Co-chairs: Brandon Hatcher and Chad Austin The course instructors have received the attendee feedback for the most recent offering of Advanced Risk Assessment and will be discussing changes that should be made for the next offering planned for Raleigh, North Carolina in 2021. Instructors will also be updating materials for the Basic Risk Assessment course
- [BSL-3 Operations and Management](https://absa.org/news/2020-02-bsl-3-operations-and-management/) - Co-chairs: Paul Jennette and Carrie Smith The course directors for BSL-3 Operations and Management are planning updates based on attendee feedback from the 2019 course offering in Birmingham, Alabama.
- [Expanding ABSA's Influence Task Force](https://absa.org/news/2020-02-expanding-absas-influence-task-force/) - Lead: Chad Austin Vice-lead: Lolly Gardiner In mid-2019, ABSA International's Council authorized the creation of a task force to evaluate and address the needs of the biosafety community regarding viral vector risk assessment. The task force's first challenge-determining whether there is even a demand for such information. Thanks to the 333 respondents to questionnaire the
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2020-02-credentialing-evaluation-board-ceb/) - Co-chairs: Paul Meechan and Donald Wang The Credentialing Evaluation Board (CEB) continues their monthly conference call to review submitted RBP/CBSP applications and other Board-related matters. Since the 2019 Conference to date the CEB received and reviewed 19 RBP and CBSP applications including one for the CBSP Exam. Summary of CEB's Application Reviews: RBP CBSP
- [Awards Committee](https://absa.org/news/2020-02-awards-committee/) - Chair: Jeff Potts Co-chair: John Veitch 2019 Wedum Recipient: Kathryn Harris, PhD, RBP(ABSA) 2019 Hanel Recipient: Elizabeth Gilman Duane, MS, RBP(ABSA), CBSP(ABSA) 2019 Richardson Recipient: Robert Hawley, PhD, RBP(ABSA), CBSP(ABSA) Scientific Poster Award: Tahsin Onur Kevenk, Veterinary Control Central Research Institute - Ankara, Turkey Informational Poster Award: Biosafety Cabinet Certification Program in Ethiopia - Sarah
- [International Engagement Committee (IEC)](https://absa.org/news/2020-02-international-engagement-committee-iec/) - Chair: Eric Cook Co-chair: Anne-Sophie Brocard The International Engagement Committee (IEC) has identified 8 general regions of the world and new contacts are identified by region. Different members of the committee specialize their focus and contacts in these regions to gain better familiarity with the biosafety practices and needs of these regions. The committee is
- [Emerging Infectious Disease Task Force](https://absa.org/news/2020-02-emerging-infectious-disease-task-force/) - Lead: AJ Troiano The task force left off in Q3 2019 in a "stand-by" mode. The originally purpose of the committee in the backdrop of the Ebola Outbreak Response of 2014-2015 was to help build Alliance Partners with ABSA for increased communication and alignment of resources when faced with emerging threats. The members worked hard
- [Training Tools and Resources (TTR)](https://absa.org/news/2020-02-training-tools-and-resources-ttr/) - Chair: Eric Cook Co-chair: Lauriane Quenee Training Tools and Resources (TTR) collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These resources are collated on the ABSA website. The committee continues to work on evaluation and review methods for making the information and resources easier
- [Exhibitors Committee](https://absa.org/news/2020-02-exhibitors-committee/) - Chair: William Peters The 63rd Annual Biosafety and Biosecurity Conference at the JW Marriott Phoenix Desert Ridge in Phoenix, Arizona is beginning one day later than usual-Saturday, October 31 to Thursday, November 5, 2020. Exhibits at the conference will be open on Monday, November 2 at 6:30-8:30 pm during the Opening Reception as well as
- [Education & Curriculum Task Force (ECTF)](https://absa.org/news/2020-02-education-curriculum-task-force-ectf/) - Lead: Brandy Nelson Vice-lead: Chad Austin The Education & Curriculum Task Force (ECTF) continues to develop ideas and initiatives in support of ECTF goals. ECTF goals center on development of a strategy and resources for academic institutions (and their biosafety professionals) to encourage and implement biosafety education at undergraduate, graduate, and post-doctoral levels, development of
- [Technical & Regulatory Review Committee (TRR)](https://absa.org/news/2020-02-technical-regulatory-review-committee-trr/) - Chair: David Pawlowski Co-chair: Esmeralda Meyer The Technical and Regulatory Review (TRR) committee has had a busy quarter to end 2019. Members of the committee reviewed and responded to 3 Federal actions or publications. First, the National Labor Relations Board was seeking comments to a proposed rule regarding the non-employee status of university and college
- [Local Arrangements Committee (LAC)](https://absa.org/news/2020-02-local-arrangements-committee-lac/) - Chair: Shelley Jones The Local Arrangements Committee (LAC) is excited to welcome you to Phoenix, Arizona, October 31 - November 5, 2020 for the 63rd Annual Biosafety and Biosecurity Conference. Our venue is the fabulous JW Marriott Phoenix Desert Ridge Resort. The LAC and ABSA Office have identified Desert Foothills as an impressive high desert,
- [President's Report](https://absa.org/news/2020-02-presidents-report/) - David Gillum, MS, RBP(ABSA) Dear ABSA International Colleagues, It is with great pleasure that I write to you as President of ABSA International. The work we do as a profession is critical for the safety and security of our coworkers, families, communities, and the ecosystems in which we live. This is especially important as we
- [Public Relations and Marketing Committee (PR/M)](https://absa.org/news/2019-08-public-relations-and-marketing-committee-pr-m/) - Co-chairs: Eric Rouse and Danielle Rintala The PR/M Committee is hard at work preparing materials and logos for the October 2019 Biosafety and Biosecurity Month. The theme is "Beyond the Lab: Increasing the Visibility of Biosafety and Biosecurity." The logos and posters for promotional materials are now available and additional promotional materials are in progress.
- [2018 Biosafety Month](https://absa.org/news/2018-09-2018-biosafety-month/) - We'll be promoting Biosafety Month at the conference in October. There are materials at to assist your organization in promoting Biosafety Month. #getyourcultureon
- [Public Relations and Marketing Committee](https://absa.org/news/2018-09-pr-marketing/) - Co-chairs: Joshua Turse, Eric Rouse, and Lolly Gardiner The Public Relations and Marketing Committee continues to concentrate on 2018 Biosafety Month, a period of time when individuals and organizations are encouraged to focus on and reinforce their attention to biosafety and biosecurity standards. 2018 Biosafety Month will be held in October this year. The theme
- [President's Report](https://absa.org/news/2018-09-presidents-report/) - Patrick Condreay, PhD, RBP Dear ABSA International Colleagues, #getyourcultureon is the hashtag for the October 2018 Biosafety Month theme of "Promoting a Culture of Biosafety and Responsibility." You can find promotional materials at the ABSA International website at . Thank you to the Public Relations/Marketing Committee for all their work on biosafety month. We hope
- [Distance Learning Committee (DLC)](https://absa.org/news/2018-05-distance-learning-committee2017-12-distance-learning-committee-2/) - Co-chairs: Kathleen Kennedy, Lisa Burley, and Rhonda O'Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. The DLC has 10 webinars scheduled with more courses to be added. Scheduled webinars cover topics including laboratory design, the culture of safety, shipping infectious substances, virology,
- [Distance Learning Committee (DLC)](https://absa.org/news/2017-12-distance-learning-committee/) - Co-chairs: Kathleen Kennedy, Lisa Burley, and Rhonda O'Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. The DLC has started planning for 2018 which includes the Biosecurity and Developing Technologies webinar and reoffering the Large-Scale Biosafety and Q&A Infectious Substance Shipping webinars. We
- [ABSA-Owned Courses](https://absa.org/news/2019-08-absa-owned-courses/) - Co-chairs: Chad Austin and Lisa Benford Basic & Advanced Risk Assessment Co-chairs: Chad Austin and Brandon Hatcher The instructors for the Risk Assessment courses have redesigned and are finalizing materials for the Advanced Risk Assessment course offering in Birmingham at the annual ABSA Conference. The revamped Advanced Risk Assessment course will include new scenarios with
- [Bylaws Committee](https://absa.org/news/2019-08-bylaws-committee/) - Co-chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. One review has been completed this quarter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International office. The office will forward
- [Publications Committee (PC)](https://absa.org/news/2019-08-publications-committee-pc/) - Co-chairs: Luis Alberto Ochoa Carrera and Aparupa Sengupta The PC has continued to meet nearly every month. The committee continues to work jointly with the Applied Biosafety Journal (ABJ) on methods to encourage and assist the submission of high-quality papers to the journal. Several potential papers have been identified among the different working groups of
- [ABSA International Membership Site](https://absa.org/news/2019-08-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [Scientific Program Committee (SPC)](https://absa.org/news/2019-08-scientific-program-committee-spc/) - Co-chairs: Jessica McCormick-Ell, Claudia Gentry-Weeks, and AJ Troiano The SPC has finalized the scientific program agenda for the 2019 ABSA Conference in Birmingham, AL. We look forward to all of the presentations and networking with colleagues. We will begin reviewing and selecting keynote speakers for the 2020 ABSA Conference in the early fall. If you have
- [ABSA International 2019 Conference](https://absa.org/news/2019-08-absa-international-2019-conference/) - The 62nd Annual Biosafety and Biosecurity ABSA Conference will be held at the Birmingham-Jefferson Convention Complex in Birmingham, Alabama from November 15-20. There will be 3 full days of intensive professional development courses to educate and inspire; 3 full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today's biosafety
- [Job Board](https://absa.org/news/2019-08-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [ABSA International Inclusion Statement](https://absa.org/news/2019-08-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental and nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices
- [Training Tools and Resources (TTR)](https://absa.org/news/2019-08-training-tools-and-resources-ttr/) - Co-chairs: Eric Cook and Lauriane Quenee TTR collects, manages, and makes recommendations for tools and resources that would be useful for biosafety professionals around the world. These resources are collated on the ABSA website. Currently, the committee is working on making the information and resources easier to find and more useful by providing reviews of
- [Emerging Infectious Disease Consortium Task Force](https://absa.org/news/2019-08-emerging-infectious-disease-consortium-task-force/) - Lead: AJ Troiano The Emerging Infectious Disease Consortium Task Force changed leadership as of 2018 with AJ Troiano, PhD, RBP, Scientist II-Life Sciences at Environmental Health & Engineering, Inc. taking over for Paul Tranchell. As such, we sought to first reinvigorate our Vision and Strategy: Vision: Collaborate with appropriate professional organizations in order to create
- [International Engagement Committee (IEC)](https://absa.org/news/2019-08-international-engagement-committee-iec/) - Co-chairs: Eric Cook and Anne-Sophie Brocard The IEC has been working to develop a survey to distribute to biosafety professionals outside of the US. The survey will target those who are not members of ABSA International and will gather information to help inform leadership about the needs and interests of these professionals and how ABSA
- [Awards Committee](https://absa.org/news/2019-08-awards-committee/) - Co-chairs: Jeff Potts and John Veitch Thank you for the Honor Award submissions that many of you have submitted. The Awards Committee will be reviewing submissions over the summer and making their selections. As usual, recipients will be recognized during the Annual ABSA Conference in November. The committee will also be asking membership for any
- [E-Communications Committee](https://absa.org/news/2019-08-e-communications-committee/) - Co-chairs: Sarah Ziegler and Matthew Anderson The committee will be sponsoring a selfie-station again this year at the ABSA Conference. The selfie station was popular last year and we hope we get even more members to stop by and snap a selfie in front of the "Sick Art" backdrop and share the pic on social
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2019-08-credentialing-maintenance-board-cmb/) - Co-chairs: Su-Hwi Hung-Cunliffe and Deborah Newby The CMB welcomed three new members: Amy Helgerson, Hallie Hoskins, and Susanne Savely in July 2019. The CMB has completed the review of 52 re-credentialing applications for the 2014-2018 cycle and five extension applications for the 2013-2018 cycle. The CMB has audited four randomly chosen applicants to verify their
- [Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC)](https://absa.org/news/2019-08-biological-select-agent-and-toxins-community-advocate-committee-bsat-cac/) - Co-chairs: Angela Birnbaum and Eric Jeppesen The BSAT CAC offered another webinar for the Select Agent community. The webinar was held on August 13, 2019 and was titled "SELECT AGENT SMORGASBORD: TRAININGS, INSPECTIONS, AND SHUTDOWNS...OH MY!" Based on survey participant feedback for this upcoming webinar, we are excited to offer more information on training development,
- [ABSA Ambassadors](https://absa.org/news/2019-08-absa-ambassadors/) - The ABSA Ambassadors continue to spread the word about ABSA and the Biosafety profession. David Gillum presented at Georgetown University's "Biosecurity Collaborations with the Research Community: Challenges and Successes." Marian Downing represented ABSA International in a Biosafety Roundtable at the Association of Public Health Laboratories (APHL) Annual Meeting entitled "Preparing Sentinel Clinical Laboratories: Safety, Biological
- [ABSA International's Promotional Videos and YouTube Channel](https://absa.org/news/2019-08-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations Committee, ABSA has new promotional videos for ABSA and our ABSA Conference. The videos can be found at https://absa.org/ and on ABSA International's YouTube channel at https://youtu.be/xAQPZxMvqRY. Also, ABSA's YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Biosafety Buyer's Guide](https://absa.org/news/2019-08-biosafety-buyers-guide/) - ABSA International launched the Biosafety Buyer's Guide in early 2014 at https://biosafetybuyersguide.org/. We have had much success with many visits to the ads and listings over the past 5 years. The guide lists companies and consultants that provide biosafety-related products and services. The most recent quarter shows the average monthly unique visitors are 4,922. The
- [Distance Learning Committee (DLC)](https://absa.org/news/2019-08-distance-learning-committee-dlc/) - Co-chairs: Kathleen Kennedy, Lisa Burley, Rhonda O'Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. The DLC has several webinars on the calendar including An Introduction to Synthetic Biology, Animal Handler Risk Assessment, Molecular Biology 101 and Virus Based Gene Transfer Vectors (Viral
- [Anthology XIV: Sustainability](https://absa.org/news/2019-08-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [ABSA International's  1st Biosecurity Symposium](https://absa.org/news/2019-08-absa-internationals-1st-biosecurity-symposium/) - ABSA International's 1st Biosecurity Symposium will be held at The Renaissance Depot Hotel in Minneapolis, Minnesota from May 12-15, 2020. The symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on
- [Finance Committee](https://absa.org/news/2019-08-finance-committee/) - Co-chairs: Jim Klenner and Sarah McAbee The Finance Committee has continued to hold regularly scheduled monthly meetings to review ABSA International's financial reports. During the May meeting, the committee accepted the auditor's report for FY 2018 with no concerns. Team liaisons on the Finance Committee are currently working with the various ABSA International Committees and
- [Nominating Committee](https://absa.org/news/2019-08-nominating-committee/) - Chair: Patrick Condreay The committee has completed the task of contacting individuals and has assembled a slate of candidates for the 2019 election. Thanks to all who have stepped forward to participate in governance of the Association. The ballot for the 2019 election has been sent out to members. Be sure to vote by end
- [Historical Committee](https://absa.org/news/2019-08-historical-committee-2/) - Co-chairs: John Balog, Manuel Barbeito, and Robert Hawley The committee continues to accept and evaluate photographs, manuscripts, manuals, and related publications relevant to the history of biosafety and the practice of biological safety. The Committee works with Ms. Susan Fugate at the USDA National Agricultural Library (NAL) to facilitate the transfer of historically important materials
- [Exhibitors Committee](https://absa.org/news/2019-08-exhibitors-committee/) - Chair: William Peters Exhibits at the 62nd Annual Biosafety and Biosecurity Conference will be open on Sunday, November 17 at 6:30-8:30 pm during the Opening Reception as well as Monday, November 18 and Tuesday, November 19 from 9:00-4:00 pm. The conference and exhibits will be held at the Birmingham-Jefferson Convention Complex in Birmingham, Alabama. We
- [Education & Curriculum Task Force (ECTF)](https://absa.org/news/2019-08-education-curriculum-task-force-ectf/) - Co-chairs: Brandy Nelson and Chad Austin The ECTF has continued to meet regularly during the second quarter of 2019 to develop ideas and initiatives in support of ECTF goals. ECTF goals center on development of a strategy and resources for academic institutions (and their biosafety professionals) to encourage and implement biosafety education at undergraduate, graduate,
- [Technical & Regulatory Review Committee (TRR)](https://absa.org/news/2019-08-technical-regulatory-review-committee-trr/) - Co-chairs: Yolanda Arriaga Stringer and David Pawlowski TRR conferred discussing two public meetings (pertaining to the National Biodefense Strategy and the National Association for Biomedical Research) for future potential contributions and the New York State Regulated Medical Waste Regulation, which it subsequently reviewed as it pertains to BSL-3 and Select Agent waste removal and treatment.
- [President's Report](https://absa.org/news/2019-08-presidents-report/) - Dear ABSA International Colleagues, Registration is open for the ABSA Conference in Birmingham, Alabama, November 14-20, 2019. The Preconference Course Committee and Scientific Program Committee have finalized both the Professional Development Courses and the Scientific Program; speakers and course presenters are in place. The International Engagement Committee co-chairs have worked with the Scientific Program Committee co-chairs
- [Scientific Program Committee](https://absa.org/news/2016-10-sciprog/) - Co-Chairs: Darlene Ward and Betsy Matos This was a crucial time for the Scientific Program Committee (SPC) and we hope you were able to join us at the 59th Annual Biosafety and Biosecurity Conference. The hard work by the SPC created a great program! New this year-the posters were categorized by scientific and informational criteria
- [Education & Curriculum Task Force (ECTF)](https://absa.org/news/2019-04-education-curriculum-task-force-ectf/) - Co-chairs: Brandy Nelson and Chad Austin The Education & Curriculum Task Force (ECTF) has continued to meet regularly during the first quarter of 2019 to develop ideas and initiatives in support of ECTF goals. ECTF goals center on development of a strategy and resources for academic institutions (and their biosafety professionals) to encourage and implement
- [Job Board](https://absa.org/news/2019-04-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [ABSA International Inclusion Statement](https://absa.org/news/2019-04-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental/ nongovernmental organizations, and the public. It is our organization’s policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices extend
- [Biosafety Career Entry and Professional Development Task Force](https://absa.org/news/2019-04-biosafety-career-entry-and-professional-development-task-force/) - Leads: Meghan Seltzer and Rebecca Moritz The Biosafety Career Entry and Professional Development Task Force was formed and held its first meeting. The goals of the task force are to identify and create resources to promote biosafety as a career, have a clear roadmap of ways to enter the profession and earn a credential, maintain
- [Technical & Regulatory Review Committee (TRR)](https://absa.org/news/2019-04-technical-regulatory-review-committee-trr-2/) - Co-chairs: Yolanda Arriaga Stringer and David Pawlowski The Technical & Regulatory Review Committee (TRR) Co-Chairs provided a comment to the ABSA Council on the National Science Foundation’s (NSF) Directorate for Biological Sciences (BIO) Request for Information on Integration Institutes for Cross-Cutting Biology and points of potential participation for ABSA International. Early participation by ABSA International
- [Expanding ABSA's Influence Task Force](https://absa.org/news/2019-04-expanding-absas-influence-task-force/) - Leads: Chad Austin and Lolly Gardiner Wanted! Persons to join the Expanding ABSA's Influence Task Force for a special Council request to develop a template risk assessment form for viral vectors. Experience with molecular virology and risk assessment preferred but not required. Please contact brenda@absaoffice.org to sign up.
- [ABSA International’s Promotional Videos and YouTube Channel](https://absa.org/news/2019-04-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations Committee, ABSA has new promotional videos for ABSA and our conference. The videos can be found at https://absa.org/ and on ABSA International’s YouTube channel at https://youtu.be/xAQPZxMvqRY. Also, ABSA’s YouTube channel has video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or link
- [Biosafety Buyer’s Guide](https://absa.org/news/2019-04-biosafety-buyers-guide/) - ABSA International launched the Biosafety Buyer’s Guide in early 2014 at https://biosafetybuyersguide.org/. We have had much success with many visits to the ads and listings over the past 5 years. The Guide lists companies and consultants that provide biosafety-related products and services. The most recent quarter shows the average monthly unique visitors are 6,685. The
- [Anthology XIV: Sustainability](https://absa.org/news/2019-04-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [ABSA International’s 1st Biosecurity Symposium](https://absa.org/news/2019-04-absa-internationals-1st-biosecurity-symposium/) - ABSA International’s 1st Biosecurity Symposium will be held at The Renaissance Depot Hotel in Minneapolis, Minnesota from May 12-15, 2020. The symposium will galvanize and bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge, and to learn from each other. The agenda includes themes on
- [ABSA International Membership Site](https://absa.org/news/2019-04-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [ABSA International 2019 Conference](https://absa.org/news/2019-04-absa-international-2019-conference/) - The 62nd Annual Biosafety and Biosecurity Conference will be held at the Birmingham-Jefferson Convention Complex in Birmingham, Alabama from November 15-20. There will be 3 full days of intensive professional development courses to educate and inspire; 3 full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today’s biosafety
- [Credentialing Evaluation Board](https://absa.org/news/2019-04-credentialing-evaluation-board/) - Co-chairs: Thomas Boyle and Don Wang Since the last report, the CEB received 32 applications to approve or deny. The CEB received 11 RBP applications; 3 applications were reviewed and approved; 2 were reviewed and denied; and 6 applications are pending. The CEB also reviewed 21 CBSP applications; 14 applications were reviewed and approved; 5
- [Awards Committee](https://absa.org/news/2019-04-awards-committee/) - Co-chairs: Jeff Potts and John Veitch The Awards Committee is planning their first meeting in 2019 to discuss improving the award submission process. After a disappointingly low number of nominees in 2018, the committee is looking to expand the open submission period as well as encourage more nominees to be submitted. Please take some time
- [NextGen Shared Interest Group](https://absa.org/news/2019-04-nextgen-shared-interest-group/) - Leads: Caitlyn Hauke and Theresa Marth The NextGen Shared Interest Group would like to host another event at this year’s ABSA International conference and is currently seeking your suggestions! Please email Caitlyn Hauke (caitlyn.a.hauke@dartmouth.edu) or Theresa Marth (Theresa.Marth@ARS.USDA.GOV) with your ideas for the conference meet up and other future events or activities you would like
- [Public Relations and Marketing Committee (PR/M)](https://absa.org/news/2019-04-public-relations-and-marketing-committee-pr-m/) - Co-chairs: Eric Rouse and Danielle Rintala The 2018 Biosafety Month was a recognized success for ABSA International. As the face of ABSA is ever evolving to further highlight the importance of biosecurity, “Biosafety Month” will now be known as “Biosafety and Biosecurity Month.” The ABSA Public Relations and Marketing (PR/M) Committee is excited to announce
- [Distance Learning Committee (DLC)](https://absa.org/news/2019-04-distance-learning-committee-dlc/) - Co-chairs: Kathleen Kennedy, Lisa Burley, and Rhonda O’Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members’ professional growth. The DLC currently has five core webinars on the calendar: Fundamentals of Microbiology, Q&A Infectious Substance Shipping, Concepts of Virology, Molecular Biology 101 and Virus Based Gene
- [Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC)](https://absa.org/news/2019-04-biological-select-agent-and-toxins-community-advocate-committee-bsat-cac/) - Co-chairs: Angela Birnbaum and Eric Jeppesen In January of 2019, Colleen Driskill stepped down from her position of Co-chair of the Biological Select Agent and Toxin Community Advocate Committee (BSAT CAC). She served as Co-chair since the initiation of the Select Agent Task Force, which became the BSAT CAC in at the end of 2017.
- [Scientific Program Committee (SPC)](https://absa.org/news/2019-04-scientific-program-committee-spc/) - Co-chairs: Jessica McCormick-Ell, Claudia Gentry-Weeks, and AJ Troiano The Scientific Program Committee is in full swing planning for the 2019 Conference in Birmingham. The SPC will begin reviewing abstract submissions in April, and we are hoping to have many submissions for consideration. This year we have more room for poster presentations, and can allow our
- [Legislative Committee](https://absa.org/news/2019-04-legislative-committee/) - Chair: Brian J. O’Shea The Legislative Committee has not met this quarter, but continues to monitor legislative discussions from Capitol Hill for any potential impacts to biological research sciences as well as discussions from the Federal Select Agent Program and the Blue Ribbon Study Panel on Biodefense.
- [Exhibitors Committee](https://absa.org/news/2019-04-exhibitors-committee/) - Chair: William Peters Exhibits at the 62nd Annual Biosafety and Biosecurity Conference will be open on Sunday, November 17 at 6:30-8:30 pm during the Opening Reception as well as Monday, November 18 and Tuesday, November 19 from 9:00-4:00 pm. The conference and exhibits will be held at the Birmingham-Jefferson Convention Complex in Birmingham, Alabama. We
- [Journal Board](https://absa.org/news/2019-04-journal-board/) - Coeditors-in-Chief: Karen B. Byers and Barbara Johnson Associate Editor: David Gillum The Editors of Applied Biosafety (APB) and the journals publishing group SAGE have submitted an application for APB to be indexed in Medline. We are hoping to be evaluated as part of the cycle starting in June. After a decision is received from MEDLINE,
- [Preconference Course Committee (PCC)](https://absa.org/news/2019-04-preconference-course-committee-pcc/) - Co-chairs: Heather Blair and Antony Schwartz Subgroups have been created and formed for new recruitment and for an instructor orientation for the professional development courses. A time is being scheduled for choosing the professional development courses for 2019.
- [ABSA-Owned Courses](https://absa.org/news/2019-04-absa-owned-courses/) - Co-chairs: Chad Austin and Lisa Benford Basic & Advanced Risk Assessment Co-chairs: Chad Austin and Brandon Hatcher The instructors for the Risk Assessment courses have completely redesigned and are preparing materials for the Advanced Risk Assessment course. The Advanced Risk Assessment course is scheduled to be offered at the upcoming ABSA International Annual Conference in
- [Bylaws Committee](https://absa.org/news/2019-04-bylaws-committee/) - Co-chairs: Amy Ryan and Timothy Sturgis The Bylaws Committee continues to edit and review the Policies & Procedures of various teams and committees. Two reviews have been completed this quarter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International office. The office will forward
- [ABSA Ambassadors](https://absa.org/news/2019-04-absa-ambassadors/) - Lead: Marian Downing The ABSA Ambassadors continue to spread the word about ABSA and the Biosafety profession. Mary Cipriano continues to work with her local hospital on their Biosafety programs. Currently, she is working with the Occupational Health Nurse to ensure appropriate Caregiver Health (for approximately 1600 employees and volunteers) regarding screening and vaccination programs.
- [Publications Committee (PC)](https://absa.org/news/2019-04-publications-committee-pc/) - Co-chairs: Luis Alberto Ochoa Carrera and Aparupa Sengupta The committee has continued to meet approximately on a monthly basis and has received the request of acceptance from new members. The PC roster has 35 active members. After several months of analysis and discussion regarding the survey submitted to the ABSA’s membership about creating a new
- [International Engagement Committee](https://absa.org/news/2019-04-international-engagement-committee/) - Co-chairs: Eric Cook and Anne-Sophie Brocard The IEC is a new committee this year. Our primary focus is to promote and help improve ABSA’s engagement, outreach, and growth beyond the United States. We just finalized a draft of our Policies and Procedures and are awaiting approval from the Council and Bylaws Committee. We have divided
- [Training Tools and Resources (TTR)](https://absa.org/news/2019-04-training-tools-and-resources-ttr/) - Co-chairs: Eric Cook and Laurianne Quenee The TTR committee continues to gather and review biosafety and biosecurity resources for inclusion on the ABSA website. Please email Eric Cook encook@sandia.gov or the ABSA office if you have any resources, links, training materials, or other sources that could be of benefit to the membership. The committee is
- [President's Report](https://absa.org/news/2019-04-presidents-report/) - Domenica (Dee) Zimmerman Dear ABSA International Colleagues, The ABSA calendar has been busy one for ABSA Council, committees, and task forces. Mark your calendars for Birmingham, Alabama from November 15 to 20, 2019 for ABSA International’s 62nd Annual Biosafety and Biosecurity Conference. The Scientific Program Committee has already issued the call for papers and is
- [Publications Committee](https://absa.org/news/2018-12-publications-committee/) - Chair: Luis Alberto Ochoa Carrera The committee has continued to meet approximately on a monthly basis and has received the request of acceptance from new members. The new members will be presented during the November call and will be assigned to their new activities. The New Emerging Technology and Diseases working group is now part
- [Job Board](https://absa.org/news/2018-12-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [ABSA International Inclusion Statement](https://absa.org/news/2018-12-absa-international-inclusion-statement/) - In alignment with our core organizational values, ABSA International (ABSA) encourages positive connections between biosafety professionals, scientists, governmental/nongovernmental organizations, and the public. It is our organization's policy to administer all activities without discrimination on the basis of age, gender, race, religion, sexual orientation, national origin, disability, marital/familial status, and veteran status. These practices extend to
- [ABSA International 2019 Conference](https://absa.org/news/2018-12-absa-international-2019-conference/) - The 62nd Annual Biosafety and Biosecurity Conference will be held at the Birmingham-Jefferson Convention Complex in Birmingham, Alabama from November 15-20. There will be 3 full days of intensive professional development courses to educate and inspire; 3 full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today's biosafety
- [Scientific Program Committee (SPC)](https://absa.org/news/2018-12-scientific-program-committee-spc/) - Co-chairs: Jessica McCormick-Ell, Claudia Gentry-Weeks, and AJ Troiano The Scientific Program Committee has started to prepare for the 2019 conference. We are reviewing the survey results and discussing proposed keynote speakers. Our monthly conference calls will be starting in December to plan the next conference program. We welcome additional suggestions for keynote speakers, which should
- [ABSA International Membership Site](https://absa.org/news/2018-12-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [Bylaws Committee](https://absa.org/news/2018-12-bylaws-committee/) - Co-chairs: Amy Ryan and Tim Sturgis The Bylaws Committee continues to edit and review the Policies and Procedures of various teams and committees. One review has been completed this quarter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International office. The office will forward
- [ABSA-Owned Courses Committee](https://absa.org/news/2018-12-absa-owned-courses-committee/) - Co-chairs: Chad Austin and Lisa Benford Principles & Practices of Biosafety (PPB) Co-chairs: Paul Jennette, Jeff Owens, and Carrie Smith The course has been in good demand, with courses frequently filling up ahead of time. The next offering is scheduled for March 2019 in San Diego, California. The course directors are sad to see Hallie
- [Preconference Course Committee (PCC)](https://absa.org/news/2018-12-preconference-course-committee-pcc-2/) - Co-chairs: Heather Blair and Antony Schwartz Thank you to the Preconference Course Committee (PCC) members, facilitators, instructors, and ABSA International office staff for making available a variety of interesting preconference courses for the ABSA International members at our annual conference. Of the courses offered, 74% of the available seats were sold with a total of
- [Anthology XIV: Sustainability](https://absa.org/news/2018-12-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [NextGen Shared Interest Group](https://absa.org/news/2018-12-nextgen-shared-interest-group/) - Co-chairs: Theresa Marth and Caitlyn Hauke The NextGen Shared Interest Group met at the ABSA International conference in October for a career panel luncheon. Biosafety professionals from government, industry, academia, and consulting shared insights and tips for success in a career in biosafety with members new to the field. There was also a discussion on
- [Distance Learning Committee (DLC)](https://absa.org/news/2018-12-distance-learning-committee-dlc/) - Co-chairs: Kathleen Kennedy, Lisa Burley, and Rhonda O'Keefe The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. The DLC has one webinar scheduled to kick off in 2019--Biosecurity at the Interface of Personalized Medicine, Gene Transfer, and Occupational Health--with more courses to be scheduled.
- [Biosafety Buyer's Guide](https://absa.org/news/2018-12-biosafety-buyers-guide/) - ABSA International launched the Biosafety Buyer's Guide in early 2014 at https://biosafetybuyersguide.org/. March 1 marked the beginning of the Guide's 5th successful year. The Guide lists companies and consultants that provide biosafety-related products and services. Over the past 4-1/2 years, we have had much success with many visits to the ads and listings. The most
- [Public Relations and Marketing Committee (PR/M)](https://absa.org/news/2018-12-public-relations-and-marketing-committee-pr-m/) - Chair: Joshua E. Turse The Public Relations and Marketing Committee would like to thank everyone for making Biosafety Month 2018 a success this year. This event was only possible through your contributions and participation. We are already looking forward to Biosafety Month 2019! Additionally, the PR/M Committee is discussing opportunities for future campaigns centered on
- [ABSA Ambassadors](https://absa.org/news/2018-12-absa-ambassadors/) - Lead: Marian Downing The ABSA Ambassadors have been busy since the last update. Activities have included: Richard Gilpin gave an ABSA Update to the IBC at Medimmune in August and November, and also presented on Biosafety IT to the ISC2 conference in September. He gave a talk on Legionella Biosafety at the ASM Maryland Chapter
- [Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC)](https://absa.org/news/2018-12-biological-select-agent-and-toxins-community-advocate-committee-bsat-cac/) - Co-chairs: Colleen Driskill and Angela Birnbaum The Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC) spent the late summer and fall preparing an agenda for the Annual Select Agent (SRA) Approved User Workshop, which took place following the ABSA International Conference on October 19, 2018 in Charleston, South Carolina. The full-day workshop was
- [Legislative Committee](https://absa.org/news/2018-12-legislative-committee/) - Chair: Brian J. O'Shea The Legislative Committee has continued to monitor legislative discussions from Capitol Hill for any potential impacts to biological research sciences as well as discussions from the Federal Select Agent Program and the Blue Ribbon Study Panel on Biodefense. The committee has also been discussing with the Public Relations Committee the possibility
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2018-12-credentialing-maintenance-board-cmb/) - Chair: Susan Cook The CMB would like to remind RBPs and CBSPs of the following recommendations to ensure an efficient and timely review of their recredentialing worksheets. Submit applications for CM credit as soon after the activity as possible. This will allow the CMB to review these applications in a timely fashion and will prevent
- [ABSA International's Promotional Videos and YouTube Channel](https://absa.org/news/2018-12-absa-internationals-promotional-videos-and-youtube-channel/) - Thanks to the Public Relations Committee, ABSA has new promotional videos for ABSA and our conference. The videos can be found at http://www.absa.org and on ABSA International's YouTube channel at https://youtu.be/xAQPZxMvqRY. Also on ABSA's YouTube channel are video interviews of conference presenters and keynotes. Feel free to share the video, use it in presentations, or
- [Exhibitors Committee](https://absa.org/news/2018-12-exhibitors-committee/) - The Exhibit Hall will be open from 9:00 am to 4:00 pm on Monday and Tuesday. The Opening Reception will be in the Exhibit Hall from 6:30 pm to 8:30 pm.
- [Education & Curriculum Task Force (ECTF)](https://absa.org/news/2018-12-education-curriculum-task-force-ectf/) - Co-chairs: Brandy Nelson and Paul Meechan The Education & Curriculum Task Force (ECTF) has continued to meet regularly including at the most recent ABSA International conference. A presentation on the work of the ECTF was given on October 16, 2018 at the ABSA International conference in Charleston, South Carolina. Presentations assist in furthering the goal
- [Technical & Regulatory Review Committee (TRR)](https://absa.org/news/2018-12-technical-regulatory-review-committee-trr/) - Co-chairs: Yolanda Arriaga Stringer and David Pawlowski The Technical & Regulatory Review Committee (TRR) enjoyed time at the ABSA International conference with a productive lunch meeting and much activity related to current reviews. The review for the NIH Office of Science Policy (OSP) Proposed Changes to the NIH Guidelines for Research Involving Recombinant or Synthetic
- [Preconference Course Committee](https://absa.org/news/2018-09-pda/) - Co-chairs: Carrie Smith and Heather Blair The committee has selected 26 courses to be offered at the 61st Annual Biosafety and Biosecurity Conference. Half-day and full-day courses will be held Friday, October 12 through Sunday, October 14. Courses cover a variety of biosafety related topics with courses for both new biosafety professionals and seasoned veterans
- [Training Tools and Resources Committee](https://absa.org/news/2018-09-ttr/) - Co-chairs: Eric Cook and Lauriane Quenee TTR will be meeting at the conference. The committee continues to review submissions. New Co-Chair will be Lauriane Quenee. She will begin in October when Dave Harbourt steps down.
- [Bylaws Committee](https://absa.org/news/2018-09-bylaws/) - Chair: Amy Ryan The committee continues to edit and review the Policies & Procedures of various teams and committees. One review has been completed this quarter. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International office. The office will forward the changes to the
- [Publications Committee](https://absa.org/news/2018-09-pub/) - Co-chairs: Bruce Whitney and Luis Alberto Ochoa Carrera The committee has continued to meet approximately on a monthly basis and has added several new members to its roster. The committee continues to work on a proposal for the next generation of the Anthology series following a survey that was sent recently to ABSA's membership. The
- [Scientific Program Committee](https://absa.org/news/2018-09-sciprog/) - Co-chairs: Betsy Matos, Jessica McCormick-Ell, and Claudia Gentry-Weeks The Scientific Program Committee is looking forward to the 19 platform sessions addressing many aspects of biological safety and biosecurity. Our four keynote speakers will address global issues in our discipline as well as basic science challenges. We have more than 10 countries represented in our platform
- [Obituary: Donald Vesley](https://absa.org/news/2018-09-donald-vesley/) - Donald Vesley (1932 - 2018) November 7, 1932 - June 19, 2018 Don was born on November 7, 1932, in Astoria, NY, and grew up in Whitestone. His mother and father were first- and second-generation Czechoslovakian Americans respect-ively; Veselsky was changed to Vesley. Don fondly recalled his childhood New York experiences such as visiting the
- [ABSA International 2018 Conference](https://absa.org/news/2018-09-absa-international-2018-conference/) - The 61st Annual Biosafety and Biosecurity Conference will be held at the Charleston Convention Center in Charleston, South Carolina from October 12-17. There will be 3 full days of intensive preconference courses to educate and inspire; 3 full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today's biosafety
- [Job Board](https://absa.org/news/2018-09-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2018-09-cmb/) - Co-chairs: Susan Cook and Deborah Newby The CMB has nearly completed the reviews for the 2013-2017 cycle. The CMB approved 38 recredentialing worksheets and over 180 applications for CM credit. The CMB also audited four applicants to verify their recredentialing worksheet submission. Based on these reviews, the CMB has the following recommendations for credential holders
- [Accreditation Committee](https://absa.org/news/2018-09-accred/) - Co-chairs: Bob Ellis and Rebecca R. Caruso The Accreditation Committee has not inspected any facilities since the last Update e-Newsletter report. We look forward to future inspection opportunities and assisting facilities with the ABSA International accreditation process.
- [Emerging Infectious Disease Consortium](https://absa.org/news/2018-09-eidc/) - Co-chairs: A. J. Troiano and Susan Weekly Due to increased job responsibilities, Paul Tranchell is no longer able to provide the time and effort needed to adequately lead this consortium. Paul appreciates the opportunity to lead this important and interesting team. A. J. Troiano, Staff Scientist II-Life Sciences at Environmental Health & Engineering, has agreed
- [Biological Select Agent and Toxins Community Advocate Committee (BSAT CAC)](https://absa.org/news/2018-09-bsat-cac/) - Co-chairs: Colleen Driskill and Angela Birnbaum The BSAT CAC added six new members in the spring and has been diligently working to fulfill their goal of providing a forum for the sharing of best practices among the select agent community. The committee presented a webinar in March focusing on "Recent Select Agent Inspection Experiences." This
- [Biosecurity Task Force 2.0](https://absa.org/news/2018-09-bstf2/) - Leads: David Gillum and Barbara Owen The Biosecurity Task Force and respective subcommittees held multiple teleconferences to establish the path forward and framework for offering a biosecurity credential through ABSA International. The task force is looking into resources needed (new training, publications, etc.) and defining the marketing strategy to launch this new biosecurity credential. To
- [ABSA Ambassadors](https://absa.org/news/2018-09-ambasadors/) - Lead: Marian Downing The ABSA Ambassadors have been very busy since the last update. Activities include: Bob Hawley presented on Biological Toxins (Georgetown U School of Medicine) and spoke on "The Biosafety Professional-Earning Credibility and Support" at the Control of Biohazards Course (Johns Hopkins). Bob and AJ Troiano gave a go-to-training session on "The Next
- [Journal Board](https://absa.org/news/2018-09-abj/) - Coeditors-in-Chief: Karen B. Byers and Barbara Johnson In recognition of National Biosafety Month, Applied Biosafety and the ILAR Journal have jointly produced a one-of-a-kind themed edition on worker safety when handling laboratory animals. The ILAR Journal's Volume 59, Issue 2 will be published online in October 2018.To further promote animal biosafety, Applied Biosafety is also providing a 30-day open
- [E-Communications Committee](https://absa.org/news/2018-09-ecom/) - Co-chairs: Matt Anderson and Sarah Ziegler The committee will be sponsoring a selfie-station again this year at the ABSA International Conference. This was popular last year and we hope we get even more members to stop by and snap a selfie in front of the "Sick Art" backdrop and share the pic on social media
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2018-09-ceb/) - Co-chairs: Thomas Boyle and Donald Wang The primary function of the Credentialing Evaluation Board (CEB) is to review new applications and re-applications for registration (RBP) or certification (CBSP) as a biological safety professional meeting the criteria established by ABSA International. There has been a change in CEB Chair. Donald Wang stepped down as Chair and
- [Exhibitors Committee](https://absa.org/news/2018-09-exhib/) - Chair: Brandon Rosendahl Due to the hotels providing free breakfasts, which will impact attendee presence in the Exhibit Hall prior to lectures, the exhibition hours will differ this year from previous conferences. The Exhibit Hall will be open from 9:30 am to 4:00 pm on Monday and Tuesday. This year's Opening Reception will be in
- [Awards Committee](https://absa.org/news/2018-09-awards/) - Co-chairs: Jeff Potts and Francine Rogers The committee has been working hard this summer to review the nominations for the 2018 Honor Awards. Nominees have been selected and will be recognized at the 61st Annual Biosafety and Biosecurity Conference in October. The committee will also be sending out a request for members to submit names
- [Education & Curriculum Task Force (ECTF)](https://absa.org/news/2018-09-ectf/) - Co-chairs: Brandy Nelson and Paul Meechan ECTF has been meeting regularly during the first half of 2018. Presentations on the activities of the ECTF and academic biosafety have been given at the Southeastern Biosafety Association meeting in Knoxville, Tennessee in May and at the Midwest Area Biosafety Symposium in Manhattan, Kansas in August. A presentation
- [Technical & Regulatory Review (TRR) Committee](https://absa.org/news/2018-09-trr-2/) - Co-chairs: Yolanda Arriaga Stringer and David Pawlowski TRR works thoroughly and often quickly to submit reviews on behalf of ABSA International. The TRR reviews this year have included submissions to the: Federal Select Agent Program on inactivation of select agents and effluent decontamination systems; USDA APHIS regarding permit for release of genetically engineered virus; NIH
- [Training Tools/Resources Committee](https://absa.org/news/2017-02-ttr/) - Chairs: Dave Harbourt, PhD and Eric Cook, MPH, CBSP The Training Tools/Resources Committee continues to make improvements to the TT/R site for ABSA International members. The committee is in the process of fixing links that aren't functional on the site as well as evaluating tools currently found on the site to ensure that they
- [Training Tools Committee](https://absa.org/news/2017-12-training-tools-committee/) - Co-chairs: Dave Harbourt and Eric Cook The Training Tools and Resources Committee has added four new members since 2016 and continues to look for new contributors from the ABSA community. The committee meets monthly through teleconference to discuss updates and revisions to our expanding resource list. In addition to looking for new members, the committee
- [Principles & Practices of Biosafety (PPB)](https://absa.org/news/2017-12-principles-practices-of-biosafety-ppb/) - Co-chairs: Paul Jennette, Jeff Owens, and Hallie Hoskins A 1-day work session for all instructors was held in July to discuss course material and course enhancements. The PPB is an evolving, comprehensive, interactive 5-day course that will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises
- [Job Board](https://absa.org/news/2018-05-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals and has opportunities available to continue to advance your career. Employers who post a position will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to the Job Board or find out
- [ABSA International 2018 Conference](https://absa.org/news/2018-05-absa-international-2018-conference/) - The 61st Annual Biosafety and Biosecurity Conference will be held at the Charleston Convention Center in Charleston, South Carolina from October 12-17. There will be 3 full days of intensive preconference courses to educate and inspire; 3 full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today's biosafety
- [Historical Committee](https://absa.org/news/2018-05-historical-committee/) - Chair: John Balog The committee met with USDA National Agricultural Library as the repository of the ABSA Biosafety Archive on April 19 with participants Bob Hawley, Ed Stygar, and John Balog. Agenda items included: deposit publications, manuals, booklets, and miscellaneous documents donated by the estate of Byron Tepper, and potentially other donations; Issues related to
- [Review Course](https://absa.org/news/2018-05-review-course/) - Co-chairs: Dan Eisenman and Shalaka Kotkar The course material is currently being reviewed and recommended changes and updates will be made.
- [Bylaws Committee](https://absa.org/news/2018-05-bylaws-committee/) - Co-chairs: Amy Ryan and Tim Sturgis The Bylaws Committee continues to edit and review the Policies and Procedures. The committee asks that all teams and committees perform an annual review and submit any changes to the ABSA International Office-the office will forward the changes to the committee for review and approval.
- [Principles & Practices of Biosafety (PPB)](https://absa.org/news/2018-05-principles-practices-of-biosafety-ppb/) - Co-chairs: Paul Jennette, Jeff Owens, and Hallie Hoskins The course continues to be well-attended. The course materials are updated after each offering by the instructors and they are currently in the process of overhauling the interactive exercises as well. The course has also begun to offer an electronic-only option for handouts for attendees to download
- [ABSA-Owned Courses](https://absa.org/news/2018-05-absa-owned-courses/) - Co-chairs: Chad Austin and Lisa Benford Basic & Advanced Risk Assessment Co-chairs: Brandon Hatcher and Chad Austin The instructors for the Risk Assessment courses are revising course materials in light of attendee feedback and plan to make the courses more interactive and expand on several advanced topics. A follow-up survey will be sent to attendees
- [ABSA International Membership Site](https://absa.org/news/2018-05-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [Training Tools Committee](https://absa.org/news/2018-05-training-tools-committee/) - Co-chairs: Dave Harbourt, Eric Cook, and Lauriane Quenee The Training Tools and Resources Committee is happy to welcome Dr. Lauriane Quenee as new Co-chair who will be replacing Dr. David Harbourt beginning in October. Over the past 6 months, the TT/R Committee has worked diligently on adding both new members and resources to the website.
- [Mentoring Committee](https://absa.org/news/2018-05-mentoring-committee/) - Co-chairs: Althea Treacy and Sarah Ziegler The Mentoring Committee is following-up on people who requested to be either mentors or mentees. They are actively recruiting and accepting both and request that anyone who wishes to be a mentor/mentee to please update their my.ABSA profile.
- [Membership Committee](https://absa.org/news/2018-05-membership-committee/) - Co-chairs: Malissa Mayer-Diaz and Kelly Flint The Membership Committee met at the conference and are working on revising the New Member Survey. They are also working with the PCC to create "roadmaps" for new attendees and ABSA International members to see what courses are of best benefit to new members who are attending the conference.
- [NextGen Shared Interest Group](https://absa.org/news/2018-05-nextgen-shared-interest-group/) - Leads: Caitlyn Hauke and Theresa Marth The NextGen Shared Interest Group has established a listserve targeting newer biosafety professionals with less than 5 years of experience in the field. The group's focus is getting started with a career in biosafety and preparing for ABSA International credentials. Those wishing to join the listserve, e-mail Michelle Gehrke
- [E-Communications Committee](https://absa.org/news/2018-05-e-communications/) - Chair: Matt Anderson Instructions how to submit blog posts and how members can earn CM points for posts have been posted on the ABSA International blog. The committee plans to host a selfie station at the conference again this year, as it was well-received last year, and to promote posting about the conference on social
- [Awards Committee](https://absa.org/news/2018-05-awards-committee/) - Chair: Jeffrey M. Potts The Awards Committee will be meeting to review nomination forms and award descriptions. Forms were posted in late April on the ABSA International website for nominations and award nominees will be evaluated over the summer. A committee meeting is being scheduled shortly.
- [Education & Curriculum Task Force (ECTF)](https://absa.org/news/2018-05-education-curriculum-task-force-ectf/) - Lead: Brandy Nelson The Education & Curriculum Task Force (ECTF) has been meeting regularly during the first quarter of 2018. ECTF goals center on development of a strategy and resources for academic institutions (and their biosafety professionals) to encourage and implement biosafety education at undergraduate, graduate, and post-doctoral levels; development of training and education strategies
- [Anthology XIV: Sustainability](https://absa.org/news/2018-05-anthology-xiv-sustainabilit/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2018-05-credentialing-maintenance-board-cmb/) - Co-chairs: Susan Cook and Deborah Newby The Credentialing Maintenance Board (CMB) received 41 renewal applications for the 2013-2017 cycle and is finalizing the review of those applications. Ten percent of those who earn enough continuing education credits to renew their credentials will be chosen for audit. In 2017, the CMB reviewed and approved over 200
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2018-05-credentialing-evaluation-board-ceb/) - Co-chairs: Donald Wang and Thomas Boyle The Credentialing Evaluation Board (CEB) continues their monthly conference call to review submitted RBP/CBSP applications and other Board-related matters. In 2018, the CEB took on the role of reviewing applications for those seeking to take the CBSP exam that was previously managed by ASM. Since the CBSP exam reviewing
- [Biosafety Buyer's Guide](https://absa.org/news/2018-05-biosafety-buyers-guide/) - ABSA International launched the Biosafety Buyer's Guide in early 2014 at https://biosafetybuyersguide.org/. The Guide lists companies and consultants that provide biosafety-related products and services. Over the past 4 years, we have had much success with many visits to the ads and listings. The most recent quarter shows the average monthly unique visitors are 9,101. The
- [Emerging Infectious Disease Consortium Task Force](https://absa.org/news/2018-05-emerging-infectious-disease-consortium-task-force/) - Lead: Paul Tranchell The Consortium is progressing towards initial collaborations with other professional organization. Members are contacting their primary partnering organizations and developing relationships. There is a need for considering a new leader for the consortium. If there is no one from the group that can step-up, we will be asking ABSA leadership for assistance
- [Affiliates Committee](https://absa.org/news/2018-05-affiliates-committee/) - Co-Chairs: Jennifer Gaudioso and Despina Felis The Affiliates Committee reviews requests by groups for acceptance into ABSA International as an Affiliate. There have not been any application submissions since the last Update e-newsletter.
- [Accreditation Board](https://absa.org/news/2018-05-accreditation-board/) - Chair: Chris Thompson The Standards Committee is in the process of revising the Standards document for BSL-2 use. We continue to have inquiries about accreditation visits. We have advertised to the public health audience, as the accreditation program was included in a poster that ABSA International presented at the APHL annual meeting.
- [Preconference Course Committee (PCC)](https://absa.org/news/2018-05-preconference-course-committee-pcc/) - Co-chairs: Carrie Smith and Heather Blair A total of 48 courses were submitted for consideration for the 61st Annual Biosafety and Biosecurity Conference. The Preconference Course Committee members reviewed the course abstracts and put together a tentative course schedule. The schedule includes a mixture of new courses and highly-rated courses that have been offered in
- [Publications Committee](https://absa.org/news/2018-05-publications-committee/) - Co-chairs: Bruce Whitney and Luis Alberto Ochoa Carrera A survey about the Anthology series will be distributed to the ABSA membership in the near future to gauge interest in continuing to publish the series. The committee was looking into publishing compilations of the ABSA journals, Council discussed that there may be some potential copyright issues
- [ABSA International's NEW Promotional Video](https://absa.org/news/2018-05-absa-internationals-new-promotional-video/) - Thanks to the Public Relations Committee, ABSA has just finished production of a new promotional video. The video can be found at http://www.absa.org and on ABSA International's YouTube channel at https://youtu.be/xAQPZxMvqRY. Feel free to share the video, use it in presentations, or link to it from your websites.
- [Exhibitors Committee](https://absa.org/news/2018-05-exhibitors/) - Chair: Brandon Rosendahl Due to the hotels providing free breakfasts, which will impact attendee presence in the Exhibit Hall prior to lectures, the exhibition hours will differ this year from previous conferences. The Exhibit Hall will be open from 9:30 am to 4:00 pm on Monday and Tuesday. This year's Opening Reception will be
- [Scientific Program Committee (SPC)](https://absa.org/news/2018-05-scientific-program-committee-spc/) - Co-chairs: Betsy Matos, Jessica McCormick-Ell, and Claudia Gentry-Weeks The Scientific Program Committee has selected the 4 keynote speakers: Dr. Fischer (Topic: Public health issues and challenges), Dr. Palmer (Topic: Implication of biosecurity on biotechnology), Dr. Turner (Topic: Host-microbe interactions and phage therapy), and Dr. Venkateswaran (Topic: Microbial observatory). Over 100 abstracts have been received, which
- [Journal Board](https://absa.org/news/2018-05-journal-board/) - Coeditors-in-Chief: Karen B. Byers and Barbara Johnson Applied Biosafety (Volume 23, Number 1) is available online. Volume 23, Number 2 of Applied Biosafety is being published and will be sent in June. The team is pleased to announce that it offers important information on a range of critical biosafety topics. Work is underway for the
- [Finance Committee](https://absa.org/news/2018-05-finance-committee/) - Chair: Jim Klenner The Finance Committee has continued to review monthly financial reports. The Finance Committee's Policies & Procedures are currently under review and being revised. The Treasurer presented questions from committee members at ABSA's Mid-Year Council Meeting. The Treasurer provided a report on the Finance Committee to Council at the Mid-Year Council Meeting.
- [President's Report](https://absa.org/news/2018-04-presidents-report/) - Patrick Condreay, PhD, RBP Dear ABSA International Colleagues, Did you know that ABSA International has a YouTube channel? Just go the YouTube homepage, browse channels and search for ABSA International. This is where you can find all of the promotional videos that were developed by the Public Relations Committee and were put together from interviews
- [ABSA International Job Board](https://absa.org/news/2017-12-absa-international-job-board/) - The Job Board allows employers to connect with biosafety and biosecurity professionals. The Job Board has opportunities available to continue to advance your career. Employers who post a position on the Job Board will gain access to some of the top professionals in the biosafety and biosecurity field. If you would like to post to
- [ABSA International Conference](https://absa.org/news/2017-12-absa-international-conference/) - The 61st Annual Biosafety and Biosecurity Conference will be held at the Charleston Convention Center in Charleston, South Carolina from October 12-17. There will be three full days of intensive preconference courses to educate and inspire; three full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today's biosafety
- [Historical Committee](https://absa.org/news/2017-12-historical-committee/) - Chair: John Balog There were two historical briefs presented at the 60th Annual Biosafety and Biosecurity Conference. The first was an overview of the early meetings. The second was a brief summary of the evolution of the profession.
- [Laboratory-Acquired Infection Database](https://absa.org/news/2017-12-laboratory-acquired-infection-database/) - Lead: Karen B. Byers The Laboratory-Acquired Infection Database now has 280 entries. The format for entries has been modified slightly to capture the data on use of personal protective equipment. The new fields are PPE not described and PPE not worn (specifically stated in article). We are indebted to all of the contributors of the
- [Review Course](https://absa.org/news/2017-12-review-course/) - Co-chairs: Willie Wong and Dan Eisenman Annual reviews of all 7 modules were completed. Suggested revisions to improve the modules were submitted to ABSA International.
- [Bylaws Committee](https://absa.org/news/2017-12-bylaws-committee/) - Chair: Amy Ryan Bylaws has reviewed six P&Ps (Affiliate Relations, E-communication, Bylaws, Distance Learning, Eagleson Lecture, and Awards). Bylaws looks forward to other committees submitting their updated P&Ps for review.
- [ABSA International Membership Site](https://absa.org/news/2017-12-absa-international-membership-site/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [ABSA-Owned Courses](https://absa.org/news/2017-12-absa-owned-courses/) - Co-chairs: Wing Wong and Chad Austin Basic/Advanced Risk Assessment Co-chairs: Brandon Hatcher and Chad Austin The Advanced Risk Assessment course was offered at the 60th Annual Biosafety and Biosecurity Conference in Albuquerque. The course enjoyed full attendance and good interactive conversations with participants. The instructors of the course received some feedback during the course and
- [Mentoring Committee](https://absa.org/news/2017-12-mentoring-committee/) - Co-chairs: Althea Treacy and Sarah Ziegler The Mentoring Committee is following-up on people who have requested to be either mentors or mentees. They are actively recruiting and accepting both, and request that anyone who wishes to be a mentor/mentee update their my.ABSA profile. They are also looking for a new chair as the current chair
- [Nominating Committee](https://absa.org/news/2017-12-nominating-committee/) - Chair: Maureen O'Leary The new chair of the Nominating Committee is Maureen O'Leary. This committee will not be meeting for a few months until it is time to begin requesting nominees for the next elections. Last year's Nominating Committee produced an excellent panel of nominees. The ABSA Ambassadors have just been added to the Membership/Leadership
- [Membership Committee](https://absa.org/news/2017-12-membership-committee/) - Co-chairs: Malissa Mayer-Diaz and Kelly Flint The Membership Committee has a new chair, Malissa Mayer-Diaz. Kelly Flint will be serving as co-chair, and Je T'aime Newton is thanked for her years of service. They are working on a "New Member" survey, and are talking on how to work with PCC and Marketing on member retention.
- [E-Communication Committee](https://absa.org/news/2017-12-e-communication-committee/) - Chair: Matt Anderson Website redesign is complete and we are in maintenance mode. We had a conference call with committee chairs and team leads in October to solicit feedback. Overall impressions were very positive and the website is vastly better than prior version. We have already fixed a few of the issues that were brought-up
- [Awards Committee](https://absa.org/news/2017-12-awards-committee/) - Chair: Jeffrey M. Potts The 2017 Honor Awards were presented at the 60th Annual Biosafety and Biosecurity Conference to well deserving recipients. The award winners were Arnold G. Wedum Distinguished Achievement Award-Richard Rebar; Everett Hanel, Jr. Presidential Award-Dee Zimmerman; John H. Richardson Special Recognition Award-Mary Jo Lanzilotta; and Richard C. Knudsen Publication Award-David Pawlowski, Recently,
- [Anthology XIV: Sustainability](https://absa.org/news/2017-12-anthology-xiv-sustainability/) - Anthology XIV: Sustainability helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information
- [Credentialing Evaluation Board (CEB)](https://absa.org/news/2017-12-credentialing-evaluation-board-ceb/) - Co-chairs: Donald Wang and Thomas Boyle Since the last ABSA update, the Credentialing Evaluation Board (CEB) received and reviewed 57 applications; 41 were for RBP and 16 for CBSP. Of the RBP applications, 26 were approved and 11 were denied with 4 in pending status, the Board is waiting or wanting additional information from the
- [Credentialing Maintenance Board (CMB)](https://absa.org/news/2017-12-credentialing-maintenance-board-cmb/) - Co-chairs: Susan Cook and Thomas Leonard The Credentialing Maintenance Board (CMB) reviewed 53 recredentialing applications for the 2011-2016 cycle. Ten percent (10%) of those who earned enough continuing education credits to renew their credentials were chosen for audit. Following the audit, 43 of the 53 individuals who applied successfully renewed their credentials. The CMB reminds
- [Biosafety Buyer's Guide](https://absa.org/news/2017-12-biosafety-buyers-guide/) - Statistics are up by over 100%! The average monthly unique visitors are 7,148. The average monthly pages are 73,341. And 238 unique visitors per day are looking at 6.94 pages per visit. ABSA International launched the Biosafety Buyer's Guide in early 2014 at http://biosafetybuyersguide.org/. In the fourth year, the Guide has had much success with
- [Emerging Infectious Disease Consortium Task Force](https://absa.org/news/emerging-infectious-disease-consortium-task-force/) - Lead: Paul Tranchell The Consortium is progressing towards initial collaborations with other professional organization. Members are contacting their primary partnering organizations and developing relationships. The quality of the initial contacts varies and team members are making progress. The following specific progress has been made. Association for Accreditation of Laboratory Animal Care (AAALAC)--Esmeralda L. Meyer Esmeralda
- [Learning Verification Committee](https://absa.org/news/2017-12-learning-verification-committee/) - Co-chairs: Niki Drazenovich and Matthew Fisher The Learning Verification Committee has finished reviewing the University of Bradford's book titled "Preventing Biological Threats: What You Can Do" and quizzes are in the process of being posted on the website. The committee will start reviewing the Anthology of Biosafety XIV: Sustainability. ABSA members currently have eight quizzes
- [Preconference Course Committee (PCC)](https://absa.org/news/2017-12-preconference-course-committee-pcc/) - Co-chairs: Carrie Smith and Heather Blair Thank you to the PCC members and PCC participants for making our 2017 courses successful! Seventy-nine percent (79%) of the seats were sold with 914 preconference registrants total (which is 3 more than last year). We have also received a lot of positive feedback overall for the courses from
- [Publications Committee](https://absa.org/news/2017-12-publications-committee/) - Co-chairs: Bruce Whitney and Luis Alberto Ochoa Carrera The committee is discussing whether or not to retire the Anthology series, make them as eBooks, or begin creating more books with new topics. The committee is considering an update of the Job Hazard Analysis CD. At this time, the committee is looking to share this material
- [Journal Board](https://absa.org/news/2017-12-journal-board/) - Coeditors-in-Chief: Karen B. Byers and Barbara Johnson The next issue of Applied Biosafety (Volume 22, Number 4, 2017) has been produced and will be mailed in the coming days. Some of the articles that are being published in this issue are already available in "Online First" on the Applied Biosafety website. The topics include inactivation of Brucella
- [Finance Committee](https://absa.org/news/2017-12-finance-committee/) - Chair: Jim Klenner The committee reviewed the 2018 budget and no concerns were raised. Monthly meetings continue and finances are reviewed each month.
- [President's Report](https://absa.org/news/2017-11-presidents-report/) - Patrick Condreay, PhD, RBP Dear ABSA International Colleagues, There were 642 of us that had the opportunity to enjoy our 60th Annual Conference in Albuquerque, New Mexico last month. We had 28 preconference courses with 936 seats filled that preceded an exciting scientific program covering a spectrum of topics and current issues of concern to
- [ABSA International "Member-Get-A-Member" Referral Program](https://absa.org/news/2016-10-mgam/) - We are asking our current members to help recruit new ABSA International members. For each new member that current members recruit, they will receive a $50.00 ABSA credit. The credit may be used towards ABSA products such as conference registration, merchandise, membership, publications, and courses. Newly recruited members must have not been members for the
- [Bylaws Committee](https://absa.org/news/2017-02-bylaws/) - Chairs: Francine Rogers, RBP, CBSP, Amy Ryan, MPH, RBP, and Tim Sturgis, RBP Two committee Co-Chairs were submitted and approved by Council for the Bylaws Committee. Bylaws did not review any P&Ps for the last quarter of 2016, but reviewed three in January. Bylaws looks forward to other committees submitting their updated P&Ps for
- [ABSA Store](https://absa.org/news/2017-02-store/) - ABSA International Membership Site Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My
- [ABSA Owned Courses](https://absa.org/news/2017-02-aoc/) - Chairs: Willie Wong, RBP, CBSP and Chad Austin, PhD Basic Risk Assessment The preconference course was well received, especially the new interactive method that was implemented for this year's class. Class survey responses are being used to modify plans for upcoming courses. The Advanced Risk Assessment course will be offered at the 2017 Annual
- [Mentoring Committee](https://absa.org/news/2017-02-mentoring/) - Co-Chairs: Althea Capul and Sarah Ziegler The Mentoring Committee has submitted an ABSA-wide request for potential Mentees and Mentors to establish Mentoring Program profiles in my.absa.org. If you are interested in becoming a Mentor or are looking to join the program as a Mentee, information can be found on the Welcome page of my.absa.org.
- [Nominating Committee](https://absa.org/news/2017-02-nominating/) - Chair: Melissa Morland, MS, MBA, RBP, CBSP The Nominating Committee held a call in January to begin working on the slate of candidates for the 2017 ABSA International Election.
- [Membership Committee](https://absa.org/news/2017-02-membership/) - Chairs: Je T'aime Newton, MS, RBP and Malissa Mayer-Diaz, RBP The Membership Committee has added new members and is working more closely with the ABSA International Office to ensure that effort is not duplicated or dropped. The committee has sent out a survey to new members. The committee is working to develop a survey
- [Anthology XIV: Sustainability](https://absa.org/news/2017-02-anthology-xiv-sustainability/) - Anthology XIV helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information to
- [Credentialing Evaluation Board](https://absa.org/news/2017-02-ceb/) - Chairs: Donald Wang, MPH, RBP, CBSP and Tom Boyle, RBP From September to the end of 2016, the Credential Evaluation Board convened monthly via phone conference calls with the exception of live (in-person) meeting at the Annual Conference. For the 2016 calendar year, the CEB received and reviewed 80 applications. During this reporting
- [Emerging Infectious Disease Consortium](https://absa.org/news/2017-02-eidc/) - Lead: Paul Tranchell The consortium has formed and is working on its path forward. We have developed a list of organizations that we would like to partner with and have members assigned to those organizations. We are working with the ABSA International Executive Director, Ed Stygar, to identify contacts and methods of contact to
- [Public Relations Committee](https://absa.org/news/2017-02-pr/) - Chairs: Rebecca Moritz, CBSP and Joshua Turse, PhD During the fall of 2016, the PR Committee worked with outside public relations experts to create a preconference public relations course that was well received. In addition, the PR Committee continues to develop materials for ABSA public relations outreach. In the coming year, the committee will
- [Technical & Regulatory Review Committee](https://absa.org/news/2017-02-trr/) - Chairs: Yolanda Arriaga Stringer, MS, RBP, CBSP and Ingrid Abbott-Permell, RBP, CBSP This quarter, the Technical & Regulatory Review Committee (TRR) evaluated the Addition of Bacillus cereus biovar anthracis to the HHS List of Select Agents and Toxins and two White House documents-An Update to the Coordinated Framework for the Regulation of Biotechnology and
- [Legislative Affairs Committee](https://absa.org/news/2017-02-legislative/) - Chairs: Meghan Seltzer, PhD and Brian O'Shea, PhD, CBSP In October, the leadership of the committee changed with Meghan Seltzer taking over as Chair and Brian O'Shea becoming Co-Chair. The Legislative Committee finished its pilot of the Legislative Monitoring Service with AIHA. Approximately 150 pieces of legislation were reviewed, and three were forwarded on
- [Learning Verification Committee](https://absa.org/news/2017-02-lv/) - Chairs: Niki Drazenovich, RBP, CBSP and Matthew Fischer, PhD, RBP The Learning Verification Committee is in the process of reviewing and generating quizzes from the last two issues of the Applied Biosafety journals and the University of Bradford resource titled Guide to Biological Security Issues. The Credentialing Maintenance Board is currently discussing the amount of CM
- [Preconference Course Committee](https://absa.org/news/2017-02-precon/) - Chairs: Corrie Ntiforo, MSPH, RBP and Carrie Smith, PhD, RBP, CBSP The PCC Chairs are currently working on sending out the 2017 New Year Welcome emails to the committee members. In addition, the Chairs are reviewing the OASIS submission site task due dates leading up to the conference so the PCC can set the
- [Select Agent Task Force](https://absa.org/news/2017-02-sra/) - Leads: Colleen Driskill, RBP, CBSP and Krista Murray, RBP, CBSP The Select Agent Task Force planned and hosted the SRA Approved Users Workshop on October 6, 2016. It was a very successful day-long program following the ABSA International Conference that included presentations and discussions related to aspects of working with Select Agents and Toxins.
- [Publications Committee](https://absa.org/news/2017-02-publications/) - Chairs: Bruce Whitney, PhD and Luis Alberto Ochoa Carrera The Publications Committee continues working to implement the database of published reports of laboratory-acquired infections. We are also looking at the future of the ABSA anthologies. Finally, we are evaluating the possibility of creating an annotated bibliography of publications useful to biosafety professionals.
- [Exhibitors Committee](https://absa.org/news/2017-02-exhibitors/) - Chair: Brandon Rosendahl The Exhibitors Committee added a new member with large experience in participating in trade shows. This will allow the committee to compare and discuss the pros and cons of various methods used in tradeshows with the aim at benefiting both vendors and attendees. At first, time management, (i.e., allocation and keeping
- [Scientific Program Committee](https://absa.org/news/2017-02-scientific-program/) - Chairs: Betsy Matos, PhD, RBP, SM(NRCM), CBSP Claudia Gentry-Weeks, PhD, CBSP Jessica McCormick-Ell, PhD, RBP, CBSP The Scientific Program Committee has reviewed all the conference surveys from Grapevine and will incorporate suggestions for the 2017 Scientific Program. We have several choices for Keynote Speakers. This year, the SPC selected topic areas (e.g., biosafety culture,
- [Journal](https://absa.org/news/2017-02-journal/) - Applied Biosafety Coeditors-in-Chief: Karen Byers and Barbara Johnson We have been focusing on the production of Volume 22: Number 1, 2017; some excellent articles are in the production pipeline. A few changes have occurred to the SAGE website including new features such as "most read" and "most cited" that are updated regularly. We will
- [Finance Committee](https://absa.org/news/2017-02-finance/) - Chairs: James Klenner, MS, RBP, CBSP and Sarah Gillette McAbee, RBP The Finance Committee meets monthly to discuss the previous monthly and year-to-date trends for revenue and expenses. The meeting is open to comments or questions from all committee members. During the last quarter of 2016, questions were raised regarding changing economic environments and
- [Principles & Practices of Biosafety (PPB)](https://absa.org/news/2017-02-ppb/) - Chairs: Paul Jennette and Jeff Owens The next PPB offering is March 5-10, 2017 at the Embassy Suites San Antonio Riverwalk in Downtown San Antonio, Texas. There will also be a course in Pittsburgh, Pennsylvania on July 9-15, 2017. To register for this course, please visit http://www.absa.org/eduppb.html.
- [Distance Learning Committee](https://absa.org/news/2017-02-distance-learning/) - Chairs: Maryjo Lanzillotta, MS, RBP, CBSP and Kathleen Kennedy, MPH The Distance Learning Committee continues to develop, review, and offer new and ongoing webinars for ABSA International members' professional growth. The DLC is planning for 2017 which includes bringing back the webinar on Current Trends in Sterilization and re-offering Q&A Infectious Substances Shipping as
- [President's Report](https://absa.org/news/2017-02-presidents-report/) - Maureen O'Leary, PhD, CBSP Dear ABSA International Colleagues, In December, I was fortunate to join colleagues from around the world to attend the WHO Biosafety Advisory Group meeting in Geneva, Switzerland. At the meeting, the WHO Biosafety Advisory Group discussed, among other things, the progress on the update to the Laboratory Biosafety Manual.
- [E-Communications Committee](https://absa.org/news/2016-10-ecomm/) - Co-Chairs: Matt Anderson and Sarah Ziegler The E-Communications Committee has made progress toward the ABSA International website redesign, finalized a navigation menu and picked the Word Press theme. The committee is accumulating photos to use on the site and developing page layouts and brainstorming "call to action" elements. The ABSA International blog has had only
- [Affiliate Relations](https://absa.org/news/2016-10-aff-rel/) - Co-Chairs: Despina Felis and Jennifer Gaudioso The ABSA International Council approved the Affiliate Ribbons for the conference in October. Several affiliates participated. Feedback from the Affiliates regarding the ribbons was positive. For more information on Affiliates go to http://absa.org/affiliates/.
- [Anthology XIV: Sustainability](https://absa.org/news/2016-10-anth/) - Anthology XIV helps us to better understand how we can create facilities that are more efficient with strategies such as reducing the energy requirements for effective autoclaves, biological safety cabinets, and animal facilities. With sustainability comes commitment for investing in the future, and this Anthology XIV will continue to provide current and forward-thinking information to
- [Credentialing Maintenance Board](https://absa.org/news/2016-10-cmb/) - Co-Chairs: Susan Cook and Thomas Leonard The Credentialing Maintenance Board (CMB) reminds the credentialed community that a convenient series of inexpensive, online opportunities for credentialing maintenance points are available through ABSA's online educational resources at http://absa.org/online-education/. Thanks to efforts of the Learning Verification Committee, credentialing maintenance points may be earned through satisfactory completion of quizzes
- [Learning Verification Committee](https://absa.org/news/2016-10-lvc/) - Co-Chairs: Niki Drazenovich and Matthew Fischer The Learning Verification Committee is in the process of reviewing additional materials to generate quizzes from. ABSA International members have 8 quizzes available online for CM points. These quizzes are available at low cost and can be located on the website at http://absa.org/online-education/.
- [Principles & Practices of Biosafety (PPB)](https://absa.org/news/2016-10-ppb/) - Co-Chairs: Paul Jennette and Jeff Owens The next PPB offering is March 5-10, 2017 at the Embassy Suites San Antonio Riverwalk in Downtown San Antonio, Texas. There will also be a course in Pittsburgh, Pennsylvania on July 9-15, 2017. To register for this course, please visit http://www.absa.org/eduppb.html.
- [Distance Learning Committee](https://absa.org/news/2016-10-dlc/) - Co-Chairs: Maryjo Lanzillotta and Kathleen Kennedy The Distance Learning Committee (DLC) continues to develop, review, and offer new and ongoing webinars for ABSA International members professional growth. New webinars offered this year include 4 distinct modules on the topic of biosecurity. Each webinar builds-off the previous yet they are able to stand alone as well
- [Training Tools Committee](https://absa.org/news/2016-10-tt/) - Co-Chairs: Dave Harbourt and Eric Cook The Training Tools and Resources Committee would like to thank Eleanor Low for her service to the committee as Chair for the past 3-years. The committee welcomes Eric Cook as the new Co-Chair and continues to be committed to providing the best training resources for our membership.
- [Legislative Committee](https://absa.org/news/2016-10-lc/) - Co-Chairs: Debra Sharpe and Meghan Seltzer The Legislative Committee's (LC) primary focus has been to streamline and oversee ABSA International's new legislative monitoring program, provided through the American Industrial Hygiene Association (AIHA) Government Affairs Office. Since the last update, the committee has reviewed 130 state legislative bills. To date, 4 state bills have been identified
- [Public Relations Committee](https://absa.org/news/2016-10-pr/) - Chair: Rebecca Moritz and Joshua Turse The Public Relations Committee worked with SME's Kelly Tyrell, University of Wisconsin Madison, and Jim Newman, KGB Texas Communications, to develop the course titled Media and Public Relations for Biosafety Professionals. This course was offered during the ABSA Conference.
- [Biosafety Buyer's Guide](https://absa.org/news/2016-10-bbg/) - ABSA launched the Biosafety Buyer's Guide in 2014 at http://biosafetybuyersguide.org. As we enter the third year, the Guide has had much success with many visits to the ads and listings. The guide lists companies and consultants that provide biosafety-related products and services. For more information, contact Karen Savage at karen@absaoffice.org.
- [Credentialing Evaluation Board](https://absa.org/news/2016-10-ceb/) - Co-Chairs: Donald Wang and Betty Kupskay From January to August 2016, the Credentialing Evaluation Board convened monthly by conference calls to review and discuss submitted and pending applications. During this period, the Board reviewed a total of 37 applications; 35 for Registered Biosafety Professional (RBP) and 2 for Certified Biological Safety Professional (CBSP). Of the
- [Awards Committee](https://absa.org/news/2016-10-awards/) - Co-Chairs: Janet Peterson and David Gillum The Awards Committee had a very busy summer. We worked with the Publications Committee to review all of the Applied Biosafety Journal articles published in the past year to choose the Knudsen Award recipient. Thanks to all of you who submitted nominations and journal articles! The Committee also worked
- [Membership Committee](https://absa.org/news/2016-10-mem-comm/) - Co-Chairs: JeT'Aime Newton and Malissa Mayer-Diaz This quarter the Membership Committee contacted all new members that were interested in getting more information/joining ABSA International committees. They are still receiving the responses and putting them into contact with the Chairs of the committees. We have 274 new members so far this year, which includes 43
- [Nominating Committee](https://absa.org/news/2016-10-nom/) - Chair: Marian Downing Many thanks to the 2016 Nominating Committee: Janet Peterson, Scott Patlovich, Hallie Hoskins, and Deb Howard. Also, thanks to all the final candidates and others who were contacted and made some difficult decisions.
- [Mentoring Committee](https://absa.org/news/2016-10-mentor/) - Co-Chairs: Althea Capul and Sarah Ziegler The Mentoring Committee has submitted an ABSA-wide request for potential Mentees and Mentors to establish Mentoring Program profiles in my.absa.org. If you are interested in becoming a Mentor or are looking to join the program as a Mentee, information can be found on the Welcome page of my.absa.org. Follow
- [ABSA International Membership Site](https://absa.org/news/2016-10-store/) - Through the ABSA Store not only can you access the Members' Directory; you can update your contact information under the "My Information" link; view events you have registered for under "My Events"; access your educational credits under the "My Professional Development" link; and print a copy of past invoices under "My Transactions." You can also
- [Letter of Appreciation and Support for Your Employer!](https://absa.org/news/2016-10-letter-appreciation/) - The Council has drafted a letter expressing gratitude to ABSA International members' employers and emphasizes the value of your participation in ABSA activities including the conference. If you would like to view this letter or would like us to send it to your employer, please e-mail info@absa.org. We also appreciate any feedback about the letter!
- [President's Report](https://absa.org/news/2016-10-presidents-report/) - Maureen O'Leary, PhD, MBA, CBSP Dear ABSA Colleagues, We had a great conference this year in Grapevine, Texas with 633 attendees with 911 spots filled in the preconference courses. Thank you for your participation and making the annual meeting such a dynamic learning experience and a place where a lot of new ideas and sharing
- [Local Arrangements Committee](https://absa.org/news/2016-10-conf-local/) - Chair: Patrick Conley The 2016 Conference Local Arrangement Committee arranged the banquet at the Glass Cactus Night Club. Attendees enjoyed Texas BBQ, line dancing, and casino games in addition to the great sunset views over Lake Grapevine.
- [Global Health Security Agenda Consortium (GHSAC)-Professional Associations Working Group](https://absa.org/news/2016-10-ghsac/) - Chair: Donald Callihan The Global Health Security Agenda Consortium met on July 6, 2016 at the U.S. Department of State Marshall Center. Don Callihan, Working Group Liaison representing ABSA International attended, along with Ed Stygar, ABSA International Executive Director. ABSA International is the coordinating organization for the Professional Membership Associations Working Group (PAWG). The mandate
- [Publications Committee](https://absa.org/news/2016-10-publications/) - Co-Chairs: Bruce Whitney and David Gillum The Publication Committee continues working to implement the database of published reports of laboratory-acquired infections. We also continue working to determine the need and feasibility of translating foreign language biosafety-related publications into English and from English into select foreign languages.

## Resources

- [Workplace Safety Plan](#workplace-safety-plan)
- [Biosafety Considerations for Research Involving SARS-CoV-2](#biosafety-considerations-for-research-involving-sars-cov-2)
- [First case of human chromoblastomycosis caused by Alternaria alternata in Brazil: a case report](#first-case-of-human-chromoblastomycosis-caused-by-alternaria-alternata-in-brazil-a-case-report) - Cavallone IN, et al. Chromoblastomycosis (CBM) is a neglected, chronic subcutaneous disease with progressive development, caused by a variety of melanized fungal species, mainly Fonsecaea pedrosoi. We report a case of CBM in which Alternaria alternata was identified as the etiological agent in a patient with no history of immunodeficiency or other medical conditions that impair the
- [Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response — United States, 2025](#tularemia-antimicrobial-treatment-and-prophylaxis-cdc-recommendations-for-naturally-acquired-infections-and-bioterrorism-response-united-states-2025) - Cavallone IN, et al. CDC recommendations to health care providers and preparedness personnel regarding treatment and postexposure prophylaxis (PEP) of tularemia. Because F. tularensis has a low infectious inoculum, it is classified as a potential bioterrorism agent that could infect thousands of persons if intentionally released.
- [WHO warns of widespread resistance to common antibiotics worldwide](#who-warns-of-widespread-resistance-to-common-antibiotics-worldwide) - One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new WHO report.
- [Monkeypox in the United States and Around the World: Current Situation](#monkeypox-in-the-united-states-and-around-the-world-current-situation) - Health authorities in Southern California have reported three cases of clade 1 monkeypox in people with no recent travel.
- [Outbreak of Neisseria meningitidis Conjunctivitis in Military Trainees — Texas, February–May 2025](#outbreak-of-neisseria-meningitidis-conjunctivitis-in-military-trainees-texas-february-may-2025) - Ching SJ, Jung GO, Osuna A, et al. Bacterial conjunctivitis is uncommon in immunocompetent adults. Neisseria meningitidis is an unusual bacterial cause of conjunctivitis.
- [Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure — San Francisco, California, December 2024–January 2025](#highly-pathogenic-avian-influenza-ah5n1-virus-infection-in-a-child-with-no-known-exposure-san-francisco-california-december-2024-january-2025) - Tobolowsky FA, Morris E, Castro L, et al. Although antibodies against influenza A(H5N1) were detected in the index patient, serologic testing of a convenience sample of nine close contacts identified no detectable A(H5)-specific antibodies. Despite an extensive investigation, the infection source remains unknown; no human-to-human transmission was identified among close contacts by rRT-PCR and serologic
- [References for "Celebrating 25 Years of the Needlestick Prevention Act"](#references-for-celebrating-25-years-of-the-needlestick-prevention-act) - References for “Celebrating 25 Years of the Needlestick Prevention Act” Poster at ABSA Raleigh Conference, October 2025
- [The U.S. confirms its first human case of New World screwworm. What is it?](#the-u-s-confirms-its-first-human-case-of-new-world-screwworm-what-is-it) - The U.S. has confirmed its first human case of the New World screwworm, a flesh-eating parasite whose northward creep from South America has put the country's cattle industry on high alert in recent months.
- [Invasive Longhorned Tick Found to be Carrier of Ehrlichiosis Pathogen](#invasive-longhorned-tick-found-to-be-carrier-of-ehrlichiosis-pathogen) - In its native and invasive range, the longhorned tick is known to transmit a wide variety of pathogens. Researchers have found evidence of infection in field-collected specimens in the U.S. with pathogens that cause Lyme disease, anaplasmosis, babesiosis, Bourbon virus disease, and theileriosis; however, it is still unknown if the tick can spread many of
- [Asian Longhorned Ticks](#asian-longhorned-ticks)
- [Chagas Disease, an Endemic Disease in the United States](#chagas-disease-an-endemic-disease-in-the-united-states) - Chagas disease, or American trypanosomiasis, is caused by the parasitic protozoan Trypanosoma cruzi, which is transmitted through congenital, oral, and vectorborne routes; vectorborne infections result from contact with the feces of infected triatomine insects (kissing bugs).
- [Ebola Outbreak in the Democratic Republic of the Congo](#ebola-outbreak-in-the-democratic-republic-of-the-congo) - On September 8, 2025, CDC issued a Travel Health Notice for people traveling to the Democratic Republic of the Congo.
- [Legionella (Legionnaires' Disease and Pontiac Fever): About Pontiac Fever](#legionella-legionnaires-disease-and-pontiac-fever-about-pontiac-fever) - Basic guidance
- [https://www.nyc.gov/site/doh/health/health-topics/legionnaires-disease.page](#https-www-nyc-gov-site-doh-health-health-topics-legionnaires-disease-page) - The NYC Health Department has finished investigating a community cluster of Legionnaires' disease in Central Harlem. As of August 29, there were: 114 confirmed cases, 90 total hospitalizations, 7 deaths.
- [Legionellosis (Legionnaires' Disease and Pontiac Fever)](#legionellosis-legionnaires-disease-and-pontiac-fever) - Outbreak response, worker awareness, etc.
- [ACIP Recommends COVID-19 Immunization Based on Individual Decision-making](#acip-recommends-covid-19-immunization-based-on-individual-decision-making) - ACIP’s recommendation applies to all individuals six months and older. It includes an emphasis that the risk-benefit of vaccination in individuals under age 65 is most favorable for those who are at an increased risk for severe COVID-19 and lowest for individuals who are not at an increased risk, according to the CDC list of
- [Coronavirus (COVID-19) | CBER-Regulated Biologics](#coronavirus-covid-19-cber-regulated-biologics)
- [Chapter 13: Measles](#chapter-13-measles)
- [USDA Announces the Phased Reopening of Southern Ports for Livestock Trade](#usda-announces-the-phased-reopening-of-southern-ports-for-livestock-trade) - APHIS Experts Evaluated Mexican Response to New World Screwworm and Found Trade Can Begin
- [About New World Screwworm Myiasis](#about-new-world-screwworm-myiasis) - New World screwworm (NWS) infestation occurs when NWS fly larvae (Cochliomyia hominivorax) infest the tissue or flesh of warm-blooded animals. In places where the flies are present, people can also become infested.
- [Secretary Rollins Takes Decisive Action and Shuts Down U.S. Southern Border Ports to Livestock Trade due to further Northward Spread of New World Screwworm in Mexico](#secretary-rollins-takes-decisive-action-and-shuts-down-u-s-southern-border-ports-to-livestock-trade-due-to-further-northward-spread-of-new-world-screwworm-in-mexico) - To ensure the protection of U.S. livestock herds, USDA is holding Mexico accountable by ensuring proactive measures are being taken to maintain a NWS free barrier. This is maintained with stringent animal movement controls, surveillance, trapping, and following the proven science to push the NWS barrier south in phases as quickly as possible.
- [Bat Cave Footage Offers Clues to How Viruses Leap Between Species](#bat-cave-footage-offers-clues-to-how-viruses-leap-between-species) - Ham A. Video from a national park in Uganda depicted a parade of predatory species feeding on and dispersing fruit bats that are known natural reservoirs of infectious diseases.
- [Measles Cases and Outbreaks](#measles-cases-and-outbreaks) - Data on measles cases/outbreak will be updated every Wednesday. Includes community resources (toolkit, care of children with measles) map, history of measles outbreaks.
- [Tracking Measles Cases in the U.S.](#tracking-measles-cases-in-the-u-s) - provides charts/graphs of updated measles cases
- [Baylisascariasis (Raccoon Roundworm Infection) in Two Unrelated Children — Los Angeles County, California, 2024](#baylisascariasis-raccoon-roundworm-infection-in-two-unrelated-children-los-angeles-county-california-2024) - Vaughan AM, Kamel D, Chang M, et al. Health care providers should suspect B. procyonis infection in patients with eosinophilic meningoencephalitis, especially young children or persons with developmental disabilities or pica and consider empiric treatment with albendazole. The public should avoid contact with raccoons and their feces.
- [Candida auris Containment Responses in Health Care Facilities that Provide Hemodialysis Services — New Jersey, North Carolina, South Carolina, and Tennessee, 2020–2023](#candida-auris-containment-responses-in-health-care-facilities-that-provide-hemodialysis-services-new-jersey-north-carolina-south-carolina-and-tennessee-2020-2023) - Kurutz A, Innes GK, Sherman A, et al. Candida auris, a frequently multidrug-resistant fungal pathogen, can spread within health care facilities. Dialysis facilities face particular infection prevention and control (IPC) challenges because their patients require complex medical care and frequent invasive procedures.
- [CDC’s Advisory Committee on Immunization Concludes Meeting with Joint Statement](#cdcs-advisory-committee-on-immunization-concludes-meeting-with-joint-statement) - Recommendations made by the ACIP are reviewed by the CDC Director, and if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report.
- [Detection and Decontamination of Chronic Wasting Disease Prions during Venison Processing](#detection-and-decontamination-of-chronic-wasting-disease-prions-during-venison-processing) - Milstein M, Gresch SC, Schwabenlander MD, Li M, Bartz JC, Bryant DN, et al. Steel and plastic surfaces used in venison processing can be directly contaminated with CWD prions, contributing to cross-contamination of CWD-negative venison. Several decontaminant solutions (commercial bleach and potassium peroxymonosulfate) are efficacious for prion inactivation on these surfaces.
- [Animal Bites & Rabies Risk: A Guide for Health Professionals](#animal-bites-rabies-risk-a-guide-for-health-professionals) - Guidance published by the Minnesota Department of Health for health practitioners involved in the care for patients potentially exposed to rabies virus.
- [CDC steps up measles travel warning after spread in airplane](#cdc-steps-up-measles-travel-warning-after-spread-in-airplane) - The CDC updated its warning about the risk of contracting measles while traveling, after the agency received at least 62 reports of travelers who were contagious while flying into the U.S. or within the country.
- [Measles Update — United States, January 1–April 17, 2025](#measles-update-united-states-january-1-april-17-2025) - Mathis AD, Raines K, Filardo TD, et al. During January 1-April 17, 2025, a total of 800 measles cases were reported in the United States, the second highest annual case count in 25 years; 82% were associated with an ongoing outbreak in close-knit communities with low vaccination coverage in New Mexico, Oklahoma, and Texas. Eighty-five
- [Outbreak of Cyclosporiasis Among Patrons of a Mexican-Style Restaurant — Limestone County, Alabama, May–June 2023](#outbreak-of-cyclosporiasis-among-patrons-of-a-mexican-style-restaurant-limestone-county-alabama-may-june-2023) - Goetzman J, Carter A, Oliveira A, Ingram LA In June 2023, a total of 47 cases of cyclosporiasis were associated with consumption of food from a Mexican-style restaurant in Alabama. Analysis of case-control data identified cilantro as the likely food source. Collaboration among multiple states and their respective agencies enabled successful traceback of cilantro to
- [Cave-Associated Histoplasmosis Outbreak Among Travelers Returning from Costa Rica — Georgia, Texas, and Washington, December 2024–January 2025](#cave-associated-histoplasmosis-outbreak-among-travelers-returning-from-costa-rica-georgia-texas-and-washington-december-2024-january-2025) - Ghai RR, Sajewski ET, Blass M, et al. Twelve members of an extended family developed mild-to-moderate histoplasmosis infections after touring the Venado Caves in Costa Rica.
- [CDC Issues Advisory for Dengue Fever in Mexico and 19 Other Countries—Here’s What It Means](#cdc-issues-advisory-for-dengue-fever-in-mexico-and-19-other-countries-heres-what-it-means) - CDC has issued a Level 1 travel advisory for individuals traveling to Brazil, Fiji, Mexico, and other countries should stay alert for the dengue disease. This disease is spread by mosquito bite and causes flu-like symptoms.
- [Risk to United States from clade I mpox outbreak in Central and Eastern Africa](#risk-to-united-states-from-clade-i-mpox-outbreak-in-central-and-eastern-africa) - CDC assessed the risk to the United States posed by the clade I mpox outbreak in the Democratic Republic of Congo and in countries in Central and Eastern Africa. Four travel-associated cases of clade Ib mpox have been confirmed in the United States—in California, Georgia, New Hampshire, and New York. Our risk assessment remains unchanged,
- [Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products — United States, October 2024–February 2025](#interim-evaluation-of-respiratory-syncytial-virus-hospitalization-rates-among-infants-and-young-children-after-introduction-of-respiratory-syncytial-virus-prevention-products-united-states) - Patton ME, Moline HL, Whitaker M, et al. Interim evaluation of respiratory syncytial virus hospitalization rates among infants and young children in the United States after introduction of respiratory syncytial virus prevention products (e.g., vaccines, long-acting monoclonal antibodies).
- [CDC DLS Safe Labs Portal - Biological Risk Assessment](#cdc-dls-safe-labs-portal-biological-risk-assessment)
- [Biosecurity Policy](#biosecurity-policy)
- [Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy](#executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy)
- [Prion Diseases (including Creutzfeldt-Jakob Disease)](#prion-diseases-including-creutzfeldt-jakob-disease) - Lab testing, case definition
- [Prion Disease: BioRisk Evaluation Tool](#prion-disease-biorisk-evaluation-tool) - Ami Patel, PhD, RBP (ABSA), Emerging Infectious Diseases Committee (EIDC), ABSA International
- [Human Metapneumovirus Seasonality and Co-Circulation with Respiratory Syncytial Virus — United States, 2014–2024](#human-metapneumovirus-seasonality-and-co-circulation-with-respiratory-syncytial-virus-united-states-2014-2024) - Jobe NB, Rose E, Winn AK, Goldstein L, Schneider ZD, Silk BJ. Circulation of both hMPV and RSV declined significantly during the 2020–21 respiratory virus season when the COVID-19 pandemic began.
- [Epidemiology of Symptomatic Human Metapneumovirus Infection in the CASCADIA Community-Based Cohort — Oregon and Washington, 2022–2024](#epidemiology-of-symptomatic-human-metapneumovirus-infection-in-the-cascadia-community-based-cohort-oregon-and-washington-2022-2024) - Shakya M, Chu HY, Englund JA, et al. In this community cohort study including participants aged 6 months–49 years, average incidence of symptomatic hMPV infection was 7.5 per 100 persons per year. Incidence was highest during January–March and among children aged 2–4 years, and clustered in households. Although most infections caused mild illness, 27% were
- [Vitamin A Toxicity](#vitamin-a-toxicity) - Olson J, et.al Vitamain A may be administered to infants and children in the United States with measles as part of supportive management. However, the use of Vitamin A should be supervised by a physician, as toxicity has been reported in Texas.
- [Measles Outbreak in Texas](#measles-outbreak-in-texas) - Includes information on who should be vaccinated, how to find vaccines, free vaccines, etc.
- [Measles Outbreak – 2025](#measles-outbreak-2025-2) - updates posted on Tuesdays and Fridays
- [Fatal Case of Splash Pad–Associated Naegleria fowleri Meningoencephalitis — Pulaski County, Arkansas, September 2023](#fatal-case-of-splash-pad-associated-naegleria-fowleri-meningoencephalitis-pulaski-county-arkansas-september-2023) - Dulski TM, Montgomery F, Ramos JM, et al. Most Naegleria fowleri infections are life-threatening and associated with swimming or diving in fresh water, such as a lake.
- [Notes from the Field: Fatal Acanthamoeba Encephalitis in a Patient Who Regularly Used Tap Water in an Electronic Nasal Irrigation Device and a Continuous Positive Airway Pressure Machine at Home — New Mexico, 2023](#notes-from-the-field-fatal-acanthamoeba-encephalitis-in-a-patient-who-regularly-used-tap-water-in-an-electronic-nasal-irrigation-device-and-a-continuous-positive-airway-pressure-machine-at-home) - Haston JC, Ali IK, Roy S, et al. Acanthamoeba, a free-living ameba, can cause encephalitis and disseminated disease that are nearly always fatal. Immunocompromised persons are at highest risk for these infections
- [Notes from the Field: Response to a Case of Travel-Associated Lassa Fever — Iowa, October–November 2024](#notes-from-the-field-response-to-a-case-of-travel-associated-lassa-fever-iowa-october-november-2024) - Von Stein DL, Barger A, Hennenfent A, et al. A fatal Lassa fever case in a patient returning from Liberia, the first U.S. case diagnosed in eight years and the ninth U.S. travel-associated case since 1969, was identified in Iowa in late 2024. Investigation identified 180 contacts. Lassa fever virus testing was performed for five
- [Laboratory Biosafety Guidelines for working with SARS-CoV-2](#laboratory-biosafety-guidelines-for-working-with-sars-cov-2) - Emphasizes this guidance is specific to SARS-CoV-2 and does not apply to other Corona Viruses
- [OSHA Influenza QuickCards (by Occupation)](#osha-influenza-quickcards-by-occupation) - General Precautions (English/Español) Healthcare Workers (English/Español) Laboratory Workers (English/Español) Poultry Workers (English/Español) Animal Handlers (English/Español) Food Handlers (English/Español)
- [Expanding Measles Outbreak in the United States and Guidance for the Upcoming Travel Season](#expanding-measles-outbreak-in-the-united-states-and-guidance-for-the-upcoming-travel-season) - Includes recommendations for clinicians, public health departments and travellers.
- [Measles](#measles-2) - Good background information and outbreak updates on Measles outbreak in Texas and NM.
- [Notes from the Field: Genomic and Wastewater Surveillance Data to Guide a Hepatitis A Outbreak Response — Los Angeles County, March 2024–June 2024](#notes-from-the-field-genomic-and-wastewater-surveillance-data-to-guide-a-hepatitis-a-outbreak-response-los-angeles-county-march-2024-june-2024) - Genomic analysis and wastewater testing can complement traditional case-based surveillance to identify and better characterize HAV outbreaks.
- [Ebola Outbreak Caused by Sudan virus in Uganda](#ebola-outbreak-caused-by-sudan-virus-in-uganda) - Includes recommendations for clinical and public health labs, clinicians and the public.
- [First Clade Ib Monkeypox Virus Infection Reported in the Americas — California, November 2024](#first-clade-ib-monkeypox-virus-infection-reported-in-the-americas-california-november-2024) - Levy V, Branzuela A, Hsieh K, et al. The first reported clade Ib MPXV infection in the Americas was identified via electronic laboratory reporting in California in a U.S. traveler who returned from East Africa.
- [Marked neurotropism and potential adaptation of H5N1 clade 2.3.4.4.b virus in naturally infected domestic cats](#marked-neurotropism-and-potential-adaptation-of-h5n1-clade-2-3-4-4-b-virus-in-naturally-infected-domestic-cats) - In April 2024, ten cats died in a rural South Dakota (SD) residence, showing respiratory and neurological symptoms. Necropsy and laboratory testing of two cats confirmed H5N1 clade 2.3.4.4b infection.
- [OSHA Guidance Update on Protecting Employees from Avian Flu (Avian Influenza) Viruses](#osha-guidance-update-on-protecting-employees-from-avian-flu-avian-influenza-viruses) - Iincludes Guidance for Poultry Employees , Animal Handlers other than Poultry Employees, Laboratory Employees, Healthcare Workers Who Treat Patients with Known or Suspected AI, Guidance for Food Handlers, etc.
- [Highly Pathogenic Avian Influenza A(H5N1) Virus Infection of Indoor Domestic Cats Within Dairy Industry Worker Households — Michigan, May 2024](#highly-pathogenic-avian-influenza-ah5n1-virus-infection-of-indoor-domestic-cats-within-dairy-industry-worker-households-michigan-may-2024) - Naraharisetti R, Weinberg M, Stoddard B, et al. HPAI A(H5N1) virus was detected in two indoor domestic cats with respiratory and neurologic illness that lived in homes of dairy workers but had no known direct exposure to HPAI A(H5N1)–affected farms.
- [Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners — United States, September 2024](#notes-from-the-field-seroprevalence-of-highly-pathogenic-avian-influenza-ah5-virus-infections-among-bovine-veterinary-practitioners-united-states-september-2024) - Leonard J, Harker EJ, Szablewski CM, et al. These findings suggest the possible benefit of systematic surveillance for rapid identification of HPAI A(H5) virus in dairy cattle, milk, and humans who are exposed to cattle to ensure appropriate hazard assessments.
- [H5N1 Virus Guidance for Farm Workers](#h5n1-virus-guidance-for-farm-workers) - poster (English and Spanish) designed to help farm workers undertand the risks of avian influenza and how to protect themselves and their families
- [ARCHIVED: Considerations for Laboratory Biosafety and Biosecurity During the Coronavirus Disease 2019 Pandemic: Applying the ISO 35001:2019 Standard and High-Reliability Organizations Principles](#considerations-for-laboratory-biosafety-and-biosecurity-during-the-coronavirus-disease-2019-pandemic-applying-the-iso-350012019-standard-and-high-reliability-organizations-principles) - Callihan D, Downing M, Meyer E, et al.
- [Tularemia — United States, 2011–2022](#tularemia-united-states-2011-2022) - Rich SN, Hinckley AF, Earley A, Petersen JM, Mead PS, Kugeler KJ Tularemia is a rare nationally notifiable zoonosis, caused by the tier-1 select agent Francisella tularensis, that has been reported from all U.S. states except Hawaii.
- [Detections of poliovirus in sewage samples require enhanced routine and catch-up vaccination and increased surveillance](#detections-of-poliovirus-in-sewage-samples-require-enhanced-routine-and-catch-up-vaccination-and-increased-surveillance-2) - Between September and December 2024, four countries in the EU/EEA (Finland, Germany, Poland, Spain) and the United Kingdom reported detections of circulating vaccine-derived poliovirus type 2 (cVDPV2) in sewage samples. This is the first time cVDPV2 has been detected in EU/EEA countries from environmental surveillance.
- [WHO accelerates efforts to support response to Sudan virus disease outbreak in Uganda](#who-accelerates-efforts-to-support-response-to-sudan-virus-disease-outbreak-in-uganda) - Following the confirmation of an outbreak of Sudan virus disease – which belongs to the same family as Ebola virus disease – in Uganda today, World Health Organization (WHO) is mobilizing efforts to support the national health authorities to swiftly contain and end the outbreak.
- [Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?](#are-we-serologically-prepared-against-an-avian-influenza-pandemic-and-could-seasonal-flu-vaccines-help-us) - I Sanz-Muñoz, et al. In this prospective observational study, immune protection against H5N1 and H7N9 avian influenza virus (AIV) was almost absent prior to vaccination. However, seasonal influenza vaccines induced a seroprotective response against the H5N1 subtype in nearly 15% of younger individuals.
- [Cat and Dog Food Manufacturers Required to Consider H5N1 in Food Safety Plans](#cat-and-dog-food-manufacturers-required-to-consider-h5n1-in-food-safety-plans) - Bird flu has been found in domestic and wild cats in several states. At this time it is known that H5N1 can be transmitted to cats and dogs when they eat products from infected poultry or cattle (e.g., unpasteurized milk, uncooked meat, or unpasteurized eggs) that have not undergone a processing step that is capable
- [The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24](#the-hospital-and-mortality-burden-of-covid-19-compared-with-influenza-in-denmark-a-national-observational-cohort-study-2022-24) - P Bager, et al. An observational study comparing the severity of COVID-19 and influenza among nearly 6 million Denmark residents finds a higher rate of hospitalizations and deaths in those infected with SARS-CoV-2—mainly among unvaccinated people, those with chronic conditions, and males—from 2022 to 2024.
- [First H5 Bird Flu Death Reported in United States](#first-h5-bird-flu-death-reported-in-united-states) - Outside the United States, more than 950 cases of H5N1 bird flu have been reported to the World Health Organization; about half of those have resulted in death.
- [Policies and Procedures for Patients with Suspected or Confirmed Human Prion Disease (E.G., Creutzfeldt-Jakob Disease [CJD])](#policies-and-procedures-for-patients-with-suspected-or-confirmed-human-prion-disease-e-g-creutzfeldt-jakob-disease-cjd) - Infection control measures and example of patient management ( appropriate confinement, containment, safe handling, disinfection, and disposal of contaminated materials and tissues generated during the course of hospitalization)
- [Human Prion Disease - Infection Control Key Points](#human-prion-disease-infection-control-key-points) - Infection control measures and Recommendations for disinfection and sterilization of prion-contaminated medical devices
- [Safe laboratory management of prions and proteopathic seeds](#safe-laboratory-management-of-prions-and-proteopathic-seeds) - Mead, Simon et al. The Lancet Neurology, Volume 20, Issue 12, 981 The UK's Advisory Committee for Dangerous Pathogens convened a subgroup to revise guidance for safe working with prions and to consider whether any measures were needed for work with proteopathic seeds, involving experts from research laboratories for prion and other neurodegenerative diseases, infectious
- [UK Prions and proteopathic seeds: Safe Working and the Prevention of Infection-Laboratory containment and control measures](#uk-prions-and-proteopathic-seeds-safe-working-and-the-prevention-of-infection-laboratory-containment-and-control-measures) - Flow chart to manage samples from human or animal source
- [Minimise transmission risk of CJD and vCJD in healthcare settings](#minimise-transmission-risk-of-cjd-and-vcjd-in-healthcare-settings) - This guidance produced by the ACDP TSE risk management subgroup aims to help minimise the risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) in healthcare and other work settings.
- [Chronic Wasting Disease Management Plan](#chronic-wasting-disease-management-plan) - The following management plan will guide Texas Parks and Wildlife Department (TPWD) and Texas Animal Health Commission (TAHC) in addressing risks, developing management strategies, and protecting big game resources from chronic wasting disease (CWD) in captive and free-ranging cervid populations in the state of Texas.
- [Clinical Overview of Drug-Resistant Tuberculosis Disease](#clinical-overview-of-drug-resistant-tuberculosis-disease) - Drug-resistant TB is transmitted in the same way as drug-susceptible TB. However, delays in the recognition of drug resistance or delays in access to effective anti-TB drugs may increase transmission and further development of drug resistance.
- [First Case of Clade I Mpox Diagnosed in the United States](#first-case-of-clade-i-mpox-diagnosed-in-the-united-states) - On November 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Advisory about the first case of clade I mpox diagnosed in the United States.
- [Packaging and Shipping Evaluation Tool](#packaging-and-shipping-evaluation-tool) - APHL’s Sentinel Laboratory Partnerships and Outreach Subcommittee of the Public Health Preparedness and Response Committee developed this Packaging and Shipping Evaluation Tool to provide a standardized resource for public health laboratories (PHLs) to assess shipments received in the laboratory.
- [Wastewater Monitoring Dashboard for Canada](#wastewater-monitoring-dashboard-for-canada) - This dashboard provides data about COVID-19, flu, RSV and mpox virus levels in wastewater.
- [Strategies for Conserving the Supply of N95® Filtering Facepiece Respirators](#strategies-for-conserving-the-supply-of-n95-filtering-facepiece-respirators) - Key Points include strategies for contingency capacity
- [CDC's Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings](#cdcs-core-infection-prevention-and-control-practices-for-safe-healthcare-delivery-in-all-settings)
- [Infection Control Guidance: SARS-CoV-2](#infection-control-guidance-sars-cov-2) - This guidance applies to all U.S. settings where healthcare is delivered, including nursing homes and home health. The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency.
- [Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2](#interim-guidance-for-managing-healthcare-personnel-with-sars-cov-2-infection-or-exposure-to-sars-cov-2) - In general, asymptomatic healthcare personnel (HCP) who have had a higher-risk exposure do not require work restriction, regardless of vaccination status, if they do not develop symptoms or test positive for SARS-CoV-2.
- [Oropouche virus VR-266](#oropouche-virus-vr-266) - ATCC is a repository of biological materials. This is a sample from Trinidad.
- [Notes from the Field: Trichophyton mentagrophytes Genotype VII — New York City, April–July 2024](#notes-from-the-field-trichophyton-mentagrophytes-genotype-vii-new-york-city-april-july-2024) - Zucker J, Caplan AS, Gunaratne SH, et al. 5 cases diagnosed in NYC in summer 2024, previously not seen in the US.
- [Locally Acquired (Autochthonous) Mosquito-Transmitted Plasmodium vivax Malaria — Saline County, Arkansas, September 2023](#locally-acquired-autochthonous-mosquito-transmitted-plasmodium-vivax-malaria-saline-county-arkansas-september-2023) - Courtney AP, Boyanton BL Jr., Strebeck PV, et al. After 20 years without locally acquired mosquito-transmitted malaria in the United States, nine cases were reported to CDC during May–August 2023.
- [Notes from the Field: Enhanced Surveillance for Raccoon Rabies Virus Variant and Vaccination of Wildlife for Management — Omaha, Nebraska, October 2023–July 2024](#notes-from-the-field-enhanced-surveillance-for-raccoon-rabies-virus-variant-and-vaccination-of-wildlife-for-management-omaha-nebraska-october-2023-july-2024) - Stein SR, Beron AJ, Nelson KM, et al. Movement of wildlife has facilitated the spread of non-bat rabies virus variants into new geographic areas of the United States, with major implications for human health.
- [Wastewater Surveillance for Poliovirus in Selected Jurisdictions, United States, 2022–2023](#wastewater-surveillance-for-poliovirus-in-selected-jurisdictions-united-states-2022-2023) - EID Whitehouse ER, Gerloff N, English R, Reckling SK, Alazawi MA, Fuschino M, et al.
- [Mpox vaccine is safe and generates a robust antibody response in adolescents](#mpox-vaccine-is-safe-and-generates-a-robust-antibody-response-in-adolescents) - MVA-BN® (Modified Vaccinia Ankara - Bavarian Nordic) is a proprietary and patented vaccine platform technology of Bavarian Nordic.
- [WHO grants approval for use of Bavarian Nordic’s mpox vaccine in adolescents](#who-grants-approval-for-use-of-bavarian-nordics-mpox-vaccine-in-adolescents) - A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox
- [Notes from the Field: Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus — Five States, October 2023–February 2024](#notes-from-the-field-mpox-cluster-caused-by-tecovirimat-resistant-monkeypox-virus-five-states-october-2023-february-2024-2) - Gigante CM, Takakuwa J, McGrath D, et al. Tecovirimat is the first-line drug for treatment of orthopoxvirus infection (e.g., smallpox and mpox). Viral mutations that render the drug ineffective can develop during treatment.
- [Clade I Mpox in Children in Africa and Expectations for Transmission in the United States](#clade-i-mpox-in-children-in-africa-and-expectations-for-transmission-in-the-united-states) - The high proportion of children with suspected mpox reported in the current outbreak is likely due to a number of factors, including spread within and between close households, younger population demographics in impacted countries, misdiagnosis of other diseases (such as measles), poor sanitary conditions, limited access to health services, and a high level of food
- [State and Hospital Officials Follow Federal Guidance After Lassa Fever Death](#state-and-hospital-officials-follow-federal-guidance-after-lassa-fever-death) - The Iowa Department of HHS has confirmed the death of a middle-aged eastern Iowa resident from Lassa fever. The individual had recently returned from travel to West Africa.
- [First Marburg Virus Disease Outbreak in the Republic of Rwanda](#first-marburg-virus-disease-outbreak-in-the-republic-of-rwanda) - This report summarizes CDC’s recommendations for public health departments and clinicians in the United States on case identification and testing and clinical laboratory biosafety considerations.
- [Notes from the Field: First Locally Acquired Dengue Virus Infections — Pasadena, California, October–December 2023](#notes-from-the-field-first-locally-acquired-dengue-virus-infections-pasadena-california-october-december-2023) - Feaster M, Patrick R, Oshiro M, et al. 2 cases of locally acquired Dengue investigated in Pasadena CA in late 2023.
- [Reemergence of Oropouche Virus in the Americas and Risk for Spread in the United States and Its Territories, 2024](#reemergence-of-oropouche-virus-in-the-americas-and-risk-for-spread-in-the-united-states-and-its-territories-2024) - Guagliardo SJ, Connelly C, Lyons S, Martin SW, Sutter R, Hughes HR, et al. Reviews information on Oropouche virus, factors influencing its spread, transmission risk in the United States, and current status of public health response tools.
- [CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised](#cdc-recommends-second-dose-of-2024-2025-covid-19-vaccine-for-people-65-years-and-older-and-for-people-who-are-moderately-or-severely-immunocompromised) - CDC endorsing that people 65 years and older and those who are moderately or severely immunocompromised receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.
- [Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure](#accelerated-longitudinal-weight-gain-among-infants-with-in-utero-covid-19-exposure) - Mollie WO, et al.Infants with in utero COVID-19 exposure vs controls exhibited differential trajectories of weight and BMI.
- [Burkholderia pseudomallei Laboratory Exposure, Arizona, USA](#burkholderia-pseudomallei-laboratory-exposure-arizona-usa) - Speiser LJ, Graf EH, Seville M, Singbartl K, Dalton ML, Harrington D, et al., May 2023
- [Chagas Disease Resources](#chagas-disease-resources) - This website includes print resources for healthcare provides and links to WHO and PAHO
- [Monkeypox after Occupational Needlestick Injury from Pustule](#monkeypox-after-occupational-needlestick-injury-from-pustule) - Caldas JP, Valdoleiros SR, Rebelo S, Tavares M. This report includes an occupational needlestick injury from a pustule
- [Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea](#case-report-and-literature-review-of-occupational-transmission-of-monkeypox-virus-to-healthcare-workers-south-korea) - Choi Y, Jeon E, Kim T, Choi S, Moon SM, Song K, et al. This report includes occupational exposure of MPOX to HCW
- [Prevention Strategies for Mpox, including Vaccinating People at Risk via Sexual Exposure, for U.S. Travelers Visiting Countries with Clade I Mpox Outbreaks](#prevention-strategies-for-mpox-including-vaccinating-people-at-risk-via-sexual-exposure-for-u-s-travelers-visiting-countries-with-clade-i-mpox-outbreaks) - This is a Health Alert Network (HAN) Health Update to provide additional information about the ongoing outbreak of clade I monkeypox virus (MPXV), the virus that causes mpox, in Central and Eastern Africa
- [Guidance for Personal Protective Equipment (PPE)](#guidance-for-personal-protective-equipment-ppe) - This guidance refers only to the following viral hemorrhagic fevers: Ebola, Marburg, Lassa, Crimean Congo Hemorrhagic Fever (CCHF), and the South American Hemorrhagic Fevers (i.e., those caused by Junin, Machupo, Chapare, Guanarito and Sabia viruses).
- [Marburg Virus Disease Outbreak in Rwanda](#marburg-virus-disease-outbreak-in-rwanda) - This is a reference website for resources including a "Weekly Special Press Briefing on the Mpox Outbreak and other Health Emergencies in Africa"
- [Marburg virus disease](#marburg-virus-disease) - This is a reference wensite including WHO's approach to responding to this outbreak
- [Oropouche virus: Infectious substances pathogen safety data sheet](#oropouche-virus-infectious-substances-pathogen-safety-data-sheet)
- [Important Information for Blood Establishments Regarding the Oropouche Virus and Blood Donation](#important-information-for-blood-establishments-regarding-the-oropouche-virus-and-blood-donation) - Worldwide, there have been no reports of transmission of OROV by transfusion of blood or blood components. FDA will continue to monitor cases of OROV disease in the U.S. and worldwide and will issue updated information as it becomes available.
- [How CDC is monitoring influenza data among people to better understand the current avian influenza A (H5N1) situation](#how-cdc-is-monitoring-influenza-data-among-people-to-better-understand-the-current-avian-influenza-a-h5n1-situation) - This site includes monitoring of Persons Exposed to Infected Animals
- [Avian Influenza, Additional Resources](#avian-influenza) - OSHA QuickCards by Occupation and additional references for Avian Influenza.
- [Transition to endemicity: Understanding COVID-19](#transition-to-endemicity-understanding-covid-19) - Antia R, Halloran ME The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating pandemic worldwide. Here, we explain basic concepts underlying the transition from an epidemic to an endemic state, where a pathogen is stably maintained in a population. We discuss how
- [APHL, Risk Assessment Guide: Testing Raw Milk Samples That May Contain Highly Pathogenic Avian Influenza](#aphl-risk-assessment-guide-testing-raw-milk-samples-that-may-contain-highly-pathogenic-avian-influenza)
- [COVID Data Tracker Weekly Review (Archived)](#covid-data-tracker-weekly-review) - May 11, 2023, marked the end of the federal COVID-19 public health emergency (PHE) declaration. This doesn’t mean that COVID-19 is over, but the end of the PHE did initiate a cascade of updates to COVID-19 data collection, reporting, and surveillance. Some surveillance metrics will remain the same, but some will change in terms of
- [Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023](#tick-borne-encephalitis-vaccine-recommendations-of-the-advisory-committee-on-immunization-practices-united-states-2023) - This report summarizes the epidemiology of and risks for infection with TBE virus, provides information on the immunogenicity and safety of TBE vaccine, and summarizes the recommendations of the ACIP for use of TBE vaccine among U.S. travelers and laboratory workers.
- [Information For Healthcare Professionals](#mpox-information-for-healthcare-professionals) - Includes recommendations for vaccination of health care workers, specimen collection and infection control.
- [ACAM2000](#fda-acam2000) - The FDA approved a new indication for ACAM2000, to include the prevention of mpox disease in individuals determined to be at high risk for mpox infection. ACAM2000 has been approved since 2007 for the prevention of smallpox disease in individuals determined to be at high risk for smallpox infection. ACAM2000 is a live replicating vaccinia
- [Mpox Caused by Human-to-Human Transmission of Monkeypox Virus in the Democratic Republic of the Congo with Spread to Neighboring Countries](#mpox-caused-by-human-to-human-transmission-of-monkeypox-virus-in-the-democratic-republic-of-the-congo-with-spread-to-neighboring-countries)
- [Mpox – African Region](#mpox-african-region)
- [Oropouche Fever: A Review](#oropouche-fever-a-review) - Sakkas H, Bozidis P, Franks A, Papadopoulou C.
- [Public Health Risk Assessment related to Oropouche Virus (OROV) in the Region of the Americas - 9 February 2024](#public-health-risk-assessment-related-to-oropouche-virus-orov-in-the-region-of-the-americas-9-february-2024) - A very thorough detailed risk assessment profile for Oropouche Virus.
- [Oropouche virus disease cases imported into the European Union](#oropouche-virus-disease-cases-imported-into-the-european-union) - Includes epidemiological information and risk assessment considerations
- [Oropouche Virus Disease Among U.S. Travelers — United States, 2024](#oropouche-virus-disease-among-u-s-travelers-united-states-2024)
- [Oropouche virus disease - Region of the Americas](#oropouche-virus-disease-region-of-the-americas)
- [Increased Oropouche Virus Activity and Associated Risk to Travelers](#increased-oropouche-virus-activity-and-associated-risk-to-travelers) - Includes information for travelers, Health Departments and testing laboratories.
- [CDC A(H5N1) Bird Flu Response Update August 16, 2024](#cdc-ah5n1-bird-flu-response-update-august-16-2024) - In this week's update, CDC shares information about ongoing serology studies in Colorado and Michigan, genetic characterization of viruses from recent human cases in Colorado poultry workers, and how CDC's National Syndromic Surveillance Program is supporting this response.
- [CDC A(H5N1) Bird Flu Response Update August 9, 2024](#cdc-ah5n1-bird-flu-response-update-august-9-2024) - CDC provides an update on its response activities related to the multistate outbreak of avian influenza A(H5N1) virus, or "H5N1 bird flu," in dairy cows and other animals in the United States.
- [CDC A(H5N1) Bird Flu Response Update August 2, 2024](#cdc-ah5n1-bird-flu-response-update-august-2-2024) - CDC provides an update on its response activities related to the multistate outbreak of avian influenza A(H5N1) virus, or "H5N1 bird flu," in dairy cows and other animals in the United States.
- [Cluster of Influenza A(H5) Cases Associated with Poultry Exposure at Two Facilities — Colorado, July 2024](#cluster-of-influenza-ah5-cases-associated-with-poultry-exposure-at-two-facilities-colorado-july-2024)
- [Providing Clarity Regarding the Regulation of Respirators Used in Health Care Settings](#providing-clarity-regarding-the-regulation-of-respirators-used-in-health-care-settings) - Currently there remains a lack of regulatory alignment among OSHA, the Food and Drug Administration (FDA), and the National Institute for Occupational Safety and Health (NIOSH) regarding respirator approval for use in health care.
- [Travel Notices: Global Polio](#travel-notices-global-polio) - Includes map of current distribution. Some international destinations have circulating poliovirus.
- [Interim Guidelines for Biosafety and COVID-19](#interim-guidelines-for-biosafety-and-covid-19) - This guidance is intended for clinical laboratory and support staff who handle or process specimens associated with COVID-19.
- [UN/OCHA COVID-19 Global Humanitarian Response Plan](#un-ocha-covid-19-global-humanitarian-response-plan) - This page focusses on the COVID-19 Global Humanitarian Response Plan (GHRP) and includes commitments, pledges and projected funding. For data on the wider emergency, including funding to countries not covered by the GHRP, please see the COVID-19 emergency page.
- [FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review](#fda-and-cdc-lift-recommended-pause-on-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough-safety-review) - CDC Press Release FDA News Release Following a thorough safety review, the FDA and CDC have determined that the recommended pause regarding the use of the Johnson & Johnson COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.
- [WHO Risk Assessment Tool app](#who-risk-assessment-tool-app) - WHO Risk Assessment Tool app is now available on App stores with the following links:ANDROID : https://play.google.com/store/apps/details?id=org.who.bioratIOS: https://apps.apple.com/in/app/who-rast/id6469030151
- [VHF Clinical Specimen Packaging and Shipping](#vhf-clinical-specimen-packaging-and-shipping) - This guidance applies to Filoviruses, Arenaviruses, Rift Valley fever virus, Crimean Congo HFV. This guidance also applies to other high-consequence diseases that require a specialized laboratory, are highly pathogenic, and have no vaccine or treatment currently available, like Nipah virus disease.
- [Laboratory Testing for Patients with a Suspected VHF or High-Consequence Disease](#laboratory-testing-for-patients-with-a-suspected-vhf-or-high-consequence-disease) - Routine laboratory testing to monitor the patient’s clinical status and diagnostic testing for other potential causes of the patient’s illness should be pursued while testing for a VHF or other high-consequence disease is underway.
- [VHF Specimen Collection](#vhf-specimen-collection) - This webpage provides guidance for staff at hospitals and clinical laboratories on collecting, transporting, and submitting specimens to laboratories to test for viral hemorrhagic fevers (VHFs) or other high-consequence diseases.
- [Guidance on Performing Routine Diagnostic Testing for Patients with Suspected VHFs or Other High-Consequence Disease](#guidance-on-performing-routine-diagnostic-testing-for-patients-with-suspected-vhfs-or-other-high-consequence-disease) - This guidance applies to viral hemorrhagic fevers caused by infections with: Filoviruses (ebolaviruses and marburgviruses), Arenaviruses [Lassa, Lujo, and South American hemorrhagic fever viruses (Guanarito virus, Sabia virus, Junin virus, Chapare virus, Machupo virus)], Rift Valley fever virus, and Crimean Congo hemorrhagic fever virus.
- [Polio Vaccination](#polio-vaccination)
- [Biosafety Laboratory Guidance for Handling and Processing Mpox Specimens](#biosafety-laboratory-guidance-for-handling-and-processing-mpox-specimens)
- [Safety Advisory Notice1—Classification of MPXV Diagnostic Samples and Waste](#safety-advisory-notice1-classification-of-mpxv-diagnostic-samples-and-waste)
- [Global clinical data platform: Viral haemorrhagic fever case report form (‎CRF)‎: module 1](#global-clinical-data-platform-viral-haemorrhagic-fever-case-report-form-crf-module-1) - The CRF is designed to collect data obtained direct from patient interview and examination, and from review of hospital or clinical notes of people with probable or confirmed viral haemorrhagic fever. Available in English, Arabic, Chinese, French and Spanish
- [About Viral Hemorrhagic Fevers](#about-viral-hemorrhagic-fevers) - Main page including an abridge description of the major VHF viruses. Includes a table with virus family, virus name, how long it takes for symptoms to start, where it is found, and if it is transmitted by animal or insect
- [Current H5N1 Bird Flu Situation in Dairy Cows](#current-h5n1-bird-flu-situation-in-dairy-cows)
- [CDC A(H5N1) Bird Flu Response Update, July 12, 2024](#cdc-ah5n1-bird-flu-response-update-july-12-2024)
- [CDC A(H5N1) Bird Flu Response Update, July 5, 2024](#cdc-ah5n1-bird-flu-response-update-july-5-2024)
- [CDC A(H5N1) Bird Flu Response Update, July 19, 2024](#cdc-ah5n1-bird-flu-response-update-july-19-2024)
- [CDC A(H5N1) Bird Flu Response Update July 26, 2024](#cdc-ah5n1-bird-flu-response-update-july-26-2024) - CDC provides an update on its response activities related to the multistate outbreak of avian influenza A(H5N1) virus, or "H5N1 bird flu," in dairy cows and other animals in the United States.
- [Technical Report: June 2024 Highly Pathogenic Avian Influenza A(H5N1) Viruses](#technical-report-june-2024-highly-pathogenic-avian-influenza-ah5n1-viruses) - This report provides an update to the April 26, 2024, report to include three additional sporadic human cases (1 in Australia and 2 in the United States) and recent activity in wild birds, poultry, and other animals, including the multi-state outbreak in U.S. dairy cattle, and updated information on monitoring for human infections with highly
- [Agent Information Sheets](#agent-information-sheets)
- [Biorisk Management Topics in the Veterinary Diagnostic Laboratory and Necropsy Suite (videos)](#working-at-animal-biosafety-level-2-2-2) - From the AAVLD USAHA Annual Meeting Oct 8, 2022 Mylissia Smith, MPH, RBP, Pacific Northwest National Laboratory Stephanie Kutz, Associate Biological Safety Officer, IBC and Laboratory Operations Manager, University of Wisconsin, Madison Nicole Marlenee, DVM, Biosafety Officer, ARO, Colorado State University Robert Heckert, BSc (Agr), DVM, Heckert Consulting PERSONAL PROTECTIVE EQUIPMENT IN BSL-3 &
- [Biorisk Assessment Models (BioRAMs) - Tools for laboratory biorisk officers](#biorisk-assessment-models-biorams-tools-for-laboratory-biorisk-officers-2) - Designed for use by laboratory biorisk officers, these models provide a visualization of relative risks and help to identify appropriate mitigation measures. They have incorporated GCBS and international biorisk officer experience in drafting sets of criteria, prioritizing the criteria, and outlining their scoring functions. The main objective of these models is to help strengthen laboratory
- [Reducing Risk for People Working with or Exposed to Animals](#reducing-risk-for-people-working-with-or-exposed-to-animals) - Summary of changes This updated guidance identifies select occupational groups that may be at increased risk of exposure to novel influenza A viruses. Specific recommendations for these groups may be updated as CDC learns more during this evolving situation. Persons in these occupational groups should consult with their supervisor or their employer’s worker safety team
- [Notes from the Field: Anthrax on a Sheep Farm in Winter — Texas, December 2023–January 2024](#notes-from-the-field-anthrax-on-a-sheep-farm-in-winter-texas-december-2023-january-2024) - Thompson JM, Spencer K, Maass M, et al. In early 2024, an unusual case of confirmed cutaneous anthrax acquired during the winter in a geographic region with enzootic anthrax occurred, and an investigation was undertaken.
- [Increased Risk of Dengue Virus Infections in the United States](#increased-risk-of-dengue-virus-infections-in-the-united-states) - Global incidence of dengue in 2024 has been the highest on record for this calendar year; the Americas are reporting record-breaking numbers of infections, infections are more common in the US as well.
- [Guidelines for Laboratory Biosafety: Handling and Processing Specimens Associated with Novel Influenza A Viruses, Including Potential A(H5N1) Virus](#guidelines-for-laboratory-biosafety-handling-and-processing-specimens-associated-with-novel-influenza-a-viruses-including-potential-ah5n1-virus) - Covers the use of personal protective equipment, testing, antiviral treatment, patient investigations, monitoring of exposed persons, and antiviral chemoprophylaxis of exposed persons
- [Highly Pathogenic Avian Influenza A(H5N1) Virus in Animals: Interim Recommendations for Prevention, Monitoring, and Public Health Investigations](#highly-pathogenic-avian-influenza-ah5n1-virus-in-animals-interim-recommendations-for-prevention-monitoring-and-public-health-investigations) - Covers the use of personal protective equipment, testing, antiviral treatment, patient investigations, monitoring of exposed persons, and antiviral chemoprophylaxis of exposed persons
- [Select Agents and Toxins Exemption: H5 Avian Influenza Virus](#select-agents-and-toxins-exemption-h5-avian-influenza-virus) - This notice temporarily exempts H5 avian influenza viruses from the requirements of the regulations listed in 9 C.F.R. Part 121 for a period of three years; this exemption is consistent with protecting animal health and animal products while allowing more laboratories to conduct research and develop solutions to address the disease. This exemption replaces all
- [Avian Influenza (Bird Flu)](#avian-influenza-bird-flu-2) - Overview site that includes current situation, background, prevention, links to other resources for prevention and monitoring, communication, information for other groups
- [Avian Influenza](#avian-influenza-6) - General reference for Avian Influenza, including how transmitted, risk to the public, outlook and references to CDC, USDA, flyer for posting, etc.
- [The COVID pandemic spurred a revision of US pathogen research rules. Will it help?](#the-covid-pandemic-spurred-a-revision-of-us-pathogen-research-rules-will-it-help) - Gillum D, et al. The US government issued a long-awaited policy update last month intended to better manage the hazards associated with risky biological research.
- [Long COVID Basics](#long-covid-basics) - Discusses the disease, prevention via vaccination, signs and symptoms, complications, testing and diagnosis, who is most at risk, etc.
- [People at Increased Risk, And Other People Who Need to Take Extra Precautions](#people-at-increased-risk-and-other-people-who-need-to-take-extra-precautions) - This page includes various groups at risk of developing severe disease including pregnant women
- [Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process](#status-of-covid-19-vaccines-within-who-eul-pq-evaluation-process) - Table including the status of COVID-19 Vaccines within WHO EUL/PQ evaluation process
- [Considerations for Evaluation of Covid19 Vaccines](#considerations-for-evaluation-of-covid19-vaccines-2)
- [Widening the Framework for Regulation of Dual-Use Research in the Wake of the COVID-19 Pandemic](#widening-the-framework-for-regulation-of-dual-use-research-in-the-wake-of-the-covid-19-pandemic) - This analysis of publicly available data on publications, preprints, and clinical trials coupled with the Global Health Security Index measure of dual-use oversight suggests that some research activities raise dualuse concerns that have gone unaddressed.
- [Choosing Safer Activities](#choosing-safer-activities) - This page includes multiple examples of outdoor activites and the risk for unvaccinated individual wearing the covering by unvaccinated
- [2019 Novel Coronavirus Research Compendium (NCRC)](#2019-novel-coronavirus-research-compendium-ncrc-2) - These teams rapidly curate and assess emerging research on SARS-CoV-2 and COVID-19. We prioritize original, high-quality research for public health action and papers receiving significant attention, regardless of quality.
- [Correctional and Detention Facilities](#correctional-and-detention-facilities) - Resources for people who work and reside in prisons, jails, and detention centers.
- [Gaps and inconsistencies in the current knowledge and implementation of biosafety and biosecurity practices for rickettsial pathogens](#gaps-and-inconsistencies-in-the-current-knowledge-and-implementation-of-biosafety-and-biosecurity-practices-for-rickettsial-pathogens) - Blacksell SD, Le KK, Rungrojn A, Wongsantichon J, Stenos J, Graves SR, Day NPJ In the case of Orientia spp., most of the available information is derived from Rickettsia spp., which may not be appropriate and overstate the risks of working with this pathogen. The advent of effective antibiotic therapy and a better understanding of
- [Inactivation of rickettsiae](#inactivation-of-rickettsiae) - Frickmann H, Dobler G. Reliable modes of inactivation were identified, allowing for the secure handling of rickettsial antigens for diagnostic purposes.
- [A giant virus infecting the amoeboflagellate <em>Naegleria</em>](#a-giant-virus-infecting-the-amoeboflagellate-naegleria) - Arthofer P, Panhölzl F, Delafont V, et al. Naeglerivirus infection was lethal to all Naegleria species tested, including the human pathogen N. fowleri. This study expands our experimental framework for investigating giant viruses and may help to better understand the basic biology of the human pathogen N. fowleri.
- [An Overview on <em>Candida auris</em> in Healthcare Settings](#an-overview-on-candida-auris-in-healthcare-settings-2) - Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E This pathogenic fungus shows an innate resilience, enabling survival and persistence in healthcare environment and the ability to rapidly colonize the patient’s skin and be easily transmitted within the healthcare setting, thus leading to a serious and prolonged outbreak.
- [Laboratory Information and Services](#laboratory-information-and-services) - The NVSL provides a wide variety of information and services, centered around diagnosis of domestic and foreign animal diseases, support of disease control and eradication programs, reagents for diagnostic testing, training, and laboratory certification.
- [Federal Order Requiring Testing for and Reporting of Highly Pathogenic Avian Influenza (HPAI) in Livestock](#federal-order-requiring-testing-for-and-reporting-of-highly-pathogenic-avian-influenza-hpai-in-livestock) - Federal Order to prevent the spread of highly pathogenic avian influenza (HPAI).
- [Antibodies to Influenza A(H5N1) Virus in Hunting Dogs Retrieving Wild Fowl, Washington, USA](#antibodies-to-influenza-ah5n1-virus-in-hunting-dogs-retrieving-wild-fowl-washington-usa) - Brown JD, Black A, Haman KH, Diel DG, Ramirez VE, Ziejka RS, et al. We detected antibodies to H5 and N1 subtype influenza A viruses in 4/194 (2%) dogs from Washington, USA, that hunted or engaged in hunt tests and training with wild birds. Historical data provided by dog owners showed seropositive dogs had high
- [Avian Influenza (Bird Flu)](#avian-influenza-bird-flu) - This page provides information about avian influenza for employers and workers.
- [Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets](#bat-borne-h9n2-influenza-virus-evades-mxa-restriction-and-exhibits-efficient-replication-and-transmission-in-ferrets) - Halwe NJ, Hamberger L, Sehl-Ewert J, et al. We show that bat H9N2 has high replication and transmission potential in ferrets, efficiently infects human lung explant cultures, and is able to evade antiviral inhibition by MxA in transgenic B6 mice. Together with its low antigenic similarity to the N2 of seasonal human strains, bat H9N2
- [Avian influenza](#avian-influenza-5) - Fact sheets are available for A(H3N8), A(H7N9), A(H5N1)
- [Avian influenza](#avian-influenza-4)
- [Avian influenza](#avian-influenza-3) - Refresh your understanding of avian influenza and its epidemiology in the United States. Review how to recognize, diagnose, and prevent the disease in various animal species. Find out how to report sick birds and other animals.
- [Highly Pathogenic Avian Influenza (HPAI)](#highly-pathogenic-avian-influenza-hpai-3) - Monitoring wild bird populations for the earliest possible detection of HPAI by conducting morbidity and mortality investigations and submitting specimens for laboratory testing. Ensuring biosecurity and biosafety on the Service-managed lands and waters to limit spread of the virus. At the request of our partners, assisting with the collection of biological samples for testing live
- [Highly Pathogenic Avian Influenza (HPAI)](#highly-pathogenic-avian-influenza-hpai-2) - Monitoring wild bird populations for the earliest possible detection of HPAI by conducting morbidity and mortality investigations and submitting specimens for laboratory testing. Ensuring biosecurity and biosafety on the Service-managed lands and waters to limit spread of the virus. At the request of our partners, assisting with the collection of biological samples for testing live
- [Avian Influenza in the Americas](#avian-influenza-in-the-americas) - The Pan American Health Organization (PAHO), has drafted a strategic and operational plan to support Member States in responding to pandemic influenza, based on WHO’s preparedness plan.
- [Bat species assemblage predicts coronavirus prevalence](#bat-species-assemblage-predicts-coronavirus-prevalence) - Meyer M, Melville DW, Baldwin HJ, et al. In line with the One Health framework, our work supports the notion that biodiversity conservation may be the most proactive measure to prevent the spread of pathogens with zoonotic potential.
- [Surveillance To Track Progress Toward Polio Eradication — Worldwide, 2022–2023](#surveillance-to-track-progress-toward-polio-eradication-worldwide-20222023)
- [WHO Guidelines on Transmissible Spongiform Encephalopathies in relation to Biological and Pharmaceutical Products](#who-guidelines-on-transmissible-spongiform-encephalopathies-in-relation-to-biological-and-pharmaceutical-products) - The purpose of this international meeting was to review the latest available data on the epidemiology, antemortem and postmortem diagnosis, detection of the infectious agents, and distribution of infectivity in tissues or body fluids of relevant species with TSEs.
- [AUTOCLAVE EMISSIONS-HAZARDOUS OR NOT](#autoclave-emissions-hazardous-or-not-2) - Hadar J, Tirosh T, et al.Early reference to inactivation of prions
- [Rapid and Highly Sensitive Detection of Variant Creutzfeldt - Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies](#rapid-and-highly-sensitive-detection-of-variant-creutzfeldt-jakob-disease-abnormal-prion-protein-on-steel-surfaces-by-protein-misfolding-cyclic-amplification-application-to-prion-decontamination-studi) - Belondrade M, et al.A current limitation for validating decontamination/sterilization of surgical instruments is the lack of a rapid model permissive to human prions. The authors developed a prion detection assay based on protein misfolding cyclic amplification (PMCA) technology combined with stainless-steel wire surfaces as carriers of prions (Surf-PMCA).
- [Review: Trends in Processing Prion-Contaminated Surgical Instruments](#review-trends-in-processing-prion-contaminated-surgical-instruments-2) - Bruna C, et al.This review sought to provide an overview of proposed methods and protocols for processing surgical instruments contaminated with prions.
- [Cleaning, disinfection and sterilization of surface prion contaminationMcDonnell, J, et. alCleaning, disinfection and sterilization of surface prion contamination](#cleaning-disinfection-and-sterilization-of-surface-prion-contamination) - McDonnell J, et al.investigate the combination of cleaning, disinfection and/or sterilization on reducing the risk of surface prion contamination.
- [Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization](#creutzfeldt-jakob-disease-recommendations-for-disinfection-and-sterilization) - Rutala W, et al.The recommendations in this article consider inactivation data but also use epidemiological studies of prion transmission, infectivity of human tissues, and efficacy of removing microbes by cleaning.
- [Classic Creutzfeldt-Jakob Disease in Canada: Quick Reference Guide 2007](#increase-in-global-and-domestic-measles-cases-and-outbreaks-ensure-children-in-the-united-states-and-those-traveling-internationally-6-months-and-older-are-current-on-mmr-vaccination-2) - This article reviews the infection control guidance relative to iatrogenic transmission of CJD.
- [Increase in Global and Domestic Measles Cases and Outbreaks: Ensure Children in the United States and Those Traveling Internationally 6 Months and Older are Current on MMR Vaccination](#increase-in-global-and-domestic-measles-cases-and-outbreaks-ensure-children-in-the-united-states-and-those-traveling-internationally-6-months-and-older-are-current-on-mmr-vaccination) - Related to 58 confirmed cases of measles in US in 2024.
- [Measles (Rubeola): Lab Tools](#measles-rubeola-lab-tools) - includes speicmen collection, storage, shipment and serology practices for measles
- [Application of the Nagoya Protocol to veterinary pathogens: concerns for the control of foot-and-mouth disease](#application-of-the-nagoya-protocol-to-veterinary-pathogens-concerns-for-the-control-of-foot-and-mouth-disease) - Horsington J, et.al.Discusses the application of the Nagoya Protocol to veterinary pathogens (concerns for the control of foot-and-mouth disease).
- [Highly Pathogenic Avian Influenza A(H5N1) Virus: Identification of Human Infection and Recommendations for Investigations and Response](#highly-pathogenic-avian-influenza-ah5n1-virus-identification-of-human-infection-and-recommendations-for-investigations-and-response) - This Health Advisory also includes a summary of interim CDC recommendations for preventing, monitoring, and conducting public health investigations of potential human infections with HPAI A(H5N1) virus.
- [1 in 5 US retail milk samples test positive for H5N1 avian flu fragments](#1-in-5-us-retail-milk-samples-test-positive-for-h5n1-avian-flu-fragments)
- [Detection of Highly Pathogenic Avian Influenza (H5N1) in Dairy Herds: Frequently Asked Questions](#detection-of-highly-pathogenic-avian-influenza-h5n1-in-dairy-herds-frequently-asked-questions) - APHIS is maintaining resources, including a list of detections in cattle to date as well as biosecurity information for farmers, veterinarians and farmworkers.
- [Updates on Highly Pathogenic Avian Influenza (HPAI)](#updates-on-highly-pathogenic-avian-influenza-hpai) - Discusses the FDA current position on pasteurization of milk and the liklihood of infectious virus being present post-pasteurization.
- [Highly Pathogenic Avian Influenza (HPAI) Detections in Livestock](#highly-pathogenic-avian-influenza-hpai-detections-in-livestock) - Covers biosecurity, handling and testing guidance for producers, veterinarians, and state animal health officials.
- [Highly Pathogenic Avian Influenza A (H5N1) Virus Infection Reported in a Person in the U.S.](#highly-pathogenic-avian-influenza-a-h5n1-virus-infection-reported-in-a-person-in-the-u-s) - Describes the case of a person who had exposure to dairy cattle in Texas presumed to be infected with HPAI A(H5N1) viruses.
- [WHO Technical Document: Global technical consultation report on proposed terminology for pathogens that transmit through the air](#who-technical-document-global-technical-consultation-report-on-proposed-terminology-for-pathogens-that-transmit-through-the-air) - International experts reach consensus on a set of descriptors to describe how pathogens are transmitted through the air and the related modes of transmission.
- [Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024](#laboratory-biosafety-guidance-related-to-sars-cov-2-covid-19-interim-guidance-11-march-2024-2-2) - Provides interim guidance on laboratory biosafety related to the SARS-CoV-2 virus to laboratories and stakeholders involved in COVID-19 laboratory work. This also includes the packaging and shipment requirements for sending specimens to WHO reference laboratories providing confirmatory and other testing for COVID-19.
- [Isolation of Batborne Neglected Zoonotic Agent Issyk-Kul Virus, Italy](#isolation-of-batborne-neglected-zoonotic-agent-issyk-kul-virus-italy) - Lelli D, Moreno A, Canziani S, et al.We isolated Issyk-Kul virus (ISKV) from a bat sampled from Italy in 2021 and conducted ISKV-specific surveillance in bats collected in Italy during 2017–2023. ISKV circulation among synanthropic and sedentary species of bat, such as Savi’s pipistrelle bat (Hypsugo savii) in northern Italy, may have public health implications
- [The importance of estimating the burden of disease from foodborne transmission of <em>Trypanosoma cruzi</em>](#he-importance-of-estimating-the-burden-of-disease-from-foodborne-transmission-of-trypanosoma-cruzi) - Robertson LJ, Havelaar AH, Keddy KH, Devleesschauwer B, Sripa B, Torgerson PRHere, we argue why this parasitic infection should be included in the new estimates of the health burden of foodborne diseases. Growing evidence indicates that foodborne transmission of T. cruzi occurs as commonly as vector-borne infection. Moreover, foodborne infection results in considerably more severe
- [Surveillance of Waterborne Disease Outbreaks Associated with Drinking Water — United States, 2015–2020](#surveillance-of-waterborne-disease-outbreaks-associated-with-drinking-water-united-states-20152020-2) - Kunz JM, Lawinger H, Miko S, et al.the report presents outbreak-contributing factors (i.e., practices and factors that lead to outbreaks) and, for the first time, categorizes outbreaks as biofilm pathogen or enteric illness associated.
- [Monitoring and Characteristics of Mpox Contacts, Virginia, USA, May–November 2022](#monitoring-and-characteristics-of-mpox-contacts-virginia-usa-maynovember-2022) - Field EN, McCarty E, Saady D, et al.During 2022, a global outbreak of mpox resulted primarily from human-to-human contact. The Virginia Department of Health (Richmond, VA, USA) implemented a contact tracing and symptom monitoring system for residents exposed to monkeypox virus, assessed their risk for infection, and offered interventions as needed.
- [Inadvertent Platelet Transfusion from Monkeypox Virus–Infected Donor to Recipient, Thailand, 2023](#inadvertent-platelet-transfusion-from-monkeypox-virusinfected-donor-to-recipient-thailand-2023-2) - Puenpa J, Intharasongkroh D, Vongpunsawad S, et al.In Thailand, platelet product from a blood donor was transfused to a recipient who had dengue. Two days later, the donor was confirmed to have monkeypox virus infection. Monkeypox virus DNA was undetectable in recipient specimens up to 2 weeks after transfusion. The recipient remained asymptomatic at 4
- [Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory](#establishment-and-application-of-a-surrogate-model-for-human-ebola-virus-disease-in-bsl-2-laboratory) - Yang W, et al. Highlights Recombinant vesicular stomatitis virus expressing Ebola virus glycoprotein is lethal in immunocompetent Syrian hamsters. The pathogenicity of VSV-EBOV/GP is species-specific, age-related, gender-associated, and challenge route-dependent. Syrian hamsters develop uveitis, multi-organ failure, and severe systemic diseases resembling symptoms of human EBOV patients. The model is available for anti-EBOV antibody and vaccine
- [Isolation of Diverse Simian Arteriviruses Causing Hemorrhagic Disease](#isolation-of-diverse-simian-arteriviruses-causing-hemorrhagic-disease) - Shaw TM, Dettle ST, Mejia A, Hayes JM, Simmons HA, Basu P, et al.Genetically diverse simian arteriviruses (simarteriviruses) naturally infect geographically and phylogenetically diverse monkeys, and cross-species transmission and emergence are of considerable concern.
- [Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021–2022](#wastewater-surveillance-for-identifying-sars-cov-2-infections-in-long-term-care-facilities-kentucky-usa-20212022) - Keck JW, Adatorwovor R, Liversedge M, et al.Persons living in long-term care facilities (LTCFs) were disproportionately affected by COVID-19. We used wastewater surveillance to detect SARS-CoV-2 infection in this setting by collecting and testing 24-hour composite wastewater samples 2–4 times weekly at 6 LTCFs in Kentucky, USA, during March 2021–February 2022.
- [Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024](#laboratory-biosafety-guidance-related-to-sars-cov-2-covid-19-interim-guidance-11-march-2024) - The latest update (11 March 2024) includes the following addition and revision: depending on the local risk assessment, less stringent risk control measures for virus isolation and propagation of currently circulating strains; biosafety aspects of waste management; detailed considerations for transportation requirements; and reference to the 4th edition Laboratory biosafety manual for GMPP (good microbiological
- [Molecular Epidemiology of Underreported Emerging Zoonotic Pathogen Streptococcus suis in Europe](#global-incidence-and-mortality-of-severe-fungal-disease-2) - Brizeula, E, et al.Streptococcus suis, a zoonotic bacterial pathogen circulated through swine, can cause severe infections in humans. Because human S. suis infections are not notifiable in most countries, incidence is underestimated.
- [Global Incidence and Mortality of Severe Fungal Disease](#global-incidence-and-mortality-of-severe-fungal-disease) - Denning DThe annual total of deaths from fungal disease worldwide has risen to 3.75 million, double the previous estimate, according to this preprint paper.
- [Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015–18: a matched cohort study and self-controlled case series](#risk-of-death-following-chikungunya-virus-disease-in-the-100-million-brazilian-cohort-201518-a-matched-cohort-study-and-self-controlled-case-series) - Cerqueira-Silva T, et alChikungunya virus disease is associated with an increased risk of death for up to 84 days after symptom onset, including deaths from cerebrovascular diseases, ischaemic heart diseases, and diabetes.
- [Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo](#case-fatality-risk-among-individuals-vaccinated-with-rvsvδg-zebov-gp-a-retrospective-cohort-analysis-of-patients-with-confirmed-ebola-virus-disease-in-the-democratic-republic-of-the-congo) - Coulborn R, et alVaccination with the Ebola vaccine significantly lowered case fatality risk vs not vaccinated.
- [Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis](#long-term-immunity-following-yellow-fever-vaccination-a-systematic-review-and-meta-analysis) - Schnyder J, et alThe gathered evidence suggests that a single dose of yellow fever vaccination provides lifelong protection in travellers.
- [West Nile virus is transmitted within mosquito populations through infectious mosquito excreta.](#west-nile-virus-is-transmitted-within-mosquito-populations-through-infectious-mosquito-excreta) - Hamel, R., et.al.This is a pre-print and has not been peer-reviewed.
- [COVID-19 Vaccine Effectiveness](#at-home-otc-covid-19-diagnostic-tests-2) - CDC says that updated (2023-2024) COVID-19 vaccines were effective against COVID-19 during September 2023 – January 2024, including against variants from the XBB lineage, which is included in the updated vaccine, and JN.1, a new variant that has become dominant in recent weeks.
- [At-Home OTC COVID-19 Diagnostic Tests](#at-home-otc-covid-19-diagnostic-tests) - Includes information on various tests, who can use, and extended expiration dating for some tests.
- [CDC updates and simplifies respiratory virus recommendations](#cdc-updates-and-simplifies-respiratory-virus-recommendations-2) - CDC released updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from a range of common respiratory viral illnesses, such as COVID-19, flu, and RSV.
- [WHO Laboratory Biosafety Manual 4th edition (LBM4)](#who-laboratory-biosafety-manual-4th-edition-lbm4) - WHO Laboratory Biosafety Manual 4th edition (LBM4) are available in all UN official languages and Vietnamese: LBM4 core doc https://iris.who.int/handle/10665/337956Risk assessment monograph https://iris.who.int/handle/10665/337966Lab design monograph https://iris.who.int/handle/10665/337960Outbreak monograph https://iris.who.int/handle/10665/337959Biosafety programme management monograph https://iris.who.int/handle/10665/337963Biosafety cabinets monograph https://iris.who.int/handle/10665/337957Decontamination monograph https://iris.who.int/handle/10665/374887PPE monograph https://iris.who.int/handle/10665/337961
- [Serve Your Community: Consider Volunteering for a Local Institutional Biosafety Committee (IBC)](#serve-your-community-consider-volunteering-for-a-local-institutional-biosafety-committee-ibc)
- [June 2021 ZOHU Call](#june-2021-zohu-call) - On-demand recording: Alaskapox Virus: An Emerging Animal-to-Human Infectious Disease?
- [Genome of Alaskapox Virus, a Novel Orthopoxvirus Isolated from Alaska](#genome-of-alaskapox-virus-a-novel-orthopoxvirus-isolated-from-alaska-2) - Gigante CM, Gao J, Tang S, McCollum AM, Wilkins K, Reynolds MG, Davidson W, McLaughlin J, Olson VA, Li Y.also provides background information on Orthopoxviruses
- [Comparative Pathology of Zoonotic Orthopoxviruses](#genome-of-alaskapox-virus-a-novel-orthopoxvirus-isolated-from-alaska) - MacNeill ALThis review provides a brief history of the impacts that a human-specific Orthopoxvirus (OPXV), Variola virus, had on mankind, recalls how critical vaccination was for the eradication of this disease, and discusses the consequences of discontinuing vaccination against OPXV.
- [Alaska reports fatal Alaskapox case](#alaska-reports-fatal-alaskapox-case) - additional details about the most recent infection are given
- [Fatal Alaskapox Infection in a Southcentral Alaska Resident](#fatal-alaskapox-infection-in-a-southcentral-alaska-resident) - This Bulletin describes a recently reported fatal case of Alaskapox in an immunosuppressed resident of the Kenai Peninsula.
- [Frequently asked questions about Alaskapox virus](#frequently-asked-questions-about-alaskapox-virus)
- [Alaskapox virus](#alaskapox-virus) - background information and references on Alaskapox
- [CDC Guidelines for the Prevention and Treatment of Anthrax, 2023](#cdc-guidelines-for-the-prevention-and-treatment-of-anthrax-2023)
- [National Prion Disease Pathology Surveillance Center](#national-prion-disease-pathology-surveillance-center) - The National Prion Disease Pathology Surveillance Center (NPDPSC) is the only Center of its kind in the U.S. We coordinate autopsies and neuropathologic examinations of suspected prion disease cases from across the country. Local autopsies are performed on-site, and other cases are performed elsewhere through a network of providers that the Center coordinates.
- [Occurance](#occurance) - CWD Case Distribution to date
- [Chronic Wasting Disease](#chronic-wasting-disease) - The CWD set of pages is a special project under CIDRAP. It contains information about latest cases reported in the US and FAQs
- [Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination](#biosafety-considerations-for-attenuated-measles-virus-vectors-used-in-virotherapy-and-vaccination) - Baldo A, Galanis E, Tangy F, Herman P.The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these
- [Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome](#manual-for-the-laboratory-based-surveillance-of-measles-rubella-and-congenital-rubella-syndrome) - Chapter 3- Includes Safety procedures for incoming clinical samples.Third edition, June 2018
- [Mumps](#mumps) - Epidemiology and Prevention of Vaccine-Preventable Diseases
- [Measles](#measles) - Epidemiology and Prevention of Vaccine-Preventable Diseases
- [Preparing for another Ebola Outbreak: The impact of viral inactivation methods on commonly measured biochemistry analytes in plasma and urine](#preparing-for-another-ebola-outbreak-the-impact-of-viral-inactivation-methods-on-commonly-measured-biochemistry-analytes-in-plasma-and-urine) - Zhou J, et al.Infectious specimens containing viruses like Ebola require sample manipulation to ensure the safety of laboratory staff, which may negatively impact biochemistry test results. We evaluated the impact of viral inactivation methods on 25 biochemistry analytes in plasma, and seven biochemistry analytes in urine.
- [Historical trends demonstrate a pattern of increasingly frequent and severe spillover events of high-consequence zoonotic viruses](#evidence-of-the-zoonotic-transmission-of-emcryptosporidium-em-among-children-and-pets-2) - Meadows AJ, Stephenson N, Madhav NK, et al
- [Evidence of the Zoonotic Transmission of <em>Cryptosporidium</em> among Children and Pets](#evidence-of-the-zoonotic-transmission-of-emcryptosporidium-em-among-children-and-pets) - Coelho NMD, Coelho WMD, Gomes JF, Meireles MV, Nagata WB, de Lima VMF, Santos-Doni TR, Silva VB, da Silveira Neto L, Nakamura AA, et al.Fecal samples were examined using ELISA and confirmed via nested PCR. Coproantigens oocysts were detected in 3.7% of children, 8.3% of dogs, and 5.5% of cats.
- [Leishmaniasis, Cutaneous](#leishmaniasis-cutaneous)
- [Pathogen Safety Data Sheets: Infectious Substances – Leishmania spp.](#leishmaniasis-1)
- [Leishmaniasis](#leishmaniasis)
- [Leishmaniasis: Prevention & Control](#leishmaniasis-prevention-control)
- [Parasite Detection in Visceral Leishmaniasis Samples by Dye-Based qPCR Using New Gene Targets of Leishmania infantum and Crithidia](#parasite-detection-in-visceral-leishmaniasis-samples-by-dye-based-qpcr-using-new-gene-targets-of-leishmania-infantum-and-crithidia) - Takamiya NT, Rogerio LA, Torres C, Leonel JAF, Vioti G, de Sousa Oliveira TMF, Valeriano KC, Porcino GN, de Miranda Santos IKF, Costa CHN, et al.The PCR assay developed here differentiates Leishmania infantum and Crithidia sp. LVH60A parasites with the ability to detect and estimate parasite load in samples from different hosts involved in infection
- [About Valley Fever (Coccidioidomycosis)](#about-valley-fever-coccidioidomycosis)
- [US Department of Agriculture (USDA) Strategy to Address Antimicrobial Resistance 2023](#us-department-of-agriculture-usda-strategy-to-address-antimicrobial-resistance-2023) - The purpose of this Strategy is to serve as a guide to USDA agencies and their collaborators on priorities to accelerate our understanding of and minimize the risk from AMR, focusing on the terrestrial and aquatic food and agriculture sector.
- [Multi-country outbreak of mpox, External situation report#31 – 22 December 2023](#multi-country-outbreak-of-mpox-external-situation-report31-22-december-2023) - A monthly update on Mpox infections provides details on the latest epidemiology and focus on a cruise ship outbreak. Excellent Bibliography on Mpox.
- [The WHO AWaRe (Access, Watch, Reserve) antibiotic book](#the-who-aware-access-watch-reserve-antibiotic-book) - The WHO AWaRe (Access, Watch, Reserve) antibiotic book provides information on antibiotis, dose, route of administration, and duration of treatment for more than 30 of the most common clinical infections in children and adults.
- [Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023](#use-of-inactivated-polio-vaccine-among-u-s-adults-updated-recommendations-of-the-advisory-committee-on-immunization-practices-united-states-2023) - Kidd S, Clark T, Routh J, Cineas S, Bahta L, Brooks ONew recommendations include that adults aged ≥18 years who are known or suspected to be unvaccinated or incompletely vaccinated against polio should complete a primary polio vaccination series with IPV.
- [Mpox Caused by Human-to-Human Transmission of Monkeypox Virus with Geographic Spread in the Democratic Republic of the Congo](#mpox-caused-by-human-to-human-transmission-of-monkeypox-virus-with-geographic-spread-in-the-democratic-republic-of-the-congo) - This notice is to notify clinicians and health departments about the occurrence, geographic spread, and sexually associated human-to-human transmission of Clade I Monkeypox virus (MPXV) in the Democratic Republic of the Congo.
- [12/11/2023: Lab Advisory: Clinical Testing Guidance for Patients with Suspected Viral Hemorrhagic Fevers](#12-11-2023-lab-advisory-clinical-testing-guidance-for-patients-with-suspected-viral-hemorrhagic-fevers) - While the risk of VHFs being brought into the US by travelers is very low, CDC recommends that clinical laboratories review the testing guidance in this article for ebolaviruses, marburgviruses, Crimean-Congo hemorrhagic fever virus, arenaviruses (Lassa, Lugo, and South American hemorrhagic fever viruses), and Nipah virus.
- [FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus](#fda-approves-first-vaccine-to-prevent-disease-caused-by-chikungunya-virus) - From FDA's Release: Ixchiq is administered as a single dose by injection into the muscle. It contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.
- [IXCHIQ](#ixchiq) - Vaccine Information
- [Pathogen Safety Data Sheets: Infectious Substances – Chikungunya virus](#chikungunya-cdc-yellow-book-2024-2) - Reference document on Chikungunya Virus
- [Chikungunya: CDC Yellow Book 2024](#chikungunya-cdc-yellow-book-2024) - This chapter includes information on the agent, transmission, diagnosis, treatment, prevention, epidemiology
- [Urgent Need to Increase Immunization Coverage for Influenza, COVID-19, and RSV and Use of Authorized/Approved Therapeutics in the Setting of Increased Respiratory Disease Activity During the 2023 – 2024 Winter Season](#urgent-need-to-increase-immunization-coverage-for-influenza-covid-19-and-rsv-and-use-of-authorized-approved-therapeutics-in-the-setting-of-increased-respiratory-disease-activity-during-the-2023-2024-w)
- [Protect yourself and others from Flu, COVID-19, and RSV](#protect-yourself-and-others-from-flu-covid-19-and-rsv) - CDC’s new page has county-level information on how Flu, COVID-19 and RSV viruses are trending in your area, and other useful info.
- [SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals](#sars-cov-2-rebound-with-and-without-use-of-covid-19-oral-antivirals) - Smith DJ, Lambrou A, Patel PAfter anti-viral treatment, no consistent association between treatment and rebound was identified.
- [Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research](#remission-of-severe-forms-of-long-covid-following-monoclonal-antibody-mca-infusions-a-report-of-signal-index-cases-and-call-for-targeted-research) - Scheppke KA, Pepe PE, et al.Three individuals with long Covid experienced full remission within a week after monoclonal antibody infusion.
- [National Wastewater Surveillance System (NWSS)](#national-wastewater-surveillance-system-nwss-2) - CDC’s National Wastewater Surveillance System (NWSS) program collects and displays wastewater data from communities across the United States.
- [Long COVID: New Info on Who Is Most Likely to Get It](#long-covid-new-info-on-who-is-most-likely-to-get-it) - People with a history of allergies, anxiety or depression, arthritis, and autoimmune diseases and women are among those who appear more vulnerable to developing long COVID, said doctors who specialize in treating the condition.
- [Isolation and Precautions for People with COVID-19](#isolation-and-precautions-for-people-with-covid-19) - From CDC: A tool to help you determine if you need to isolate or take other steps to prevent spreading COVID-19.
- [Considerations for Handling Potential SARS-CoV-2 Samples](#considerations-for-handling-potential-sars-cov-2-samples) - Available in [English revised] [Spanish] [French revised]Urdu translation upon request to ABSA Office
- [Lyme Disease](#lyme-disease) - Lyme disease is the most common vector-borne disease in the United States. Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks.
- [Brucellosis](#brucellosis) - Brucellosis is an infectious disease caused by bacteria. People can get the disease when they are in contact with infected animals or animal products contaminated with the bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others.
- [Rabies](#rabies) - Rabies is a fatal but preventable viral disease. It can spread to people and pets if they are bitten or scratched by a rabid animal. In the United States, rabies is mostly found in wild animals like bats, raccoons, skunks, and foxes. However, in many other countries dogs still carry rabies, and most rabies deaths
- [Emerging coronaviruses: Genome structure, replication, and pathogenesis](#emerging-coronaviruses-genome-structure-replication-and-pathogenesis) - Chen Y, Liu Q, Guo D
- [Severe Acute Respiratory Syndrome (SARS)](#severe-acute-respiratory-syndrome-sars-2) - Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus called SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in February 2003. The illness spread to more than two dozen countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained.
- [Middle East Respiratory Syndrome (MERS)](#middle-east-respiratory-syndrome-mers) - Middle East Respiratory Syndrome (MERS) is viral respiratory illness that is new to humans. It was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including the United States. Most people infected with MERS-CoV developed severe respiratory illness, including fever, cough, and shortness of breath. Many of them have
- [Severe Acute Respiratory Syndrome (SARS)](#severe-acute-respiratory-syndrome-sars) - Severe acute respiratory syndrome (SARS) is a viral respiratory disease caused by a SARS-associated coronavirus. It was first identified at the end of February 2003 during an outbreak that emerged in China and spread to 4 other countries. WHO co-ordinated the international investigation with the assistance of the Global Outbreak Alert and Response Network (GOARN)
- [Plague](#plague) - Plague is a disease that affects humans and other mammals. It is caused by the bacterium, Yersinia pestis. Humans usually get plague after being bitten by a rodent flea that is carrying the plague bacterium or by handling an animal infected with plague.
- [West Nile Virus](#salmonella-2) - West Nile virus (WNV) is the leading cause of mosquito-borne disease in the continental United States. It is most commonly spread to people by the bite of an infected mosquito. Cases of WNV occur during mosquito season, which starts in the summer and continues through fall. There are no vaccines to prevent or medications to
- [Salmonella](#salmonella) - CDC estimates Salmonella bacteria cause about 1.35 million infections, 26,500 hospitalizations, and 420 deaths in the United States every year. Food is the source for most of these illnesses.
- [Influenza in Animals](#influenza-in-animals)
- [WAHIS: World Animal Health Information System](#wahis-world-animal-health-information-system) - WAHIS is the global animal health reference database of the World Organisation for Animal Health (WOAH). WAHIS data reflects the validated information since 2005 reported by the Veterinary Services from Member and non-Member Countries and Territories on terrestrial and aquatic Listed diseases in domestic animals and wildlife, as well as on emerging diseases and zoonoses.
- [The European Union One Health 2021 Zoonoses Report](#animal-diseases-2) - This report of the European Food Safety Authority and the European Centre for Disease Prevention and Control presents the results of zoonoses monitoring and surveillance activities carried out in 2021 in 27 MSs, the United Kingdom (Northern Ireland) and nine non-MSs.
- [Animal Diseases](#animal-diseases) - This portal gives easy access to resources and information on both terrestrial and aquatic animal diseases.
- [US Outbreaks of Zoonotic Diseases Spread between Animals & People](#us-outbreaks-of-zoonotic-diseases-spread-between-animals-amp-people)
- [Prioritizing Zoonotic Diseases for Multisectoral, One Health Collaboration in the United States](#prioritizing-zoonotic-diseases-for-multisectoral-one-health-collaboration-in-the-united-states) - The U.S. Centers for Disease Control and Prevention (CDC), the U.S. Department of Agriculture (USDA), and the U.S. Department of the Interior (DOI) organized a One Health Zoonotic Disease Prioritization (OHZDP) workshop to further joint efforts to address zoonotic disease challenges in the United States. The workshop was held December 5-7, 2017, at the Department
- [Zoonotic Disease Fact Sheet](#zoonotic-disease-fact-sheet)
- [Pathogen Safety Data Sheets](#pathogen-safety-data-sheets) - Pathogen Safety Data Sheets (PSDSs) are technical documents used by individuals working with pathogens in the laboratory.
- [Study identifies six drugs that can be repurposed for treatment of toxoplasmosis](#study-identifies-six-drugs-that-can-be-repurposed-for-treatment-of-toxoplasmosis) - A group in Brazil screend 160 compounds belonging to the COVID Box, a library of compounds developed by Medicines for Malaria Venture (MMV) to combat SARS-CoV-2.
- [Half a million children die of malaria every year. Finally we can change that](#half-a-million-children-die-of-malaria-every-year-finally-we-can-change-that) - Advisors to the WHO recently recommended a second malaria vaccine.
- [A Candida auris–specific adhesin, Scf1, governs surface association, colonization, and virulence](#a-candida-aurisspecific-adhesin-scf1-governs-surface-association-colonization-and-virulence) - Santana DJ, et al.C. auris has a specific and dominant adhesin called Surface Colonization Factor (SCF1), which adheres by cation-dependent interactions to a wide range of biotic and abiotic surfaces.
- [France kicks off bird flu vaccination despite trade backlash risk](#france-kicks-off-bird-flu-vaccination-despite-trade-backlash-risk) - France began vaccinating ducks against bird flu in October to try and stem the virus that killed millions of birds worldwide, a move that prompted the United States to impose trade restrictions on French poultry imports.
- [Influenza is on the rise; how do I prevent it?](#influenza-is-on-the-rise-how-do-i-prevent-it)
- [Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests](#rapid-bedside-inactivation-of-ebola-virus-for-safe-nucleic-acid-tests) - Methods for inactivating EBOV
- [Guidance for Working with Human Specimens](#guidance-for-working-with-human-specimens) - Work with all human specimens must be conducted according to the appropriate containment and work practices.
- [Marburg Virus Disease Detected in West Africa for First Time](#marburg-virus-disease-detected-in-west-africa-for-first-time) - The finding of the Ebola-like disease, which killed a man in Guinea, has prompted public health measures.
- [Ivory Coast detects first Ebola case in 25 years](#ivory-coast-detects-first-ebola-case-in-25-years)
- [Human infection with avian influenza A(H10N3) – China](#a-man-in-china-is-found-to-have-h10n3-bird-flu-a-reminder-of-a-continued-concern-for-pandemic-flu-2)
- [A man in China is found to have H10N3 bird flu, a reminder of a continued ‘concern for pandemic flu.’](#a-man-in-china-is-found-to-have-h10n3-bird-flu-a-reminder-of-a-continued-concern-for-pandemic-flu)
- [Case Series of Laboratory-Associated Zika Virus Disease, United States, 2016–2019](#case-series-of-laboratory-associated-zika-virus-disease-united-states-2016-2019-2) - Hills SL, et al.We report 4 cases of laboratory-associated Zika virus disease in the United States during 2016–2019.
- [Risk Assessment Questions for Working with Human Blood:<br>A Year into the COVID Pandemic](#risk-assessment-questions-for-working-with-human-blooda-year-into-the-covid-pandemic-2) - This document provides the questions that should be addressed in order to determine what biosafety mitigation strategies need to be used when handling and processing unfixed human blood during the pandemic. The issues addressed should be included in the IBC protocol narrative. The final determination of handling requirements must be made in consultation with the
- [Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020](#use-of-ebola-vaccine-recommendations-of-the-advisory-committee-on-immunization-practices-united-states-2020) - Choi MJ, Cossaboom CM, Whitesell AN, et al.
- [SARS-CoV-2 Infection in Healthcare Personnel With High-risk Occupational Exposure: Evaluation of 7-Day Exclusion From Work Policy](#sars-cov-2-infection-in-healthcare-personnel-with-high-risk-occupational-exposure-evaluation-of-7-day-exclusion-from-work-policy) - Maltezou HC, Dedoukou X, Tseroni M, Tsonou P, Raftopoulos V, Papadima K, Mouratidou E, Poufta S, Panagiotakopoulos G, Hatzigeorgiou D, Sipsas NWe prospectively studied 3398 occupationally exposed HCP in Greece.
- [Marburg virus disease: A summary for clinicians](#marburg-virus-disease-a-summary-for-clinicians) - Kortepeter, M, et.al.
- [CDC Takes Action to Prepare Against “G4” Swine Flu Viruses in China with Pandemic Potential](#cdc-takes-action-to-prepare-against-g4-swine-flu-viruses-in-china-with-pandemic-potential-2)
- [Swine flu strain with human pandemic potential increasingly found in pigs in China](#swine-flu-strain-with-human-pandemic-potential-increasingly-found-in-pigs-in-china) - Commentary on the PNAS paper
- [World’s second-deadliest Ebola outbreak ends in Democratic Republic of the Congo](#worlds-second-deadliest-ebola-outbreak-ends-in-democratic-republic-of-the-congo) - Highlights official end of outbreak in the DRC, as another outreak emerges. Vaccines and new drugs were successfully used in this oubreak.
- [Candidaemia Mortality Has not Changed Over the Last 2 Decades in Brazil](#candidaemia-mortality-has-not-changed-over-the-last-2-decades-in-brazil) - Dalla Lana DF, Falci DR, Sanha V, Jaskulski Filho SD, Schuch F, Pasqualotto ACFull article available for a cost; summary: https://agencia.fapesp.br/mortality-rate-from-icandida-i-infections-remains-high-in-brazil-despite-therapeutic-advances/41849/
- [Influenza A Virus in Swine Surveillance Information](#influenza-a-virus-in-swine-surveillance-information-2-2) - Sun et. al, subscription needed Genetics
- [The Culture of Biosafety, Biosecurity, and Responsible Conduct in the Life Sciences: A Comprehensive Literature Review](#the-culture-of-biosafety-biosecurity-and-responsible-conduct-in-the-life-sciences-a-comprehensive-literature-review) - Perkins D, et.al
- [Modes of Transmission of Zika Virus](#modes-of-transmission-of-zika-virus) - Gregory CJ, Oduyebo T, et al.
- [Zika Virus (ZIKV), German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’](#a-literature-review-of-zika-virus-2) - Seitz R, et al.
- [A Literature Review of Zika Virus](#a-literature-review-of-zika-virus) - Plourde AR, Bloch EM
- [The history of zika virus](#the-history-of-zika-virus)
- [World Health Organization Guidelines for Containment of Poliovirus Following Type-Specific Polio Eradication — Worldwide, 2015](#world-health-organization-guidelines-for-containment-of-poliovirus-following-type-specific-polio-eradication-worldwide-2015) - Previsani N, et al.
- [Polio vaccination: past, present and future](#polio-vaccination-past-present-and-future) - A useful overview of the polio eradication strategy in 2015.
- [Ebola: Pushed to the limit and beyond](#ebola-pushed-to-the-limit-and-beyond)
- [Transmission of Ebola Viruses: What We Know and What We Do Not Know](#transmission-of-ebola-viruses-what-we-know-and-what-we-do-not-know) - Osterholm MT, et al.
- [A Brilliantly Designed Hazmat Suit for Ebola Workers](#ebola-pushed-to-the-limit-and-beyond-2) - A skunkworks team at Johns Hopkins University has developed a prototype protective suit to better shield healthcare workers on the frontlines.
- [Ebola 2014: Clarifying the Confusion—A Public Health and Laboratory Containment Perspective](#ebola-2014-clarifying-the-confusion-a-public-health-and-laboratory-containment-perspective) - Channing D. Sheets and Patricia L. PayneVOLUME 19, NUMBER 3, 2014
- [Update – Swine-origin triple reassortant influenza A(H3N2) variant viruses in North America](#update-swine-origin-triple-reassortant-influenza-ah3n2-variant-viruses-in-north-america)
- [Capsule—Reduction of Sharp Injuries, Early Warning System for Medical Examiners, Ebola-Vaccine Development and Tips for Lab Workers Planning to Work in Low-Resource Countries](#capsule-reduction-of-sharp-injuries-early-warning-system-for-medical-examiners-ebola-vaccine-development-and-tips-for-lab-workers-planning-to-work-in-low-resource-countries) - Felix K. GmuenderVOLUME 16, NUMBER 1, 2011
- [Proposed Framework for the Oversight of Dual Use Life Sciences Research: Strategies for Minimizing the Potential Misuse of Research Information](#proposed-framework-for-the-oversight-of-dual-use-life-sciences-research-strategies-for-minimizing-the-potential-misuse-of-research-information)
- [Biorisk management: Laboratory biosecurity guidance](#biorisk-management-laboratory-biosecurity-guidance-2)
- [Book Review—Viral Haemorrhagic Fevers-Perspectives in Medical Virology (Volume 11) by Colin R. Howard](#book-review-viral-haemorrhagic-fevers-perspectives-in-medical-virology-volume-11-by-colin-r-howard-2) - Jens H. KuhnVOLUME 11, NUMBER 2, 2006
- [Crisis and Emergency Risk Communication](#crisis-and-emergency-risk-communication) - Barbara ReynoldsVOLUME 10, NUMBER 1, 2005
- [Book Review—Ebola and Marburg Viruses — Molecular and Cellular Biology Edited by Hans-Dieter Klenk and Heinz Feldmann](#book-review-viral-haemorrhagic-fevers-perspectives-in-medical-virology-volume-11-by-colin-r-howard) - Jens H. KuhnVOLUME 10, NUMBER 1, 2005
- [Issues Affecting Respirator Selection for Workers Exposed to Infectious Aerosols: Emphasis on Healthcare Settings](#issues-affecting-respirator-selection-for-workers-exposed-to-infectious-aerosols-emphasis-on-healthcare-settings) - Steven W. Lenhart, Teresa Seitz, Douglas Trout, and Nancy BollingerVOLUME 9, NUMBER 1, 2004
- [Book Review—Ebola and Marburg Viruses: A View of Infection Using Electron Microscopy by E. I. Ryabchikova and B. B. Price](#book-review-ebola-and-marburg-viruses-a-view-of-infection-using-electron-microscopy-by-e-i-ryabchikova-and-b-b-price) - Jens H. KuhnVOLUME 9, NUMBER 1, 2004
- [Biosecurity Central](#biosecurity-central) - Biosecurity Central is a publicly available web-based library that helps users find relevant and reliable sources of information for key areas of biosecurity. It includes guidelines, policies, legislaation, protocols, & training materials for worldwide agencies.
- [What’s the research progress of mRNA vaccines for infectious diseases?](#whats-the-research-progress-of-mrna-vaccines-for-infectious-diseases)
- [Flu vs. COVID-19: How the 2 Illnesses Compare, According to Experts](#flu-vs-covid-19-how-the-2-illnesses-compare-according-to-experts)
- [Sabin Vaccine Institute Receives Additional $34.5 Million from BARDA for Further Development of Ebola Sudan and Marburg Vaccines](#sabin-vaccine-institute-receives-additional-34-5-million-from-barda-for-further-development-of-ebola-sudan-and-marburg-vaccines)
- [COVID-19 pandemic drove flu to historic lows, and may have eliminated one virus type completely](#covid-19-pandemic-drove-flu-to-historic-lows-and-may-have-eliminated-one-virus-type-completely)
- [Ebola vaccine regimen safe and effective for children and adults](#ebola-vaccine-regimen-safe-and-effective-for-children-and-adults)
- [VirusMED Atlas Centralizes Atomic Structures of Virus Strains](#virusmed-atlas-centralizes-atomic-structures-of-virus-strains)
- [Zika Virus Disease – India](#zika-virus-disease-india) - On 8 July 2021, a Zika virus (ZIKV) infection was laboratory-confirmed in a resident of Kerala state, south-west India.
- [Fears that Ebola 'lurks under the radar' of immune system as new cases linked to past outbreak](#fears-that-ebola-lurks-under-the-radar-of-immune-system-as-new-cases-linked-to-past-outbreak) - Findings are 'really weird' and show deadly disease can persist in survivors longer than thought
- [Antibiotic-Resistant Biofilm Survives Silver Bullet](#antibiotic-resistant-biofilm-survives-silver-bullet)
- [Mechanism of Zika neurological complications revealed](#proceedings-of-the-national-academy-of-sciences-pnas-a-mutation-mediated-evolutionary-adaptation-of-zika-virus-in-mosquito-and-mammalian-host-2)
- [Johnson & Johnson’s two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response](#johnson-johnsons-two-dose-ebola-vaccine-regimen-is-safe-well-tolerated-and-produces-a-strong-immune-response) - Malenfant JH, Joyce A, Choi MJ, et al.The ACIP has expanded the recommendation for Ebola vaccine to health care personnel at special pathogens treatment centers and laboratorians and support staff members at Laboratory Response Network facilities.
- [Study highlights impact of antibiotic resistance on older Americans](#study-highlights-impact-of-antibiotic-resistance-on-older-americans)
- [Proceedings of the National Academy of Sciences (PNAS): A mutation-mediated evolutionary adaptation of Zika virus in mosquito and mammalian host](#proceedings-of-the-national-academy-of-sciences-pnas-a-mutation-mediated-evolutionary-adaptation-of-zika-virus-in-mosquito-and-mammalian-host) - Yu X, et al.
- [Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term](#modes-of-transmission-of-zika-virus-2) - Katzelnick LC, Zambrana JV, et al.
- [Monkeypox cases are rising–here is what we know so far](#monkeypox-cases-are-risinghere-is-what-we-know-so-far)
- [Rapid Risk Assessment: Monkeypox multi-country outbreak](#rapid-risk-assessment-monkeypox-multi-country-outbreak) - Timeline of the Monkeypox outbreak in Europe
- [Laboratory testing for the monkeypox virus](#laboratory-testing-for-the-monkeypox-virus-2) - This interim guide includes PPE, disinfection, shipping practices
- [Bird Flu Current Situation Summary](#u-s-case-of-human-avian-influenza-ah5-virus-reported-2) - includes status updates on wild birds, poultry flocks and human infections.
- [U.S. Case of Human Avian Influenza A(H5) Virus Reported](#u-s-case-of-human-avian-influenza-ah5-virus-reported)
- [Pathogenicity and virulence of Marburg virus](#pathogenicity-and-virulence-of-marburg-virus) - Abir, M, et.al.
- [A(H7N9) - Northern Hemisphere 2022-2023](#ah7n9-northern-hemisphere-2022-2023influenza-2) - Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses and potency testing reagents
- [Changes in skin wrinkles and pores due to long-term mask wear](#changes-in-skin-wrinkles-and-pores-due-to-long-term-mask-wear) - Park, M et.al.This study investigated changes in skin wrinkles and pores caused by long-term mask wear and whether or not use of moisturizers has an effect on any changes.
- [Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021](#use-of-ebola-vaccine-expansion-of-recommendations-of-the-advisory-committee-on-immunization-practices-to-include-two-additional-populations-united-states-2021) - Malenfant JH, Joyce A, Choi MJ, et al.The ACIP has expanded the recommendation for Ebola vaccine to health care personnel at special pathogens treatment centers and laboratorians and support staff members at Laboratory Response Network facilities.
- [Citizen Science Surveillance of Triazole-Resistant Aspergillus fumigatus in United Kingdom Residential Garden Soils](#citizen-science-surveillance-of-triazole-resistant-aspergillus-fumigatus-in-united-kingdom-residential-garden-soils) - Shelton JMG, et al.Composting may be a potential health risk among individuals predisposed to pulmonary infections caused by Asperigillus fumigatus (pulmonary aspergillosis), as well as immunocompetent individuals with increased exposure to A fumigatus fungal spores.
- [Highly Pathogenic Avian Influenza in a Non-commercial Backyard Flock In New York State](#highly-pathogenic-avian-influenza-in-a-non-commercial-backyard-flock-in-new-york-state)
- [Avian Flu Cases Raise Concern](#avian-flu-cases-raise-concern)
- [Recent Bird Flu Infections in U.S. Wild Birds and Poultry Pose a Low Risk to the Public](#recent-bird-flu-infections-in-u-s-wild-birds-and-poultry-pose-a-low-risk-to-the-public)
- [Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors](#what-is-ebola-virus-disease-2) - Liu J, et. al
- [Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets](#efficacy-of-an-inactivated-zika-vaccine-against-virus-infection-during-pregnancy-in-mice-and-marmosets) - In-Jeong K, et.al.A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal studies.
- [HPAI H5: outbreak assessment](#hpai-h5-outbreak-assessment) - DEFRA Outbreak Assessment 11, Ref: VITT/1200 HPAI in the UK and Europe (conclusion chapter, abridged, edited)
- [Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel](#occupational-exposure-to-severe-acute-respiratory-coronavirus-virus-2-sars-cov-2-and-risk-of-infection-among-healthcare-personnel) - Shah VP, Breeher LE, Alleckson JM, Rivers DG, Wang Z, Stratton ER, Farah W, Hainy CM, Swift MD
- [European Biosecurity Regulation Forum Guidelines for the implementation of Action B2](#european-biosecurity-regulation-forum-guidelines-for-the-implementation-of-action-b2)
- [Culture of Biosafety, Biosecurity, and Responsible Conduct in the Life Sciences: (Self) Assessment Framework](#culture-of-biosafety-biosecurity-and-responsible-conduct-in-the-life-sciences-self-assessment-framework-2)
- [Biosecurity Law & Policy](#biosecurity-law-policy) - The Law & Policy section will give you a clear understanding of the many laws, regulations, policies, and guidance documents that exist around Biorisk Management.
- [Laboratory Biosafety and Biosecurity Risk Assessment Technical Guidance Document](#laboratory-biosafety-and-biosecurity-risk-assessment-technical-guidance-document) - Includes biosecurity risk assessment considerations
- [Antimicrobial Resistance Information from FDA](#antimicrobial-resistance-information-from-fda) - Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. The FDA is dedicated to addressing the challenges AMR presents by helping to preserve the effectiveness of currently available antimicrobial drugs and promoting the development of new medical products
- [Highly Pathogenic Avian Influenza (HPAI)](#highly-pathogenic-avian-influenza-hpai) - Includes the most recent report for confirmed HPAI Findings in Wild Birds. It also includes resources for emergency response.
- [Avian Influenza: Virus Persistence](#avian-influenza-virus-persistence) - In general, moisture and temperature are the two main determinants of viral persistence. At temperatures of 17 to 25 ºC most AI viruses will not survive longer than a few days, even under moist conditions. In general, higher humidity and cooler temperatures permit virus survival in moist substrates over longer periods of time (DEFRA, 2017)
- [Monkeypox: Updates on Testing, Vaccination & Treatment](#monkeypox-updates-on-testing-vaccination-treatment) - Webinar
- [Monkeypox, wild animals, and potential big problem](#monkeypox-wild-animals-and-potential-big-problem-2)
- [Clinical and virological features of first human monkeypox cases in Germany](#clinical-and-virological-features-of-first-human-monkeypox-cases-in-germany) - Noe S, Zange S, et al.
- [Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2](#monkeypox-genomic-surveillance-will-challenge-lessons-learned-from-sars-cov-2-2) - Pfaff F, Hofmann D, Beer M.Circulating monkeypox virus might be undergoing adaption for the human host, so we must keep its genetic changes under tight surveillance so as to be prepared when sudden epidemiological changes and prevent the emergence of a variola virus epigone.
- [FACT SHEET: Biden-⁠Harris Administration’s Monkeypox Outbreak Response](#fact-sheet-biden-harris-administrations-monkeypox-outbreak-response)
- [Monkeypox may have undergone 'accelerated evolution,' scientists say](#monkeypox-may-have-undergone-accelerated-evolution-scientists-say) - The monkeypox virus has mutated at a far faster rate than would normally be expected and likely underwent a period of "accelerated evolution,"a new study suggests.
- [Penicillin Allergy](#penicillin-allergy) - Patterson, R. et.al.Identification of true penicillin allergy is critical as 80% to 90% of people once considered allergic are ultimately able to tolerate penicillins resulting in the decreased need for broad-spectrum antibiotics and development of multi-drug resistant organisms.
- [HHS Expanding Monkeypox Testing Capacity to Five Commercial Laboratory Companies](#hhs-expanding-monkeypox-testing-capacity-to-five-commercial-laboratory-companies)
- [Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 1 2020–June 2021](#reported-exposures-among-in-person-workers-with-sars-cov-2-infection-in-6-states-september-1-2020june-2021) - Free H, Luckhaupt SE, et al.Workers in protective service occupations (48.8%) and public administration industries (35.6%) reported exposure at work most often
- [Health Alert Network: Updated Case-finding Guidance: Monkeypox Outbreak—United States, 2022](#health-alert-network-updated-case-finding-guidance-monkeypox-outbreakunited-states-2022)
- [Test Procedure: Monkeypox virus Generic Real-Time PCR Test](#test-procedure-monkeypox-virus-generic-real-time-pcr-test-2)
- [Monkeypox Outbreak — Nine States, May 2022](#monkeypox-outbreak-nine-states-may-2022-2) - Minhaj FS, Ogale YP, Whitehill F, et al.
- [Influenza A(H3N2) Outbreak on a University Campus — Michigan, October–November 2021](#influenza-ah3n2-outbreak-on-a-university-campus-michigan-octobernovember-2021) - Delahoy MJ, Mortenson L, Bauman L, et al.
- [Global influenza virological surveillance](#global-influenza-virological-surveillance) - Data collected through global and regional data sharing platforms
- [Flu Symptoms & Diagnosis](#flu-symptoms-diagnosis)
- [Virus Persistence](#virus-persistence)
- [The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus](#the-virucidal-effects-of-405-nm-visible-light-on-sars-cov-2-and-influenza-a-virus) - Rathnasinghe R, Jangra S, Miorin L, et al.
- [Prevent Seasonal Flu](#prevent-seasonal-flu)
- [A revision of the system of nomenclature for influenza viruses: a WHO Memorandum](#a-revision-of-the-system-of-nomenclature-for-influenza-viruses-a-who-memorandum) - Bulletin of the World Health Organization, 58 (4): 585-591 (1980)
- [Types of Influenza Viruses](#types-of-influenza-viruses)
- [Influenza (Flu)](#influenza-flu)
- [Pathogen Safety Data Sheets: Infectious Substances – Monkeypox virus](#pathogen-safety-data-sheets-infectious-substances-monkeypox-virus)
- [Information For Veterinarians](#information-for-veterinarians) - Includes information for public health veterinarians and animal health officials
- [Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022](#use-of-jynneos-smallpox-and-monkeypox-vaccine-live-nonreplicating-for-preexposure-vaccination-of-persons-at-risk-for-occupational-exposure-to-orthopoxviruses-recommendations-of-the-advisory-committee) - Rao AK, Petersen BW, Whitehill F, et al.
- [Laboratory Procedures and Biosafety Guidelines: Select Agent Regulations](#laboratory-procedures-and-biosafety-guidelines-select-agent-regulations)
- [Autopsy and Handling of Human Remains](#autopsy-and-handling-of-human-remains)
- [Considerations for Monkeypox Vaccination](#considerations-for-monkeypox-vaccination)
- [Disinfectants for Emerging Viral Pathogens (EVPs): List Q](#disinfectants-for-emerging-viral-pathogens-evps-list-q) - List Q Tier 1 is for Monkeypox Virus
- [Laboratory Procedures and Biosafety Guidelines: Disposal of Waste](#laboratory-procedures-and-biosafety-guidelines-disposal-of-waste)
- [Laboratory Procedures and Biosafety Guidelines: Culturing Specimens for Monkeypox Virus](#laboratory-procedures-and-biosafety-guidelines-culturing-specimens-for-monkeypox-virus)
- [Laboratory Procedures and Biosafety Guidelines: Manipulating Diagnostic Specimens Suspected to Contain Monkeypox Virus](#laboratory-procedures-and-biosafety-guidelines-manipulating-diagnostic-specimens-suspected-to-contain-monkeypox-virus)
- [Information For Laboratory Personnel](#information-for-laboratory-personnel-2)
- [Monkeypox Resource Center](#monkeypox-resource-center)
- [U.S. Monkeypox 2022: Situation Summary](#u-s-monkeypox-2022-situation-summary)
- [Monkeypox](#monkeypox)
- [Monkeypox: Questions and Answers](#monkeypox-questions-and-answers)
- [Monkeypox Fact Sheet](#poxviruses-2)
- [Poxviruses](#poxviruses)
- [Prevention and Vaccine](#prevention-and-vaccine)
- [Your 5 Moments for Hand Hygiene](#your-5-moments-for-hand-hygiene)
- [Ebola (Ebola Virus Disease)](#ebola-ebola-virus-disease)
- [Interim Guidance for Enhanced Influenza Surveillance: Additional Specimen Collection for Detection of Influenza A (H3N2) Variant Virus Infections](#interim-guidance-for-enhanced-influenza-surveillance-additional-specimen-collection-for-detection-of-influenza-a-h3n2-variant-virus-infections)
- [Influenza A Virus in Swine Surveillance Information](#influenza-a-virus-in-swine-surveillance-information) - This surveillance tool is used to identify viruses that may be circulating in swine, and gain knowledge to contribute to improved animal health diagnostics and vaccines.
- [Interim Guidance on Specimen Collection, Processing, and Testing for Patients with Suspect Influenza A (H3N2)v Virus Infection](#interim-guidance-on-specimen-collection-processing-and-testing-for-patients-with-suspect-influenza-a-h3n2v-virus-infection)
- [Information on Swine/Variant Influenza](#information-on-swine-variant-influenza)
- [Global Influenza Programme: Pandemic influenza preparedness](#global-influenza-programme-pandemic-influenza-preparedness) - The impact of pandemic influenza outbreaks on individuals and societies can be reduced by being well prepared. This means having a comprehensive plan, that has been tested and refined through conducting exercises, engaging the whole of society. National plans should be flexible enough to respond to outbreaks of various intensity. Communication will be one of
- [Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017](#community-mitigation-guidelines-to-prevent-pandemic-influenza-united-states-2017) - Qualls N, Levitt A, Kanade N, et al.
- [Summary of Influenza Risk Assessment Tool (IRAT) Results](#summary-of-influenza-risk-assessment-tool-irat-results) - The Influenza Risk Assessment Tool (IRAT) is an evaluation tool conceived by CDC and further developed with assistance from global animal and human health influenza experts. The IRAT is used to assess the potential pandemic risk posed by influenza A viruses that are not currently circulating in people. Input is provided by U.S. government animal
- [The International Reagent Resource (IRR)](#the-international-reagent-resource-irr-2) - The International Reagent Resource (IRR), formerly named Influenza Reagent Resource (IRR), was established by the Centers for Disease Control and Prevention (CDC)
- [Influenza](#influenza) - NIAID is conducting and supporting research to find new and improved ways to diagnose, treat and prevent influenza infection.
- [WHO- and CIDRAP-led flu vaccine roadmap presents path to better vaccines](#who-and-cidrap-led-flu-vaccine-roadmap-presents-path-to-better-vaccines)
- [Flu Activity & Surveillance](#flu-activity-surveillance-2) - Includes data from US Clinical Laboratories, Public Health Laboratories, Outpatient Illness Network, and other sources
- [Influenza Virus Vaccine Safety & Availability](#influenza-virus-vaccine-safety-availability) - Information on Seasonal Influenza vaccine, and approved vaccines.
- [2022 Detections of Highly Pathogenic Avian Influenza](#2022-detections-of-highly-pathogenic-avian-influenza-2) - Includes the most recent report for confirmed HPAI Findings in Wild Birds. It also includes resources for emergency response.
- [Avian Influenza](#avian-influenza-2)
- [CDC Locally Acquired Cases of Malaria in Florida and Texas - July 2023](#cdc-cyclosporiasis-illnesses-in-the-united-states-2023-2) - CDC says: locally acquired mosquito-transmitted malaria cases can occur, as Anopheles mosquito vectors exist throughout the United States. In 2003 there were 8 cases of locally acquired P. vivax malaria identified in Palm Beach County, FL.
- [CDC Cyclosporiasis Illnesses in the United States, 2023](#cdc-cyclosporiasis-illnesses-in-the-united-states-2023) - CDC says: Cyclosporiasis illnesses are reported year-round in the United States. However, during the spring and summer months there is often an increase in cyclosporiasis acquired in the United States.
- [Sporicidal disinfectants shown more effective against Candida auris](#sporicidal-disinfectants-shown-more-effective-against-candida-auris)
- [Waterborne Infectious Diseases Associated with Exposure to Tropical Cyclonic Storms, United States, 1996–2018](#waterborne-infectious-diseases-associated-with-exposure-to-tropical-cyclonic-storms-united-states-19962018) - Lynch VD, Shaman JThe authors used surveillance data from the National Notifiable Diseases Surveillance System (NNDSS; https://www.cdc.gov/nndss) to identify weekly cases of cryptosporidiosis, giardiasis, Legionnaires’ disease, Escherichia coli infections, salmonellosis, and shigellosis during 1996–2018 for each US state.
- [Candida auris in Dog Ears](#candida-auris-in-dog-ears) - Yadav A, Wang Y, Jain K, Panwar VAR, Kaur H, Kasana V, Xu J, Chowdhary AThe authors analysed the microbial cultures of skin and ear swabs of 87 dogs in Delhi and performed fungal meta-barcode sequencing of ear and skin samples of 7 dogs with confirmed otitis externa (OE).
- [Risk Assessment tool for Fungi](#risk-assessment-tool-for-fungi)
- [Ebola](#ebola)
- [Ebola Virus Disease](#ebola-virus-disease-2) - Ebola virus disease (EVD), implications of introduction in the Americas (PDF), 13 August 2014 [SPANISH VERSION] Enfermedad por el virus del Ébola, implicaciones de la introducción en las Américas(PDF)
- [Ebola Infection Prevention and Control Resources](#ebola-infection-prevention-and-control-resources)
- [Ebola Preparedness Protocols](#ebola-preparedness-protocols)
- [Ebola Action Center](#ebola-action-center)
- [Ebola virus disease: Symptoms and treatment](#ebola-virus-disease-symptoms-and-treatment)
- [Pathogen Safety Data Sheets: Infectious Substances – Ebolavirus](#pathogen-safety-data-sheets-infectious-substances-ebolavirus)
- [EBOLA STRATEGY: Ebola and Marburg virus disease epidemics: preparedness, alert, control and evaluation](#ebola-strategy-ebola-and-marburg-virus-disease-epidemics-preparedness-alert-control-and-evaluation)
- [Ebola virus disease](#ebola-virus-disease)
- [Ebola Vaccines](#ebola-vaccines)
- [Ebola Vaccine: Information about ERVEBO®](#ebola-vaccine-information-about-ervebo)
- [Dissemination of carbapenemase-producing Enterobacterales through wastewater and gulls at a wastewater treatment plant in Sweden](#dissemination-of-carbapenemase-producing-enterobacterales-through-wastewater-and-gulls-at-a-wastewater-treatment-plant-in-sweden) - Woksepp H, Karlsson K, Börjesson S, Karlsson Lindsjö O, Söderlund R, Bonnedahl JThe report includes the detection of carbapenemase-producing Enterobacterales (CPE) isolated from Swedish wastewater and gull faeces
- [Stability of Monkeypox Virus in Body Fluids and Wastewater](#stability-of-monkeypox-virus-in-body-fluids-and-wastewater) - Yinda C, Morris DH, Fischer RJ, et al.The findings suggest that, because virus stability is sufficient to support environmental MPXV transmission in healthcare settings, exposure and dose-response will be limiting factors for those transmission routes
- [ECDC proposes targeted human testing for avian flu in areas with ongoing outbreaks](#ecdc-proposes-targeted-human-testing-for-avian-flu-in-areas-with-ongoing-outbreaks)
- [Risk Assessment for public health related to outbreaks caused by Highly Pathogenic Avian Influenza (HPAI) A(H5N1), clade 2.3.4.4b, in animal species in the Region of the Americas - 20 September 2023](#risk-assessment-for-public-health-related-to-outbreaks-caused-by-highly-pathogenic-avian-influenza-hpai-ah5n1-clade-2-3-4-4b-in-animal-species-in-the-region-of-the-americas-20-september-2023)
- [Epidemiological Alert - Anticipation of the onset of respiratory virus season - 22 September 2023](#epidemiological-alert-anticipation-of-the-onset-of-respiratory-virus-season-22-september-2023) - Several countries from the southern hemisphere have been reporting an early start of the increase of acute respiratory infection during the recent 2023 season of circulation of respiratory viruses, suggesting a shift of seasonal pattern observed prior to the COVID-19 pandemic.
- [Influenza A (H1N1) variant virus - the Netherlands](#influenza-a-h1n1-variant-virus-the-netherlands) - This is the first human infection caused by influenza A(H1N1)v virus reported in the Netherlands in 2023.
- [Important Updates on Locally Acquired Malaria Cases Identified in Florida, Texas, and Maryland](#important-updates-on-locally-acquired-malaria-cases-identified-in-florida-texas-and-maryland)
- [Severe Vibrio vulnificus Infections in the United States Associated with Warming Coastal Waters](#severe-vibrio-vulnificus-infections-in-the-united-states-associated-with-warming-coastal-waters)
- [Waterborne infections rise after hurricanes, decades of data show](#waterborne-infections-rise-after-hurricanes-decades-of-data-show)
- [Copper-Infused Solid Surface Kills Drug-Resistant Fungus Plaguing Nursing Homes](#copper-infused-solid-surface-kills-drug-resistant-fungus-plaguing-nursing-homes)
- [Cluster of Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Among Patients in an Adult Intensive Care Unit — Idaho, 2021–2022](#cluster-of-carbapenemase-producing-carbapenem-resistant-pseudomonas-aeruginosa-among-patients-in-an-adult-intensive-care-unit-idaho-20212022) - Cahill ME, Jaworski M, Harcy V, et alAntibiotic resistant P. aeruginosa was found in patients treated in an ICU months apart; multifaceted interventions, including sink hygiene practices, engineering controls, and administrative controls, are critical to limiting multidrug-resistant organism spread in health care settings.
- [Information For Laboratory Personnel](#information-for-laboratory-personnel) - Includes aboratory biosafety guidelines, testing, reporting procedures, use of PPE, specimen collection, packaging and transport, etc.
- [Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season](#prevention-and-control-of-seasonal-influenza-with-vaccines-recommendations-of-the-advisory-committee-on-immunization-practices-united-states-202324-influenza-season) - Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HKIncludes recommendations for the use of vaccines for the prevention and control of seasonal influenza during the 2023–24 influenza season (children, adults > 65, pregnant women, immune suppressed, etc.).
- [When Will the Next COVID Vaccine Be Available, and Who Should Get It?](#when-will-the-next-covid-vaccine-be-available-and-who-should-get-it) - Includes info on when the vaccine may be approved and who will benefit most from a booster.
- [ASHRAE Publishes Standard 241, Control of Infectious Aerosols](#ashrae-publishes-standard-241-control-of-infectious-aerosols) - ASHRAE has published its pioneering consensus-based, code enforceable standard, developed to reduce the risk of infectious aerosol transmission in buildings.
- [New standard on cutting risk of infectious aerosol spread sets high bar for building ventilation but is work in progress](#new-standard-on-cutting-risk-of-infectious-aerosol-spread-sets-high-bar-for-building-ventilation-but-is-work-in-progress) - The first-ever ASHRAE standard on reducing the risk of indoor infectious aerosol transmission sets new targets for building operators in terms of air system design, installation, operation, and maintenance.
- [Update on SARS CoV-2 Variant BA.2.86](#update-on-sars-cov-2-variant-ba-2-86) - CDC is tracking a new SARS-CoV-2 variant called BA.2.86 (Pirola) and working to better understand its potential impact on public health.
- [PPE/Safe Glove Removal –The “Beaking” Method](#ppe-safe-glove-removal-the-beaking-method) - If your lab coat or glove cuffs are contaminated, the “Beaking” Method is the safest glove removal method. Targeted audience:Biosafety ProfessionalsResearchers LaboratoriansClinical / Diagnostic LaboratoriansShipping / Receiving StaffStudentsTrainers / Educators
- [Links to Zika Information Collections by Publisher](#links-to-zika-information-collections-by-publisher) - Collections by publisher, US and International Governmental resources
- [Prevention and Transmission](#prevention-and-transmission)
- [Publications: Zika Virus](#publications-zika-virus)
- [A Complex Virus, A Coordinated Response: PUBLIC HEALTH LABORATORIES BATTLE ZIKA](#a-complex-virus-a-coordinated-response-public-health-laboratories-battle-zika)
- [Preventing and Managing Laboratory Worker Exposure to Zika Virus](#preventing-and-managing-laboratory-worker-exposure-to-zika-virus)
- [Zika Transmission](#zika-transmission) - see the section titled “Through laboratory and healthcare setting exposure”
- [Zika Virus: For Laboratories](#zika-virus-for-laboratories-2) - laboratory safety, testing, and training resources
- [MMWR  Ebola Reports](#mmwr-ebola-reports)
- [Infectious Substance Special Permits](#infectious-substance-special-permits)
- [Donning Biological PPE - Ebola Patients](#donning-biological-ppe-ebola-patients)
- [Transporting Infectious Substances safely](#transporting-infectious-substances-safely) - This document includes Monkeypox in the EXAMPLE OF CATEGORY A: UN2814, INFECTIOUS SUBSTANCES AFFECTING HUMANS
- [Monkeypox Biosafety Fact Sheet](#monkeypox-biosafety-fact-sheet) - Members of the APHL Biosafety and Biosecurity Committee developed this fact sheet to assist laboratorians with safely testing potential monkeypox samples.
- [Key Facts About Monkeypox Vaccine](#key-facts-about-monkeypox-vaccine) - JYNNEOS is the only FDA-licensed vaccine in the United States to prevent monkeypox disease in individuals 18 years of age and older.
- [Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022](#evidence-of-surface-contamination-in-hospital-rooms-occupied-by-patients-infected-with-monkeypox-germany-june-2022) - Dominik N.We systematically examined surfaces of two hospital rooms occupied by monkeypox patients and the adjacent anterooms, which are used for donning and doffing personal protective equipment (PPE), for monkeypox virus contamination using PCR. In addition, we assessed the infectivity on cell culture of the collected samples by virus isolation.
- [Monkeypox](#monkeypox-3) - Videos and links related to
- [Infection Prevention and Control of Monkeypox in Healthcare Settings](#infection-prevention-and-control-of-monkeypox-in-healthcare-settings-2) - These recommendations are intended for healthcare settings.
- [Inactivation of orthopoxvirus for diagnostic PCR analysis](#inactivation-of-orthopoxvirus-for-diagnostic-pcr-analysis) - Vinner L, et al.Diagnoses of ongoing viral infections commonly rely on PCR methodology.
- [How to Report Results from Orthopoxvirus, Non-Variola Orthopoxvirus, and Monkeypox Virus Laboratory Diagnostic Testing](#how-to-report-results-from-orthopoxvirus-non-variola-orthopoxvirus-and-monkeypox-virus-laboratory-diagnostic-testing) - These data will contribute to understanding the spread of the Monkeypox virus and can contribute to predicting increases in testing demand and planning for potential supply chain issues for reagents and other testing materials.
- [Infection-competent monkeypox virus contamination identified in domestic settings following an imported case of monkeypox into the UK](#infection-competent-monkeypox-virus-contamination-identified-in-domestic-settings-following-an-imported-case-of-monkeypox-into-the-uk) - Atkinson B, et al.This report confirms the potential for infection-competent monkeypox virus to be recovered in environmental settings associated with known positive cases and the necessity for rapid environmental assessment to reduce potential exposure to close contacts and the general public.
- [Technical Report: Multi-National Monkeypox Outbreak, United States, 2022](#technical-report-multi-national-monkeypox-outbreak-united-states-2022)
- [2022 U.S. Map & Case Count](#2022-u-s-map-case-count) - Total confirmed monkeypox/orthopoxvirus cases
- [Mpox (Monkeypox) outbreak toolbox](#monkeypox-outbreak-toolbox) - Included case definitions: suspected, probable, confirmed
- [Monkeypox multi-country outbreak](#monkeypox-multi-country-outbreak) - In 2022, for the first time, many outbreaks were reported in EU Member States and worldwide (in non-endemic countries) that had no epidemiological links to travel or imported mammals.
- [Monkeypox](#monkeypox-2)
- [EMS Response to the Current Outbreak of Monkeypox](#ems-response-to-the-current-outbreak-of-monkeypox) - Given the actions of the public health authorities, it is very unlikely that EMS clinicians will encounter a person infected with Monkeypox during routine operations. However, EMS professionals should follow an identify, isolate, and inform strategy, as outlined in NETEC’s webinar The I’s Have It: Identify, Isolate, and Inform to stop the spread of illness.
- [White House Declares Monkeypox a Public Health Emergency](#white-house-declares-monkeypox-a-public-health-emergency)
- [MONKEYPOX: An old disease in new places -- where do we go from here?](#monkeypox-an-old-disease-in-new-places-where-do-we-go-from-here) - Susan McLellan, MD, MPH
- [WHO: US has biggest jump in monkeypox cases](#monkeypox-pill-puts-drugmaker-on-the-map-2)
- [Preventing Worker Fatigue Among Ebola Healthcare Workers and Responders](#preventing-worker-fatigue-among-ebola-healthcare-workers-and-responders)
- [For Clinicians](#for-clinicians) - information for healthcare workers and settings
- [INTERIM GUIDANCE: Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola](#interim-guidance-interim-infection-prevention-and-control-guidance-for-care-of-patients-with-suspected-or-confirmed-filovirus-haemorrhagic-fever-in-health-care-settings-with-focus-on-ebola)
- [VIRAL HAEMORRHAGIC FEVER Guidelines for the management of patients with suspected viral haemorrhagic fever](#viral-haemorrhagic-fever-guidelines-for-the-management-of-patients-with-suspected-viral-haemorrhagic-fever)
- [Antimicrobial Resistance](#antimicrobial-resistance)
- [Risk communication and community engagement (RCCE) for monkeypox outbreaks: Interim guidance, 24 June 2022](#risk-communication-and-community-engagement-rcce-for-monkeypox-outbreaks-interim-guidance-24-june-2022)
- [Notice of Enforcement Discretion Regarding Monkeypox Medical Waste](#notice-of-enforcement-discretion-regarding-monkeypox-medical-waste) - Discusses handling of medical waste based on whether testing indicates it is from the West African clade (Cat. B) or the Congo Basin clade (Cat. A)
- [Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply](#monkeypox-update-fda-authorizes-emergency-use-of-jynneos-vaccine-to-increase-vaccine-supply) - For individuals 18 years of age and older determined to be at high risk of monkeypox infection, the EUA now allows for a fraction of the JYNNEOS dose to be administered between the layers of the skin (intradermally).
- [08/23/2022: Lab Advisory: Monkeypox Virus Testing Considerations to Prevent False Positive Test Results](#08-23-2022-lab-advisory-monkeypox-virus-testing-considerations-to-prevent-false-positive-test-results) - Worldwide, there have been no reports of transmission of monkeypox virus through blood transfusion and the risk of transfusion-transmission remains theoretical.
- [Information for Blood Establishments Regarding the Monkeypox Virus and Blood Donation](#information-for-blood-establishments-regarding-the-monkeypox-virus-and-blood-donation)
- [Assessment of best-selling respirators and masks: Do we have acceptable respiratory protection for the next pandemic?](#assessment-of-best-selling-respirators-and-masks-do-we-have-acceptable-respiratory-protection-for-the-next-pandemic) - Chaaban O, et.al.
- [Control of airborne particles in surgical procedures during the Covid-19 pandemic: scoping review](#new-covid-19-test-to-treat-initiative-and-locator-tool-2) - Laguardia, GCA, et.al
- [New COVID-19 Test to Treat Initiative and Locator Tool](#new-covid-19-test-to-treat-initiative-and-locator-tool) - A new way to get tested for Covid and treated at the same site, if appropriate. People who test positive at home can also bring those tests to the sites to be evaluated for treatment.
- [At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative: FDA Safety Communication](#at-home-covid-19-antigen-tests-take-steps-to-reduce-your-risk-of-false-negative-fda-safety-communication)
- [Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission — United States, August 2022](#strategies-adopted-by-gay-bisexual-and-other-men-who-have-sex-with-men-to-prevent-monkeypox-virus-transmission-united-states-august-2022) - Delaney KP, Sanchez T, Hannah M, et al.
- [Monkeypox Pill Puts Drugmaker on the Map](#monkeypox-pill-puts-drugmaker-on-the-map)
- [Monkeypox: The State of the Science](#what-you-need-to-know-about-monkeypox)
- [Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Additional Safety Protections Pertaining to Monkeypox Virus](#safety-alert-regarding-use-of-fecal-microbiota-for-transplantation-and-additional-safety-protections-pertaining-to-monkeypox-virus) - The FDA is informing health care providers of the potential risk of transmission of monkeypox virus through fecal microbiota for transplantation (FMT) products-- additional safety protections are needed.
- [What You Need To Know About Monkeypox](#what-you-need-to-know-about-monkeypox-2) - The interview discusses modes transmission, communication, and vaccination.
- [Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022](#epidemiologic-and-clinical-characteristics-of-monkeypox-cases-united-states-may-17july-22-2022) - Delaney KP, Sanchez T, Hannah M, et al.
- [Zika Virus Vaccines](#zika-virus-vaccines) - NIAID is developing multiple vaccine candidates to prevent Zika virus infection.
- [Zika Virus: For Healthcare Providers](#zika-virus-for-healthcare-providers) - clinical evaluation, sexual transmission, infection control
- [Zika virus: Symptoms and treatment](#zika-virus-symptoms-and-treatment)
- [Zika](#zika)
- [Zika virus disease](#zika-virus-disease)
- [Zika virus disease (publications)](#zika-virus-response-updates-from-fda-2)
- [Zika Virus Response Updates from FDA](#zika-virus-response-updates-from-fda)
- [Interim Guidance for Protecting Workers from Occupational Exposure to Zika Virus](#interim-guidance-for-protecting-workers-from-occupational-exposure-to-zika-virus)
- [Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022](#paxlovid-associated-with-decreased-hospitalization-rate-among-adults-with-covid-19-united-states-aprilseptember-2022-2) - Shah MM, Joyce B, Plumb ID, et al.
- [An Analysis of the Origins of the COVID-19 Pandemic](#an-analysis-of-the-origins-of-the-covid-19-pandemic-2) - The objective of this report was to review publicly available, open-source information to examine the two prevailing theories of origin of the SARS-CoV-2 virus: a natural zoonotic outbreak or a research-related incident.
- [Scientists race to test vaccines for Uganda’s Ebola outbreak](#scientists-race-to-test-vaccines-for-ugandas-ebola-outbreak) - Current approved vaccines cannot control this outbreak because it’s being driven by a distant viral relative of Zaire ebolavirus, known as Sudan ebolavirus, which last caused an outbreak, also in Uganda, in 2012.
- [USDA APHIS VS - Natonal Animal Health Laboratory Network Antmicrobial Resistance Pilot Project](#usda-aphis-vs-na􀆟onal-animal-health-laboratory-network-an􀆟microbial-resistance-pilot-project)
- [SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages](#sars-cov-2-infection-drives-an-inflammatory-response-in-human-adipose-tissue-through-infection-of-adipocytes-and-macrophages) - Martínez-Colón GJ, Ratnasiri K, et al.Authors state that the data suggest that SARS-CoV-2 infection of adipose tissue could contribute to COVID-19 severity through replication of virus within adipocytes and through induction of local and systemic inflammation driven by infection of adipose tissue-resident macrophages.
- [Antimicrobial Stewardship: Building Competencies in Judicious Use to Combat Antimicrobial Resistance](#antimicrobial-stewardship-building-competencies-in-judicious-use-to-combat-antimicrobial-resistance) - An innovative collection of resources on antimicrobial resistance and antimicrobial stewardship is now available for use by veterinary educators. Funded by a Higher Education Challenge Grant from the USDA National Institute of Food and Agriculture, a multi-institutional team of biomedical scientists, clinicians, and education specialists partnered to develop the competency-based resources to help veterinary students
- [Joint General Session . Global114. One Health and AMR: Joining Forces Towards A Global Approach](#joint-general-session-global114-one-health-and-amr-joining-forces-towards-a-global-approach) - This is an on-demand session with pre-recorded presentations discussing AMR surveillance and the current epidemiology and drivers of AMR.
- [Handbook of Antibiotic Stewardship in Companion Animal Veterinary Settings](#handbook-of-antibiotic-stewardship-in-companion-animal-veterinary-settings) - Animal Veterinary Settings. A first-of- its-kind comprehensive guide to implementing the AVMA Core Principles of Antimicrobial Stewardship in your clinic.
- [Antimicrobial Resistance and Stewardship Initiative](#antimicrobial-resistance-and-stewardship-initiative)
- [Uganda declares Ebola Virus Disease outbreak](#uganda-declares-ebola-virus-disease-outbreak) - WHO declares outbreak in Uganda with a rare Ebola Sudan virus.
- [Antimicrobial resistance](#antimicrobial-resistance-2-3)
- [Antimicrobial resistance](#antimicrobial-resistance-2)
- [The Dutch success model](#antimicrobial-resistance-overview-amr-2)
- [Antimicrobial Resistance Overview (AMR)](#antimicrobial-resistance-overview-amr)
- [Animal Pathogen AMR Data](#antimicrobial-resistance-2-2)
- [Infectious and Potentially Infectious Materials](#infectious-and-potentially-infectious-materials)
- [Guidance for Laboratories](#guidance-for-laboratories)
- [COVID-19 & Antimicrobial Resistance](#covid-19-amp-antimicrobial-resistance) - U.S. Impact of Antimicrobial Resistance, Special Report 2022. Atlanta, GAImpact of the COVID-19 pandemic on the work done by CDC to control AR
- [COVID-19 Data Review: Update on COVID-19–Related Mortality](#covid-19-data-review-update-on-covid-19related-mortality) - COVID-19 Data Reviews provide timely updates and share preliminary results of analyses that can improve the understanding of the pandemic and inform further scientific inquiry.
- [WHO fungal priority pathogens list to guide research, development and public health action](#who-fungal-priority-pathogens-list-to-guide-research-development-and-public-health-action-2) - The WHO fungal priority pathogens list (WHO FPPL) is the first global effort to systematically prioritize fungal pathogens, considering their unmet research and development (R&D) needs and perceived public health importance.
- [BU researchers create hybrid COVID virus, causing friction with the government](#bu-researchers-create-hybrid-covid-virus-causing-friction-with-the-governmentstay-up-to-date-with-covid-19-vaccines-including-boosters) - Recent research conducted by Boston University scientists involving a hybrid version of the COVID-19 virus is causing a stir in the scientific community. The work seemingly caught one of the research’s primary funding sources off guard, and has generated headlines alleging that the researchers created a more lethal version of COVID-19.
- [Stay Up to Date with COVID-19 Vaccines Including Boosters](#stay-up-to-date-with-covid-19-vaccines-including-boosters)
- [Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups](#coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines-for-use-as-a-booster-dose-in-younger-age-groups)
- [The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions: A systematic literature review and meta-analysis](#the-effectiveness-of-coronavirus-disease-2019-covid-19-vaccine-in-the-prevention-of-postcovid-19-conditions-a-systematic-literature-review-and-meta-analysis) - Marra AR, Kobayashi T, Suzuki H, et al.
- [Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022](#effectiveness-of-bivalent-mrna-vaccines-in-preventing-symptomatic-sars-cov-2-infection-increasing-community-access-to-testing-program-united-states-septembernovember-2022) - Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al.
- [Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022](#vaccines-and-immunization-for-monkeypox-interim-guidance-16-november-2022) - Key points follow. Mass vaccination is not required nor recommended for monkeypox at this time; Primary preventive (pre-exposure) vaccination (PPV) is recommended for individuals at high-risk of exposure.
- [Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022](#safety-monitoring-of-bivalent-covid-19-mrna-vaccine-booster-doses-among-persons-aged-12-years-united-states-august-31october-23-2022) - Hause AM, Marquez P, Zhang B, et al.Early safety findings from v-safe and the Vaccine Adverse Event Reporting System for bivalent booster doses administered to persons aged ≥12 years during the first 7 weeks of vaccine availability are similar to those previously described for monovalent vaccine booster vaccines.
- [Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022](#severe-monkeypox-in-hospitalized-patients-united-states-august-10october-10-2022) - Miller MJ, Cash-Goldwasser S, Marx GE, et al.
- [Biosafety Practices for Monkeypox Response (588-618-22)](#biosafety-practices-for-monkeypox-response-588-618-22) - Discusses Public Health risk assessments and BSL-2/3 laboratory procedures for handling monkeypox
- [WHO fungal priority pathogens list to guide research, development and public health action](#who-fungal-priority-pathogens-list-to-guide-research-development-and-public-health-action) - The WHO fungal priority pathogens list (WHO FPPL) is the first global effort to systematically prioritize fungal pathogens, considering their unmet research and development (R&D) needs and perceived public health importance.
- [Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles](#coinfection-by-influenza-a-virus-and-respiratory-syncytial-virus-produces-hybrid-virus-particles) - Haney, J., Vijayakrishnan, S., Streetley, J. et al.The observations define a previously unknown interaction between respiratory viruses that might affect virus pathogenesis by expanding virus tropism and enabling immune evasion.
- [Monkeypox Virus Infection Resulting from an Occupational Needlestick — Florida, 2022](#monkeypox-virus-infection-resulting-from-an-occupational-needlestick-florida-2022) - Mendoza R, Petras JK, Jenkins P, et al.
- [Ocular Monkeypox — United States, July–September 2022](#ocular-monkeypox-united-states-julyseptember-2022) - Cash-Goldwasser S, Labuda SM, McCormick DW, et al.
- [Monkeypox Case Investigation — Cook County Jail, Chicago, Illinois, July–August 2022](#monkeypox-case-investigation-cook-county-jail-chicago-illinois-julyaugust-2022) - Hagan LM, Beeson A, Hughes S, et al.
- [Nation’s first MPX case in healthcare worker exposed on the job is reported in L.A. County](#nations-first-mpx-case-in-healthcare-worker-exposed-on-the-job-is-reported-in-l-a-county)
- [Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022](#monkeypox-dna-levels-correlate-with-virus-infectivity-in-clinical-samples-israel-2022) - Paran N, et al. In this study, the authors test for a correlation between MPXV DNA copies in patient specimens.
- [Monkeypox: UKHSA laboratory assessments of inactivation methods](#monkeypox-ukhsa-laboratory-assessments-of-inactivation-methods) - Multiple protocols for inactivation of MPX are included in this resource, for example, Buffer AVL, 70% ethanol, L6 Buffer and others
- [Testing and detection of zoonotic influenza virus infections in humans in the EU/EEA, and occupational safety and health measures for those exposed at work](#testing-and-detection-of-zoonotic-influenza-virus-infections-in-humans-in-the-eu-eea-and-occupational-safety-and-health-measures-for-those-exposed-at-work) - Guidance for identifying human infections with animal influenza viruses and inform risk assessments and public health measures.
- [Outbreak of Ebola virus disease (Sudan ebolavirus) in Central Uganda](#outbreak-of-ebola-virus-disease-sudan-ebolavirus-in-central-uganda) - The CDC is reporting a recently confirmed outbreak of Ebola virus disease (EVD) in Uganda caused by Sudan virus (species Sudan ebolavirus) to summarize CDC’s recommendations for U.S. public health departments and clinicians, case identification and testing, and clinical laboratory biosafety considerations.
- [Notes from the Field: Outbreak of Cryptosporidiosis Among Collegiate Swimmers and Evidence of Secondary Transmission — Massachusetts and Rhode Island, 2023](#notes-from-the-field-outbreak-of-cryptosporidiosis-among-collegiate-swimmers-and-evidence-of-secondary-transmission-massachusetts-and-rhode-island-2023) - Chiumento G, Osinski A, DeVoe K, et al.
- [Threats and outbreaks of food- and water borne diseases](#threats-and-outbreaks-of-food-and-water-borne-diseases) - This resource lists rapid outbreak assessment and epidemiological updates on outbreaks of food- and water borne diseases.
- [Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021](#increased-hospitalizations-involving-fungal-infections-during-covid-19-pandemic-united-states-january-2020december-2021) - Gold J, Adjei S, Gundlapalli AV, Huang YA, Chiller T, Benedict K, et al.COVID-19 infection is a substantial risk factor for certain fungal infections, particularly those caused by invasive molds.
- [WHO fungal priority pathogens list to guide research, development and public health action](#who-fungal-priority-pathogens-list-to-guide-research-development-and-public-health-action-3) - This document is the first global effort to systematically prioritize fungal pathogens, considering their unmet research and development (R&D) needs and perceived public health importance.
- [USDA starts highly pathogenic avian influenza vaccine trials](#interim-recommendations-for-use-of-bivalent-mrna-covid-19-vaccines-for-persons-aged-6-months-united-states-april-2023-2)
- [Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023](#interim-recommendations-for-use-of-bivalent-mrna-covid-19-vaccines-for-persons-aged-6-months-united-states-april-2023) - Moulia DL, Wallace M, Roper LE, et al.Updated vaccine recommendations for children > 6 months and adults >65.
- [Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada](#omicron-covid-19-case-estimates-based-on-previous-sars-cov-2-wastewater-load-regional-municipality-of-peel-ontario-canada) - Cheng L, Dhiyebi H, Varia M, Atanas K, Srikanthan N, Hayat S, et al..At the peak of the Omicron BA.2 outbreak in April 2022, reported COVID-19 cases were underestimated 19-fold because of changes in clinical testing.
- [Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023](#safety-monitoring-of-mrna-covid-19-vaccine-third-doses-among-children-aged-6-months5-years-united-states-june-17-2022may-7-2023) - Hause AM, Marquez P, Zhang B, et al.
- [Guidelines for safe recreational water environments. Volume 2: Swimming pools and similar environments](#guidelines-for-safe-recreational-water-environments-volume-2-swimming-pools-and-similar-environments)
- [Surveillance and outbreak management of water-related infectious diseases associated with water-supply systems](#surveillance-and-outbreak-management-of-water-related-infectious-diseases-associated-with-water-supply-system)
- [Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda](#guidelines-for-drinking-water-quality-fourth-edition-incorporating-the-first-and-second-addenda)
- [Foodborne and Waterborne Disease Outbreak Investigation Manual](#waterborne-disease-risk-assessment-program-2021-annual-report-2)
- [Waterborne Disease Risk Assessment Program2021 Annual Report](#waterborne-disease-risk-assessment-program-2021-annual-report)
- [National Outbreak Reporting System (NORS)](#national-outbreak-reporting-system-nors)
- [Waterborne Disease Outbreak Investigation Toolkit](#waterborne-disease-outbreak-investigation-toolkit)
- [Waterborne Disease & Outbreak Surveillance Reporting](#waterborne-disease-outbreak-surveillance-reporting)
- [Surveillance for Waterborne Disease Outbreaks Associated with Drinking Water — United States, 2013–2014](#surveillance-for-waterborne-disease-outbreaks-associated-with-drinking-water-united-states-20132014) - Benedict KM, Reses H, Vigar M, et al.
- [Detection of Waterborne Viruses Using High Affinity Molecularly Imprinted Polymers](#detection-of-waterborne-viruses-using-high-affinity-molecularly-imprinted-polymers) - Ali IK, Roy S
- [A Real-Time PCR Assay for Simultaneous Detection and Differentiation of Four Common Entamoeba Species That Infect Humans](#a-real-time-pcr-assay-for-simultaneous-detection-and-differentiation-of-four-common-entamoeba-species-that-infect-humans) - Ali IK, Roy S
- [Immunization, Vaccines and Biologicals](#immunization-vaccines-and-biologicals) - WHO Immunization, Vaccines, and Biologicals Department's list of vaccine-preventable diseases
- [Hepatitis A](#hepatitis-a)
- [Vaccine preventable viral diseases and risks associated with waterborne transmission](#vaccine-preventable-viral-diseases-and-risks-associated-with-waterborne-transmission) - Ruggeri FM, Lucia Fiore L
- [Personal Hygiene During an Emergency](#personal-hygiene-during-an-emergency)
- [Making Water Safe in an Emergency](#making-water-safe-in-an-emergency)
- [A global overview of national regulations and standards for drinking-water quality](#a-global-overview-of-national-regulations-and-standards-for-drinking-water-quality-2)
- [Summary of the Safe Drinking Water Act](#summary-of-the-safe-drinking-water-act)
- [Water, Sanitation, & Hygiene (WASH)-related Emergencies & Outbreaks](#water-sanitation-hygiene-wash-related-emergencies-outbreaks)
- [Outbreaks Associated with Treated Recreational Water — United States, 2015–2019](#outbreaks-associated-with-treated-recreational-water-united-states-20152019) - Hlavsa MC, Aluko SK, Miller AD, et al.
- [Outbreaks of healthcare-associated infections linked to water-containing hospital equipment: a literature review](#outbreaks-of-healthcare-associated-infections-linked-to-water-containing-hospital-equipment-a-literature-review) - Yiek WK, Coenen O, Nillesen M, van Ingen J, Bowles E, Tostmann A
- [Hospital water and opportunities for infection prevention](#hospital-water-and-opportunities-for-infection-prevention) - Decker BK, Palmore TN
- [Healthcare Outbreaks Associated With a Water Reservoir and Infection Prevention Strategies](#healthcare-outbreaks-associated-with-a-water-reservoir-and-infection-prevention-strategies) - Kanamori H, et al.
- [Occupational and Environmental Exposures to Waterborne Microbial Diseases](#occupational-and-environmental-exposures-to-waterborne-microbial-diseases) - Samadpour M, Evans PS, Everett KDE, Ghatpande P, Ma GJ, Miksch RR
- [Waterborne Urinary Tract Infections: Have We Overlooked an Important Source of Exposure?](#waterborne-urinary-tract-infections-have-we-overlooked-an-important-source-of-exposure) - Graham JP, Amato HK, Mendizabal-Cabrera R, Alvarez D, Ramay BM
- [Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States](#estimate-of-burden-and-direct-healthcare-cost-of-infectious-waterborne-disease-in-the-united-states) - Collier SA, Deng L, Adam EA, et al.
- [Waterborne Disease & Outbreak Surveillance Reporting](#waterborne-disease-amp-outbreak-surveillance-reporting)
- [Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae — New York City, December 2021–March 2023](#notes-from-the-field-first-reported-u-s-cases-of-tinea-caused-by-trichophyton-indotineae-new-york-city-december-2021march-2023) - Caplan AS, Chaturvedi S, Zhu Y, et al.
- [Fungal Infections Associated with Contaminated Methylprednisolone Injections](#fungal-infections-associated-with-contaminated-methylprednisolone-injections) - Smith RM, Schaefer MK, Kainer MA, et al.The authors concluded: Analysis of data from a large, multistate outbreak of fungal infections showed substantial morbidity and mortality.
- [Healthcare-Associated Fungal Meningitis](#healthcare-associated-fungal-meningitis) - This is a disease-specific page form the CDC
- [Outbreak of Suspected Fungal Meningitis in U.S. Patients who Underwent Surgical Procedures under Epidural Anesthesia in Matamoros, Mexico](#outbreak-of-suspected-fungal-meningitis-in-u-s-patients-who-underwent-surgical-procedures-under-epidural-anesthesia-in-matamoros-mexico) - This report includes specific Recommendations for Clinical Laboratories
- [The devil lurking in the dust: How extreme weather is driving a deadly fungus further into the American West](#the-devil-lurking-in-the-dust-how-extreme-weather-is-driving-a-deadly-fungus-further-into-the-american-west) - Discusses the spread of Valley fever, under-reporting, diagnostic failures, effects of climate change, etc.
- [ZOHU Call: Sporotrichosis: overview and updates on an emerging zoonotic disease threat](#zohu-call-sporotrichosis-overview-and-updates-on-an-emerging-zoonotic-disease-threat-2) - Cat-transmitted sporotrichosis has emerged as a zoonotic epidemic and major public health threat in Brazil with the potential of spreading to the United States
- [Infectious: Pathogens and How We Fight Them](#infectious-pathogens-and-how-we-fight-them) - John S. Tregoning, PhDThis book celebrates the research dedicated to understanding and controlling harmful microbes.
- [Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022](#epidemiological-update-poliomyelitis-in-the-region-of-the-americas-7-april-2023-2) - Bigouette JP, Henderson E, Traoré MA, et al.
- [Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case — New York, March 9–October 11, 2022](#wastewater-testing-and-detection-of-poliovirus-type-2-genetically-linked-to-virus-isolated-from-a-paralytic-polio-case-new-york-march-9october-11-2022) - Ryerson AB, Lang D, Alazawi MA, et al.
- [ACTIVIDADES CLAVES PARA LA CONTENCIÓN DE POLIOVIRUS, RESOLUCION WHA71.16](#actividades-claves-para-la-contencion-de-poliovirus-resolucion-wha71-16)
- [Consideraciones en el marco de la contención de los poliovirus en las Américas, GAPIII- Regional](#consideraciones-en-el-marco-de-la-contencion-de-los-poliovirus-en-las-americas-gapiii-regional)
- [Orientación para minimizar el riesgo en las instalaciones que obtienen, manipulan o almacenan materiales potencialmente infecciosos de poliovirus](#orientacion-para-minimizar-el-riesgo-en-las-instalaciones-que-obtienen-manipulan-o-almacenan-materiales-potencialmente-infecciosos-de-poliovirus)
- [Polio vaccines: WHO position paper – June 2022](#polio-vaccines-who-position-paper-june-2022) - This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
- [Example of Poliovirus Exposure/Injury Protocol for personnel handling Poliovirus-related samples](#example-of-poliovirus-exposure-injury-protocol-for-personnel-handling-poliovirus-related-samples)
- [Supporting Risk-Based Decision-Making to Minimize Facility-Associated Re-Introduction of Poliovirus: Phase I](#supporting-risk-based-decision-making-to-minimize-facility-associated-re-introduction-of-poliovirus-phase-i) - LouAnn C. Burnett, Ryan Ritterson, Rocco Casagrande
- [Diagnostic procedures following an accidental exposure to poliovirus](#diagnostic-procedures-following-an-accidental-exposure-to-poliovirus)
- [Poliomyelitis: For Healthcare Providers: Infection and Transmission](#poliomyelitis-for-healthcare-providers-infection-and-transmission)
- [Plan regional sobre la contención de los poliovirus en las Américas. GAPIII-Regional](#plan-regional-sobre-la-contencion-de-los-poliovirus-en-las-americas-gapiii-regional) - LA OMS publicó el plan de acción mundial conocido como GAPIII,a con el propósito de difundir la estrategia mundial encaminada a minimizer el riesgo de restablecimiento de la circulación del poliovirus a partir de material infeccioso y potencialmente infeccioso que se almacenan en las instalaciones en diferentes sectores, incluidos desde luego los laboratorios.
- [WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use](#who-global-action-plan-to-minimize-poliovirus-facility-associated-risk-after-type-specific-eradication-of-wild-polioviruses-and-sequential-cessation-of-oral-polio-vaccine-use-2)
- [WHO Guidance to minimize  risks for facilities collecting, handling, or storing materials,  potentially infectious  for Polioviruses](#who-global-action-plan-to-minimize-poliovirus-facility-associated-risk-after-type-specific-eradication-of-wild-polioviruses-and-sequential-cessation-of-oral-polio-vaccine-use) - This guidance intends to facilitate the identification of materials potentially infectious for polioviruses within laboratories that handle human stool specimens, respiratory samples or environmental sewage.
- [WHO Global Action Plan For Laboratory Containment of Wild Polioviruses, second edition](#who-global-action-plan-for-laboratory-containment-of-wild-polioviruses-second-edition-2) - Definitions of the different Polioviruses included CDC GAPIII definitions and examples
- [Poliovirus](#poliovirus)
- [Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples– the United Kingdom of Great Britain and Northern Ireland and the United States of America](#detection-of-circulating-vaccine-derived-polio-virus-2-cvdpv2-in-environmental-samples-the-united-kingdom-of-great-britain-and-northern-ireland-and-the-united-states-of-america) - In late July, a case of VDPV2 was reported in an unvaccinated individual in Rockland County, who presented with paralysis. The case had no recent history of international travel. This is the first case of poliomyelitis reported in the country since 2013.
- [Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater — New York, June–August 2022](#public-health-response-to-a-case-of-paralytic-poliomyelitis-in-an-unvaccinated-person-and-detection-of-poliovirus-in-wastewater-new-york-june-august-2022)
- [Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater — New York, June–August 2022](#public-health-response-to-a-case-of-paralytic-poliomyelitis-in-an-unvaccinated-person-and-detection-of-poliovirus-in-wastewater-new-york-june-august-2022-2) - Link-Gelles R, Lutterloh E, Schnabel Ruppert P, et al.Based on the typical incubation period for paralytic polio, the presumed period of exposure occurred 7 to 21 days before the onset of paralysis. Epidemiologic investigation revealed that the patient attended a large gathering 8 days before symptom onset and had not traveled internationally during the presumed
- [Epidemiological Update - Poliomyelitis in the Region of the Americas - 7 April 2023](#epidemiological-update-poliomyelitis-in-the-region-of-the-americas-7-april-2023)
- [Potential Risk for New Mpox Cases](#potential-risk-for-new-mpox-cases)
- [2022-23 Mpox (Monkeypox) Outbreak: Global Trends](#2022-23-mpox-monkeypox-outbreak-global-trends) - This is a global overview of the mpox epidemiological situation and response activities across a variety of domains such as epidemiology, clinical management and communications.
- [Lab Advisory: Guidance for Marburg Virus Disease Specimen Testing](#lab-advisory-guidance-for-marburg-virus-disease-specimen-testing)
- [CDC Travel Alert 2 Marburg in Equatorial Guinea](#cdc-travel-alert-2-marburg-in-equatorial-guinea)
- [Marburg Virus Disease Outbreaks in Equatorial Guinea and Tanzania](#marburg-virus-disease-outbreaks-in-equatorial-guinea-and-tanzania) - Alert concerning two confirmed outbreaks of Marburg virus disease (MVD)—one in Equatorial Guinea and one in Tanzania.
- [Correlations and Timeliness of COVID-19 Surveillance Data Sources and Indicators ― United States, October 1, 2020–March 22, 2023](#correlations-and-timeliness-of-covid-19-surveillance-data-sources-and-indicators-united-states-october-1-2020march-22-2023) - Scobie HM, Panaggio M, Binder AM, et al.Surveillance data from October 1, 2020–March 22, 2023
- [COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023](#covid-19-surveillance-after-expiration-of-the-public-health-emergency-declaration-united-states-may-11-2023) - Silk BJ, Scobie HM, Duck WM, et al.The authors indicate the following: "Changes to the national COVID-19 monitoring strategy and COVID Data Tracker capitalize on marked improvements in multiple surveillance systems."
- [End of the Federal COVID-19 Public Health Emergency (PHE) Declaration](#persistent-prosopagnosia-following-covid-19-2) - The federal COVID-19 PHE declaration ended on May 11, 2023.
- [Persistent prosopagnosia following COVID-19](#persistent-prosopagnosia-following-covid-19) - Kieseler ML, Duchaine BLong covid effects may include the inability to recgonize faces.
- [CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine](#cdc-simplifies-covid-19-vaccine-recommendations-allows-older-adults-and-immunocompromised-adults-to-get-second-dose-of-the-updated-vaccine)
- [Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023](#effectiveness-of-monovalent-mrna-covid-19-vaccination-in-preventing-covid-19associated-invasive-mechanical-ventilation-and-death-among-immunocompetent-adults-during-the-omicron-variant-period-ivy-ne-2) - DeCuir J, Surie D, Zhu Y, et al.
- [Ventilation Improvements Among K–12 Public School Districts — United States, August–December 2022](#ventilation-improvements-among-k12-public-school-districts-united-states-augustdecember-2022) - Mark-Carew M, Kang G, Pampati S, Mead KR, Martin SB Jr., Barrios LCTo reduce school transmission of SARS-CoV-2, K–12 public school districts implemented various types of ventilation improvements.
- [Early Treatment with Pegylated Interferon Lambda for Covid-19](#early-treatment-with-pegylated-interferon-lambda-for-covid-19) - Reis G, et.al.Among predominantly vaccinated outpatients with Covid-19, the incidence of hospitalization or an emergency department visit was significantly lower among those who received a single dose of pegylated interferon lambda than among those who received placebo.
- [Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023](#early-estimates-of-bivalent-mrna-booster-dose-vaccine-effectiveness-in-preventing-symptomatic-sars-cov-2-infection-attributable-to-omicron-ba-5-and-xbb-xbb-1-5-related-sublineages-amo-2) - Link-Gelles R, Ciesla AA, Roper LE, et al.
- [COVID-19 Mortality and Progress Toward Vaccinating Older Adults — World Health Organization, Worldwide, 2020–2022](#covid-19-mortality-and-progress-toward-vaccinating-older-adults-world-health-organization-worldwide-20202022-2) - Wong MK, Brooks DJ, Ikejezie J, et al.COVID-19–associated mortality among persons aged ≥60 years exceeded 80% of total COVID-19 mortality in 2020 and 2021 across all income groups.
- [Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears](#notes-from-the-field-aircraft-wastewater-surveillance-for-early-detection-of-sars-cov-2-variants-john-f-kennedy-international-airport-new-york-city-augustseptember-2022)
- [This Week](#this-week) - (updated polio infection numbers worldwide)
- [Know Your Treatment Options for COVID-19](#know-your-treatment-options-for-covid-19) - .
- [FAQs- NIH OSP Review of Requests to Lower the Minimum Required Biosafety Containment Level for Research Subject to the NIH Guidelines](#faqs-nih-osp-review-of-requests-to-lower-the-minimum-required-biosafety-containment-level-for-research-subject-to-the-nih-guidelines) - In the last 2 years, the NIH OSP has received multiple requests to lower containment from BL3 to BL2 for research with certain agents, including SARS-CoV-2.
- [‘Incredibly concerning’: Bird flu outbreak at Spanish mink farm triggers pandemic fears](#incredibly-concerning-bird-flu-outbreak-at-spanish-mink-farm-triggers-pandemic-fears) - Big outbreak at a Spanish farm reignites fears of an H5N1 influenza pandemic
- [Features, Evaluation, and Treatment of Coronavirus (COVID-19)](#features-evaluation-and-treatment-of-coronavirus-covid-19-2) - Cascella M, Rajnik M, Aleem A, et al.The authors say: "This review article aims to comprehensively describe the etiology, epidemiology, pathophysiology, clinical features, diagnostic methods, and the latest novel therapeutics in the management of COVID-19."
- [Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022](#early-estimates-of-bivalent-mrna-vaccine-effectiveness-in-preventing-covid-19associated-hospitalization-among-immunocompetent-adults-aged-65-years-ivy-network-18-states-september-8november-30-2022) - Surie D, DeCuir J, Zhu Y, et al.
- [Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022](#early-estimates-of-bivalent-mrna-vaccine-effectiveness-in-preventing-covid-19associated-emergency-department-or-urgent-care-encounters-and-hospitalizations-among-immunocompetent-adults-vision-network) - Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al.
- [Important Updates on COVID-19 Therapeutics for Treatment and Prevention](#important-updates-on-covid-19-therapeutics-for-treatment-and-prevention) - The majority of Omicron sublineages circulating in the United States have reduced susceptibility to the monoclonal antibody, bebtelovimab and the monoclonal antibody combination, cilgavimab and tixagevimab (EvusheldTM). Antiviral therapeutics for the treatment of COVID-19, ritonavir-boosted nirmatrelvir (Paxlovid™), remdesivir (Veklury®), and molnupiravir (Lagevrio™), retain activity against currently circulating Omicron sublineages.
- [Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States](#council-of-state-and-territorial-epidemiologists-cdc-surveillance-case-definition-for-multisystem-inflammatory-syndrome-in-children-associated-with-sars-cov-2-infection-united-states) - Melgar M, Lee EH, Miller AD, et al.
- [WHO recommends new name for monkeypox disease](#who-recommends-new-name-for-monkeypox-disease-2) - WHO will begin using a new preferred term “mpox” as a synonym for monkeypox
- [Monkeypox Technical Reports](#monkeypox-technical-reports) - These are technical reports intended for scientific audiences.
- [Drug-resistant nontyphoidal Salmonella](#drug-resistant-nontyphoidal-salmonella)
- [Methicillin-resistant Staphylococcus aureus (MRSA)](#methicillin-resistant-staphylococcus-aureus-mrsa)
- [About the AR Lab Network](#cdc-amp-fda-antimicrobial-resistance-ar-isolate-bank) - Nationwide impact of the AR Lab Network and their capabilities
- [About CDC’s AR Lab Network](#about-cdcs-ar-lab-network) - AR Lab Network supports nationwide lab capacity to rapidly detect antimicrobial resistance
- [Drug-Resistant Candida Species](#drug-resistant-candida-species)
- [Candida auris: A drug-resistant fungus that spreads in healthcare facilities - A CDC message to laboratory staff](#candida-auris-a-drug-resistant-fungus-that-spreads-in-healthcare-facilities)
- [CDC Actions to Prevent the Spread of Antifungal Resistance](#cdc-actions-to-prevent-the-spread-of-antifungal-resistance)
- [Drug-Resistant Candida auris](#drug-resistant-candida-auris)
- [COVID-19 Workplace Safety Plan](#covid-19-workplace-safety-plan) - This is a good example for a workplace safety plan that can be adapted to any or all infectious diseases with potential to cause outbreaks
- [COVID-19 Forecasting and Mathematical Modeling](#covid-19-forecasting-and-mathematical-modeling) - Forecasts of disease burden help inform public health decision making by projecting the likely impact of COVID-19 in the next few weeks.
- [Increase in Extensively Drug-Resistant Shigellosis in the United States](#increase-in-extensively-drug-resistant-shigellosisin-the-united-states) - In 2022, about 5% of Shigella infections reported to CDC were caused by XDR strains, compared with 0% in2015.
- [Bird Flu in Pets and Other Animals](#bird-flu-in-pets-and-other-animals-2)
- [Highlights in the History of Avian Influenza (Bird Flu) Timeline – 2020-2023](#highlights-in-the-history-of-avian-influenza-bird-flu-timeline-2020-2023)
- [Updated Assessment on Covid-19 Origins](#an-analysis-of-the-origins-of-the-covid-19-pandemic) - The IC assesses that SARS-CoV-2, probably emerged and infected humans through an initial small-scale exposure that occurred no later than November 2019 with the first known cluster of COVID-19 cases arising in Wuhan, China in December 2019.
- [People Who Are Immunocompromised](#people-who-are-immunocompromised) - Additional info for the immunocompromised: Know how to protect yourself and what to do if you get sick.
- [COVID-19 Personal Plan](#covid-19-personal-plan) - Tools, information, and action steps to share with your family, friends, and healthcare provider
- [Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States, February 2023](#interim-clinical-treatment-considerations-for-severe-manifestations-of-mpox-united-states-february-2023) - Rao AK, Schrodt CA, Minhaj FS, et al.
- [COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022](#covid-19-incidence-and-mortality-among-unvaccinated-and-vaccinated-persons-aged-12-years-by-receipt-of-bivalent-booster-doses-and-time-since-vaccination-24-u-s-jurisdictions-october-3-2021december-24) - Johnson AG, Linde L, Ali AR, et al.
- [Lab Leak Most Likely Caused Pandemic, Energy Dept. Says](#lab-leak-most-likely-caused-pandemic-energy-dept-says)
- [Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023](#interim-estimates-of-202223-seasonal-influenza-vaccine-effectiveness-wisconsin-october-2022february-2023) - McLean HQ, Petrie JG, Hanson KE, et al.The 2022–23 influenza vaccine provides substantial protection against circulating influenza A viruses and remains the best way to protect against influenza. Influenza vaccination is recommended as long as influenza viruses are circulating.
- [Notes from the Field: Aircraft Wastewater Surveillance for Early Detection of SARS-CoV-2 Variants — John F. Kennedy International Airport, New York City, August–September 2022](#notes-from-the-field-aircraft-wastewater-surveillance-for-early-detection-of-sars-cov-2-variants-john-f-kennedy-international-airport-new-york-city-augustseptember-2022-2) - Morfino RC, Bart SM, Franklin A, et al.Summary from publication: During August 1–September 9, 2022, the biotech company Ginkgo Bioworks, in collaboration with CDC, evaluated the feasibility of SARS-CoV-2 variant detection in aircraft wastewater from incoming international flights.
- [Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection](#association-of-covid-19-vaccination-with-risk-for-incident-diabetes-after-covid-19-infection) - Kwan, A., et.alDiabetes risk after COVID-19 infection was higher in unvaccinated than vaccinated patients, suggesting a benefit of vaccination.
- [Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study](#viral-burden-rebound-in-hospitalised-patients-with-covid-19-receiving-oral-antivirals-in-hong-kong-a-population-wide-retrospective-cohort-study) - Wong, C., et.al.Viral burden rebound rates are similar between patients with antiviral treatment and those without. Importantly, viral burden rebound was not associated with adverse clinical outcomes.
- [Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection](#quantitative-sars-cov-2-viral-load-curves-in-paired-saliva-samples-and-nasal-swabs-inform-appropriate-respiratory-sampling-site-and-analytical-test-sensitivity-required-for-earliest-viral-detection) - Savela ES, et al. The authors state: "Our study illustrates the value of acquiring early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appropriate analytical sensitivity and respiratory site for detecting earliest infections."
- [Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21](#association-between-bnt162b2-vaccination-and-reported-incidence-of-post-covid-19-symptoms-cross-sectional-study-2020-21) - Kuodi, P., Gorelik, Y., Zayyad, H. et al.Vaccination with at least two doses of COVID-19 vaccine was associated with a substantial decrease in reporting the most common post-acute COVID-19 symptoms, bringing it back to baseline. Our results suggest that, in addition to reducing the risk of acute illness, COVID-19 vaccination may have a protective effect
- [Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States](#sars-cov-2-variant-classifications-and-definitions-2) - Kalish H, et al.The authors measured antibody prevalence in study participants who had not previously been diagnosed with a SARS-CoV-2 infection during the first wave of the COVID-19 pandemic
- [A comparison of performance metrics for cloth masks as source control devices for simulated cough and exhalation aerosols](#a-comparison-of-performance-metrics-for-cloth-face-masks-as-source-control-devices-for-simulated-cough-and-exhalation-aerosols) - Lindsley WG, et al.The authors studied the source control performance of 15 cloth masks, two medical masks, and two N95 filtering facepiece respirators by measuring their ability to block aerosols < or = to 7 micrometers
- [Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections](#transmission-event-of-sars-cov-2-delta-variant-reveals-multiple-vaccine-breakthrough-infections) - Farinholt T, Doddapaneni H, Qin X, et al.The authors say "Our observations support continued efforts to generate SARS-CoV-2 genomic sequences from positive patient samples, to identify possible vaccine breakthrough mutations."
- [Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink](#guillain-barre-syndrome-after-covid-19-vaccination-in-the-vaccine-safety-datalink) - Hanson KE, Goddard K, Lewis N, et al. Surveillance data from the Vaccine Safety Datalink showed increased incidence rate of confirmed GBS 1 to 21 days after receiving the Ad.26.COV2.S (Janssen).
- [SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway](#sars-cov-2-omicron-is-an-immune-escape-variant-with-an-altered-cell-entry-pathway) - Willett BJ, Grove J, MacLean OA et al. This study shows evasion of neutralization by Omicron BA.1 and BA.2 variants in vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 and mRNA-1273.
- [Overview of Risk Assessment and Risk Management in Laboratory Animal Biosafety](#overview-of-risk-assessment-and-risk-management-in-laboratory-animal-biosafety) - These videos, sponsored by ABSA International and Elizabeth R. Griffin Program, describe the procedures animal handlers should follow when Working Safety in Animal Biosafety level 1, 2, or 3. Each video provides guidance on a wide range of topics including donning and doffing personal protective equipment, decontamination of work areas, handling of animals, working with sharps, and transporting animals.
- [Working at Animal Biosafety Level 1](#working-at-animal-biosafety-level-1) - These videos, sponsored by ABSA International and Elizabeth R. Griffin Program, describe the procedures animal handlers should follow when Working Safety in Animal Biosafety level 1, 2, or 3. Each video provides guidance on a wide range of topics including donning and doffing personal protective equipment, decontamination of work areas, handling of animals, working with sharps, and transporting animals.
- [Working at Animal Biosafety Level 2](#working-at-animal-biosafety-level-2) - These videos, sponsored by ABSA International and Elizabeth R. Griffin Program, describe the procedures animal handlers should follow when Working Safety in Animal Biosafety level 1, 2, or 3. Each video provides guidance on a wide range of topics including donning and doffing personal protective equipment, decontamination of work areas, handling of animals, working with sharps, and transporting animals.
- [Working at Animal Biosafety Level 3](#working-at-animal-biosafety-level-2-2) - These videos, sponsored by ABSA International and Elizabeth R. Griffin Program, describe the procedures animal handlers should follow when Working Safety in Animal Biosafety level 1, 2, or 3. Each video provides guidance on a wide range of topics including donning and doffing personal protective equipment, decontamination of work areas, handling of animals, working with sharps, and transporting animals.
- [Working with Livestock in a BSL-3 Facility](#working-with-livestock-in-a-bsl-3-facility)
- [Livestock Behavior and Handling in a BSL-3 Facility](#livestock-behavior-and-handling-in-a-bsl-3-facility)
- [Cattle Handling in a BSL-3 Facility](#cattle-handling-in-a-bsl-3-facility)
- [Swine Handling in a BSL-3 Facility](#swing-handling-in-a-bsl-3-facility)
- [ARCHIVED: Industry Calls for More Oversight of Covid-19 Temperature Scanners](#industry-calls-for-more-oversight-of-covid-19-temperature-scanners)
- [ARCHIVED: High-Tech Face Masks Aim to Step Up the Fight Against Covid-19](#high-tech-face-masks-aim-to-step-up-the-fight-against-covid-19) - n participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well tolerated
- [ARCHIVED: The Next Trick: Pulling Coronavirus Out of Thin Air](#the-next-trick-pulling-coronavirus-out-of-thin-air) - CDC is offering a series of brief (15-20 minute) webinars addressing topics around COVID-19 vaccination.
- [ARCHIVED: Wall Street Journal: The Coronavirus Crisis](#wall-street-journal-wsj-the-coronavirus-crisis) - The Wall Street Journal's coverage of the pandemic, from the latest news to deeper looks into how the disease is affecting life and business.
- [ARCHIVED: Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021](#reduced-risk-of-reinfection-with-sars-cov-2-after-covid-19-vaccination-kentucky-mayjune-2021)
- [ARCHIVED: Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals](#coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-for-certain-immunocompromised-individuals)
- [ARCHIVED: Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021](#effectiveness-of-covid-19-vaccines-in-preventing-hospitalization-among-adults-aged-65-years-covid-net-13-states-februaryapril-2021)
- [ARCHIVED: Infections After Inoculation Are Rare](#infections-after-inoculation-are-rare) - Breakthrough cases represent 0.008% of the fully vaccinated population and are in line with expectations because the approved vaccines in the U.S. are not 100% effective.
- [ARCHIVED: Risk of rare blood clotting higher for COVID-19 than for vaccines](#risk-of-rare-blood-clotting-higher-for-covid-19-than-for-vaccines-2) - COVID-19 infection leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.
- [ARCHIVED: Annual Covid Vaccine Booster Shots Likely Needed, Pfizer CEO Says](#annual-covid-vaccine-booster-shots-likely-needed-pfizer-ceo-says) - Due to variants of the coronavirus, people likely will need a booster shot within a year to suppress the pool of those individuals susceptible to Covid-19 per Pfizer Chief Executive Albert Bourla.
- [ARCHIVED: German scientists claim to have solved Covid vaccine blood clot puzzle](#german-scientists-claim-to-have-solved-covid-vaccine-blood-clot-puzzle) - Jabs could be tweaked to stop reaction happening, new research suggests
- [ARCHIVED: After detecting new hybrid coronavirus variant, Vietnam races to increase testing and restrictions](#after-detecting-new-hybrid-coronavirus-variant-vietnam-races-to-increase-testing-and-restrictions) - The CDC is investigating a few dozen cases of myocarditis, an inflammation of the heart muscle, found in young adults and adolescent vaccine recipients.
- [ARCHIVED: Delaying a COVID vaccine’s second dose boosts immune response](#delaying-a-covid-vaccines-second-dose-boosts-immune-response) - Older people who waited 11–12 weeks for their second jab had higher peak antibody levels than did those who waited only 3 weeks.
- [ARCHIVED: The Yankees Covid Outbreak May Be Bad News for Ditching Masks](#the-yankees-covid-outbreak-may-be-bad-news-for-ditching-masks) - The spate of cases is a bad bounce—and it might show that lifting mask mandates for the vaxxed won’t be a grand slam.
- [ARCHIVED: Another new coronavirus has jumped to people](#another-new-coronavirus-has-jumped-to-people) - Dubbed CCoV-HuPn-2018, this new virus is the first canine coronavirus (CCoV) to ever be isolated from a human.
- [ARCHIVED: “Vaccine-Induced Covid-19 Mimicry” Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines](#vaccine-induced-covid-19-mimicry-syndrome-splice-reactions-within-the-sars-cov-2-spike-open-reading-frame-result-in-spike-protein-variants-that-may-cause-thromboembolic-events-in-patients-immunized-wi) - Kowarz E, Krutzke L, Reis J, et al.
- [ARCHIVED: Mucormycosis: The 'black fungus' maiming Covid patients in India](#mucormycosis-the-black-fungus-maiming-covid-patients-in-india)
- [ARCHIVED: UK scientists warn over Indian COVID ‘variant of concern’: Report](#uk-scientists-warn-over-indian-covid-variant-of-concern-report-2)
- [ARCHIVED: COVID mRNA vaccines induce immune response in pregnant, lactating women](#covid-mrna-vaccines-induce-immune-response-in-pregnant-lactating-women)
- [ARCHIVED: Pfizer Uncovers Fake Vaccines Overseas](#pfizer-uncovers-fake-vaccines-overseas) - In Mexico, about 80 people received fraudulent doses, and in Poland authorities recovered vials containing antiwrinkle drugs.
- [ARCHIVED: Where to Buy N95s, KN95s, and Surgical-Style Masks You Can Trust](#where-to-buy-n95s-kn95s-and-surgical-style-masks-you-can-trust)
- [ARCHIVED: How Contagious Is the Delta Variant?](#how-contagious-is-the-delta-variant)
- [ARCHIVED: Why some experts recommend upgrading to N95 masks to help fight the delta variant](#why-some-experts-recommend-upgrading-to-n95-masks-to-help-fight-the-delta-variant)
- [ARCHIVED: BioNTech CEO Not Sure About Third Vaccine Dose](#biontech-ceo-not-sure-about-third-vaccine-dose)
- [ARCHIVED: Once-a-Day Pill to Treat Covid-19 Is Tested](#once-a-day-pill-to-treat-covid-19-is-tested)
- [ARCHIVED: U.K. Plans to Roll Out Booster Shots in September](#u-k-plans-to-roll-out-booster-shots-in-september) - The U.K. is one of the first governments to set out provisional plans for booster shots. It isconcerned that possible further Covid-19 outbreaks over the winter could coincide with awave of influenza and put pressure on the country’s health system
- [ARCHIVED: Delta Outbreaks Revive Limits](#delta-outbreaks-revive-limits) - The developments underscore how the morphing pathogen continues to challenge a return to pre-pandemic life world-wide.
- [ARCHIVED: Antibody Drug Cuts Risk of Death for Sickest Patients](#antibody-drug-cuts-risk-of-death-for-sickest-patients) - Trial results for a new Regeneron treatment have buoyed hopes that doctors could soon have a new way to tackle severe hospital cases.
- [ARCHIVED: The delta variant adds a speed bump to the pandemic escape route](#the-delta-variant-adds-a-speed-bump-to-the-pandemic-escape-route) - The Delta strain is now a variant of concern, with indications it is more infectious than other strains.
- [ARCHIVED: Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020](#seroprevalence-of-sars-cov-2-among-frontline-health-care-personnel-in-a-multistate-hospital-network-13-academic-medical-centers-apriljune-2020) - Self WH, Tenforde MW, Stubblefield WB, et al. Reports on the infection rate of healthcare personnel.
- [ARCHIVED: Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020–May 2021](#genomic-surveillance-for-sars-cov-2-variants-circulating-in-the-united-states-december-2020may-2021) - During April 11–24, 2021, the B.1.1.7 and P.1 variants represented an estimated 66% and 5% of U.S. infections, respectively, demonstrating the potential for new variants to emerge and become predominant.
- [ARCHIVED: COVID-19 VaST Work Group Report – May 17, 2021](#covid-19-vast-work-group-report-may-17-2021) - The CDC is investigating a few dozen cases of myocarditis, an inflammation of the heart muscle, found in young adults and adolescent vaccine recipients.
- [ARCHIVED: Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses](#ad26-vector-based-covid-19-vaccine-encoding-a-prefusion-stabilized-sars-cov-2-spike-immunogen-induces-potent-humoral-and-cellular-immune-responses)
- [ARCHIVED: Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine](#interim-results-of-a-phase-12a-trial-of-ad26-cov2-s-covid-19-vaccine) - Sadoff J, et al.
- [ARCHIVED: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine](#safety-and-efficacy-of-the-bnt162b2-mrna-covid-19-vaccine) - Polack F, et al.
- [ARCHIVED: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine](#efficacy-and-safety-of-the-mrna-1273-sars-cov-2-vaccine) - Baden L.R.et al.
- [ARCHIVED: The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020](#the-advisory-committee-on-immunization-practices-interim-recommendation-for-use-of-moderna-covid-19-vaccine-united-states-december-2020)
- [ARCHIVED: Facility-Wide Testing for SARS-CoV-2 in Nursing Homes — Seven U.S. Jurisdictions, March–June 2020](#facility-wide-testing-for-sars-cov-2-in-nursing-homes-seven-u-s-jurisdictions-marchjune-2020) - Hatfield KM, Reddy SC, Forsberg K, et al.
- [ARCHIVED: CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel](#cdc-2019-novel-coronavirus-2019-ncov-real-time-rt-pcr-diagnostic-panel)
- [ARCHIVED: Your Coronavirus Test Is Positive. Maybe It Shouldn’t Be](#your-coronavirus-test-is-positive-maybe-it-shouldnt-be) - PCR cycle thresholds may be critical to determine how infectious a person is.
- [ARCHIVED: Can Airport Testing Get People Flying Again?](#can-airport-testing-get-people-flying-again) - A review of certain airline testing procedures and requirements.
- [ARCHIVED: Charting a Covid-19 Immune Response](#charting-a-covid-19-immune-response) - A visual explanation of the immune response for a Covid-19 infection.
- [ARCHIVED: Identify the Different Symptoms of the Flu and Covid-19](#identify-the-different-symptoms-of-the-flu-and-covid-19) - With fears of a “twindemic” in the United States this fall, here’s a guide to understanding what’s making you feel terrible.
- [ARCHIVED: Looking to Reopen, Colleges Become Labs for Coronavirus Tests and Tracking Apps](#looking-to-reopen-colleges-become-labs-for-coronavirus-tests-and-tracking-apps) - Wastewater testing and tracking apps are being used to track potential student exposure.
- [ARCHIVED: Chinese Vaccine Maker in Talks With Countries on Early Approval](#chinese-vaccine-maker-in-talks-with-countries-on-early-approval)
- [ARCHIVED: Coronavirus re-infections raise concerns about immunity](#coronavirus-re-infections-raise-concerns-about-immunity) - Two European patients are confirmed to have been re-infected with COVID-19, raising concerns about people’s immunity to the coronavirus as the world struggles to tame the pandemic.
- [ARCHIVED: Why Antibody Tests Won’t Help You Much](#why-antibody-tests-wont-help-you-much)
- [ARCHIVED: What if the First Coronavirus Vaccines Aren’t the Best?](#what-if-the-first-coronavirus-vaccines-arent-the-best)
- [ARCHIVED: The WHO’s Flawed Design Was No Match for Covid](#the-whos-flawed-design-was-no-match-for-covid) - A review of the WHO response/limitations to the newly emerging SARS-CoV-2.
- [ARCHIVED: How Covid Sends Some Bodies to War With Themselves](#how-covid-sends-some-bodies-to-war-with-themselves)
- [ARCHIVED: ‘A Smoking Gun’: Infectious Coronavirus Retrieved From Hospital Air](#a-smoking-gun-infectious-coronavirus-retrieved-from-hospital-air) - A research team at the University of Florida succeeded in isolating live virus from aerosols collected at a distance of seven to 16 feet from patients hospitalized with Covid-19 — farther than the six feet recommended in social distancing guidelines.
- [ARCHIVED: Experimental Assessment of Carbon Dioxide Content in Inhaled Air With or Without Face Masks in Healthy Children](#experimental-assessment-of-carbon-dioxide-content-in-inhaled-air-with-or-without-face-masks-in-healthy-children) - Walach H, Weikl R, Prentice J, et al. A large-scale survey3 in Germany of adverse effects in parents and children using data of 25 930 children has shown that 68% of the participating children had problems when wearing nose and mouth coverings.
- [ARCHIVED: COVID-19 Employer Information for Office Buildings](#covid-19-employer-information-for-office-buildings-2) - Includes information on building ventilation, slowing the spread at work, employee awareness and training.
- [ARCHIVED: Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine — United States, September 6, 2020–May 1, 2021](#myths-and-facts-about-covid-19-vaccines-2) - The greater decline in COVID-19 morbidity and mortality in older adults, the age group with the highest vaccination rates, demonstrates the potential impact of increasing population-level vaccination coverage.
- [ARCHIVED: COVID-19 vaccination and immune thrombocytopenia](#covid-19-vaccination-and-immune-thrombocytopenia) - Pishko A, Bussel JB, Cines DB.A prospective cohort analysis finds a link between the ChAdOx1 vaccine and an autoimmune disorder known as immune thrombocytopenia—but questions remain and causality is yet to be established.
- [ARCHIVED: Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021](#hospitalization-of-adolescents-aged-1217-years-with-laboratory-confirmed-covid-19-covid-net-14-states-march-1-2020april-24-2021) - Havers FP, Whitaker M, Self JL, et al.
- [ARCHIVED: Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia](#novel-canine-coronavirus-isolated-from-a-hospitalized-pneumonia-patient-east-malaysia) - Vlasova A N, Diaz A, et.al.
- [ARCHIVED: Moderna Says New Variant Vaccine Is Ready for Human Testing](#moderna-says-new-variant-vaccine-is-ready-for-human-testing-2)
- [ARCHIVED: Moderna Rolls Out Doses to Fight New Strain](#moderna-rolls-out-doses-to-fight-new-strain)
- [ARCHIVED: Israeli Study Finds Pfizer Shot Equally Effective for Young and Old](#israeli-study-finds-pfizer-shot-equally-effective-for-young-and-old-2) - A single shot of the Pfizer-BioNTech vaccine is 85% effective in preventing symptomatic disease 15 to 28 days after being administered, an Israeli study found.
- [ARCHIVED: Single Pfizer Vaccine Dose Shown to Be 85% Effective](#single-pfizer-vaccine-dose-shown-to-be-85-effective) - A single shot of the Pfizer-BioNTech vaccine is 85% effective in preventing symptomatic disease 15 to 28 days after being administered, an Israeli study found.
- [ARCHIVED: Coming Soon: The ‘Vaccine Passport’](#coming-soon-the-vaccine-passport) - "In the near future, travel may require digital documentation showing that passengers have been vaccinatedor tested for the coronavirus."
- [ARCHIVED: U.K. Mutation Resists Vaccine](#u-k-mutation-resists-vaccine)
- [ARCHIVED: Vaccines Could Blunt U.K. Epidemic in Weeks](#vaccines-could-blunt-u-k-epidemic-in-weeks)
- [ARCHIVED: Covid-19 Story Tip: Flu Cases Dramatically Low So Far This Season](#covid-19-story-tip-flu-cases-dramatically-low-so-far-this-season) - Johns Hopkins Medicine experts say cases of the flu are extremely low nationwide this year, because more people received the flu vaccine, schools and businesses are holding virtual classes or meetings and fewer people have been traveling.
- [ARCHIVED: You Are Unvaccinated and Got Sick. These Are Your Odds](#you-are-unvaccinated-and-got-sick-these-are-your-odds) - Comparing the dangerous effects of three diseases with the minimal side effects of their corresponding vaccines.
- [ARCHIVED: The Risks of the Covid Vaccine, in Context](#the-risks-of-the-covid-vaccine-in-context)
- [ARCHIVED: Hang in There, Help Is on the Way](#hang-in-there-help-is-on-the-way) - "Times are tough now, but the end is in sight. If we hunker down, keep our families safe during the holidays and monitor our health at home, life will get better in the spring. Here’s how to get through it."
- [ARCHIVED: Employers Can Require Workers to Get Covid-19 Vaccine, U.S. Says](#employers-can-require-workers-to-get-covid-19-vaccine-u-s-says)
- [ARCHIVED: Can You Get a Covid Test at Home?](#can-you-get-a-covid-test-at-home)
- [ARCHIVED: When Will Covid Vaccines Be Available for Kids?](#when-will-covid-vaccines-be-available-for-kids)
- [ARCHIVED: ‘Nobody Sees Us’: Testing-Lab Workers Strain Under Demand](#nobody-sees-us-testing-lab-workers-strain-under-demand) - Laboratory technologists have been working nonstop to help the nation diagnose an ever-growing number of coronavirus cases.
- [ARCHIVED: Watching What We Flush Could Help Keep a Pandemic Under Control](#watching-what-we-flush-could-help-keep-a-pandemic-under-control) - Wastewater testing is demonstrating the ability to predict an increase in COVID cases several days in advance.
- [ARCHIVED: Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective](#pfizers-early-data-shows-vaccine-is-more-than-90-effective)
- [ARCHIVED: Who Should Get a Covid-19 Vaccine First?](#who-should-get-a-covid-19-vaccine-first)
- [ARCHIVED: Covid-19 Vaccine Safety Efforts to Feature App Tracking](#covid-19-vaccine-safety-efforts-to-feature-app-tracking-2)
- [ARCHIVED: Denmark to Cull Mink for Coronavirus Risk](#denmark-to-cull-mink-for-coronavirus-risk)
- [Transmission of COVID-19 and other infectious diseases in public washrooms: A systematic review](#transmission-of-covid-19-and-other-infectious-diseases-in-public-washrooms-a-systematic-review) - Vardoulakis S, et.al
- [Bloodborne Viral Pathogen Contamination in the Era of Laboratory Automation](#bloodborne-viral-pathogen-contamination-in-the-era-of-laboratory-automation) - Bryan A., et.alAn interesting reference for testing for SARS-CoV-2 and others -- A low level of viral contamination of automated clinical laboratory equipment occurs in clinical use. Given the risks associated with highly infectious agents, there is a need for risk-mitigation procedures when handling all samples.
- [Concordance of SARS-CoV-2 RNA in Aerosols From a Nurses Station and in Nurses and Patients During a Hospital Ward Outbreak](#concordance-of-sars-cov-2-rna-in-aerosols-from-a-nurses-station-and-in-nurses-and-patients-during-a-hospital-ward-outbreak) - Stern, R, et.al
- [Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy](#neurodevelopmental-outcomes-at-1-year-in-infants-of-mothers-who-tested-positive-for-sars-cov-2-during-pregnancy) - Edlow A, et. alPreliminary findings suggest that COVID-19 exposure may be associated with neurodevelopmental changes and highlight the need for prospective investigation of outcomes in children exposed to COVID-19 in utero.
- [Ventilation Improvement Strategies Among K–12 Public Schools — The National School COVID-19 Prevention Study, United States, February 14–March 27, 2022](#ventilation-improvement-strategies-among-k12-public-schools-the-national-school-covid-19-prevention-study-united-states-february-14march-27-2022)
- [Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022](#interim-recommendations-of-the-advisory-committee-on-immunization-practices-for-use-of-moderna-and-pfizer-biontech-covid-19-vaccines-in-children-aged-6-months5-years-united-states-june-2022-2)
- [Rescission: Requirement for Negative Pre-Departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for all Airline or Other Aircraft Passengers Arriving into the United States from Any Foreign Country](#rescission-requirement-for-negative-pre-departure-covid-19-test-result-or-documentation-of-recovery-from-covid-19-for-all-airline-or-other-aircraft-passengers-arriving-into-the-united-states-from-an-2) - As of 12:01AM ET on June 12, 2022, all air passengers, regardless of citizenship or vaccination status, are no longer required to show a negative viral COVID-19 test result, or documentation of recovery from COVID-19, before boarding a flight to the United States.
- [Aerosol particle emission increases exponentially above moderate exercise intensity resulting in superemission during maximal exercise](#aerosol-particle-emission-increases-exponentially-above-moderate-exercise-intensity-resulting-in-superemission-during-maximal-exercise) - Mutsch B, Heiber M, Grätz F, Hain R, Schönfelder M, Kaps S, Schranner D, Kähler CJ, Wackerhage H
- [Rates of COVID-19 Cases and Deaths by Vaccination Status](#rates-of-covid-19-cases-and-deaths-by-vaccination-status)
- [Laboratory Biosafety Resources Related to SARS-CoV- 2/COVID-19 Virus Samples/Materials](#laboratory-biosafety-resources-related-to-sars-cov-2-covid-19-virus-samples-materials) - FAQs for handling samples from clinical trials and for research
- [COVID-19 Safe handling and processing for samples in laboratory](#covid-19-safe-handling-and-processing-for-samples-in-laboratory) - This PHE guidance has been produced in collaboration with the Health and Safety Executive and will be updated when new information becomes available.
- [SARS CoV 2 Laboratory Safety Guidance](#sars-cov-2-laboratory-safety-guidance) - Slide presentation on Laboratory Safety practices
- [Technical disease cards, The World Organisation for Animal Health (OIE)](#technical-disease-cards-the-world-organisation-for-animal-health-oie) - The OIE has updated the technical disease cards for 34 important animal diseases, including 33 OIE-listed diseases. These are currently available in English only.
- [How Long Can I Keep Wearing the Same Respirator Mask?](#how-long-can-i-keep-wearing-the-same-respirator-mask)
- [How long covid is accelerating a revolution in medical research](#how-long-covid-is-accelerating-a-revolution-in-medical-research)
- [Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19](#updated-information-on-availability-and-use-of-treatments-for-outpatients-with-mild-to-moderate-covid-19-who-are-at-increased-risk-for-severe-outcomes-of-covid-19)
- [COVID-19 Vaccination for Children and Teens with Disabilities](#covid-19-vaccination-for-children-and-teens-with-disabilities)
- [Covid-19 vaccines and hearing loss and tinnitus](#covid-19-vaccines-and-hearing-loss-and-tinnitus) - Rausch, C, et al(No. 1, 2022) page 18
- [Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022](#effectiveness-of-covid-19-mrna-vaccination-in-preventing-covid-19associated-hospitalization-among-adults-with-previous-sars-cov-2-infection-united-states-june-2021february-2022) - Plumb ID, Feldstein LR, Barkley E, et al.
- [Association of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal Anomalies](#association-of-covid-19-vaccination-during-early-pregnancy-with-risk-of-congenital-fetal-anomalies) - Ruderman RS, Mormol J, Trawick E, et al
- [Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples](#coronavirus-covid-19-update-fda-authorizes-first-covid-19-diagnostic-test-using-breath-samples)
- [Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022](#seroprevalence-of-infection-induced-sars-cov-2-antibodies-united-states-september-2021february-2022) - Clarke KE, Jones JM, Deng Y, et al.
- [Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children](#coronavirus-covid-19-update-fda-approves-first-covid-19-treatment-for-young-children)
- [Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022](#hospitalizations-of-children-aged-511-years-with-laboratory-confirmed-covid-19-covid-net-14-states-march-2020february-2022) - Shi DS, Whitaker M, Marks KJ, et al.
- [Do I qualify for a COVID-19 vaccine booster and which one?](#coronavirus-covid-19-update-fda-authorizes-second-booster-dose-of-two-covid-19-vaccines-for-older-and-immunocompromised-individuals-2) - Use this chart to find out if you're eligible for a COVID-19 vaccine booster and which one.
- [Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals](#coronavirus-covid-19-update-fda-authorizes-second-booster-dose-of-two-covid-19-vaccines-for-older-and-immunocompromised-individuals) - The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.
- [Taiwan’s science academy fined for biosafety lapses after lab worker contracts COVID-19](#taiwans-science-academy-fined-for-biosafety-lapses-after-lab-worker-contracts-covid-19-2) - A research assistant at an Academia Sinica lab fell ill in November 2021 after working with infected animals
- [COVID-19 Antigen Testing Biosafety Guidance](#covid-19-antigen-testing-biosafety-guidance) - This document describes recommended biosafety practices to protect personnel and the work area from contamination with Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when collecting and testing specimens for coronavirus disease 2019 (COVID-19) using an antigen test (ex. BD VeritorTM, Quidel SofiaTM or Abbott BinaxNOW TM ).
- [COVID-19 and the gain of function debates](#covid-19-and-the-gain-of-function-debates) - Warmbrod, K. et al. Improving biosafety measures requires a more precise definition of which experiments would raise safety concerns
- [Biosafety advisory: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2)](#biosafety-advisory-sars-cov-2-severe-acute-respiratory-syndrome-coronavirus-2) - This recent update includes Classification of full length SARS-CoV-2 RNA as a Risk Group 2 human pathogen and a Risk Group 1 animal pathogen.
- [Get the Most out of Masking](#get-the-most-out-of-masking)
- [COVID-19 (SARS-CoV-2) Special Collection](#covid-19-sars-cov-2-special-collection) - This collection highlights all COVID-19/SARS-CoV-2 research published across ASM Journals. All content is free to read and available for text and data mining via PubMed Central.
- [New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2](#new-studies-contend-wuhan-market-animals-not-laboratory-first-infected-humans-with-sars-cov2)
- [Take a look at SARS-CoV-2's family tree. It's full of surprises](#take-a-look-at-sars-cov-2s-family-tree-its-full-of-surprises-2)
- [Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant](#coronavirus-covid-19-update-fda-authorizes-new-monoclonal-antibody-for-treatment-of-covid-19-that-retains-activity-against-omicron-variant)
- [Spikevax and Moderna COVID-19 Vaccine](#spikevax-and-moderna-covid-19-vaccine) - The FDA has given full approval to the Moderna COVID-19 Vaccine which will now be marketed as Spikevax, for the prevention of COVID-19 in individuals 18 years of age and older.
- [Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022](#effectiveness-of-maternal-vaccination-with-mrna-covid-19-vaccine-during-pregnancy-against-covid-19associated-hospitalization-in-infants-aged-6-months-17-states-july-2021january-2022) - Halasa NB, Olson SM, Staat MA, et al.Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants aged
- [Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review](#development-of-graves-disease-after-sars-cov-2-mrna-vaccination-a-case-report-and-literature-review) - Lui, DT, et. alLiterature review of thyroid dysfunction after SARS-CoV-2 vaccination.
- [Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022](#effectiveness-of-covid-19-pfizer-biontech-bnt162b2-mrna-vaccination-in-preventing-covid-19associated-emergency-department-and-urgent-care-encounters-and-hospitalizations-among-nonimmunocompromised-chi) - Klein NP, Stockwell MS, Demarco M, et al.Two doses protect against COVID-19–associated emergency department and urgent care encounters among children and adolescents. However, vaccine effectiveness (VE) was lower during Omicron predominance and decreased with time since vaccination; a booster dose restored VE to 81% among adolescents aged 16–17 years. Overall, 2-dose VE against COVID-19–associated hospitalization
- [Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022](#waning-2-dose-and-3-dose-effectiveness-of-mrna-vaccines-against-covid-19associated-emergency-department-and-urgent-care-encounters-and-hospitalizations-among-adults-during-periods-of-delta-and-omicron) - Ferdinands JM, Rao S, Dixon BE, et al.
- [Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing](#heat-inactivation-of-clinical-covid-19-samples-on-an-industrial-scale-for-low-risk-and-efficient-high-throughput-qrt-pcr-diagnostic-testing) - Delpuech O, Douthwaite JA, Hill T, et al.Heating as the sole method of virus inactivation is ideally suited to streamlined and more rapid workflows such as ‘direct to PCR’ assays that do not involve RNA extraction or chemical neutralisation methods.
- [Taiwan’s science academy fined for biosafety lapses after lab worker contracts COVID-19](#taiwans-science-academy-fined-for-biosafety-lapses-after-lab-worker-contracts-covid-19) - Silver ALapses in donning and doffing, BSC use, use of PPE cited in LAI in Taiwanans the pandemic is showing signs of ebbing. In white-tailed deer and other wildlife, however, infections appear widespread.
- [SARS-CoV-2 is moving between humans and wildlife](#sars-cov-2-is-moving-between-humans-and-wildlife) - Baillie K UIn humans the pandemic is showing signs of ebbing. In white-tailed deer and other wildlife, however, infections appear widespread.
- [APHIS Announces Final Strategic Framework for Enhancing Surveillance for SARS-CoV-2 and other Emerging Diseases Under the American Rescue Plan](#aphis-announces-final-strategic-framework-for-enhancing-surveillance-for-sars-cov-2-and-other-emerging-diseases-under-the-american-rescue-plan-2)
- [SARS-CoV-2 in the Air: What’s Known and What Isn’t](#sars-cov-2-in-the-air-whats-known-and-what-isnt) - Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.
- [Variants of Concern](#variants-of-concern)
- [SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance — Los Angeles County, California, November 7, 2021–January 8, 2022](#sars-cov-2-infection-and-hospitalization-among-adults-aged-18-years-by-vaccination-status-before-and-during-sars-cov-2-b-1-1-529-omicron-variant-predominance-los-angeles-county-california-november-7) - Danza P, Koo TH, Haddix M, et al. Omicron summary relative to infection and hospitalization of adults.
- [Emerging Vaccine-Breakthrough SARS-CoV-2 Variants](#emerging-vaccine-breakthrough-sars-cov-2-variants) - Wang R, et.al
- [Multiple early factors anticipate post-acute COVID-19 sequelae](#multiple-early-factors-anticipate-post-acute-covid-19-sequelae) - Su Y, et. al The study found four factors that could be identified early in a person’s coronavirus infection that appeared to correlate with increased risk of having lasting symptoms weeks later.
- [COVID-19 clinical care pathway (‎CARE)‎: confirm SARS-CoV-2 infection, assess symptoms, risk factors and severity, respond with appropriate care and treatment, evaluate clinical response and recovery](#covid-19-clinical-care-pathway-care-confirm-sars-cov-2-infection-assess-symptoms-risk-factors-and-severity-respond-with-appropriate-care-and-treatment-evaluate-clinical-response-and-recovery)
- [COVID-19 Community Levels](#covid-19-community-levels) - CDC is launching a new tool to monitor COVID-19 Community Levels. Each county’s COVID-19 Community Level is ranked as low, medium, or high. The community level, updated regularly, will be tied to high, medium or low precautions based on certain factors such as hospitalizations, cases and beds filled.
- [Predictors of SARS-CoV-2 infection following high-risk exposure](#predictors-of-sars-cov-2-infection-following-high-risk-exposure) - Andrejko KL, et al. Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified.
- [Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021](#myocarditis-cases-reported-after-mrna-based-covid-19-vaccination-in-the-us-from-december-2020-to-august-2021) - Oster ME, et al. In this descriptive study of 1626 cases of myocarditis in a national passive reporting system, the crude reporting rates within 7 days after vaccination exceeded the expected rates across multiple age and sex strata.
- [A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient](#a-case-of-varicella-zoster-virus-meningitis-following-bnt162b2-mrna-covid-19-vaccination-in-an-immunocompetent-patient) - Maruki T, et al. We encountered a patient who developed VZV meningitis shortly after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine.
- [Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021](#receipt-of-covid-19-vaccine-during-pregnancy-and-preterm-or-small-for-gestational-age-at-birth-eight-integrated-health-care-organizations-united-states-december-15-2020july-22-2021) - Lipkind HS, Vazquez-Benitez G, DeSilva M, et al. In a retrospective cohort of >40,000 pregnant women, COVID-19 vaccination during pregnancy was not associated with preterm birth or small-for-gestational-age at birth overall, stratified by trimester of vaccination, or number of vaccine doses received during pregnancy, compared with unvaccinated pregnant women.
- [Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019: A Prospective Cohort Study of 46,000 Healthcare Workers](#effect-of-influenza-vaccination-on-risk-of-coronavirus-disease-2019-a-prospective-cohort-study-of-46-000-healthcare-workers) - Kristensen JH, et al. The present findings indicate that influenza vaccination does not affect the risk of SARS-CoV-2 infection or COVID-19.
- [Overview of Testing for SARS-CoV-2, the virus that causes COVID-19](#overview-of-testing-for-sars-cov-2-the-virus-that-causes-covid-19) - This document provides guidance on the different types of viral tests for SARS-CoV-2 available in the United States and their intended uses. It does not address issues regarding payment for or insurance coverage of such testing.
- [Outcomes of SARS-CoV-2–Positive Youths Tested in Emergency Departments: The Global PERN–COVID-19 Study](#outcomes-of-sars-cov-2positive-youths-tested-in-emergency-departments-the-global-perncovid-19-study) - Funk AL, et al. Among 3221 SARS-CoV-2–positive youths enrolled in a global prospective cohort study with outcome data, 3.3% had severe outcomes within 14 days. Across a subgroup of 2510 SARS-CoV-2–positive youths discharged home after testing, 0.5% had severe outcomes during the 2-week follow-up period.
- [Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India](#cumulative-mortality-and-factors-associated-with-outcomes-of-mucormycosis-after-covid-19-at-a-multispecialty-tertiary-care-center-in-india) - Choksi T, et al. An outbreak of COVID-19-associated rhino-orbitocerebral mucormycosis (CAM) has occurred in many parts of the world. Although the clinical profile and risk factors for CAM have been studied, cumulative mortality and its risk factors have not.
- [Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study](#risk-factors-and-disease-profile-of-post-vaccination-sars-cov-2-infection-in-uk-users-of-the-covid-symptom-study-app-a-prospective-community-based-nested-case-control-study) - Antonelli M, et al. This study aimed to identify risk factors for post-vaccination SARS-CoV-2 infection and describe the characteristics of post-vaccination illness.
- [SARS-CoV-2 in animals, Hong Kong](#sars-cov-2-in-animals-hong-kong) - Zoonotic potential description: based on the current epidemiological findings, there is suspicion of animal-to-human transmission.This event pertains to the whole country.
- [Development and Application of a Polydimethylsiloxane-Based Passive Air Sampler to Assess Personal Exposure to SARS-CoV-2](#development-and-application-of-a-polydimethylsiloxane-based-passive-air-sampler-to-assess-personal-exposure-to-sars-cov-2) - Angel DM, et al. Detection of SARS-CoV-2 using Fresh Air Clips demonstrates that exposure to airborne or droplet virus can be detected using passive sampling methods.
- [HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung](#hkumed-finds-omicron-sars-cov-2-can-infect-faster-and-better-than-delta-in-human-bronchus-but-with-less-severe-infection-in-lung) - Premiminary data indicates that Omicron infects and mulitplies 70x faster than the Delta variant, but causes a lower infection in the lung.
- [HKU microbiologists find that two doses of BNT162b2 (BioNTech ) or Coronavac (Sinovac) vaccines are inadequate against Omicron virus variants](#hku-microbiologists-find-that-two-doses-of-bnt162b2-biontech-or-coronavac-sinovac-vaccines-are-inadequate-against-omicron-virus-variants)
- [Scientists find ‘stealth’ version of Omicron that may be harder to track](#scientists-find-stealth-version-of-omicron-that-may-be-harder-to-track) - Variant lacks feature that allows probable cases to be distinguished among positive PCR tests
- [Do I Still Need a Pulse Oximeter?](#do-i-still-need-a-pulse-oximeter) - New research from South Africa shows that using a pulse oximeter to check oxygen levels after a Covid diagnosis really does save lives.
- [Studies Suggest Why Omicron Is Less Severe: It Spares the Lungs](#studies-suggest-why-omicron-is-less-severe-it-spares-the-lungs)
- [Counterfeit Covid Masks Are Still Sold Everywhere, Despite Misleading Claims](#counterfeit-covid-masks-are-still-sold-everywhere-despite-misleading-claims)
- [Using Therapeutics to Prevent and Treat COVID-19](#using-therapeutics-to-prevent-and-treat-covid-19) - Good summary of vaccine information (elegibility, ages, boosters, side effects, safety, etc.).
- [Key Things to Know About COVID-19 Vaccines](#key-things-to-know-about-covid-19-vaccines-2) - Good summary of vaccine information (elegibility, ages, boosters, side effects, safety, etc.).
- [SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests](#sars-cov-2-viral-mutations-impact-on-covid-19-tests-2) - A review of molecular, antigen, and serology tests that are affected by viral mutations differently due to the inherent design differences of each test.
- [Over The Counter (OTC) Home Testing and CLIA Applicability Frequently Asked Questions](#over-the-counter-otc-home-testing-and-clia-applicability-frequently-asked-questions) - Outlines how the Clinical Laboratory Improvement Amendments of 1988 (CLIA) apply to over-the-counter (OTC) home testing when used in different settings, particularly when the test is performed by someone other than the individual who needs testing.
- [Ending Isolation and Precautions for People with COVID-19: Interim Guidance](#ending-isolation-and-precautions-for-people-with-covid-19-interim-guidance) - CDC is shortening the recommended time for isolation for the public. People with COVID-19 should isolate for 5 days and if they are asymptomatic or their symptoms are resolving (without fever for 24 hours), follow that by 5 days of wearing a mask when around others to minimize the risk of infecting people they encounter.
- [Guidelines for Working with Free-Ranging Wild Mammals in the Era of the COVID-19 Pandemic](#guidelines-for-working-with-free-ranging-wild-mammals-in-the-era-of-the-covid-19-pandemic) - These recommendations were developed to minimize the risk of SARS-CoV-2 transmission from people to freeranging, wild mammals.
- [Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021](#investigation-of-a-sars-cov-2-b-1-1-529-omicron-variant-cluster-nebraska-novemberdecember-2021)
- [Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa)](#airborne-transmission-of-sars-cov-2-delta-variant-within-tightly-monitored-isolation-facility-new-zealand-aotearoa-2) - Fox-Lewis A, Williamson F, Harrower J, Ren X, Sonder GJB, McNeill A, et al.
- [Omicron Variant: What You Need to Know](#omicron-variant-what-you-need-to-know) - Updated information on the Omicron variant
- [New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant](#new-sars-cov-2-variant-of-concern-identified-omicron-b-1-1-529-variant) - Due to the increased transmissibility of the Omicron variant and concerns about potential impacts on the healthcare system, the CDC is updating recommendations to enhance protection for healthcare personnel, patients, and visitors, and ensure adequate staffing in healthcare facilities.
- [Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure](#rapid-increase-of-omicron-variant-infections-in-the-united-states-management-of-healthcare-personnel-with-sars-cov-2-infection-or-exposure) - Due to the increased transmissibility of the Omicron variant and concerns about potential impacts on the healthcare system, the CDC is updating recommendations to enhance protection for healthcare personnel, patients, and visitors, and ensure adequate staffing in healthcare facilities.
- [SARS-CoV-2 variants of concern](#sars-cov-2-variants-of-concern) - One-stop-shop to scroll and search for VOI, VOC, variants under monitoring, and de-escalated variants
- [COVID-19: Scientific Updates](#covid-19-scientific-updates) - Part 2 outlines what makes a good mask study and why so many fail.
- [COMMENTARY: What can masks do? Part 2: What makes for a good mask study — and why most fail](#commentary-what-can-masks-do-part-2-what-makes-for-a-good-mask-study-and-why-most-fail-2) - Part 2 outlines what makes a good mask study and why so many fail.
- [COMMENTARY: What can masks do? Part 1: The science behind COVID-19 protection](#commentary-what-can-masks-do-part-1-the-science-behind-covid-19-protection-2-2) - Part 1 of a two-part commentary explains the differences in cloth face coverings and surgical masks, the science of respiratory protection, and the hierarchy of disease controls.
- [Lab Testing Capacity and Capability Data Dashboard](#lab-testing-capacity-and-capability-data-dashboard-2) - APHL has conducted a weekly survey of 99 state, local and territorial public health laboratories (PHLs) to collect the status of current and projected capability and capacity of laboratories to test for SARS-CoV-2, the virus that causes the Coronavirus Disease (COVID-19).
- [Africa Centres for Disease Control and Prevention’s Statement regarding the new SARS-COV-2 virus variant B.1.1.529](#africa-centres-for-disease-control-and-preventions-statement-regarding-the-new-sars-cov-2-virus-variant-b-1-1-529) - On 25 November 2021, the National Institute for Communicable Diseases (NICD) in South Africa announced the detection of a new variant of the SARS-COV-2, the virus that causes COVID-19, following genomic sequencing. This variant is currently labelled as lineage B.1.1.529.
- [§ 73.13 Restricted experiments.](#73-13-restricted-experiments)
- [Tracking SARS-CoV-2 variants](#tracking-sars-cov-2-variants) - WHO, in collaboration with partners, expert networks, national authorities, institutions and researchers have been monitoring and assessing the evolution of SARS-CoV-2 since January 2020
- [Interactive Ventilation Tool](#interactive-ventilation-tool) - Good ventilation, along with other preventive actions, like staying 6 feet apart and correctly wearing masks, can help prevent you from getting and spreading COVID-19.
- [About the COVID-19 Vaccine: Frequently Asked Questions](#about-the-covid-19-vaccine-frequently-asked-questions) - The AAP maintains this section on COVID-19 and the pediatric population. It includes FAQs, vaccination recommendations, vaccine research, post vaccination monitoring and more.
- [Key planning recommendations for mass gatherings in the context of COVID-19](#key-planning-recommendations-for-mass-gatherings-in-the-context-of-covid-19-2) - The purpose of this document is to provide guidance to host governments, health authorities and national or international event organizers on taking decisions related to holding mass gatherings in the context of the COVID-19 pandemic, and on decreasing the risks of SARS-CoV-2 transmission
- [Biosafety Professionals: A Role in the Pandemic Response Team](#biosafety-professionals-a-role-in-the-pandemic-response-team)
- [New Clues Emerge About Whether Vaccines Can Help Fight Long Covid](#new-clues-emerge-about-whether-vaccines-can-help-fight-long-covid-2) - The latest research suggests that vaccinations help reduce the likelihood of developinglonger-term symptoms after a Covid-19 infection and may help some people withsymptoms feel better.
- [The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency](#the-spike-protein-of-sars-cov-2-variant-a-30-is-heavily-mutated-and-evades-vaccine-induced-antibodies-with-high-efficiency) - Arora P, Rocha C, Kempf A, et al.
- [COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021](#covid-19-vaccination-and-noncovid-19-mortality-risk-seven-integrated-health-care-organizations-united-states-december-14-2020july-31-2021) - Xu S, Huang R, Sy LS, et al.
- [COVID-19 Vaccines for Children and Teens](#covid-19-vaccines-for-children-and-teens)
- [The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021](#the-advisory-committee-on-immunization-practices-interim-recommendations-for-additional-primary-and-booster-doses-of-covid-19-vaccines-united-states-2021) - Mbaeyi S, Oliver SE, Collins JP, et al.
- [COVID-19 Vaccine Booster Shots](#covid-19-vaccine-booster-shots-2)
- [Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021](#laboratory-confirmed-covid-19-among-adults-hospitalized-with-covid-19like-illness-with-infection-induced-or-mrna-vaccine-induced-sars-cov-2-immunity-nine-states-januaryseptember-2021) - Olson SM, Newhams MM, Halasa NB, et al.
- [Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021](#effectiveness-of-pfizer-biontech-mrna-vaccination-against-covid-19-hospitalization-among-persons-aged-1218-years-united-states-juneseptember-2021) - Olson SM, Newhams MM, Halasa NB, et al.
- [UV Inactivation of SARS-CoV-2 across the UVC Spectrum: KrCl* Excimer, Mercury-Vapor, and Light-Emitting-Diode (LED) Sources](#uv-inactivation-of-sars-cov-2-across-the-uvc-spectrum-krcl-excimer-mercury-vapor-and-light-emitting-diode-led-sources) - Ma, B, et.al
- [COMMENTARY: What can masks do? Part 2: What makes for a good mask study — and why most fail](#commentary-what-can-masks-do-part-2-what-makes-for-a-good-mask-study-and-why-most-fail)
- [COMMENTARY: What can masks do? Part 1: The science behind COVID-19 protection](#commentary-what-can-masks-do-part-1-the-science-behind-covid-19-protection)
- [Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021](#severity-of-disease-among-adults-hospitalized-with-laboratory-confirmed-covid-19-before-and-during-the-period-of-sars-cov-2-b-1-617-2-delta-predominance-covid-net-14-states-januaryaugust-2021) - Taylor CA, Patel K, Pham H, et al.
- [The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study](#the-durability-of-immunity-against-reinfection-by-sars-cov-2-a-comparative-evolutionary-study) - Townsend J, et.al
- [WHO names 26-scientist group to investigate origins of COVID-19, future outbreaks](#who-names-26-scientist-group-to-investigate-origins-of-covid-19-future-outbreaks)
- [Cruise Ship Travel During COVID-19](#cruise-ship-travel-during-covid-19)
- [Holiday Celebrations: Safer Ways to Celebrate Holidays](#holiday-celebrations-safer-ways-to-celebrate-holidays)
- [Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load](#estimating-salivary-carriage-of-severe-acute-respiratory-syndrome-coronavirus-2-in-nonsymptomatic-people-and-efficacy-of-mouthrinse-in-reducing-viral-load-2) - Chaudhary P, et.al
- [Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic](#tuberculosis-deaths-rise-for-the-first-time-in-more-than-a-decade-due-to-the-covid-19-pandemic)
- [You’ve been exposed to COVID-19 - Now what?](#youve-been-exposed-to-covid-19) - You had close contact, masked or unmasked, indoors or outdoors, with someone during their contagious period*. Now what?Based on CDC guidance as of 07/30/21
- [You were tested for COVID-19 now what?](#you-were-tested-for-covid-19-now-what-2) - WHILE YOU WAIT for your COVID-19 results, protect your family, friends and community
- [Occupational Exposure to COVID-19; Emergency Temporary Standard](#occupational-exposure-to-covid-19-emergency-temporary-standard) - Interim final rule, request for comments. OSHA is issuing an emergency temporary standard (ETS) to protect healthcare and healthcare support service workers from occupational exposure to COVID-19 in settings where people with COVID-19 are reasonably expected to be present.
- [COVID-19 Science Update](#covid-19-science-update) - This weekly series provides brief summaries of new COVID-19-related studies on many topics, including epidemiology, clinical treatment and management, laboratory science, and modeling.
- [Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11](#pfizer-asks-f-d-a-to-authorize-its-covid-19-vaccine-for-children-5-to-11)
- [Expelled Larger Droplets During Upper Endoscopy and Colonoscopy Are Transmission Risk for COVID-19](#expelled-larger-droplets-during-upper-endoscopy-and-colonoscopy-are-transmission-risk-for-covid-19) - Large droplets expelled by patients during upper endoscopy and colonoscopy procedures pose a risk for COVID-19 transmission to nearby healthcare workers
- [Air Filters: A Guide to Smart—and Not So Smart—Models as Covid-19 and Wildfires Drive Demand](#air-filters-a-guide-to-smartand-not-so-smartmodels-as-covid-19-and-wildfires-drive-demand)
- [What Science Knows Now About the Risk of Covid-19 Transmission on Planes](#what-science-knows-now-about-the-risk-of-covid-19-transmission-on-planes)
- [Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study](#merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderate-covid-1)
- [Multicomponent Strategies to Prevent SARS-CoV-2 Transmission — Nine Overnight Youth Summer Camps, United States, June–August 2021](#multicomponent-strategies-to-prevent-sars-cov-2-transmission-nine-overnight-youth-summer-camps-united-states-juneaugust-2021) - Van Naarden Braun K, Drexler M, Rozenfeld RA, et al.
- [Pediatric COVID-19 Cases in Counties With and Without School Mask Requirements — United States, July 1–September 4, 2021](#pediatric-covid-19-cases-in-counties-with-and-without-school-mask-requirements-united-states-july-1september-4-2021-2) - Budzyn SE, Panaggio MJ, Parks SE, et al.
- [Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021](#safety-monitoring-of-an-additional-dose-of-covid-19-vaccine-united-states-august-12september-19-2021) - Hause AM, Baggs J, Gee J, et al.
- [Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments](#beware-of-fraudulent-coronavirus-tests-vaccines-and-treatments)
- [Guidance for Operating Youth and Summer Camps During COVID-19](#guidance-for-operating-youth-and-summer-camps-during-covid-19)
- [Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age](#pfizer-and-biontech-submit-initial-data-to-u-s-fda-from-pivotal-trial-of-covid-19-vaccine-in-children-5-to-12-years-of-age)
- [COVID-19 Quarantine vs. Isolation](#covid-19-quarantive-vs-isolation-2) - Comparison between isolation and quarantine in the context of COVID-19 vaccination
- [SARS-CoV-2 Testing Prior to International Airline Travel, December 2020-May 2021](#sars-cov-2-testing-prior-to-international-airline-travel-december-2020-may-2021) - Tande AJ, Binnicker MJ, Ting HH, Del Rio C, Jalil L, Brawner M, Carter PW,Toomey K, Shah ND, Berbari EF Among 9,853 passengers with a negative SARS-CoV-2 PCR performed within 72 hours of departure from December 2020 through May 2021, five (0.05%) passengers with active SARS-CoV-2 infection were identified with rapid antigen tests and confirmed
- [COVID-19 Emergency Temporary Standard for Healthcare](#covid-19-emergency-temporary-standard-for-healthcare)
- [Booster Shots and Third Doses for COVID-19 Vaccines: What You Need to Know](#booster-shots-and-third-doses-for-covid-19-vaccines-what-you-need-to-know)
- [What to know about booster shots and third doses of the COVID-19 vaccine](#what-to-know-about-booster-shots-and-third-doses-of-the-covid-19-vaccine)
- [SARS-CoV-2 and Biosafety in Laboratory](#sars-cov-2-and-biosafety-in-laboratory) - A Al-Shuwaika, et.al
- [Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021](#use-of-covid-19-vaccines-after-reports-of-adverse-events-among-adult-recipients-of-janssen-johnson-johnson-and-mrna-covid-19-vaccines-pfizer-biontech-and-moderna-update-from-the-advisory-committee-on)
- [COVID-19 Vaccine Equity for Racial and Ethnic Minority Groups](#covid-19-vaccine-equity-for-racial-and-ethnic-minority-groups-2)
- [08/02/2021: Lab Alert: Clarifications about the Retirement of the CDC 2019 Novel Coronavirus (2019-nCov) Real-Time RT-PCR Diagnostic Panel](#08-02-2021-lab-alert-clarifications-about-the-retirement-of-the-cdc-2019-novel-coronavirus-2019-ncov-real-time-rt-pcr-diagnostic-panel)
- [How Dangerous Is the Delta Variant (B.1.617.2)?](#how-dangerous-is-the-delta-variant-b-1-617-2) - Discusses how contagious the Delta variant is, whether current vaccines protect against it and how dangerous it is.
- [CDC: Understanding Variants](#cdc-understanding-variants)
- [Delta Variant: What We Know About the Science](#delta-variant-what-we-know-about-the-science)
- [CDC: The Delta Variant: What You Should Know](#cdc-the-delta-variant-what-you-should-know) - provides information on the Delta variant and what you can do to help slow the spread
- [Virus Clues Found in Wastewater](#virus-clues-found-in-wastewater)
- [Pfizer Vaccine’s Protection Still Strong After 6 Months](#pfizer-vaccines-protection-still-strong-after-6-months)
- [COVID-19 Diagnostics Commons](#covid-19-diagnostics-commons) - Evidence Commons is the first interactive national repository of information on COVID-19 test research.
- [Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study](#persistent-symptoms-in-adult-patients-one-year-after-covid-19-a-prospective-cohort-study) - Seeble J, et al. Neurocognitive long COVID symptoms can persist at least for one year after COVID-19 symptom onset, and reduce life quality significantly.
- [Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk](#evaluation-of-messenger-rna-from-covid-19-btn162b2-and-mrna-1273-vaccines-in-human-milk) - Yarden Golan PhD, Mary Prahl MD, Arianna Cassidy MD, et al Vaccine-associated mRNA was not detected in 13 milk samples collected 4 to 48 hours after vaccination from 7 breastfeeding individuals.
- [Non Human Primate COVID-19 Biosafety Technical page](#non-human-primate-covid-19-biosafety-technical-page) - The purpose of this technical page is to introduce the concept of biosafety, how to implement biosafety practices at the non-human primate/human interface in “range country captive centers,” settings, (hereafter referred to as centers) and how COVID-19 impacts and challenges effective and safe biosafety practices in these centers. Our goal is to promote human and
- [What’s in it for me? The Fundamentals and Implementing ISO 35001: Biorisk Management (588-621-21)](#whats-in-it-for-me-the-fundamentals-and-implementing-iso-35001-biorisk-management-588-621-21) - PREVIOUSLY RECORDED WEBINAR: This webinar highlights the major components of the ISO 35001 standard and the value of laboratory implementation and describe different approaches to apply ISO 35001 in a laboratory setting including SARS-CoV-2 testing
- [Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets](#responses-to-acute-infection-with-sars-cov-2-in-the-lungs-of-rhesus-macaques-baboons-and-marmosets) - Singh, D.K., Singh, B., Ganatra, S.R. et al. Table 1 shows detection of SARS CoV-2 viral RNA in BAL, and nasal swabs
- [Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021](#disparities-in-covid-19-vaccination-coverage-among-health-care-personnel-working-in-long-term-care-facilities-by-job-category-national-healthcare-safety-network-united-states-march-2021-2) - Lee JT, Althomsons SP, Wu H, et al.
- [Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage](#guidance-for-implementing-covid-19-prevention-strategies-in-the-context-of-varying-community-transmission-levels-and-vaccination-coverage) - Christie A, Brooks JT, Hicks LA, et al.
- [Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021](#outbreak-of-sars-cov-2-infections-including-covid-19-vaccine-breakthrough-infections-associated-with-large-public-gatherings-barnstable-county-massachusetts-july-2021) - Brown CM, Vostok J, Johnson H, et al.
- [COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021](#covid-19-vaccine-safety-in-adolescents-aged-12-17-years-united-states-december-14-2020-july-16-2021) - Hause AM, Gee J, Baggs J, et al.
- [Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses](#antibody-response-after-a-third-dose-of-the-mrna-1273-sars-cov-2-vaccine-in-kidney-transplant-recipients-with-minimal-serologic-response-to-2-doses) - Ilies Benotmane, Gabriela Gautier, Peggy Perrin, et al
- [Had COVID? You’ll probably make antibodies for a lifetime](#had-covid-youll-probably-make-antibodies-for-a-lifetime) - People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Vaccines may have the same effect.
- [Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols — United States, 2021](#efficacy-of-portable-air-cleaners-and-masking-for-reducing-indoor-exposure-to-simulated-exhaled-sars-cov-2-aerosols-united-states-2021) - Lindsley WG, Derk RC, Coyle JP, et al.A combination of HEPA air cleaners and universal masking reduced exposure by up to 90%.
- [Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial](#safety-tolerability-and-immunogenicity-of-an-inactivated-sars-cov-2-vaccine-in-healthy-adults-aged-18-59-years-a-randomised-double-blind-placebo-controlled-phase-1-2-clinical-trial) - Sinovac vaccine phase 1/2 clinical trial results
- [NIH COVID-19 Treatment Guidelines: What's New in the Guidelines](#nih-covid-19-treatment-guidelines) - The COVID-19 Treatment Guidelines Panel (the Panel) is committed to updating this document to ensure that health care providers, patients, and policy experts have the most recent information regarding the optimal management of COVID-19 Treatment Guidelines
- [COVID-19 Vaccine Tracker](#covid-19-vaccine-tracker) - This project is supported by McGill University Interdisciplinary Initiative in Infection and Immunity (MI4). The COVID19 Vaccine Tracker is designed to provide clear, accessible, and comprehensive updates about COVID19 vaccine development and approvals worldwide. It includes links to phase 1, phase 2, phase 3 clinical trials.
- [COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines](#covid-19-subcommittee-of-the-who-global-advisory-committee-on-vaccine-safety-gacvs-updated-guidance-regarding-myocarditis-and-pericarditis-reported-with-covid-19-mrna-vaccines) - Updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines
- [Chemical Fume Hood: How it Works to Protect You](#chemical-fume-hood-how-it-works-to-protect-you) - (YouTube video & accompanying PDFs) Dartmouth College, in cooperation with the Division of Safety and Health at the National Institutes of Health and the National Biosafety and Biocontainment Training Program (NBBTP) About the animation(PDF 770KB) Chemical Fume Hood Flyer(PDF 740KB)
- [Coronavirus (COVID-19) Update: June 25, 2021](#coronavirus-covid-19-update-june-25-2021) - the FDA announced revisions to the patient and provider fact sheets for the Moderna and Pfizer-BioNTech COVID-19 vaccines regarding the suggested increased risks of myocarditis and pericarditis following vaccination.
- [Post-COVID Conditions](#post-covid-conditions-2) - Post-COVID conditions are a wide range of new, returning, or ongoing health problems people can experience more than four weeks after first being infected with the virus that causes COVID-19.
- [Contact Tracing Resources for Health Departments](#contact-tracing-resources-for-health-departments-2)
- [FDA warns that vapors from alcohol-based hand sanitizers can have side effects](#fda-warns-that-vapors-from-alcohol-based-hand-sanitizers-can-have-side-effects)
- [Biological Risk Management for Point-of-Care Testing Sites](#biological-risk-management-for-point-of-care-testing-sites) - Use this guidance to help make sure you reduce those risks as much as possible to keep you and your coworkers, patients, customers, family, and community safe and healthy while you perform POC tests.
- [Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic — United States, March–April 2021](#symptoms-of-depression-anxiety-post-traumatic-stress-disorder-and-suicidal-ideation-among-state-tribal-local-and-territorial-public-health-workers-during-the-covid-19-pandemic-united-states-marchapri) - Bryant-Genevier J, Rao CY, Lopes-Cardozo B, et al.
- [COVID-19 Vaccines for People with Underlying Medical Conditions](#covid-19-vaccines-for-people-with-underlying-medical-conditions) - This information aims to help people with certain medical conditions (weakened immune systems, Bell's Palsy history, GBS history) make an informed decision about receiving a COVID-19 vaccine.
- [SARS-CoV-2 Specimens: Packing and Shipping](#sars-cov-2-specimens-packing-and-shipping) - Quick reference guide adapted from the CDC Laboratory Training course for shipping Covid samples.
- [Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020](#antibodies-to-sars-cov-2-in-all-of-us-research-program-participants-january-2-march-18-2020) - Althoff, Keri, et.al.Interim final rule, request for comments. OSHA is issuing an emergency temporary standard (ETS) to protect healthcare and healthcare support service workers from occupational exposure to COVID-19 in settings where people with COVID-19 are reasonably expected to be present.
- [COVID-19 Healthcare Emergency Temporary Standard](#covid-19-healthcare-emergency-temporary-standard) - US Department of Labor's OSHA issues emergency temporary standard to protect health care workers from the coronavirus. OSHA also releases new guidance for all industries.
- [“Nanotraps” Designed to Capture and Clear SARS-CoV-2](#nanotraps-designed-to-capture-and-clear-sars-cov-2) - Jennifer Abbasi
- [First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland](#first-dose-chadox1-and-bnt162b2-covid-19-vaccines-and-thrombocytopenic-thromboembolic-and-hemorrhagic-events-in-scotland) - Simpson CR, et. al.
- [Myths and Facts about COVID-19 Vaccines](#myths-and-facts-about-covid-19-vaccines) - Answers to help address common myths and rumors.
- [Is your workplace covered by the COVID-19 Healthcare ETS?](#covid-19-healthcare-emergency-temporary-standard-2) - Flow chart to help determine if your workplace is covered by the new Covid ETS.
- [Brazilian town experiment shows mass vaccination can wipe out COVID-19](#brazilian-town-experiment-shows-mass-vaccination-can-wipe-out-covid-19)
- [Frequently Asked Questions about COVID-19 Vaccination](#frequently-asked-questions-about-covid-19-vaccination)
- [Coronavirus (COVID-19) Update: June 1, 2021](#coronavirus-covid-19-update-june-1-2021) - The FDA issued a Class I recall to warn the public to stop using the Lepu Medical Technology SARS-CoV-2 Antigen Rapid Test Kit and the Leccurate SARS-CoV-2 Antibody Rapid Test Kit
- [COVID-19 and Animals](#covid-19-and-animals) - Discusses the risk of animals spreading Covid and the risk of spreading Covid to animals, also research with animals.
- [Guidance for Institutions of Higher Education (IHEs)](#guidance-for-institutions-of-higher-education-ihes) - Added guidance on offering and promoting COVID-19 vaccination, prevention strategies for IHEs where everyone is fully vaccinated and for IHEs where not everyone is fully vaccinated, general guidance.
- [Patterns in COVID-19 Vaccination Coverage, by Social Vulnerability and Urbanicity — United States, December 14, 2020–May 1, 2021](#patterns-in-covid-19-vaccination-coverage-by-social-vulnerability-and-urbanicity-united-states-december-14-2020may-1-2021)
- [Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults](#effect-of-2-inactivated-sars-cov-2-vaccines-on-symptomatic-covid-19-infection-in-adults) - Al Kaabi N, Zhang Y, Xia S, et al
- [Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission](#indoor-air-changes-and-potential-implications-for-sars-cov-2-transmission) - Allen J, Ibrahim A
- [No COVID-19 cases found after well-controlled indoor concert](#no-covid-19-cases-found-after-well-controlled-indoor-concert)
- [EEOC Issues Updated COVID-19 Technical Assistance](#eeoc-issues-updated-covid-19-technical-assistance) - Provides additional information on vaccinations in the employment context.
- [A global database of COVID-19 vaccinations](#a-global-database-of-covid-19-vaccinations) - Mathieu E, Ritchie H, Ortiz-Ospina E, et al.
- [Mask Use and Ventilation Improvements to Reduce COVID-19 Incidence in Elementary Schools — Georgia, November 16–December 11, 2020](#mask-use-and-ventilation-improvements-to-reduce-covid-19-incidence-in-elementary-schools-georgia-november-16december-11-2020) - Gettings J, Czarnik M, Morris E, et al.
- [COVID-19 Health and Safety Resources](#covid-19-health-and-safety-resources) - Get tip sheets and other guidance to prevent the spread of COVID-19 in the workplace.
- [Assessing the Risk of SARS-CoV-2 Transmission via Surgical Electrocautery Plume](#assessing-the-risk-of-sars-cov-2-transmission-via-surgical-electrocautery-plume) - Sowerby L J, Nichols A C, Gibson R, et al.
- [Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients](#antibody-response-to-2-dose-sars-cov-2-mrna-vaccine-series-in-solid-organ-transplant-recipients) - Boyarski B, Werbel W, Avery R, et al.
- [A paradigm shift to combat indoor respiratory infection](#a-paradigm-shift-to-combat-indoor-respiratory-infection) - Morawska L, et al.
- [A Next-Generation Rapid, Accurate SARS-CoV-2 Antibody Test](#a-next-generation-rapid-accurate-sars-cov-2-antibody-test)
- [Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351](#comparable-environmental-stability-and-disinfection-profiles-of-the-currently-circulating-sars-cov-2-variants-of-concern-b-1-1-7-and-b-1-351-2) - Meister T L, Fortmann J, Todt D, et al.
- [Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses](#neutralizing-antibody-vaccine-for-pandemic-and-pre-emergent-coronaviruses) - Saunders, K.O., Lee, E., Parks, R. et al.
- [Laboratory Modeling of SARS-CoV-2 Exposure Reduction Through Physically Distanced Seating in Aircraft Cabins Using Bacteriophage Aerosol — November 2020](#laboratory-modeling-of-sars-cov-2-exposure-reduction-through-physically-distanced-seating-in-aircraft-cabins-using-bacteriophage-aerosol-november-2020) - Based on laboratory modeling of exposure to SARS-CoV-2 on single-aisle and twin-aisle aircraft, exposures in scenarios in which the middle seat was vacant were reduced by 23% to 57%, compared with full aircraft occupancy, depending upon the model.
- [Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages](#monitoring-differences-between-the-sars-cov-2-b-1-1-7-variant-and-other-lineages)
- [CDC Tightens Its N95 Guidances](#cdc-tightens-its-n95-guidances) - Agency says end of mask shortages means less need for alternative policies.
- [In the Tales Told by Sewage, Public Health and Privacy Collide](#in-the-tales-told-by-sewage-public-health-and-privacy-collide) - Sewage epidemiology has been embraced in other countries for decades, but not in the U.S. Will Covid change that?
- [Linked Clusters of SARS-CoV-2 Variant B.1.351 — Maryland, January–February 2021](#linked-clusters-of-sars-cov-2-variant-b-1-351-maryland-januaryfebruary-2021) - Feder KA, Pearlowitz M, Goode A, et al.
- [Hand Hygiene Compliance Rate During the COVID-19 Pandemic](#hand-hygiene-compliance-rate-during-the-covid-19-pandemic-2)
- [Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021](#updated-recommendations-from-the-advisory-committee-on-immunization-practices-for-use-of-the-janssen-johnson-johnson-covid-19-vaccine-after-reports-of-thrombosis-with-thrombocytopenia-syndrome-among) - MacNeil JR, Su JR, Broder KR, et al.
- [Mask use in the context of COVID-19](#mask-use-in-the-context-of-covid-19) - This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care managers and health workers.
- [Science Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2](#science-brief-community-use-of-cloth-masks-to-control-the-spread-of-sars-cov-2) - Data were added from studies published since the last update that further demonstrate that mask wearing reduces new infections. Data were added that demonstrate the importance of mask fit to improve performance and reduce community exposure to SARS-CoV-2. A section was added on the health effects of mask wearing
- [Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study](#interacting-epidemics-in-amazonian-brazil-prior-dengue-infection-associated-with-increased-covid-19-risk-in-a-population-based-cohort-study) - It is possible for people to be infected through contact with contaminated surfaces or objects (fomites), but the risk is generally considered to be low.
- [Science Brief: SARS-CoV-2 and Surface (Fomite) Transmission for Indoor Community Environments](#science-brief-sars-cov-2-and-surface-fomite-transmission-for-indoor-community-environments) - It is possible for people to be infected through contact with contaminated surfaces or objects (fomites), but the risk is generally considered to be low.
- [Scientific Brief: SARS-CoV-2 Transmission](#scientific-brief-sars-cov-2-transmission) - This science brief has been updated to reflect current knowledge about SARS-CoV-2 transmission and reformatted to be more concise.
- [Study finds low rate of mom-to-baby COVID-19 spread, effect on infants](#study-finds-low-rate-of-mom-to-baby-covid-19-spread-effect-on-infants)
- [SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery](#sars-cov-2-infection-of-primary-human-lung-epithelium-for-covid-19-modeling-and-drug-discovery) - Mulay A, Konda B, Garcia G Jr, et al.
- [The novel coronavirus’ spike protein plays additional key role in illness](#the-novel-coronavirus-spike-protein-plays-additional-key-role-in-illness) - Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular disease
- [CDC Director Statement on Pfizer’s Use of COVID-19 Vaccine in Adolescents Age 12 and Older](#cdc-director-statement-on-pfizers-use-of-covid-19-vaccine-in-adolescents-age-12-and-older) - CDC’s Advisory Committee on Immunization Practices’ (ACIP) reviewed and recommended the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine and its use in 12- through 15-year-old adolescents.
- [CDC Recommends Use of Johnson & Johnson’s Janssen COVID-19 Vaccine Resume](#cdc-recommends-use-of-johnson-johnsons-janssen-covid-19-vaccine-resume-2)
- [Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021](#effectiveness-of-pfizer-biontech-and-moderna-vaccines-against-covid-19-among-hospitalized-adults-aged-65-years-united-states-januarymarch-2021)
- [Global Variants Report (Covid Data Tracker) (Updated weekly)](#global-variants-report-covid-data-tracker-updated-weekly) - Maps and a list of countries that have reported variants of SARS-CoV-2.
- [Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes](#interim-infection-prevention-and-control-recommendations-to-prevent-sars-cov-2-spread-in-nursing-homes-2) - This guidance has been updated and organized according to IPC practices that should remain in place whether or not nursing homes are experiencing outbreaks of SARS-CoV-2.
- [FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines](#fda-continues-important-steps-to-ensure-quality-safety-and-effectiveness-of-authorized-covid-19-vaccines) - During an inspection of Emergent BioSolutions that ended Tuesday, the FDA cited a number of observations concerning whether the facility’s processes met FDA requirements and standards.
- [SARS-CoV-2 Variant Classifications and Definitions](#sars-cov-2-variant-classifications-and-definitions) - More in depth information for laboratories testing for Covid-19 variants.
- [J&J Vaccine and Blood Clots: The Risks, if Any, Are Very Low](#jj-vaccine-and-blood-clots-the-risks-if-any-are-very-low) - Out of an “abundance of caution,” the F.D.A. is advising doctors to pause the Johnson & Johnson vaccine
- [COVID-19 Breakthrough Case Investigations and Reporting](#covid-19-breakthrough-case-investigations-and-reporting) - This page provides information and resources to help public health departments and laboratories investigate and report COVID-19 vaccine breakthrough cases.
- [Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine](#cases-of-cerebral-venous-sinus-thrombosis-with-thrombocytopenia-after-receipt-of-the-johnson-johnson-covid-19-vaccine) - CDC and the FDA are reviewing data involving six U.S. cases of a rare type of blood clot in individuals after receiving the J&J COVID-19 vaccine that were reported to the Vaccine Adverse Event Reporting System.
- [Self-Testing](#self-testing) - Self-collection kits and tests are available either by prescription or over the counter in a pharmacy or retail store without a prescription.
- [Safety Precautions When Using Electrostatic Sprayers, Foggers, Misters, or Vaporizers for Surface Disinfection During the COVID-19 Pandemic](#safety-precautions-when-using-electrostatic-sprayers-foggers-misters-or-vaporizers-for-surface-disinfection-during-the-covid-19-pandemic) - In most situations, cleaning surfaces (using soap or detergent) is enough to reduce SAR-CoV-2, the virus that causes COVID-19. Clean surfaces before disinfecting.
- [Healthy Buildings for Health: COVID-19 Risk Calculator](#healthy-buildings-for-health-covid-19-risk-calculator) - Gain an understanding of how to reduce the risk of COVID-19 transmission in indoor environments using affordable control strategies.
- [For Specific Industries and Occupations: Health and Safety Steps for Specific Occupations](#for-specific-industries-and-occupations-health-and-safety-steps-for-specific-occupations) - Guidance, fact sheets, and tools for many industries and occupations
- [Personal and Social Activities](#personal-and-social-activities) - Current advice for visiting a restaurant, bar, nail salon, the library, traveling overnight, hosting a cook-out, etc.
- [COVID-19 Vaccination Toolkits](#covid-19-vaccination-toolkits) - Toolkits for Healthcare, long term care, pharmacies, schools, clinicians, employers of essential workers, etc.
- [COVID-19 Vaccine: Quick Reference Guide for Healthcare Professionals](#getting-your-covid-19-vaccine-2-2) - A table that provides basic information on the proper storage, preparation, and administration of the currently authorized COVID-19 vaccine products in the United States.
- [Getting Your COVID-19 Vaccine](#getting-your-covid-19-vaccine) - How to find a vaccine site and prepare for vaccination.
- [Cleaning and Disinfecting Your Facility: Every Day and When Someone is Sick](#cleaning-and-disinfecting-your-facility-every-day-and-when-someone-is-sick)
- [Cleaning and Disinfecting Your Home: Every Day and When Someone Is Sick](#cleaning-and-disinfecting-your-home-every-day-and-when-someone-is-sick)
- [Practical Guidelines for Collection, Manipulation and Inactivation of SARS‐CoV‐2 and COVID‐19 Clinical Specimens](#practical-guidelines-for-collection-manipulation-and-inactivation-of-sarscov2-and-covid19-clinical-specimens) - Bain W, et al.
- [Safer Travel Ideas](#safer-travel-ideas)
- [Laboratory biosafety guidance related to coronavirus disease (COVID-19)](#laboratory-biosafety-guidance-related-to-coronavirus-disease-covid-19) - The purpose of this document is to provide interim guidance on laboratory biosafety related to the COVID-19 virus to laboratories and stakeholders involved in COVID-19 virus laboratory work. This also includes the packaging and shipment requirements for sending specimens to WHO reference laboratories providing confirmatory testing for COVID-19. Includes additional biosafety recommendations for the usage
- [Laboratory biosafety guidance related to coronavirus disease (COVID-19)](#biosafety-risk-assessment-of-the-severe-acute-respiratory-syndrome-sars-coronavirus-and-containment-measures-for-the-diagnostic-and-research-laboratories-2) - WHO Laboratory Risk Assessment tool is on page 9.
- [Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents](#pfizer-biontech-announce-positive-topline-results-of-pivotal-covid-19-vaccine-study-in-adolescents) - n participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well tolerated
- [Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021](#interim-estimates-of-vaccine-effectiveness-of-bnt162b2-and-mrna-1273-covid-19-vaccines-in-preventing-sars-cov-2-infection-among-health-care-personnel-first-responders-and-other-essential-and-frontline) - Thompson MG, Burgess JL, Naleway AL, et al.These findings indicate that authorized mRNA COVID-19 vaccines are effective for preventing SARS-CoV-2 infection, regardless of symptom status, among working-age adults in real-world conditions.
- [Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development](#biological-risk-assessment-general-considerations-for-laboratories-2) - The FDA authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening. In addition, 2 serial screening tests were authorized for use in a point-of-care (POC) setting with and without a prescription.
- [Biological Risk Assessment: General Considerations for Laboratories](#biological-risk-assessment-general-considerations-for-laboratories)
- [International Travel During COVID-19](#international-travel-during-covid-19-2) - Recommendations/requirements for international travel (masks, testing, quarantine) for vaccinated and unvaccinated Americans.
- [Domestic Travel During COVID-19](#domestic-travel-during-covid-19) - This page is about travel that is different from your everyday activities, away from your local community.
- [COVID-19 Vaccine Webinar Series](#covid-19-vaccine-webinar-series) - CDC is offering a series of brief (15-20 minute) webinars addressing topics around COVID-19 vaccination.
- [State-by-State COVID-19 Guidance: Assisting businesses with evolving COVID-19 orders and helping them effectively continue operations.](#state-by-state-covid-19-guidance-assisting-businesses-with-evolving-covid-19-orders-and-helping-them-effectively-continue-operations) - This resource includes the latest COVID-19 rules, restrictions, orders and guidance that affect businesses across the country to ensure our clients can continue operations as effectively as possible.
- [Ventilation in Buildings](#ventilation-in-buildings) - Added three new Frequently Asked Questions (FAQs) on the usefulness of carbon dioxide monitors to inform ventilation decisions, the useful of temperature and relative humidity to control the spread of COVID-19, and the use of fans indoors.
- [Migration and Border Health](#migration-and-border-health) - Find guidance and resources on preventing and controlling COVID-19 infections in globally mobile populations.
- [In vitro inactivation of SARS-CoV-2 by commonly used disinfection products and methods](#in-vitro-inactivation-of-sars-cov-2-by-commonly-used-disinfection-products-and-methods) - Xiling, G., Yin, C., Ling, W. et al."we used a sequenced SARS-CoV-2 strain from an infected person in Jiangsu, China, to evaluate the inactivation effect of commonly used disinfection methods on SARS-CoV-2. We tested the effect of chlorine-containing disinfectants, two kinds of QAC named Di-N-decyl dimethyl ammonium bromide (DNB) and Di-N-decyl dimethyl ammonium chloride (DNC),
- [Science Brief: Transmission of SARS-CoV-2 in K-12 schools](#science-brief-transmission-of-sars-cov-2-in-k-12-schools) - Updated guidance related to K-12 schools and transmission of SARS-CoV-2- recommendation that "3 feet between students in classrooms could provide a feasible definition of physical distancing so long as other prevention measures are maximized.
- [Interim Guidelines for COVID-19 Antibody Testing](#interim-guidelines-for-covid-19-antibody-testing) - Updated information on available serologic tests. Updated information on relationship between presence of anti-SARS-CoV-2 antibodies and immunity from subsequent infection. Guidance on interpretation of SARS-CoV-2 serologic tests performed on persons previously vaccinated for SARS-CoV-2. Guidance for quarantine of seropositive persons who have had recent exposure to someone with suspected or confirmed COVID-19.
- [National Emphasis Program – Coronavirus Disease 2019 (COVID-19)](#national-emphasis-program-coronavirus-disease-2019-covid-19) - This Direction describes policies and procedures for implementing a National Emphasis Program (NEP) to ensure that employees in highhazard industries or work tasks are protected from the hazard of contracting SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the cause of Coronavirus Disease 2019 (COVID-19).
- [Applied Biosafety: Coverage of COVID-19](#applied-biosafety-coverage-of-covid-19) - To support the continued growth and rapid development of research around the world during the COVID-19 pandemic, we have collected all of the Journal's relevant articles on this important and evolving topic. All articles included are available freely online.
- [When You’ve Been Fully Vaccinated](#when-youve-been-fully-vaccinated) - How to Protect Yourself and Others
- [CISA Support to the COVID-19 Vaccine Rollout](#cisa-support-to-the-covid-19-vaccine-rollout) - CISA provides resources for entities storing and distributing the COVID-19 vaccines

## LAIs

- [Zika virus | Korea | unknown](https://absa.org/lai/zika-virus-korea-unknown/)
- [Zika virus | Seoul, So. Korea | unknown](https://absa.org/lai/zika-virus-seoul-so-korea-unknown/)
- [Zika Virus | ZIKV research vaccine development laboratory - South Korea | Unknown](https://absa.org/lai/zika-virus-zikv-research-vaccine-development-laboratory-south-korea-unknown/)
- [Yersinia pestis, Burkholderia mallei, Venezuelan Equine Encephalitis, Chikungunya, Vaccinia | Fort Dietrick, Maryland, USA | 1989-2002](https://absa.org/lai/yersinia-pestis-burkholderia-mallei-venezuelan-equine-encephalitis-chikungunya-vaccinia-fort-dietrick-maryland-usa-1989-2002/)
- [Zika | Pennsylvania and New York in USA | 2016(2), 2017(1)](https://absa.org/lai/zika-pennsylvania-and-new-york-in-usa-20162-20171/)
- [Zika Virus (ZIKV) Brazilian strain | Rio de Janeiro, Brazil | 17/06/2017](https://absa.org/lai/zika-virus-zikv-brazilian-strain-rio-de-janeiro-brazil-17-06-2017/)
- [Zika Virus | Allegheny County, Pittsburgh, PA- USA | 9/6/16](https://absa.org/lai/zika-virus-allegheny-county-pittsburgh-pa-usa-9-6-16/)
- [Zika virus | Bandafassi, Senegal | 2008](https://absa.org/lai/zika-virus-bandafassi-senegal-2008/)
- [Vibrio cholera | Sweden | published in 1992](https://absa.org/lai/vibrio-cholera-sweden-published-in-1992/)
- [Vibrio cholerae | Austria | 8-Apr](https://absa.org/lai/vibrio-cholerae-austria-8-apr/)
- [Vibrio cholerae Inaba strain 20A67 and Vibrio cholerae Ogawa strain  | Washington, DC, USA | Case 1: 01/06/1965 - Case 2: 13/07/1965](https://absa.org/lai/vibrio-cholerae-inaba-strain-20a67-and-vibrio-cholerae-ogawa-strain-washington-dc-usa-case-1-01-06-1965-case-2-13-07-1965/)
- [Vibrio parahaemolyticus | Calcutta, India | 1972](https://absa.org/lai/vibrio-parahaemolyticus-calcutta-india-1972/)
- [Vibrio parahaemolyticus | Taiwan | Jul-99](https://absa.org/lai/vibrio-parahaemolyticus-taiwan-jul-99/)
- [Viral hepatatis, tuberculosis and brucellosis as the tmost common ones, followed by amebiasis, malaria, zoster, toxoplasmosis, varicella, mumps, mycosis, listeriosis and others | Wroclaw region, Poland | 1990-2002, hospital setting, study of multiple LAIs](https://absa.org/lai/viral-hepatatis-tuberculosis-and-brucellosis-as-the-tmost-common-ones-followed-by-amebiasis-malaria-zoster-toxoplasmosis-varicella-mumps-mycosis-listeriosis-and-others-wroclaw-region-polan/)
- [Vpr-Deleted Molecular clone of HIV-1 | USA | Unknown](https://absa.org/lai/vpr-deleted-molecular-clone-of-hiv-1-usa-unknown/)
- [West Nile Virus | Cairo, Egypt | 1952](https://absa.org/lai/west-nile-virus-cairo-egypt-1952/)
- [West Nile Virus | Canadian Forces Base, Suffield, Alberta. | 2003](https://absa.org/lai/west-nile-virus-canadian-forces-base-suffield-alberta-2003/)
- [West Nile Virus | South Africa | unknown](https://absa.org/lai/west-nile-virus-south-africa-unknown/)
- [West Nile virus | Suffield, Alberta, Canada | 2003](https://absa.org/lai/west-nile-virus-suffield-alberta-canada-2003/)
- [West Nile Virus | United States | August 2002, October 2002](https://absa.org/lai/west-nile-virus-united-states-august-2002-october-2002/)
- [West Nile virus lineage 2 | South Africa | unknown](https://absa.org/lai/west-nile-virus-lineage-2-south-africa-unknown/)
- [West Nile Virus, lineage 2 | U. of Pretoria, 15km North of Pretoria, South Africa | 5/16/08](https://absa.org/lai/west-nile-virus-lineage-2-u-of-pretoria-15km-north-of-pretoria-south-africa-5-16-08/)
- [Yersinia pestis | Arizona, U.S.A. | 2/11/07](https://absa.org/lai/yersinia-pestis-arizona-u-s-a-2-11-07/)
- [Yersinia pestis | Chicago, IL. U.S.A. | 18/09/2009](https://absa.org/lai/yersinia-pestis-chicago-il-u-s-a-18-09-2009/)
- [Yersinia pestis | Fuzhou, Fujian province, China | 1/6/48](https://absa.org/lai/yersinia-pestis-fuzhou-fujian-province-china-1-6-48/)
- [Vaccinia virus | Piladelphia, U.S.A. | 4-Oct](https://absa.org/lai/vaccinia-virus-piladelphia-u-s-a-4-oct/)
- [Vaccinia virus | Rio de Janeiro, Brazil | Article published in 2003 (Exposure in 2002)](https://absa.org/lai/vaccinia-virus-rio-de-janeiro-brazil-article-published-in-2003-exposure-in-2002/)
- [vaccinia virus | San Diego, CA, USA | 18-Dec](https://absa.org/lai/vaccinia-virus-san-diego-ca-usa-18-dec/)
- [Vaccinia virus | Shahrekord, Iran | 2013-2014](https://absa.org/lai/vaccinia-virus-shahrekord-iran-2013-2014/)
- [vaccinia virus | USA | 2005-2007](https://absa.org/lai/vaccinia-virus-usa-2005-2007/)
- [vaccinia virus | USA | unknown](https://absa.org/lai/vaccinia-virus-usa-unknown/)
- [vaccinia virus | Virginia, USA | 26-28 June 2008](https://absa.org/lai/vaccinia-virus-virginia-usa-26-28-june-2008/)
- [Vaccinia virus | Vladivostok, Russia | Article published in 2000](https://absa.org/lai/vaccinia-virus-vladivostok-russia-article-published-in-2000/)
- [Vaccinia, Adenovirus, N. meningitides, E. coli 0157:H7, Shigella flexneri. | United States in NIH-funded laboratories | 1976 through Dec 2010](https://absa.org/lai/vaccinia-adenovirus-n-meningitides-e-coli-0157h7-shigella-flexneri-united-states-in-nih-funded-laboratories-1976-through-dec-2010/)
- [Venezuelan Equine Encephalitis virus | New York, USA | 10/19/63](https://absa.org/lai/venezuelan-equine-encephalitis-virus-new-york-usa-10-19-63/)
- [Venezuelan Equine Encephalomyelitis virus (VEE_ | Moscow, Russia | 1956-1975](https://absa.org/lai/venezuelan-equine-encephalomyelitis-virus-vee_-moscow-russia-1956-1975/)
- [verotoxin-producing Escherichia coli (VTEC) (O157:H7) | Scotland | unknown](https://absa.org/lai/verotoxin-producing-escherichia-coli-vtec-o157h7-scotland-unknown/)
- [Vesicular Stomatitis Virus (Rhabdoviridae, Vesilculovirus, Vesicular Stomatitis Antigenic Group) | Moscow, Russia | 1964](https://absa.org/lai/vesicular-stomatitis-virus-rhabdoviridae-vesilculovirus-vesicular-stomatitis-antigenic-group-moscow-russia-1964/)
- [vesicular stomatitis virus | Balboa Heights, Panama Canal Zone  | 1962](https://absa.org/lai/vesicular-stomatitis-virus-balboa-heights-panama-canal-zone-1962/)
- [vesicular stomatitis virus | Madison, Wisconsin USA | unknown](https://absa.org/lai/vesicular-stomatitis-virus-madison-wisconsin-usa-unknown/)
- [Vesicular Stomatitis Virus | Wisconsin, USA | published in 1950](https://absa.org/lai/vesicular-stomatitis-virus-wisconsin-usa-published-in-1950/)
- [Vesivirus | Corvallis, Oregon, U.S.A. | Article published in 2006](https://absa.org/lai/vesivirus-corvallis-oregon-u-s-a-article-published-in-2006/)
- [Vaccinia virus | Minas Gerais, Brazil | unknown](https://absa.org/lai/vaccinia-virus-minas-gerais-brazil-unknown/)
- [Vaccinia virus | multiple | multiple](https://absa.org/lai/vaccinia-virus-multiple-multiple/)
- [Vaccinia virus | Oklahoma, U.S.A. | Article published in April 21, 2003](https://absa.org/lai/vaccinia-virus-oklahoma-u-s-a-article-published-in-april-21-2003/)
- [Trypanosoma brucei gambiense,  Toxoplasma gondi | Belgium | 2007-2012](https://absa.org/lai/trypanosoma-brucei-gambiense-toxoplasma-gondi-belgium-2007-2012/)
- [Trypanosoma cruzi (strain CL) | San Francisco, USA | 2/19/85](https://absa.org/lai/trypanosoma-cruzi-strain-cl-san-francisco-usa-2-19-85/)
- [Trypanosoma cruzi (strain Y) | Maringa, Parana State, Brazil | 2003](https://absa.org/lai/trypanosoma-cruzi-strain-y-maringa-parana-state-brazil-2003/)
- [Trypanosoma cruzi | Venezuela | 1988-1996](https://absa.org/lai/trypanosoma-cruzi-venezuela-1988-1996/)
- [Trypanosoma gambiense (strain FEO ITMAP-1893) | Bordeaux, France | 3/5/92](https://absa.org/lai/trypanosoma-gambiense-strain-feo-itmap-1893-bordeaux-france-3-5-92/)
- [Trypanosoma gambiense | Ibadan, Nigeria | Unknown](https://absa.org/lai/trypanosoma-gambiense-ibadan-nigeria-unknown/)
- [unknown | Canada | 01/01/2016-12/31/2022](https://absa.org/lai/unknown-canada-01-01-2016-12-31-2022/)
- [unknown | national parks, USA | unknown](https://absa.org/lai/unknown-national-parks-usa-unknown/)
- [vaccina virus recombined with hepatitis C virus protein | Beidenkopf, Germany | unknown](https://absa.org/lai/vaccina-virus-recombined-with-hepatitis-c-virus-protein-beidenkopf-germany-unknown/)
- [Vaccinia (VACV Western reserve strain - contaminant of the recombinant construct OVA-vac with which the lab was working | Virginia, USA | June 26-28, 2008](https://absa.org/lai/vaccinia-vacv-western-reserve-strain-contaminant-of-the-recombinant-construct-ova-vac-with-which-the-lab-was-working-virginia-usa-june-26-28-2008/)
- [Vaccinia (Western Reserve) | Unknown | Unknown](https://absa.org/lai/vaccinia-western-reserve-unknown-unknown/)
- [vaccinia | Tucson, Arizona | Article published in 2003](https://absa.org/lai/vaccinia-tucson-arizona-article-published-in-2003/)
- [Vaccinia vaccine | Woden Valley, Camberra, Australia. | Article published on December 2009.](https://absa.org/lai/vaccinia-vaccine-woden-valley-camberra-australia-article-published-on-december-2009/)
- [Vaccinia virus -recombinant WR strain, thymidiine kinase negative | Great Britain | unknown](https://absa.org/lai/vaccinia-virus-recombinant-wr-strain-thymidiine-kinase-negative-great-britain-unknown/)
- [Vaccinia virus (Western Reserve) | Boston, MA, USA | 11/22/13](https://absa.org/lai/vaccinia-virus-western-reserve-boston-ma-usa-11-22-13/)
- [Vaccinia virus | Arizona, USA | 2007](https://absa.org/lai/vaccinia-virus-arizona-usa-2007/)
- [Vaccinia virus | Boston, Massachusetts, U.S.A. | 2007](https://absa.org/lai/vaccinia-virus-boston-massachusetts-u-s-a-2007/)
- [Vaccinia virus | Canada | 1/2/03](https://absa.org/lai/vaccinia-virus-canada-1-2-03/)
- [Vaccinia virus | Iran | Unknown (diagnostic samples taken 2013-2014)](https://absa.org/lai/vaccinia-virus-iran-unknown-diagnostic-samples-taken-2013-2014/)
- [Vaccinia Virus | Massachusetts, Boston. U.S.A | 23-11-2013](https://absa.org/lai/vaccinia-virus-massachusetts-boston-u-s-a-23-11-2013/)
- [Tanapox virus | Beaverton, Oregon, USA | 1966](https://absa.org/lai/tanapox-virus-beaverton-oregon-usa-1966/)
- [TB, hepatitis A, hepatitis B, non-A non-B hepatitis, rubella, mycoplasma, Campylobacter, paratyphus, Salmonella, Chicken pox (Varicella zoster) | Japan | 1979-1988](https://absa.org/lai/tb-hepatitis-a-hepatitis-b-non-a-non-b-hepatitis-rubella-mycoplasma-campylobacter-paratyphus-salmonella-chicken-pox-varicella-zoster-japan-1979-1988/)
- [tick-born encephalitis virus | Slovenia | 1992](https://absa.org/lai/tick-born-encephalitis-virus-slovenia-1992/)
- [Titi Monkey Adenovirus (TMAdV) | Davis, CA, USA | 2009](https://absa.org/lai/titi-monkey-adenovirus-tmadv-davis-ca-usa-2009/)
- [Toxoplasma gondii (RH strain, BK strain) | unknown | unknown](https://absa.org/lai/toxoplasma-gondii-rh-strain-bk-strain-unknown-unknown/)
- [Toxoplasma gondii (RH strain) | Kent, UK | unknown](https://absa.org/lai/toxoplasma-gondii-rh-strain-kent-uk-unknown/)
- [Toxoplasma gondii | Finland | 1983](https://absa.org/lai/toxoplasma-gondii-finland-1983/)
- [Toxoplasma gondii | London, UK | unknown](https://absa.org/lai/toxoplasma-gondii-london-uk-unknown/)
- [Toxoplasma gondii | Unknown | None provided](https://absa.org/lai/toxoplasma-gondii-unknown-none-provided/)
- [Treponema pallidum | Madras, India | September, 1964](https://absa.org/lai/treponema-pallidum-madras-india-september-1964/)
- [Treponema pallidum, Nichols strain | Minneapolis, Minnesota USA | 20-May-75](https://absa.org/lai/treponema-pallidum-nichols-strain-minneapolis-minnesota-usa-20-may-75/)
- [Trichophyton simii | Madras, India | 1979](https://absa.org/lai/trichophyton-simii-madras-india-1979/)
- [Trichophyton verrucosum, Microsporum canis | Belgium | 2007-2012](https://absa.org/lai/trichophyton-verrucosum-microsporum-canis-belgium-2007-2012/)
- [Streptobacillus moniliformis | Minnesota, USA | unknown](https://absa.org/lai/streptobacillus-moniliformis-minnesota-usa-unknown/)
- [Streptococcus pneumoniae Type I | U.S.A. | Article published December 7, 1984](https://absa.org/lai/streptococcus-pneumoniae-type-i-u-s-a-article-published-december-7-1984/)
- [Streptococcus pyogenes group A | Cambridge, United Kingdom | 1981](https://absa.org/lai/streptococcus-pyogenes-group-a-cambridge-united-kingdom-1981/)
- [Suspension of the live yeast form of Sporothrix schenckii | Hokuriku district, Japan | 15/07/1966](https://absa.org/lai/suspension-of-the-live-yeast-form-of-sporothrix-schenckii-hokuriku-district-japan-15-07-1966/)
- [T. gondii | Glasgow, UK | published in 2001](https://absa.org/lai/t-gondii-glasgow-uk-published-in-2001/)
- [T.gondii and L.monocytogenes | Glasgow, UK | published in 2001](https://absa.org/lai/t-gondii-and-l-monocytogenes-glasgow-uk-published-in-2001/)
- [Tacaribe virus  | unknown | unknown](https://absa.org/lai/tacaribe-virus-unknown-unknown/)
- [Simian immunodeficiency virus (SIV)  | USA | reported in 1992](https://absa.org/lai/simian-immunodeficiency-virus-siv-usa-reported-in-1992/)
- [Simian immunodeficiency virus (SIV) | Unknown | 03/1990, unknown](https://absa.org/lai/simian-immunodeficiency-virus-siv-unknown-03-1990-unknown/)
- [Simian immunodeficiency virus (SIV) | unknown | Mar-90](https://absa.org/lai/simian-immunodeficiency-virus-siv-unknown-mar-90/)
- [Sin Nombre virus | Boulder, Colorado | 6/14/2005, 7/6/2005](https://absa.org/lai/sin-nombre-virus-boulder-colorado-6-14-2005-7-6-2005/)
- [Sin Nombre virus, hantavirus | Boulder County, Colorado, USA | 14/6/2005, 6/7/2005](https://absa.org/lai/sin-nombre-virus-hantavirus-boulder-county-colorado-usa-14-6-2005-6-7-2005/)
- [Sin Nombre virus, hantavirus | California, USA | unknown](https://absa.org/lai/sin-nombre-virus-hantavirus-california-usa-unknown/)
- [Sin Nombre Virus, hantavirus | Plumas County, California | Jun3 2004](https://absa.org/lai/sin-nombre-virus-hantavirus-plumas-county-california-jun3-2004/)
- [Sin Nombre virus, Whitewater Arroyo virus or Guanarito virus | unknown | unknown](https://absa.org/lai/sin-nombre-virus-whitewater-arroyo-virus-or-guanarito-virus-unknown-unknown/)
- [Smallpox | Birmingham, England | smallpox](https://absa.org/lai/smallpox-birmingham-england-smallpox/)
- [Sporothrix schenckii | Laboratory for Mycology, Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany, USA | Oct-89](https://absa.org/lai/sporothrix-schenckii-laboratory-for-mycology-wadsworth-center-for-laboratories-and-research-new-york-state-department-of-health-albany-usa-oct-89/)
- [Sporothrix schenckii | Mexico | Article published in July 2016](https://absa.org/lai/sporothrix-schenckii-mexico-article-published-in-july-2016/)
- [Staphylococcus aureus | Malatya, Turkey |](https://absa.org/lai/staphylococcus-aureus-malatya-turkey/)
- [Staphylococcus aureus, MRSA, EMRSA | Sydney, New South Wales, Australia | 2-Jan](https://absa.org/lai/staphylococcus-aureus-mrsa-emrsa-sydney-new-south-wales-australia-2-jan/)
- [Staphylococcus aureus, MRSA, MSSA | The Netherlands | unknown](https://absa.org/lai/staphylococcus-aureus-mrsa-mssa-the-netherlands-unknown/)
- [Staphylococcus, Shigella B | Minnesota, USA | 1986](https://absa.org/lai/staphylococcus-shigella-b-minnesota-usa-1986/)
- [Streptobacillus moniliformis (rat bite fever) | California, USA | 1/8/84](https://absa.org/lai/streptobacillus-moniliformis-rat-bite-fever-california-usa-1-8-84/)
- [Simian Foamy Virus | Germany | 1976](https://absa.org/lai/simian-foamy-virus-germany-1976/)
- [simian foamy virus | unknown | unknown](https://absa.org/lai/simian-foamy-virus-unknown-unknown/)
- [simian foamy virus, human foamy virus | unknown | unknown](https://absa.org/lai/simian-foamy-virus-human-foamy-virus-unknown-unknown/)
- [simian foamy viruses | USA | published in 1997](https://absa.org/lai/simian-foamy-viruses-usa-published-in-1997/)
- [SARS-CoV-2 | Taipei, Taiwan | 21-Nov](https://absa.org/lai/sars-cov-2-taipei-taiwan-21-nov/)
- [SARS-CoV-2, Coronavirus, COVID, COVID-19 | Taipei, Taiwan | 20-Dec](https://absa.org/lai/sars-cov-2-coronavirus-covid-covid-19-taipei-taiwan-20-dec/)
- [SARS-CoV-2, COVID-19 | Taipei, Taiwan | 2021](https://absa.org/lai/sars-cov-2-covid-19-taipei-taiwan-2021/)
- [SARS-CoV, coronavirus, SARS | Guangzhou, Guangdong Province, China | 16/12/2003-8/1/2004](https://absa.org/lai/sars-cov-coronavirus-sars-guangzhou-guangdong-province-china-16-12-2003-8-1-2004/)
- [SARS-CoV, SARS, coronavirus | Taiwan | 2003](https://absa.org/lai/sars-cov-sars-coronavirus-taiwan-2003/)
- [Semliki Forest Virus | Germany | 10/6/1978 (first sign of illness)](https://absa.org/lai/semliki-forest-virus-germany-10-6-1978-first-sign-of-illness/)
- [Shiga Toxin from Escherichia coli O157:H7 | State of Pennsylvania, USA | 2013](https://absa.org/lai/shiga-toxin-from-escherichia-coli-o157h7-state-of-pennsylvania-usa-2013/)
- [Shigella | Taiwan | 2006](https://absa.org/lai/shigella-taiwan-2006/)
- [Shigella boydii | Germany | Article published in 1981](https://absa.org/lai/shigella-boydii-germany-article-published-in-1981/)
- [Shigella dysenteriae | Texas, USA | 29/10/1996-1/11/1996](https://absa.org/lai/shigella-dysenteriae-texas-usa-29-10-1996-1-11-1996/)
- [Shigella flexneri | a ""country [clinical] laboratory"" in Australia | prior to 04/06/1982](https://absa.org/lai/shigella-flexneri-a-country-clinical-laboratory-in-australia-prior-to-04-06-1982/)
- [Shigella flexneri | Netherlands | Article published in 1985](https://absa.org/lai/shigella-flexneri-netherlands-article-published-in-1985/)
- [Shigella flexneri, Salmonella typhimurium, Salmonella typhi, M. tuberculosis, non-A non-B hepatitis | Great Britain | 1986-1987](https://absa.org/lai/shigella-flexneri-salmonella-typhimurium-salmonella-typhi-m-tuberculosis-non-a-non-b-hepatitis-great-britain-1986-1987/)
- [Shigella sonnei | Reading, Berkshire Co., England | prior to 01/01/1983](https://absa.org/lai/shigella-sonnei-reading-berkshire-co-england-prior-to-01-01-1983/)
- [Shigella sonnei | U.S.A. | Jan-96](https://absa.org/lai/shigella-sonnei-u-s-a-jan-96/)
- [Shigella sonnei and Salmonella paratyphi B | Unknown | prior to 1978](https://absa.org/lai/shigella-sonnei-and-salmonella-paratyphi-b-unknown-prior-to-1978/)
- [Shigella, Brucella, Salmonella, Staphylococcus aureus, MRSA, Neisseris meningitidis, Escherichia coli O157:H7, Coccidioides, Clostridium difficile, Bacillus anthracis | USA | 2002-2004](https://absa.org/lai/shigella-brucella-salmonella-staphylococcus-aureus-mrsa-neisseris-meningitidis-escherichia-coli-o157h7-coccidioides-clostridium-difficile-bacillus-anthracis-usa-2002-2004/)
- [Simian Foamy Virus (SFV) | Franceville, Gabon | Article published in 2010](https://absa.org/lai/simian-foamy-virus-sfv-franceville-gabon-article-published-in-2010/)
- [Simian Foamy Virus (SFV) | U.S.A. | Article published in 2005](https://absa.org/lai/simian-foamy-virus-sfv-u-s-a-article-published-in-2005/)
- [Salmonella Typhimurium | Maine, US | 02/05/2013, 02/08/2013](https://absa.org/lai/salmonella-typhimurium-maine-us-02-05-2013-02-08-2013/)
- [Salmonella typhimurium | Maryland, U.S. | November, 2011](https://absa.org/lai/salmonella-typhimurium-maryland-u-s-november-2011/)
- [Salmonella Typhimurium | Several states in USA: Illinois, Indiana, Kentucky, Maine, Massachusetts, Missouri, New Hampshire, New Jersey, Ohio, Pennsylvania, Virginia, Washington, and Wisconsin. | 01/11/2013, 03/05/2013](https://absa.org/lai/salmonella-typhimurium-several-states-in-usa-illinois-indiana-kentucky-maine-massachusetts-missouri-new-hampshire-new-jersey-ohio-pennsylvania-virginia-washington-and-wisconsin-01-11/)
- [Salmonella typhimurium strain LT-2 | Leeds, West Yorkshire, England | unknown](https://absa.org/lai/salmonella-typhimurium-strain-lt-2-leeds-west-yorkshire-england-unknown/)
- [Salmonella, Mycobacterium tuberculosis, Brucella, Shigella, Coxiella burnetii, Mycoplasma, Campylobacter, Bacillus Calmette Guerin, Bartonella, Listeria | Belgium | 2007-2012](https://absa.org/lai/salmonella-mycobacterium-tuberculosis-brucella-shigella-coxiella-burnetii-mycoplasma-campylobacter-bacillus-calmette-guerin-bartonella-listeria-belgium-2007-2012/)
- [Salmonellya typhimurium | Minesota, U.S.A. | Article published in November 1988](https://absa.org/lai/salmonellya-typhimurium-minesota-u-s-a-article-published-in-november-1988/)
- [SARS | Institute of Preventive Medicine, National Defence University, Taipei-Taiwan | 17/12/2004](https://absa.org/lai/sars-institute-of-preventive-medicine-national-defence-university-taipei-taiwan-17-12-2004/)
- [SARS | Taipei, Taiwan | 12/6/03](https://absa.org/lai/sars-taipei-taiwan-12-6-03/)
- [SARS coronavirus | Beijing, China | 4-Mar](https://absa.org/lai/sars-coronavirus-beijing-china-4-mar/)
- [SARS coronavirus | Beijing, China | February and April, 2004](https://absa.org/lai/sars-coronavirus-beijing-china-february-and-april-2004/)
- [SARS coronavirus | Taipei, Taiwan | 3-Dec](https://absa.org/lai/sars-coronavirus-taipei-taiwan-3-dec/)
- [SARS virus and polio virus type 1 | Beijing, China | 03/2004, 04/2004](https://absa.org/lai/sars-virus-and-polio-virus-type-1-beijing-china-03-2004-04-2004/)
- [SARS-CoV | Singapore | 7/23/03](https://absa.org/lai/sars-cov-singapore-7-23-03/)
- [Salmonella typhi, Salmonella agona | Arkansas, USA | Jun-80](https://absa.org/lai/salmonella-typhi-salmonella-agona-arkansas-usa-jun-80/)
- [Salmonella typhi, Salmonella paratyphi A, Salmonella paratyphi B (the abstract did not specify which caused the 2 laboratory associated cases) | Denmark | 1986-1990](https://absa.org/lai/salmonella-typhi-salmonella-paratyphi-a-salmonella-paratyphi-b-the-abstract-did-not-specify-which-caused-the-2-laboratory-associated-cases-denmark-1986-1990/)
- [Salmonella typhi, Salmonella typhimurium, Salmonella virchow, Vibrio cholerae, Group A Streptococcus | Great Britain | 1984-1985](https://absa.org/lai/salmonella-typhi-salmonella-typhimurium-salmonella-virchow-vibrio-cholerae-group-a-streptococcus-great-britain-1984-1985/)
- [Salmonella typhi; Salmonella give | Townsville, Queensland Australia | 27/12/1989; 04/01/1990](https://absa.org/lai/salmonella-typhi-salmonella-give-townsville-queensland-australia-27-12-1989-04-01-1990/)
- [Salmonella Typhimurium | 38 States in USA : AK, AL, AZ, CA, CO, FL, GA, IA, ID, IL, IN, KS, KY, MA, MD, MI, MN, MO, NC, ND, NE, NH, NJ, N , NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, WA, WI, and WY | 20/08/2010 to 29/06/2011](https://absa.org/lai/salmonella-typhimurium-38-states-in-usa-ak-al-az-ca-co-fl-ga-ia-id-il-in-ks-ky-ma-md-mi-mn-mo-nc-nd-ne-nh-nj-n-nv-ny-oh-ok-or-pa-sc-sd-tn-tx-ut-wa-wi-and-wy/)
- [Salmonella Typhimurium | California, Colorado, Florida, Georgia, Iowa, Maine, Michigan, Missouri, North Carolina, New Hampshire, New Jersey, New Mexico, New York, Oklahoma, Texas, Washington | 03/17/2017 thru 06/22/2017](https://absa.org/lai/salmonella-typhimurium-california-colorado-florida-georgia-iowa-maine-michigan-missouri-north-carolina-new-hampshire-new-jersey-new-mexico-new-york-oklahoma-texas-washington-03-17-2/)
- [Rocky Mountain Spotted Fever | Atlanta, Georgia, USA | 1977](https://absa.org/lai/rocky-mountain-spotted-fever-atlanta-georgia-usa-1977/)
- [Salmonella enterica (serotype Typhi) | South Africa  | 2012-2016](https://absa.org/lai/salmonella-enterica-serotype-typhi-south-africa-2012-2016/)
- [Salmonella enterica Enteritidis | Madison, Wisconsin, USA | unknown](https://absa.org/lai/salmonella-enterica-enteritidis-madison-wisconsin-usa-unknown/)
- [Salmonella enterica Serovar Typhimurium | Saskatchewan, Canada | 2011](https://absa.org/lai/salmonella-enterica-serovar-typhimurium-saskatchewan-canada-2011/)
- [Salmonella enterica subspecies enterica serotype Typhi (S. Typhi) | Amsterdam, Netherlands | Unknown](https://absa.org/lai/salmonella-enterica-subspecies-enterica-serotype-typhi-s-typhi-amsterdam-netherlands-unknown/)
- [Salmonella enterica Typhi | South Africa | 2012-2016](https://absa.org/lai/salmonella-enterica-typhi-south-africa-2012-2016/)
- [Salmonella enterica typhi | Tokyo, Japan | 11/8/23](https://absa.org/lai/salmonella-enterica-typhi-tokyo-japan-11-8-23/)
- [Salmonella enteritidis (phage type 8) | Maine, US | 11/14/06](https://absa.org/lai/salmonella-enteritidis-phage-type-8-maine-us-11-14-06/)
- [Salmonella enteritidis and Neisseria meningitidis | U.S.A. | Article published in 1983](https://absa.org/lai/salmonella-enteritidis-and-neisseria-meningitidis-u-s-a-article-published-in-1983/)
- [Salmonella enteritidis and Neisseria meningitidis, group C | Baltimore, U.S.A. | Article published on 1983](https://absa.org/lai/salmonella-enteritidis-and-neisseria-meningitidis-group-c-baltimore-u-s-a-article-published-on-1983/)
- [Salmonella serotype typhi | USA | 1985-1994](https://absa.org/lai/salmonella-serotype-typhi-usa-1985-1994/)
- [Salmonella typhi | Baltimore, Maryland, USA | unknown](https://absa.org/lai/salmonella-typhi-baltimore-maryland-usa-unknown/)
- [Salmonella typhi | Kuala Lumpur Malaysia | unknown](https://absa.org/lai/salmonella-typhi-kuala-lumpur-malaysia-unknown/)
- [Salmonella typhi | Kuala Lumpur, Malaysia | 1992 (Article published in March, 1997)](https://absa.org/lai/salmonella-typhi-kuala-lumpur-malaysia-1992-article-published-in-march-1997/)
- [Salmonella typhi | Massachusetts, USA | 1/1/1977-12/31/1979](https://absa.org/lai/salmonella-typhi-massachusetts-usa-1-1-1977-12-31-1979/)
- [Salmonella typhi | unknown, USA | 1980](https://absa.org/lai/salmonella-typhi-unknown-usa-1980/)
- [Salmonella typhi | USA | 1/1/1977-9/30/1979](https://absa.org/lai/salmonella-typhi-usa-1-1-1977-9-30-1979/)
- [Salmonella typhi | USA | January 1977-August 1979](https://absa.org/lai/salmonella-typhi-usa-january-1977-august-1979/)
- [Rift Valley fever virus  | U.S.A.  | December 22, 1932.](https://absa.org/lai/rift-valley-fever-virus-u-s-a-december-22-1932/)
- [Rift Valley fever virus  | U.S.A. | October-December 1934.](https://absa.org/lai/rift-valley-fever-virus-u-s-a-october-december-1934/)
- [Rift Valley Fever virus | Bronx, New York | December, 1932](https://absa.org/lai/rift-valley-fever-virus-bronx-new-york-december-1932/)
- [ringworm, Bacillus anthracis, Brucella spp., Erysipelothrix rhusiopathiae, Leptospira spp., Newcastle virus, Chlamydia psittaci, Orf virus, Salmonella, Streptococcus suis, M. tuberculosis, M. bovis | Great Britain | prior to 1982](https://absa.org/lai/ringworm-bacillus-anthracis-brucella-spp-erysipelothrix-rhusiopathiae-leptospira-spp-newcastle-virus-chlamydia-psittaci-orf-virus-salmonella-streptococcus-suis-m-tuberculosis-m-bovis/)
- [Rocio | New Haven, Connecticut | 1981](https://absa.org/lai/rocio-new-haven-connecticut-1981/)
- [Rocky Mountain Spotted Fever (RMSF) | Georgia, USA | 23/02/1977](https://absa.org/lai/rocky-mountain-spotted-fever-rmsf-georgia-usa-23-02-1977/)
- [Recombinant raccoonpox virus | Madison, Wisconsin, USA | 2003](https://absa.org/lai/recombinant-raccoonpox-virus-madison-wisconsin-usa-2003/)
- [Recombinant Vaccinia virus strain Western Reserve | Germany | Unknown](https://absa.org/lai/recombinant-vaccinia-virus-strain-western-reserve-germany-unknown/)
- [recombinant vaccinia viruses expressing RSV glycoprotein G and RSV 22K protein | London UK | Sep-90](https://absa.org/lai/recombinant-vaccinia-viruses-expressing-rsv-glycoprotein-g-and-rsv-22k-protein-london-uk-sep-90/)
- [recombinant WR strain vaccinia virus expressing VSV(IND serotype) protein N | Pullman, Washington, USA | 1986](https://absa.org/lai/recombinant-wr-strain-vaccinia-virus-expressing-vsvind-serotype-protein-n-pullman-washington-usa-1986/)
- [Rickettisa akari, Rickettsia rickettsii | USA | 1969](https://absa.org/lai/rickettisa-akari-rickettsia-rickettsii-usa-1969/)
- [Rickettsia rickettsii | Fort Dietrick, Maryland, USA | 1955-1965](https://absa.org/lai/rickettsia-rickettsii-fort-dietrick-maryland-usa-1955-1965/)
- [Rickettsia rickettsii | Fort Dietrick, Maryland, USA | 1971-1976](https://absa.org/lai/rickettsia-rickettsii-fort-dietrick-maryland-usa-1971-1976/)
- [Rickettsia rickettsii | Frederick, MD | 1971-1976](https://absa.org/lai/rickettsia-rickettsii-frederick-md-1971-1976/)
- [Rickettsia sp. (Rocky Mounted Spotted Fever) | Atlanta, GA, USA | 18/02/1977](https://absa.org/lai/rickettsia-sp-rocky-mounted-spotted-fever-atlanta-ga-usa-18-02-1977/)
- [Rickettsia typhi | Bethesda, USA | 09/03/1978, 15/03/1978, 16/03/1978](https://absa.org/lai/rickettsia-typhi-bethesda-usa-09-03-1978-15-03-1978-16-03-1978/)
- [Rickettsia typhi | Jalan Pahang, Kuala Lumpur | unknown](https://absa.org/lai/rickettsia-typhi-jalan-pahang-kuala-lumpur-unknown/)
- [Rickettsia typhi | Seoul, Korea | Article published in 1990](https://absa.org/lai/rickettsia-typhi-seoul-korea-article-published-in-1990/)
- [Rickettsia typhi | unknown | unknown](https://absa.org/lai/rickettsia-typhi-unknown-unknown/)
- [Rickettsia, rickettsii | Ft. Dietrick, Maryland, USA | 1955-1965](https://absa.org/lai/rickettsia-rickettsii-ft-dietrick-maryland-usa-1955-1965/)
- [Plasmodium falciparum | Unknown, USA | 01-30/04/2011](https://absa.org/lai/plasmodium-falciparum-unknown-usa-01-30-04-2011/)
- [Plasmodium falciparum | Washington D.C., USA | 30/6/1982](https://absa.org/lai/plasmodium-falciparum-washington-d-c-usa-30-6-1982/)
- [Plasmodium falciparum | Washington, D.C. (U.S.A.) | 30/06/1982 (Article published in 1983)](https://absa.org/lai/plasmodium-falciparum-washington-d-c-u-s-a-30-06-1982-article-published-in-1983/)
- [Plasmodium vivax | London, England | 06/06/1968, 15//07/1968, 13/08/1968](https://absa.org/lai/plasmodium-vivax-london-england-06-06-1968-15-07-1968-13-08-1968/)
- [Plasmodium vivax | Unknown City, USA | 01-31/03/2012](https://absa.org/lai/plasmodium-vivax-unknown-city-usa-01-31-03-2012/)
- [Plasmodium vivax | Unknown City, USA | 11/9/04](https://absa.org/lai/plasmodium-vivax-unknown-city-usa-11-9-04/)
- [polio | United States, South Africa | 1941 to 1976](https://absa.org/lai/polio-united-states-south-africa-1941-to-1976/)
- [polio virus | worldwide | 1931-2017](https://absa.org/lai/polio-virus-worldwide-1931-2017/)
- [Poliomyelitis Virus | New Haven, CT, USA | 24/08/1945 (hospitalization date)](https://absa.org/lai/poliomyelitis-virus-new-haven-ct-usa-24-08-1945-hospitalization-date/)
- [Poliovirus type 1 | The Netherlands | 1992](https://absa.org/lai/poliovirus-type-1-the-netherlands-1992/)
- [prion, BSE, bovine spongiform encephalopathy, CJD, Creutzfeld-Jakob Disease | Jouy-en-Josas, France | 31-May-10](https://absa.org/lai/prion-bse-bovine-spongiform-encephalopathy-cjd-creutzfeld-jakob-disease-jouy-en-josas-france-31-may-10/)
- [Prions/bovine spongiform encephalopathy (BSE)/variant Creutzfeldt-Jakob disease (vCJD) | France | 10-May](https://absa.org/lai/prions-bovine-spongiform-encephalopathy-bse-variant-creutzfeldt-jakob-disease-vcjd-france-10-may/)
- [Puumala virus, hantavirus | Finland | unknown](https://absa.org/lai/puumala-virus-hantavirus-finland-unknown/)
- [Rabies virus | Unknown | 1973 and 1977](https://absa.org/lai/rabies-virus-unknown-1973-and-1977/)
- [Rabies virus, highly concentrated | New York, USA | Mar-77](https://absa.org/lai/rabies-virus-highly-concentrated-new-york-usa-mar-77/)
- [rabies virus, modified live rabies virus | New York, USA | 1977](https://absa.org/lai/rabies-virus-modified-live-rabies-virus-new-york-usa-1977/)
- [Ratpox [cowpox] | Russia | published in 1988](https://absa.org/lai/ratpox-cowpox-russia-published-in-1988/)
- [Pichinde virus (Arenavirus) | Houston, Texas, USA | Prior to 1974](https://absa.org/lai/pichinde-virus-arenavirus-houston-texas-usa-prior-to-1974/)
- [Plasmodium falciparum | London, England | 5/16/79](https://absa.org/lai/plasmodium-falciparum-london-england-5-16-79/)
- [Neisseria meningitidis serogroup C and serogroup B | California USA; Massachusetts USA | published in 1991](https://absa.org/lai/neisseria-meningitidis-serogroup-c-and-serogroup-b-california-usa-massachusetts-usa-published-in-1991/)
- [Neisseria meningitidis serogroups B and C | Alabama, Michigan, United States | 15/07/2000, 24/12/2000, others from 1985-2000](https://absa.org/lai/neisseria-meningitidis-serogroups-b-and-c-alabama-michigan-united-states-15-07-2000-24-12-2000-others-from-1985-2000/)
- [Neisseria meningitidis, serogroup C | Quebec, Canada | 10/3/91](https://absa.org/lai/neisseria-meningitidis-serogroup-c-quebec-canada-10-3-91/)
- [Neisseria Meningitidis. group C | Switzerland | Unknown](https://absa.org/lai/neisseria-meningitidis-group-c-switzerland-unknown/)
- [Newcastle Disease virus (NDV) | Australia | 1987](https://absa.org/lai/newcastle-disease-virus-ndv-australia-1987/)
- [Newcastle virus, Albiston-Gorrie strain | Geelong, outside Melbourne, Australia | reported in 1987](https://absa.org/lai/newcastle-virus-albiston-gorrie-strain-geelong-outside-melbourne-australia-reported-in-1987/)
- [norovirus | unknown | 2004](https://absa.org/lai/norovirus-unknown-2004/)
- [Norwalk virus | U.S.A. | Article published in March, 1989](https://absa.org/lai/norwalk-virus-u-s-a-article-published-in-march-1989/)
- [Novel adenovirus (BaAdV-1, BaAdV-2( | Texas, USA | 1997; analysiis in 2013](https://absa.org/lai/novel-adenovirus-baadv-1-baadv-2-texas-usa-1997-analysiis-in-2013/)
- [Omsk Hemorrhagic Fever Virus (Flavidivirdiae, Flavivirus, Tick-borne Encephalitis Antigenic Compliex | Moscow, Russia  | 1970](https://absa.org/lai/omsk-hemorrhagic-fever-virus-flavidivirdiae-flavivirus-tick-borne-encephalitis-antigenic-compliex-moscow-russia-1970/)
- [Only first initial was provided- V (suspected to be Marburg Virus) | Novosibirsk, Russia | 11/4/90](https://absa.org/lai/only-first-initial-was-provided-v-suspected-to-be-marburg-virus-novosibirsk-russia-11-4-90/)
- [Orentia tsutsugamushi | Seoul, Korea | 2000](https://absa.org/lai/orentia-tsutsugamushi-seoul-korea-2000/)
- [orf virus | Houston, Texas, USA | Feb-82](https://absa.org/lai/orf-virus-houston-texas-usa-feb-82/)
- [Orientia tsutsugamushi  | Korea | unknown](https://absa.org/lai/orientia-tsutsugamushi-korea-unknown/)
- [Orientia tsutsugamushi and Rickettsia typhi | Worldwide | 1931 - 2000](https://absa.org/lai/orientia-tsutsugamushi-and-rickettsia-typhi-worldwide-1931-2000/)
- [Orientia tsutsugamushi, Rickettsia typhi, scrub typhus, murine typhus | worldwide | 1931-2000](https://absa.org/lai/orientia-tsutsugamushi-rickettsia-typhi-scrub-typhus-murine-typhus-worldwide-1931-2000/)
- [parvovirus B19, HIV-1 | worldwide | 1935-2006](https://absa.org/lai/parvovirus-b19-hiv-1-worldwide-1935-2006/)
- [Pasteurella multocida | Columbia, Missouri, USA | unknown](https://absa.org/lai/pasteurella-multocida-columbia-missouri-usa-unknown/)
- [Pasteurella pestis, Yersinia pestis | Fort Dietrick, Maryland, USA | 27/08/1959](https://absa.org/lai/pasteurella-pestis-yersinia-pestis-fort-dietrick-maryland-usa-27-08-1959/)
- [Penicillium marneffei | Paris, France | 1994](https://absa.org/lai/penicillium-marneffei-paris-france-1994/)
- [Neisseria meningitidis | Unknown | Report from 2007](https://absa.org/lai/neisseria-meningitidis-unknown-report-from-2007/)
- [Neisseria meningitidis | unknown | unknown](https://absa.org/lai/neisseria-meningitidis-unknown-unknown/)
- [Neisseria meningitidis | Various | 1985 to 2001](https://absa.org/lai/neisseria-meningitidis-various-1985-to-2001/)
- [Neisseria meningitidis Group B | France | Nov-87](https://absa.org/lai/neisseria-meningitidis-group-b-france-nov-87/)
- [Neisseria meningitidis Group C  | United Kingdom | 30-Jan-92](https://absa.org/lai/neisseria-meningitidis-group-c-united-kingdom-30-jan-92/)
- [Neisseria meningitidis Group C | France | Apr-85](https://absa.org/lai/neisseria-meningitidis-group-c-france-apr-85/)
- [Neisseria meningitidis serogroup B | San Francisco, CA, USA | 27/04/2012](https://absa.org/lai/neisseria-meningitidis-serogroup-b-san-francisco-ca-usa-27-04-2012/)
- [Neisseria gonorrhoeae | Unknown | ~ 1979](https://absa.org/lai/neisseria-gonorrhoeae-unknown-1979/)
- [Neisseria gonorrhoeae | unknown | before 1998](https://absa.org/lai/neisseria-gonorrhoeae-unknown-before-1998/)
- [Neisseria gonorrhoeae | Zagreb, Croatia | Article published in 2015](https://absa.org/lai/neisseria-gonorrhoeae-zagreb-croatia-article-published-in-2015/)
- [Neisseria gonorrhoeae strain 188 T1 | Ottawa, Canada | Not stated](https://absa.org/lai/neisseria-gonorrhoeae-strain-188-t1-ottawa-canada-not-stated/)
- [Neisseria meningitides | Boston, Massachusets, USA | 9-Oct](https://absa.org/lai/neisseria-meningitides-boston-massachusets-usa-9-oct/)
- [Neisseria meningitides, Staphylococcus aureus, Escherichia coli, Lymphocytic choriomeningitis virus (LCV), Salmonella enterica, Brucella melitensis, Coccidioides immitis, Francisella tularensis, Mycobacterium tuberculosis | Canada | 2018](https://absa.org/lai/neisseria-meningitides-staphylococcus-aureus-escherichia-coli-lymphocytic-choriomeningitis-virus-lcv-salmonella-enterica-brucella-melitensis-coccidioides-immitis-francisella-tularensis-mycob/)
- [Neisseria meningitidis | Alberta, Canada | unknown](https://absa.org/lai/neisseria-meningitidis-alberta-canada-unknown/)
- [Neisseria meningitidis | Boston, Massachusetts, USA | 9-Oct](https://absa.org/lai/neisseria-meningitidis-boston-massachusetts-usa-9-oct/)
- [Neisseria meningitidis | Chapel Hill, North Carolina, USA | unknown](https://absa.org/lai/neisseria-meningitidis-chapel-hill-north-carolina-usa-unknown/)
- [Neisseria meningitidis | Defence Research Establishment Suffield, Canada | Unknown](https://absa.org/lai/neisseria-meningitidis-defence-research-establishment-suffield-canada-unknown/)
- [Neisseria meningitidis | England/Wales | January 1985 - December 1999](https://absa.org/lai/neisseria-meningitidis-england-wales-january-1985-december-1999/)
- [Neisseria meningitidis | Paris, France | 7-Oct](https://absa.org/lai/neisseria-meningitidis-paris-france-7-oct/)
- [Mycobacterium tuberculosis | Little Rock, Arkansas, USA | unknown B](https://absa.org/lai/mycobacterium-tuberculosis-little-rock-arkansas-usa-unknown-b/)
- [Mycobacterium tuberculosis | Little Rock, Arkansas, USA | Unknown C](https://absa.org/lai/mycobacterium-tuberculosis-little-rock-arkansas-usa-unknown-c/)
- [Mycobacterium tuberculosis | Nantes, France | 1997](https://absa.org/lai/mycobacterium-tuberculosis-nantes-france-1997/)
- [Mycobacterium tuberculosis | Norwood, Massachusetts, USA | unknown](https://absa.org/lai/mycobacterium-tuberculosis-norwood-massachusetts-usa-unknown/)
- [Mycobacterium tuberculosis | Portugal | Unknown](https://absa.org/lai/mycobacterium-tuberculosis-portugal-unknown/)
- [Mycobacterium tuberculosis | Seattle, Washington, USA | 2004 A](https://absa.org/lai/mycobacterium-tuberculosis-seattle-washington-usa-2004-a/)
- [Mycobacterium tuberculosis | Seattle, Washington, USA | 2004 B](https://absa.org/lai/mycobacterium-tuberculosis-seattle-washington-usa-2004-b/)
- [Mycobacterium tuberculosis | The Netherlands | Unknown](https://absa.org/lai/mycobacterium-tuberculosis-the-netherlands-unknown/)
- [Mycobacterium tuberculosis | Unknown | Published in 1991](https://absa.org/lai/mycobacterium-tuberculosis-unknown-published-in-1991/)
- [Mycobacterium tuberculosis | unknown, USA | 1975](https://absa.org/lai/mycobacterium-tuberculosis-unknown-usa-1975/)
- [Mycobacterium tuberculosis | US | 1985](https://absa.org/lai/mycobacterium-tuberculosis-us-1985/)
- [Mycobacterium tuberculosis | Washington, USA | 05/1997 through 09/1997](https://absa.org/lai/mycobacterium-tuberculosis-washington-usa-05-1997-through-09-1997/)
- [Mycobacterium tuberculosis, Brucella spp, Hepatitis virus and Shigella spp. | U.K., Wales and Scotland  | Article published in 1976](https://absa.org/lai/mycobacterium-tuberculosis-brucella-spp-hepatitis-virus-and-shigella-spp-u-k-wales-and-scotland-article-published-in-1976/)
- [Mycobacterium tuberculosis, Coxiella burnetii, Brucella melitensis, foamy virus | worldwide | 1980-2015](https://absa.org/lai/mycobacterium-tuberculosis-coxiella-burnetii-brucella-melitensis-foamy-virus-worldwide-1980-2015/)
- [Mycobacterium tuberculosis, Hepatitis B, Non-A Non-B hepatitis, Rubella, Hepatitis A, Mycoplasma, Camplylobacter enteritis, Paratyphus, Salmonella, Varicella | Japan | 1980-1990](https://absa.org/lai/mycobacterium-tuberculosis-hepatitis-b-non-a-non-b-hepatitis-rubella-hepatitis-a-mycoplasma-camplylobacter-enteritis-paratyphus-salmonella-varicella-japan-1980-1990/)
- [Mycobacterium tuberculosis; Tuberculosis | Washington State | 1996 - 2000](https://absa.org/lai/mycobacterium-tuberculosis-tuberculosis-washington-state-1996-2000/)
- [Mycoplasma caviae | Carshalton, England | Article published in 1971](https://absa.org/lai/mycoplasma-caviae-carshalton-england-article-published-in-1971/)
- [Neisseria gonorrhoeae | Chapel Hill, NC USA | 7/16/83](https://absa.org/lai/neisseria-gonorrhoeae-chapel-hill-nc-usa-7-16-83/)
- [Neisseria gonorrhoeae | Frankfurt, Germany | unknown, symptoms presented 11/27/1980](https://absa.org/lai/neisseria-gonorrhoeae-frankfurt-germany-unknown-symptoms-presented-11-27-1980/)
- [Neisseria gonorrhoeae | San Diego, CA, USA | unknown](https://absa.org/lai/neisseria-gonorrhoeae-san-diego-ca-usa-unknown/)
- [Mycobacterium tuberculosis | 4 Canadian cities (exact cities not specified) | Unknown (Report 2003)](https://absa.org/lai/mycobacterium-tuberculosis-4-canadian-cities-exact-cities-not-specified-unknown-report-2003/)
- [Mycobacterium tuberculosis | 50 states, the District of Columbia, Puerto Rico, the Virgin Islands, Guam, American Samoa, and the Northern Mariana Islands were surveyed |  1 January 1990 to 31 December 1994 (survey results)](https://absa.org/lai/mycobacterium-tuberculosis-50-states-the-district-of-columbia-puerto-rico-the-virgin-islands-guam-american-samoa-and-the-northern-mariana-islands-were-surveyed-1-january-1990-to-31-december/)
- [Mycobacterium tuberculosis | Amsterdam, Netherlands | 06/1994; 08/1994](https://absa.org/lai/mycobacterium-tuberculosis-amsterdam-netherlands-06-1994-08-1994/)
- [Mycobacterium tuberculosis | Chandigarh, India | 1987](https://absa.org/lai/mycobacterium-tuberculosis-chandigarh-india-1987/)
- [Mycobacterium tuberculosis | East Bay, California | December, 1978](https://absa.org/lai/mycobacterium-tuberculosis-east-bay-california-december-1978/)
- [Mycobacterium tuberculosis | Germany, Austria and Switzerland | Not stated](https://absa.org/lai/mycobacterium-tuberculosis-germany-austria-and-switzerland-not-stated/)
- [Mycobacterium tuberculosis | Japan | 02/1985, unknown](https://absa.org/lai/mycobacterium-tuberculosis-japan-02-1985-unknown/)
- [Mycobacterium tuberculosis | Japan | before 2004](https://absa.org/lai/mycobacterium-tuberculosis-japan-before-2004/)
- [Mycobacterium tuberculosis | Little Rock, Arkansas, USA | unknown A](https://absa.org/lai/mycobacterium-tuberculosis-little-rock-arkansas-usa-unknown-a/)
- [Marburg virus | unknown | before 2014](https://absa.org/lai/marburg-virus-unknown-before-2014/)
- [Mayaro virus | Cayenne, French Guiyana | 1998](https://absa.org/lai/mayaro-virus-cayenne-french-guiyana-1998/)
- [mimivirus | Marseille, France | 4-Dec](https://absa.org/lai/mimivirus-marseille-france-4-dec/)
- [Mimivirus | Marseille, France | December, 2004](https://absa.org/lai/mimivirus-marseille-france-december-2004/)
- [Monkey B virus, Herpes B virus, Macacine alphaherpesvirus 1 | Beijing, China | 04/03/2021, 06/03/2021](https://absa.org/lai/monkey-b-virus-herpes-b-virus-macacine-alphaherpesvirus-1-beijing-china-04-03-2021-06-03-2021/)
- [Monkeypox, Mpox | California, USA | 22-Aug](https://absa.org/lai/monkeypox-mpox-california-usa-22-aug/)
- [Mycobacterium bovis | East Lansing, Michigan, USA | 2018](https://absa.org/lai/mycobacterium-bovis-east-lansing-michigan-usa-2018/)
- [Mycobacterium Kansasii | Belgium | Aug-94](https://absa.org/lai/mycobacterium-kansasii-belgium-aug-94/)
- [Mycobacterium leprae | India | Unknown](https://absa.org/lai/mycobacterium-leprae-india-unknown/)
- [Mycobacterium tuberculosis  | Unknown, contributed by author in Boston, USA | Article published 03/01/1997](https://absa.org/lai/mycobacterium-tuberculosis-unknown-contributed-by-author-in-boston-usa-article-published-03-01-1997/)
- [Leishmania (Viannia) naiffi | Recife, PE, Brazil and Paranati, Matto Grosso, Brazil | published in 2012](https://absa.org/lai/leishmania-viannia-naiffi-recife-pe-brazil-and-paranati-matto-grosso-brazil-published-in-2012/)
- [Leptospira | Andaman & Nicobar Islands, India | 21/04/2003](https://absa.org/lai/leptospira-andaman-nicobar-islands-india-21-04-2003/)
- [Leptospira interrogans serovar hardjo | Ames, Iowa, USA | unknown](https://absa.org/lai/leptospira-interrogans-serovar-hardjo-ames-iowa-usa-unknown/)
- [Leptospira sp. | Ames, Iowa, USA | 1987](https://absa.org/lai/leptospira-sp-ames-iowa-usa-1987/)
- [Leptospirosis | Andaman & Nicobar Islands, India | 21/04/2003](https://absa.org/lai/leptospirosis-andaman-nicobar-islands-india-21-04-2003/)
- [Lymphocytic chorimeningitis | Unknown | 6/10/65](https://absa.org/lai/lymphocytic-chorimeningitis-unknown-6-10-65/)
- [Lymphocytic choriomeningitis virus  |  Lausanne, Switzerland | pre-September 2015](https://absa.org/lai/lymphocytic-choriomeningitis-virus-lausanne-switzerland-pre-september-2015/)
- [Lymphocytic Choriomeningitis Virus (LCM) | New York State, USA | 1971to1973](https://absa.org/lai/lymphocytic-choriomeningitis-virus-lcm-new-york-state-usa-1971to1973/)
- [lymphocytic choriomeningitis virus (LCMV) | Atlanta USA | 1989](https://absa.org/lai/lymphocytic-choriomeningitis-virus-lcmv-atlanta-usa-1989/)
- [Lymphocytic choriomeningitis virus (LCMV) | Unknown (likely La Jolla, CA, USA) | 2001, 2002, 2003](https://absa.org/lai/lymphocytic-choriomeningitis-virus-lcmv-unknown-likely-la-jolla-ca-usa-2001-2002-2003/)
- [Lymphocytic Choriomeningitis Virus (LCMV) | Vanderburgh, Indiana. U.S.A. | 12-Apr](https://absa.org/lai/lymphocytic-choriomeningitis-virus-lcmv-vanderburgh-indiana-u-s-a-12-apr/)
- [Lymphocytic choriomeningitis virus | Hatfield, Pretoria, South Africia | 16-May-08](https://absa.org/lai/lymphocytic-choriomeningitis-virus-hatfield-pretoria-south-africia-16-may-08/)
- [lymphocytic choriomeningitis virus, LCMV | Swizerland | 2013](https://absa.org/lai/lymphocytic-choriomeningitis-virus-lcmv-swizerland-2013/)
- [lymphocytic choriomeningitis virus, LCMV | unknown | 17-May](https://absa.org/lai/lymphocytic-choriomeningitis-virus-lcmv-unknown-17-may/)
- [lymphocytic choriomeningitis virus, Machupo, Sabia, hantavirus, Puumala virus, SARS, influenza B, Coxsackievirus | worldwide | 1935-2006](https://absa.org/lai/lymphocytic-choriomeningitis-virus-machupo-sabia-hantavirus-puumala-virus-sars-influenza-b-coxsackievirus-worldwide-1935-2006/)
- [Lymphocytogenic choriomeningitis virus, LCMV | Basel, Switzerland | 17-May](https://absa.org/lai/lymphocytogenic-choriomeningitis-virus-lcmv-basel-switzerland-17-may/)
- [Lymphocytogenic choriomeningitis virus, LCMV | Lausanne, Switzerland | 2016](https://absa.org/lai/lymphocytogenic-choriomeningitis-virus-lcmv-lausanne-switzerland-2016/)
- [Machupo virus |  | 1972](https://absa.org/lai/machupo-virus-1972/)
- [Machupo virus | Santa Cruz, Bolivia | 18/8/1994](https://absa.org/lai/machupo-virus-santa-cruz-bolivia-18-8-1994/)
- [human parvovirus B19 | London, England; Paris, France; Munich, FRG; Fukuoka, Japan; Washington, USA | unknown](https://absa.org/lai/human-parvovirus-b19-london-england-paris-france-munich-frg-fukuoka-japan-washington-usa-unknown/)
- [influenza A (H1N1) | Madison, Wisconsin, USA | 27/8/1994](https://absa.org/lai/influenza-a-h1n1-madison-wisconsin-usa-27-8-1994/)
- [Influenza A H2N2 (A/Japan/305/57) | Germany | 2004-2005](https://absa.org/lai/influenza-a-h2n2-a-japan-305-57-germany-2004-2005/)
- [Influenza A virus (A/Seal/Mass/1/80[H7N7]) | Cape Cod, Massachusetts, USA | 1979-12 - 1980-08](https://absa.org/lai/influenza-a-virus-a-seal-mass-1-80h7n7-cape-cod-massachusetts-usa-1979-12-1980-08/)
- [influenza B virus | Miyagi, Japan | unknown](https://absa.org/lai/influenza-b-virus-miyagi-japan-unknown/)
- [Japanese Encephalitis Virus (JE) | Not stated | reported in 1993](https://absa.org/lai/japanese-encephalitis-virus-je-not-stated-reported-in-1993/)
- [Junin virus | Buenos Aires, Argentina | 1974-1978](https://absa.org/lai/junin-virus-buenos-aires-argentina-1974-1978/)
- [Junin virus, Argentine hemorrhagic fever | Buenos Aires, Argentina | unknown](https://absa.org/lai/junin-virus-argentine-hemorrhagic-fever-buenos-aires-argentina-unknown/)
- [Korean haemorrhagic fever | Sendai, Japan | 03/1975 and 01/1978](https://absa.org/lai/korean-haemorrhagic-fever-sendai-japan-03-1975-and-01-1978/)
- [Kyasanur Forest Disease Virus | Moscow, Russia  | 1988](https://absa.org/lai/kyasanur-forest-disease-virus-moscow-russia-1988/)
- [Kyasanur Forest Disease Virus | unknown | 1957](https://absa.org/lai/kyasanur-forest-disease-virus-unknown-1957/)
- [Kyasanur Forest Disease Virus | Washington, D.C., USA | 1957](https://absa.org/lai/kyasanur-forest-disease-virus-washington-d-c-usa-1957/)
- [Kyasanur Forest Virus Disease Virus | Shimoga and Uttara Kannada District in India | 1957-1972](https://absa.org/lai/kyasanur-forest-virus-disease-virus-shimoga-and-uttara-kannada-district-in-india-1957-1972/)
- [HIV, Hepatitis C | Italy |](https://absa.org/lai/hiv-hepatitis-c-italy/)
- [HIV, human immunodeficiency virus type 1, HIV-1 | USA | 1985-1987](https://absa.org/lai/hiv-human-immunodeficiency-virus-type-1-hiv-1-usa-1985-1987/)
- [Human Colonic Adenocarcinoma | U.S.A. | Article published in August 2013](https://absa.org/lai/human-colonic-adenocarcinoma-u-s-a-article-published-in-august-2013/)
- [human colonic adenocarcinoma cell line | unknown | unknown](https://absa.org/lai/human-colonic-adenocarcinoma-cell-line-unknown-unknown/)
- [Human Immunodeficiency Virus | USA | 1981-2001](https://absa.org/lai/human-immunodeficiency-virus-usa-1981-2001/)
- [human immunodeficiency virus, HIV | worldwide | 1984-1997](https://absa.org/lai/human-immunodeficiency-virus-hiv-worldwide-1984-1997/)
- [Human parvovirus B19 (HPV/B19) | Japan | 1 - between 13-20 /08/1987; 2 - beginning of 06/1987](https://absa.org/lai/human-parvovirus-b19-hpv-b19-japan-1-between-13-20-08-1987-2-beginning-of-06-1987/)
- [Hepatitis B Virus | Auckland, New Zealand | published in 1982](https://absa.org/lai/hepatitis-b-virus-auckland-new-zealand-published-in-1982/)
- [Hepatitis C, Shigella sonnei, Shigella flexneri, Escherichia coli O157, Mycobacterium tuberculosis | United Kingdom | 1994-1995](https://absa.org/lai/hepatitis-c-shigella-sonnei-shigella-flexneri-escherichia-coli-o157-mycobacterium-tuberculosis-united-kingdom-1994-1995/)
- [Hepatitis,  Tuberculosis, Chickenpox, Salmonellosis, Shigella, Malaria | United Kingdom | 1979](https://absa.org/lai/hepatitis-tuberculosis-chickenpox-salmonellosis-shigella-malaria-united-kingdom-1979/)
- [Herpes B | Kalamazoo, MI, USA | 5/30/89](https://absa.org/lai/herpes-b-kalamazoo-mi-usa-5-30-89/)
- [Herpes B | Pensacola, FL, USA | 03/04/1987, 03/10/1987, 03/11/1987](https://absa.org/lai/herpes-b-pensacola-fl-usa-03-04-1987-03-10-1987-03-11-1987/)
- [Herpes B | unknown | unknown A](https://absa.org/lai/herpes-b-unknown-unknown-a/)
- [Herpes B | unknown | unknown B](https://absa.org/lai/herpes-b-unknown-unknown-b/)
- [Herpes B virus | Indianapolis, Indiana, USA | 10/7/57](https://absa.org/lai/herpes-b-virus-indianapolis-indiana-usa-10-7-57/)
- [Herpes B virus | Kagoshima, Japan | 2019](https://absa.org/lai/herpes-b-virus-kagoshima-japan-2019/)
- [Herpes B Virus | Pensacola Florida, USA | March 4, March 10, March 11](https://absa.org/lai/herpes-b-virus-pensacola-florida-usa-march-4-march-10-march-11/)
- [herpes B virus | unknown | unknown](https://absa.org/lai/herpes-b-virus-unknown-unknown/)
- [Herpes B virus, monkey B virus | Middlesex, England | 24/09/1957](https://absa.org/lai/herpes-b-virus-monkey-b-virus-middlesex-england-24-09-1957/)
- [Herpes B virus, monkey B virus | New York, USA | 22/10/1932](https://absa.org/lai/herpes-b-virus-monkey-b-virus-new-york-usa-22-10-1932/)
- [herpes B virus, vaccinia, Lassa | worldwide | 1935-2006](https://absa.org/lai/herpes-b-virus-vaccinia-lassa-worldwide-1935-2006/)
- [Herpes virus, Hepatitis B virus, Parvovirus B19, Human immunodeficiency virus, Rubella virus, Avian influenza virus, Rabies virus, Recombinanant viral vector | Belgium | 2007-2012](https://absa.org/lai/herpes-virus-hepatitis-b-virus-parvovirus-b19-human-immunodeficiency-virus-rubella-virus-avian-influenza-virus-rabies-virus-recombinanant-viral-vector-belgium-2007-2012/)
- [Histoplasma capsulatum var capsulatum | Spain | 2011](https://absa.org/lai/histoplasma-capsulatum-var-capsulatum-spain-2011/)
- [HIV | Germany | published in 2000](https://absa.org/lai/hiv-germany-published-in-2000/)
- [HIV | United States | 1985-2015](https://absa.org/lai/hiv-united-states-1985-2015/)
- [HIV from replicationcompetentclone | not stated | unknown](https://absa.org/lai/hiv-from-replicationcompetentclone-not-stated-unknown/)
- [HIV-2 | Baltimore, Maryland | published in 2001](https://absa.org/lai/hiv-2-baltimore-maryland-published-in-2001/)
- [Hantavirus  | UK | January - July 1977](https://absa.org/lai/hantavirus-uk-january-july-1977/)
- [Hantavirus | Blacksburg, VA and Randolph County | 4-Jul](https://absa.org/lai/hantavirus-blacksburg-va-and-randolph-county-4-jul/)
- [hantavirus | China | unknown](https://absa.org/lai/hantavirus-china-unknown/)
- [hantavirus | multiple cities, China | 01/01/1995 to 12/31/2015](https://absa.org/lai/hantavirus-multiple-cities-china-01-01-1995-to-12-31-2015/)
- [Hantavirus, Sin Nombre Virus (monongahela) | Randolph County, West Virginia, USA | 4-Jul](https://absa.org/lai/hantavirus-sin-nombre-virus-monongahela-randolph-county-west-virginia-usa-4-jul/)
- [Hantavirus: SinNombre(SNV) and Andes | Maryland, USA | reported in 2004](https://absa.org/lai/hantavirus-sinnombresnv-and-andes-maryland-usa-reported-in-2004/)
- [Helicobacter pylori | Fukuoka, Japan | unknown](https://absa.org/lai/helicobacter-pylori-fukuoka-japan-unknown/)
- [Helicobacter pylori | Paris, France | unknown](https://absa.org/lai/helicobacter-pylori-paris-france-unknown/)
- [Helicobacter pylori | unknown | unknown](https://absa.org/lai/helicobacter-pylori-unknown-unknown/)
- [Hemorrhagic Fever with Renal Syndrome virus (HFRS virus) | Japan | 1985](https://absa.org/lai/hemorrhagic-fever-with-renal-syndrome-virus-hfrs-virus-japan-1985/)
- [Hemorrhagic Fever with the Renal Syndrome (Bunyaviridae, Hantavirus( | Moscow, Russia | 9/1958, autumn 1967](https://absa.org/lai/hemorrhagic-fever-with-the-renal-syndrome-bunyaviridae-hantavirus-moscow-russia-9-1958-autumn-1967/)
- [Hepatitis A, Hepatitis B and non-A, non-B Hepatitis, Tuberculosis, Shigella,  Brucella, Herpes, unidentified bowel infections  | British Laboratories (200 England, 24 Scotland, 11 Wales and 5 Northern Ireland) | 1982 - 1983](https://absa.org/lai/hepatitis-a-hepatitis-b-and-non-a-non-b-hepatitis-tuberculosis-shigella-brucella-herpes-unidentified-bowel-infections-british-laboratories-200-england-24-scotland-11-wales-and-5-northern/)
- [Francisella tularensis type B subspecies holarctica | Winnipeg, Manitoba, Canada; Brandon, Manitoba, Canada | July 2018 and August 2019](https://absa.org/lai/francisella-tularensis-type-b-subspecies-holarctica-winnipeg-manitoba-canada-brandon-manitoba-canada-july-2018-and-august-2019/)
- [Francisella tularensis, Coxiella burnetii, Venezuelan Equine Encephalitis | Fort Detrick, Maryland, USA | 1989-2002](https://absa.org/lai/francisella-tularensis-coxiella-burnetii-venezuelan-equine-encephalitis-fort-detrick-maryland-usa-1989-2002/)
- [Ganjam virus | Africa | published in 1984](https://absa.org/lai/ganjam-virus-africa-published-in-1984/)
- [Ganjam virus | Pune, India | From July 26th to August 24th, 1977](https://absa.org/lai/ganjam-virus-pune-india-from-july-26th-to-august-24th-1977/)
- [Gastrospirillum hominis | unknown | unknown](https://absa.org/lai/gastrospirillum-hominis-unknown-unknown/)
- [Haemophilus ducreyi CIP 542 | unknown | unknown](https://absa.org/lai/haemophilus-ducreyi-cip-542-unknown-unknown/)
- [Hantaan virus | Seoul, Korea | 1971, 1979](https://absa.org/lai/hantaan-virus-seoul-korea-1971-1979/)
- [Hantaan virus | unknown |](https://absa.org/lai/hantaan-virus-unknown/)
- [Escherichia coli O157:H7 | Most likley USA, no city given. | Not reported, but the paper was published in 2004.](https://absa.org/lai/escherichia-coli-o157h7-most-likley-usa-no-city-given-not-reported-but-the-paper-was-published-in-2004/)
- [Escherichia coli O157:H7 | New York State, USA | 1999-2004](https://absa.org/lai/escherichia-coli-o157h7-new-york-state-usa-1999-2004/)
- [Escherichia coli O157:H7 | Philadelphia, PA, USA (authors) | 11/26/2002 (date of stool isolate)](https://absa.org/lai/escherichia-coli-o157h7-philadelphia-pa-usa-authors-11-26-2002-date-of-stool-isolate/)
- [Escherichia coli O157:H7 | Washington, D.C., USA | 3-Dec](https://absa.org/lai/escherichia-coli-o157h7-washington-d-c-usa-3-dec/)
- [Escherichia coli O157:H7 | Wyndmoor, Pennsylvania, USA | 2-May](https://absa.org/lai/escherichia-coli-o157h7-wyndmoor-pennsylvania-usa-2-may/)
- [Escherichia coli O157:H7 strain NZ 2149-92 | Switzerland | ca 1992](https://absa.org/lai/escherichia-coli-o157h7-strain-nz-2149-92-switzerland-ca-1992/)
- [Escherichia coli, E. coli, O157:H7, STEC | Pennsylvania, USA | 2013](https://absa.org/lai/escherichia-coli-e-coli-o157h7-stec-pennsylvania-usa-2013/)
- [Filovirus | USA | published in 1990](https://absa.org/lai/filovirus-usa-published-in-1990/)
- [Filovirus | Virginia, Pennsylvania and Texas (U.S.A.) | Article published in 1990](https://absa.org/lai/filovirus-virginia-pennsylvania-and-texas-u-s-a-article-published-in-1990/)
- [foot and mouth disease virus | England | 19/11/2007](https://absa.org/lai/foot-and-mouth-disease-virus-england-19-11-2007/)
- [Fowl plague virus |  | 1977](https://absa.org/lai/fowl-plague-virus-1977/)
- [fowl plague virus | Melbourne, Victoria, Australia | 1977](https://absa.org/lai/fowl-plague-virus-melbourne-victoria-australia-1977/)
- [Francisella tularensis | Frederick, Maryland, USA | 1956 (9); 1957 (18); 1958 (14); 1959 (1)](https://absa.org/lai/francisella-tularensis-frederick-maryland-usa-1956-9-1957-18-1958-14-1959-1/)
- [Francisella tularensis | Ft. Dietrick, Maryland, USA | 2009](https://absa.org/lai/francisella-tularensis-ft-dietrick-maryland-usa-2009/)
- [Francisella tularensis | Martha's Vineyard, Massachusetts, USA | 2000](https://absa.org/lai/francisella-tularensis-marthas-vineyard-massachusetts-usa-2000/)
- [Francisella tularensis | Oklahoma, USA | 2007](https://absa.org/lai/francisella-tularensis-oklahoma-usa-2007/)
- [Francisella tularensis | Unknown (likely Washington DC or Bethesda, MD, USA) | Reported 2012](https://absa.org/lai/francisella-tularensis-unknown-likely-washington-dc-or-bethesda-md-usa-reported-2012/)
- [Francisella tularensis | Unknown | Article published in June 2000](https://absa.org/lai/francisella-tularensis-unknown-article-published-in-june-2000/)
- [Francisella tularensis Type A | Boston, MA, USA | 01/05/2004, 01/05/2004, 01/09/2004](https://absa.org/lai/francisella-tularensis-type-a-boston-ma-usa-01-05-2004-01-05-2004-01-09-2004/)
- [Ebola virus Zaire, also Machupo, Japanese Encephalitis Virus, Dengue, Lassa, Junin, Rift Valley Fever | Maryland, USA | 2004](https://absa.org/lai/ebola-virus-zaire-also-machupo-japanese-encephalitis-virus-dengue-lassa-junin-rift-valley-fever-maryland-usa-2004/)
- [Echinoccus spp. | north Karnataka India | unknown](https://absa.org/lai/echinoccus-spp-north-karnataka-india-unknown/)
- [Echo 11 Virus | London, England | 14/12/1978](https://absa.org/lai/echo-11-virus-london-england-14-12-1978/)
- [Encephalitozoon cuniculi | unknown | before 2003](https://absa.org/lai/encephalitozoon-cuniculi-unknown-before-2003/)
- [Enterobacter aerogenes | Richland, WA. | Not stated](https://absa.org/lai/enterobacter-aerogenes-richland-wa-not-stated/)
- [Escherichia coli | unknown | 1980](https://absa.org/lai/escherichia-coli-unknown-1980/)
- [Escherichia coli 0157:h7 | Washington State, USA | 1987](https://absa.org/lai/escherichia-coli-0157h7-washington-state-usa-1987/)
- [Escherichia coli O117:K1:H7 | Denmark | unknown (1997-2002)](https://absa.org/lai/escherichia-coli-o117k1h7-denmark-unknown-1997-2002/)
- [Escherichia coli O157 infection | United Kingdom | Article published on November 20, 1993.](https://absa.org/lai/escherichia-coli-o157-infection-united-kingdom-article-published-on-november-20-1993/)
- [Escherichia coli O157:H7 | 49 states, USA | 1982 to 2002](https://absa.org/lai/escherichia-coli-o157h7-49-states-usa-1982-to-2002/)
- [Escherichia coli O157:H7 | Canada | 2017](https://absa.org/lai/escherichia-coli-o157h7-canada-2017/)
- [Ebola virus | Ft. Dietrick, Maryland, USA | 11/2/04](https://absa.org/lai/ebola-virus-ft-dietrick-maryland-usa-11-2-04/)
- [Ebola virus | Hamburg, Germany | 12/3/09 A](https://absa.org/lai/ebola-virus-hamburg-germany-12-3-09-a/)
- [Ebola virus | Hamburg, Germany | 12/3/09 B](https://absa.org/lai/ebola-virus-hamburg-germany-12-3-09-b/)
- [Ebola virus | Reston, VA | 11/16/94](https://absa.org/lai/ebola-virus-reston-va-11-16-94/)
- [Ebola virus | Russia | 5/5/04](https://absa.org/lai/ebola-virus-russia-5-5-04/)
- [Ebola virus | Tai National Park, Cote-d'Ivoire | 16/10/1994](https://absa.org/lai/ebola-virus-tai-national-park-cote-divoire-16-10-1994/)
- [Ebola virus | Wiltshire England | Nov-76](https://absa.org/lai/ebola-virus-wiltshire-england-nov-76/)
- [Ebola virus Zaire | Hamburg, Germany | 12/3/09](https://absa.org/lai/ebola-virus-zaire-hamburg-germany-12-3-09/)
- [Cryptosporidium | 1980 case unknown, the second date: Caldwell Veterinary Teaching Center , Idaho | Two dates: one known as 1980 and the second unknown](https://absa.org/lai/cryptosporidium-1980-case-unknown-the-second-date-caldwell-veterinary-teaching-center-idaho-two-dates-one-known-as-1980-and-the-second-unknown/)
- [Cryptosporidium | Fort Collins, CO, USA | 03/23/1987-04/26/1987](https://absa.org/lai/cryptosporidium-fort-collins-co-usa-03-23-1987-04-26-1987/)
- [Cryptosporidium | Not clear, but mostlikely Auburn Univeristy, Alabama USA | Not reported](https://absa.org/lai/cryptosporidium-not-clear-but-mostlikely-auburn-univeristy-alabama-usa-not-reported/)
- [Cryptosporidium | Philadelphia, Pennsylvania, U.S.A | 13-02-2015](https://absa.org/lai/cryptosporidium-philadelphia-pennsylvania-u-s-a-13-02-2015/)
- [Cryptosporidium | Unknown | Between September 1981 and April 1982](https://absa.org/lai/cryptosporidium-unknown-between-september-1981-and-april-1982/)
- [Cryptosporidium sp | Raleigh, North Carolina, USA | unknown](https://absa.org/lai/cryptosporidium-sp-raleigh-north-carolina-usa-unknown/)
- [Cryptosporidium sp. | Auburn, AL, USA | Article published in 1982](https://absa.org/lai/cryptosporidium-sp-auburn-al-usa-article-published-in-1982/)
- [Dengue  type 1 | Taiwan | 2004](https://absa.org/lai/dengue-type-1-taiwan-2004/)
- [Dengue | South Korea | 2014](https://absa.org/lai/dengue-south-korea-2014/)
- [dengue virus | Cambridge, Massachusetts, USA | 2-Nov](https://absa.org/lai/dengue-virus-cambridge-massachusetts-usa-2-nov/)
- [dengue virus | North Carolina, USA | 18-Jul](https://absa.org/lai/dengue-virus-north-carolina-usa-18-jul/)
- [Dengue virus | Osaka, Japan | 2/5/80](https://absa.org/lai/dengue-virus-osaka-japan-2-5-80/)
- [Dengue Virus Serotype 2 (DENV-type 2) | Australia  | 2011 publication](https://absa.org/lai/dengue-virus-serotype-2-denv-type-2-australia-2011-publication/)
- [Dengue Virus type 2 | Pune, India | Unknown (ca 1983)](https://absa.org/lai/dengue-virus-type-2-pune-india-unknown-ca-1983/)
- [Dhori Virus (Orthomyxoviridae) | Moscow, Russia | 6/1978,7/1978, 3/1979, 4/1979](https://absa.org/lai/dhori-virus-orthomyxoviridae-moscow-russia-6-19787-1978-3-1979-4-1979/)
- [E.coli 0157 | United Kingdom | spring 1996](https://absa.org/lai/e-coli-0157-united-kingdom-spring-1996/)
- [E.coli O157:H7 | New York State, USA | 1999, 2000, 2003, and 2004](https://absa.org/lai/e-coli-o157h7-new-york-state-usa-1999-2000-2003-and-2004/)
- [Ebola | Winnipeg, Canada | 7-Nov-16](https://absa.org/lai/ebola-winnipeg-canada-7-nov-16/)
- [Ebola virus | Atlanta, Georgia, USA | 22/12/2014](https://absa.org/lai/ebola-virus-atlanta-georgia-usa-22-12-2014/)
- [Ebola virus | Cote d'Ivoire | 1994](https://absa.org/lai/ebola-virus-cote-divoire-1994/)
- [Coxiella burnetii | USA | 2009 Survey](https://absa.org/lai/coxiella-burnetii-usa-2009-survey/)
- [Coxiella burnetti | Brookings, South Dakota, USA | reported in 2013](https://absa.org/lai/coxiella-burnetti-brookings-south-dakota-usa-reported-in-2013/)
- [Coxiella burnetti | Charleston, South Carolina, USA | 1991](https://absa.org/lai/coxiella-burnetti-charleston-south-carolina-usa-1991/)
- [Coxiella burnetti | Denver, Colorado, USA | Apr-80](https://absa.org/lai/coxiella-burnetti-denver-colorado-usa-apr-80/)
- [Coxiella burnetti | Little Rock, AR, USA | 05/1985, 10/1985](https://absa.org/lai/coxiella-burnetti-little-rock-ar-usa-05-1985-10-1985/)
- [Coxsackie virus type A24 | United States of America | 1978](https://absa.org/lai/coxsackie-virus-type-a24-united-states-of-america-1978/)
- [Creutzfeld-Jakob disease | New York | 3/31/88](https://absa.org/lai/creutzfeld-jakob-disease-new-york-3-31-88/)
- [Creutzfeld-Jakob disease | Ottawa, Canada | 3/31/88](https://absa.org/lai/creutzfeld-jakob-disease-ottawa-canada-3-31-88/)
- [Creutzfeldt-Jakob disease | California, U.S.A. | May-June, 1990.](https://absa.org/lai/creutzfeldt-jakob-disease-california-u-s-a-may-june-1990/)
- [Creutzfeldt-Jakob Disease | France | 17/06/2019](https://absa.org/lai/creutzfeldt-jakob-disease-france-17-06-2019/)
- [Creutzfeldt-Jakob disease | Germany | May, 1992.](https://absa.org/lai/creutzfeldt-jakob-disease-germany-may-1992/)
- [Creutzfeldt-Jakob Disease | Tolouse, France | 12/11/21](https://absa.org/lai/creutzfeldt-jakob-disease-tolouse-france-12-11-21/)
- [Creutzfeldt-Jakob disease | U.S.A. | Article published in 1988](https://absa.org/lai/creutzfeldt-jakob-disease-u-s-a-article-published-in-1988/)
- [Crimean-Congo Hemorrhagic Fever Virus (Bunyaviridae, Bunyaviirus, CHF-Congo Antigenic Group | Moscow, Russia | 1970](https://absa.org/lai/crimean-congo-hemorrhagic-fever-virus-bunyaviridae-bunyaviirus-chf-congo-antigenic-group-moscow-russia-1970/)
- [Cryptosporidium  | Turku, Finland. | Article published in 1986](https://absa.org/lai/cryptosporidium-turku-finland-article-published-in-1986/)
- [Coxiella burnetii | Germany | no date given](https://absa.org/lai/coxiella-burnetii-germany-no-date-given/)
- [Coxiella burnetii | Netherlands | A few weeks before June, 1983.](https://absa.org/lai/coxiella-burnetii-netherlands-a-few-weeks-before-june-1983/)
- [Coxiella burnetii | San Francisco, CA. U.S.A. | 1979](https://absa.org/lai/coxiella-burnetii-san-francisco-ca-u-s-a-1979/)
- [Coxiella burnetii | Texas | reported in 2009](https://absa.org/lai/coxiella-burnetii-texas-reported-in-2009/)
- [Coxiella burnetii | Toronto, Ontario, Canada | unknown, prior to 1982](https://absa.org/lai/coxiella-burnetii-toronto-ontario-canada-unknown-prior-to-1982/)
- [Coxiella burnetii | unknown | unknown](https://absa.org/lai/coxiella-burnetii-unknown-unknown/)
- [Chikungunya virus, SARS, H5N1 avian influenza, MRSA, Staphylococcus aureus, H3N2 influenza | USA, multiple cities | variable](https://absa.org/lai/chikungunya-virus-sars-h5n1-avian-influenza-mrsa-staphylococcus-aureus-h3n2-influenza-usa-multiple-cities-variable/)
- [Chlamydia pneumoniae | San Francisco, California. U.S.A. | October, 1989](https://absa.org/lai/chlamydia-pneumoniae-san-francisco-california-u-s-a-october-1989/)
- [Chlamydia pneumoniae Kajaani 6 | Finland | Unknown (two cases potentially 1987)](https://absa.org/lai/chlamydia-pneumoniae-kajaani-6-finland-unknown-two-cases-potentially-1987/)
- [Chlamydia trachomatis | Beer Sheva, Israel | Article published in 1986](https://absa.org/lai/chlamydia-trachomatis-beer-sheva-israel-article-published-in-1986/)
- [Chlamydia trachomatis | LA, California. U.S.A. | Article reported in 1982](https://absa.org/lai/chlamydia-trachomatis-la-california-u-s-a-article-reported-in-1982/)
- [Chlamydia trachomatis | Los Angeles, California, USA | Article published in 1984](https://absa.org/lai/chlamydia-trachomatis-los-angeles-california-usa-article-published-in-1984/)
- [Chlamydophila/Chlamydia pneumoniae | Finland | Dec-90](https://absa.org/lai/chlamydophila-chlamydia-pneumoniae-finland-dec-90/)
- [Coccidioides immitis | Ohio, USA | unknown](https://absa.org/lai/coccidioides-immitis-ohio-usa-unknown/)
- [Coccidioides immitis, Coccidioides posadasii | Toronto, Ontario, Canada | 2/4/12](https://absa.org/lai/coccidioides-immitis-coccidioides-posadasii-toronto-ontario-canada-2-4-12/)
- [Coccidioides immitis, Histoplasma capsulatum, Blastomyces dermatitidis | Various locations | 1948, 1952, other](https://absa.org/lai/coccidioides-immitis-histoplasma-capsulatum-blastomyces-dermatitidis-various-locations-1948-1952-other/)
- [Coccidioides posadasii | Chile | 2017](https://absa.org/lai/coccidioides-posadasii-chile-2017/)
- [Corynebacterium diphtheriae NCTC 10684 | Germany | Mar-96](https://absa.org/lai/corynebacterium-diphtheriae-nctc-10684-germany-mar-96/)
- [Corynebacterium diphtheriae var gravis | London, United Kingdom | Nov-97](https://absa.org/lai/corynebacterium-diphtheriae-var-gravis-london-united-kingdom-nov-97/)
- [Corynebacterium diptheriae | UK | Nov-97](https://absa.org/lai/corynebacterium-diptheriae-uk-nov-97/)
- [Corynebacterium equi, Rhodococcus equi | Osaka, Japan | 1987](https://absa.org/lai/corynebacterium-equi-rhodococcus-equi-osaka-japan-1987/)
- [cowpox virus | Georgia, USA | 10-Jul](https://absa.org/lai/cowpox-virus-georgia-usa-10-jul/)
- [Cowpox virus | U.S.A. | Article published on April 26, 2012](https://absa.org/lai/cowpox-virus-u-s-a-article-published-on-april-26-2012/)
- [Coxiella burneti | Bristol, England | 1981](https://absa.org/lai/coxiella-burneti-bristol-england-1981/)
- [Burkholderia pseudomallei | Phoenix, Arizona, USA | January, 2021](https://absa.org/lai/burkholderia-pseudomallei-phoenix-arizona-usa-january-2021/)
- [Burkholderia pseudomallei | Thailand  | Article published on June 11, 2014](https://absa.org/lai/burkholderia-pseudomallei-thailand-article-published-on-june-11-2014/)
- [Burkholderia pseudomallei | USA | 2008-2013](https://absa.org/lai/burkholderia-pseudomallei-usa-2008-2013/)
- [Burkholderia pseudomallei,  | unknown | unknown](https://absa.org/lai/burkholderia-pseudomallei-unknown-unknown/)
- [Burkolderia (Pseudomonas) pseudomallei | Toronto, Ontario, Canada | 1966](https://absa.org/lai/burkolderia-pseudomonas-pseudomallei-toronto-ontario-canada-1966/)
- [Calcivirus (San Miguel sea lion virus serotype 5; SMSV-5) | United States of America | 1996 or 1997](https://absa.org/lai/calcivirus-san-miguel-sea-lion-virus-serotype-5-smsv-5-united-states-of-america-1996-or-1997/)
- [Campylobacter fetus ss jejuni | Albuquerque, NM, USA | unknown](https://absa.org/lai/campylobacter-fetus-ss-jejuni-albuquerque-nm-usa-unknown/)
- [Campylobacter jejuni | Toronto Canada | unknown](https://absa.org/lai/campylobacter-jejuni-toronto-canada-unknown/)
- [Campylobacter jejuni strain VLA2/18 | uknown | unknown](https://absa.org/lai/campylobacter-jejuni-strain-vla2-18-uknown-unknown/)
- [Candidatus Mycoplasma haemohominis | Australia | 18-Feb](https://absa.org/lai/candidatus-mycoplasma-haemohominis-australia-18-feb/)
- [Case 1 - Leptospira interrogans serogroup Icterohaemorrhagiae strain CF1, Case 2 - Leptospira interrogans serogroup Sejroe serovar hardjo | UK | published in 1988](https://absa.org/lai/case-1-leptospira-interrogans-serogroup-icterohaemorrhagiae-strain-cf1-case-2-leptospira-interrogans-serogroup-sejroe-serovar-hardjo-uk-published-in-1988/)
- [cell-culture-adapted Hantavirus | Maryland | reported in 1994](https://absa.org/lai/cell-culture-adapted-hantavirus-maryland-reported-in-1994/)
- [Cercopithecid herpesvirus 1, Herpesvirus simiae | Pensacola, Florida. U.S.A. | Between 28-03-1987 and 7/04/1987](https://absa.org/lai/cercopithecid-herpesvirus-1-herpesvirus-simiae-pensacola-florida-u-s-a-between-28-03-1987-and-7-04-1987/)
- [Cercopithecine herpesvirus 1 (B virus) | USA | 29/10/1997](https://absa.org/lai/cercopithecine-herpesvirus-1-b-virus-usa-29-10-1997/)
- [Cercopithicene herpesvirus 1 (B virus) | USA | 29/10/1997](https://absa.org/lai/cercopithicene-herpesvirus-1-b-virus-usa-29-10-1997/)
- [Chiamydia pneumoniae, | Finland (multiple laboratories) | 1993](https://absa.org/lai/chiamydia-pneumoniae-finland-multiple-laboratories-1993/)
- [chikunguna virus, Dugbe virus, Wesselbron virus, dengue virus | Ibadan, Nigeria | 1963-1977](https://absa.org/lai/chikunguna-virus-dugbe-virus-wesselbron-virus-dengue-virus-ibadan-nigeria-1963-1977/)
- [Burkholderia pseudomallei | CO, WA, CA, MD, TX | 2010-2011](https://absa.org/lai/burkholderia-pseudomallei-co-wa-ca-md-tx-2010-2011/)
- [Burkholderia pseudomallei | Los Angeles, CA, USA | 7/25/03](https://absa.org/lai/burkholderia-pseudomallei-los-angeles-ca-usa-7-25-03/)
- [Burkholderia pseudomallei | multiple US locations primarily California and Maryland | 2017-2019](https://absa.org/lai/burkholderia-pseudomallei-multiple-us-locations-primarily-california-and-maryland-2017-2019/)
- [Brucella spp. | Istambul, Turkey | Article published in 2004](https://absa.org/lai/brucella-spp-istambul-turkey-article-published-in-2004/)
- [Brucella spp. | Lanzhou, China | 24/07/19 to 20/08/19](https://absa.org/lai/brucella-spp-lanzhou-china-24-07-19-to-20-08-19/)
- [Brucella spp. | Riyadh, Saudi Arabia | 01/01/1983 to 12/31/2000](https://absa.org/lai/brucella-spp-riyadh-saudi-arabia-01-01-1983-to-12-31-2000/)
- [Brucella spp. | Riyadh, Saudi Arabia | 01/01/1991 to 12/31/2000](https://absa.org/lai/brucella-spp-riyadh-saudi-arabia-01-01-1991-to-12-31-2000/)
- [Brucella spp. | Riyahdh, Saudi Arabia | 1984, 1985, 1986, 1987, 1988, 1990](https://absa.org/lai/brucella-spp-riyahdh-saudi-arabia-1984-1985-1986-1987-1988-1990/)
- [Brucella spp. | Texas, USA | 9/2/06](https://absa.org/lai/brucella-spp-texas-usa-9-2-06/)
- [Brucella spp. | unknown | unknown](https://absa.org/lai/brucella-spp-unknown-unknown/)
- [Brucella spp. | worldwide | unknown](https://absa.org/lai/brucella-spp-worldwide-unknown/)
- [Brucella spp., Brucella melitensis | China, multiple cities | unknown](https://absa.org/lai/brucella-spp-brucella-melitensis-china-multiple-cities-unknown/)
- [Brucella spp., Brucella melitensis, Brucella abortus | New York, New York, USA | 2015-2017](https://absa.org/lai/brucella-spp-brucella-melitensis-brucella-abortus-new-york-new-york-usa-2015-2017/)
- [Brucella suis | Alaska, USA | 2012](https://absa.org/lai/brucella-suis-alaska-usa-2012/)
- [Brucella suis | Kansas City, U.S.A | May 24, 2010 (Case 3); March 15,2010 (Case 4)](https://absa.org/lai/brucella-suis-kansas-city-u-s-a-may-24-2010-case-3-march-152010-case-4/)
- [Brucella suis | Mississippi, U.S.A. | October 18, 2010 (Case 5)](https://absa.org/lai/brucella-suis-mississippi-u-s-a-october-18-2010-case-5/)
- [Brucella suis | Townsville, Australia | 1996-2000](https://absa.org/lai/brucella-suis-townsville-australia-1996-2000/)
- [Buffalopox virus (BPXV) | India | 2010](https://absa.org/lai/buffalopox-virus-bpxv-india-2010/)
- [Burkholderia (Pseudomonas) pseudomallei | North Queensland, Australia | unknown](https://absa.org/lai/burkholderia-pseudomonas-pseudomallei-north-queensland-australia-unknown/)
- [Burkholderia (Pseudomonas) pseudomallei | Syracuse NY, USA | Jun-80](https://absa.org/lai/burkholderia-pseudomonas-pseudomallei-syracuse-ny-usa-jun-80/)
- [Burkholderia mallei | Frederick, Maryland, USA | 1944 (2); 1945 (4); 1953 (1)](https://absa.org/lai/burkholderia-mallei-frederick-maryland-usa-1944-2-1945-4-1953-1/)
- [Burkholderia mallei | USAMRIID | 5/5/00](https://absa.org/lai/burkholderia-mallei-usamriid-5-5-00/)
- [Burkholderia pseudomallei | Case 1: Broward County, FL, USA and Case 2: Miami-Dade County, FL, USA | 22/08/2005, 22/09/2005](https://absa.org/lai/burkholderia-pseudomallei-case-1-broward-county-fl-usa-and-case-2-miami-dade-county-fl-usa-22-08-2005-22-09-2005/)
- [Brucella melitensis, Brucella abortus, Brucella suis | worldwide | 1982-2007](https://absa.org/lai/brucella-melitensis-brucella-abortus-brucella-suis-worldwide-1982-2007/)
- [Brucella melitensis, Brucella suis | unknown | unknown](https://absa.org/lai/brucella-melitensis-brucella-suis-unknown-unknown/)
- [Brucella melitensis, Brucella suis, Francisella tularensis, Coccidioides spp. | U.S.A. | 2004 - 2010](https://absa.org/lai/brucella-melitensis-brucella-suis-francisella-tularensis-coccidioides-spp-u-s-a-2004-2010/)
- [Brucella melitensis, Rev-1 | Girona, Spain | July to September 1982](https://absa.org/lai/brucella-melitensis-rev-1-girona-spain-july-to-september-1982/)
- [Brucella sp. | Babol, Iran | 1997 - 2002](https://absa.org/lai/brucella-sp-babol-iran-1997-2002/)
- [Brucella sp. | Germany | 2002-2003](https://absa.org/lai/brucella-sp-germany-2002-2003/)
- [Brucella sp. | Serdang, Selangor, Malaysia | Article published in 2014](https://absa.org/lai/brucella-sp-serdang-selangor-malaysia-article-published-in-2014/)
- [Brucella sp. | Spain | Article published in 2003](https://absa.org/lai/brucella-sp-spain-article-published-in-2003/)
- [Brucella sp. | Spain | pre-1970 -1999](https://absa.org/lai/brucella-sp-spain-pre-1970-1999/)
- [Brucella spp | China | 2006-2016](https://absa.org/lai/brucella-spp-china-2006-2016/)
- [Brucella spp. | China | 2010](https://absa.org/lai/brucella-spp-china-2010/)
- [Brucella spp. | Florida, U.S.A. | July 13-14, 2009 (Case 2)](https://absa.org/lai/brucella-spp-florida-u-s-a-july-13-14-2009-case-2/)
- [Brucella spp. | Germany | 1962-1995](https://absa.org/lai/brucella-spp-germany-1962-1995/)
- [Brucella spp. | Houston, Texas. U.S.A. | June 1981-1982](https://absa.org/lai/brucella-spp-houston-texas-u-s-a-june-1981-1982/)
- [Brucella spp. | Indiana, USA; Minnesota, USA | 17/07/2006; 21/07/2006; 08/08/2006](https://absa.org/lai/brucella-spp-indiana-usa-minnesota-usa-17-07-2006-21-07-2006-08-08-2006/)
- [Brucella melitensis | unknown | 1/2/79](https://absa.org/lai/brucella-melitensis-unknown-1-2-79/)
- [Brucella melitensis | unknown | unknown](https://absa.org/lai/brucella-melitensis-unknown-unknown/)
- [Brucella melitensis | Wisconsin, USA | 7/31/08](https://absa.org/lai/brucella-melitensis-wisconsin-usa-7-31-08/)
- [Brucella melitensis biovar | China, University and hospital settings | 2011-2017](https://absa.org/lai/brucella-melitensis-biovar-china-university-and-hospital-settings-2011-2017/)
- [Brucella melitensis biovar | Multiple cities in China | Multiple LAIs between 2006 and 2017](https://absa.org/lai/brucella-melitensis-biovar-multiple-cities-in-china-multiple-lais-between-2006-and-2017/)
- [Brucella melitensis | Kansas City, U.S.A. | Article published in 2011](https://absa.org/lai/brucella-melitensis-kansas-city-u-s-a-article-published-in-2011/)
- [Brucella melitensis | Kuala Lumpur, Malaysia | 25/02/2009, 03/03/2009](https://absa.org/lai/brucella-melitensis-kuala-lumpur-malaysia-25-02-2009-03-03-2009/)
- [Brucella melitensis | London. England | unknown but symptoms presented in June/July of 1995](https://absa.org/lai/brucella-melitensis-london-england-unknown-but-symptoms-presented-in-june-july-of-1995/)
- [Brucella melitensis | Massachusetts, USA | 2008](https://absa.org/lai/brucella-melitensis-massachusetts-usa-2008/)
- [Brucella melitensis | Michigan, USA | Mar-88](https://absa.org/lai/brucella-melitensis-michigan-usa-mar-88-2/)
- [Brucella melitensis | Milwaukee, Wisconsin, U.S.A. | Dec-92](https://absa.org/lai/brucella-melitensis-milwaukee-wisconsin-u-s-a-dec-92/)
- [Brucella melitensis | Nairobi, Kenya | Article published in 1992](https://absa.org/lai/brucella-melitensis-nairobi-kenya-article-published-in-1992/)
- [Brucella melitensis | Nairobi, Kenya and Oxford, UK | unknown A](https://absa.org/lai/brucella-melitensis-nairobi-kenya-and-oxford-uk-unknown-a/)
- [Brucella melitensis | Nairobi, Kenya and Oxford, UK | unknown B](https://absa.org/lai/brucella-melitensis-nairobi-kenya-and-oxford-uk-unknown-b/)
- [Brucella melitensis | New York State, USA | August-October 2001, Nov 2001](https://absa.org/lai/brucella-melitensis-new-york-state-usa-august-october-2001-nov-2001/)
- [Brucella melitensis | Riyadh, Saudi Arabia | unknown](https://absa.org/lai/brucella-melitensis-riyadh-saudi-arabia-unknown/)
- [Brucella melitensis | Rome, Italy | 6-Jul](https://absa.org/lai/brucella-melitensis-rome-italy-6-jul/)
- [Brucella melitensis | Royal Oak, MI, USA | 08/05/1996-08/09/1996](https://absa.org/lai/brucella-melitensis-royal-oak-mi-usa-08-05-1996-08-09-1996/)
- [Brucella melitensis | Saudi Arabia | Article published in 1989](https://absa.org/lai/brucella-melitensis-saudi-arabia-article-published-in-1989/)
- [Brucella melitensis | Seville, Spain | June-September 1988](https://absa.org/lai/brucella-melitensis-seville-spain-june-september-1988/)
- [Brucella melitensis | Singapore | 2018](https://absa.org/lai/brucella-melitensis-singapore-2018/)
- [Brucella melitensis | southern Israel | 2002-2009](https://absa.org/lai/brucella-melitensis-southern-israel-2002-2009/)
- [Brucella melitensis | Sweden | 2013](https://absa.org/lai/brucella-melitensis-sweden-2013/)
- [Brucella melitensis | United Arab Emirates | unknown](https://absa.org/lai/brucella-melitensis-united-arab-emirates-unknown/)
- [Brucella canis M- strain | unknown | unknown](https://absa.org/lai/brucella-canis-m-strain-unknown-unknown/)
- [Brucella ceti | Southern Maine, USA | 1/29/12](https://absa.org/lai/brucella-ceti-southern-maine-usa-1-29-12/)
- [Brucella melitensis  | Brussels, Belgium | August 16, 1982 for lab worker](https://absa.org/lai/brucella-melitensis-brussels-belgium-august-16-1982-for-lab-worker/)
- [Brucella melitensis  | Michigan USA | Mar-88](https://absa.org/lai/brucella-melitensis-michigan-usa-mar-88/)
- [Brucella melitensis  | Nice Cedex, France | 21-Dec-96](https://absa.org/lai/brucella-melitensis-nice-cedex-france-21-dec-96/)
- [Brucella melitensis  | Oxford, UK | 1991](https://absa.org/lai/brucella-melitensis-oxford-uk-1991/)
- [Brucella melitensis | Afyonkarahisar, Turkey | 2008 publication](https://absa.org/lai/brucella-melitensis-afyonkarahisar-turkey-2008-publication/)
- [Brucella melitensis | Atlanta, Georgia USA | unknown](https://absa.org/lai/brucella-melitensis-atlanta-georgia-usa-unknown/)
- [Brucella melitensis | Beer-Sheva, Israel | 04/1997 and 06/1997](https://absa.org/lai/brucella-melitensis-beer-sheva-israel-04-1997-and-06-1997/)
- [Brucella melitensis | Chicago, Il | Nov-80](https://absa.org/lai/brucella-melitensis-chicago-il-nov-80/)
- [Brucella melitensis | Copenhagen, Denmark | 12-Jul](https://absa.org/lai/brucella-melitensis-copenhagen-denmark-12-jul/)
- [Brucella melitensis | East Lansing, Michigan, USA | December 10, 1938-February 10, 1939](https://absa.org/lai/brucella-melitensis-east-lansing-michigan-usa-december-10-1938-february-10-1939/)
- [Brucella melitensis | East Lansing, Michigan, USA | December, 1938](https://absa.org/lai/brucella-melitensis-east-lansing-michigan-usa-december-1938/)
- [Brucella melitensis | England | 7/1/95](https://absa.org/lai/brucella-melitensis-england-7-1-95/)
- [Brucella melitensis | Jerusalem, Israel | pre-1985](https://absa.org/lai/brucella-melitensis-jerusalem-israel-pre-1985/)
- [Brucella abortus | Sassari, Italy | 10/1990 to 03/1991](https://absa.org/lai/brucella-abortus-sassari-italy-10-1990-to-03-1991/)
- [Brucella abortus | unknown | 1985 or before](https://absa.org/lai/brucella-abortus-unknown-1985-or-before/)
- [Brucella abortus RB51 | New York, U.S.A. | 7-Nov](https://absa.org/lai/brucella-abortus-rb51-new-york-u-s-a-7-nov/)
- [Brucella abortus Strain 19 | Spain | Unknown, presented 24/02/1982](https://absa.org/lai/brucella-abortus-strain-19-spain-unknown-presented-24-02-1982/)
- [Brucella abortus strain S19 | Buenos Aires (?), Argentina | symptoms led to referrals 1999 to 2006](https://absa.org/lai/brucella-abortus-strain-s19-buenos-aires-argentina-symptoms-led-to-referrals-1999-to-2006/)
- [Brucella abortus, Strain 19 | Ames, IA | 1988](https://absa.org/lai/brucella-abortus-strain-19-ames-ia-1988/)
- [Blastomyces dermatididis, Coccidioides immitis, Histoplasma capsulatum, Sporothrix schenckii, Talaromyces marneffei | worldwide | 1900-2020](https://absa.org/lai/blastomyces-dermatididis-coccidioides-immitis-histoplasma-capsulatum-sporothrix-schenckii-talaromyces-marneffei-worldwide-1900-2020/)
- [Blastomyces dermatiditis | Boulder, Colorado, USA | 1998](https://absa.org/lai/blastomyces-dermatiditis-boulder-colorado-usa-1998/)
- [Blastomyces dermatiditis | unknown | 1971 and 1980](https://absa.org/lai/blastomyces-dermatiditis-unknown-1971-and-1980/)
- [Blastomyces dermatitidis | Cleveland, Ohio. U.S.A. | Article published in 1970 (exposure in August 1968)](https://absa.org/lai/blastomyces-dermatitidis-cleveland-ohio-u-s-a-article-published-in-1970-exposure-in-august-1968/)
- [Bordetella pertussis | Bethesda, Maryland is the location of the first author; the other authors are in 4 other states in the USA. | published in 1983](https://absa.org/lai/bordetella-pertussis-bethesda-maryland-is-the-location-of-the-first-author-the-other-authors-are-in-4-other-states-in-the-usa-published-in-1983/)
- [Bordetella pertussis | Bethesda, Maryland, USA | unknown, presented to OMS 6/27/1985](https://absa.org/lai/bordetella-pertussis-bethesda-maryland-usa-unknown-presented-to-oms-6-27-1985/)
- [Bordetella pertussis | Georgia, USA | prior to 1995](https://absa.org/lai/bordetella-pertussis-georgia-usa-prior-to-1995/)
- [bovine spongiform encephalopathy prion, BSE, mad cow disease, vCJD, variant Creutzfeldt-Jakob disease | France | 10-May](https://absa.org/lai/bovine-spongiform-encephalopathy-prion-bse-mad-cow-disease-vcjd-variant-creutzfeldt-jakob-disease-france-10-may/)
- [bovine spongiform encephalopathy, BSE, Creutzfeldt-Jakob disease, CJD, vCJD | France | 10-May](https://absa.org/lai/bovine-spongiform-encephalopathy-bse-creutzfeldt-jakob-disease-cjd-vcjd-france-10-may/)
- [bovine spongiform encephalopathy, BSE, prion | Paris, France | 10-May](https://absa.org/lai/bovine-spongiform-encephalopathy-bse-prion-paris-france-10-may/)
- [Bovine stomatitis virus | Auburn, Alabama, USA | Feb-78](https://absa.org/lai/bovine-stomatitis-virus-auburn-alabama-usa-feb-78/)
- [Brucella  | Gansu Province, China | 2019](https://absa.org/lai/brucella-gansu-province-china-2019/)
- [Brucella | Ankara Turkey | pre 2003](https://absa.org/lai/brucella-ankara-turkey-pre-2003/)
- [Brucella | Chongqing, China | 16/12/2020](https://absa.org/lai/brucella-chongqing-china-16-12-2020/)
- [Brucella | Turkey | unknown](https://absa.org/lai/brucella-turkey-unknown/)
- [Brucella abortus (RB51 strain) | Various states and provinces in the USA and Canada | October-November 2007](https://absa.org/lai/brucella-abortus-rb51-strain-various-states-and-provinces-in-the-usa-and-canada-october-november-2007/)
- [Brucella abortus | Brazil | 2012-05](https://absa.org/lai/brucella-abortus-brazil-2012-05/)
- [Brucella abortus | Canada | Article published in July 2, 1985.](https://absa.org/lai/brucella-abortus-canada-article-published-in-july-2-1985/)
- [Brucella abortus | Japan | 2019](https://absa.org/lai/brucella-abortus-japan-2019/)
- [Arthorderma benhamiae | Japan | 2001](https://absa.org/lai/arthorderma-benhamiae-japan-2001/)
- [Avian Influenza A(H7N2) | New York, U.S.A.  | 2016](https://absa.org/lai/avian-influenza-ah7n2-new-york-u-s-a-2016/)
- [Bacille Calmette-Guerin (BCG) | Copenhagen, Denmark | 1977 or earlier](https://absa.org/lai/bacille-calmette-guerin-bcg-copenhagen-denmark-1977-or-earlier/)
- [Bacillus anthracis | A university in Hunan Province, China | 14/12/2017](https://absa.org/lai/bacillus-anthracis-a-university-in-hunan-province-china-14-12-2017/)
- [Bacillus anthracis | California, U.S.A. | June 9, 2004.](https://absa.org/lai/bacillus-anthracis-california-u-s-a-june-9-2004/)
- [Bacillus anthracis | CDC | 5-Apr-02](https://absa.org/lai/bacillus-anthracis-cdc-5-apr-02/)
- [Bacillus anthracis | France | 2009](https://absa.org/lai/bacillus-anthracis-france-2009/)
- [Bacillus anthracis | Sverdlovsk, Union of Soviet Socialist Republics | 4/1/80](https://absa.org/lai/bacillus-anthracis-sverdlovsk-union-of-soviet-socialist-republics-4-1-80/)
- [Bacillus anthracis, Yersinia pestis, Francisella tularensis, Burkholderia pseudomallei, Burkholderia mallei, alphavirus, bunyavirus, flavivirus, filovirus, orthopox virus, botulinum toxin | Ft. Dietrick, Maryland, USA | 1989-2002](https://absa.org/lai/bacillus-anthracis-yersinia-pestis-francisella-tularensis-burkholderia-pseudomallei-burkholderia-mallei-alphavirus-bunyavirus-flavivirus-filovirus-orthopox-virus-botulinum-toxin-ft-dietri/)
- [Bacillus Calmette-Guerin (BCG) vaccine | Copenhagen, Denmark | Unknown (bacteriologically verified in 1975)](https://absa.org/lai/bacillus-calmette-guerin-bcg-vaccine-copenhagen-denmark-unknown-bacteriologically-verified-in-1975/)
- [Bacillus cereus | Chicago, Illinois, USA | 11-Aug](https://absa.org/lai/bacillus-cereus-chicago-illinois-usa-11-aug/)
- [Bacillus cereus | Chicago, Illinois, USA | 2011](https://absa.org/lai/bacillus-cereus-chicago-illinois-usa-2011/)
- [bacteria, viruses, fungi, toxins, prions, parasites, Escherichi coli, Coxiella burnetii, Neisseria meningitidis, Brucella melitensis, SARS-CoV-2, pertussis toxin | Canada | 2022](https://absa.org/lai/bacteria-viruses-fungi-toxins-prions-parasites-escherichi-coli-coxiella-burnetii-neisseria-meningitidis-brucella-melitensis-sars-cov-2-pertussis-toxin-canada-2022/)
- [Bacteroides asaccharolyticus | Boston Massachusetts | unknown](https://absa.org/lai/bacteroides-asaccharolyticus-boston-massachusetts-unknown/)
- [African horsesickness virus | South Africa | 1985, 1989, 1989,1982](https://absa.org/lai/african-horsesickness-virus-south-africa-1985-1989-19891982/)
- [AHC virus (enterovirus 70) | Japan | Article published in 1976](https://absa.org/lai/ahc-virus-enterovirus-70-japan-article-published-in-1976/)
- [Anthroderma benhamiae | Japan | Article published in 2002](https://absa.org/lai/anthroderma-benhamiae-japan-article-published-in-2002/)
- [arboviruses | worldwide | unknown](https://absa.org/lai/arboviruses-worldwide-unknown/)
- [arboviruses, Western Equine Encephalitis, Venezuelan Equine Encephalitis, Chikungunya, Mayaro, Louping Ill, Tick-borne encephalitis, Saint Louis encephalitis, Kyansasur Forest, West Nile | worldwide | 1935-2006](https://absa.org/lai/arboviruses-western-equine-encephalitis-venezuelan-equine-encephalitis-chikungunya-mayaro-louping-ill-tick-borne-encephalitis-saint-louis-encephalitis-kyansasur-forest-west-nile-worldwide/)
- [Arenavirus SP H 114202 | not known | not known](https://absa.org/lai/arenavirus-sp-h-114202-not-known-not-known/)
- [Zika Virus | United States | 2016–2019](https://absa.org/lai/zika-virus-united-states-2016-2019/)
- [Seoul Virus and Hantavirus | Shenyang, People’s Republic of China | 2006](https://absa.org/lai/seoul-virus-and-hantavirus-shenyang-peoples-republic-of-china-2006/)
- [SARS coronavirus | National Institute of Virology in Beijing - China | 07/03/2004–22/03/2004](https://absa.org/lai/sars-coronavirus-national-institute-of-virology-in-beijing-china-07-03-2004-22-03-2004/)
- [Sabiá virus | Connecticut, USA | 8/8/94](https://absa.org/lai/sabia-virus-connecticut-usa-8-8-94/)
- [Sabiá virus | São Paulo, Brazil |](https://absa.org/lai/sabia-virus-sao-paulo-brazil/)
- [Rabies Virus “fixed” laboratory strain | Texas, USA | 17/02/1973](https://absa.org/lai/rabies-virus-fixed-laboratory-strain-texas-usa-17-02-1973/)
- [Neisseria meningitidis | Örebro, Sweden | 11/30/05](https://absa.org/lai/neisseria-meningitidis-orebro-sweden-11-30-05/)
- [Meticillin-Resistant Staphylococcus aureus (MRSA) multilocus sequence type 5 (paediatric) and 8 (New York/Japan strain) | The Netherlands | 2004](https://absa.org/lai/meticillin-resistant-staphylococcus-aureus-mrsa-multilocus-sequence-type-5-paediatric-and-8-new-york-japan-strain-the-netherlands-2004/)
- [Leishmania mexicana | Tübingen, Germany | Article published in december 1997](https://absa.org/lai/leishmania-mexicana-tubingen-germany-article-published-in-december-1997/)
- [Francisella tularensis | Hradec Králové, Czechia | May, 1989](https://absa.org/lai/francisella-tularensis-hradec-kralove-czechia-may-1989/)
- [Echovirus 11 | Köln, Federal Republic of Germany | 1978](https://absa.org/lai/echovirus-11-koln-federal-republic-of-germany-1978/)
- [Crimean-Congo Haemorrhagic Fever (CCHF) virus | Turkey | 2002 to 2014](https://absa.org/lai/crimean-congo-haemorrhagic-fever-cchf-virus-turkey-2002-to-2014/)
- [Brucella melitensis | München, Germany | Article published in 1994](https://absa.org/lai/brucella-melitensis-munchen-germany-article-published-in-1994/)

## RGDB Agents

- [Virus: Caliciviridae Calicivirus](https://absa.org/infectious_agent/virus-caliciviridae-calicivirus-1/)
- [Bacteria: Abiotrophia adiacens](https://absa.org/infectious_agent/bacteria-abiotrophia-adiacens/)
- [Bacteria: Salmonella choleraesuis](https://absa.org/infectious_agent/bacteria-salmonella-choleraesuis-1/)
- [Bacteria: Pasteurella multocida](https://absa.org/infectious_agent/bacteria-pasteurella-multocida/)
- [Fungus: Trichospora mucoides](https://absa.org/infectious_agent/fungus-trichospora-mucoides/)
- [Fungus: Trichosporon spp](https://absa.org/infectious_agent/fungus-trichosporon-spp/)
- [Fungus: Xylohypha bantiana](https://absa.org/infectious_agent/fungus-xylohypha-bantiana/)
- [Fungus: Zymonema dermatitidis](https://absa.org/infectious_agent/fungus-zymonema-dermatitidis/)
- [Fungus: Coniothyrium glycines](https://absa.org/infectious_agent/fungus-coniothyrium-glycines/)
- [Fungus: Trichophyton simii](https://absa.org/infectious_agent/fungus-trichophyton-simii/)
- [Fungus: Trichophyton soudanense](https://absa.org/infectious_agent/fungus-trichophyton-soudanense/)
- [Fungus: Trichophyton spp](https://absa.org/infectious_agent/fungus-trichophyton-spp/)
- [Fungus: Trichophyton tonsurans](https://absa.org/infectious_agent/fungus-trichophyton-tonsurans/)
- [Fungus: Trichophyton verrucosum](https://absa.org/infectious_agent/fungus-trichophyton-verrucosum/)
- [Fungus: Trichophyton violoaceum](https://absa.org/infectious_agent/fungus-trichophyton-violoaceum/)
- [Fungus: Trichophyton yaoundei](https://absa.org/infectious_agent/fungus-trichophyton-yaoundei/)
- [Fungus: Rhizopus oryzae](https://absa.org/infectious_agent/fungus-rhizopus-oryzae/)
- [Fungus: Rhizopus spp](https://absa.org/infectious_agent/fungus-rhizopus-spp/)
- [Fungus: Rhodotorula mucilaginosa](https://absa.org/infectious_agent/fungus-rhodotorula-mucilaginosa/)
- [Fungus: Rhodotorula rubra](https://absa.org/infectious_agent/fungus-rhodotorula-rubra/)
- [Fungus: Scedosporium apiospermum](https://absa.org/infectious_agent/fungus-scedosporium-apiospermum/)
- [Fungus: Scedosporium proliferans](https://absa.org/infectious_agent/fungus-scedosporium-proliferans/)
- [Fungus: Scedosporium prolificans](https://absa.org/infectious_agent/fungus-scedosporium-prolificans/)
- [Fungus: Sclerophthora rayssiae](https://absa.org/infectious_agent/fungus-sclerophthora-rayssiae/)
- [Fungus: Sporothrix schenckii](https://absa.org/infectious_agent/fungus-sporothrix-schenckii/)
- [Fungus: Stachybotrys chartarum](https://absa.org/infectious_agent/fungus-stachybotrys-chartarum/)
- [Fungus: Synchytrium endobioticum](https://absa.org/infectious_agent/fungus-synchytrium-endobioticum/)
- [Fungus: Trichophyton concentricum](https://absa.org/infectious_agent/fungus-trichophyton-concentricum/)
- [Fungus: Trichophyton equinum](https://absa.org/infectious_agent/fungus-trichophyton-equinum/)
- [Fungus: Trichophyton erinacei](https://absa.org/infectious_agent/fungus-trichophyton-erinacei/)
- [Fungus: Trichophyton gourvilii](https://absa.org/infectious_agent/fungus-trichophyton-gourvilii/)
- [Fungus: Trichophyton megnini](https://absa.org/infectious_agent/fungus-trichophyton-megnini/)
- [Fungus: Trichophyton mentagrophytes](https://absa.org/infectious_agent/fungus-trichophyton-mentagrophytes/)
- [Fungus: Trichophyton quinckeanum](https://absa.org/infectious_agent/fungus-trichophyton-quinckeanum/)
- [Fungus: Trichophyton rubrum](https://absa.org/infectious_agent/fungus-trichophyton-rubrum/)
- [Fungus: Trichophyton schoenleinii](https://absa.org/infectious_agent/fungus-trichophyton-schoenleinii/)
- [Fungus: Rhinocladiella pedrosoi](https://absa.org/infectious_agent/fungus-rhinocladiella-pedrosoi/)
- [Fungus: Rhinocladiella spinifera](https://absa.org/infectious_agent/fungus-rhinocladiella-spinifera/)
- [Fungus: Rhinosporidium seeberi](https://absa.org/infectious_agent/fungus-rhinosporidium-seeberi/)
- [Fungus: Rhizomucor spp.](https://absa.org/infectious_agent/fungus-rhizomucor-spp/)
- [Fungus: Rhizopus micosporus](https://absa.org/infectious_agent/fungus-rhizopus-micosporus/)
- [Fungus: Ochroconis gallopava](https://absa.org/infectious_agent/fungus-ochroconis-gallopava/)
- [Fungus: Ophiostoma stenoceras](https://absa.org/infectious_agent/fungus-ophiostoma-stenoceras/)
- [Fungus: Paecilomyces variotii](https://absa.org/infectious_agent/fungus-paecilomyces-variotii/)
- [Fungus: Paracoccidioides brasiliensis](https://absa.org/infectious_agent/fungus-paracoccidioides-brasiliensis/)
- [Fungus: Penicillium marneffei](https://absa.org/infectious_agent/fungus-penicillium-marneffei/)
- [Fungus: Peronosclerospora  philippinensis](https://absa.org/infectious_agent/fungus-peronosclerospora-philippinensis/)
- [Fungus: Phialophora compacta](https://absa.org/infectious_agent/fungus-phialophora-compacta/)
- [Fungus: Phialophora pedrosoi](https://absa.org/infectious_agent/fungus-phialophora-pedrosoi/)
- [Fungus: Phialophora verrucosa](https://absa.org/infectious_agent/fungus-phialophora-verrucosa/)
- [Fungus: Phoma glycinicola](https://absa.org/infectious_agent/fungus-phoma-glycinicola/)
- [Fungus: Phytophthora cinnamomi](https://absa.org/infectious_agent/fungus-phytophthora-cinnamomi/)
- [Fungus: Pneumocystis jirovecii](https://absa.org/infectious_agent/fungus-pneumocystis-jirovecii/)
- [Fungus: Pseudallescheria boydii](https://absa.org/infectious_agent/fungus-pseudallescheria-boydii/)
- [Fungus: Ramichloridium mackenziei](https://absa.org/infectious_agent/fungus-ramichloridium-mackenziei/)
- [Fungus: Rhinocladiella compacta](https://absa.org/infectious_agent/fungus-rhinocladiella-compacta/)
- [Fungus: Mucor spp](https://absa.org/infectious_agent/fungus-mucor-spp/)
- [Fungus: Nannizzia gypsea](https://absa.org/infectious_agent/fungus-nannizzia-gypsea/)
- [Fungus: Nannizzia incurvata](https://absa.org/infectious_agent/fungus-nannizzia-incurvata/)
- [Fungus: Nannizzia obtusa](https://absa.org/infectious_agent/fungus-nannizzia-obtusa/)
- [Fungus: Nannizzia otae](https://absa.org/infectious_agent/fungus-nannizzia-otae/)
- [Fungus: Nannizzia persicolor](https://absa.org/infectious_agent/fungus-nannizzia-persicolor/)
- [Fungus: Nectria haematococca](https://absa.org/infectious_agent/fungus-nectria-haematococca/)
- [Fungus: Neotestudina rosatii](https://absa.org/infectious_agent/fungus-neotestudina-rosatii/)
- [Fungus: Microsporum duboisii](https://absa.org/infectious_agent/fungus-microsporum-duboisii/)
- [Fungus: Microsporum equinum](https://absa.org/infectious_agent/fungus-microsporum-equinum/)
- [Fungus: Microsporum ferrugineum](https://absa.org/infectious_agent/fungus-microsporum-ferrugineum/)
- [Fungus: Microsporum gallinae](https://absa.org/infectious_agent/fungus-microsporum-gallinae/)
- [Fungus: Microsporum gypseum](https://absa.org/infectious_agent/fungus-microsporum-gypseum/)
- [Fungus: Microsporum langeroni](https://absa.org/infectious_agent/fungus-microsporum-langeroni/)
- [Fungus: Microsporum nanum](https://absa.org/infectious_agent/fungus-microsporum-nanum/)
- [Fungus: Microsporum persicolor](https://absa.org/infectious_agent/fungus-microsporum-persicolor/)
- [Fungus: Microsporum praecox](https://absa.org/infectious_agent/fungus-microsporum-praecox/)
- [Fungus: Microsporum rivalieri](https://absa.org/infectious_agent/fungus-microsporum-rivalieri/)
- [Fungus: Microsporum spp](https://absa.org/infectious_agent/fungus-microsporum-spp/)
- [Fungus: Monosporium apiospermum](https://absa.org/infectious_agent/fungus-monosporium-apiospermum/)
- [Fungus: Histoplasma capsulatum var. capsulatum](https://absa.org/infectious_agent/fungus-histoplasma-capsulatum-var-capsulatum/)
- [Fungus: Histoplasma capsulatum var. duboisii](https://absa.org/infectious_agent/fungus-histoplasma-capsulatum-var-duboisii/)
- [Fungus: Histoplasma farcinimosum](https://absa.org/infectious_agent/fungus-histoplasma-farcinimosum/)
- [Fungus: Histoplasma spp](https://absa.org/infectious_agent/fungus-histoplasma-spp/)
- [Fungus: Hortaea werneckii](https://absa.org/infectious_agent/fungus-hortaea-werneckii/)
- [Fungus: Leptosphaeria senegalensis](https://absa.org/infectious_agent/fungus-leptosphaeria-senegalensis/)
- [Fungus: Leptosphaeria thompkinsii](https://absa.org/infectious_agent/fungus-leptosphaeria-thompkinsii/)
- [Fungus: Loboa loboi](https://absa.org/infectious_agent/fungus-loboa-loboi/)
- [Fungus: Madurella grisea](https://absa.org/infectious_agent/fungus-madurella-grisea/)
- [Fungus: Madurella mycetomatis](https://absa.org/infectious_agent/fungus-madurella-mycetomatis/)
- [Fungus: Madurella mycetomi](https://absa.org/infectious_agent/fungus-madurella-mycetomi/)
- [Fungus: Malassezia  furfur](https://absa.org/infectious_agent/fungus-malassezia-furfur/)
- [Fungus: Microsporum audouinii](https://absa.org/infectious_agent/fungus-microsporum-audouinii/)
- [Fungus: Microsporum canis](https://absa.org/infectious_agent/fungus-microsporum-canis/)
- [Fungus: Microsporum distortum](https://absa.org/infectious_agent/fungus-microsporum-distortum/)
- [Fungus: Fusarium chlamydosporium](https://absa.org/infectious_agent/fungus-fusarium-chlamydosporium/)
- [Fungus: Fusarium moniliforme](https://absa.org/infectious_agent/fungus-fusarium-moniliforme/)
- [Fungus: Fusarium solani](https://absa.org/infectious_agent/fungus-fusarium-solani/)
- [Fungus: Geotrichum spp](https://absa.org/infectious_agent/fungus-geotrichum-spp/)
- [Fungus: Giberrella moniliformis](https://absa.org/infectious_agent/fungus-giberrella-moniliformis/)
- [Fungus: Coccidioides immitis](https://absa.org/infectious_agent/fungus-coccidioides-immitis/)
- [Fungus: Coccidioides posadasii](https://absa.org/infectious_agent/fungus-coccidioides-posadasii/)
- [Fungus: Cryptococcus bacillisporus](https://absa.org/infectious_agent/fungus-cryptococcus-bacillisporus/)
- [Fungus: Cryptococcus neoformans](https://absa.org/infectious_agent/fungus-cryptococcus-neoformans/)
- [Fungus: Dactylaria gallopava](https://absa.org/infectious_agent/fungus-dactylaria-gallopava/)
- [Fungus: Dermatophilus congolensis](https://absa.org/infectious_agent/fungus-dermatophilus-congolensis/)
- [Fungus: Emmonsia parva](https://absa.org/infectious_agent/fungus-emmonsia-parva/)
- [Fungus: Emmonsiella capsulata](https://absa.org/infectious_agent/fungus-emmonsiella-capsulata/)
- [Fungus: Epidermophyton floccosum](https://absa.org/infectious_agent/fungus-epidermophyton-floccosum/)
- [Fungus: Epidermophyton spp](https://absa.org/infectious_agent/fungus-epidermophyton-spp/)
- [Fungus: Exophiala castellanii](https://absa.org/infectious_agent/fungus-exophiala-castellanii/)
- [Fungus: Exophiala dermatitidis](https://absa.org/infectious_agent/fungus-exophiala-dermatitidis/)
- [Fungus: Exophiala mansonii](https://absa.org/infectious_agent/fungus-exophiala-mansonii/)
- [Fungus: Exophiala spinifera](https://absa.org/infectious_agent/fungus-exophiala-spinifera/)
- [Fungus: Filobasidiella bacillispora](https://absa.org/infectious_agent/fungus-filobasidiella-bacillispora/)
- [Fungus: Filobasidiella neoformans](https://absa.org/infectious_agent/fungus-filobasidiella-neoformans/)
- [Fungus: Fonsecaea compacta](https://absa.org/infectious_agent/fungus-fonsecaea-compacta/)
- [Fungus: Fonsecaea pedrosoi](https://absa.org/infectious_agent/fungus-fonsecaea-pedrosoi/)
- [Fungus: Cladosporium bantianum](https://absa.org/infectious_agent/fungus-cladosporium-bantianum/)
- [Fungus: Cladosporium carrionii](https://absa.org/infectious_agent/fungus-cladosporium-carrionii/)
- [Fungus: Cladosporium trichoides](https://absa.org/infectious_agent/fungus-cladosporium-trichoides/)
- [Fungus: Aspergillus flavus](https://absa.org/infectious_agent/fungus-aspergillus-flavus/)
- [Fungus: Aspergillus fumigatus](https://absa.org/infectious_agent/fungus-aspergillus-fumigatus/)
- [Fungus: Aspergillus nidulans](https://absa.org/infectious_agent/fungus-aspergillus-nidulans/)
- [Fungus: Aspergillus niger](https://absa.org/infectious_agent/fungus-aspergillus-niger/)
- [Fungus: Aspergillus ochraceus](https://absa.org/infectious_agent/fungus-aspergillus-ochraceus/)
- [Fungus: Aspergillus spp](https://absa.org/infectious_agent/fungus-aspergillus-spp/)
- [Fungus: Aspergillus ustus](https://absa.org/infectious_agent/fungus-aspergillus-ustus/)
- [Fungus: Basidiobolus haptosporus](https://absa.org/infectious_agent/fungus-basidiobolus-haptosporus/)
- [Fungus: Blastomyces dermatitidis](https://absa.org/infectious_agent/fungus-blastomyces-dermatitidis/)
- [Fungus: Candida albicans](https://absa.org/infectious_agent/fungus-candida-albicans/)
- [Fungus: Candida glabrata](https://absa.org/infectious_agent/fungus-candida-glabrata/)
- [Fungus: Candida parapsilosis](https://absa.org/infectious_agent/fungus-candida-parapsilosis/)
- [Fungus: Candida spp](https://absa.org/infectious_agent/fungus-candida-spp/)
- [Fungus: Candida tropicalis](https://absa.org/infectious_agent/fungus-candida-tropicalis/)
- [Fungus: Capronia mansonii](https://absa.org/infectious_agent/fungus-capronia-mansonii/)
- [Fungus: Ceratocystis ulmi](https://absa.org/infectious_agent/fungus-ceratocystis-ulmi/)
- [Fungus: Cladophialophora arxii](https://absa.org/infectious_agent/fungus-cladophialophora-arxii/)
- [Fungus: Cladophialophora bantiana](https://absa.org/infectious_agent/fungus-cladophialophora-bantiana/)
- [Fungus: Cladophialophora carrionii](https://absa.org/infectious_agent/fungus-cladophialophora-carrionii/)
- [Fungus: Acremonium kiliense](https://absa.org/infectious_agent/fungus-acremonium-kiliense/)
- [Fungus: Acremonium recifei](https://absa.org/infectious_agent/fungus-acremonium-recifei/)
- [Fungus: Ajellomyces capsulatus](https://absa.org/infectious_agent/fungus-ajellomyces-capsulatus/)
- [Fungus: Ajellomyces dermatitidis](https://absa.org/infectious_agent/fungus-ajellomyces-dermatitidis/)
- [Fungus: Aphanomyces astaci](https://absa.org/infectious_agent/fungus-aphanomyces-astaci/)
- [Fungus: Arthroderma benhamiae](https://absa.org/infectious_agent/fungus-arthroderma-benhamiae/)
- [Fungus: Arthroderma simii](https://absa.org/infectious_agent/fungus-arthroderma-simii/)
- [Fungus: Arthroderma vanbreuseghemii](https://absa.org/infectious_agent/fungus-arthroderma-vanbreuseghemii/)
- [Fungus: Aspergillus brasiliensis](https://absa.org/infectious_agent/fungus-aspergillus-brasiliensis/)
- [Virus: Togaviridae Western equine encephalitis virus](https://absa.org/infectious_agent/virus-togaviridae-western-equine-encephalitis-virus/)
- [Virus: Toroviridae Toroviridae](https://absa.org/infectious_agent/virus-toroviridae-toroviridae/)
- [Virus: Unclassified Hepatitis viruses](https://absa.org/infectious_agent/virus-unclassified-hepatitis-viruses/)
- [Bacteria: Bacillus cereus Biovar anthracis](https://absa.org/infectious_agent/bacteria-bacillus-cereus-biovar-anthracis/)
- [Bacteria: Xanthomonas oryzae](https://absa.org/infectious_agent/bacteria-xanthomonas-oryzae/)
- [Virus: Arenaviridae Lujo virus](https://absa.org/infectious_agent/virus-arenaviridae-lujo-virus/)
- [Virus: Arenaviridae Chapare](https://absa.org/infectious_agent/virus-arenaviridae-chapare/)
- [Virus: Flaviviridae Siberian tick-borne encephalitis virus](https://absa.org/infectious_agent/virus-flaviviridae-siberian-tick-borne-encephalitis-virus/)
- [Fungus: Absidia corymbifera](https://absa.org/infectious_agent/fungus-absidia-corymbifera/)
- [Fungus: Absidia spp](https://absa.org/infectious_agent/fungus-absidia-spp/)
- [Fungus: Acremonium falciforme](https://absa.org/infectious_agent/fungus-acremonium-falciforme/)
- [Virus: Togaviridae Chikungunya virus](https://absa.org/infectious_agent/virus-togaviridae-chikungunya-virus/)
- [Virus: Togaviridae Eastern equine encephalitis virus](https://absa.org/infectious_agent/virus-togaviridae-eastern-equine-encephalitis-virus/)
- [Virus: Togaviridae Equine viral arteritis](https://absa.org/infectious_agent/virus-togaviridae-equine-viral-arteritis/)
- [Virus: Togaviridae Everglade virus](https://absa.org/infectious_agent/virus-togaviridae-everglade-virus/)
- [Virus: Togaviridae Getah virus](https://absa.org/infectious_agent/virus-togaviridae-getah-virus/)
- [Virus: Togaviridae Kyzylagach virus](https://absa.org/infectious_agent/virus-togaviridae-kyzylagach-virus/)
- [Virus: Togaviridae Mayaro virus](https://absa.org/infectious_agent/virus-togaviridae-mayaro-virus/)
- [Virus: Togaviridae Middelburg virus](https://absa.org/infectious_agent/virus-togaviridae-middelburg-virus/)
- [Virus: Togaviridae Mucambo virus](https://absa.org/infectious_agent/virus-togaviridae-mucambo-virus/)
- [Virus: Togaviridae Ndumu virus](https://absa.org/infectious_agent/virus-togaviridae-ndumu-virus/)
- [Virus: Togaviridae O'Nyong-Nyong virus](https://absa.org/infectious_agent/virus-togaviridae-onyong-nyong-virus/)
- [Virus: Togaviridae Ross river virus](https://absa.org/infectious_agent/virus-togaviridae-ross-river-virus/)
- [Virus: Togaviridae Rubella virus](https://absa.org/infectious_agent/virus-togaviridae-rubella-virus/)
- [Virus: Togaviridae Rubivirus](https://absa.org/infectious_agent/virus-togaviridae-rubivirus/)
- [Virus: Togaviridae Sagiyama virus](https://absa.org/infectious_agent/virus-togaviridae-sagiyama-virus/)
- [Virus: Togaviridae Semliki forest virus](https://absa.org/infectious_agent/virus-togaviridae-semliki-forest-virus/)
- [Virus: Togaviridae Sindbis virus](https://absa.org/infectious_agent/virus-togaviridae-sindbis-virus/)
- [Virus: Togaviridae Tonate virus](https://absa.org/infectious_agent/virus-togaviridae-tonate-virus/)
- [Virus: Togaviridae Venezuelan equine encephalitis virus](https://absa.org/infectious_agent/virus-togaviridae-venezuelan-equine-encephalitis-virus/)
- [Virus: Togaviridae Alphaviruses](https://absa.org/infectious_agent/virus-togaviridae-alphaviruses/)
- [Virus: Togaviridae Aura virus](https://absa.org/infectious_agent/virus-togaviridae-aura-virus/)
- [Virus: Togaviridae Barmah Forest](https://absa.org/infectious_agent/virus-togaviridae-barmah-forest/)
- [Virus: Togaviridae Bebaru virus](https://absa.org/infectious_agent/virus-togaviridae-bebaru-virus/)
- [Virus: Togaviridae Cabassou virus](https://absa.org/infectious_agent/virus-togaviridae-cabassou-virus/)
- [Virus: Rhabdoviridae Australian bat lyssavirus](https://absa.org/infectious_agent/virus-rhabdoviridae-australian-bat-lyssavirus/)
- [Virus: Rhabdoviridae Bovine ephemeral fever virus](https://absa.org/infectious_agent/virus-rhabdoviridae-bovine-ephemeral-fever-virus/)
- [Virus: Rhabdoviridae Duvenhage virus](https://absa.org/infectious_agent/virus-rhabdoviridae-duvenhage-virus/)
- [Virus: Rhabdoviridae Eel rhabdovirus (EVA, EVX, B12, C26)](https://absa.org/infectious_agent/virus-rhabdoviridae-eel-rhabdovirus-eva-evx-b12-c26/)
- [Virus: Rhabdoviridae Egtved virus (Viral hemorrhagic septicemia virus)](https://absa.org/infectious_agent/virus-rhabdoviridae-egtved-virus-viral-hemorrhagic-septicemia-virus/)
- [Virus: Rhabdoviridae Infectious hematopoietic necrosis virus](https://absa.org/infectious_agent/virus-rhabdoviridae-infectious-hematopoietic-necrosis-virus/)
- [Virus: Rhabdoviridae Invertebrate lyssaviruses](https://absa.org/infectious_agent/virus-rhabdoviridae-invertebrate-lyssaviruses/)
- [Virus: Rhabdoviridae Invertebrate vesiculoviruses (other)](https://absa.org/infectious_agent/virus-rhabdoviridae-invertebrate-vesiculoviruses-other/)
- [Virus: Rhabdoviridae Mokola virus](https://absa.org/infectious_agent/virus-rhabdoviridae-mokola-virus/)
- [Virus: Rhabdoviridae Pike fry rhabdovirus](https://absa.org/infectious_agent/virus-rhabdoviridae-pike-fry-rhabdovirus/)
- [Virus: Rhabdoviridae Piry](https://absa.org/infectious_agent/virus-rhabdoviridae-piry/)
- [Virus: Rhabdoviridae Rabies virus](https://absa.org/infectious_agent/virus-rhabdoviridae-rabies-virus/)
- [Virus: Rhabdoviridae Spring viremia of carp virus](https://absa.org/infectious_agent/virus-rhabdoviridae-spring-viremia-of-carp-virus/)
- [Virus: Rhabdoviridae Vertebrate lyssaviruses](https://absa.org/infectious_agent/virus-rhabdoviridae-vertebrate-lyssaviruses/)
- [Virus: Rhabdoviridae Vertebrate vesiculoviruses (other)](https://absa.org/infectious_agent/virus-rhabdoviridae-vertebrate-vesiculoviruses-other/)
- [Virus: Rhabdoviridae Vesicular stomatitis virus](https://absa.org/infectious_agent/virus-rhabdoviridae-vesicular-stomatitis-virus/)
- [Virus: Retroviridae Murine sarcoma viruses (MuSV)](https://absa.org/infectious_agent/virus-retroviridae-murine-sarcoma-viruses-musv/)
- [Virus: Retroviridae Oncornavirus B](https://absa.org/infectious_agent/virus-retroviridae-oncornavirus-b/)
- [Virus: Retroviridae Oncornavirus C, except HTLV I and II](https://absa.org/infectious_agent/virus-retroviridae-oncornavirus-c-except-htlv-i-and-ii/)
- [Virus: Retroviridae Ovine lymphosarcoma virus (OLV)](https://absa.org/infectious_agent/virus-retroviridae-ovine-lymphosarcoma-virus-olv/)
- [Virus: Retroviridae Ovine pulmonary adenomatosis virus](https://absa.org/infectious_agent/virus-retroviridae-ovine-pulmonary-adenomatosis-virus/)
- [Virus: Retroviridae Porcine sarcoma virus](https://absa.org/infectious_agent/virus-retroviridae-porcine-sarcoma-virus/)
- [Virus: Retroviridae Rat leukemia virus](https://absa.org/infectious_agent/virus-retroviridae-rat-leukemia-virus/)
- [Virus: Retroviridae Rat lymphosarcoma virus (Rat LSA)](https://absa.org/infectious_agent/virus-retroviridae-rat-lymphosarcoma-virus-rat-lsa/)
- [Virus: Retroviridae Reticuloendotheliosis viruses (REV)](https://absa.org/infectious_agent/virus-retroviridae-reticuloendotheliosis-viruses-rev/)
- [Virus: Retroviridae Retroviruses of fish and reptiles](https://absa.org/infectious_agent/virus-retroviridae-retroviruses-of-fish-and-reptiles/)
- [Virus: Retroviridae Simian foamy viruses](https://absa.org/infectious_agent/virus-retroviridae-simian-foamy-viruses/)
- [Virus: Retroviridae Simian immunodeficiency virus](https://absa.org/infectious_agent/virus-retroviridae-simian-immunodeficiency-virus/)
- [Virus: Retroviridae Simian sarcoma virus, SSV-1](https://absa.org/infectious_agent/virus-retroviridae-simian-sarcoma-virus-ssv-1/)
- [Virus: Retroviridae Simian sarcoma viruses (SSV)](https://absa.org/infectious_agent/virus-retroviridae-simian-sarcoma-viruses-ssv/)
- [Virus: Retroviridae Snake sarcoma viruses](https://absa.org/infectious_agent/virus-retroviridae-snake-sarcoma-viruses/)
- [Virus: Retroviridae Maedi-visna virus](https://absa.org/infectious_agent/virus-retroviridae-maedi-visna-virus/)
- [Virus: Retroviridae Mason-Pfizer monkey virus](https://absa.org/infectious_agent/virus-retroviridae-mason-pfizer-monkey-virus/)
- [Virus: Retroviridae Monkey mammary tumor viruses (MPTV)](https://absa.org/infectious_agent/virus-retroviridae-monkey-mammary-tumor-viruses-mptv/)
- [Virus: Retroviridae Murine mammary tumor viruses (MMTV)](https://absa.org/infectious_agent/virus-retroviridae-murine-mammary-tumor-viruses-mmtv/)
- [Virus: Retroviridae Murine leukemia virus](https://absa.org/infectious_agent/virus-retroviridae-murine-leukemia-virus/)
- [Virus: Retroviridae Bovine foamy virus](https://absa.org/infectious_agent/virus-retroviridae-bovine-foamy-virus/)
- [Virus: Retroviridae Bovine immunodeficiency virus (BIV)](https://absa.org/infectious_agent/virus-retroviridae-bovine-immunodeficiency-virus-biv/)
- [Virus: Retroviridae Bovine leukemia virus](https://absa.org/infectious_agent/virus-retroviridae-bovine-leukemia-virus/)
- [Virus: Retroviridae Bovine lymphosarcoma virus (Bovine leukaemia virus, BLV)](https://absa.org/infectious_agent/virus-retroviridae-bovine-lymphosarcoma-virus-bovine-leukaemia-virus-blv/)
- [Virus: Retroviridae Bovine syncytial virus (BSV)](https://absa.org/infectious_agent/virus-retroviridae-bovine-syncytial-virus-bsv/)
- [Virus: Retroviridae Caprine arthrisis/encephalomyeltis virus (CAEV)](https://absa.org/infectious_agent/virus-retroviridae-caprine-arthrisisencephalomyeltis-virus-caev/)
- [Virus: Retroviridae Equine infectious anemia virus](https://absa.org/infectious_agent/virus-retroviridae-equine-infectious-anemia-virus/)
- [Virus: Retroviridae Feline foamy virus](https://absa.org/infectious_agent/virus-retroviridae-feline-foamy-virus/)
- [Virus: Retroviridae Feline immunodefiency virus (FIV)](https://absa.org/infectious_agent/virus-retroviridae-feline-immunodefiency-virus-fiv/)
- [Virus: Retroviridae Feline leukemia virus](https://absa.org/infectious_agent/virus-retroviridae-feline-leukemia-virus/)
- [Virus: Retroviridae Feline lymphosarcoma virus (FeLV, Feline leukaemia virus)](https://absa.org/infectious_agent/virus-retroviridae-feline-lymphosarcoma-virus-felv-feline-leukaemia-virus/)
- [Virus: Retroviridae Feline sarcoma virus (FeSV)](https://absa.org/infectious_agent/virus-retroviridae-feline-sarcoma-virus-fesv/)
- [Virus: Retroviridae Gibbon leukemia virus](https://absa.org/infectious_agent/virus-retroviridae-gibbon-leukemia-virus/)
- [Virus: Retroviridae Guinea pig lymphosarcoma virus (guinea pig LSA)](https://absa.org/infectious_agent/virus-retroviridae-guinea-pig-lymphosarcoma-virus-guinea-pig-lsa/)
- [Virus: Retroviridae Hamster lymphosarcoma virus (Hamster LSA)](https://absa.org/infectious_agent/virus-retroviridae-hamster-lymphosarcoma-virus-hamster-lsa/)
- [Virus: Retroviridae Human Immunodeficiency virus (HIV)](https://absa.org/infectious_agent/virus-retroviridae-human-immunodeficiency-virus-hiv/)
- [Virus: Retroviridae Human T-cell lymphotropic viruses 1 + 2](https://absa.org/infectious_agent/virus-retroviridae-human-t-cell-lymphotropic-viruses-1-2/)
- [Virus: Retroviridae Lentivirinae , except HIV-1 and HI](https://absa.org/infectious_agent/virus-retroviridae-lentivirinae-except-hiv-1-and-hi/)
- [Virus: Retroviridae Leukomogenic murine oncovirus (Murine lymphosarcoma virus: MuLV)](https://absa.org/infectious_agent/virus-retroviridae-leukomogenic-murine-oncovirus-murine-lymphosarcoma-virus-mulv/)
- [Virus: Retroviridae Lymphosarcoma viruses of nonhuman primates](https://absa.org/infectious_agent/virus-retroviridae-lymphosarcoma-viruses-of-nonhuman-primates/)
- [Virus: Reoviridae Golden shiner virus disease (GSV)](https://absa.org/infectious_agent/virus-reoviridae-golden-shiner-virus-disease-gsv/)
- [Virus: Reoviridae Ibaraki virus](https://absa.org/infectious_agent/virus-reoviridae-ibaraki-virus/)
- [Virus: Reoviridae Mouse rotavirus (EDIM, epizootic diarhoea of infant mice)](https://absa.org/infectious_agent/virus-reoviridae-mouse-rotavirus-edim-epizootic-diarhoea-of-infant-mice/)
- [Virus: Reoviridae Orbiviruses](https://absa.org/infectious_agent/virus-reoviridae-orbiviruses/)
- [Virus: Reoviridae Orungo virus](https://absa.org/infectious_agent/virus-reoviridae-orungo-virus/)
- [Virus: Reoviridae Rat rotavirus](https://absa.org/infectious_agent/virus-reoviridae-rat-rotavirus/)
- [Virus: Reoviridae Reoviruses](https://absa.org/infectious_agent/virus-reoviridae-reoviruses/)
- [Virus: Reoviridae Rotavirus](https://absa.org/infectious_agent/virus-reoviridae-rotavirus/)
- [Virus: Reoviridae Rotaviruses for animals (other)](https://absa.org/infectious_agent/virus-reoviridae-rotaviruses-for-animals-other/)
- [Virus: Reoviridae Vertebrate coltiviruses](https://absa.org/infectious_agent/virus-reoviridae-vertebrate-coltiviruses/)
- [Virus: Retroviridae Avian leucosis virus (ALV)](https://absa.org/infectious_agent/virus-retroviridae-avian-leucosis-virus-alv/)
- [Virus: Retroviridae Avian sarcoma viruses (Rous sarcoma virus, RSV)](https://absa.org/infectious_agent/virus-retroviridae-avian-sarcoma-viruses-rous-sarcoma-virus-rsv/)
- [Virus: Reoviridae (Ortho) reoviruses](https://absa.org/infectious_agent/virus-reoviridae-ortho-reoviruses/)
- [Virus: Reoviridae African horse sickness virus](https://absa.org/infectious_agent/virus-reoviridae-african-horse-sickness-virus/)
- [Virus: Reoviridae Bluetongue virus](https://absa.org/infectious_agent/virus-reoviridae-bluetongue-virus/)
- [Virus: Reoviridae Changuinola](https://absa.org/infectious_agent/virus-reoviridae-changuinola/)
- [Virus: Reoviridae Chuzan virus](https://absa.org/infectious_agent/virus-reoviridae-chuzan-virus/)
- [Virus: Reoviridae Colorado tick fever virus](https://absa.org/infectious_agent/virus-reoviridae-colorado-tick-fever-virus/)
- [Virus: Reoviridae Coltiviruses](https://absa.org/infectious_agent/virus-reoviridae-coltiviruses/)
- [Virus: Reoviridae Epizootic hemorrhagic disease in deer (EHD)](https://absa.org/infectious_agent/virus-reoviridae-epizootic-hemorrhagic-disease-in-deer-ehd/)
- [Virus: Poxviridae Swinepox virus](https://absa.org/infectious_agent/virus-poxviridae-swinepox-virus/)
- [Virus: Poxviridae Tanapox](https://absa.org/infectious_agent/virus-poxviridae-tanapox/)
- [Virus: Poxviridae Taterapox (Gerbilpox)](https://absa.org/infectious_agent/virus-poxviridae-taterapox-gerbilpox/)
- [Virus: Poxviridae Uasin Gishu disease virus](https://absa.org/infectious_agent/virus-poxviridae-uasin-gishu-disease-virus/)
- [Virus: Poxviridae Vaccinia virus](https://absa.org/infectious_agent/virus-poxviridae-vaccinia-virus/)
- [Virus: Poxviridae Variola (major and minor) virus](https://absa.org/infectious_agent/virus-poxviridae-variola-major-and-minor-virus/)
- [Virus: Poxviridae Whitepox (Variola)](https://absa.org/infectious_agent/virus-poxviridae-whitepox-variola/)
- [Virus: Poxviridae Yabapox virus](https://absa.org/infectious_agent/virus-poxviridae-yabapox-virus/)
- [Virus: Poxviridae Yabapox virus (Tana and Yaba)](https://absa.org/infectious_agent/virus-poxviridae-yabapox-virus-tana-and-yaba/)
- [Virus: Poxviridae Yatapox viruses (Tana & Yaba)](https://absa.org/infectious_agent/virus-poxviridae-yatapox-viruses-tana-yaba/)
- [Virus: Prion Bovine spongiform encephalopathy (BSE)](https://absa.org/infectious_agent/virus-prion-bovine-spongiform-encephalopathy-bse/)
- [Virus: Prion Chronic wasting disease](https://absa.org/infectious_agent/virus-prion-chronic-wasting-disease/)
- [Virus: Prion Creutzfeldt-Jacob disease](https://absa.org/infectious_agent/virus-prion-creutzfeldt-jacob-disease/)
- [Virus: Prion Fatal Familial Insomnia](https://absa.org/infectious_agent/virus-prion-fatal-familial-insomnia/)
- [Virus: Prion Gerstmann-Straussler-Scheinker syndrome](https://absa.org/infectious_agent/virus-prion-gerstmann-straussler-scheinker-syndrome/)
- [Virus: Prion Kuru](https://absa.org/infectious_agent/virus-prion-kuru/)
- [Virus: Prion Kuru & Creutzfeldt-Jacob agents](https://absa.org/infectious_agent/virus-prion-kuru-creutzfeldt-jacob-agents/)
- [Virus: Prion Scrapie](https://absa.org/infectious_agent/virus-prion-scrapie/)
- [Virus: Prion Transmissible mink encephalopathy](https://absa.org/infectious_agent/virus-prion-transmissible-mink-encephalopathy/)
- [Virus: Prion Variant Creutzfeldt-Jacob disease](https://absa.org/infectious_agent/virus-prion-variant-creutzfeldt-jacob-disease/)
- [Virus: Poxviridae Sheeppox virus](https://absa.org/infectious_agent/virus-poxviridae-sheeppox-virus/)
- [Virus: Poxviridae Smallpox (Variola major)](https://absa.org/infectious_agent/virus-poxviridae-smallpox-variola-major/)
- [Virus: Poxviridae Elephantpox virus](https://absa.org/infectious_agent/virus-poxviridae-elephantpox-virus/)
- [Virus: Poxviridae Entomopoxviruses](https://absa.org/infectious_agent/virus-poxviridae-entomopoxviruses/)
- [Virus: Poxviridae Fibroma viruses](https://absa.org/infectious_agent/virus-poxviridae-fibroma-viruses/)
- [Virus: Poxviridae Fowlpox virus](https://absa.org/infectious_agent/virus-poxviridae-fowlpox-virus/)
- [Virus: Poxviridae Goat pox virus](https://absa.org/infectious_agent/virus-poxviridae-goat-pox-virus/)
- [Virus: Poxviridae Horsepox virus](https://absa.org/infectious_agent/virus-poxviridae-horsepox-virus/)
- [Virus: Poxviridae Lumpy skin disease virus](https://absa.org/infectious_agent/virus-poxviridae-lumpy-skin-disease-virus/)
- [Virus: Poxviridae Milker's node virus](https://absa.org/infectious_agent/virus-poxviridae-milkers-node-virus/)
- [Virus: Poxviridae Molluscum contagiosum virus](https://absa.org/infectious_agent/virus-poxviridae-molluscum-contagiosum-virus/)
- [Virus: Poxviridae Monkeypox virus](https://absa.org/infectious_agent/virus-poxviridae-monkeypox-virus/)
- [Virus: Poxviridae Myxoma virus](https://absa.org/infectious_agent/virus-poxviridae-myxoma-virus/)
- [Virus: Poxviridae Orf virus](https://absa.org/infectious_agent/virus-poxviridae-orf-virus/)
- [Virus: Poxviridae other pathogenic orthopoxviruses not in RG 2 or 4](https://absa.org/infectious_agent/virus-poxviridae-other-pathogenic-orthopoxviruses-not-in-rg-2-or-4/)
- [Virus: Poxviridae Paravaccinia virus](https://absa.org/infectious_agent/virus-poxviridae-paravaccinia-virus/)
- [Virus: Poxviridae Pseudocowpox viruses (bovine papular stomatitis, milker's nodes, paravaccinia)](https://absa.org/infectious_agent/virus-poxviridae-pseudocowpox-viruses-bovine-papular-stomatitis-milkers-nodes-paravaccinia/)
- [Virus: Poxviridae Rabbitpox virus](https://absa.org/infectious_agent/virus-poxviridae-rabbitpox-virus/)
- [Virus: Poxviridae Racoonpox](https://absa.org/infectious_agent/virus-poxviridae-racoonpox/)
- [Virus: Poxviridae Sealpox virus](https://absa.org/infectious_agent/virus-poxviridae-sealpox-virus/)
- [Virus: Picornaviridae Poliovirus](https://absa.org/infectious_agent/virus-picornaviridae-poliovirus/)
- [Virus: Picornaviridae Poliovirus (Vaccine Strains Sabin Type-1, Type-2, Type-3](https://absa.org/infectious_agent/virus-picornaviridae-poliovirus-vaccine-strains-sabin-type-1-type-2-type-3/)
- [Virus: Picornaviridae Porcine enterovirus type 1 (Teschen disease)](https://absa.org/infectious_agent/virus-picornaviridae-porcine-enterovirus-type-1-teschen-disease/)
- [Virus: Picornaviridae Rhinovirus](https://absa.org/infectious_agent/virus-picornaviridae-rhinovirus/)
- [Virus: Picornaviridae Swine vesicular disease virus](https://absa.org/infectious_agent/virus-picornaviridae-swine-vesicular-disease-virus/)
- [Virus: Picornaviridae Turkey hepatitis virus](https://absa.org/infectious_agent/virus-picornaviridae-turkey-hepatitis-virus/)
- [Virus: Poxviridae Alastrim (Variola minor)](https://absa.org/infectious_agent/virus-poxviridae-alastrim-variola-minor/)
- [Virus: Poxviridae Ausdyk (contagious ecthyma of camels)](https://absa.org/infectious_agent/virus-poxviridae-ausdyk-contagious-ecthyma-of-camels/)
- [Virus: Poxviridae Avipoxviruses (other)](https://absa.org/infectious_agent/virus-poxviridae-avipoxviruses-other/)
- [Virus: Poxviridae Buffalopox virus](https://absa.org/infectious_agent/virus-poxviridae-buffalopox-virus/)
- [Virus: Poxviridae Camel pox virus](https://absa.org/infectious_agent/virus-poxviridae-camel-pox-virus/)
- [Virus: Poxviridae Chamois contagious ecthyma](https://absa.org/infectious_agent/virus-poxviridae-chamois-contagious-ecthyma/)
- [Virus: Poxviridae Cowpox virus](https://absa.org/infectious_agent/virus-poxviridae-cowpox-virus/)
- [Virus: Poxviridae Ectromelia virus](https://absa.org/infectious_agent/virus-poxviridae-ectromelia-virus/)
- [Virus: Picornaviridae Murine poliovirus (Theiler's encephalomyelitis virus, TO, FA, GD7)](https://absa.org/infectious_agent/virus-picornaviridae-murine-poliovirus-theilers-encephalomyelitis-virus-to-fa-gd7/)
- [Virus: Picornaviridae Parecho](https://absa.org/infectious_agent/virus-picornaviridae-parecho/)
- [Virus: Picornaviridae Picornaviruses of crustaceans and molluscs](https://absa.org/infectious_agent/virus-picornaviridae-picornaviruses-of-crustaceans-and-molluscs/)
- [Virus: Picornaviridae Picornaviruses of fishes](https://absa.org/infectious_agent/virus-picornaviridae-picornaviruses-of-fishes/)
- [Virus: Picornaviridae Picornaviruses of insects (e.g. Drosophila C virus, Cricket paralysis virus)](https://absa.org/infectious_agent/virus-picornaviridae-picornaviruses-of-insects-eg-drosophila-c-virus-cricket-paralysis-virus/)
- [Virus: Picornaviridae Picornavirus-like viruses (e.g. Bee acute paralysis virus, bee viruses X and Y)](https://absa.org/infectious_agent/virus-picornaviridae-picornavirus-like-viruses-eg-bee-acute-paralysis-virus-bee-viruses-x-and-y/)
- [Virus: Parvoviridae Lapine parvovirus](https://absa.org/infectious_agent/virus-parvoviridae-lapine-parvovirus/)
- [Virus: Parvoviridae Mink enteritis virus](https://absa.org/infectious_agent/virus-parvoviridae-mink-enteritis-virus/)
- [Virus: Parvoviridae Parvovirus](https://absa.org/infectious_agent/virus-parvoviridae-parvovirus/)
- [Virus: Parvoviridae Porcine parvovirus](https://absa.org/infectious_agent/virus-parvoviridae-porcine-parvovirus/)
- [Virus: Picornaviridae Acute haemorrhagic conjunctivitis virus (AHC)](https://absa.org/infectious_agent/virus-picornaviridae-acute-haemorrhagic-conjunctivitis-virus-ahc/)
- [Virus: Picornaviridae Aphthovirus](https://absa.org/infectious_agent/virus-picornaviridae-aphthovirus/)
- [Virus: Picornaviridae Avian encephalomyelitis virus](https://absa.org/infectious_agent/virus-picornaviridae-avian-encephalomyelitis-virus/)
- [Virus: Picornaviridae Bovine enteroviruses types 1-7](https://absa.org/infectious_agent/virus-picornaviridae-bovine-enteroviruses-types-1-7/)
- [Virus: Picornaviridae Bovine rhinoviruses (Types 1 to 3)](https://absa.org/infectious_agent/virus-picornaviridae-bovine-rhinoviruses-types-1-to-3/)
- [Virus: Picornaviridae Cardiovirus](https://absa.org/infectious_agent/virus-picornaviridae-cardiovirus/)
- [Virus: Picornaviridae Coxsackie virus](https://absa.org/infectious_agent/virus-picornaviridae-coxsackie-virus/)
- [Virus: Picornaviridae Duck hepatitis virus](https://absa.org/infectious_agent/virus-picornaviridae-duck-hepatitis-virus/)
- [Virus: Picornaviridae Echo virus](https://absa.org/infectious_agent/virus-picornaviridae-echo-virus/)
- [Virus: Picornaviridae Echoviruses](https://absa.org/infectious_agent/virus-picornaviridae-echoviruses/)
- [Virus: Picornaviridae Encephalomyocarditis virus](https://absa.org/infectious_agent/virus-picornaviridae-encephalomyocarditis-virus/)
- [Virus: Picornaviridae Enterovirus](https://absa.org/infectious_agent/virus-picornaviridae-enterovirus/)
- [Virus: Picornaviridae Equine rhinoviruses (Types 1 to 3)](https://absa.org/infectious_agent/virus-picornaviridae-equine-rhinoviruses-types-1-to-3/)
- [Virus: Picornaviridae Foot and mouth disease virus](https://absa.org/infectious_agent/virus-picornaviridae-foot-and-mouth-disease-virus/)
- [Virus: Picornaviridae Hepatitis A virus](https://absa.org/infectious_agent/virus-picornaviridae-hepatitis-a-virus/)
- [Virus: Picornaviridae Monkey enteroviruses (SEV)](https://absa.org/infectious_agent/virus-picornaviridae-monkey-enteroviruses-sev/)
- [Virus: Paramyxoviridae Subsclerosing pancencephalitis](https://absa.org/infectious_agent/virus-paramyxoviridae-subsclerosing-pancencephalitis/)
- [Virus: Paramyxoviridae Turkey rhinotracheitis (TRT)](https://absa.org/infectious_agent/virus-paramyxoviridae-turkey-rhinotracheitis-trt/)
- [Virus: Parvoviridae Adeno-associated viruses AAV](https://absa.org/infectious_agent/virus-parvoviridae-adeno-associated-viruses-aav/)
- [Virus: Parvoviridae Aleutian mink disease virus](https://absa.org/infectious_agent/virus-parvoviridae-aleutian-mink-disease-virus/)
- [Virus: Parvoviridae Animal parvoviruses](https://absa.org/infectious_agent/virus-parvoviridae-animal-parvoviruses/)
- [Virus: Parvoviridae Canine parvovirus (CPV)](https://absa.org/infectious_agent/virus-parvoviridae-canine-parvovirus-cpv/)
- [Virus: Parvoviridae Feline panleukopenia virus](https://absa.org/infectious_agent/virus-parvoviridae-feline-panleukopenia-virus/)
- [Virus: Parvoviridae Goose parvovirus](https://absa.org/infectious_agent/virus-parvoviridae-goose-parvovirus/)
- [Virus: Parvoviridae Hamster H-1 virus](https://absa.org/infectious_agent/virus-parvoviridae-hamster-h-1-virus/)
- [Virus: Parvoviridae Kilham rat virus (KRV)](https://absa.org/infectious_agent/virus-parvoviridae-kilham-rat-virus-krv/)
- [Virus: Paramyxoviridae Mumps virus](https://absa.org/infectious_agent/virus-paramyxoviridae-mumps-virus/)
- [Virus: Paramyxoviridae Newcastle disease virus](https://absa.org/infectious_agent/virus-paramyxoviridae-newcastle-disease-virus/)
- [Virus: Paramyxoviridae Nipah virus](https://absa.org/infectious_agent/virus-paramyxoviridae-nipah-virus/)
- [Virus: Paramyxoviridae Parainfluenza viruses](https://absa.org/infectious_agent/virus-paramyxoviridae-parainfluenza-viruses/)
- [Virus: Paramyxoviridae Peste des petits ruminants virus (PPRV)](https://absa.org/infectious_agent/virus-paramyxoviridae-peste-des-petits-ruminants-virus-pprv/)
- [Virus: Paramyxoviridae Phocine distemper virus](https://absa.org/infectious_agent/virus-paramyxoviridae-phocine-distemper-virus/)
- [Virus: Paramyxoviridae Pneumonia virus of mice](https://absa.org/infectious_agent/virus-paramyxoviridae-pneumonia-virus-of-mice/)
- [Virus: Paramyxoviridae Respiratory syncytial virus](https://absa.org/infectious_agent/virus-paramyxoviridae-respiratory-syncytial-virus/)
- [Virus: Paramyxoviridae Rinderpest virus (Cattle plague virus)](https://absa.org/infectious_agent/virus-paramyxoviridae-rinderpest-virus-cattle-plague-virus/)
- [Virus: Paramyxoviridae Sendai virus (murine parainfluenza virus type 1)](https://absa.org/infectious_agent/virus-paramyxoviridae-sendai-virus-murine-parainfluenza-virus-type-1/)
- [Virus: Papovaviridae Leopard frog papovavirus](https://absa.org/infectious_agent/virus-papovaviridae-leopard-frog-papovavirus/)
- [Virus: Papovaviridae Monkey (SV40, SA-12, STMV, LPV)](https://absa.org/infectious_agent/virus-papovaviridae-monkey-sv40-sa-12-stmv-lpv/)
- [Virus: Papovaviridae Mouse (K virus)](https://absa.org/infectious_agent/virus-papovaviridae-mouse-k-virus/)
- [Virus: Papovaviridae Papillomaviruses (HPV)](https://absa.org/infectious_agent/virus-papovaviridae-papillomaviruses-hpv/)
- [Virus: Papovaviridae Papillomaviruses of dog, rabbit (Shope papillomavirus), horse, cat, cattle and goat](https://absa.org/infectious_agent/virus-papovaviridae-papillomaviruses-of-dog-rabbit-shope-papillomavirus-horse-cat-cattle-and-goat/)
- [Virus: Papovaviridae Polyoma virus](https://absa.org/infectious_agent/virus-papovaviridae-polyoma-virus/)
- [Virus: Papovaviridae Rabbit (RK virus)](https://absa.org/infectious_agent/virus-papovaviridae-rabbit-rk-virus/)
- [Virus: Papovaviridae Shope papilloma virus](https://absa.org/infectious_agent/virus-papovaviridae-shope-papilloma-virus/)
- [Virus: Papovaviridae Simian virus 40 (SV40)](https://absa.org/infectious_agent/virus-papovaviridae-simian-virus-40-sv40/)
- [Virus: Paramyxoviridae Avian paramyxovirus (not 1)](https://absa.org/infectious_agent/virus-paramyxoviridae-avian-paramyxovirus-not-1/)
- [Virus: Paramyxoviridae Avian paramyxovirus 1 (Newcastle Disease Virus)](https://absa.org/infectious_agent/virus-paramyxoviridae-avian-paramyxovirus-1-newcastle-disease-virus/)
- [Virus: Paramyxoviridae Bovine respiratory syncytial virus (BRSV)](https://absa.org/infectious_agent/virus-paramyxoviridae-bovine-respiratory-syncytial-virus-brsv/)
- [Virus: Paramyxoviridae Canine distemper virus (Carre's virus)](https://absa.org/infectious_agent/virus-paramyxoviridae-canine-distemper-virus-carres-virus/)
- [Virus: Paramyxoviridae Equine morbillivirus (EMV) (see Hendra virus)](https://absa.org/infectious_agent/virus-paramyxoviridae-equine-morbillivirus-emv-see-hendra-virus/)
- [Virus: Paramyxoviridae Hendra virus](https://absa.org/infectious_agent/virus-paramyxoviridae-hendra-virus/)
- [Virus: Paramyxoviridae Human metapneumonovirus](https://absa.org/infectious_agent/virus-paramyxoviridae-human-metapneumonovirus/)
- [Virus: Paramyxoviridae Mapuera](https://absa.org/infectious_agent/virus-paramyxoviridae-mapuera/)
- [Virus: Paramyxoviridae Measles virus](https://absa.org/infectious_agent/virus-paramyxoviridae-measles-virus/)
- [Virus: Paramyxoviridae Menangle](https://absa.org/infectious_agent/virus-paramyxoviridae-menangle/)
- [Virus: Paramyxoviridae Morbillivirus](https://absa.org/infectious_agent/virus-paramyxoviridae-morbillivirus/)
- [Virus: Papovaviridae Bovine polyomavirus (BpoV)](https://absa.org/infectious_agent/virus-papovaviridae-bovine-polyomavirus-bpov/)
- [Virus: Papovaviridae Cotton rabbit papilloma virus](https://absa.org/infectious_agent/virus-papovaviridae-cotton-rabbit-papilloma-virus/)
- [Virus: Papovaviridae Hamster (HaP virus)](https://absa.org/infectious_agent/virus-papovaviridae-hamster-hap-virus/)
- [Virus: Iridoviridae Tipula iridescent virus (TIV)](https://absa.org/infectious_agent/virus-iridoviridae-tipula-iridescent-virus-tiv/)
- [Virus: Orthomyxoviridae Avian influenza virus (Fowl plague)](https://absa.org/infectious_agent/virus-orthomyxoviridae-avian-influenza-virus-fowl-plague/)
- [Virus: Orthomyxoviridae Dhori virus (DHOV)](https://absa.org/infectious_agent/virus-orthomyxoviridae-dhori-virus-dhov/)
- [Virus: Orthomyxoviridae Eel influenza virus A (EV-2)](https://absa.org/infectious_agent/virus-orthomyxoviridae-eel-influenza-virus-a-ev-2/)
- [Virus: Orthomyxoviridae Equine influenza virus 1 (H7N7) and 2 (H3N8)](https://absa.org/infectious_agent/virus-orthomyxoviridae-equine-influenza-virus-1-h7n7-and-2-h3n8/)
- [Virus: Orthomyxoviridae Influenza virus](https://absa.org/infectious_agent/virus-orthomyxoviridae-influenza-virus/)
- [Virus: Orthomyxoviridae Influenza virus (vaccine strain)](https://absa.org/infectious_agent/virus-orthomyxoviridae-influenza-virus-vaccine-strain/)
- [Virus: Orthomyxoviridae Seal influenza virus A](https://absa.org/infectious_agent/virus-orthomyxoviridae-seal-influenza-virus-a/)
- [Virus: Orthomyxoviridae Swine influenza virus A](https://absa.org/infectious_agent/virus-orthomyxoviridae-swine-influenza-virus-a/)
- [Virus: Orthomyxoviridae Thogoto virus](https://absa.org/infectious_agent/virus-orthomyxoviridae-thogoto-virus/)
- [Virus: Orthomyxoviridae Tick-borne orthomyxoviridae](https://absa.org/infectious_agent/virus-orthomyxoviridae-tick-borne-orthomyxoviridae/)
- [Virus: Orthomyxoviridae Influenza A virus subtype H5N1](https://absa.org/infectious_agent/virus-orthomyxoviridae-influenza-a-virus-subtype-h5n1/)
- [Virus: Orthomyxoviridae Influenza A virus subtype H7N9](https://absa.org/infectious_agent/virus-orthomyxoviridae-influenza-a-virus-subtype-h7n9/)
- [Virus: Orthomyxoviridae 1918 Pandemic Influenza virus](https://absa.org/infectious_agent/virus-orthomyxoviridae-1918-pandemic-influenza-virus/)
- [Virus: Orthomyxoviridae Whale influenza virus A](https://absa.org/infectious_agent/virus-orthomyxoviridae-whale-influenza-virus-a/)
- [Virus: Papovaviridae BK and JC viruses](https://absa.org/infectious_agent/virus-papovaviridae-bk-and-jc-viruses/)
- [Virus: Papovaviridae Bovine papilloma virus](https://absa.org/infectious_agent/virus-papovaviridae-bovine-papilloma-virus/)
- [Virus: Herpesviridae Rhadinovirus, except H.ateles,H. saimiri](https://absa.org/infectious_agent/virus-herpesviridae-rhadinovirus-except-hatelesh-saimiri/)
- [Virus: Herpesviridae Salmonid herpesvirus (Herpesvirus salmonis)](https://absa.org/infectious_agent/virus-herpesviridae-salmonid-herpesvirus-herpesvirus-salmonis/)
- [Virus: Herpesviridae Suid herpesvirus 2](https://absa.org/infectious_agent/virus-herpesviridae-suid-herpesvirus-2/)
- [Virus: Herpesviridae Thetalymphocryptovirus](https://absa.org/infectious_agent/virus-herpesviridae-thetalymphocryptovirus/)
- [Virus: Herpesviridae Turbot herpesvirus disease](https://absa.org/infectious_agent/virus-herpesviridae-turbot-herpesvirus-disease/)
- [Virus: Herpesviridae Varicella Zoster virus](https://absa.org/infectious_agent/virus-herpesviridae-varicella-zoster-virus/)
- [Virus: Iridoviridae Bullfrog (TEV)](https://absa.org/infectious_agent/virus-iridoviridae-bullfrog-tev/)
- [Virus: Iridoviridae Erythrocytic necrosis virus](https://absa.org/infectious_agent/virus-iridoviridae-erythrocytic-necrosis-virus/)
- [Virus: Iridoviridae Frog viruses (FV 1 to 3, FV 9 to 24)](https://absa.org/infectious_agent/virus-iridoviridae-frog-viruses-fv-1-to-3-fv-9-to-24/)
- [Virus: Iridoviridae Gecko virus](https://absa.org/infectious_agent/virus-iridoviridae-gecko-virus/)
- [Virus: Iridoviridae Iridoviruses of chilids, perch, goldfish, common cod, carp and cat-fish](https://absa.org/infectious_agent/virus-iridoviridae-iridoviruses-of-chilids-perch-goldfish-common-cod-carp-and-cat-fish/)
- [Virus: Iridoviridae Iridoviruses of crustaceans and mollusces](https://absa.org/infectious_agent/virus-iridoviridae-iridoviruses-of-crustaceans-and-mollusces/)
- [Virus: Iridoviridae Leopard frog iridoviruses (I 4 to 5)](https://absa.org/infectious_agent/virus-iridoviridae-leopard-frog-iridoviruses-i-4-to-5/)
- [Virus: Iridoviridae Lymphocystis disease virus](https://absa.org/infectious_agent/virus-iridoviridae-lymphocystis-disease-virus/)
- [Virus: Iridoviridae Newt viruses (T 6 to 21, LT 1 to 4)](https://absa.org/infectious_agent/virus-iridoviridae-newt-viruses-t-6-to-21-lt-1-to-4/)
- [Virus: Herpesviridae Phocid herpesvirus 1](https://absa.org/infectious_agent/virus-herpesviridae-phocid-herpesvirus-1/)
- [Virus: Herpesviridae Pigeon herpesvirus infection](https://absa.org/infectious_agent/virus-herpesviridae-pigeon-herpesvirus-infection/)
- [Virus: Herpesviridae Pike herpesvirus](https://absa.org/infectious_agent/virus-herpesviridae-pike-herpesvirus/)
- [Virus: Herpesviridae Pseudorabies virus](https://absa.org/infectious_agent/virus-herpesviridae-pseudorabies-virus/)
- [Virus: Herpesviridae Rhadinovirus, except H. ateles and H. saimiri](https://absa.org/infectious_agent/virus-herpesviridae-rhadinovirus-except-h-ateles-and-h-saimiri/)
- [Virus: Herpesviridae Felid herpesvirus 1](https://absa.org/infectious_agent/virus-herpesviridae-felid-herpesvirus-1/)
- [Virus: Herpesviridae Gamma herpes](https://absa.org/infectious_agent/virus-herpesviridae-gamma-herpes/)
- [Virus: Herpesviridae Herpes saimiri](https://absa.org/infectious_agent/virus-herpesviridae-herpes-saimiri/)
- [Virus: Herpesviridae Herpes simplex viruses](https://absa.org/infectious_agent/virus-herpesviridae-herpes-simplex-viruses/)
- [Virus: Herpesviridae Herpes virus B (Herpesvirus simiae)](https://absa.org/infectious_agent/virus-herpesviridae-herpes-virus-b-herpesvirus-simiae/)
- [Virus: Herpesviridae Herpes zoster](https://absa.org/infectious_agent/virus-herpesviridae-herpes-zoster/)
- [Virus: Herpesviridae Herpesvirus ateles](https://absa.org/infectious_agent/virus-herpesviridae-herpesvirus-ateles/)
- [Virus: Herpesviridae Herpesvirus HHV 6 - 8](https://absa.org/infectious_agent/virus-herpesviridae-herpesvirus-hhv-6-8/)
- [Virus: Herpesviridae Herpesvirus of the rabbit](https://absa.org/infectious_agent/virus-herpesviridae-herpesvirus-of-the-rabbit/)
- [Virus: Herpesviridae Herpesvirus saimiri](https://absa.org/infectious_agent/virus-herpesviridae-herpesvirus-saimiri/)
- [Virus: Herpesviridae Herpesvirus simiae (B virus)](https://absa.org/infectious_agent/virus-herpesviridae-herpesvirus-simiae-b-virus/)
- [Virus: Herpesviridae Herpesviruses of crustaceans and molluscs](https://absa.org/infectious_agent/virus-herpesviridae-herpesviruses-of-crustaceans-and-molluscs/)
- [Virus: Herpesviridae Herpesviruses of reptiles](https://absa.org/infectious_agent/virus-herpesviridae-herpesviruses-of-reptiles/)
- [Virus: Herpesviridae Herpesviruses of sheep and goat](https://absa.org/infectious_agent/virus-herpesviridae-herpesviruses-of-sheep-and-goat/)
- [Virus: Herpesviridae Herpesviruses of the frog (Fv4, FV5-8)](https://absa.org/infectious_agent/virus-herpesviridae-herpesviruses-of-the-frog-fv4-fv5-8/)
- [Virus: Herpesviridae Human B lymphotropic virus](https://absa.org/infectious_agent/virus-herpesviridae-human-b-lymphotropic-virus/)
- [Virus: Herpesviridae Lymphocrypto virus](https://absa.org/infectious_agent/virus-herpesviridae-lymphocrypto-virus/)
- [Virus: Herpesviridae Marek's disease virus](https://absa.org/infectious_agent/virus-herpesviridae-mareks-disease-virus/)
- [Virus: Herpesviridae Murine cytomegalovirus](https://absa.org/infectious_agent/virus-herpesviridae-murine-cytomegalovirus/)
- [Virus: Herpesviridae Oncorhynchus-Masou virus](https://absa.org/infectious_agent/virus-herpesviridae-oncorhynchus-masou-virus/)
- [Virus: Herpesviridae Caprine herpesvirus 1](https://absa.org/infectious_agent/virus-herpesviridae-caprine-herpesvirus-1/)
- [Virus: Herpesviridae Carp herpesvirus](https://absa.org/infectious_agent/virus-herpesviridae-carp-herpesvirus/)
- [Virus: Herpesviridae Catfish herpesvirus](https://absa.org/infectious_agent/virus-herpesviridae-catfish-herpesvirus/)
- [Virus: Herpesviridae Channel catfish virus disease (CCV) (Herpesvirus ictalurus)](https://absa.org/infectious_agent/virus-herpesviridae-channel-catfish-virus-disease-ccv-herpesvirus-ictalurus/)
- [Virus: Herpesviridae Cytomegalovirus (CMV)](https://absa.org/infectious_agent/virus-herpesviridae-cytomegalovirus-cmv/)
- [Virus: Herpesviridae Cytomegaloviruses of mouse, guinea pig and rat](https://absa.org/infectious_agent/virus-herpesviridae-cytomegaloviruses-of-mouse-guinea-pig-and-rat/)
- [Virus: Herpesviridae Epstein-Barr virus (EBV)](https://absa.org/infectious_agent/virus-herpesviridae-epstein-barr-virus-ebv/)
- [Virus: Herpesviridae Equid herpesvirus 1 (EHV-1)](https://absa.org/infectious_agent/virus-herpesviridae-equid-herpesvirus-1-ehv-1/)
- [Virus: Herpesviridae Equid herpesviruses 2, 3 (EHV-2, 3)](https://absa.org/infectious_agent/virus-herpesviridae-equid-herpesviruses-2-3-ehv-2-3/)
- [Virus: Hepadnaviridae Duck hepatidis B](https://absa.org/infectious_agent/virus-hepadnaviridae-duck-hepatidis-b/)
- [Virus: Hepadnaviridae Ground squirrel hepatitis B virus](https://absa.org/infectious_agent/virus-hepadnaviridae-ground-squirrel-hepatitis-b-virus/)
- [Virus: Hepadnaviridae Hepatitis B virus](https://absa.org/infectious_agent/virus-hepadnaviridae-hepatitis-b-virus/)
- [Virus: Hepadnaviridae Hepatitis D virus](https://absa.org/infectious_agent/virus-hepadnaviridae-hepatitis-d-virus/)
- [Virus: Hepadnaviridae Woodchuck hepatitis B virus](https://absa.org/infectious_agent/virus-hepadnaviridae-woodchuck-hepatitis-b-virus/)
- [Virus: Herpesviridae Alcelaphine herpesvirus 1 (Bovine malignant catarrhal fever)](https://absa.org/infectious_agent/virus-herpesviridae-alcelaphine-herpesvirus-1-bovine-malignant-catarrhal-fever/)
- [Virus: Herpesviridae Avian herpesvirus 1 (ILT)](https://absa.org/infectious_agent/virus-herpesviridae-avian-herpesvirus-1-ilt/)
- [Virus: Herpesviridae Baboon herpesvirus (Cercopithecine herpesvirus 2)](https://absa.org/infectious_agent/virus-herpesviridae-baboon-herpesvirus-cercopithecine-herpesvirus-2/)
- [Virus: Herpesviridae Bovine herpesvirus 1](https://absa.org/infectious_agent/virus-herpesviridae-bovine-herpesvirus-1/)
- [Virus: Herpesviridae Bovine herpesviruses 2 to 4](https://absa.org/infectious_agent/virus-herpesviridae-bovine-herpesviruses-2-to-4/)
- [Virus: Herpesviridae Canid herpesvirus 1](https://absa.org/infectious_agent/virus-herpesviridae-canid-herpesvirus-1/)
- [Virus: Flaviviridae Negishi virus](https://absa.org/infectious_agent/virus-flaviviridae-negishi-virus/)
- [Virus: Flaviviridae Omsk hemorrhagic fever virus](https://absa.org/infectious_agent/virus-flaviviridae-omsk-hemorrhagic-fever-virus/)
- [Virus: Flaviviridae Powassan virus](https://absa.org/infectious_agent/virus-flaviviridae-powassan-virus/)
- [Virus: Flaviviridae Rocio virus](https://absa.org/infectious_agent/virus-flaviviridae-rocio-virus/)
- [Virus: Flaviviridae Russian spring-summer encephalitis](https://absa.org/infectious_agent/virus-flaviviridae-russian-spring-summer-encephalitis/)
- [Virus: Flaviviridae Sal Vieja virus](https://absa.org/infectious_agent/virus-flaviviridae-sal-vieja-virus/)
- [Virus: Flaviviridae Sammarez reef virus](https://absa.org/infectious_agent/virus-flaviviridae-sammarez-reef-virus/)
- [Virus: Flaviviridae San Perlita virus](https://absa.org/infectious_agent/virus-flaviviridae-san-perlita-virus/)
- [Virus: Flaviviridae Sarafend](https://absa.org/infectious_agent/virus-flaviviridae-sarafend/)
- [Virus: Flaviviridae Saumarez Reef](https://absa.org/infectious_agent/virus-flaviviridae-saumarez-reef/)
- [Virus: Flaviviridae Spondweni virus](https://absa.org/infectious_agent/virus-flaviviridae-spondweni-virus/)
- [Virus: Flaviviridae St. Louis encephalitis virus](https://absa.org/infectious_agent/virus-flaviviridae-st-louis-encephalitis-virus/)
- [Virus: Flaviviridae Tick-borne encephalitis virus](https://absa.org/infectious_agent/virus-flaviviridae-tick-borne-encephalitis-virus/)
- [Virus: Flaviviridae Wesselsbron virus](https://absa.org/infectious_agent/virus-flaviviridae-wesselsbron-virus/)
- [Virus: Flaviviridae West Nile virus](https://absa.org/infectious_agent/virus-flaviviridae-west-nile-virus/)
- [Virus: Flaviviridae Yellow fever virus (vaccine strain 17D)](https://absa.org/infectious_agent/virus-flaviviridae-yellow-fever-virus-vaccine-strain-17d/)
- [Virus: Flaviviridae Yellow fever virus, wild type](https://absa.org/infectious_agent/virus-flaviviridae-yellow-fever-virus-wild-type/)
- [Virus: Flaviviridae Zika virus](https://absa.org/infectious_agent/virus-flaviviridae-zika-virus/)
- [Virus: Flaviviridae Louping ill virus](https://absa.org/infectious_agent/virus-flaviviridae-louping-ill-virus/)
- [Virus: Flaviviridae Murray Valley encephalitis virus](https://absa.org/infectious_agent/virus-flaviviridae-murray-valley-encephalitis-virus/)
- [Virus: Flaviviridae Absettarov](https://absa.org/infectious_agent/virus-flaviviridae-absettarov/)
- [Virus: Flaviviridae Border disease virus](https://absa.org/infectious_agent/virus-flaviviridae-border-disease-virus/)
- [Virus: Flaviviridae Bovine diarrhoea virus](https://absa.org/infectious_agent/virus-flaviviridae-bovine-diarrhoea-virus/)
- [Virus: Flaviviridae Central European encephalitis](https://absa.org/infectious_agent/virus-flaviviridae-central-european-encephalitis/)
- [Virus: Flaviviridae Dengue virus](https://absa.org/infectious_agent/virus-flaviviridae-dengue-virus/)
- [Virus: Flaviviridae Far Eastern Tick-borne encephalitis](https://absa.org/infectious_agent/virus-flaviviridae-far-eastern-tick-borne-encephalitis/)
- [Virus: Flaviviridae Flaviviruses](https://absa.org/infectious_agent/virus-flaviviridae-flaviviruses/)
- [Virus: Flaviviridae Hanzalova](https://absa.org/infectious_agent/virus-flaviviridae-hanzalova/)
- [Virus: Flaviviridae Hepatitis C virus](https://absa.org/infectious_agent/virus-flaviviridae-hepatitis-c-virus/)
- [Virus: Flaviviridae Hepatitis G virus](https://absa.org/infectious_agent/virus-flaviviridae-hepatitis-g-virus/)
- [Virus: Flaviviridae Hog cholera virus (Classical Swine Fever virus)](https://absa.org/infectious_agent/virus-flaviviridae-hog-cholera-virus-classical-swine-fever-virus/)
- [Virus: Flaviviridae Hypr virus](https://absa.org/infectious_agent/virus-flaviviridae-hypr-virus/)
- [Virus: Flaviviridae Israel turkey meningoencephalitis virus](https://absa.org/infectious_agent/virus-flaviviridae-israel-turkey-meningoencephalitis-virus/)
- [Virus: Flaviviridae Japanese B encephalitis virus](https://absa.org/infectious_agent/virus-flaviviridae-japanese-b-encephalitis-virus/)
- [Virus: Flaviviridae Japanese encephalitis, Nakayama virus](https://absa.org/infectious_agent/virus-flaviviridae-japanese-encephalitis-nakayama-virus/)
- [Virus: Flaviviridae Kokobera virus](https://absa.org/infectious_agent/virus-flaviviridae-kokobera-virus/)
- [Virus: Flaviviridae Koutango virus](https://absa.org/infectious_agent/virus-flaviviridae-koutango-virus/)
- [Virus: Flaviviridae Kumlinge virus](https://absa.org/infectious_agent/virus-flaviviridae-kumlinge-virus/)
- [Virus: Flaviviridae Kunjin](https://absa.org/infectious_agent/virus-flaviviridae-kunjin/)
- [Virus: Flaviviridae Kyasanur forest disease virus](https://absa.org/infectious_agent/virus-flaviviridae-kyasanur-forest-disease-virus/)
- [Virus: Coronaviridae Middle eastern respiratory (MERS)](https://absa.org/infectious_agent/virus-coronaviridae-middle-eastern-respiratory-mers/)
- [Virus: Coronaviridae Murine hepatitis virus](https://absa.org/infectious_agent/virus-coronaviridae-murine-hepatitis-virus/)
- [Virus: Coronaviridae Porcine epidemic diarrhoea virus](https://absa.org/infectious_agent/virus-coronaviridae-porcine-epidemic-diarrhoea-virus/)
- [Virus: Coronaviridae Porcine haemagglutinating encephalomyelitis virus](https://absa.org/infectious_agent/virus-coronaviridae-porcine-haemagglutinating-encephalomyelitis-virus/)
- [Virus: Coronaviridae Porcine transmissible gastroenteritis virus](https://absa.org/infectious_agent/virus-coronaviridae-porcine-transmissible-gastroenteritis-virus/)
- [Virus: Coronaviridae Rat coronavirus](https://absa.org/infectious_agent/virus-coronaviridae-rat-coronavirus/)
- [Virus: Coronaviridae SARS](https://absa.org/infectious_agent/virus-coronaviridae-sars/)
- [Virus: Coronaviridae Turkey coronavirus](https://absa.org/infectious_agent/virus-coronaviridae-turkey-coronavirus/)
- [Virus: Filoviridae Ebola virus](https://absa.org/infectious_agent/virus-filoviridae-ebola-virus/)
- [Virus: Filoviridae Marburg virus](https://absa.org/infectious_agent/virus-filoviridae-marburg-virus/)
- [Virus: Circoviridae Chicken anaemia virus](https://absa.org/infectious_agent/virus-circoviridae-chicken-anaemia-virus/)
- [Virus: Circoviridae Porcine circovirus](https://absa.org/infectious_agent/virus-circoviridae-porcine-circovirus/)
- [Virus: Coronaviridae Avian infectious bronchitis virus](https://absa.org/infectious_agent/virus-coronaviridae-avian-infectious-bronchitis-virus/)
- [Virus: Coronaviridae Berne virus](https://absa.org/infectious_agent/virus-coronaviridae-berne-virus/)
- [Virus: Coronaviridae Bovine coronavirus](https://absa.org/infectious_agent/virus-coronaviridae-bovine-coronavirus/)
- [Virus: Coronaviridae Breda virus](https://absa.org/infectious_agent/virus-coronaviridae-breda-virus/)
- [Virus: Coronaviridae Canine coronavirus](https://absa.org/infectious_agent/virus-coronaviridae-canine-coronavirus/)
- [Virus: Coronaviridae Coronavirus](https://absa.org/infectious_agent/virus-coronaviridae-coronavirus/)
- [Virus: Coronaviridae Feline infectious peritonitis virus](https://absa.org/infectious_agent/virus-coronaviridae-feline-infectious-peritonitis-virus/)
- [Virus: Coronaviridae Human coronavirus](https://absa.org/infectious_agent/virus-coronaviridae-human-coronavirus/)
- [Virus: Bunyaviridae Sin Nombre virus (former Muerto Canyon)](https://absa.org/infectious_agent/virus-bunyaviridae-sin-nombre-virus-former-muerto-canyon/)
- [Virus: Bunyaviridae Tensaw virus](https://absa.org/infectious_agent/virus-bunyaviridae-tensaw-virus/)
- [Virus: Bunyaviridae Toscana virus](https://absa.org/infectious_agent/virus-bunyaviridae-toscana-virus/)
- [Virus: Bunyaviridae Turuna virus](https://absa.org/infectious_agent/virus-bunyaviridae-turuna-virus/)
- [Virus: Bunyaviridae Uukuniemi virus](https://absa.org/infectious_agent/virus-bunyaviridae-uukuniemi-virus/)
- [Virus: Bunyaviridae Zinga (See Rift Valley Fever)](https://absa.org/infectious_agent/virus-bunyaviridae-zinga-see-rift-valley-fever/)
- [Virus: Caliciviridae Bovine enteric calicivirus](https://absa.org/infectious_agent/virus-caliciviridae-bovine-enteric-calicivirus/)
- [Virus: Caliciviridae Calicivirus](https://absa.org/infectious_agent/virus-caliciviridae-calicivirus-2/)
- [Virus: Caliciviridae Canine calicivirus](https://absa.org/infectious_agent/virus-caliciviridae-canine-calicivirus/)
- [Virus: Caliciviridae Feline calicivirus](https://absa.org/infectious_agent/virus-caliciviridae-feline-calicivirus/)
- [Virus: Caliciviridae Hepatitis E virus](https://absa.org/infectious_agent/virus-caliciviridae-hepatitis-e-virus/)
- [Virus: Caliciviridae Norovirus (former Norwalk virus)](https://absa.org/infectious_agent/virus-caliciviridae-norovirus-former-norwalk-virus/)
- [Virus: Caliciviridae Porcine enteric calicivirus](https://absa.org/infectious_agent/virus-caliciviridae-porcine-enteric-calicivirus/)
- [Virus: Caliciviridae Rabbit haemorrhagic disease](https://absa.org/infectious_agent/virus-caliciviridae-rabbit-haemorrhagic-disease/)
- [Virus: Caliciviridae San Miguel sealion virus](https://absa.org/infectious_agent/virus-caliciviridae-san-miguel-sealion-virus/)
- [Virus: Caliciviridae Sapovirus (former Sapporo virus)](https://absa.org/infectious_agent/virus-caliciviridae-sapovirus-former-sapporo-virus/)
- [Virus: Caliciviridae Vesicular exanthema of swine virus](https://absa.org/infectious_agent/virus-caliciviridae-vesicular-exanthema-of-swine-virus/)
- [Virus: Bunyaviridae Rift Valley Fever, (Zinga virus)](https://absa.org/infectious_agent/virus-bunyaviridae-rift-valley-fever-zinga-virus/)
- [Virus: Bunyaviridae Sandfly fever virus](https://absa.org/infectious_agent/virus-bunyaviridae-sandfly-fever-virus/)
- [Virus: Bunyaviridae Seoul virus](https://absa.org/infectious_agent/virus-bunyaviridae-seoul-virus/)
- [Virus: Bunyaviridae Bruconha virus](https://absa.org/infectious_agent/virus-bunyaviridae-bruconha-virus/)
- [Virus: Bunyaviridae Bunya viruses (Bunyaviridae)](https://absa.org/infectious_agent/virus-bunyaviridae-bunya-viruses-bunyaviridae/)
- [Virus: Bunyaviridae Bunyamwera virus](https://absa.org/infectious_agent/virus-bunyaviridae-bunyamwera-virus/)
- [Virus: Bunyaviridae Bunyavirus](https://absa.org/infectious_agent/virus-bunyaviridae-bunyavirus/)
- [Virus: Bunyaviridae Cache Valley virus](https://absa.org/infectious_agent/virus-bunyaviridae-cache-valley-virus/)
- [Virus: Bunyaviridae California encephalitis virus](https://absa.org/infectious_agent/virus-bunyaviridae-california-encephalitis-virus/)
- [Virus: Bunyaviridae Crimean-Congo haemorrhagic fever](https://absa.org/infectious_agent/virus-bunyaviridae-crimean-congo-haemorrhagic-fever/)
- [Virus: Bunyaviridae Dobrava/Belgrade virus (DOBV)](https://absa.org/infectious_agent/virus-bunyaviridae-dobravabelgrade-virus-dobv/)
- [Virus: Bunyaviridae Germiston](https://absa.org/infectious_agent/virus-bunyaviridae-germiston/)
- [Virus: Bunyaviridae Hanta virus](https://absa.org/infectious_agent/virus-bunyaviridae-hanta-virus/)
- [Virus: Bunyaviridae Hantaan (Korean haemorrhagic fever)](https://absa.org/infectious_agent/virus-bunyaviridae-hantaan-korean-haemorrhagic-fever/)
- [Virus: Bunyaviridae Hazara virus](https://absa.org/infectious_agent/virus-bunyaviridae-hazara-virus/)
- [Virus: Bunyaviridae Kairi virus](https://absa.org/infectious_agent/virus-bunyaviridae-kairi-virus/)
- [Virus: Bunyaviridae Nairobi Sheep Disease](https://absa.org/infectious_agent/virus-bunyaviridae-nairobi-sheep-disease/)
- [Virus: Bunyaviridae Oropouche virus](https://absa.org/infectious_agent/virus-bunyaviridae-oropouche-virus/)
- [Virus: Bunyaviridae Other bunyaviridae known to be pathogenic](https://absa.org/infectious_agent/virus-bunyaviridae-other-bunyaviridae-known-to-be-pathogenic/)
- [Virus: Bunyaviridae other hantaviruses](https://absa.org/infectious_agent/virus-bunyaviridae-other-hantaviruses/)
- [Virus: Bunyaviridae Prospect Hill virus](https://absa.org/infectious_agent/virus-bunyaviridae-prospect-hill-virus/)
- [Virus: Bunyaviridae Puumala virus](https://absa.org/infectious_agent/virus-bunyaviridae-puumala-virus/)
- [Virus: Arenaviridae Tamiami virus](https://absa.org/infectious_agent/virus-arenaviridae-tamiami-virus/)
- [Virus: Astroviridae Astroviruses](https://absa.org/infectious_agent/virus-astroviridae-astroviruses/)
- [Virus: Baculoviridae Invertebrate baculoviruses](https://absa.org/infectious_agent/virus-baculoviridae-invertebrate-baculoviruses/)
- [Virus: Birnaviridae Drosophila X virus](https://absa.org/infectious_agent/virus-birnaviridae-drosophila-x-virus/)
- [Virus: Birnaviridae Infectious bursal disease virus](https://absa.org/infectious_agent/virus-birnaviridae-infectious-bursal-disease-virus/)
- [Virus: Birnaviridae Infectious pancreatic necrosis virus](https://absa.org/infectious_agent/virus-birnaviridae-infectious-pancreatic-necrosis-virus/)
- [Virus: Birnaviridae Rotifer birnavirus](https://absa.org/infectious_agent/virus-birnaviridae-rotifer-birnavirus/)
- [Virus: Bornaviridae Borna disease virus](https://absa.org/infectious_agent/virus-bornaviridae-borna-disease-virus/)
- [Virus: Bunyaviridae Aino virus](https://absa.org/infectious_agent/virus-bunyaviridae-aino-virus/)
- [Virus: Bunyaviridae Akabane virus](https://absa.org/infectious_agent/virus-bunyaviridae-akabane-virus/)
- [Virus: Bunyaviridae Belgrade (see Dobrava)](https://absa.org/infectious_agent/virus-bunyaviridae-belgrade-see-dobrava/)
- [Virus: Bunyaviridae Bhanja](https://absa.org/infectious_agent/virus-bunyaviridae-bhanja/)
- [Virus: Arenaviridae Machupo virus](https://absa.org/infectious_agent/virus-arenaviridae-machupo-virus/)
- [Virus: Arenaviridae Mobala virus](https://absa.org/infectious_agent/virus-arenaviridae-mobala-virus/)
- [Virus: Arenaviridae Mopeia viruses](https://absa.org/infectious_agent/virus-arenaviridae-mopeia-viruses/)
- [Virus: Arenaviridae Parana virus](https://absa.org/infectious_agent/virus-arenaviridae-parana-virus/)
- [Virus: Arenaviridae Pichinde virus](https://absa.org/infectious_agent/virus-arenaviridae-pichinde-virus/)
- [Virus: Arenaviridae Sabia virus](https://absa.org/infectious_agent/virus-arenaviridae-sabia-virus/)
- [Virus: Arenaviridae Simian haemorrhagic fever virus](https://absa.org/infectious_agent/virus-arenaviridae-simian-haemorrhagic-fever-virus/)
- [Virus: Arenaviridae Tacaribe complex](https://absa.org/infectious_agent/virus-arenaviridae-tacaribe-complex/)
- [Parasite: Trypanosoma spp](https://absa.org/infectious_agent/parasite-trypanosoma-spp/)
- [Parasite: Varroa jacobsoni](https://absa.org/infectious_agent/parasite-varroa-jacobsoni/)
- [Parasite: Wuchereria bancroftii](https://absa.org/infectious_agent/parasite-wuchereria-bancroftii/)
- [Parasite: Wuchereria malayi](https://absa.org/infectious_agent/parasite-wuchereria-malayi/)
- [Parasite: Wuchereria spp](https://absa.org/infectious_agent/parasite-wuchereria-spp/)
- [Virus: Adenoviridae Adenovirus (human, all types)](https://absa.org/infectious_agent/virus-adenoviridae-adenovirus-human-all-types/)
- [Virus: Adenoviridae Adenovirus of the guinea pig (GPAV)](https://absa.org/infectious_agent/virus-adenoviridae-adenovirus-of-the-guinea-pig-gpav/)
- [Virus: Asfaviridae African swine fever virus](https://absa.org/infectious_agent/virus-asfaviridae-african-swine-fever-virus/)
- [Virus: Adenoviridae Aviadenoviruses](https://absa.org/infectious_agent/virus-adenoviridae-aviadenoviruses/)
- [Virus: Arenaviridae Amapari virus](https://absa.org/infectious_agent/virus-arenaviridae-amapari-virus/)
- [Virus: Arenaviridae Equine arteritis](https://absa.org/infectious_agent/virus-arenaviridae-equine-arteritis/)
- [Virus: Arenaviridae Flexal virus](https://absa.org/infectious_agent/virus-arenaviridae-flexal-virus/)
- [Virus: Arenaviridae Guanarito virus](https://absa.org/infectious_agent/virus-arenaviridae-guanarito-virus/)
- [Virus: Arenaviridae Ippy virus](https://absa.org/infectious_agent/virus-arenaviridae-ippy-virus/)
- [Virus: Arenaviridae Junin virus](https://absa.org/infectious_agent/virus-arenaviridae-junin-virus/)
- [Virus: Arenaviridae Lactate dehydrogenase-elevating virus](https://absa.org/infectious_agent/virus-arenaviridae-lactate-dehydrogenase-elevating-virus/)
- [Virus: Arenaviridae Lassa virus](https://absa.org/infectious_agent/virus-arenaviridae-lassa-virus/)
- [Virus: Arenaviridae LCM-Lassa complex](https://absa.org/infectious_agent/virus-arenaviridae-lcm-lassa-complex/)
- [Virus: Arenaviridae Lymphocytic choriomeningitis (neurotropic) virus](https://absa.org/infectious_agent/virus-arenaviridae-lymphocytic-choriomeningitis-neurotropic-virus/)
- [Virus: Arenaviridae Lymphocytic choriomeningitis (non-neurotropic) strains](https://absa.org/infectious_agent/virus-arenaviridae-lymphocytic-choriomeningitis-non-neurotropic-strains/)
- [Parasite: Trichuris trichiura](https://absa.org/infectious_agent/parasite-trichuris-trichiura/)
- [Parasite: Trypanosoma brucei brucei](https://absa.org/infectious_agent/parasite-trypanosoma-brucei-brucei/)
- [Parasite: Trypanosoma brucei gambiense](https://absa.org/infectious_agent/parasite-trypanosoma-brucei-gambiense/)
- [Parasite: Trypanosoma brucei rhodesiense](https://absa.org/infectious_agent/parasite-trypanosoma-brucei-rhodesiense/)
- [Parasite: Trypanosoma cruzi](https://absa.org/infectious_agent/parasite-trypanosoma-cruzi/)
- [Parasite: Trypanosoma rangeli](https://absa.org/infectious_agent/parasite-trypanosoma-rangeli/)
- [Parasite: Toxocara canis](https://absa.org/infectious_agent/parasite-toxocara-canis/)
- [Parasite: Toxocara cati](https://absa.org/infectious_agent/parasite-toxocara-cati/)
- [Parasite: Toxocara spp](https://absa.org/infectious_agent/parasite-toxocara-spp/)
- [Parasite: Toxoplasma gondii](https://absa.org/infectious_agent/parasite-toxoplasma-gondii/)
- [Parasite: Toxoplasma spp](https://absa.org/infectious_agent/parasite-toxoplasma-spp/)
- [Parasite: Trichinella nativa](https://absa.org/infectious_agent/parasite-trichinella-nativa/)
- [Parasite: Trichinella nelsoni](https://absa.org/infectious_agent/parasite-trichinella-nelsoni/)
- [Parasite: Trichinella pseudospiralis](https://absa.org/infectious_agent/parasite-trichinella-pseudospiralis/)
- [Parasite: Trichinella spiralis](https://absa.org/infectious_agent/parasite-trichinella-spiralis/)
- [Parasite: Trichinella spp](https://absa.org/infectious_agent/parasite-trichinella-spp/)
- [Parasite: Trichomonas vaginalis](https://absa.org/infectious_agent/parasite-trichomonas-vaginalis/)
- [Parasite: Trichostrongylus colubriformis](https://absa.org/infectious_agent/parasite-trichostrongylus-colubriformis/)
- [Parasite: Trichostrongylus orientalis](https://absa.org/infectious_agent/parasite-trichostrongylus-orientalis/)
- [Parasite: Trichostrongylus spp](https://absa.org/infectious_agent/parasite-trichostrongylus-spp/)
- [Parasite: Sarcocystis spp](https://absa.org/infectious_agent/parasite-sarcocystis-spp/)
- [Parasite: Sarcocystis suihominis](https://absa.org/infectious_agent/parasite-sarcocystis-suihominis/)
- [Parasite: Schistosoma haematobium](https://absa.org/infectious_agent/parasite-schistosoma-haematobium/)
- [Parasite: Schistosoma intercalatum](https://absa.org/infectious_agent/parasite-schistosoma-intercalatum/)
- [Parasite: Schistosoma japonicum](https://absa.org/infectious_agent/parasite-schistosoma-japonicum/)
- [Parasite: Schistosoma mansoni](https://absa.org/infectious_agent/parasite-schistosoma-mansoni/)
- [Parasite: Schistosoma mekongi](https://absa.org/infectious_agent/parasite-schistosoma-mekongi/)
- [Parasite: Schistosoma spp](https://absa.org/infectious_agent/parasite-schistosoma-spp/)
- [Parasite: Strongyloides spp](https://absa.org/infectious_agent/parasite-strongyloides-spp/)
- [Parasite: Strongyloides stercoralis](https://absa.org/infectious_agent/parasite-strongyloides-stercoralis/)
- [Parasite: Taenia saginata](https://absa.org/infectious_agent/parasite-taenia-saginata/)
- [Parasite: Taenia solium](https://absa.org/infectious_agent/parasite-taenia-solium/)
- [Parasite: Taenia spp](https://absa.org/infectious_agent/parasite-taenia-spp/)
- [Parasite: Ternidens deminutus](https://absa.org/infectious_agent/parasite-ternidens-deminutus/)
- [Parasite: Theileria annulata](https://absa.org/infectious_agent/parasite-theileria-annulata/)
- [Parasite: Theileria parva](https://absa.org/infectious_agent/parasite-theileria-parva/)
- [Parasite: Plasmodium spp](https://absa.org/infectious_agent/parasite-plasmodium-spp/)
- [Parasite: Plasmodium vivax](https://absa.org/infectious_agent/parasite-plasmodium-vivax/)
- [Parasite: Pneumocystis carinii](https://absa.org/infectious_agent/parasite-pneumocystis-carinii/)
- [Parasite: Pseudoterranova decipiens](https://absa.org/infectious_agent/parasite-pseudoterranova-decipiens/)
- [Parasite: Naegleria fowleri](https://absa.org/infectious_agent/parasite-naegleria-fowleri/)
- [Parasite: Naegleria gruberi](https://absa.org/infectious_agent/parasite-naegleria-gruberi/)
- [Parasite: Naegleria spp](https://absa.org/infectious_agent/parasite-naegleria-spp/)
- [Parasite: Necator americanus](https://absa.org/infectious_agent/parasite-necator-americanus/)
- [Parasite: Necator spp](https://absa.org/infectious_agent/parasite-necator-spp/)
- [Parasite: Oesophagostomum dentatum](https://absa.org/infectious_agent/parasite-oesophagostomum-dentatum/)
- [Parasite: Onchocerca spp](https://absa.org/infectious_agent/parasite-onchocerca-spp/)
- [Parasite: Onchocerca volvulus](https://absa.org/infectious_agent/parasite-onchocerca-volvulus/)
- [Parasite: Opisthorchis felineus](https://absa.org/infectious_agent/parasite-opisthorchis-felineus/)
- [Parasite: Opisthorchis sinensis](https://absa.org/infectious_agent/parasite-opisthorchis-sinensis/)
- [Parasite: Opisthorchis spp](https://absa.org/infectious_agent/parasite-opisthorchis-spp/)
- [Parasite: Opisthorchis viverrini](https://absa.org/infectious_agent/parasite-opisthorchis-viverrini/)
- [Parasite: Paragonimus spp](https://absa.org/infectious_agent/parasite-paragonimus-spp/)
- [Parasite: Paragonimus westermanii](https://absa.org/infectious_agent/parasite-paragonimus-westermanii/)
- [Parasite: Piroplasma spp](https://absa.org/infectious_agent/parasite-piroplasma-spp/)
- [Parasite: Plasmodium cynomologi](https://absa.org/infectious_agent/parasite-plasmodium-cynomologi/)
- [Parasite: Plasmodium falciparum](https://absa.org/infectious_agent/parasite-plasmodium-falciparum/)
- [Parasite: Plasmodium malariae](https://absa.org/infectious_agent/parasite-plasmodium-malariae/)
- [Parasite: Plasmodium ovale](https://absa.org/infectious_agent/parasite-plasmodium-ovale/)
- [Parasite: Plasmodium simian parasites](https://absa.org/infectious_agent/parasite-plasmodium-simian-parasites/)
- [Parasite: Loa loa](https://absa.org/infectious_agent/parasite-loa-loa/)
- [Parasite: Loa spp](https://absa.org/infectious_agent/parasite-loa-spp/)
- [Parasite: Mansonella ozzardi](https://absa.org/infectious_agent/parasite-mansonella-ozzardi/)
- [Parasite: Mansonella perstans](https://absa.org/infectious_agent/parasite-mansonella-perstans/)
- [Parasite: Mansonella streptocerca](https://absa.org/infectious_agent/parasite-mansonella-streptocerca/)
- [Parasite: Metagonimus spp](https://absa.org/infectious_agent/parasite-metagonimus-spp/)
- [Parasite: Microsporidium spp.](https://absa.org/infectious_agent/parasite-microsporidium-spp/)
- [Parasite: Naegleria australiensis](https://absa.org/infectious_agent/parasite-naegleria-australiensis/)
- [Parasite: Hymenolepis nana](https://absa.org/infectious_agent/parasite-hymenolepis-nana/)
- [Parasite: Hymenolepis spp](https://absa.org/infectious_agent/parasite-hymenolepis-spp/)
- [Parasite: Isopora belli](https://absa.org/infectious_agent/parasite-isopora-belli/)
- [Parasite: Isopora spp](https://absa.org/infectious_agent/parasite-isopora-spp/)
- [Parasite: Leishmania aethiopica](https://absa.org/infectious_agent/parasite-leishmania-aethiopica/)
- [Parasite: Leishmania braziliensis](https://absa.org/infectious_agent/parasite-leishmania-braziliensis/)
- [Parasite: Leishmania donovani](https://absa.org/infectious_agent/parasite-leishmania-donovani/)
- [Parasite: Leishmania major](https://absa.org/infectious_agent/parasite-leishmania-major/)
- [Parasite: Leishmania mexicana](https://absa.org/infectious_agent/parasite-leishmania-mexicana/)
- [Parasite: Leishmania peruviana](https://absa.org/infectious_agent/parasite-leishmania-peruviana/)
- [Parasite: Leishmania spp.](https://absa.org/infectious_agent/parasite-leishmania-spp/)
- [Parasite: Leishmania tropica](https://absa.org/infectious_agent/parasite-leishmania-tropica/)
- [Parasite: Entamoeba dispar](https://absa.org/infectious_agent/parasite-entamoeba-dispar/)
- [Parasite: Entamoeba histolytica](https://absa.org/infectious_agent/parasite-entamoeba-histolytica/)
- [Parasite: Enterobius spp](https://absa.org/infectious_agent/parasite-enterobius-spp/)
- [Parasite: Enterobius vermicularis](https://absa.org/infectious_agent/parasite-enterobius-vermicularis/)
- [Parasite: Enterocytozoon bieneusi](https://absa.org/infectious_agent/parasite-enterocytozoon-bieneusi/)
- [Parasite: Fasciola gigantica](https://absa.org/infectious_agent/parasite-fasciola-gigantica/)
- [Parasite: Fasciola hepatica](https://absa.org/infectious_agent/parasite-fasciola-hepatica/)
- [Parasite: Fasciola spp](https://absa.org/infectious_agent/parasite-fasciola-spp/)
- [Parasite: Fasciolopsis buski](https://absa.org/infectious_agent/parasite-fasciolopsis-buski/)
- [Parasite: Fasciolopsis spp](https://absa.org/infectious_agent/parasite-fasciolopsis-spp/)
- [Parasite: Giardia duodenalis](https://absa.org/infectious_agent/parasite-giardia-duodenalis/)
- [Parasite: Giardia intestinalis](https://absa.org/infectious_agent/parasite-giardia-intestinalis/)
- [Parasite: Giardia lamblia](https://absa.org/infectious_agent/parasite-giardia-lamblia/)
- [Parasite: Giardia spp](https://absa.org/infectious_agent/parasite-giardia-spp/)
- [Parasite: Gnathostoma spinigerum](https://absa.org/infectious_agent/parasite-gnathostoma-spinigerum/)
- [Parasite: Gongylonema pulchrum](https://absa.org/infectious_agent/parasite-gongylonema-pulchrum/)
- [Parasite: Haemonchus contortus](https://absa.org/infectious_agent/parasite-haemonchus-contortus/)
- [Parasite: Heterophyes spp](https://absa.org/infectious_agent/parasite-heterophyes-spp/)
- [Parasite: Hymenolepis diminuta](https://absa.org/infectious_agent/parasite-hymenolepis-diminuta/)
- [Parasite: Eimeria tenella](https://absa.org/infectious_agent/parasite-eimeria-tenella/)
- [Parasite: Encephalitozoon cuniculi](https://absa.org/infectious_agent/parasite-encephalitozoon-cuniculi/)
- [Parasite: Encephalitozoon hellem](https://absa.org/infectious_agent/parasite-encephalitozoon-hellem/)
- [Parasite: Encephalitozoon intestinalis](https://absa.org/infectious_agent/parasite-encephalitozoon-intestinalis/)
- [Parasite: Cysticercus cellulosae](https://absa.org/infectious_agent/parasite-cysticercus-cellulosae/)
- [Parasite: Dicrocoelium dendriticum](https://absa.org/infectious_agent/parasite-dicrocoelium-dendriticum/)
- [Parasite: Dientamoeba fragilis](https://absa.org/infectious_agent/parasite-dientamoeba-fragilis/)
- [Parasite: Dipetalonema perstans](https://absa.org/infectious_agent/parasite-dipetalonema-perstans/)
- [Parasite: Dipetalonema spp](https://absa.org/infectious_agent/parasite-dipetalonema-spp/)
- [Parasite: Dipetalonema streptocerca](https://absa.org/infectious_agent/parasite-dipetalonema-streptocerca/)
- [Parasite: Diphyllobothrium latum](https://absa.org/infectious_agent/parasite-diphyllobothrium-latum/)
- [Parasite: Diphyllobothrium spp](https://absa.org/infectious_agent/parasite-diphyllobothrium-spp/)
- [Parasite: Dipylidium caninum](https://absa.org/infectious_agent/parasite-dipylidium-caninum/)
- [Parasite: Dracunculus medinensis](https://absa.org/infectious_agent/parasite-dracunculus-medinensis/)
- [Parasite: Dracunculus spp](https://absa.org/infectious_agent/parasite-dracunculus-spp/)
- [Parasite: Echinococcus granulosus](https://absa.org/infectious_agent/parasite-echinococcus-granulosus/)
- [Parasite: Echinococcus multilocularis](https://absa.org/infectious_agent/parasite-echinococcus-multilocularis/)
- [Parasite: Echinococcus spp](https://absa.org/infectious_agent/parasite-echinococcus-spp/)
- [Parasite: Echinococcus vogeli](https://absa.org/infectious_agent/parasite-echinococcus-vogeli/)
- [Parasite: Eimeria bovis](https://absa.org/infectious_agent/parasite-eimeria-bovis/)
- [Parasite: Eimeria suis](https://absa.org/infectious_agent/parasite-eimeria-suis/)
- [Parasite: Capillaria hepatica](https://absa.org/infectious_agent/parasite-capillaria-hepatica/)
- [Parasite: Capillaria philippinensis](https://absa.org/infectious_agent/parasite-capillaria-philippinensis/)
- [Parasite: Capillaria spp](https://absa.org/infectious_agent/parasite-capillaria-spp/)
- [Parasite: Clonorchis sinensis](https://absa.org/infectious_agent/parasite-clonorchis-sinensis/)
- [Parasite: Clonorchis spp](https://absa.org/infectious_agent/parasite-clonorchis-spp/)
- [Parasite: Clonorchis viverrini](https://absa.org/infectious_agent/parasite-clonorchis-viverrini/)
- [Parasite: Coccidia spp](https://absa.org/infectious_agent/parasite-coccidia-spp/)
- [Parasite: Cochliomyia hominivorax](https://absa.org/infectious_agent/parasite-cochliomyia-hominivorax/)
- [Parasite: Contracaecum osculatum](https://absa.org/infectious_agent/parasite-contracaecum-osculatum/)
- [Parasite: Cryptosporidium parvum](https://absa.org/infectious_agent/parasite-cryptosporidium-parvum/)
- [Parasite: Cryptosporidium spp](https://absa.org/infectious_agent/parasite-cryptosporidium-spp/)
- [Parasite: Custocercis spp](https://absa.org/infectious_agent/parasite-custocercis-spp/)
- [Parasite: Cyclospora cayetanensis](https://absa.org/infectious_agent/parasite-cyclospora-cayetanensis/)
- [Parasite: Cyclospora spp](https://absa.org/infectious_agent/parasite-cyclospora-spp/)
- [Parasite: Balantidium spp](https://absa.org/infectious_agent/parasite-balantidium-spp/)
- [Parasite: Blastocystis hominis](https://absa.org/infectious_agent/parasite-blastocystis-hominis/)
- [Parasite: Brugia malayi](https://absa.org/infectious_agent/parasite-brugia-malayi/)
- [Parasite: Brugia pahangi](https://absa.org/infectious_agent/parasite-brugia-pahangi/)
- [Parasite: Brugia spp](https://absa.org/infectious_agent/parasite-brugia-spp/)
- [Parasite: Brugia timori](https://absa.org/infectious_agent/parasite-brugia-timori/)
- [Bacteria: Yersinia ruckeri](https://absa.org/infectious_agent/bacteria-yersinia-ruckeri/)
- [Bacteria: Yersinia spp.](https://absa.org/infectious_agent/bacteria-yersinia-spp/)
- [Parasite: Acanthamoeba castellanii](https://absa.org/infectious_agent/parasite-acanthamoeba-castellanii/)
- [Parasite: Acanthamoeba culbertsoni](https://absa.org/infectious_agent/parasite-acanthamoeba-culbertsoni/)
- [Parasite: Acanthamoeba spp](https://absa.org/infectious_agent/parasite-acanthamoeba-spp/)
- [Parasite: Ancylostoma braziliense](https://absa.org/infectious_agent/parasite-ancylostoma-braziliense/)
- [Parasite: Ancylostoma ceylanicum](https://absa.org/infectious_agent/parasite-ancylostoma-ceylanicum/)
- [Parasite: Ancylostoma duodenale](https://absa.org/infectious_agent/parasite-ancylostoma-duodenale/)
- [Parasite: Ancylostoma spp](https://absa.org/infectious_agent/parasite-ancylostoma-spp/)
- [Parasite: Angiostrongylus cantonensis](https://absa.org/infectious_agent/parasite-angiostrongylus-cantonensis/)
- [Parasite: Angiostrongylus costaricensis](https://absa.org/infectious_agent/parasite-angiostrongylus-costaricensis/)
- [Parasite: Angiostrongylus spp](https://absa.org/infectious_agent/parasite-angiostrongylus-spp/)
- [Parasite: Anisakis simplex](https://absa.org/infectious_agent/parasite-anisakis-simplex/)
- [Parasite: Ascaris lumbricoides](https://absa.org/infectious_agent/parasite-ascaris-lumbricoides/)
- [Parasite: Ascaris spp](https://absa.org/infectious_agent/parasite-ascaris-spp/)
- [Parasite: Ascaris suum](https://absa.org/infectious_agent/parasite-ascaris-suum/)
- [Parasite: Babesia divergens](https://absa.org/infectious_agent/parasite-babesia-divergens/)
- [Parasite: Babesia microti](https://absa.org/infectious_agent/parasite-babesia-microti/)
- [Parasite: Babesia spp](https://absa.org/infectious_agent/parasite-babesia-spp/)
- [Parasite: Balantidium coli](https://absa.org/infectious_agent/parasite-balantidium-coli/)
- [Bacteria: Yersinia intermedia](https://absa.org/infectious_agent/bacteria-yersinia-intermedia/)
- [Bacteria: Yersinia kristensenii](https://absa.org/infectious_agent/bacteria-yersinia-kristensenii/)
- [Bacteria: Yersinia pestis](https://absa.org/infectious_agent/bacteria-yersinia-pestis/)
- [Bacteria: Yersinia pseudotuberculosis](https://absa.org/infectious_agent/bacteria-yersinia-pseudotuberculosis/)
- [Bacteria: Yersinia pseudotuberculosis subsp. pestis](https://absa.org/infectious_agent/bacteria-yersinia-pseudotuberculosis-subsp-pestis/)
- [Bacteria: Yersinia rohdei](https://absa.org/infectious_agent/bacteria-yersinia-rohdei/)
- [Bacteria: Vibrio vulnificus](https://absa.org/infectious_agent/bacteria-vibrio-vulnificus/)
- [Bacteria: Virgibacillus  pantothenicus](https://absa.org/infectious_agent/bacteria-virgibacillus-pantothenicus/)
- [Bacteria: Waddlia chondrophila](https://absa.org/infectious_agent/bacteria-waddlia-chondrophila/)
- [Bacteria: Xanthomonas arboricola pv. corylina](https://absa.org/infectious_agent/bacteria-xanthomonas-arboricola-pv-corylina/)
- [Bacteria: Xanthomonas arboricola pv. pruni](https://absa.org/infectious_agent/bacteria-xanthomonas-arboricola-pv-pruni/)
- [Bacteria: Xanthomonas campestris pv. orizicola](https://absa.org/infectious_agent/bacteria-xanthomonas-campestris-pv-orizicola/)
- [Bacteria: Xanthomonas campestris pv. oryzae](https://absa.org/infectious_agent/bacteria-xanthomonas-campestris-pv-oryzae/)
- [Bacteria: Xanthomonas fragariae](https://absa.org/infectious_agent/bacteria-xanthomonas-fragariae/)
- [Bacteria: Xanthomonas translucens pv. translucens](https://absa.org/infectious_agent/bacteria-xanthomonas-translucens-pv-translucens/)
- [Bacteria: Xanthomonas vesicatoria pv. vesicatoria](https://absa.org/infectious_agent/bacteria-xanthomonas-vesicatoria-pv-vesicatoria/)
- [Bacteria: Xylella fastidiosa](https://absa.org/infectious_agent/bacteria-xylella-fastidiosa/)
- [Bacteria: Xylophilus ampelinus](https://absa.org/infectious_agent/bacteria-xylophilus-ampelinus/)
- [Bacteria: Yersinia enterocolitica](https://absa.org/infectious_agent/bacteria-yersinia-enterocolitica/)
- [Bacteria: Yersinia frederiksenii](https://absa.org/infectious_agent/bacteria-yersinia-frederiksenii/)
- [Bacteria: Veillonella parvula](https://absa.org/infectious_agent/bacteria-veillonella-parvula/)
- [Bacteria: Vibrio alginolyticus](https://absa.org/infectious_agent/bacteria-vibrio-alginolyticus/)
- [Bacteria: Vibrio carchariae](https://absa.org/infectious_agent/bacteria-vibrio-carchariae/)
- [Bacteria: Vibrio cholerae](https://absa.org/infectious_agent/bacteria-vibrio-cholerae/)
- [Bacteria: Vibrio cincinnatiensis](https://absa.org/infectious_agent/bacteria-vibrio-cincinnatiensis/)
- [Bacteria: Vibrio fluvialis](https://absa.org/infectious_agent/bacteria-vibrio-fluvialis/)
- [Bacteria: Vibrio furnissii](https://absa.org/infectious_agent/bacteria-vibrio-furnissii/)
- [Bacteria: Vibrio hollisae](https://absa.org/infectious_agent/bacteria-vibrio-hollisae/)
- [Bacteria: Vibrio ichthyoenteri](https://absa.org/infectious_agent/bacteria-vibrio-ichthyoenteri/)
- [Bacteria: Vibrio metschnikovii](https://absa.org/infectious_agent/bacteria-vibrio-metschnikovii/)
- [Bacteria: Vibrio mimicus](https://absa.org/infectious_agent/bacteria-vibrio-mimicus/)
- [Bacteria: Vibrio ordalii](https://absa.org/infectious_agent/bacteria-vibrio-ordalii/)
- [Bacteria: Vibrio parahaemolyticus](https://absa.org/infectious_agent/bacteria-vibrio-parahaemolyticus/)
- [Bacteria: Vibrio salmonicida](https://absa.org/infectious_agent/bacteria-vibrio-salmonicida/)
- [Bacteria: Vibrio spp.](https://absa.org/infectious_agent/bacteria-vibrio-spp/)
- [Bacteria: Vibrio trachuri](https://absa.org/infectious_agent/bacteria-vibrio-trachuri/)
- [Bacteria: Ureaplasma diversum](https://absa.org/infectious_agent/bacteria-ureaplasma-diversum/)
- [Bacteria: Ureaplasma gallorale](https://absa.org/infectious_agent/bacteria-ureaplasma-gallorale/)
- [Bacteria: Ureaplasma urealyticum](https://absa.org/infectious_agent/bacteria-ureaplasma-urealyticum/)
- [Bacteria: Vagococcus salmoninarum](https://absa.org/infectious_agent/bacteria-vagococcus-salmoninarum/)
- [Bacteria: Tatumella ptyseos](https://absa.org/infectious_agent/bacteria-tatumella-ptyseos/)
- [Bacteria: Taylorella equigenitalis](https://absa.org/infectious_agent/bacteria-taylorella-equigenitalis/)
- [Bacteria: Tissierella praeacuta](https://absa.org/infectious_agent/bacteria-tissierella-praeacuta/)
- [Bacteria: Treponema amylovorum](https://absa.org/infectious_agent/bacteria-treponema-amylovorum/)
- [Bacteria: Treponema carateum](https://absa.org/infectious_agent/bacteria-treponema-carateum/)
- [Bacteria: Treponema denticola](https://absa.org/infectious_agent/bacteria-treponema-denticola/)
- [Bacteria: Treponema lecithinolyticum](https://absa.org/infectious_agent/bacteria-treponema-lecithinolyticum/)
- [Bacteria: Treponema maltophilum](https://absa.org/infectious_agent/bacteria-treponema-maltophilum/)
- [Bacteria: Treponema medium](https://absa.org/infectious_agent/bacteria-treponema-medium/)
- [Bacteria: Treponema pallidum](https://absa.org/infectious_agent/bacteria-treponema-pallidum/)
- [Bacteria: Treponema paraluiscuniculi](https://absa.org/infectious_agent/bacteria-treponema-paraluiscuniculi/)
- [Bacteria: Treponema pectinovorum](https://absa.org/infectious_agent/bacteria-treponema-pectinovorum/)
- [Bacteria: Treponema pertenue](https://absa.org/infectious_agent/bacteria-treponema-pertenue/)
- [Bacteria: Treponema socranskii](https://absa.org/infectious_agent/bacteria-treponema-socranskii/)
- [Bacteria: Treponema spp.](https://absa.org/infectious_agent/bacteria-treponema-spp/)
- [Bacteria: Treponema vincentii](https://absa.org/infectious_agent/bacteria-treponema-vincentii/)
- [Bacteria: Tsukamurella inchonensis](https://absa.org/infectious_agent/bacteria-tsukamurella-inchonensis/)
- [Bacteria: Tsukamurella pulmonis](https://absa.org/infectious_agent/bacteria-tsukamurella-pulmonis/)
- [Bacteria: Tsukamurella tyrosinosolvens](https://absa.org/infectious_agent/bacteria-tsukamurella-tyrosinosolvens/)
- [Bacteria: Turicella otitidis](https://absa.org/infectious_agent/bacteria-turicella-otitidis/)
- [Bacteria: Streptococcus spp.](https://absa.org/infectious_agent/bacteria-streptococcus-spp/)
- [Bacteria: Streptococcus suis](https://absa.org/infectious_agent/bacteria-streptococcus-suis/)
- [Bacteria: Streptococcus uberis](https://absa.org/infectious_agent/bacteria-streptococcus-uberis/)
- [Bacteria: Streptomyces somaliensis](https://absa.org/infectious_agent/bacteria-streptomyces-somaliensis/)
- [Bacteria: Sutterella wadsworthensis](https://absa.org/infectious_agent/bacteria-sutterella-wadsworthensis/)
- [Bacteria: Suttonella indologenes](https://absa.org/infectious_agent/bacteria-suttonella-indologenes/)
- [Bacteria: Tatlockia maceachernii](https://absa.org/infectious_agent/bacteria-tatlockia-maceachernii/)
- [Bacteria: Tatlockia micdadei](https://absa.org/infectious_agent/bacteria-tatlockia-micdadei/)
- [Bacteria: Streptococcus mitis](https://absa.org/infectious_agent/bacteria-streptococcus-mitis/)
- [Bacteria: Streptococcus mutans](https://absa.org/infectious_agent/bacteria-streptococcus-mutans/)
- [Bacteria: Streptococcus oralis](https://absa.org/infectious_agent/bacteria-streptococcus-oralis/)
- [Bacteria: Streptococcus parasanguinis](https://absa.org/infectious_agent/bacteria-streptococcus-parasanguinis/)
- [Bacteria: Streptococcus phocae](https://absa.org/infectious_agent/bacteria-streptococcus-phocae/)
- [Bacteria: Streptococcus pneumoniae](https://absa.org/infectious_agent/bacteria-streptococcus-pneumoniae/)
- [Bacteria: Streptococcus porcinus](https://absa.org/infectious_agent/bacteria-streptococcus-porcinus/)
- [Bacteria: Streptococcus pyogenes](https://absa.org/infectious_agent/bacteria-streptococcus-pyogenes/)
- [Bacteria: Streptococcus salivarius](https://absa.org/infectious_agent/bacteria-streptococcus-salivarius/)
- [Bacteria: Streptococcus sanguinis](https://absa.org/infectious_agent/bacteria-streptococcus-sanguinis/)
- [Bacteria: Streptococcus sobrinus](https://absa.org/infectious_agent/bacteria-streptococcus-sobrinus/)
- [Bacteria: Streptococcus somaliensis](https://absa.org/infectious_agent/bacteria-streptococcus-somaliensis/)
- [Bacteria: Staphylococcus saprophyticus subsp. saprophyticus](https://absa.org/infectious_agent/bacteria-staphylococcus-saprophyticus-subsp-saprophyticus/)
- [Bacteria: Staphylococcus schleiferi](https://absa.org/infectious_agent/bacteria-staphylococcus-schleiferi/)
- [Bacteria: Stenotrophomonas africana](https://absa.org/infectious_agent/bacteria-stenotrophomonas-africana/)
- [Bacteria: Stenotrophomonas maltophilia](https://absa.org/infectious_agent/bacteria-stenotrophomonas-maltophilia/)
- [Bacteria: Streptobacillus moniliformis](https://absa.org/infectious_agent/bacteria-streptobacillus-moniliformis/)
- [Bacteria: Streptobacillus spp.](https://absa.org/infectious_agent/bacteria-streptobacillus-spp/)
- [Bacteria: Streptococcus acidominimus](https://absa.org/infectious_agent/bacteria-streptococcus-acidominimus/)
- [Bacteria: Streptococcus agalactiae](https://absa.org/infectious_agent/bacteria-streptococcus-agalactiae/)
- [Bacteria: Streptococcus anginosus](https://absa.org/infectious_agent/bacteria-streptococcus-anginosus/)
- [Bacteria: Streptococcus bovis](https://absa.org/infectious_agent/bacteria-streptococcus-bovis/)
- [Bacteria: Streptococcus canis](https://absa.org/infectious_agent/bacteria-streptococcus-canis/)
- [Bacteria: Streptococcus constellatus](https://absa.org/infectious_agent/bacteria-streptococcus-constellatus/)
- [Bacteria: Streptococcus difficilis](https://absa.org/infectious_agent/bacteria-streptococcus-difficilis/)
- [Bacteria: Streptococcus dysgalactiae](https://absa.org/infectious_agent/bacteria-streptococcus-dysgalactiae/)
- [Bacteria: Streptococcus equi subsp. equi](https://absa.org/infectious_agent/bacteria-streptococcus-equi-subsp-equi/)
- [Bacteria: Streptococcus equi subsp. zooepidemicus](https://absa.org/infectious_agent/bacteria-streptococcus-equi-subsp-zooepidemicus/)
- [Bacteria: Streptococcus equinus](https://absa.org/infectious_agent/bacteria-streptococcus-equinus/)
- [Bacteria: Streptococcus gallolyticus](https://absa.org/infectious_agent/bacteria-streptococcus-gallolyticus/)
- [Bacteria: Streptococcus iniae](https://absa.org/infectious_agent/bacteria-streptococcus-iniae/)
- [Bacteria: Streptococcus intermedius](https://absa.org/infectious_agent/bacteria-streptococcus-intermedius/)
- [Bacteria: Staphylococcus lugdunensis](https://absa.org/infectious_agent/bacteria-staphylococcus-lugdunensis/)
- [Bacteria: Staphylococcus lutrae](https://absa.org/infectious_agent/bacteria-staphylococcus-lutrae/)
- [Bacteria: Staphylococcus pasteuri](https://absa.org/infectious_agent/bacteria-staphylococcus-pasteuri/)
- [Bacteria: Staphylococcus saccharolyticus](https://absa.org/infectious_agent/bacteria-staphylococcus-saccharolyticus/)
- [Bacteria: Staphylococcus saprophyticus](https://absa.org/infectious_agent/bacteria-staphylococcus-saprophyticus/)
- [Bacteria: Staphylococcus saprophyticus subsp. bovis](https://absa.org/infectious_agent/bacteria-staphylococcus-saprophyticus-subsp-bovis/)
- [Bacteria: Sphingobacterium multivorum](https://absa.org/infectious_agent/bacteria-sphingobacterium-multivorum/)
- [Bacteria: Sphingobacterium spiritivorum](https://absa.org/infectious_agent/bacteria-sphingobacterium-spiritivorum/)
- [Bacteria: Sphingobacterium thalpophilum](https://absa.org/infectious_agent/bacteria-sphingobacterium-thalpophilum/)
- [Bacteria: Sphingomonas parapaucimobilis](https://absa.org/infectious_agent/bacteria-sphingomonas-parapaucimobilis/)
- [Bacteria: Sphingomonas paucimobilis](https://absa.org/infectious_agent/bacteria-sphingomonas-paucimobilis/)
- [Bacteria: Spiroplasma mirum](https://absa.org/infectious_agent/bacteria-spiroplasma-mirum/)
- [Bacteria: Sporichthya brevicatena](https://absa.org/infectious_agent/bacteria-sporichthya-brevicatena/)
- [Bacteria: Staphylococcus aureus](https://absa.org/infectious_agent/bacteria-staphylococcus-aureus/)
- [Bacteria: Staphylococcus caprae](https://absa.org/infectious_agent/bacteria-staphylococcus-caprae/)
- [Bacteria: Staphylococcus epidermidis](https://absa.org/infectious_agent/bacteria-staphylococcus-epidermidis/)
- [Bacteria: Staphylococcus felis](https://absa.org/infectious_agent/bacteria-staphylococcus-felis/)
- [Bacteria: Staphylococcus haemolyticus](https://absa.org/infectious_agent/bacteria-staphylococcus-haemolyticus/)
- [Bacteria: Staphylococcus hyicus](https://absa.org/infectious_agent/bacteria-staphylococcus-hyicus/)
- [Bacteria: Staphylococcus intermedius](https://absa.org/infectious_agent/bacteria-staphylococcus-intermedius/)
- [Bacteria: Selenomonas noxia](https://absa.org/infectious_agent/bacteria-selenomonas-noxia/)
- [Bacteria: Serpulina hyodysenteriae](https://absa.org/infectious_agent/bacteria-serpulina-hyodysenteriae/)
- [Bacteria: Serpulina intermedia](https://absa.org/infectious_agent/bacteria-serpulina-intermedia/)
- [Bacteria: Serpulina pilosicol](https://absa.org/infectious_agent/bacteria-serpulina-pilosicol/)
- [Bacteria: Serpulina spp.](https://absa.org/infectious_agent/bacteria-serpulina-spp/)
- [Bacteria: Serratia grimesii](https://absa.org/infectious_agent/bacteria-serratia-grimesii/)
- [Bacteria: Serratia liquefaciens](https://absa.org/infectious_agent/bacteria-serratia-liquefaciens/)
- [Bacteria: Serratia marcescens](https://absa.org/infectious_agent/bacteria-serratia-marcescens/)
- [Bacteria: Serratia proteamaculans](https://absa.org/infectious_agent/bacteria-serratia-proteamaculans/)
- [Bacteria: Serratia rubidaea](https://absa.org/infectious_agent/bacteria-serratia-rubidaea/)
- [Bacteria: Serratia spp.](https://absa.org/infectious_agent/bacteria-serratia-spp/)
- [Bacteria: Shewanella algae](https://absa.org/infectious_agent/bacteria-shewanella-algae/)
- [Bacteria: Shigella boydii](https://absa.org/infectious_agent/bacteria-shigella-boydii/)
- [Bacteria: Shigella dysenteriae](https://absa.org/infectious_agent/bacteria-shigella-dysenteriae/)
- [Bacteria: Shigella dysenteriae (Type 1)](https://absa.org/infectious_agent/bacteria-shigella-dysenteriae-type-1/)
- [Bacteria: Shigella flexneri](https://absa.org/infectious_agent/bacteria-shigella-flexneri/)
- [Bacteria: Shigella sonnei](https://absa.org/infectious_agent/bacteria-shigella-sonnei/)
- [Bacteria: Shigella spp.](https://absa.org/infectious_agent/bacteria-shigella-spp/)
- [Bacteria: Sphaerophorus necrophorus](https://absa.org/infectious_agent/bacteria-sphaerophorus-necrophorus/)
- [Bacteria: Selenomonas flueggei](https://absa.org/infectious_agent/bacteria-selenomonas-flueggei/)
- [Bacteria: Selenomonas infelix](https://absa.org/infectious_agent/bacteria-selenomonas-infelix/)
- [Bacteria: Salmonella choleraesuis](https://absa.org/infectious_agent/bacteria-salmonella-choleraesuis-2/)
- [Bacteria: Salmonella dublin](https://absa.org/infectious_agent/bacteria-salmonella-dublin/)
- [Bacteria: Salmonella enteritidis](https://absa.org/infectious_agent/bacteria-salmonella-enteritidis/)
- [Bacteria: Salmonella gallinarum](https://absa.org/infectious_agent/bacteria-salmonella-gallinarum/)
- [Bacteria: Salmonella gallinarum-pullorum](https://absa.org/infectious_agent/bacteria-salmonella-gallinarum-pullorum/)
- [Bacteria: Salmonella (other serovars)](https://absa.org/infectious_agent/bacteria-salmonella-other-serovars/)
- [Bacteria: Salmonella meleagridis](https://absa.org/infectious_agent/bacteria-salmonella-meleagridis/)
- [Bacteria: Salmonella paratyphi, A, B, C, S](https://absa.org/infectious_agent/bacteria-salmonella-paratyphi-a-b-c-s/)
- [Bacteria: Salmonella pullorum](https://absa.org/infectious_agent/bacteria-salmonella-pullorum/)
- [Bacteria: Salmonella  spp.](https://absa.org/infectious_agent/bacteria-salmonella-spp/)
- [Bacteria: Salmonella typhi](https://absa.org/infectious_agent/bacteria-salmonella-typhi/)
- [Bacteria: Salmonella typhimurium](https://absa.org/infectious_agent/bacteria-salmonella-typhimurium/)
- [Bacteria: Salmonella enterica](https://absa.org/infectious_agent/bacteria-salmonella-enterica/)
- [Bacteria: Sanguibacter inulinus](https://absa.org/infectious_agent/bacteria-sanguibacter-inulinus/)
- [Bacteria: Sanguibacter keddieii](https://absa.org/infectious_agent/bacteria-sanguibacter-keddieii/)
- [Bacteria: Sanguibacter suarezii](https://absa.org/infectious_agent/bacteria-sanguibacter-suarezii/)
- [Bacteria: Schistosoma spp.](https://absa.org/infectious_agent/bacteria-schistosoma-spp/)
- [Bacteria: Selenomonas artemidis](https://absa.org/infectious_agent/bacteria-selenomonas-artemidis/)
- [Bacteria: Selenomonas dianae](https://absa.org/infectious_agent/bacteria-selenomonas-dianae/)
- [Bacteria: Rickettsia sennetsu](https://absa.org/infectious_agent/bacteria-rickettsia-sennetsu/)
- [Bacteria: Rickettsia siberica](https://absa.org/infectious_agent/bacteria-rickettsia-siberica/)
- [Bacteria: Rickettsia spp.](https://absa.org/infectious_agent/bacteria-rickettsia-spp/)
- [Bacteria: Rickettsia tsutsugamushi](https://absa.org/infectious_agent/bacteria-rickettsia-tsutsugamushi/)
- [Bacteria: Rickettsia typhi (mooseri)](https://absa.org/infectious_agent/bacteria-rickettsia-typhi-mooseri/)
- [Bacteria: Riemerella anatipestifer](https://absa.org/infectious_agent/bacteria-riemerella-anatipestifer/)
- [Bacteria: Riemerella columbina](https://absa.org/infectious_agent/bacteria-riemerella-columbina/)
- [Bacteria: Rochalimaea spp](https://absa.org/infectious_agent/bacteria-rochalimaea-spp/)
- [Bacteria: Saccharopolyspora rectivirgula](https://absa.org/infectious_agent/bacteria-saccharopolyspora-rectivirgula/)
- [Bacteria: Salmonella abortusequi](https://absa.org/infectious_agent/bacteria-salmonella-abortusequi/)
- [Bacteria: Salmonella abortusovis](https://absa.org/infectious_agent/bacteria-salmonella-abortusovis/)
- [Bacteria: Salmonella arizonae](https://absa.org/infectious_agent/bacteria-salmonella-arizonae/)
- [Bacteria: Rickettsia massiliae](https://absa.org/infectious_agent/bacteria-rickettsia-massiliae/)
- [Bacteria: Rickettsia montanensis](https://absa.org/infectious_agent/bacteria-rickettsia-montanensis/)
- [Bacteria: Rickettsia mooseri](https://absa.org/infectious_agent/bacteria-rickettsia-mooseri/)
- [Bacteria: Rickettsia parkeri](https://absa.org/infectious_agent/bacteria-rickettsia-parkeri/)
- [Bacteria: Rickettsia prowazekii](https://absa.org/infectious_agent/bacteria-rickettsia-prowazekii/)
- [Bacteria: Rickettsia rhipicephali](https://absa.org/infectious_agent/bacteria-rickettsia-rhipicephali/)
- [Bacteria: Rickettsia rickettsii](https://absa.org/infectious_agent/bacteria-rickettsia-rickettsii/)
- [Bacteria: Pseudomonas syringae pv. persicae](https://absa.org/infectious_agent/bacteria-pseudomonas-syringae-pv-persicae/)
- [Bacteria: Pseudomonas syringae pv. pisi](https://absa.org/infectious_agent/bacteria-pseudomonas-syringae-pv-pisi/)
- [Bacteria: Pseudoramibacter alactolyticus](https://absa.org/infectious_agent/bacteria-pseudoramibacter-alactolyticus/)
- [Bacteria: Psychrobacter phenylpyruvicus](https://absa.org/infectious_agent/bacteria-psychrobacter-phenylpyruvicus/)
- [Bacteria: Ralstonia picketti](https://absa.org/infectious_agent/bacteria-ralstonia-picketti/)
- [Bacteria: Ralstonia solanacearum](https://absa.org/infectious_agent/bacteria-ralstonia-solanacearum/)
- [Bacteria: Renibacterium salmoninarum](https://absa.org/infectious_agent/bacteria-renibacterium-salmoninarum/)
- [Bacteria: Rathayibacter toxicus](https://absa.org/infectious_agent/bacteria-rathayibacter-toxicus/)
- [Bacteria: Rhodococcus chubuensis](https://absa.org/infectious_agent/bacteria-rhodococcus-chubuensis/)
- [Bacteria: Rhodococcus equi](https://absa.org/infectious_agent/bacteria-rhodococcus-equi/)
- [Bacteria: Rickettsia aeschlimannii](https://absa.org/infectious_agent/bacteria-rickettsia-aeschlimannii/)
- [Bacteria: Rickettsia africae](https://absa.org/infectious_agent/bacteria-rickettsia-africae/)
- [Bacteria: Rickettsia akari](https://absa.org/infectious_agent/bacteria-rickettsia-akari/)
- [Bacteria: Rickettsia australis](https://absa.org/infectious_agent/bacteria-rickettsia-australis/)
- [Bacteria: Rickettsia belii](https://absa.org/infectious_agent/bacteria-rickettsia-belii/)
- [Bacteria: Rickettsia canadensis](https://absa.org/infectious_agent/bacteria-rickettsia-canadensis/)
- [Bacteria: Rickettsia conorii](https://absa.org/infectious_agent/bacteria-rickettsia-conorii/)
- [Bacteria: Rickettsia helvetica](https://absa.org/infectious_agent/bacteria-rickettsia-helvetica/)
- [Bacteria: Rickettsia honei](https://absa.org/infectious_agent/bacteria-rickettsia-honei/)
- [Bacteria: Rickettsia japonica](https://absa.org/infectious_agent/bacteria-rickettsia-japonica/)
- [Bacteria: Pseudoalteromonas piscicida](https://absa.org/infectious_agent/bacteria-pseudoalteromonas-piscicida/)
- [Bacteria: Pseudomonas aeruginosa](https://absa.org/infectious_agent/bacteria-pseudomonas-aeruginosa/)
- [Bacteria: Pseudomonas alcaligenes](https://absa.org/infectious_agent/bacteria-pseudomonas-alcaligenes/)
- [Bacteria: Pseudomonas anguilliseptica](https://absa.org/infectious_agent/bacteria-pseudomonas-anguilliseptica/)
- [Bacteria: Pseudomonas cepacia](https://absa.org/infectious_agent/bacteria-pseudomonas-cepacia/)
- [Bacteria: Pseudomonas luteola](https://absa.org/infectious_agent/bacteria-pseudomonas-luteola/)
- [Bacteria: Pseudomonas mendocina](https://absa.org/infectious_agent/bacteria-pseudomonas-mendocina/)
- [Bacteria: Pseudomonas oryzihabitans](https://absa.org/infectious_agent/bacteria-pseudomonas-oryzihabitans/)
- [Bacteria: Pseudomonas spp.](https://absa.org/infectious_agent/bacteria-pseudomonas-spp/)
- [Bacteria: Proteus mirabilis](https://absa.org/infectious_agent/bacteria-proteus-mirabilis/)
- [Bacteria: Proteus morganii](https://absa.org/infectious_agent/bacteria-proteus-morganii/)
- [Bacteria: Proteus penneri](https://absa.org/infectious_agent/bacteria-proteus-penneri/)
- [Bacteria: Proteus rettgeri](https://absa.org/infectious_agent/bacteria-proteus-rettgeri/)
- [Bacteria: Proteus spp.](https://absa.org/infectious_agent/bacteria-proteus-spp/)
- [Bacteria: Proteus vulgaris](https://absa.org/infectious_agent/bacteria-proteus-vulgaris/)
- [Bacteria: Providencia alcalifaciens](https://absa.org/infectious_agent/bacteria-providencia-alcalifaciens/)
- [Bacteria: Providencia rettgeri](https://absa.org/infectious_agent/bacteria-providencia-rettgeri/)
- [Bacteria: Providencia rustigianii](https://absa.org/infectious_agent/bacteria-providencia-rustigianii/)
- [Bacteria: Providencia spp.](https://absa.org/infectious_agent/bacteria-providencia-spp/)
- [Bacteria: Providencia stuartii](https://absa.org/infectious_agent/bacteria-providencia-stuartii/)
- [Bacteria: Prevotella buccalis](https://absa.org/infectious_agent/bacteria-prevotella-buccalis/)
- [Bacteria: Prevotella corporis](https://absa.org/infectious_agent/bacteria-prevotella-corporis/)
- [Bacteria: Prevotella denticola](https://absa.org/infectious_agent/bacteria-prevotella-denticola/)
- [Bacteria: Prevotella disiens](https://absa.org/infectious_agent/bacteria-prevotella-disiens/)
- [Bacteria: Prevotella intermedia](https://absa.org/infectious_agent/bacteria-prevotella-intermedia/)
- [Bacteria: Prevotella loescheii](https://absa.org/infectious_agent/bacteria-prevotella-loescheii/)
- [Bacteria: Prevotella melaninogenica](https://absa.org/infectious_agent/bacteria-prevotella-melaninogenica/)
- [Bacteria: Prevotella nigrescens](https://absa.org/infectious_agent/bacteria-prevotella-nigrescens/)
- [Bacteria: Prevotella oralis](https://absa.org/infectious_agent/bacteria-prevotella-oralis/)
- [Bacteria: Prevotella oris](https://absa.org/infectious_agent/bacteria-prevotella-oris/)
- [Bacteria: Prevotella ruminicola](https://absa.org/infectious_agent/bacteria-prevotella-ruminicola/)
- [Bacteria: Prevotella spp.](https://absa.org/infectious_agent/bacteria-prevotella-spp/)
- [Bacteria: Prevotella tannerae](https://absa.org/infectious_agent/bacteria-prevotella-tannerae/)
- [Bacteria: Propionibacterium acnes](https://absa.org/infectious_agent/bacteria-propionibacterium-acnes/)
- [Bacteria: Propionibacterium avidum](https://absa.org/infectious_agent/bacteria-propionibacterium-avidum/)
- [Bacteria: Propionibacterium granulosum](https://absa.org/infectious_agent/bacteria-propionibacterium-granulosum/)
- [Bacteria: Propionibacterium lymphophilum](https://absa.org/infectious_agent/bacteria-propionibacterium-lymphophilum/)
- [Bacteria: Propionibacterium propionicum](https://absa.org/infectious_agent/bacteria-propionibacterium-propionicum/)
- [Bacteria: Proteus hausen](https://absa.org/infectious_agent/bacteria-proteus-hausen/)
- [Bacteria: Proteus inconstans](https://absa.org/infectious_agent/bacteria-proteus-inconstans/)
- [Bacteria: Porphyromonas levii](https://absa.org/infectious_agent/bacteria-porphyromonas-levii/)
- [Bacteria: Porphyromonas macacae](https://absa.org/infectious_agent/bacteria-porphyromonas-macacae/)
- [Bacteria: Porphyromonas spp.](https://absa.org/infectious_agent/bacteria-porphyromonas-spp/)
- [Bacteria: Prevotella albensis](https://absa.org/infectious_agent/bacteria-prevotella-albensis/)
- [Bacteria: Prevotella bivia](https://absa.org/infectious_agent/bacteria-prevotella-bivia/)
- [Bacteria: Prevotella brevis](https://absa.org/infectious_agent/bacteria-prevotella-brevis/)

## IconLinks

- [Membership](https://absa.org/iconlink/membership/)

## Venues

- [Tremont House](https://absa.org/venue/tremont-house/)
- [Arthur R. Outlaw Mobile Convention Center](https://absa.org/venue/arthur-r-outlaw-mobile-convention-center/)
- [University of Pennsylvania, Facilities & Real Estate Services (FRES), Conference Room #01](https://absa.org/venue/university-of-pennsylvania-facilities-real-estate-services-fres/)
- [Embassy Suites by Hilton Charlotte Uptown](https://absa.org/venue/embassy-suites-by-hilton-charlotte-uptown/)
- [Azusa Pacific University](https://absa.org/venue/)
- [Almaty, Kazakhstan](https://absa.org/venue/almaty-kazakhstan/)
- [Fiesta Inn Ciudad de México Aeropuerto](https://absa.org/venue/fiesta-inn-ciudad-de-mexico-aeropuerto/)
- [Westin Seattle](https://absa.org/venue/westin-seattle/)
- [Courtyard Toronto Downtown](https://absa.org/venue/courtyard-toronto-downtown/)
- [Fiesta Inn Aeropuerto Hotel](https://absa.org/venue/fiesta-inn-aeropuerto-hotel/)
- [ALOFT Boston Seaport District](https://absa.org/venue/)
- [Hyatt Place Perimeter](https://absa.org/venue/hyatt-place-perimeter/)
- [University of California, Irvine](https://absa.org/venue/)
- [University of California,Irvine](https://absa.org/venue/)
- [North Carolina State Laboratory of Public Health](https://absa.org/venue/)
- [Waterview in Bicentennial Park](https://absa.org/venue/waterview-in-bicentennial-park/)
- [mecc, Maastricht, The Netherlands](https://absa.org/venue/)
- [Broad Institute](https://absa.org/venue/)
- [Westin San Diego Bayview](https://absa.org/venue/)
- [Embassy Suites Omaha Downtown Old Market](https://absa.org/venue/embassy-suites-omaha-downtown-old-market/)
- [Pfizer](https://absa.org/venue/pfizer/)
- [Hotel Murano](https://absa.org/venue/hotel-murano/)
- [Auburn University](https://absa.org/venue/)
- [UT El Paso](https://absa.org/venue/)
- [Hilton Baltimore Inner Harbor](https://absa.org/venue/hilton-baltimore-inner-harbor/)
- [Embassy Suites–Denver Downton Convention Center](https://absa.org/venue/embassy-suites-denver-downton-convention-center/)
- [World Nature Forum](https://absa.org/venue/)
- [Dutch's Daughter or Virtual Option](https://absa.org/venue/)
- [Victoria Gastro Pub](https://absa.org/venue/victoria-gastro-pub/)
- [Handlery Hotel San Diego](https://absa.org/venue/handlery-hotel-san-diego/)
- [Universities at Shady Grove](https://absa.org/venue/universities-at-shady-grove/)
- [Rydges Lakeland Resort Queenstown](https://absa.org/venue/rydges-lakeland-resort-queenstown/)
- [Delta Hotels by Marriott Montreal](https://absa.org/venue/delta-hotels-by-marriott-montreal/)
- [CHI Health Center](https://absa.org/venue/chi-health-center/)
- [University of Basel - Kollegienhaus](https://absa.org/venue/university-of-basel-kollegienhaus/)
- [Arizona State Public Health Laboratory](https://absa.org/venue/arizona-state-public-health-laboratory/)
- [Astra Zeneca, 1 Medimmune Way, Gaithersburg, MD](https://absa.org/venue/astra-zeneca-1-medimmune-way-gaithersburg-md/)
- [Online](https://absa.org/venue/online/)
- [University of Pennsylvania](https://absa.org/venue/university-of-pennsylvania/)
- [Baltimore Marriott Waterfront](https://absa.org/venue/baltimore-marriott-waterfront/)
- [Embassy Suites–Alexandria Old Town](https://absa.org/venue/embassy-suites-alexandria-old-town/)
- [The Center for Discovery and Innovation](https://absa.org/venue/the-center-for-discovery-and-innovation/)
- [Zoom](https://absa.org/venue/zoom/)
- [Wisconin Center](https://absa.org/venue/wisconin-center/)
- [Christoph Willibald Gluck Hall](https://absa.org/venue/christoph-willibald-gluck-hall/)
- [Raleigh Convention Center](https://absa.org/venue/raleigh-convention-center/)
- [Virtual](https://absa.org/venue/virtual/)
- [Renaissance Baltimore Harborplace Hotel](https://absa.org/venue/renaissance-baltimore-harborplace-hotel/)
- [JW Marriott Phoenix Desert Ridge Resort & Spa](https://absa.org/venue/jw-marriott-phoenix-desert-ridge-resort-spa/)
- [north carolina public health lab](https://absa.org/venue/north-carolina-public-health-lab/)
- [University of Zurich](https://absa.org/venue/university-of-zurich/)
- [Westin Perimeter North Hotel](https://absa.org/venue/westin-perimeter-north-hotel/)
- [UT Southwestern, Dallas](https://absa.org/venue/ut-southwestern-dallas/)
- [Hyatt Regency Crystal City at Reagan National Airport](https://absa.org/venue/hyatt-regency-crystal-city-at-reagan-national-airport/)
- [Genesis Kitchen](https://absa.org/venue/genesis-kitchen/)
- [Hood College](https://absa.org/venue/hood-college/)
- [University of Southern California](https://absa.org/venue/university-of-southern-california/)
- [Dhaka, Bangladesh](https://absa.org/venue/dhaka-bangladesh/)
- [Universidad de Guanajuato](https://absa.org/venue/universidad-de-guanajuato/)
- [Clarion Inn and Frederick Event Center](https://absa.org/venue/clarion-inn-and-frederick-event-center/)
- [Baylor Univeristy, Waco, TX](https://absa.org/venue/baylor-univeristy-waco-tx/)
- [UCSF](https://absa.org/venue/ucsf/)
- [Double Tree By Hilton Chicago](https://absa.org/venue/double-tree-by-hilton-chicago/)
- [Clemson University](https://absa.org/venue/clemson-university/)
- [Tula Community Center](https://absa.org/venue/tula-community-center/)
- [Luxembourg](https://absa.org/venue/luxembourg/)
- [Minneapolis Convention Center](https://absa.org/venue/minneapolis-convention-center/)
- [VIENNA](https://absa.org/venue/vienna/)
- [Renaissance The Depot Hotel Minneapolis](https://absa.org/venue/renaissance-the-depot-hotel-minneapolis/)
- [La Jolla Institute](https://absa.org/venue/la-jolla-institute/)
- [Hyatt Regency Bethesda](https://absa.org/venue/hyatt-regency-bethesda/)
- [Rome, Italy](https://absa.org/venue/rome-italy/)
- [BioScience Research Collaborative (Rice University)](https://absa.org/venue/bioscience-research-collaborative-rice-university/)
- [UCI National BSL-3 Training Program](https://absa.org/venue/uci-national-bsl-3-training-program-2/)
- [Birmingham-Jefferson Convention Complex (BJCC)](https://absa.org/venue/birmingham-jefferson-convention-complex-bjcc/)
- [Johns Hopkins Mt. Washington Conference Center, Baltimore MD](https://absa.org/venue/johns-hopkins-mt-washington-conference-center-baltimore-md/)
- [Memphis Convention Center](https://absa.org/venue/memphis-convention-center/)
- [UMass Medical School](https://absa.org/venue/umass-medical-school/)
- [Renaissance Polat Istanbul Hotel  Yeşilyurt Mahallesi, Sahil Yolu Cd. No: 2, Istanbul, Turkey](https://absa.org/venue/renaissance-polat-istanbul-hotel-yesilyurt-mahallesi-sahil-yolu-cd-no-2-istanbul-turkey/)
- [Delta Hotels by Marriott Winnipeg](https://absa.org/venue/delta-hotels-by-marriott-winnipeg/)
- [Embassy Suites by Hilton San Diego Bay Downtown](https://absa.org/venue/embassy-suites-by-hilton-san-diego-bay-downtown/)
- [Celgene San Diego Campus](https://absa.org/venue/celgene-san-diego-campus/)
- [Hilton Baltimore](https://absa.org/venue/hilton-baltimore/)
- [Kent State University, Kent, Ohio](https://absa.org/venue/kent-state-university-kent-ohio/)
- [Frick Chemistry Laboratory, Princeton University](https://absa.org/venue/frick-chemistry-laboratory-princeton-university/)
- [Te Papa](https://absa.org/venue/te-papa/)
- [Holiday Inn Gaithersburg MD; 2 Mongomery Village Ave.](https://absa.org/venue/holiday-inn-gaithersburg-md-2-mongomery-village-ave/)
- [University of Tennessee, Knoxville](https://absa.org/venue/university-of-tennessee-knoxville/)
- [Joseph B. Martin Conference Center](https://absa.org/venue/joseph-b-martin-conference-center/)
- [Texas A&M University Institute for Preclinical Studies](https://absa.org/venue/texas-am-university-institute-for-preclinical-studies/)
- [Holiday Inn Gaithersburg MD](https://absa.org/venue/holiday-inn-gaithersburg-md/)
- [Johns Hopkins University Mt Washington Conference Center](https://absa.org/venue/johns-hopkins-university-mt-washington-conference-center/)
- [Charleston Convention Center](https://absa.org/venue/charleston-convention-center/)
- [Embassy Suites by Hilton Portland Downtown](https://absa.org/venue/embassy-suites-by-hilton-portland-downtown/)
- [Crowne Plaza Atlanta Perimeter at Ravinia](https://absa.org/venue/crowne-plaza-atlanta-perimeter-at-ravinia/)
- [Hard Times Cafe](https://absa.org/venue/hard-times-cafe/)
- [Fiesta Americana Hotel](https://absa.org/venue/fiesta-americana-hotel/)
- [Snuffy’s Pantagis Renaissance](https://absa.org/venue/snuffys-pantagis-renaissance/)
- [Kula Lampur Malaysia](https://absa.org/venue/kula-lampur-malaysia/)
- [11960 Bayan Lepas, Penang.](https://absa.org/venue/11960-bayan-lepas-penang/)
- [Embassy Suites by Hilton](https://absa.org/venue/embassy-suites-by-hilton/)
- [University of Colorado Boulder](https://absa.org/venue/university-of-colorado-boulder/)
- [Seaworld Resort & Conference Center](https://absa.org/venue/seaworld-resort-conference-center/)
- [Embassy Suites Tampa Convention Center](https://absa.org/venue/embassy-suites-tampa-convention-center/)
- [Hologic, Inc.](https://absa.org/venue/hologic-inc/)
- [UCI National BSL-3 Training Program](https://absa.org/venue/uci-national-bsl-3-training-program/)
- [National Institutes of Health, Conference Room 508/509](https://absa.org/venue/national-institutes-of-health-conference-room-508509/)
- [Tulane University](https://absa.org/venue/tulane-university/)
- [Natcher Conference Center](https://absa.org/venue/natcher-conference-center/)
- [The University of Iowa](https://absa.org/venue/the-university-of-iowa/)
- [Casa Monica Resort](https://absa.org/venue/casa-monica-resort/)
- [Morelia, Michoacán, Mexico](https://absa.org/venue/morelia-michoacan-mexico/)
- [Clarion Inn](https://absa.org/venue/clarion-inn/)
- [Mt. Washington Conference Center](https://absa.org/venue/mt-washington-conference-center/)
- [Yale West Campus Conference Center](https://absa.org/venue/yale-west-campus-conference-center/)
- [Hilton Fort Collins](https://absa.org/venue/hilton-fort-collins/)
- [Albuquerque Convention Center](https://absa.org/venue/albuquerque-convention-center/)
- [Webinar](https://absa.org/venue/webinar/)
- [Baltimore Convention Center](https://absa.org/venue/baltimore-convention-center/)
- [UC Irvine BSL-3 Training Center](https://absa.org/venue/uc-irvine-bsl-3-training-center/)
- [Embassy Suites—Pittsburgh Downtown](https://absa.org/venue/embassy-suites-pittsburgh-downtown/)
- [Embassy Suites San Antonio Riverwalk – Downtown](https://absa.org/venue/embassy-suites-san-antonio-riverwalk-downtown/)

## Organizers

- [ISTC](https://absa.org/organizer/istc/)
- [Deutsche Gesellschaft für Internationale (giz)](https://absa.org/organizer/deutsche-gesellschaft-fur-internationale-giz/)
- [BACAC](https://absa.org/organizer/bacac/)
- [CSHEMA](https://absa.org/organizer/cshema/)
- [Texas A&M](https://absa.org/organizer/texas-aampm/)
- [Arizona Biosafety Alliance (AZBA)](https://absa.org/organizer/arizona-biosafety-alliance-azba/)
- [Tulane University Biocontainment Institute](https://absa.org/organizer/)
- [Kerri Kwist](https://absa.org/organizer/)
- [Hanson Wade](https://absa.org/organizer/)
- [AMG World](https://absa.org/organizer/amg-world/)
- [Biosafety and Biosecurity Training Course (BBTC®)](https://absa.org/organizer/biosafety-and-biosecurity-training-course/)
- [Southwest Center for Occupational and Environmental Health](https://absa.org/organizer/southwest-center-for-occupational-and-environmental-health/)
- [Cambridge Healthtech Institute (CHI)](https://absa.org/organizer/cambridge-healthtech-institute-chi/)
- [BioRisk Reduction](https://absa.org/organizer/biorisk-reduction/)
- [Swiss Biosafety Network SBNet](https://absa.org/organizer/swiss-biosafety-network-sbnet-2/)
- [BioRAFT](https://absa.org/organizer/bioraft/)
- [CRDF Global](https://absa.org/organizer/crdf-global/)
- [German LabConCert](https://absa.org/organizer/german-labconcert/)
- [2598](https://absa.org/organizer/2598-3/)
- [2598](https://absa.org/organizer/2598-2/)
- [2598](https://absa.org/organizer/2598/)
- [153437](https://absa.org/organizer/153437/)
- [3246](https://absa.org/organizer/3246/)
- [The Alliance of Hazardous Materials Professionals (AHMP) Cyber Chapter](https://absa.org/organizer/the-alliance-of-hazardous-materials-professionals-ahmp-cyber-chapter/)
- [American Society of Safety Professionals (ASSP) -NOVA Chapter](https://absa.org/organizer/american-society-of-safety-professionals-assp-nova-chapter/)
- [Washington Metropolitan Area Construction Safety Association (WMACSA)](https://absa.org/organizer/washington-metropolitan-area-construction-safety-association-wmacsa/)
- [Front Range Biosafety Association (FRaBSA)](https://absa.org/organizer/front-range-biosafety-association-frabsa/)
- [CaBSA](https://absa.org/organizer/cabsa/)
- [National Training Center for Biosafety and Biosecurity (NTCBB)](https://absa.org/organizer/national-training-center-for-biosafety-and-biosecurity-ntcbb/)
- [Swiss Biosafety Network (SBNet)](https://absa.org/organizer/swiss-biosafety-network-sbnet/)
- [Global Biorisk Advisory Council (GBAC)](https://absa.org/organizer/global-biorisk-advisory-council-gbac/)
- [American Society for Microbiology](https://absa.org/organizer/american-society-for-microbiology/)
- [Asia-Pacific Biosafety Association](https://absa.org/organizer/asia-pacific-biosafety-association/)
- [Norcal Biosafety Association](https://absa.org/organizer/norcal-biosafety-association/)
- [EuroSciCon](https://absa.org/organizer/euroscicon-2/)
- [EBSA](https://absa.org/organizer/ebsa/)
- [AIHA](https://absa.org/organizer/aiha/)
- [Euroscicon](https://absa.org/organizer/euroscicon/)
- [Madridge Conferences](https://absa.org/organizer/madridge-conferences/)
- [BSI EHS Services and Solutions](https://absa.org/organizer/bsi-ehs-services-and-solutions/)
- [ME Conferences](https://absa.org/organizer/me-conferences/)
- [CABS-ACSB](https://absa.org/organizer/cabs-acsb/)
- [National Biosafety and Biocontainment Training Program](https://absa.org/organizer/national-biosafety-and-biocontainment-training-program/)
- [OSHA](https://absa.org/organizer/osha/)
- [Southeastern Biological Safety Association (SEBSA)](https://absa.org/organizer/southeastern-biological-safety-association-sebsa/)
- [Association of Public Health Laboratories (APHL)](https://absa.org/organizer/association-of-public-health-laboratories-aphl/)
- [New England Biosafety Association](https://absa.org/organizer/new-england-biosafety-association/)
- [USDA Agricultural Research Service](https://absa.org/organizer/usda-agricultural-research-service/)
- [Centers for Disease Control and Prevention (CDC)](https://absa.org/organizer/centers-for-disease-control-and-prevention-cdc/)
- [Dr. Richard Gilpin](https://absa.org/organizer/dr-richard-gilpin/)
- [Atrium EHS](https://absa.org/organizer/atrium-ehs/)
- [The New Jersey American Industrial Hygiene Association (NJAIHA)](https://absa.org/organizer/the-new-jersey-american-industrial-hygiene-association-njaiha/)
- [TSY Consultancy](https://absa.org/organizer/tsy-consultancy/)
- [American Bio Recovery Association (ABRA)](https://absa.org/organizer/american-bio-recovery-association-abra/)
- [ABSANZ](https://absa.org/organizer/absanz/)
- [Biological Safety Information Network (BioNet)](https://absa.org/organizer/biological-safety-information-network-bionet/)
- [National Institutes of Health](https://absa.org/organizer/national-institutes-of-health/)
- [Southern Biosafety Association (SBA)](https://absa.org/organizer/southern-biosafety-association-sba/)
- [NIH Division of Occupational Health and Safety](https://absa.org/organizer/nih-division-of-occupational-health-and-safety/)
- [MABioN](https://absa.org/organizer/mabion/)
- [Elizabeth R. Griffin Research Foundation](https://absa.org/organizer/elizabeth-r-griffin-research-foundation/)
- [American Association of Laboratory Animal Science (AALAS)](https://absa.org/organizer/american-association-of-laboratory-animal-science-aalas/)
- [American College of Occupational and Environmental Medicine (ACOEM)](https://absa.org/organizer/american-college-of-occupational-and-environmental-medicine-acoem/)
- [Eagleson Institute](https://absa.org/organizer/eagleson-institute/)
- [Mid-Atlantic Biological Safety Association (MABSA)](https://absa.org/organizer/id-atlantic-biological-safety-association-mabsa/)
- [Asociación Mexicana de Bioseguridad, A.C. (AMEXBIO)](https://absa.org/organizer/asociacion-mexicana-de-bioseguridad-a-c-amexbio/)
- [Chesapeake Area Biological Safety Association (ChABSA)](https://absa.org/organizer/chesapeake-area-biological-safety-association-chabsa/)
- [Johns Hopkins University](https://absa.org/organizer/johns-hopkins-university/)
- [Harvard Medical School](https://absa.org/organizer/harvard-medical-school/)
- [Yale University](https://absa.org/organizer/yale-university/)
- [United States Department of Agriculture, Agricultural Research Service](https://absa.org/organizer/united-states-department-of-agriculture-agricultural-research-service/)
- [UC Irvine](https://absa.org/organizer/uc-irvine/)
- [ABSA International](https://absa.org/organizer/absa-international/)

## Events

- [08. Conspiracy Theories, Mis- and Disinformation](https://absa.org/event/08-conspiracy-theories-mis-and-disinformation/) - Conspiracy Theories, Mis- and Disinformation is a course to help anyone who communicates about biosafety and biosecurity to understand the context of mis- and disinformation around laboratories and how to better respond in the moment. The course includes introductions to concepts, terminology, and the history of conspiracy theory and misleading information. Participants will learn strategies to identify, understand, and respond to conspiracy theories and mis- and disinformation. The course will include practical exercises and break out groups to develop skills in identification of and response to false information around laboratories.
- [01. Intro to Flow Cytometry Biosafety](https://absa.org/event/01-intro-to-flow-cytometry-biosafety/) - Intro to Flow Cytometry Biosafety will provide safety professionals and anyone working in a laboratory setting a foundation on flow cytometry and cell sorting and strategies for mitigating the risks associated with typical flow cytometry instrumentation and procedures. This course will include a detailed overview of how flow cytometers work, common sample types that are handled in flow cytometry laboratories, a typical flow cytometry workflow, and considerations for core facilities/shared resource laboratories. The risks associated with flow cytometry and cell sorting will be discussed as well as mitigation strategies that can be implemented to reduce these risks. The course will be presented by experts from the International Society for Advancement of Cytometry (ISAC) Biosafety Committee and will include an overview of the ISAC Biosafety Standards. This course will include lecture material, breakout sessions where attendees will evaluate risks and develop plans for risk mitigation using real-world examples, and ample time for questions.
- [International Workshop on One Health Research: Improving Food Security and Resilience](https://absa.org/event/international-workshop-on-one-health-research-improving-food-security-and-resilience/) - International Workshop on One Health Research: Improving Food Security and Resilience April 15– 17, 2026 Tremont House 2300 Ship Mechanic Row St, Galveston, TX 77550 Complex public health problems such as emerging infectious diseases, occupational health risks faced by agriculture workers, and ongoing concerns with food safety require multidisciplinary and inter-institutional approaches to protect the
- [BSL-3 Laboratory Training](https://absa.org/event/bsl-3-laboratory-training/) - BSL-3 laboratory training is a four-day intensive training for laboratory staff, managers, biosafety professionals, and individuals with direct or indirect involvement with work in high-containment. These courses are designed to prepare individuals for the basics of safely working in and around BSL-3 laboratories and includes a mixture of practical and classroom courses covering: Review of
- [69th Annual Biosafety and Biosecurity Hybrid Conference](https://absa.org/event/69th-annual-biosafety-and-biosecurity-hybrid-conference/) - October 10-14, 2026 Mobile Convention Center Mobile, Alabama Intensive professional development courses to educate and inspire Three full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today’s biosafety and biosecurity professionals In-person exhibits showcasing the latest in laboratory biosafety and biosecurity products and services Invaluable networking opportunities
- [Workshop on Advancing Containment Practices in Animal Research](https://absa.org/event/workshop-on-advancing-containment-practices-in-animal-research/) - Join the Eagleson Institute and the American Association for Laboratory Animal Science (AALAS) for a new, in-depth workshop focused on advancing containment practices in animal research. This one-and-a-half-day event brings together Laboratory Animal Veterinarians, Biosafety Professionals, Occupational Health Professionals, Facility Managers/Engineers, and Animal Care Staff for advanced discussions and hands-on learning. Participants will explore how
- [14. Plant & Insect Permit Pathways: Navigating the Regulatory Maze from MTA to EPA](https://absa.org/event/14-plant-insect-permit-pathways-navigating-the-regulatory-maze-from-mta-to-epa/) - Part I Foundations and Frameworks – Plant and plant pest research is the backbone of both genetically modified, disease resistance and breeding of both academic and biotechnology research so it is important that research is conducted legally and ethically. The first webinar will cover the importance of having the Material Transfer Agreement (MTA) in place before research begins and a Non-disclosure Agreement (NDA) to protect confidential business information (CBI) and Intellectual Property (IP) rights. We will discuss the Cartagena Protocol on Biosafety, which is an international agreement on biosafety and a supplement to the Convention on Biological Diversity to understand requirements for access and benefit sharing between countries. The class will walk you through setting up an eFile account which is used for applying for permits. This will be the first session of 2 and it will be conducted over a 2-hour period with time for questions and answers. Part II: Federal Compliance – PPQ, BRS, VS, PHYTO, EPA, Biopesticides, Wildlife & Fisheries – The second part of the series will provide participants with an overview of the federal regulations that allow you to import, export and move biological material inside and outside the U.S. legally. The class will expand on the first session by walking you through the ins and outs of applying for different permits. This course will cover the foundations of whether a permit is needed, how to apply for a permit, what type of permit you need, permit conditions, and the result of non-compliance.
- [13. From Message to Impact: Using AI to Improve Biosafety Communication](https://absa.org/event/13-from-message-to-impact-using-ai-to-improve-biosafety-communication/) - Virus-based Gene Transfer Vectors is an intermediate course that will examine the molecules, processes, and techniques involved in recombinant gene expression. Participants will explore the technology of how viruses are converted into vector systems for the transfer of gene expression constructs. Common viral vector systems, including retroviruses, lentiviruses, adenoviruses, poxviruses, herpesviruses, alphaviruses, and baculoviruses will be discussed with an emphasis on the biosafety characteristics of the vectors derived from these viruses. This course is targeted for the biosafety professional who is not actively conducting laboratory research yet requires a basic understanding of recombinant DNA methodology.
- [09. Introduction to Biosafety in the Clinical Setting](https://absa.org/event/09-introduction-to-biosafety-in-the-clinical-setting/) - The clinical setting poses a different environment than research laboratories. This course provides foundations for applying biosafety concepts in the clinical setting. Course topics include common issues and lessons learned pertaining to clinical facilities including pharmacies, laboratories, clinics, infusion areas, ORs, and waste disposal facilities; PPE, disinfection, risk assessments, and safety practices in the clinical setting; speaking biosafety to doctors, nursing staff, pharmacy staff, infection prevention and control, diagnostic microbiology lab personnel, and hospital EHS staff; applying NIH Guidelines and the BMBL to the clinical setting; gaps in oversight of research safety for clinical trials, and risk assessments for unconventional or highly specialized delivery mechanisms for biologics. The course will conclude with a focus on clinical trials including the role of an IRB and how it can overlap with an IBC; the process for investigational products to obtain FDA approval to be deemed as safe and effective therapeutics; and the evolving regulatory environment in the U.S. for biologics such as vaccines, regenerative medicines, and gene therapy. The course is designed to be highly interactive with discussions, surveys, and group exercises.
- [MABSA Quarterly Hybrid Dinner Meeting](https://absa.org/event/mabsa-quarterly-hybrid-dinner-meeting/) - MABSA is pleased to announce our quarterly hybrid meeting. November 13, 2025 Time: 5 pm - 7:30 pm Location: University of Pennsylvania, Facilities & Real Estate Services (FRES) - Conference Room #01 3401 Walnut Street (3160 Chestnut Street GPS address), Philadelphia, PA 19104 Meeting agenda, parking and direction to meeting room via this link. Zoom link will be
- [How to Mitigate and Respond to Threats in the Laboratory](https://absa.org/event/how-to-mitigate-and-respond-to-threats-in-the-laboratory/) - Joint ABSA and APHL FREE Webinar
- [2026Biosafety and Biosecurity Training Course (BBTC®)](https://absa.org/event/2026biosafety-and-biosecurity-training-course-bbtc/) - ABSA BBTC Fort Collins August 10-14, 2026 Hilton Fort Collins Fort Collins, Colorado A WEEK-LONG COURSE COVERING ANIMAL, GENERAL, AND PLANT BIOSAFETY AND BIOSECURITY The Biosafety and Biosecurity Training Course® (BBTC) is designed for persons who are interested in the varying aspects of the responsibility of biosafety professionals. It is also suitable for persons who
- [Principles & Practices of Biosafety®, Charlotte, NC](https://absa.org/event/principles-practices-of-biosafety-charlotte-nc/) - Principles & Practices of Biosafety® will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises will be used throughout to provide hands-on experience and to encourage networking and problem-solving among participants and instructors. Objectives At the end of the course each participant will be able to:
- [Principles & Practices of Biosafety®, San Diego, CA](https://absa.org/event/principles-practices-of-biosafety-san-diego-ca/) - Principles & Practices of Biosafety® will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises will be used throughout to provide hands-on experience and to encourage networking and problem-solving among participants and instructors. Objectives At the end of the course each participant will be able to:
- [Strengthening and Modernizing Biosafety Oversight: Region 1 Listening Session](https://absa.org/event/strengthening-and-modernizing-biosafety-oversight-region-1-listening-session/) - Strengthening and Modernizing Biosafety Oversight: Region 1 Listening Session Event Date: 09/30/2025 Time: 2:00-5:00 PM ET NIH, in partnership with the New England Biological Safety Association, the Northeast Biological Safety Association, the Mid-Atlantic Biological Safety Association and the Chesapeake Area Biological Safety Association, will be holding the first in a series of public listening sessions
- [2025 ABSANZ Annual Conference](https://absa.org/event/2025-absanz-annual-conference-future-proofing-biosafety-adapting-to-a-world-of-disruption-and-change/) - We are delighted to invite you to join us at the 13th ABSANZ Conference on ‘Future-Proofing Biosafety: Adapting to a World of Disruption and Change’. Join us as we bring together leading experts, regulators and industry stakeholders to discuss evolving challenges and innovative solutions in the fields of biosafety and biosecurity.
- [3V. Introduction to the Science and Biosafety of Cell and Gene Therapy Clinical Trials](https://absa.org/event/3v-introduction-to-the-science-and-biosafety-of-cell-and-gene-therapy-clinical-trials/) - The use of recombinant and synthetic nucleic acid molecules in clinical trials is growing at an explosive pace. This course is intended to introduce biosafety professionals to the science and biosafety of gene-based investigational products in clinical trials including gene-based vaccines, gene modified cellular products, gene therapy and gene editing. This course will provide an overview of molecular biology, virology and viral vectors. Participants will discuss risk assessments and best practices for dealing with risks associated with diverse types of biological hazards.
- [4V. Clinical Biosafety Essentials: A Guide to Integrating Safety Practices from Research to Clinical Environments](https://absa.org/event/4v-clinical-biosafety-essentials-a-guide-to-integrating-safety-practices-from-research-to-clinical-environments/) - This course addresses the growing need for Biosafety Professionals to apply biosafety principles in the clinical environment. Clinical trials for biological therapeutics are becoming increasingly common. Therefore, safety professionals on regulatory committees such as the Institutional Biosafety Committee must possess a strong understanding of clinical safety, terminology, and regulatory requirements in order to perform an adequate risk assessment of the proposed hazard mitigation measures for these studies. In this course we will explore various clinical spaces, their unique biosafety considerations, and relevant hospital regulations that apply to patient safety, staff safety and a safe environment of care. You will also acquire the knowledge necessary to apply these safety practices in accordance with both research and clinical safety regulations while developing, in collaboration with clinical colleagues, processes that maintain staff safety at all levels.
- [AZBA Fall Meeting](https://absa.org/event/azba-fall-meeting/) - AZBA Fall Meeting Thursday, September 25, 2025 9:50am Arizona time (currently Pacific Time): Join for welcome and socialize 10:00am – 12:00 pm: Speakers Join us on Zoom Cost – Free 9:50 – 10:00 Welcome and Socialize 10:00 – 10:30 Speaker: Irene Ruberto, PhD, MPH Vector-borne & Zoonotic Diseases (VBZD) & Mycotic Diseases Program
- [ISO/TS5441:2024 Competence Requirements for Biorisk Management Advisors: what it is, how to use it](https://absa.org/event/iso-ts54412024-competence-requirements-for-biorisk-management-advisors-what-it-is-how-to-use-it/) - ISO/TS5441:2024 Competence Requirements for Biorisk Management Advisors: what it is, how to use it ONLINE, September 24th 2025, 10:00-12:00 CET Instructor: Ursula Jenal In spring 2024, the International Organization for Standardization, ISO, published the technical specification ISO/TS5441:2024 Competence Requirements for Biorisk Management Advisors (BMA). ISO/TS5441 compiles all information on required knowledge, skills and experience a
- [2025 BioNet September Lunch Meeting](https://absa.org/event/2025-bionet-september-lunch-meeting/) - The BioNet September Lunch Meeting will be held at Azusa Pacific University, 901 E Alosta Ave, Azusa, CA 91702, located in the Greater Los Angeles Region. The event is set to occur on September 19th, 2025 from 11am to 1pm Pacific Time. Specific directions regarding parking and a map to the conference room will be
- [08. Virus-based Gene Transfer Vectors](https://absa.org/event/08-virus-based-gene-transfer-vectors/) - Virus-based Gene Transfer Vectors is an intermediate course that will examine the molecules, processes, and techniques involved in recombinant gene expression. Participants will explore the technology of how viruses are converted into vector systems for the transfer of gene expression constructs. Common viral vector systems, including retroviruses, lentiviruses, adenoviruses, poxviruses, herpesviruses, alphaviruses, and baculoviruses will be discussed with an emphasis on the biosafety characteristics of the vectors derived from these viruses. This course is targeted for the biosafety professional who is not actively conducting laboratory research yet requires a basic understanding of recombinant DNA methodology.
- [12. Laboratories & 1st Responders: Coordination, Planning, & Emergency Response](https://absa.org/event/12-laboratories-1st-responders-coordination-planning-emergency-response/) - Laboratories & 1st Responders: Coordination, Planning, & Emergency Response webinar will provide researchers, administrators, and safety professionals working in laboratory facilities with recommendations and best practices on how to establish beneficial working relationships with regional emergency response agencies. This webinar will provide an overview of emergency management functions, strategies for engaging 1st responders, recommendations on how to prepare research facilities for emergencies, and breakout sessions and case studies to discuss how to build relationships, support 1st responders, develop response procedures, and conduct exercise planning. Ample time will be provided throughout the webinar to discuss participant experiences and concerns.
- [07. Molecular Biology 101](https://absa.org/event/07-molecular-biology-101/) - Molecular Biology 101 is intended for those professionals that participate in protocol review, facilities planning, and other risk assessment activities but lack a basic understanding of molecular biology and techniques. Following this course, attendees will be able to do more than regurgitate facts and use the new understanding of the principles of molecular biology in various situations at their institution. This course will cover topics such as the chemistry of nucleic acids, DNA replication, RNA transcription, and protein translation, the Central Dogma of Biology, DNA cloning, transfection of prokaryotic and eukaryotic cells, restriction enzymes, and recombinant DNA lab methodologies (including PCR, DNA fingerprinting, sequencing, and detection protocols). While this course will not turn you into a molecular biologist, it will give you enough background information to understand the nature and manipulation of genetic material and hopefully unveil the mystery of deoxyribonucleic acid.
- [10V. Infectious Substance Shipping Program Management](https://absa.org/event/10v-infectious-substance-shipping-program-management/) - This course is tailored for individuals responsible for establishing and overseeing infectious substance shipping programs within their facilities. This webinar series aims to assist institutions in developing robust shipping programs tailored to their needs. Course elements include: training; written policies; written descriptions of program plans; transport and shipping specific SOPs; safety and security plans; emergency response plans; logistics and supplies; carrier selection and support; MOUs and authorizations; access control and personnel assurance. The instructor will provide a detailed and comprehensive shipping program assessment and implementation guidance document. Attendees will receive an introduction to this document and step-by-step guidance on its completion. By completing the assessment document, attendees will conduct a thorough review to identify areas for improving existing shipping programs. This interactive, instructor led, web-based training will invite attendees to share examples of how these elements are addressed at their own institution.
- [9V. Keeping it Going: Maintaining and Improving a Select Agent Program Over the Long Term](https://absa.org/event/9v-keeping-it-going-maintaining-and-improving-a-select-agent-program-over-the-long-term/) - Keeping a select agent program going can be difficult, especially in the face of ever-changing regulatory requirements and limited resources. Established procedures may suddenly become unacceptable, interrupting research and frustrating laboratorians. Likewise, a single unexpected adverse event can put an entire program at risk. Being prepared to deal with such changes and events is critical to maintaining a robust program. Anticipating future challenges can be even more advantageous, elevating a program from good to great. A proactive approach can minimize the impact of new requirements and reduce duration and frequency of crises sparked by sudden, unexpected requirements or events. This course will explore strategies for maintaining and improving an existing program, including how to anticipate and respond to new requirements. The focus will be on U.S. select agent requirements, although a small section on comparable requirements in the international community will be included. Strategies will be based on the instructors’ experience with their program with additional input solicited from class attendees during open discussions. Topics will include select agent program history; effective oversight; efficiently meeting ongoing requirements; reporting, responding to, and analyzing incidents; suitability program case studies; inactivation requirements, including “failure” investigation; and inspection preparation and response. The course will consist of topical presentations followed by group discussions aimed at facilitating application of presented strategies to attendees’ individual programs and providing a platform to capitalize on attendees’ collective experience.
- [8V. Host Pathogen Interactions for Biosafety Professionals](https://absa.org/event/8v-host-pathogen-interactions-for-biosafety-professionals/) - The course is intended to introduce biosafety professionals to host-pathogen interactions by focusing on fundamentals of immunology, microbiology and their interplay as they pertain to biosafety risk assessments utilizing instructional videos, case studies, established lab acquired infections and publications. Information from this course can assist biosafety professionals assess risks from microbiological research including potential effects of genetic modifications on virulence and infectivity of pathogens, susceptibility of hosts in in-vitro and in-vivo models for IBC review, assessing impact to the wellbeing of research animal hosts for IACUC review, as well as the occupational safety and occupational health of research personnel.
- [5V. Integrating AI into Biotechnology: A Biosecurity Risk Assessment Workshop (Part 2) – Embodied AI and Automation in Biorisk Management](https://absa.org/event/5v-integrating-ai-into-biotechnology-a-biosecurity-risk-assessment-workshop-part-2-embodied-ai-and-automation-in-biorisk-management/) - As AI becomes increasingly integrated into laboratory operations and risk management, it presents both challenges and opportunities for improving safety and mitigating biological threats. This advanced workshop builds on last year’s course, focusing on biosecurity risk assessment frameworks for AI-enabled systems, with a focus on embodied AI agents and automation. Drawing from recent advances, including the use of humanoid robotic systems with AI in high-containment environments, this course will combine theoretical foundations with hands-on applications. Attendees will engage in case studies and group exercises to assess biosecurity risks associated with AI-driven tools and systems in laboratory settings.
- [6V. Anatomy of an IBC meeting: Understanding the Structure, Function, and Operations of an Institutional Biosafety Committee](https://absa.org/event/6v-anatomy-of-an-ibc-meeting-understanding-the-structure-function-and-operations-of-an-institutional-biosafety-committee/) - This four-hour course provides an in-depth look at the anatomy of an Institutional Biosafety Committee (IBC) meeting, exploring its role within the broader biosafety program. Participants will gain a comprehensive understanding of IBC meeting operations, including committee structure, member responsibilities, and the processes that ensure compliance and risk mitigation. Topics covered include the intersection of biosafety programs and IBC functions; roles and responsibilities of IBC members, biosafety staff, and ad-hoc consultants based on their expertise; managing nonconformity issues and implementing corrective actions; the role of pre- and post-IBC meetings in streamlining operations; utilizing the IBC meeting matrix to improve efficiency and decision-making; engaging special reviewers and external consultants when needed; structuring an IBC meeting into different sections such as recombinant DNA, infectious agents, IRE, and subcommittees; handling NIH reportable incidents and urgent post-submission requests; and understanding IBC registration forms, help documents, and compliance tools. Through case studies and discussion-based activities, attendees will leave with a clearer understanding of how to effectively contribute to and enhance IBC meetings. This course is ideal for current and prospective IBC members, biosafety professionals, and institutional stakeholders involved in biological research oversight.
- [2V. Program Management Fundamentals for the Biosafety Professionals](https://absa.org/event/2v-program-management-fundamentals-for-the-biosafety-professionals/) - This course is designed for biosafety professionals who are responsible for overseeing biosafety departments. The principles and practices briefly covered in this course are closely related to the Program Management Professional (PMP) certification. By understanding the core competencies of the PMP framework, biosafety professionals can apply project management methodologies to enhance the planning, execution, and evaluation of their biosafety programs. This integration of program management skills with biosafety expertise ensures that participants are well-prepared to lead effective, compliant and sustainable biosafety programs within their organizations. In addition, the course aligns with key international standards and guidelines, such as ISO 35001, which specifies requirements for a biosafety risk management system. Participants will gain insights into how to integrate ISO 35001 principles into their biosafety programs, ensuring a systematic and effective approach to biosafety risk management. The course also covers the World Health Organization (WHO) Biosafety Programme Management Associated Monograph, providing a global perspective on best practices for managing biosafety risks. By familiarizing themselves with the WHO guidelines, participants will be better equipped to implement and maintain robust biosafety programs that meet international standards.
- [1V. A Helpful Guide to Becoming a Well-Rounded Biosafety Professional Workshop](https://absa.org/event/1v-a-helpful-guide-to-becoming-a-well-rounded-biosafety-professional-workshop/) - Biosafety professionals must grasp the complexity of various hazards present in laboratories, which include not only biological agents but also chemical, radiological, and physical hazards. This course will provide an overview of these key hazards and equip participants with the knowledge needed to assess and mitigate risks within their institutions. Topics will cover biological hazards (including risk assessments and a brief review of laboratory regulations), select agents, chemical hazards (with an emphasis on safety data sheets and hazard communication), industrial hygiene (including respiratory safety, air quality, and waste anesthetic gas management), radiological hazards (including lasers), and animal-related hazards (such as physical risks and allergens). The course will conclude with practical tabletop exercises, allowing participants to apply the concepts learned throughout the course, including risk assessment development, emergency response, and handling unique laboratory conditions.
- [4th Biosecurity Symposium](https://absa.org/event/4th-biosecurity-symposium/) - ABSA International’s 4th Biosecurity Virtual Symposium May 12-13, 2026 The Symposium will bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge on diverse biosecurity topics. The Symposium will offer attendees an opportunity to learn the latest in biosecurity and have thought-provoking conversations about real-world
- [ABSA International Biosafety and Biosecurity Month](https://absa.org/event/absa-international-biosafety-and-biosecurity-month/) - ABSA International Biosafety and Biosecurity Month ABSA International is proud to announce the 12th anniversary of Biosafety and Biosecurity Month in October 2025. Use this month to shine the spotlight on training ideas, stewardship and engagement, how to foster positive relationships within the research community, or supporting responsible and ethical research through our profession.
- [Biosafety Association for Central Asia and Caucasus (BACAC) Conference](https://absa.org/event/biosafety-association-for-central-asia-and-caucasus-bacac-conference/) - The International Science and Technology Center (ISTC), in collaboration with the Biosafety Association of Central Asia and the Caucasus (BACAC) and the German Biosecurity Programme through GIZ, is co-organizing an international conference entitled “Future Challenges of Biosafety and Biosecurity”, which will take place in Almaty, Kazakhstan.
- [06. Large-scale Biosafety](https://absa.org/event/06-large-scale-biosafety/) - Large-scale Biosafety will review biosafety for work at large-scale, which the NIH rDNA Guidelines defines as >10L. The course will review Appendix K from GLSP to BSL-3 LS, with a focus on primary and secondary containment. It will review basic bioprocessing steps, such as fermentation/cell culture and purification technologies. Examples of classic and newer single use technologies will be provided. Pearls and pitfalls of the various technologies will be discussed, using various scenarios. The course will include a review of risk assessment techniques used for large scale bioprocesses and a discussion of large-scale related to vaccines, viral vectors, and recombinant proteins.
- [APHL/ABSA Webinar: Temporary Laboratories: Uses and Safety Concerns](https://absa.org/event/aphl-absa-webinar-temporary-laboratories-uses-and-safety-concerns/) - This webinar in collaboration with the American Biological Safety Association (ABSA) will delve further into the topic of mobile and temporary laboratories. Topics will include how they may be employed for preparedness events and disaster relief, their ability to be utilized as BSL-2 and/or BSL-3 spaces, and concerns with validation of operating parameters, certification and commissioning. Experts with personal experience will discuss the usefulness of these temporary facilities, various appropriate procedural applications and potential problems.
- [11. Field Biosafety: Protecting Researchers and Communities in Wildlife Disease Investigations](https://absa.org/event/11-field-biosafety-protecting-researchers-and-communities-in-wildlife-disease-investigations/) - This webinar will provide comprehensive training on field biosafety, designed specifically for biosafety professionals, researchers, veterinarians, and field personnel involved in wildlife disease research. The course is structured to offer practical guidance on assessing biosafety risks in diverse field settings and effectively implementing the Field Biosafety Levels (FBSLs)—a structured framework for zoonotic disease protection. Participants will learn to critically evaluate risks, determine appropriate biosafety levels, and apply best practices in real-world scenarios. Over the two sessions, participants will be introduced to key principles of field biosafety and detailed considerations for advising researchers on potential risks. Participants will also explore the practical application of Field Biosafety Levels (FBSLs) as a proposed standardized approach to managing zoonotic risks in diverse field environments. In the final session, participants will be given a brief recap, followed by an interactive implementation practice exercise. Real-world examples, including visual aids illustrating proper and improper biosafety practices, will be reviewed. Participants will engage in active discussions, analyzing images to identify potential biosafety hazards and propose solutions. The webinar concludes with an open Q&A session.
- [AMEXBio - XVII INTERNATIONAL SYMPOSIUM OF BIOSAFETY AND BIOSECURITY: Strengthening Biosafety Programs](https://absa.org/event/amexbio-xvii-international-symposium-of-biosafety-and-biosecurity-strengthening-biosafety-programs/) - Annual Meeting with two days of presymposium courses and two days of conferences. Join us to discuss, share, and propose solutions to strengthen biosafety and biological risk management programsin Mexicoa and the region. WHO SHOULD ATTEND? PROFESSIONALS IN HUMAN HEALTH, AGRICULTURE, ACADEMIA, AND INDUSTRY WITH AN INTEREST IN THE MANAGEMENT OF BIOLOGICAL AND BIOTECHNOLOGICAL RISKS.
- [CSHEMA 72nd Annual Conference](https://absa.org/event/cshema-72nd-annual-conference/) - Join us in Seattle for the premier event in campus safety, health, and environmental management. The CSHEMA Annual Conference brings together EHS professionals from across the country for engaging discussions, expert-led sessions, and valuable networking opportunities.
- [Strategic Biocontainment Laboratory Planning and Operations Workshop:  The ABCs of High Containment Operations](https://absa.org/event/strategic-biocontainment-laboratory-planning-and-operations-workshop-the-abcs-of-high-containment-operations/) - Strategic Biocontainment Laboratory Planning and Operations Workshop The ABCs of High Containment Operations November 17-21, 2025 Toronto, Ontario, Canada https://cabs-acsb.ca/highcontainPlan.aspx CABS-ACSB and Merrick & Company are pleased to co-present the Strategic Biocontainment Laboratory Planning and Operations Workshop. This comprehensive, hands-on workshop is designed for professionals involved in the planning, renovation, operation, and management of high-containment
- [05. Concepts of Virology](https://absa.org/event/05-concepts-of-virology/) - Concepts of Virology will briefly review gene expression in eukaryotes and examine several concepts of virology. Characteristics of different viral families will be presented as well as general replication strategies employed by different viruses. Mechanisms of viral pathogenesis and strategies for antiviral intervention will also be explored. Participants should have a familiarity with molecular biology. The course is targeted to the biosafety professional who does not actively conduct laboratory research but would like to gain a basic knowledge of virology.
- [Biosafety Day in the State of Maryland](https://absa.org/event/biosafety-day-in-the-state-of-maryland/) - Governor Wes Moore has officially proclaimed June 4, 2025 as Biosafety Day in the State of Maryland — a momentous acknowledgment of the critical work that biosafety professionals do every day to protect public health, promote scientific advancement, and support laboratory safety. This proclamation is especially meaningful as it coincides with our 2025 ChABSA Annual Symposium,
- [New World screwworm webinar](https://absa.org/event/new-world-screwworm-webinar/) - Join AgriLife Extension for a free educational event from 2-4:30 p.m. June 9 on New World screwworm detection and response efforts. In response to the growing concern about the New World screwworm, the Texas A&M AgriLife Extension Service will host a webinar on June 9 to provide more information to agricultural producers and the public.
- [15th Annual Preventing and Treating Biological Exposures: An Occupational Health Colloquium](https://absa.org/event/15th-annual-preventing-and-treating-biological-exposures-an-occupational-health-colloquium/) - Join The Eagleson Institute and the Elizabeth R Griffin Program in Boston, MA this September for the 15th Annual Preventing and Treating Biological Exposures: An Occupational Health Colloquium This event, co-sponsored by ABSA International, connects biosafety professionals with occupational health professionals, bringing together the people who know, with the people who need to know. Topics
- [Too Shy to Ask the Listserv panel discussion](https://absa.org/event/too-shy-to-ask-the-listserv-panel-discussion/) - On Thursday, May 1, 2025 MABioN is hosting another edition of our Too Shy to Ask the Listserv panel discussion. The webinar will be from 1-2pm (Central Time)/ 2-3pm (Eastern) Have you ever had a biosafety question but you were too shy to post it on the ABSA listserv? Well this webinar is for you. Participants can
- [04. Fundamentals of Microbiology and Infectious Disease](https://absa.org/event/04-fundamentals-of-microbiology-and-infectious-disease/) - Fundamentals of Microbiology and Infectious Disease is intended for those professionals who participate in protocol review, facilities planning, and any other risk assessment activities, but are unsure as to the actual nature of the disease risks of microbiological agents. Biological safety and risk assessment will not be covered in this course. The proposed topics will cover infectious agents, virulence factors, pathogenicities, host-microbe interactions, susceptibility, modes of transmission, and the changes seen in the microbial world. If you don’t know the difference between a TCID50, PFU, or ID50; or why HBV is stable in dried blood and HIV is not; or why influenza is an inhalation hazard; or why public health officials advocate flu shots each year—then this course is for you.
- [2024 SEBSA Biosafety Symposium](https://absa.org/event/2024-sebsa-biosafety-symposium-2/) - Join Southeastern Biological Safety Association (SEBSA) for our live symposium. Besides wide range of talks we will have tours of Auburn University Poultry Research Farm. More information
- [2025 BioNet Symposium](https://absa.org/event/2025-bionet-symposium/) - Please join BioNet for our annual half day symposium which will be held in a hybrid format on May 16, 2025 from 9:00am - 2:00pm Pacific Time at the La Jolla Institute, 9420 Athena Circle, La Jolla, CA 92037 or Web Meeting by Zoom. Topics to be discussed include the following: Updated enforcement of the
- [10. Navigating Your Career: Strategies for Success in Challenging Job Markets](https://absa.org/event/10-navigating-your-career-strategies-for-success-in-challenging-job-markets/) - In today’s competitive job market, a strong LinkedIn profile and strategic networking are essential to stand out and secure meaningful career opportunities. This comprehensive webinar, Navigating Your Career: Strategies for Success in Challenging Job Markets, is designed to equip professionals with the tools and insights they need to enhance their online presence, craft impactful resumes, and leverage networking for career advancement.
- [03. Dual-Use and Gain-of-Function Research in Uncertain Legislative Times](https://absa.org/event/03-dual-use-and-gain-of-function-research-in-uncertain-legislative-times/) - Dual-Use and Gain-of-Function Research in Uncertain Legislative Times is a webinar designed for biosafety/biosecurity professionals and communicators to understand the changing landscape of biosecurity policy surrounding high-consequence of research. The goal is to understand the 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential in advance of the May 6, 2025 implementation date, and work together to craft strategies for biosafety and biosecurity professionals to adapt institutional responses in light of continuing government action through, for example, the Risky Research Review Act under consideration in Congress. The webinar will be highly interactive, with a focus on practitioner views of the current policy and future uncertainty, led by a biosecurity expert with over 15 years’ experience studying, teaching on, and crafting policy for biosecurity for a variety of national and international groups. By the conclusion of this webinar, participants will gain an understanding of how to ensure compliance goals are met in advance of the May implementation deadline but are responsive to the possibility of new regulatory requirements as early as the end of the year.
- [AZBA Spring Meeting](https://absa.org/event/azba-spring-meeting/) - AZBA Spring Meeting Thursday, April 17, 2025 1:00 – 3:00 pm MST Join us on Zoom Cost – Free 1:00 - 1:10 Welcome and Board Updates - AZBA Board 1:10 - 1:40 Speaker: Ashley Wright Area Associate Agent, Livestock Cochise County Cooperative Extension 1:40 - 2:10 Speaker: Yan Zhang, DVM, PhD, DACVM Director, Arizona Veterinary
- [U.S. Customs & Border Protection Importation of Biologicals Workshop @ Univ of Michigan](https://absa.org/event/u-s-customs-border-protection-importation-of-biologicals-workshop-univ-of-michigan/) - U.S. Customs & Border Protection Importation of Biologicals Workshop @ UM The University of Michigan will host the U.S. Customs & Border Protection Importation of Biologicals Workshop on May 6, 2025. The workshop will include representatives from several federal government agencies who will share their responsibilities, discuss regulatory and safety challenges of importing biological materials,
- [ChABSA Annual Scientific Symposium (In Person and Virtual)](https://absa.org/event/chabsa-annual-scientific-symposium-in-person-and-virtual/) - The ChABSA 2025 Annual Scientific Symposium will be held June 4, 2025 at the Universities at Shady Grove in Rockville, MD. The symposium is an event for the biosafety and biosecurity community, bringing together leaders, biosafety professionals, scientists, innovators, influencers and partners to share issues, trends and best practices driving biosafety and biosecurity and public
- [Building Blocks for Success- Creating a Solid Foundation for Your BSL3 Biocontainment Program](https://absa.org/event/building-blocks-for-success-creating-a-solid-foundation-for-your-bsl3-biocontainment-program/) - Join Tulane University Biocontainment Institute’s knowledgeable staff for a comprehensive training program that will empower you to build a robust and secure biocontainment infrastructure. By combining the essential elements of biosafety, biocontainment operations, quality assurance in research, and project management, we will guide you in constructing a solid foundation for a successful and safer biocontainment
- [CaBSA Technical Meeting](https://absa.org/event/cabsa-technical-meeting/) - Addressing Biosecurity Barriers in High-Risk Biological Research – David Gillum, Associate Vice President of Compliance and Research Administration at the University of Nevada, Reno.
- [Biosafety and Biosecurity Training Course (BBTC®)](https://absa.org/event/biosafety-and-biosecurity-training-course-bbtc/) - ABSA BBTC® Fort Collins August 4-8, 2025 Hilton Fort Collins Fort Collins, Colorado Registration will open Spring 2025. A WEEK-LONG COURSE COVERING ANIMAL, GENERAL, AND PLANT BIOSAFETY AND BIOSECURITY The Biosafety and Biosecurity Training Course (BBTC®) is designed for persons who are interested in the varying aspects of the responsibility of biosafety professionals. It is
- [68th Annual Biosafety and Biosecurity Hybrid Conference](https://absa.org/event/68th-annual-biosafety-and-biosecurity-hybrid-conference/) - October 24-29, 2025 Raleigh Convention Center Raleigh, North Carolina Intensive professional development courses to educate and inspire Three full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today’s biosafety and biosecurity professionals In-person exhibits showcasing the latest in laboratory biosafety and biosecurity products and services Invaluable networking opportunities
- [Principles & Practices of Biosafety® | Alexandria, VA](https://absa.org/event/principles-practices-of-biosafety-alexandria-va/) - A COMPREHENSIVE, INTERACTIVE 5-DAY COURSE Principles & Practices of Biosafety® will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises will be used throughout to provide hands-on experience and to encourage networking and problem-solving among participants and instructors. OBJECTIVES At the end of the course each participant will be able to: Describe potentially hazardous biological materials, the risks associated with their use, and the means to minimize risk and to protect against or prevent release or exposure Discuss ways to provide effective technical expertise in situations involving potentially hazardous biological materials Identify, locate, and efficiently use key biosafety resources
- [BioNet February Lunch Meeting](https://absa.org/event/bionet-february-lunch-meeting/) - Please join us for our virtual BioNet February Lunch Meeting on February 28th from 11am-1pm. Topics to be covered include: Serving the Biosafety Profession, University of Southern California (USC) Animal Research Safety Program, and Roundtable Discussion – Impact of the Recent Southern California Wildfires on Institutions in the Los Angeles Area.
- [01. From Lab to LinkedIn: Communication Strategies & Tools for Biosafety Professionals](https://absa.org/event/01-from-lab-to-linkedin-communication-strategies-tools-for-biosafety-professionals/) - This professional development webinar focuses on helping safety professionals effectively communicate with a range of audiences in and out of the field. Learn how to translate complex safety concepts into clear, engaging messages that resonate with different stakeholders, from public relations or information officers to institutional leadership. Key topics include: developing your professional brand as a safety expert; representing ABSA International and the biosafety profession with credibility; and creating targeted communication strategies for different generations through their preferred media and communication channels. Attendees will also learn to build effective routine communication with PR and PI staff, not just during emergencies and adapting messages for various platforms and audience needs.
- [SEBSA Symposium](https://absa.org/event/sebsa-symposium-2/) - The SEBSA Symposium is a chance for biosafety professionals to learn and network with others in the Southeast. The program will feature scientific presentations, a training exercise, and a networking dinner. All times are Eastern.
- [18. Gain-of-Function Research and PEPP](https://absa.org/event/18-gain-of-function-research-and-pepp/) - Gain-of-function research and PEPP is a webinar designed for biosafety/biosecurity professionals and communicators to understand new federal guidance on “gain of function” or Category 2 research and pathogens of enhanced pandemic potential (PEPP). The goal is to develop an understanding and the tools to explain what Category 2 research is, how it differs from Category 1 research (“dual-use research of concern”), and the role of ethical analysis in these categories for assessing research with PEPP. The webinar will focus on practitioner views of the current policy, led by a biosecurity expert with over 15 years’ experience studying, teaching on, and crafting policy for biosecurity for a variety of national and international groups. By the conclusion of this webinar, participants will gain an understanding of how to assess Category 2 research in the context of the new policy moving into its 2025 implementation, and the role of institutional compliance officers (including IBCs) in assessing Category 2 research in their own institutions.
- [UCI BSL-3 Laboratory Training](https://absa.org/event/uci-bsl-3-laboratory-training-4/) - BSL-3 laboratory training is a four-day intensive training for laboratory staff, managers, biosafety professionals, and individuals with direct or indirect involvement with work in high-containment. These courses are designed to prepare individuals for the basics of safely working in and around BSL-3 laboratories and includes a mixture of practical and classroom courses covering: Review of
- [UCI BSL-3 Laboratory Training](https://absa.org/event/uci-bsl-3-laboratory-training-6/) - BSL-3 laboratory training is a four-day intensive training for laboratory staff, managers, biosafety professionals, and individuals with direct or indirect involvement with work in high-containment. These courses are designed to prepare individuals for the basics of safely working in and around BSL-3 laboratories and includes a mixture of practical and classroom courses covering: Review of
- [UCI BSL-3 Laboratory Training](https://absa.org/event/uci-bsl-3-laboratory-training-5/) - BSL-3 laboratory training is a four-day intensive training for laboratory staff, managers, biosafety professionals, and individuals with direct or indirect involvement with work in high-containment. These courses are designed to prepare individuals for the basics of safely working in and around BSL-3 laboratories and includes a mixture of practical and classroom courses covering: Review of
- [UCI BSL-3 Laboratory Training](https://absa.org/event/uci-bsl-3-laboratory-training-3/) - BSL-3 laboratory training is a four-day intensive training for laboratory staff, managers, biosafety professionals, and individuals with direct or indirect involvement with work in high-containment. These courses are designed to prepare individuals for the basics of safely working in and around BSL-3 laboratories and includes a mixture of practical and classroom courses covering: Review of
- [BSL-3 Seminar Series](https://absa.org/event/bsl-3-seminar-series/) - Fundamentals of BSL-3 (Virtual): A 4-hour virtual BSL-3 overview providing a solid foundation for standalone learning or as preparation for the rest of the BSL-3 Seminar Series. Advanced BSL-3 Work Practices and Procedures: Engage in three detailed case studies, examining the impact of project changes on practices, PPE, and controls, tailored for advanced learners. Tour
- [October is Biosafety and Biosecurity Month!](https://absa.org/event/biosafety-and-biosecurity-month/) - ABSA International is proud to announce the 11th anniversary of Biosafety and Biosecurity Month in October 2024. Use this month to shine the spotlight on training ideas, stewardship and engagement, how to foster positive relationships within the research community, or supporting responsible and ethical research through our profession.
- [7V. Introduction to the Science and Biosafety of Cell and Gene Therapy Clinical Trials](https://absa.org/event/7v-introduction-to-the-science-and-biosafety-of-cell-and-gene-therapy-clinical-trials/) - The use of recombinant and synthetic nucleic acid molecules in clinical trials is growing at an explosive pace. This course is intended to introduce biosafety professionals to the science and biosafety of gene-based investigational products in clinical trials including gene-based vaccines, gene modified cellular products, gene therapy and gene editing. This course will provide an overview of molecular biology, virology and viral vectors. Participants will discuss risk assessments and best practices for dealing with risks associated with diverse types of biological hazards.
- [EBSA Pre-conference courses and conference](https://absa.org/event/ebsa-pre-conference-courses-and-conference/) - Bridging BioSafety Join us for 2 days of preconference courses and conference in Maastricht, The Netherlands
- [New England Biological Safety Association (NEBSA) 2024 Symposium](https://absa.org/event/new-england-biological-safety-association-nebsa-2024-symposium/) - Join NEBSA's 2024 in-person, full day symposium on October 16. 2024 Registration Information: Regular registration fee is $75 and includes lunch and breaks. Student and IBC Community Member discounted registrations of $20 are also available. Register here Preliminary Agenda is here Location: Broad Institute, 415 Main Street, Cambridge, MA
- [BioNet September Lunch Meeting](https://absa.org/event/bionet-september-lunch-meeting/) - Please join us for our Friday, September 13th, for our BioNet September Lunch Meeting to discuss the following topics: Road to Compliance - Lab Coat Vending Machines, Biosafety Challenges in Gnotobiotic Rodent Facilities, and Service Animals In Labs - BioNET Support Letter Discussion. This event will occur from 11am-1pm via Zoom. The registration link has
- [11. Virus-based Gene Transfer Vectors](https://absa.org/event/11-virus-based-gene-transfer-vectors/) - Virus-based Gene Transfer Vectors is an intermediate course that will examine the molecules, processes, and techniques involved in recombinant gene expression. Participants will explore the technology of how viruses are converted into vector systems for the transfer of gene expression constructs. Common viral vector systems, including retroviruses, lentiviruses, adenoviruses, poxviruses, herpesviruses, alphaviruses, and baculoviruses will be discussed with an emphasis on the biosafety characteristics of the vectors derived from these viruses. This course is targeted for the biosafety professional who is not actively conducting laboratory research yet requires a basic understanding of recombinant DNA methodology.
- [6V. Disposal of Research Animal Carcasses](https://absa.org/event/6v-disposal-of-research-animal-carcasses/) - This course will focus on research-based, unique scenarios presented with animals in research and diagnostic environments. Course topics include: composting, incineration, rendering challenges, carcass movement, unique agent requirements, complex variety of animal species (large, small, wildlife, companion, research, diagnostic), mixed hazard waste issues. The attendees will see strategies to assess risk and apply best practices and regulatory requirements to common and diverse situations. Course will be interactive, with breakout sessions and real-world examples.
- [MABSA 36th Annual Hybrid Symposium on 6/21/2024](https://absa.org/event/mabsa-36th-annual-hybrid-symposium-on-6-21-2024/) - MABSA is pleased to announce our upcoming 36th Annual Hybrid Biosafety Symposium. Please register and pay at www.mabsa.org. Date : Friday, June 21, 2024 Location: Pfizer, 401 N Middletown Rd, Pearl River, NY 10965 Members $50.00 in person/$25.00 virtual Non-Members $70.00 in person/$45 virtual (Non-member registration offers one year membership in 2024) Students $20.00 in
- [Principles & Practices of Biosafety® - Denver, CO](https://absa.org/event/principles-practices-of-biosafety-denver-co/) - ABSA INTERNATIONAL Principles & Practices of Biosafety® July 8-12, 2024 Embassy Suites—Denver Downtown Convention Center Denver, CO Registration coming soon. Download the Flyer A COMPREHENSIVE, INTERACTIVE 5-DAY COURSE Principles & Practices of Biosafety® will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises will be used
- [MABSA Hybrid Dinner Meeting](https://absa.org/event/mabsa-hybrid-dinner-meeting/) - MABSA is pleased to announce our upcoming biosafety hybrid dinner meeting. Please register and pay at www.mabsa.org. Please RSVP by February 10, 2023 for in person attendance, and indicate any dietary restrictions. Members attending the meeting virtually will be free. Please send your name and email for registration to treasurer@mabsa.org so we can send the zoom link to you a
- [EHS&S for Biopharma West Summit](https://absa.org/event/ehss-for-biopharma-west-summit/) - The inaugural EHS&S for Biopharma & Pharma West Summit offers an unparalleled opportunity to connect with global EHS&S leaders with the shared goal of eliminating risk and ensuring compliance in biopharmaceutical R&D and manufacturing sites. Over the course of two days featuring more than 18 case studies, discussions sessions and workshops, you'll engage with global
- [MABSA Biosafety Hybrid Dinner Meeting](https://absa.org/event/mabsa-biosafety-hybrid-dinner-meeting/) - MABSA is pleased to announce our upcoming biosafety hybrid dinner meeting. Please register and pay at www.mabsa.org. LOCATION NYU Langone Health (New York, NY) AGENDA 5:00 pm – 5.30 pm Registration and Networking 5:30 pm – 6:00 pm Training Program for High Containment/BSL3 LaboratoriesLudovic Desvignes, PhD, Assoc Professor, Dept. of Medicine, Vaccine Center & Virology Institute Director, High-Containment Laboratories, Office
- [Harvard Yale Biosafety Symposium 2023](https://absa.org/event/harvard-yale-biosafety-symposium-2023/)
- [2023 ChABSA Annual Symposium and Pre-Symposium Courses](https://absa.org/event/2023-chabsa-annual-symposium-and-pre-symposium-courses/) - Early Bird Pricing Ends Sunday The Chesapeake Area Biological Safety Association is pleased to continue to offer ABSA International Affiliate members ChABSA member pricing. This year the Annual Scientific Symposium and Workshops will be held in-person with live streaming. This is a great way to get your continuing education while increasing your professional knowledge. See
- [10. Molecular Biology 101](https://absa.org/event/10-molecular-biology-101/) - Molecular Biology 101 is intended for those professionals that participate in protocol review, facilities planning, and other risk assessment activities but lack a basic understanding of molecular biology and techniques. Following this course, attendees will be able to do more than regurgitate facts and use the new understanding of the principles of molecular biology in various situations at their institution. This course will cover topics such as the chemistry of nucleic acids, DNA replication, RNA transcription, and protein translation, the Central Dogma of Biology, DNA cloning, transfection of prokaryotic and eukaryotic cells, restriction enzymes, and recombinant DNA lab methodologies (including PCR, DNA fingerprinting, sequencing, and detection protocols). While this course will not turn you into a molecular biologist, it will give you enough background information to understand the nature and manipulation of genetic material and hopefully unveil the mystery of deoxyribonucleic acid.
- [ChABSA Hybrid Technical Seminar: Cyberbiosecurity: A Unique Marriage of Biosecurity and Information Systems](https://absa.org/event/chabsa-hybrid-technical-seminar-cyberbiosecurity-a-unique-marriage-of-biosecurity-and-information-systems/) - Cyberbiosecurity: A Unique Marriage of Biosecurity and Information Systems Presented By: Julianne L. Baron, Ph.D., CPH, RBP, President, Science and Safety Consulting, LLC Increasing reliance on the internet and technology in research and biomedical laboratories has opened these organizations up to increased focus for cyberattacks. These attacks may be perpetrated by external actors or individuals
- [3V. Introduction to Biosafety in the Clinical Setting](https://absa.org/event/3v-introduction-to-biosafety-in-the-clinical-setting/) - The clinical setting poses a different environment than research laboratories. This course provides foundations for applying biosafety concepts in the clinical setting. Course topics include common issues and lessons learned pertaining to clinical facilities including pharmacies, laboratories, clinics, infusion areas, ORs, and waste disposal facilities; PPE, disinfection, risk assessments, and safety practices in the clinical setting; speaking biosafety to doctors, nursing staff, pharmacy staff, infection prevention and control, diagnostic microbiology lab personnel, and hospital EHS staff; applying NIH Guidelines and the BMBL to the clinical setting; gaps in oversight of research safety for clinical trials, and risk assessments for unconventional or highly specialized delivery mechanisms for biologics. The course will conclude with a focus on clinical trials including the role of an IRB and how it can overlap with an IBC; the process for investigational products to obtain FDA approval to be deemed as safe and effective therapeutics; and the evolving regulatory environment in the U.S. for biologics such as vaccines, regenerative medicines, and gene therapy. The course is designed to be highly interactive with discussions, surveys, and group exercises.
- [4V. Bio-Hazardous Drugs](https://absa.org/event/4v-bio-hazardous-drugs/) - The anticipated implementation of United States Pharmacopeia (USP) 800 in healthcare created a new resolve to conduct thorough risk assessments of healthcare formularies. The role of this assessment was to identify the hazards posed by these drugs, to evaluate the exposure risks associated with these hazards, and to determine the potential health consequences of both acute and chronic exposure. Most healthcare facilities that conducted these risk assessments utilized a risk matrix that incorporated criteria commonly used in toxicology to evaluate exposure to chemicals. As the pharmaceutical industry quickly turns to novel biologics to treat and/or correct disease, a risk assessment of the biological hazards associated with these novel biologics is warranted. This course will provide information on these biologics; explore the known and anticipated biological properties of each; discuss the potential these biologics have to cause infections, to be shed, to contaminate the environment, and to be transmitted to others; and will cover the pertinent controls needed to contain these biologics, to prevent inadvertent exposure to these materials, to remove them from the environment, and to ensure staff and patients are appropriately educated.
- [2V. Infectious Substance Shipping Program Management](https://absa.org/event/2v-infectious-substance-shipping-program-management/) - This course is tailored for individuals responsible for establishing and overseeing infectious substance shipping programs within their facilities. This webinar series aims to assist institutions in developing robust shipping programs tailored to their needs. Course elements include: training; written policies; written descriptions of program plans; transport and shipping specific SOPs; safety and security plans; emergency response plans; logistics and supplies; carrier selection and support; MOUs and authorizations; access control and personnel assurance. The instructor will provide a detailed and comprehensive shipping program assessment and implementation guidance document. Attendees will receive an introduction to this document and step-by-step guidance on its completion. By completing the assessment document, attendees will conduct a thorough review to identify areas for improving existing shipping programs. This interactive, instructor led, web-based training will invite attendees to share examples of how these elements are addressed at their own institution.
- [1V. Plant and Arthropod Biosafety Basics](https://absa.org/event/1v-plant-and-arthropod-biosafety-basics/) - Plant research is the backbone of both genetically modified, disease resistance, and breeding of both academic and biotechnology research. Attendees will discover what is needed to design a greenhouse and lab that will contain genetically modified material and insects as well as an overview of Arthropod Containment Levels. This course will feature a diverse array of advanced scenarios and interactive exercises showcasing the spectrum of biological, genetically modified, arthropod, and other risks and hazards commonly encountered in greenhouses, fields, and laboratories supporting plant research. Attendees will be guided through strategies for identifying potential hazards, assessing the magnitude and extent of induced risks and cost, and developing effective control measures to protect the safety of workers, plants, and the environment. The course employs “real world” examples to improve understanding of greenhouse and field operations.
- [5V. Animal Research for Biosafety Professionals – An Introduction](https://absa.org/event/5v-animal-research-for-biosafety-professionals-an-introduction/) - Animal Research has contributed to major scientific advances in biomedical, veterinary, and environmental sciences and in public health. However, these efforts often pose significant risks to the health and safety of research and facility staff due to the wide range of species, complex experimental procedures and equipment, and facility hazards that are involved. Balancing optimal worker safety and animal welfare with research objectives yields the best results but requires a solid understanding of how animal programs are managed and an ability to identify and mitigate inherent risks. This course provides a thorough introduction to routine hazards commonly encountered in animal programs that utilize rodents, small animals, nonhuman primates, aquatics, and agricultural species, with a primary focus on identifying and managing biological, chemical, radiological, and physical hazards. Topics include assessment and management of animal program hazards; universal regulations, guidelines, and quality standards that apply to animal research; duties and responsibilities of key program personnel; local oversight systems; best practices that enhance the quality of animal care; and strategies for biosafety professionals to develop and maintain effective partnerships with program staff and institutional animal care and use committee members. Opportunities will be provided to apply new knowledge and skills through interactive group activities and problem-solving sessions. The instructors are experienced laboratory animal veterinarians who are actively involved in the management, oversight, and evaluation of animal care and use programs. The primary target audience for this course are biosafety and general safety professionals with limited experience in the animal research environment.
- [8V. IBC Basics](https://absa.org/event/8v-ibc-basics/) - IBC Basics is an introductory course on the function and administration of Institutional Biosafety Committees (IBCs) delivered by expert staff from the National Institutes of Health (NIH) Office of Science Policy (OSP). IBC Basics will promote the professional development of those associated with IBCs by providing an opportunity to learn about the role of NIH OSP, the content of the NIH Guidelines for Research Involving Recombinant and Synthetic Nucleic Acid Molecules, and understand the range of biosafety oversight responsibilities that IBCs have under the NIH Guidelines. This course provides an overview and may be helpful for those new to the field.
- [09. Large-scale Biosafety](https://absa.org/event/09-large-scale-biosafety/) - Large-scale Biosafety will review biosafety for work at large-scale, which the NIH rDNA Guidelines defines as >10L. The course will review Appendix K from GLSP to BSL-3 LS, with a focus on primary and secondary containment. It will review basic bioprocessing steps, such as fermentation/cell culture and purification technologies. Examples of classic and newer single use technologies will be provided. Pearls and pitfalls of the various technologies will be discussed, using various scenarios. The course will include a review of risk assessment techniques used for large scale bioprocesses and a discussion of large-scale related to vaccines, viral vectors, and recombinant proteins.
- [15. Q&A Infectious Substance Shipping](https://absa.org/event/15-qa-infectious-substance-shipping/) - Q&A Infectious Substance Shipping webinar provides an opportunity for participants to learn about recent changes to international regulations and interact with a panel of shipping experts. Regulatory experts from organizations to be determined and have been invited along with a packaging expert from Saf-T-Pak/Labelmaster to discuss hazardous material shipping. Participants will be afforded an opportunity to submit questions for the panel to review in advance. As many questions as possible will be discussed during the webinar. Questions not addressed will be collated, answered by the experts, and provided to all participants along with a transcript of the session.
- [Principles & Practices of Biosafety® | Omaha, NE](https://absa.org/event/principles-practices-of-biosafety-omaha-ne/) - A COMPREHENSIVE, INTERACTIVE 5-DAY COURSE Principles & Practices of Biosafety® will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises will be used throughout to provide hands-on experience and to encourage networking and problem-solving among participants and instructors. OBJECTIVES At the end of the course each participant will be able to: Describe potentially hazardous biological materials, the risks associated with their use, and the means to minimize risk and to protect against or prevent release or exposure Discuss ways to provide effective technical expertise in situations involving potentially hazardous biological materials Identify, locate, and efficiently use key biosafety resources
- [Principles & Practices of Biosafety® | Pittsburgh, PA](https://absa.org/event/principles-practices-of-biosafety-pittsburgh-pa-2/) - A COMPREHENSIVE, INTERACTIVE 5-DAY COURSE Principles & Practices of Biosafety® will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises will be used throughout to provide hands-on experience and to encourage networking and problem-solving among participants and instructors. OBJECTIVES At the end of the course each participant will be able to: Describe potentially hazardous biological materials, the risks associated with their use, and the means to minimize risk and to protect against or prevent release or exposure Discuss ways to provide effective technical expertise in situations involving potentially hazardous biological materials Identify, locate, and efficiently use key biosafety resources
- [13. Animal Handler Risk Assessment](https://absa.org/event/13-animal-handler-risk-assessment/) - This introductory webinar will provide an overview of the hazards associated with animal work and focus on the questions that should be asked in a risk assessment to elucidate the information needed to build a complete risk assessment profile for work conducted with animals and with animal derived tissues and specimens. The webinar will cover strategies for implementing the risk assessment, including how and when to involve other specialists, and integrating the process into the overall occupational health program. Circumstances where additional information is needed to complete the risk assessment will be identified; such situations will require follow-up interviews and in some cases site visits by the biosafety professional. Translation of the risk assessment into recommendations for risk mitigation will be discussed.
- [16. Gain-of-Function Research: Biosafety vs. Biosecurity](https://absa.org/event/16-gain-of-function-research-biosafety-vs-biosecurity/) - Gain-of-function research: biosafety v. biosecurity is a webinar designed for biosafety/biosecurity professionals and communicators to understand “gain-of-function" research that involves the creation of novel pathogens with pandemic potential. The goal is to develop an understanding and the tools to explain what gain-of-function research is; communicate why it is an important policy issue; and dispel myths about these and other studies that may constitute “dual-use research of concern”. The webinar will discuss the history and current debate, policy initiatives currently under consideration, and common myths and misunderstandings about these kinds of studies. A particular focus will be the difference between gain-of-function as a biosafety issue, compared to its biosecurity implications. At the conclusion, participants will grasp the policy, ethics, and history of gain-of-function research. The webinar will be led by a biosecurity expert with over 15 years’ experience studying, teaching on, and crafting policy for biosecurity for a variety of national and international groups.
- [14. APHIS 101:  Arthropod and Plant Research Permits](https://absa.org/event/14-aphis-101-arthropod-and-plant-research-permits/) - APHIS 101: Arthropod and Plant Research Permits is a webinar for those that work with plant pathogens, arthropods, or with genetically modified plants and insects. This course will provide participants with an overview of APHIS (Animal Plant Health Inspection Services) eFile including BRS (Biotechnology Regulatory Services), PPQ (Plant Protection and Quarantine), and VS (Veterinary Services) permitting. It will also review EPA (Environmental Protection Agency) labeling and wildlife permits and address intrastate and interstate movement of permitted organisms. The course will offer various scenarios and interactive exercises that show the process of applying for and acquiring permits. Participants will be guided through permit strategies.
- [17. Export Compliance for the Biosafety Professional](https://absa.org/event/17-export-compliance-for-the-biosafety-professional/) - Export Compliance for the Biosafety Professional is designed to help biosafety officers and other professionals understand how U.S. export control laws and regulations intersect with the roles and responsibilities of a biosafety administrator. The webinar will discuss the regulatory framework governing exports from the United States, how to navigate export compliance challenges in academic and medical research environments, and best practices for handling biological exports while maintaining safety and security.
- [08. Concepts of Virology](https://absa.org/event/08-concepts-of-virology/) - Concepts of Virology will briefly review gene expression in eukaryotes and examine several concepts of virology. Characteristics of different viral families will be presented as well as general replication strategies employed by different viruses. Mechanisms of viral pathogenesis and strategies for antiviral intervention will also be explored. Participants should have a familiarity with molecular biology. The course is targeted to the biosafety professional who does not actively conduct laboratory research but would like to gain a basic knowledge of virology.
- [06. Working with Highly Pathogenic Avian Influenza Virus (HPAIV)](https://absa.org/event/06-working-with-highly-pathogenic-avian-influenza-virus-hpaiv/) - Highly pathogenic avian influenza virus (HPAIV) has recently become widespread globally in animals. Human infections are rare but are reported consistently. Therefore, work with HPAIV may encompass a wide variety of activities including lab-based research, animal work, field studies, and handling of positive diagnostic specimens. The goal of this workshop is to enable the audience to understand the basics of HPAIV, the risk associated with handling the virus or positive samples, and mitigations for handling it. An introduction to the basic biology of HPAIV including a brief description of pathobiology including modes of transmission and exposure routes among different species. A summary of what is known about transmission of the virus to and from wild birds. What is known about transmission from avian species to mammals will be covered from both a virus, exposure route, and disease pathogenesis perspective. Biosafety and biosecurity for handing HPAIV in the lab, animal research and field specimens will be described.
- [USDA ARS 8th International Biosafety & Biocontainment Symposium](https://absa.org/event/usda-ars-8th-international-biosafety-biocontainment-symposium/) - February 10-13, 2025 Hilton Baltimore Inner Harbor Baltimore, Maryland Valuable professional development courses 2½ days of scientific presentations Exhibits showcasing the latest agricultural biosafety, biosecurity, and biocontainment products and services Network with professionals from the biosafety, biosecurity, and scientific research industries, organizations, and agencies
- [67th Annual Biosafety and Biosecurity Hybrid Conference](https://absa.org/event/67th-annual-biosafety-and-biosecurity-conference/) - The ABSA International conference is the largest biosafety and biosecurity conference in the world! The conference will provide solutions to tackle your most challenging issues, present fascinating case studies, and showcase the latest developments in biosafety and biosecurity. ABSA International’s educational sessions offer insights into the every-changing world of biosafety and biosecurity, keeping you updated on the latest techniques and best practices. You’ll have opportunities to network with your peers and discuss common issues, share advice, and exchange ideas. There will also be commercial exhibits showcasing the latest technologies in biosafety and biosecurity.
- [Preventing and Treating Biological Exposures: An Occupational Health Colloquium](https://absa.org/event/preventing-and-treating-biological-exposures-an-occupational-health-colloquium-2/) - Colloquium topics include: Newly updated Lentiviral Vector Guidelines Presented for the first time with primary author Gary Fujimoto, this program will discuss new issues associated with lentiviral and retroviral vectors along with updated recommendations for post-exposure prophylaxis. With the FDA approvals for multiple vector-based therapies, the number of individuals working with these agents is rapidly
- [SOLD OUT: Principles & Practices of Biosafety®](https://absa.org/event/principles-practices-of-biosafety-san-diego/) - ABSA INTERNATIONAL Principles & Practices of Biosafety® March 10-15, 2024 Embassy Suites San Diego Bay Downtown San Diego, CA Registration for this offering is currently closed. If you would like to add your name to the waitlist for early notification for the next session, please contact the ABSA Office at info@absa.org. Having your name on
- [Principles & Practices of Biosafety®](https://absa.org/event/principles-practices-of-biosafety-pittsburgh-pa/) - ABSA INTERNATIONAL Principles & Practices of Biosafety® July 9-14, 2023 Embassy Suites–Pittsburgh Downtown Pittsburgh, PA Principles & Practices of Biosafety® will introduce the essential elements of biosafety and provide extensive resource lists for use after the course. Interactive exercises will be used throughout to provide hands-on experience and to encourage networking and problem-solving among participants and instructors. Sessions begin at 8:00 am each day and end with a roundtable discussion between 5:15 and 5:30 pm with two coffee breaks and lunch provided.
- [07. Fundamentals of Microbiology and Infectious Disease](https://absa.org/event/07-fundamentals-of-microbiology-and-infectious-disease/) - Fundamentals of Microbiology and Infectious Disease is intended for those professionals that participate in protocol review, facilities planning, and any other risk assessment activities, but are unsure as to the actual nature of the disease risks of microbiological agents. Biological safety and risk assessment will not be covered in this course. The proposed topics will cover infectious agents, virulence factors, pathogenicities, host-microbe interactions, susceptibility, modes of transmission, and the changes seen in the microbial world. If you don’t know the difference between a TCID50, PFU, or ID50; or why HBV is stable in dried blood and HIV is not; or why influenza is an inhalation hazard; or why public health officials advocate flu shots each year—then this course is for you.
- [2024 April BioNet Symposium](https://absa.org/event/2024-april-bionet-symposium/) - 2024 BioNET Symposium Friday, April 26, 2024 9:00am am- 2:00 pm, PDT In Person: La Jolla Institute 9420 Athena Circle, La Jolla, CA 92037 OR Web Meeting via Zoom Link will be sent to registrants 24 hours prior to the meeting. Lunch will be provided for in-person meeting attendees. Topics include the following: Biosafety Level
- [Inaugural SBA-AMEXBIO International Symposium - 2024](https://absa.org/event/inaugural-sba-amexbio-international-symposium-2024/) - “Biosafety Beyond the Borders: Unifying Biosafety and Biosecurity” This collaborative, international symposium will consist of: Pre-symposium Courses (Four Course Options, 4-hours each) Full-day Symposium Vendor Booths More Info
- [04. Battling Professional Burnout by Taking Control of Your Biosafety Career](https://absa.org/event/04-battling-professional-burnout-by-taking-control-of-your-biosafety-career/) - Professional “burnout” arises from constant exposure to emotional and interpersonal stress and has been defined by the psychological community as exhibiting dimensions of exhaustion, cynicism, and inefficacy. While traditional means of addressing burnout include interventions such as rest, proper diet, and techniques for relaxation, an emerging body of knowledge is also identifying positive engagement as a promising option for consideration. The dimensions of engagement include renewed dedication, absorption, and vigor. In other words, reframing the way individuals approach their work and establishing strategies for gaining control of their careers can be a powerful means of addressing burnout. In this presentation, four practicing and credentialed biosafety professionals will share their collective experiences on how enhanced control over and a better understanding of the role of biosafety’s role can lead to a more professionally rewarding career. Strategies and examples of the techniques that have been used to achieve these goals will be described, and ample time will be allocated for questions and discussion.
- [Harvard Yale IBC Symposium 2024](https://absa.org/event/harvard-yale-ibc-symposium-2024/) - Harvard Yale IBC Symposium (HYS) 2024 Introduction and Overview The theme of the 2024 HYS symposium is high-risk research, including dual use research of concern, gain of function, transfer of drug resistance that may not be acquired naturally, altering the host range of pathogens, or enhancing a potential pandemic pathogen. The event will kick-off with
- [Harvard Yale IBC Symposium 2024 Pre-conference Courses](https://absa.org/event/harvard-yale-ibc-symposium-2024-pre-conference-courses/) - Harvard Yale IBC Symposium (HYS) 2024 Introduction and Overview The theme of the 2024 HYS symposium is high-risk research, including dual use research of concern, gain of function, transfer of drug resistance that may not be acquired naturally, altering the host range of pathogens, or enhancing a potential pandemic pathogen. The event will kick-off with
- [1V. Personnel Security in Laboratory Biosecurity Programs](https://absa.org/event/1v-personal-security-in-laboratory-biosecurity-programs/) - Personnel security is comprised of security measures focused on people and behaviors rather than typical physical barriers approaches. Personnel security can be thought as the "administrative controls" in any advanced security program. This course will teach administration, management, and researchers the basic principles of threat assessment and introduce participants to the role of comprehensive personnel security in a laboratory biosecurity programs. The course is intended to give participants a basic tool-kit that will allow them to implement successful comprehensive insider threat mitigation strategies using personnel security approaches at their home institutes and to convey concepts in personnel security to their colleagues. Participants will be presented with relevant case studies in order to learn about relevant threats in the biomedical and health sectors. Participants will learn about all aspects of personnel security including: suitability, reliability, peer and self reporting strategies, threat assessment, OPSEC, INFOSEC, and an introduction to elicitation, manipulation and surveillance awareness. These concepts will be put in to practice in interactive, live role-playing scenarios that include interview tactics, deception detection elicitation and surveillance detection. Regulatory issues relevant to implementation of personnel security management programs, in particular changes to the Select Agent Regulations pertaining to Tier 1 agents, will also be discussed.
- [12. PR & Communication Essentials for Biosafety Professionals](https://absa.org/event/12-pr-communication-essentials-for-biosafety-professionals/) - PR Essentials for Biosafety Professionals is a webinar for anyone who communicates with different audiences about biosafety. The course will provide a foundation in public relations practices including practical tips on how to: effectively communicate key biosafety messages to media and others within your organization; craft messages for different audiences, execute media training tactics and effectively position biosafety and yourself as the biosafety SME (Subject Matter Expert) within an organization. The webinar will highlight specific public relations techniques and media strategies, provide real-life scenarios, Dos and Don’ts for working with media and offer real-time discussions to apply lessons in practice-and-critique drills. At the end of this two-hour course, participants will have a baseline understanding of the importance of key message development, how to effectively work with members of the media (indu stry, trade, consumer) and how to leverage biosafety and subject matter expertise within an organization. The webinar will be led by communications experts with over 25 years’ experience developing and sharing messages with a wide variety of target audiences, including media.
- [Webinar: From Bench to Bedside: Navigating Biosafety in Gene and Cellular Therapy](https://absa.org/event/webinar-from-bench-to-bedside-navigating-biosafety-in-gene-and-cellular-therapy/) - The topic From Bench to Bedside: Navigating Biosafety in Gene and Cellular Therapy is presented by Dr. Alka Arora, Quality Program Manager at UHN. The advancement of cell and gene therapy towards standard clinical practice necessitates rigorous biosafety measures at every phase of development, spanning from initial basic laboratory research to clinical trial and commercial
- [International High Containment Operations and Maintenance Workshop](https://absa.org/event/international-high-containment-operations-and-maintenance-workshop/) - The Vaccine and Infectious Disease Organization (VIDO). the Canadian Association for Biological Safety/ L’Association Canadienne Pour La Sécurité Biologique (CABS-ACSB) and Merrick Canada ULC are pleased to co-present the International High Containment Operations and Maintenance Workshop . This workshop addresses the increasing needs of facility operators, maintenance and operations staff for training in relevant aspects
- [2024 Canadian Biosafety Symposium](https://absa.org/event/2024-canadian-biosafety-symposium/) - The Canadian Association for Biological Safety/L’Association Canadienne pour la Sécurité Biologique (CABS-ACSB) is happy to present the 2024 Canadian Biosafety Symposium! Join us in person in Saskatoon, Saskatchwean from September 17-19, 2024 for Canada’s annual event for biosafety professionals and personnel involved in biosafety and/or biocontainment facilities. The 2024 Canadian Biosafety Symposium is Canada's premier source of new knowledge and opportunity for dialogue across the biosafety community. It is the forum for advancing professional development and for building capacity for new solutions to be applied to the emerging challenges in laboratory biosafety and biosecurity. The Symposium consists of oral presentations and panels related to biosafety and biosecurity and provides networking opportunities for all biosafety professionals.
- [18th Annual Applied Biosafety Meeting](https://absa.org/event/18th-annual-applied-biosafety-meeting/) - Swiss Biosafety Network (SBNet) is pleased to announce its 18th Annual Applied Biosafety Meeting scheduled for August 22nd/23rd 2024 in Naters/Brig, Valais, Switzerland.
- [05. Biosafety and Good Manufacturing Practices (GMP): How to Live in Harmony](https://absa.org/event/05-biosafety-and-good-manufacturing-practices-gmp-how-to-live-in-harmony/) - Biosafety and Good Manufacturing Practices (GMP): How to Live in Harmony is a webinar that will help anyone who works in a GMP/quality environment that also must consider biosafety requirements. The webinar will discuss what GMP is, why it is important, and how to harmonize GMP and biosafety requirements and regulations. At the conclusion, participants will understand what GMP is, why it is critical for manufacturing facilities, and how to ensure biocontainment is maintained while also ensuring product safety. The webinar will be led by a biosafety professional with over 5 years’ experience in a GMP/manufacturing environment.
- [18th CDC International Symposium on Biosafety](https://absa.org/event/18th-cdc-international-symposium-on-biosafety/) - ABSA International is partnering with Eagleson Institute and Centers for Disease Control and Prevention to bring you the 18th CDC International Symposium on Biosafety Keynote addresses: James Connelly, CEO My Green Lab Renee Horton, PhD, Armstrong Flight Research Center, NASA. New this year: Tours: Emory Primate Center Field Research Station CDC Emergency Operations Center, Teaching
- [03. Prevent and Manage Amplicon Contamination in Laboratories](https://absa.org/event/03-prevent-and-manage-amplicon-contamination-in-laboratories/) - Preventing and Managing Amplicon Contamination in the Laboratory is a webinar that will help biosafety professionals, researchers, laboratory personnel, and other health and safety professionals to understand amplicon contamination, how to mitigate contamination events, and how to prevent future contamination. The webinar will discuss the lab processes that produce nucleic acid amplicons, their impacts to human health, the signs and symptoms of amplicon contamination, and how they can impact laboratory work or research. At the conclusion, participants will be able to develop strategies to manage and prevent amplicon contamination and understand the importance of this topic for biosafety professionals.
- [2024 BioNet Hybrid Lunch Meeting](https://absa.org/event/2024-bionet-hybrid-lunch-meeting/) - Please register for our 2024 BioNet Hybrid Lunch Meeting which will happen on February 23rd, 2024. Topics covered include: Viral Vector Overview and ABSA Credentials. Participants are eligible for up to 0.25CM points. Register Now
- [2V. Tactical Implementation of Biosecurity Principles: An Advanced, Scenario-Driven Course on Risk and Threat Management Programs](https://absa.org/event/2v-tactical-implementation-of-biosecurity-principles-an-advanced-scenario-driven-course-on-risk-and-threat-management-programs/) - A distinguishing factor between security and biosecurity programs is the fact that biosecurity programs are focused on assets that are biological in nature. This brings forth unique distinctions in implementing risk- and threat-based approaches to prevent the release, loss, or theft of these assets. This advanced workshop will challenge attendees to fully analyze a single biosecurity driven scenario through a series of risk and threat management decision-making. Participants will learn the principles of biosecurity, which set it apart from traditional security, by applying tactical methodology to analysis of a real-world biosecurity case study. The outcomes of this intensive course will be identification of biosecurity-specific risk and threats, their corresponding prioritization against a mitigation plan, approaches for blending these inputs for comprehensive biorisk management, and finally, an integrated biosecurity plan. Participants will leave the course with tools that will be applicable to their host institutions for future engagements building effective integrated biosecurity plans against scenarios.
- [4V. Using One Health to Advance Biosecurity](https://absa.org/event/4v-using-one-health-to-advance-biosecurity/) - Agricultural biosecurity is a critical component of the One Health concept. It includes various strategies designed to safeguard the health and welfare of agriculturally important animals, the environment, and society in general by preventing infections and their spread among these species, humans, and nontarget species, including wildlife. Increased movement of live animals and their products, as well as the growing trend towards intensification and expansion of animal production systems, represents a significant risk to food supply chains, public health, and the economy due to the possible emergence and spread of exotic animal pests and pathogens, zoonotic diseases, and foodborne agents. Effective management and control of these challenging and complex risks requires application of core principles and cohesive strategies that emphasize sustainability through improved husbandry and health management practices.
- [3V. Using the Incident Command System for Responding to Biosecurity Incidents](https://absa.org/event/3v-using-the-incident-command-system-for-responding-to-biosecurity-incidents/) - The Incident Command System (ICS) is the national gold standard for responding to any size incident in the United States. President George W. Bush mandated its use for all Federal Agencies and strongly recommended its use at all levels of government and within private organizations. The authors of this course have a significant amount of ICS experience, including the highest level of qualification in ICS: Type 1 Incident Commander. They have successfully used ICS in real-life laboratory incidents and Biosecurity exercises. The instructors intend to give the participants an overview of ICS and enough information to incorporate the system into their plans, training, and exercises. This will enable participants to begin maximizing response effectiveness and efficiency during a real laboratory incident.
- [01. What is Biosecurity? Why is it Important?](https://absa.org/event/01-what-is-biosecurity-why-is-it-important/) - In order to mitigate biorisks, entities must integrate biosafety and biosecurity to effectively identify, assess, control, evaluate, and develop informed plans to mitigate risks inherent to their activities. In this webinar we will discuss the importance of biosecurity as a part of a robust biorisk management program. We will define biosecurity, explore the importance of biosecurity, provide employee awareness considerations, and address the basics of developing integrated biosecurity plans. We will also discuss considerations for special communities, such as laboratory animals and clinical laboratory services.
- [Virus-based Gene Transfer Vectors](https://absa.org/event/virus-based-gene-transfer-vectors/) - Virus-based Gene Transfer Vectors is an intermediate course that will examine the molecules, processes, and techniques involved in recombinant gene expression. Participants will explore the technology of how viruses are converted into vector systems for the transfer of gene expression constructs. Common viral vector systems, including retroviruses, lentiviruses, adenoviruses, poxviruses, herpesviruses, alphaviruses, and baculoviruses will be discussed with an emphasis on the biosafety characteristics of the vectors derived from these viruses. This course is targeted for the biosafety professional who is not actively conducting laboratory research yet requires a basic understanding of recombinant DNA methodology.
- [Molecular Biology 101](https://absa.org/event/molecular-biology-101/) - Molecular Biology 101 is intended for those professionals that participate in protocol review, facilities planning, and other risk assessment activities but lack a basic understanding of molecular biology and techniques. Following this course, attendees will be able to do more than regurgitate facts and use the new understanding of the principles of molecular biology in various situations at their institution. This course will cover topics such as the chemistry of nucleic acids, DNA replication, RNA transcription, and protein translation, the Central Dogma of Biology, DNA cloning, transfection of prokaryotic and eukaryotic cells, restriction enzymes, and recombinant DNA lab methodologies (including PCR, DNA fingerprinting, sequencing, and detection protocols). While this course will not turn you into a molecular biologist, it will give you enough background information to understand the nature and manipulation of genetic material and hopefully unveil the mystery of deoxyribonucleic acid.
- [Large-scale Biosafety](https://absa.org/event/large-scale-biosafety/) - Large-scale Biosafety will review biosafety for work at large-scale, which the NIH rDNA Guidelines defines as >10L. The course will review Appendix K from GLSP to BSL-3 LS, with a focus on primary and secondary containment. It will review basic bioprocessing steps, such as fermentation/cell culture and purification technologies. Examples of classic and newer single use technologies will be provided. Pearls and pitfalls of the various technologies will be discussed, using various scenarios. The course will include a review of risk assessment techniques used for large scale bioprocesses and a discussion of large-scale related to vaccines, viral vectors, and recombinant proteins.
- [02. Updating Your Preparedness Toolbox for Future Outbreaks or Pandemics](https://absa.org/event/02-updating-your-preparedness-toolbox-for-future-outbreaks-or-pandemics/) - What’s coming next in the world? Do you have the tools you need to be prepared for the next outbreak or pandemic? Updating Your Preparedness Toolbox for Future Outbreaks or Pandemics is a roundtable discussion that will feature several biosafety and public health professionals. The panelists, who work across government, academia, industry, and public health, will discuss aspects of their institution’s response to emerging and reemerging pathogens and infectious disease emergencies. Lessons learned from previous emergencies will be shared. Topics will include risk assessment, communication challenges and solutions, program and policy changes, and occupational health.
- [CABS-ACSB Webinar: Why do Biosafety Professionals Move to Other Countries?](https://absa.org/event/cabs-acsb-webinar-why-do-biosafety-professionals-move-to-other-countries/) - Please join us on January 30, 2024 for the next webinar available to CABS-ACSB Members as part of our webinar series! The topic Why do Biosafety Professionals Move to Other Countries? is presented by Luis Ochoa Carrera, Office of Environmental Health and Safety at Michigan State University. In some countries, biosafety professionals are known as
- [FREE MABioN Webinar - Considerations for Working with LCMV - From Bench to Bedside](https://absa.org/event/free-mabion-webinar-considerations-for-working-with-lcmv-from-bench-to-bedside/) - Webinar summary: Lymphocytic choriomeningitis virus (LCMV) is a single-stranded RNA arenavirus commonly used in laboratory animal models to examine acute and chronic viral infections and immunopathology. However, there is wide variation in LCMV biosafety practices between institutions, based on differing interpretations of guidelines and risk data. This lack of consensus can pose a challenge to
- [FRaBSA Fall Meeting](https://absa.org/event/frabsa-fall-meeting/) - FRaBSA Fall Meeting January 26, 2024 (all times are MST) Agenda 11:30-12:00 pm Gathering/Welcome/Introductions- Megan Brose, FRaBSA President Business Meeting-Megan Brose, FRaBSA President Outreach Committee Report, Education Committee Report, Communication Committee Report, Finance Report, New Topics 12:00-12:30 pm Sponsor Presentation: Merrick 12:30-1:15 pm Proposed Updates to the NIH Guidelines and Other Stories Kathryn Harris, Senior
- [ChABSA Hybrid Technical Seminar: Infectious and Emerging Infectious Disease (Virtual Only)](https://absa.org/event/chabsa-hybrid-technical-seminar-infectious-and-emerging-infectious-disease-virtual-only/) - Join Chesapeake Area Biological Safety Association for a virtual presentation by: Gene Olinger, Ph.D., M.B.A., Adjunct Associate Professor, Infectious Diseases, Associate Director for Maximum Containment Training, NEIDL
- [Select Agents ChABSA Technical Seminar - Hybrid Event](https://absa.org/event/select-agents-chabsa-technical-seminar-hybrid-event/) - Elected President of ABSA International, Sherry Bohn, PhD, MSL, CBSP (ABSA), acting director of environmental health and safety (EHS) at the University of Maryland, Baltimore will present on the “ins and outs” of the Select Agent Program, when you need to and don’t need to register, and much more. A microbiologist by training, Dr. Bohn
- [Emergency Planning For Different Laboratories: A Panel Discussion - Hybrid Meeting](https://absa.org/event/emergency-planning-for-different-laboratories-a-panel-discussion-hybrid-meeting/) - Join the Chesapeake Area Biological Safety Association for a panel discussion about emergency planning for different types of laboratories with distinguished panelists: Garth Phoebus, M.S., Chief of Emergency Management, USAMRIID Jonathan Bratt, M.S., C.E.M., N.R.P., Assistant CP, Office of Enterprise Resilience, University of Maryland, Baltimore David Ferris, Executive Director, Safety and Emergency Management, George Mason
- [2024 ABSA Biosafety and Biosecurity Training Course (BBTC®) Fort Collins](https://absa.org/event/2024-absa-bbtc-fort-collins/) - August 5-9, 2024 Hilton Fort Collins Fort Collins, Colorado A WEEK-LONG COURSE COVERING ANIMAL, GENERAL, AND PLANT BIOSAFETY AND BIOSECURITY Download the course flyer (PDF)The Biosafety and Biosecurity Training Course (BBTC®) is designed for persons who are interested in the varying aspects of the responsibility of biosafety professionals. It is also suitable for persons who
- [7V. Laboratory Facility Programming and Design Best Practices](https://absa.org/event/7v-laboratory-facility-programming-and-design-best-practices/) - This course will offer guidance of key principles underlying the programming and design of research and diagnostics laboratories. It is intended for architects, designers, and biosafety professionals desiring an increased awareness of the complexity and challenges associated with designing a laboratory. Participants will be introduced to the laboratory design process as it relates to programming and pre-design, building zoning, operational efficiency, biosafety and biosecurity considerations, and flexible/expandable strategies. Participants will participate in guided discussions, develop diagrams to illustrate best practice concepts, and analyze existing plans with respect to the design principles under discussion.
- [14. The FBI’s Weapons of Mass Destruction (WMD) Program  and Safeguarding the Bioeconomy](https://absa.org/event/14-the-fbis-weapons-of-mass-destruction-wmd-program-and-safeguarding-the-bioeconomy/) - The FBI’s Weapons of Mass Destruction (WMD) Program and Safeguarding the Bioeconomy webinar will demonstrate how the FBI’s WMD Program interfaces with biosafety officers. This information can be helpful especially as biosafety offices deal with the evolving threat that biotechnology can pose. With its rapid growth, the U.S. bioeconomy increasingly serves as a critical foundation for American competitiveness in a global environment. When it comes to security, biological threats have historically focused on emerging infectious diseases or the possibility of engineering a virus that could start a zombie apocalypse. As biology continues to converge with cyber, new security challenges will arise. This presentation will highlight the need to radically redefine what we consider biological and cyber threats.
- [10V. Institutional Biosafety and Biosecurity – Enhancing Oversight through Effective Governance](https://absa.org/event/10v-institutional-biosafety-and-biosecurity-enhancing-oversight-through-effective-governance/) - This course will discuss the importance of ensuring institutions have robust and comprehensive biosafety and biosecurity governance structures in place. Information will be provided about Federal activities related to strengthening biosafety and biosecurity practices and oversight. Participants will discuss and share tools and best practices that institutions can employ to enhance their biosafety and biosecurity programs.Participants will break into small groups to discuss a case study involving a biosafety incident occurring at an institution subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), which illustrates the importance of institutional biosafety oversight and how inadequate local oversight can result in significant problems. Participants should ideally have a working knowledge of the roles and responsibilities of institutions, Institutional Biosafety Committees (IBCs), and Institutional Review Entities (IREs) for biosafety and biosecurity oversight of research subject to the NIH Guidelines and the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC).
- [The Importance of Biosecurity for Public Health and Safety](https://absa.org/event/the-importance-of-biosecurity-for-public-health-and-safety/) - The SWCOEH Industrial Hygiene Seminar Series is presented by industrial hygienists, safety professionals, and other public health professionals to discuss emerging issues, trends in technology, current research, and applicable tools for use in the field. Industry professionals and academic experts provide practical lessons in management, equipment, compliance, and the latest in research and technology. SWCOEH
- [13. Maintaining Your ABSA Credentials: I have it, now how do I keep it?](https://absa.org/event/13-maintaining-your-absa-credentials-i-have-it-now-how-do-i-keep-it/) - Maintaining Your ABSA Credentials: I have it, now how do I keep it? is a webinar designed for those who currently hold the ABSA International Registered Biosafety Professional (RBP) and/or Certified Biological Safety Professional (CBSP) credentials. The webinar will outline the re-credentialing process, review form options, and highlight the various ways to earn credentialing maintenance (CM) points, including tips on finding lower cost professional development opportunities. Presenters will review how and when approval is needed and explain how to complete the Application for Credentialing Maintenance Points form for an activity not already on the approved list of professional development opportunities. The webinar will provide ideas for tracking activities over the 5-year period, guidance on what records to save in case you are chosen for audit, and tips on avoiding common mistakes throughout the process. A brief tour of the relevant areas of the ABSA website will be shown and then there will be time for questions and answers.
- [2023 Biosafety and Biosecurity Month](https://absa.org/event/2023-biosafety-and-biosecurity-month/) - ABSA International is proud to announce the 10th anniversary of Biosafety and Biosecurity Month in October 2023. Rather than a theme for 2023, we like to bring Biosafety and Biosecurity Month back to the core components of ethical research, transparency, training, engagement, and stewardship of biosafety and biosecurity. Use this month to shine the spotlight
- [BSL-3 Operations, Maintenance & Verification Training](https://absa.org/event/bsl-3-operations-maintenance-verification-training/) - This introductory course is a four-day training designed to certify personnel for safe entry into an operational BSL-3 laboratory. This course consists of a mixture of classroom and practical training that includes an introduction to microbiology, biosafety, risk assessment concept, BSL-3 lab characteristics, emergency management and personal protective equipment (PPE) use including procedures for donning
- [06. Virus-based Gene Transfer Vectors](https://absa.org/event/06-virus-based-gene-transfer-vectors/) - Virus-based Gene Transfer Vectors is an intermediate course that will examine the molecules, processes, and techniques involved in recombinant gene expression. Participants will explore the technology of how viruses are converted into vector systems for the transfer of gene expression constructs. Common viral vector systems, including retroviruses, lentiviruses, adenoviruses, poxviruses, herpesviruses, alphaviruses, and baculoviruses will be discussed with an emphasis on the biosafety characteristics of the vectors derived from these viruses. This course is targeted for the biosafety professional who is not actively conducting laboratory research yet requires a basic understanding of recombinant DNA methodology.
- [Safety for NonProfits Inc. and the Biosafety Professional](https://absa.org/event/safety-for-nonprofits-inc-and-the-biosafety-professional/) - Safety for NonProfits Inc. and the Biosafety Professional A free webinar Friday, September 22, 2023 2:00pm (CDT) Register Now Registration for the live webinar must be completed 1 business day prior to the start of the training. Registrations received after will receive access to the recording only. Thinking about providing your biosafety (or EHS) expertise
- [12. Techniques and Tools for Conducting Relevant Literature Reviews](https://absa.org/event/12-techniques-and-tools-for-conducting-relevant-literature-reviews/) - Techniques and Tools for Conducting Relevant Literature Reviews will cover how to efficiently conduct high-impact research that can inform biosafety practices. The course will discuss the general purpose of a literature review, how to best organize the resources you collect, and techniques for synthesizing the literature. It will cover basic information on the kinds of scholarly texts available, where to search for information, citation best practices, and plagiarism avoidance. With many tools in the marketplace, this webinar will also provide an overview of reliable reference management tools to help curate resources and provide basic guidance on knowledge management tools to promote information retention over time.
- [ChABSA Hybrid Technical Seminar:  Empirical Research in Biosafety: Filling Key Data Gaps](https://absa.org/event/chabsa-hybrid-technical-seminar-empirical-research-in-biosafety-filling-key-data-gaps/) - Empirical Research in Biosafety: Filling Key Data Gaps Presented By: Rocco Casagrande, Ph.D., Executive Chairman, Gryphon Scientific In this session, we will present data from our empirical work in biosafety and our work exploiting existing data sets to inform biosafety. We will discuss our methodological framework for studying aerosols generated by laboratory accidents, and present information on the
- [3rd International Biosecurity Virtual Symposium](https://absa.org/event/3rd-international-biosecurity-virtual-symposium/) - May 7-8, 2024 The Symposium will bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge on diverse biosecurity topics. The Symposium will offer attendees an opportunity to learn the latest in biosecurity and have thought-provoking conversations about real-world biosecurity issues, concerns, and scenarios. Who should
- [05. Molecular Biology 101](https://absa.org/event/05-molecular-biology-101/) - Molecular Biology 101 is intended for those professionals that participate in protocol review, facilities planning, and other risk assessment activities but lack a basic understanding of molecular biology and techniques. Following this course, attendees will be able to do more than regurgitate facts and use the new understanding of the principles of molecular biology in various situations at their institution. This course will cover topics such as the chemistry of nucleic acids, DNA replication, RNA transcription, and protein translation, the Central Dogma of Biology, DNA cloning, transfection of prokaryotic and eukaryotic cells, restriction enzymes, and recombinant DNA lab methodologies (including PCR, DNA fingerprinting, sequencing, and detection protocols). While this course will not turn you into a molecular biologist, it will give you enough background information to understand the nature and manipulation of genetic material and hopefully unveil the mystery of deoxyribonucleic acid.
- [6V. Selection and Use of Personal Protective Equipment (PPE)](https://absa.org/event/6v-selection-and-use-of-personal-protective-equipment-ppe/) - Recent infectious disease outbreaks highlighted the need for the proper use of Personal Protective Equipment (PPE). The guidance on use of appropriate PPE varies greatly and can often be contradicting and therefore confusing to the end user. Furthermore, availability of different PPE often varies depending on the situation and location. Selection of appropriate PPE should be based on a comprehensive risk assessment that takes in consideration the different hazards present, as well as the procedures/activities to be conducted. Often times, locations where PPE is needed vary as well, from a well-controlled laboratory environment to collection room or a field location, and even in a patient room setting. Each of these situations require staff to be able to perform a comprehensive risk assessment, often in a fast-evolving situation and with a minimal understanding of specifications associated with different PPE components available to them. This course will provide overview of different PPE options available; specifications associated with each option, and address a risk assessment process for selection of appropriate PPE for different environments. The examples will include some of the most common issues and considerations when selecting PPE such as supply chain issues as well as strategies to address behavioral concerns that may arise. In groups, participants will develop risk assessment for different scenarios, present their risk assessment to the class, and evaluate each other’s PPE selection based on their risk assessment. Instructors will guide participants through the process by providing critical feedback on the PPE features and selection process as they progress. The course will go through an effective risk assessment process which is critical for proper selection of appropriate PPE. The course is intended for those who want to be able to lead or aid in the selection of appropriate PPE in order to enhance both biosafety and biosecurity at their institution.
- [4V. IBC and IRE Basics](https://absa.org/event/4v-ibc-and-ire-basics/) - IBC Basics is an introductory course on the function and administration of Institutional Biosafety Committees (IBCs) delivered by expert staff from the National Institutes of Health (NIH) Office of Science Policy (OSP). IBC Basics will promote the professional development of those associated with IBCs by providing an opportunity to learn about the role of NIH OSP, the content of the NIH Guidelines for Research Involving Recombinant and Synthetic Nucleic Acid Molecules, and understand the range of biosafety oversight responsibilities that IBCs have under the NIH Guidelines. This course provides an overview and may be helpful for those new to the field or for those who are also interested in the Institutional Biosafety and Biosecurity Oversight Governance workshop.
- [5V. Keeping it Going: Maintaining and Improving a Select Agent Program over the Long Term](https://absa.org/event/5v-keeping-it-going-maintaining-and-improving-a-select-agent-program-over-the-long-term/) - Keeping a select agent program going can be difficult, especially in the face of ever-changing regulatory requirements and limited resources. Established procedures may suddenly become unacceptable, interrupting research, and frustrating laboratorians. Likewise, a single unexpected adverse event can put an entire program at risk. Being prepared to deal with such changes and events is critical to maintaining a robust program. Anticipating future challenges can be even more advantageous, elevating a program from good to great. A proactive approach can minimize the impact of new requirements and reduce duration and frequency of crises sparked by sudden, unexpected requirements or events. This course will explore strategies for maintaining and improving an existing program, including how to anticipate and respond to new requirements. The focus will be on U.S. select agent requirements, although a small section on comparable requirements in the international community will be included. Strategies will be based on the instructors’ experience with their program with additional input solicited from class participants during open discussions. Topics will include select agent program history; effective oversight; efficiently meeting ongoing requirements; reporting, responding to, and analyzing incidents; suitability program case studies; inactivation requirements, including “failure” investigation; and inspection preparation and response. The course will consist of topical presentations followed by group discussions aimed at facilitating application of presented strategies to participants’ individual programs and providing a platform to capitalize on participants’ collective experience.
- [3V. When & Why Does Biosafety Need a Seat at the Plant Research Design Table?](https://absa.org/event/3v-when-why-does-biosafety-need-a-seat-at-the-plant-research-design-table/) - Plant Biosafety is a niche within the biosafety community. How to build and maintain a greenhouse, arthropod and seed processing program can be challenging for biosafety managers because there have not been many courses offered on this topic. This class offers the basics from head house to pathogen/arthropod containment greenhouse design. Plant research is the backbone of both genetically modified, disease resistance, growth enhancement, seed health and breeding of both academic and biotechnology research. Plant biosafety is a niche within biosafety that makes you ask – Do the engineers and project managers understand the need for and when to ask for biosafety input? This course will provide participants with an overview of designing greenhouses from headhouse, seed activities to arthropod containment using the APHIS and ACL containment guidelines. The course will offer a variety of advanced scenarios and interactive exercises that demonstrate the range of biological and other risks routinely encountered in plant research. Participants will be guided through strategies for identifying potential hazards, assessing the magnitude and extent of induced risks and cost, and developing effective control measures to protect the safety of workers, plants, and the environment. The course employs “real world” examples to improve understanding of greenhouse, arthropod and seed operations.
- [2V. Introduction to the Science and Biosafety of Cell and Gene Therapy Clinical Trials](https://absa.org/event/2v-introduction-to-the-science-and-biosafety-of-cell-and-gene-therapy-clinical-trials/) - The use of recombinant and synthetic nucleic acid molecules in clinical trials is growing at an explosive pace. This course is intended to introduce biosafety professionals to the science and biosafety of gene-based investigational products in clinical trials including gene-based vaccines, gene modified cellular products, gene therapy and gene editing. This course will provide an overview of molecular biology, virology and viral vectors. Participants will discuss risk assessments and best practices for dealing with risks associated with diverse types of biological hazards.
- [1V. Introduction to Biosafety in the Clinical Setting](https://absa.org/event/1v-introduction-to-biosafety-in-the-clinical-setting/) - The clinical setting poses a different environment than research laboratories. This course provides foundations for applying biosafety concepts in the clinical setting. Topics covered include common issues and lessons learned pertaining to clinical facilities including pharmacies, laboratories, clinics, infusion areas, ORs, and waste disposal facilities; PPE, disinfection, risk assessments, and safety practices in the clinical setting; speaking biosafety to doctors, nursing staff, pharmacy staff, infection prevention and control, diagnostic microbiology lab personnel, and hospital EHS staff; applying NIH Guidelines and the BMBL to the clinical setting; gaps in oversight of research safety for clinical trials, and risk assessments for unconventional or highly specialized delivery mechanisms for biologics. The course will conclude with a focus on clinical trials including the role of an IRB and how it can overlap with an IBC; the process for investigational products to obtain FDA approval to be deemed as safe and effective therapeutics; and the evolving regulatory environment in the U.S. for biologics such as vaccines, regenerative medicines, and gene therapy. The course is designed to be highly interactive with discussions, surveys, and team exercises.
- [11. Large-scale Biosafety](https://absa.org/event/11-large-scale-biosafety/) - Large-scale Biosafety will review biosafety for work at large-scale, which the NIH rDNA Guidelines defines as >10L. The course will review Appendix K from GLSP to BSL-3 LS, with a focus on primary and secondary containment. It will review basic bioprocessing steps, such as fermentation/cell culture and purification technologies. Examples of classic and newer single use technologies will be provided. Pearls and pitfalls of the various technologies will be discussed, using various scenarios. The course will include a review of risk assessment techniques used for large scale bioprocesses and a discussion of large-scale related to vaccines, viral vectors, and recombinant proteins.
- [04. Concepts of Virology](https://absa.org/event/04-concepts-of-virology/) - Concepts of Virology will briefly review gene expression in eukaryotes and examine several concepts of virology. Characteristics of different viral families will be presented as well as general replication strategies employed by different viruses. Mechanisms of viral pathogenesis and strategies for antiviral intervention will also be explored. Participants should have a familiarity with molecular biology. The course is targeted to the biosafety professional who does not actively conduct laboratory research but would like to gain a basic knowledge of virology.
- [Lab Facilities Summit West](https://absa.org/event/lab-facilities-summit-west/) - Changing regulations, skilled labor attraction and retention issues, increased sustainability goals, and rising costs are just some of the challenges facing the global lab community. However on top of these common planning, design, and regulatory challenges, lab owners on the West Coast are facing unique complexities such as aging stock, high costs, environmental challenges, and state-specific
- [UCI BSL-3 Laboratory Training](https://absa.org/event/uci-bsl-3-laboratory-training-2/) - Researcher training is a four-day intensive training for laboratory staff working in high-containment. These courses are designed to prepare new staff for the basics of safely working in BSL-3 laboratories and include a mixture of practical and classroom courses covering: Review of biosafety principles and levels Risk assessment and management Waste management Laboratory management Safety
- [UCI BSL-3 Laboratory Training](https://absa.org/event/uci-bsl-3-laboratory-training/) - Researcher training is a four-day intensive training for laboratory staff working in high-containment. These courses are designed to prepare new staff for the basics of safely working in BSL-3 laboratories and include a mixture of practical and classroom courses covering: Review of biosafety principles and levels Risk assessment and management Waste management Laboratory management Safety
- [MABSA 35th ANNUAL HYBRID  BIOSAFETY SYMPOSIUM](https://absa.org/event/mabsa-35th-annual-hybrid-biosafety-symposium/) - MABSA is pleased to announce our upcoming 35th Annual Hybrid Biosafety Symposium. Please register and pay at www.mabsa.org. DATE: Thursday, June 15, 2023 **In-person registration deadline is 05/31/2023.** LOCATION: Merck & Company, Inc. (Rahway, NJ) AGENDA 8:10am - 8:30 am -- ABSA update Lou Ann Burnett, MS, CBSP(ABSA), Past President of ABSA 8:30 am – 9:20
- [The Association of Biosafety for Australia and New Zealand, 11th Annual Conference](https://absa.org/event/the-association-of-biosafety-for-australia-and-new-zealand-11th-annual-conference-30-october-3-november-queenstown-new-zealand/) - The 2023 conference will be the first opportunity for our community to come together in New Zealand, since the onset of the COVID-19 pandemic. We’re excited to be hosting the 2023 ABSANZ Conference in Queenstown, a city well-known as New Zealand's gateway to world-class nature, food and wine as well as cultural activities and experiences.
- [17th Annual Applied Biosafety Meeting](https://absa.org/event/17th-annual-applied-biosafety-meeting/) - The 17th Applied Biosafety Meeting will take place over two days in Basel on August 24th/25th 2023. More information on the event as well as the preliminary program may be found on our website: www.swissbiosafety.ch
- [Canadian Biosafety Symposium](https://absa.org/event/canadian-biosafety-symposium/) - The Canadian Biosafety Symposium will feature presentations on an array of biosafety topics, including emergency management for labs, building a biosafety culture, biosafety and public health, emerging and re-emerging diseases, laboratory acquired infections, ergonomics and safety, biowaste management and disinfection, regulations, airflow, ventilation, design and biosafety, animal issues, audits and inspections, occupational health and surveillance.
- [66th Annual Biosafety and Biosecurity Hybrid Conference](https://absa.org/event/66th-annual-biosafety-and-biosecurity-hybrid-conference/) - October 13-18, 2023 CHI Health Center Omaha, Nebraska Intensive professional development courses to educate and inspire Three full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today’s biosafety and biosecurity professionals In-person exhibits showcasing the latest in laboratory biosafety and biosecurity products and services Invaluable networking opportunities to
- [BSL-3 Operations, Maintenance, and Verification (ANSI Z9.14) Training](https://absa.org/event/bsl-3-operations-maintenance-and-verification-ansi-z9-14-training/) - This introductory course is a four-day training designed to certify personnel for safe entry into an operational BSL-3 laboratory. This course consists of a mixture of classroom and practical training that includes an introduction to microbiology, biosafety, risk assessment concept, BSL-3 lab characteristics, emergency management and personal protective equipment (PPE) use including procedures for donning
- [09. Occupational Health: An Overview](https://absa.org/event/09-occupational-health-an-overview/) - Occupational health is a multi-disciplinary approach to programs and services aimed at protecting and preserving the health of the workforce within the various research and laboratory environments. This live webinar will serve as an overview of research and laboratory occupational health and will include a wide range of topics to consider in an effective occupational health program. Attendees will have the opportunity to obtain key knowledge of the components necessary for an effective occupational health program, applicable to their own program or for the establishment of such a program. Emphasis will be on developing or improving your program within regulatory requirements and application of best evidence-based practices, as well as the availability of internal and community resources. The sessions will highlight health and safety hazards (biological, chemical, physical, psychological) in research and laboratory settings (clinical, bench laboratory, animal work, field work); stress the use of risk assessment to determine priorities and to clarify decision-making; and identify approaches to the services necessary to provide illness and injury prevention across the continuum of work (pre-work baseline, periodic, post exposure, and exit from the workplace).
- [07. Train-the-Trainer: Beyond the Basics](https://absa.org/event/07-train-the-trainer-beyond-the-basics/) - Train-the-Trainer: Beyond the Basics is a webinar designed to take your instructor-led training to the next level. Using hands-on, practical applications you will learn to address the unique needs of adult learners (including accessibility needs), effectively plan your next training, and utilize tips and tricks to improve your facilitation. This webinar will show you how to use a simple planning tool as a guide to make the most of your development time and more easily help you design an effective PowerPoint presentation. Looking to use tools to enhance your training? Join us as we incorporate a variety of interactive tools such as whiteboards and polls to gain real-time feedback. This webinar will show you how to effectively use questions to engage your in-person and virtual audiences, and help you establish rapport and trust with your participants. The webinar will be led by a training manager with 25 years’ experience designing and developing educational experiences for private and public clients.
- [10. Q&A Infectious Substance Shipping](https://absa.org/event/10-qa-infectious-substance-shipping-2023/) - Q&A Infectious Substance Shipping webinar provides an opportunity for participants to learn about recent changes to international regulations and interact with a panel of shipping experts. Regulatory experts from organizations to be determined and have been invited along with a packaging expert from Saf-T-Pak/Labelmaster to discuss hazardous material shipping. Participants will be afforded an opportunity to submit questions for the panel to review in advance. As many questions as possible will be discussed during the webinar. Questions not addressed will be collated, answered by the experts, and provided to all participants along with a transcript of the session.
- [03. Fundamentals of Microbiology and Infectious Disease](https://absa.org/event/03-fundamentals-of-microbiology-and-infectious-disease/) - Fundamentals of Microbiology and Infectious Disease is intended for those professionals that participate in protocol review, facilities planning, and any other risk assessment activities, but are unsure as to the actual nature of the disease risks of microbiological agents. Biological safety and risk assessment will not be covered in this course. The proposed topics will cover infectious agents, virulence factors, pathogenicities, host-microbe interactions, susceptibility, modes of transmission, and the changes seen in the microbial world. If you don’t know the difference between a TCID50, PFU, or ID50; or why HBV is stable in dried blood and HIV is not; or why influenza is an inhalation hazard; or why public health officials advocate flu shots each year—then this course is for you.
- [Environmental Health and Safety Academy II](https://absa.org/event/environmental-health-and-safety-academy-ii/2023-04-10/) - Monday, March 27, 2023 - Friday, April 10, 2023 New attendees are welcome! Participation in Part I (held in spring 2022) is not required to enroll in this course. About the Course The Environmental Health & Safety Academy is a unique course designed to provide you with the general skills needed to identify, evaluate and control workplace hazards, particularly those found
- [ABSA BBTC FORT COLLINS® AUGUST 7-11, 2023 FORT COLLINS, COLORADO](https://absa.org/event/absa-bbtc-fort-collins/)
- [Preventing and Treating Biological Exposures: An Occupational Health Colloquium](https://absa.org/event/preventing-and-treating-biological-exposures-an-occupational-health-colloquium/) - Preventing and Treating Biological Exposures: An Occupational Health Colloquium (June 11-14, 2023) ABSA International is a co-sponsor of the 13th annual “Occupational Health Colloquium: Preventing and Treating Biological Exposures”. The Colloquium is being held June 11-14, 2023 at the Embassy Suites in Alexandria, VA. It begins with a special event, a unique day-long “Behind the Scenes”
- [30th International Biodetection Technologies: Advanced Technologies & Methods for Global Health & Biodefense](https://absa.org/event/30th-international-biodetection-technologies-advanced-technologies-methods-for-global-health-biodefense/) - CHI announces final details for the 30th International Biodetection Technologies virtual conference on June 7-8, 2023. This internationally recognized meeting is for experts in detection & identification of biological threats. This 2-part event will address the key topics in detection and present the latest R&D and technological innovation in ready-to-market systems. In addition, this meeting
- [SEBSA Symposium](https://absa.org/event/sebsa-symposium/) - The Southeastern Biosafety Association invites you to join us in Atlanta for informative talks, helpful tours, and of course networking with other Biosafety professionals.
- [01. Arthropod Research, Containment, Biosafety and Beyond](https://absa.org/event/01-arthropod-research-containment-biosafety-and-beyond/) - Virus-based Gene Transfer Vectors is an intermediate course that will examine the molecules, processes, and techniques involved in recombinant gene expression. Participants will explore the technology of how viruses are converted into vector systems for the transfer of gene expression constructs. Common viral vector systems, including retroviruses, lentiviruses, adenoviruses, poxviruses, herpesviruses, alphaviruses, and baculoviruses will be discussed with an emphasis on the biosafety characteristics of the vectors derived from these viruses. This course is targeted for the biosafety professional who is not actively conducting laboratory research yet requires a basic understanding of recombinant DNA methodology.
- [BioRisk Reduction Bloodborne Pathogens Training Tier I & II (Laboratory Personnel and Laboratory Management)](https://absa.org/event/biorisk-reduction-bloodborne-pathogens-training-tier-i-ii-laboratory-personnel-and-laboratory-management/) - Tier I Approved for 0.125 CM points 23-2280 Tier II Awaiting ABSA Response for CM points Basic Bloodborne Pathogens and Biosafety Training Course Tier I $25/person and Tier II - Laboratory Personnel at no additional cost! Prerequisite for Tier III OSHA BBP Program Management Course (Separate) Group and organizational rates are available. Contact us via our
- [Fundamentals of BSL-3:  Virtual](https://absa.org/event/fundamentals-of-bsl-3-virtual/) - Topics include: BSL-1, BSL-2, BSL3 Differences; Guidelines and Resources; PPE; Disinfection; Biosafety Cabinets
- [BSL-3 Spring Seminar Series](https://absa.org/event/bsl-3-spring-seminar-series/) - Monday: Tours of ASU Biodesign Institute and the Walton Center for Planetary Health Tuesday-Wednesday: BSL-3 Design and Operations Thursday-Friday: BSL-3 Practices and Procedures
- [USDA ARS 7th International Biosafety & Biocontainment Hybrid Symposium](https://absa.org/event/usda-ars-7th-international-biosafety-biocontainment-hybrid-symposium-biorisk-management-in-modern-agriculture/) - USDA ARS 7th International Biosafety & Biocontainment Hybrid Symposium: Biorisk Management in Modern Agriculture February 6-9, 2023 Renaissance Baltimore Harborplace Hotel Baltimore, Maryland Valuable professional development courses 2½ days of scientific presentations Exhibits showcasing the latest agricultural biosafety, biosecurity, and biocontainment products and services Network with professionals from the biosafety, biosecurity, and scientific research industries,
- [Managing hazardous and biohazardous materials/waste in the laboratory setting](https://absa.org/event/managing-hazardous-and-biohazardous-materials-waste-in-the-laboratory-setting/) - ChABSA Technical Seminar Announcement Return to Hybrid – In Person and Virtual Option Jake Giovanucci of Triumvirate Environmental Will present on: “Managing hazardous and biohazardous materials/waste in the laboratory setting” Laboratories can generate biohazardous and hazardous waste. Confusion is not uncommon on what the differences are when it comes to disposal and handling. This webinar
- [History of Biosafety and Biowarfare](https://absa.org/event/history-of-biosafety-and-biowarfare/) - $10 0.125 ABSA CM points #22-2256 Sign-Up Here Did you know Biosafety is a Direct Effect of Biowarfare? Learn how: Biosafety and Biosecurity have become what they are today by learning about the beginning of the Biosafety Profession through the effect of Biowarfare during World War II to Modern threats facing society. The discovery of
- [ARS2V. Agricultural Risk Assessment](https://absa.org/event/ars2v-agricultural-risk-assessment/) - This course will cover critical differences between the “normal” laboratory risk assessment process (as outlined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL)) and the more holistic agricultural risk assessment process that is required to focus on both worker health and safety as well as release to the environment. Biocontainment is a part of
- [ARS1V. Plant Pathology and Containment](https://absa.org/event/ars1v-plant-pathology-and-containment/) - The course will provide a background overview and illustration of how containment facilities for plant research can be designed, constructed, and operated to meet various standards and guidelines. The standards will be based on those given by US agencies though international entities will also be referenced. Principles of plant diseases and the organisms that cause
- [MABSA Hybrid Dinner Meeting: COVID19 Vaccine Development in the Context of High Containment](https://absa.org/event/mabsa-hybrid-dinner-meeting-covid19-vaccine-development-in-the-context-of-high-containment/) - MABSA is pleased to announce our upcoming biosafety hybrid dinner meeting. Presentation: COVID19 Vaccine Development in the Context of High Containment Speaker: Brian J. O’Shea, Ph.D., CBSP, SM(NRCM), Associate Director - High Containment Operations, Pfizer Vaccine Research & Development Location: University of Pennsylvania, 3401 Walnut Street (3160 Chestnut Street GPS address), Philadelphia, PA 19104
- [2022 Biosafety and Biosecurity Month](https://absa.org/event/2022-biosafety-and-biosecurity-month/) - ABSA International is proud to announce the 9th anniversary of Biosafety and Biosecurity Month in October 2022. Rather than a theme for 2022, we like to bring Biosafety and Biosecurity Month back to the core components of ethical research, transparency, training, engagement, and stewardship of biosafety and biosecurity. Use this month to shine the spotlight
- [4V. BSL-3 Design and Operations: Lessons from the Trenches](https://absa.org/event/4v-bsl-3-design-and-operations-lessons-from-the-trenches/) - Friday, February 17, 2023, from 10:00 AM - 3:00 PM CDT 4V. BSL-3 Design and Operations: Lessons from the Trenches Matt Anderson, PhD, RBP(ABSA), CBSP(ABSA), University of Nebraska—Lincoln, Lincoln, NB Many academic institutions have built Biosafety Level 3 containment laboratories over the past 15 years, anticipating these facilities to be an instrument to attract researchers
- [Q&A Infectious Substance Shipping](https://absa.org/event/qa-infectious-substance-shipping/) - Q&A Infectious Substance Shipping A distance learning opportunity August 19, 2022 12:00 – 3:00pm (CDT) Q&A Infectious Substance Shipping webinar provides an opportunity for participants to learn about recent changes to international regulations and interact with a panel of shipping experts. Regulatory experts from organizations including the DOT, InMark, and FAA have been invited along with a packaging expert from Saf-T-Pak to discuss hazardous material shipping. Participants will be afforded an opportunity to submit questions for the panel to review in advance. As many questions as possible will be discussed during the webinar. Questions not addressed will be collated, answered by the experts, and provided to all participants along with a transcript of the session.
- [5V. Laboratory Transition: Planning for the Inevitability of Change](https://absa.org/event/5v-laboratory-transition-planning-for-the-inevitability-of-change/) - Thursday, September 29, 2022, from 10:00 AM - 3:00 PM CDT 5V. Laboratory Transition: Planning for the Inevitability of Change Lauren Richardson, DVM, MPH, DACVPM, Merrick & Company, Greenwood Village, CO Ryan Gregory, P.Eng, CxA, Merrick & Company, Greenwood Village, CO Aurel Tamburri, MHM, D.OHS, CRSP, University of Toronto, Toronto, Ontario, Canada Life sciences facilities
- [3V. Articulating the Value of Your Biosafety Program](https://absa.org/event/3v-articulating-the-value-of-your-biosafety-program/) - Monday, October 3 and Friday, October 7, 2022, from 10:30 AM - 3:00 PM CDT 3V. Articulating the Value of Your Biosafety Program Robert Emery, DrPH, CBSP(ABSA), University of Texas Health Science Center—Houston, Houston, TX Scott Patlovich, DrPH, CBSP(ABSA), University of Texas Health Science Center—Houston, Houston, TX Kristen King, DrPH, CBSP(ABSA), University of Texas Health
- [1V. Animal Research for Biosafety Professionals – An Introduction](https://absa.org/event/1v-animal-research-for-biosafety-professionals-an-introduction/) - Monday, September 12, and Wednesday, September 14, 2022, from 12:30 PM - 5:00 PM CDT 1V. Animal Research for Biosafety Professionals – An Introduction Susan Harper, DVM, DACLAM, DACVPM, RBP(ABSA), NIH—Office of Animal Care and Use, Bethesda, MD Lesley Colby, DVM, DACLAM, University of Washington, Seattle, WA Animal Research has contributed to major scientific advances
- [16th Applied Biosafety Meeting](https://absa.org/event/16th-applied-biosafety-meeting/) - The 16th Applied Biosafety Meeting will take place over two days in Geneva on August 25th/26th 2022. The preliminary programme may be downloaded from our website @ www.swissbiosafety.ch .
- [17th CDC International Symposium on Biosafety](https://absa.org/event/17th-cdc-international-symposium-on-biosafety/) - 17th CDC International Symposium on Biosafety Beyond the Pandemic: Building on the Lessons Learned August 27-31, 2022
- [65th Annual Biosafety and Biosecurity Hybrid Conference](https://absa.org/event/65th-annual-biosafety-and-biosecurity-conference/) - Three full days of intensive professional development courses to educate and inspire. Three full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today’s biosafety and biosecurity professionals. Exhibits showcasing the latest in laboratory biosafety and biosecurity products and services Invaluable networking opportunities to share and learn from other biosafety and biosecurity professionals

## Portfolio

- [Karen Byers](https://absa.org/portfolio-items/karen-byers/)
- [LouAnn Burnett, MS](https://absa.org/portfolio-items/louann-burnett/)
- [Sherry Bohn, PhD, MSL](https://absa.org/portfolio-items/sherry-bohn/)
- [Heather Blair, MPH](https://absa.org/portfolio-items/heather-blair/)
- [Angela Birnbaum, MPH](https://absa.org/portfolio-items/angela-birnbaum/)
- [Scott Alderman, MS](https://absa.org/portfolio-items/scott-alderman-ms-cbsp/)
- [Carol McGhan, MPH](https://absa.org/portfolio-items/carol-mcghan/)
- [Jessica McCormick-Ell, PhD](https://absa.org/portfolio-items/jessica-mccormick-ell/)
- [Betsy Matos, PhD](https://absa.org/portfolio-items/betsy-matos/)
- [Betty Kupskay, MSc](https://absa.org/portfolio-items/betty-kupskay/)
- [Jim Klenner, MS](https://absa.org/portfolio-items/jim-klenner/)
- [Julie Johnson, PhD](https://absa.org/portfolio-items/julie-johnson/)
- [Robert Heckert, PhD, DVM](https://absa.org/portfolio-items/robert-heckert/)
- [David Gillum](https://absa.org/portfolio-items/david-gillum/)
- [Lolly Gardiner, MBA](https://absa.org/portfolio-items/lolly-gardiner/)
- [Benjamin Fontes](https://absa.org/portfolio-items/benjamin-fontes/)
- [Kelly Flint](https://absa.org/portfolio-items/kelly-flint/)
- [Robert Ellis, PhD](https://absa.org/portfolio-items/robert-ellis/)
- [Marian Downing](https://absa.org/portfolio-items/marian-downing/)
- [Patricia Delarosa, PhD](https://absa.org/portfolio-items/patricia-delarosa/)
- [Danielle Daniely, PhD, MPH](https://absa.org/portfolio-items/danielle-daniely/)
- [Patrick Condreay, PhD](https://absa.org/portfolio-items/patrick-condreay/)
- [Michelle McKinney](https://absa.org/portfolio-items/michelle-mckinney/)
- [Rebecca Moritz, MS](https://absa.org/portfolio-items/rebecca-moritz/)
- [Paul Meechan, PhD](https://absa.org/portfolio-items/paul-meechan/)
- [Melissa Mørland, MS](https://absa.org/portfolio-items/melissa-morland/)
- [Krista Murray, MS](https://absa.org/portfolio-items/krista-murray/)
- [Barbara Fox Nellis](https://absa.org/portfolio-items/barbara-fox-nellis/)
- [Maureen O'Leary, PhD, M BA](https://absa.org/portfolio-items/maureen-oleary/)
- [Barbara Owen](https://absa.org/portfolio-items/barbara-owen/)
- [Scott Patlovich, DrPH](https://absa.org/portfolio-items/scott-patlovich/)
- [Richard Rebar](https://absa.org/portfolio-items/richard-rebar/)
- [Kalpana Rengarajan, PhD, MPH, JM](https://absa.org/portfolio-items/kalpana-rengarajan/)
- [Ros Rutledge-Burns](https://absa.org/portfolio-items/ros-rutledge-burns/)
- [Antony Schwartz, PhD](https://absa.org/portfolio-items/antony-schwartz/)
- [Meghan Seltzer, PhD](https://absa.org/portfolio-items/meghan-seltzer/)
- [Hsiang-Ming Wang, PhD](https://absa.org/portfolio-items/hsiang-ming-wang/)
- [Rachel Gamble, DrPH](https://absa.org/portfolio-items/rachel-gamble-drph/)
- [Brandon Hatcher, PhD](https://absa.org/portfolio-items/brandon-hatcher-phd/)
- [Biosafety Buyer's Guide](https://absa.org/portfolio-items/biosafety-buyers-guide/)
- [2007 Historical Round Table](https://absa.org/portfolio-items/2007-historical-round-table/) - Historical Roundtable 50th Annual Biosafety and Biosecurity Conference Nashville, Tennessee October 7-10, 2007 Moderator: Randall Morin, DrPH ABSA Historical Committee At the 50th Annual Biosafety and Biosecurity Conference ABSA invited founders of the ABSA International (then, the American Biological Safety Association) and pioneers of biosafety to share their experiences and perspectives of biosafety. This important
- [Applied Biosafety: Journal of ABSA International](https://absa.org/portfolio-items/applied-biosafety-journal-of-absa-international-apb/)
- [Dee Zimmerman](https://absa.org/portfolio-items/dee-zimmerman/)
- [Jim Welch](https://absa.org/portfolio-items/jim-welch/)
- [Margaret Juergensmeyer, PhD, RBP](https://absa.org/portfolio-items/margaret-juergensmeyer/)
- [Miguel Grimaldo, DSc, PhD, Meng](https://absa.org/portfolio-items/miguel-grimaldo/)
- [Luis Alberto Ochoa Carrera, MSc](https://absa.org/portfolio-items/luis-alberto-ochoa-carrera/)
- [Risk Group Database](https://absa.org/portfolio-items/risk-group-database/)
- [2007 Historical Interviews](https://absa.org/portfolio-items/2007-historical-interviews/) - Historical Interviews 50th Annual Biosafety and Biosecurity Conference Nashville, Tennessee October 7-10, 2007 At the 50th Annual Biosafety and Biosecurity Conference ABSA invited founders of the ABSA International (then, the American Biological Safety Association) and pioneers of biosafety to share their experiences and perspectives of biosafety. This important biosafety information was captured in a historical
- [2007 Historical Panels](https://absa.org/portfolio-items/2007-historical-panels/) - Historical Panels 50th Annual Biosafety and Biosecurity Conference Nashville, Tennessee October 7-10, 2007 Moderator: Randall Morin, DrPH ABSA Historical Committee At the 50th Annual Biosafety and Biosecurity Conference ABSA invited founders of the ABSA International (then, the American Biological Safety Association) and pioneers of biosafety to share their experiences and perspectives of biosafety. This important
- [EIDC Toolboxes](https://absa.org/portfolio-items/eidc-toolboxes/) - EIDC Toolboxes
- [Animal Biosafety Videos](https://absa.org/portfolio-items/animal-biosafety-videos/) - Animal Biosafety Videos
- [Waterborne Diseases Toolbox](https://absa.org/portfolio-items/waterborne-diseases-toolbox/) - Waterborne Diseases Toolbox
- [Parasites Toolbox](https://absa.org/portfolio-items/parasites-toolbox/) - Parasites Toolbox
- [Training Tools & Resources](https://absa.org/portfolio-items/training-tools-resources/)
- [LAI Database](https://absa.org/portfolio-items/lai-database/)

## Fusion Elements

- [MemberCarosel](https://absa.org/fusion_element/membercarosel/) - ABSA International (ABSA) serves the growing needs of biosafety and biosecurity professionals throughout the world.
- [FeaturedEvents](https://absa.org/fusion_element/featuredevents-2/) - Code of Conduct for Members
- [CBSP Acceptable Course Titles (archived)](https://absa.org/fusion_element/cbsp-acceptable-course-titles-archived/)
- [altDevelopmentBlue](https://absa.org/fusion_element/about-3-2-2-2-2/) - CAREER / CREDENTIALS About the Biosafety Profession About Professional Credentials in Biosafety Registered Biosafety Professional (RBP) Certified Biological Safety Professional (CBSP) Credentialing Maintenance Program Earn .125 CM points posting to the ABSA International Blog Introduction to Biosafety Biosafety Curriculum for Undergraduate and Graduate Students Biosafety Job Board TRAINING Webinars Recordings from Past Webinars, Conferences, Symposia
- [BSBSmonth](https://absa.org/fusion_element/bsbsmonth/) - ABSA International Biosafety and Biosecurity Month ABSA International is proud to announce the 11th anniversary of Biosafety and Biosecurity Month in October 2024. Use this month to shine the spotlight on training ideas, stewardship and engagement, how to foster positive relationships within the research community, or supporting responsible and ethical research through our profession. 2024
- [Election Results](https://absa.org/fusion_element/election-results/)
- [ProfDevHome](https://absa.org/fusion_element/profdevhome/) - Professional Development opportunities for training and continuing education credits About the webinars from ABSA International Do you wonder what types of online courses ABSA offers? Login to ABSA International’s Professional Development Training Site Also Available: Recordings from Past Webinars, Conferences, Symposia Upcoming Webinars 14. Plant & Insect Permit Pathways: Navigating the Regulatory Maze from MTA
- [OtherT&C](https://absa.org/fusion_element/othertc/)
- [Election Ballot Information](https://absa.org/fusion_element/election-ballot-information/)
- [BSBSmomthPostConf](https://absa.org/fusion_element/bsbsmomthpostconf/)
- [Bio-Awards Nominations](https://absa.org/fusion_element/bio-awards-nominations/) - 2025 ABSA Honor Awards Nominations The Awards Committee requests your help in identifying the best candidates to be considered for this year’s Honor Awards: Nominations are being sought for: Arnold G. Wedum Distinguished Achievement Award Everett Hanel, Jr. Presidential Award John H. Richardson Special Recognition Award Diane Fleming Leadership Award Hashimoto Recognition Award Do you
- [LBMDownload](https://absa.org/fusion_element/lbmdownload/) - Download WHO Laboratory biosafety manual, 3rd edition (11 August 2004) Laboratory biosafety manual, 4th edition (21 December 2020) Summary of Changes to the World Health Organization Laboratory Biosafety Manual 4th Edition
- [BMBLDownload](https://absa.org/fusion_element/bmbldownload/) - Download CDC/NIH Biosafety in Microbiological and Biomedical Laboratories 6th edition (BMBL-6) 2020 CDC/NIH Biosafety in Microbiological and Biomedical Laboratories 5th edition (BMBL-5) 2009 Summary of Changes to the Biosafety in Microbiological and Biomedical Laboratories 6th Edition (BMBL-6) BMBL-5 & 6 Side-by-Side Comparison (MS Excel)
- [New to Biosafety](https://absa.org/fusion_element/new-to-biosafety/)
- [job board](https://absa.org/fusion_element/job-board/)
- [**Blue non-member notice](https://absa.org/fusion_element/blue-non-member-notice/)
- [**Blue must be logged in as member](https://absa.org/fusion_element/blue-must-be-logged-in-as-member/) - You must be logged in as a member of ABSA International to access this content. Log in
- [**Logged In Admin/Member](https://absa.org/fusion_element/logged-in-admin-member/)
- [MarkYourCalendar](https://absa.org/fusion_element/markyourcalendar/) - ABSA International (ABSA) serves the growing needs of biosafety and biosecurity professionals throughout the world.
- [ABSA Blog](https://absa.org/fusion_element/absa-blog/) - ABSA International (ABSA) serves the growing needs of biosafety and biosecurity professionals throughout the world.
- [Membership Testimonials](https://absa.org/fusion_element/membership-testimonials/) - ABSA International (ABSA) serves the growing needs of biosafety and biosecurity professionals throughout the world.
- [ResourcesPostcards](https://absa.org/fusion_element/resourcespostcards/) - ABSA International (ABSA) serves the growing needs of biosafety and biosecurity professionals throughout the world.
- [I want to...Blue](https://absa.org/fusion_element/about-2-2-2-2-2-2/) - REGISTER / ATTEND Webinars Affiliate Events Principles & Practices of Biosafety® MAY 12-13, 2026 | 4th Biosecurity Virtual Symposium AUG 10-14, 2026 | Biosafety and Biosecurity Training Course® – ABSA BBTC Fort Collins OCT 10-14, 2026 | 69th Annual Biosafety and Biosecurity Hybrid Conference LEARN ABOUT Biosafety Professional Credentials in Biosafety ABSA International ABSA Affiliates
- [altResourcesBlue](https://absa.org/fusion_element/about-3-2-2-3/) - EMERGING INFECTIOUS DISEASES EIDC ToolboxesAnthrax | AR/AMR | Fungi | Influenza | MMR | Parasites | Polio | Pox | Prions | SARS-CoV-2 | VHF | Waterborne Diseases | Zika | Other Zoonotic Agents Current Outbreaks & Updates Risk Group Database Laboratory-Acquired Infection (LAI) Database BIOSAFETY AND BIOSECURITY RESOURCES Tools & Resources Viral Vector Tools
- [altWhoWeAreBlue](https://absa.org/fusion_element/about-3-2-3/) - ABOUT ABSA INTERNATIONAL About ABSA International History President Council Teams & Committees Elections Position Statements, Reviews & Comments Office Staff Affiliates/Partners/Alliances New to Biosafety? MEMBERSHIP Membershipindividual, student, organization, corporation ABSA Store Member Documents & Resources Download Anthology of Biosafety Series OnBoard – meetings & filesharing ABSA International Communitiesmembers-only Howspace platform for networking and discussion groups
- [altDevelopment](https://absa.org/fusion_element/about-3-2-2-2/) - CAREER / CREDENTIALS About the Biosafety Profession About Professional Credentials in Biosafety Registered Biosafety Professional (RBP) Certified Biological Safety Professional (CBSP) Credentialing Maintenance Program Get Involved TRAINING Webinars Recordings from Past Webinars, Conferences, Symposia ON-DEMAND Advanced Biosafety Training Series Basic Disinfection Module Basic Biosafety Module Biosafety Cabinet Basics Learning Verification Opportunities ABSA members qualify for
- [profDevOLD](https://absa.org/fusion_element/profdevold/)
- [WebinarsPostcards](https://absa.org/fusion_element/webinarspostcards/) - ABSA International (ABSA) serves the growing needs of biosafety and biosecurity professionals throughout the world.
- [changes button](https://absa.org/fusion_element/changes-button/)
- [BiosafetyResources](https://absa.org/fusion_element/biosafetyresources/)
- [Resources](https://absa.org/fusion_element/resources-2/) - Code of Conduct for Members
- [Announcement](https://absa.org/fusion_element/announcement/)
- [full-widthContainer](https://absa.org/fusion_element/full-widthcontainer/)
- [CBSP Application?](https://absa.org/fusion_element/cbsp-application/)
- [altWho We Are](https://absa.org/fusion_element/about-3-2/) - ABOUT ABSA INTERNATIONAL About ABSA International History President Council Teams & Committees Elections Position Statements, Reviews & Comments Office Staff Affiliates/Partners/Alliances MEMBERSHIP Membershipindividual, student, organization, corporation ABSA Store Member Documents & Resources Download Anthology of Biosafety Series OnBoard – meetings & filesharing ABSA International Communitiesmembers-only Howspace platform for networking and discussion groups connect.ABSA.orgMemberclicks site to
- [**Logged In Non-ABSA](https://absa.org/fusion_element/logged-in-non-absa/)
- [**Logged In ABSA Member](https://absa.org/fusion_element/logged-in-absa-member/)
- [Blog](https://absa.org/fusion_element/blog/) - Code of Conduct for Members
- [BlogTitlesOnly](https://absa.org/fusion_element/blog-2/) - Code of Conduct for Members
- [MarkCalendars](https://absa.org/fusion_element/markcalendars/)
- [NewBlog](https://absa.org/fusion_element/newblog/) - MEMBERS: Join us at ABSA International Communities! Applied Biosafety invites you to submit your manuscript for online publication Looking for Waterborne Diseases or Fungal Diseases resources to conduct your risk assessments?
- [Got Credentials?](https://absa.org/fusion_element/got-credentials/)
- [Prof Dev](https://absa.org/fusion_element/prof-dev/)
- [New to Biosafety?](https://absa.org/fusion_element/new-to-biosafety-2/)
- [resources carosel](https://absa.org/fusion_element/resources-carosel/)
- [Mark Your Calendars](https://absa.org/fusion_element/mark-your-calendars/)
- [NewOrange-ButtonMenu](https://absa.org/fusion_element/neworange-buttonmenu/)
- [NewBlue-Menu](https://absa.org/fusion_element/newblue-menu/)
- [BBR column](https://absa.org/fusion_element/bbr-column/)
- [BiosafetyCalendar](https://absa.org/fusion_element/biosafetycalendar/)
- [Buttons](https://absa.org/fusion_element/buttons/)
- [Upcoming Webinars](https://absa.org/fusion_element/upcoming-webinars/)
- [BSBSpromoAwards](https://absa.org/fusion_element/bsbspromoawards/) - 2023 ABSA International Biosafety and Biosecurity Promotional Awards The Biosafety and Biosecurity Promotional Awards have been created to recognize ABSA International members in their efforts in promoting biosafety through marketing initiatives. A first and second place award in each category shall be given, when merited. These awards will be presented during the 66th Annual Biosafety
- [altResources](https://absa.org/fusion_element/about-3-2-2/) - EMERGING INFECTIOUS DISEASES About Toolboxes and Current Outbreaks Anthrax Antibiotic / Antimicrobial Resistance (AR/AMR) Fungi Influenza MMR (Measles, Mumps, Rubella) Parasites Poliovirus Pox Viruses Prion Diseases SARS-CoV-2/COVID-19 Viral Hemorrhagic Fevers Waterborne Disease Zika Virus Other Zoonotic Agents BIOSAFETY AND BIOSECURITY RESOURCES Tools & Resources Viral Vector Tools Animal Biosafety Videos Biosafety Links Summary of Changes
- [Icons 3](https://absa.org/fusion_element/icons-3/)
- [Icons 2](https://absa.org/fusion_element/icons-2/)
- [Icons 1](https://absa.org/fusion_element/icons-1/)
- [IconLinks](https://absa.org/fusion_element/iconlinks/)
- [apbCFP](https://absa.org/fusion_element/apbcfp/)
- [AboutWebinarsVid](https://absa.org/fusion_element/aboutwebinarsvid/) - About the webinars from ABSA International Do you wonder what types of online courses ABSA offers?
- [Webinar Recordings](https://absa.org/fusion_element/webinar-recordings/) - Also Available: Recordings of Past Webinars, Conferences, & Symposia
- [CouncilMember](https://absa.org/fusion_element/councilmember/) - Code of Conduct for Members
- [ElectionsNom](https://absa.org/fusion_element/electionsnom/)
- [BlueSlidingBox](https://absa.org/fusion_element/blueslidingbox/)
- [ElectionNom2023](https://absa.org/fusion_element/electionnom2023/)
- [bluebox](https://absa.org/fusion_element/bluebox/)
- [CredentialsMenu](https://absa.org/fusion_element/credentialsmenu/) - Professional Credentials in Biosafety Registered Biological Safety Professional (RBP) Certified Biological Safety Professional (CBSP) Credentialing Maintenance Program
- [I want to...](https://absa.org/fusion_element/about-2-2-2-2-2/) - REGISTER/ATTEND Webinars Affiliate Events Principles & Practices of Biosafety® MAY 12-13, 2026 | 4th Biosecurity Virtual Symposium AUG 10-14, 2026 | Biosafety and Biosecurity Training Course® – ABSA BBTC Fort Collins OCT 10-14, 2026 | 69th Annual Biosafety and Biosecurity Hybrid Conference LEARN ABOUT Biosafety Professional Credentials in Biosafety ABSA International ABSA Affiliates / Partners
- [toggles](https://absa.org/fusion_element/toggles/)
- [Webinars](https://absa.org/fusion_element/webinars/)
- [virtPPB](https://absa.org/fusion_element/virtppb-2/)
- [2007 Historical Interviews](https://absa.org/fusion_element/2007-historical-interviews-2/)
- [2007 Historical Panels](https://absa.org/fusion_element/2007-historical-panels-2/)
- [2007 Historical Round Table](https://absa.org/fusion_element/2007-historical-round-table-2/)
- [EIDCside](https://absa.org/fusion_element/eidcside-2/)
- [bmbl](https://absa.org/fusion_element/bmbl-2/)
- [2021HonorAwards](https://absa.org/fusion_element/2021honorawards-2/)
- [jobBoard](https://absa.org/fusion_element/jobboard-2/)
- [connect.absa](https://absa.org/fusion_element/connect-absa-2/)
- [blogHomeColumn](https://absa.org/fusion_element/bloghomecolumn-2/)
- [2022Election](https://absa.org/fusion_element/2022election-2/)
- [HomeTop](https://absa.org/fusion_element/hometop-2/)
- [TopMobile](https://absa.org/fusion_element/topmobile-2/)
- [BlogPostcard](https://absa.org/fusion_element/blogpostcard-2/)
- [WebinarPostcards](https://absa.org/fusion_element/webinarpostcards-2/)
- [AffilTab - About](https://absa.org/fusion_element/affiltab-about/)
- [AffilTab - Find and Affiliate](https://absa.org/fusion_element/affiltab-find-and-affiliate/)
- [PPBshortTestimonials](https://absa.org/fusion_element/ppbshorttestimonials-2/)
- [PPBlongTestimonials](https://absa.org/fusion_element/ppblongtestimonials-2/)
- [PPBeventTemplate](https://absa.org/fusion_element/ppbeventtemplate-2/)
- [Membership](https://absa.org/fusion_element/membership-2/)
- [MembershipColumn](https://absa.org/fusion_element/membershipcolumn-2/)
- [credentials](https://absa.org/fusion_element/credentials-2/)
- [BiosafetyLinks](https://absa.org/fusion_element/biosafetylinks-2/)
- [TT/ResourcesSidebar](https://absa.org/fusion_element/ttresourcessidebar-2/)
- [TrainingTool](https://absa.org/fusion_element/trainingtool-2/) - [/fusion_builder_column_inner][/fusion_builder_row_inner][/fusion_text]
- [MembersSliderSmall](https://absa.org/fusion_element/membersslidersmall-2/)
- [MemberTestimonials](https://absa.org/fusion_element/membertestimonials-2/)
- [current issue](https://absa.org/fusion_element/current-issue-2/)
- [Webinar](https://absa.org/fusion_element/webinar-2/)
- [TextTEST](https://absa.org/fusion_element/texttest-2/)
- [JobsColumn](https://absa.org/fusion_element/jobscolumn-2/)
- [JobPosting](https://absa.org/fusion_element/jobposting-2/)
- [Blog Tagline](https://absa.org/fusion_element/blog-tagline-2/)
- [Blog Post Image](https://absa.org/fusion_element/blog-post-image-2/)
- [vidbuttons](https://absa.org/fusion_element/vidbuttons-2/)
- [PPB Testimonials2019](https://absa.org/fusion_element/ppb-testimonials2019-2/)
- [ABSANominees](https://absa.org/fusion_element/absanominees-2/)
- [WebinarPostcards](https://absa.org/fusion_element/webinarpostcards/)
- [BlogPostcard](https://absa.org/fusion_element/blogpostcard/)
- [TopMobile](https://absa.org/fusion_element/topmobile/)
- [HomeTop](https://absa.org/fusion_element/hometop/)
- [2022Election](https://absa.org/fusion_element/2022election/)
- [blogHomeColumn](https://absa.org/fusion_element/bloghomecolumn/)
- [connect.absa](https://absa.org/fusion_element/connect-absa/)
- [jobBoard](https://absa.org/fusion_element/jobboard/)
- [2021HonorAwards](https://absa.org/fusion_element/2021honorawards/)
- [bmbl](https://absa.org/fusion_element/bmbl/)
- [EIDCside](https://absa.org/fusion_element/eidcside/)
- [2007 Historical Round Table](https://absa.org/fusion_element/2007-historical-round-table/)
- [2007 Historical Panels](https://absa.org/fusion_element/2007-historical-panels/)
- [2007 Historical Interviews](https://absa.org/fusion_element/2007-historical-interviews/)
- [virtPPB](https://absa.org/fusion_element/virtppb/)
- [ABSANominees](https://absa.org/fusion_element/absanominees/)
- [PPB Testimonials2019](https://absa.org/fusion_element/ppb-testimonials2019/)
- [vidbuttons](https://absa.org/fusion_element/vidbuttons/)
- [Blog Post Image](https://absa.org/fusion_element/blog-post-image/)
- [Blog Tagline](https://absa.org/fusion_element/blog-tagline/)
- [JobPosting](https://absa.org/fusion_element/jobposting/)
- [JobsColumn](https://absa.org/fusion_element/jobscolumn/)
- [TextTEST](https://absa.org/fusion_element/texttest/)
- [Webinar](https://absa.org/fusion_element/webinar/)
- [current issue](https://absa.org/fusion_element/current-issue/)
- [MemberTestimonials](https://absa.org/fusion_element/membertestimonials/)
- [MembersSliderSmall](https://absa.org/fusion_element/membersslidersmall/)
- [TrainingTool](https://absa.org/fusion_element/trainingtool/) - [/fusion_builder_column_inner][/fusion_builder_row_inner][/fusion_text]
- [TT/ResourcesSidebar](https://absa.org/fusion_element/ttresourcessidebar/)
- [BiosafetyLinks](https://absa.org/fusion_element/biosafetylinks/)
- [credentials](https://absa.org/fusion_element/credentials/)
- [MembershipColumn](https://absa.org/fusion_element/membershipcolumn/)
- [Membership](https://absa.org/fusion_element/membership/)
- [PPBeventTemplate](https://absa.org/fusion_element/ppbeventtemplate/)
- [PPBlongTestimonials](https://absa.org/fusion_element/ppblongtestimonials/)
- [PPBshortTestimonials](https://absa.org/fusion_element/ppbshorttestimonials/)

## Series

- [SEBSA Symposium](https://absa.org/series/sebsa-symposium/)
- [Environmental Health and Safety Academy II](https://absa.org/series/environmental-health-and-safety-academy-ii/)

## Categories

- [Uncategorized](https://absa.org/category/uncategorized/)
- [ABSA Groups](https://absa.org/category/absagroups/)
- [Professional Development Team](https://absa.org/category/absagroups/profdev/)
- [Distance Learning Committee](https://absa.org/category/absagroups/profdev/dlc/)
- [Journal Board](https://absa.org/category/absagroups/profdev/journal/)
- [Learning Verification Committee](https://absa.org/category/absagroups/profdev/lvc/)
- [ABSA Owned Courses Committee](https://absa.org/category/absagroups/profdev/aocc/)
- [Preconference Course Committee](https://absa.org/category/absagroups/profdev/pcc/)
- [Publications Committee](https://absa.org/category/absagroups/profdev/pub/)
- [Training Tools/Resources Committee](https://absa.org/category/absagroups/profdev/ttr/)
- [Defining the Profession Team](https://absa.org/category/absagroups/profession/)
- [Credentialing Evaluation Board](https://absa.org/category/absagroups/profession/ceb/)
- [Credentialing Maintenance Board](https://absa.org/category/absagroups/profession/cmb/)
- [Management Team](https://absa.org/category/absagroups/mgmt/)
- [Awards Committee](https://absa.org/category/absagroups/mgmt/awardscom/)
- [Bylaws Committee](https://absa.org/category/absagroups/mgmt/bylaws/)
- [Finance Committee](https://absa.org/category/absagroups/mgmt/finance/)
- [E-Communications Committee](https://absa.org/category/absagroups/mgmt/e-comm/)
- [ABSA Council](https://absa.org/category/absagroups/council/)
- [Membership Leadership Team](https://absa.org/category/absagroups/memteam/)
- [Affiliate Relations](https://absa.org/category/absagroups/memteam/aff/)
- [Membership Committee](https://absa.org/category/absagroups/memteam/membership/)
- [Mentoring Committee](https://absa.org/category/absagroups/memteam/mentoring/)
- [Nominating Committee](https://absa.org/category/absagroups/mgmt/nominating/)
- [Accreditation Team](https://absa.org/category/absagroups/accreditation/)
- [Accreditation Board](https://absa.org/category/absagroups/accreditation/accredboard/)
- [Accreditation Committee](https://absa.org/category/absagroups/accreditation/accredcom/)
- [Regulatory & Technical Affairs Team](https://absa.org/category/absagroups/regtech/)
- [Legislative Committee](https://absa.org/category/absagroups/regtech/legislative/)
- [Technical & Regulatory Review Committee](https://absa.org/category/absagroups/regtech/trr/)
- [Public Relations/Marketing Committee](https://absa.org/category/absagroups/memteam/pr/)
- [Conference Services Team](https://absa.org/category/absagroups/conf/)
- [Exhibitors Advisory Committee](https://absa.org/category/absagroups/conf/exhibcom/)
- [Local Arrangements Committee](https://absa.org/category/absagroups/conf/local/)
- [Scientific Program Committee](https://absa.org/category/absagroups/conf/sciprog/)
- [Task Forces / Shared Interests Groups](https://absa.org/category/absagroups/tf/)
- [ABSA Ambassadors](https://absa.org/category/absagroups/memteam/ambassadors/)
- [Historical](https://absa.org/category/absagroups/mgmt/historical/)
- [GHSAC](https://absa.org/category/absagroups/tf/ghsac/)
- [Emerging Infectious Disease Consortium](https://absa.org/category/absagroups/regtech/eidc/)
- [BSAT Community Advocate Committee](https://absa.org/category/absagroups/regtech/bsat/)
- [ABSA President](https://absa.org/category/absagroups/council/president/)
- [Announcements](https://absa.org/category/absagroups/announcements/)
- [BSAT CAC](https://absa.org/category/absagroups/regtech/trr/bsat-cac/)
- [ABSA Blog](https://absa.org/category/absa-blog/)
- [Biosecurity](https://absa.org/category/absa-blog/biosecurity/)
- [Education](https://absa.org/category/absa-blog/education/)
- [Emerging Disease](https://absa.org/category/absa-blog/emerging-disease/)
- [News](https://absa.org/category/absa-blog/news/)
- [Public Health](https://absa.org/category/absa-blog/public-health/)
- [Regulatory Updates](https://absa.org/category/absa-blog/regulatory/)
- [Risk Assessment](https://absa.org/category/absa-blog/risk-assessment/)
- [Training](https://absa.org/category/absa-blog/training/)
- [World Health](https://absa.org/category/absa-blog/world-health/)
- [Principles & Practices of Biosafety](https://absa.org/category/absagroups/profdev/principles-practices-of-biosafety/)
- [Containment](https://absa.org/category/absa-blog/containment/)
- [Biosafety](https://absa.org/category/absa-blog/biosafety/)
- [Laboratory-Acquired Infection Database](https://absa.org/category/absagroups/profdev/pub/laboratory-acquired-infection-database/)
- [Education & Curriculum Task Force](https://absa.org/category/absagroups/tf/education-curriculum-task-force/)
- [NextGen Shared Interest Group](https://absa.org/category/absagroups/tf/nextgen-shared-interest-group/)
- [Videos](https://absa.org/category/videos/)
- [Expanding ABSA’s Influence](https://absa.org/category/absagroups/tf/influence/)
- [International Engagement Committee](https://absa.org/category/absagroups/memteam/international/)
- [Obituary](https://absa.org/category/absagroups/obituary/)
- [Biosafety Career Entry and Professional Development](https://absa.org/category/absagroups/tf/biosafety-career-entry-and-professional-development/)
- [Public Health Outreach (PHO) Shared Interest Group (SIG)](https://absa.org/category/absagroups/tf/public-health-outreach-task-force/)
- [Advanced Risk Assessment](https://absa.org/category/absagroups/profdev/aocc/advanced-risk-assessment/)
- [Career](https://absa.org/category/career/)
- [COVID-19](https://absa.org/category/absa-blog/covid-19/)
- [Biosecurity Credentialing Task Force](https://absa.org/category/absagroups/tf/biosecurity-credentialing-task-force/)
- [Exam Development Board](https://absa.org/category/absagroups/profession/examdev/)
- [Membership Resource Committee](https://absa.org/category/absagroups/memteam/membership-resource-committee/)
- [BRM Connect Task Force](https://absa.org/category/absagroups/tf/brm-connect-task-force/)
- [Featured](https://absa.org/category/featured/)
- [Member Resources Committee](https://absa.org/category/absagroups/memteam/member-resources-committee/)
- [Biosecurity Symposium Steering Committee](https://absa.org/category/absagroups/conf/biosecurity-symposium-steering-committee/)

## Tags

- [PPB](https://absa.org/tag/ppb/)
- [BSL-3](https://absa.org/tag/bsl-3/)
- [Current](https://absa.org/tag/current/)
- [Camels](https://absa.org/tag/camels/)
- [Infectious Disease](https://absa.org/tag/infectious-disease/)
- [MERS](https://absa.org/tag/mers/)
- [Viruses](https://absa.org/tag/viruses/)
- [ABSA](https://absa.org/tag/absa/)
- [Initiatives](https://absa.org/tag/initiatives/)
- [Select Agent Program](https://absa.org/tag/select-agent-program/)
- [Transparency](https://absa.org/tag/transparency/)
- [Biosafety](https://absa.org/tag/biosafety/)
- [Public Health](https://absa.org/tag/public-health/)
- [Risk Assessment](https://absa.org/tag/risk-assessment/)
- [Zika](https://absa.org/tag/zika/)
- [Training](https://absa.org/tag/training/)
- [Africa](https://absa.org/tag/africa/)
- [Ebola](https://absa.org/tag/ebola/)
- [Trial](https://absa.org/tag/trial/)
- [Vaccine](https://absa.org/tag/vaccine/)
- [ABSL-2](https://absa.org/tag/absl2/)
- [ABSL-3](https://absa.org/tag/absl3/)
- [Containment](https://absa.org/tag/containment/)
- [Biosafety Cabinets](https://absa.org/tag/biosafety-cabinets/)
- [NSF](https://absa.org/tag/nsf/)
- [Regulations](https://absa.org/tag/regulations/)
- [Update](https://absa.org/tag/update/)
- [Salmonella](https://absa.org/tag/salmonella/)
- [CDC](https://absa.org/tag/cdc/)
- [LAI](https://absa.org/tag/lai/)
- [Investigation](https://absa.org/tag/investigation/)
- [Respirators](https://absa.org/tag/respirators/)
- [Education](https://absa.org/tag/education/)
- [NIOSH](https://absa.org/tag/niosh/)
- [Work Safe](https://absa.org/tag/work-safe/)
- [Portland](https://absa.org/tag/portland/)
- [San Diego](https://absa.org/tag/san-diego/)
- [COVID-19](https://absa.org/tag/covid-19/)
- [biosecurity](https://absa.org/tag/biosecurity/)
- [shipping](https://absa.org/tag/shipping/)
- [international](https://absa.org/tag/international/)
- [Denver](https://absa.org/tag/denver/)

## Presenters/Instructors

- [Patrick Condreay](https://absa.org/people/patrick-condreay/)
- [Paul Jennette](https://absa.org/people/paul-jennette/)
- [Paul Meechan](https://absa.org/people/paul-meechan/)
- [Jeffrey Owens](https://absa.org/people/jeffrey-owens/)
- [Elizabeth Weirich](https://absa.org/people/elizabeth-weirich/)
- [Dee Zimmerman](https://absa.org/people/dee-zimmerman/)
- [Eric Cook](https://absa.org/people/eric-cook/)
- [Brian Petuch](https://absa.org/people/brian-petuch/)
- [Carrie Smith](https://absa.org/people/carrie-smith/)
- [James Klenner](https://absa.org/people/james-klenner/)
- [Natasha Griffith](https://absa.org/people/natasha-griffith/)
- [Brandon Hatcher](https://absa.org/people/brandon-hatcher/)
- [Sunny Hoffman](https://absa.org/people/sunny-hoffman/)
- [Jessica McCormick-Ell](https://absa.org/people/jessica-mccormick-ell/)
- [Rebecca McGirr](https://absa.org/people/rebecca-mcgirr/)
- [Drew Fayram, MS, RBP](https://absa.org/people/drew-fayram/)
- [Janet Griffiths](https://absa.org/people/janet-griffiths/)
- [Deborah Howard](https://absa.org/people/deborah-howard/)
- [Christina Egan](https://absa.org/people/christina-egan/)
- [Julie Johnson](https://absa.org/people/julie-johnson/)
- [Becky McGirr](https://absa.org/people/becky-mcgirr/)
- [Channing Sheets](https://absa.org/people/channing-sheets/)
- [MS](https://absa.org/people/ms/)
- [RBP](https://absa.org/people/rbp/)
- [Karin S. Wasler](https://absa.org/people/karin-s-wasler/)
- [Nicole Drumhiller](https://absa.org/people/nicole-drumhiller/)
- [Anna Muldoon](https://absa.org/people/anna-muldoon/)
- [Cristine C. Lawson](https://absa.org/people/cristine-c-lawson/)
- [Lesley Decker](https://absa.org/people/lesley-decker/)
- [Devon McMenimen](https://absa.org/people/devon-mcmenimen/)
- [Josh Turse](https://absa.org/people/josh-turse/)
- [Misa Winters](https://absa.org/people/misa-winters/)
- [Kristen King](https://absa.org/people/kristen-king/)
- [Robert Emery](https://absa.org/people/robert-emery/)
- [Scott Patlovich](https://absa.org/people/scott-patlovich/)
- [Zack Beckler](https://absa.org/people/zack-beckler/)
- [Diego Diel](https://absa.org/people/diego-diel/)
- [Travis McCarthy](https://absa.org/people/travis-mccarthy/)
- [Erica Spackman](https://absa.org/people/erica-spackman/)
- [Susan Stoga](https://absa.org/people/susan-stoga/)
- [Patricia Thomas](https://absa.org/people/patricia-thomas/)
- [Nicholas G. Evans](https://absa.org/people/nicholas-g-evans/)
- [Sheila Stygar](https://absa.org/people/sheila-stygar/)

## Keywords

- [OSHA](https://absa.org/keywords/osha/)
- [template](https://absa.org/keywords/template/)
- [fact sheet](https://absa.org/keywords/fact-sheet/)
- [ag-bsl](https://absa.org/keywords/ag-bsl/)
- [risk assessment](https://absa.org/keywords/risk-assessment/)
- [disease](https://absa.org/keywords/disease/)
- [ECP](https://absa.org/keywords/ecp/)
- [bioethics](https://absa.org/keywords/bioethics/)
- [guide](https://absa.org/keywords/guide/)
- [case study](https://absa.org/keywords/case-study/)
- [puzzle](https://absa.org/keywords/puzzle/)
- [game](https://absa.org/keywords/game/)
- [DURC](https://absa.org/keywords/durc/)
- [autoclave](https://absa.org/keywords/autoclave/)
- [fume hood](https://absa.org/keywords/fume-hood/)
- [ABSA](https://absa.org/keywords/absa/)
- [ABSL-1](https://absa.org/keywords/absl-1/)
- [ABSL-2](https://absa.org/keywords/absl-2/)
- [ABSL-3](https://absa.org/keywords/absl-3/)
- [Biosecurity Research Institute](https://absa.org/keywords/biosecurity-research-institute/)
- [BSL-3](https://absa.org/keywords/bsl-3/)
- [livestock](https://absa.org/keywords/livestock/)
- [cattle](https://absa.org/keywords/cattle/)
- [sheep](https://absa.org/keywords/sheep/)
- [swine](https://absa.org/keywords/swine/)
- [disinfection](https://absa.org/keywords/disinfection/)
- [Exercise](https://absa.org/keywords/exercise/)
- [select agent](https://absa.org/keywords/select-agent/)
- [BSC](https://absa.org/keywords/bsc/)
- [biosafety cabinet](https://absa.org/keywords/biosafety-cabinet/)
- [NIH](https://absa.org/keywords/nih/)
- [design](https://absa.org/keywords/design/)
- [lab design](https://absa.org/keywords/lab-design/)
- [facility design](https://absa.org/keywords/facility-design/)
- [equipment](https://absa.org/keywords/equipment/)
- [BSL-2](https://absa.org/keywords/bsl-2/)
- [CDC](https://absa.org/keywords/cdc/)
- [biosecurity](https://absa.org/keywords/biosecurity/)
- [LAI](https://absa.org/keywords/lai/)
- [aerosol](https://absa.org/keywords/aerosol/)
- [California](https://absa.org/keywords/california/)
- [viral vectors](https://absa.org/keywords/viral-vectors/)
- [training](https://absa.org/keywords/training/)
- [virus](https://absa.org/keywords/virus/)
- [biosafety](https://absa.org/keywords/biosafety/)
- [N95](https://absa.org/keywords/n95/)
- [MMP](https://absa.org/keywords/mmp/)
- [poster](https://absa.org/keywords/poster/)
- [stewardship](https://absa.org/keywords/stewardship/)
- [Culture of Biosafety](https://absa.org/keywords/culture-of-biosafety/)
- [IBC](https://absa.org/keywords/ibc/)
- [transgenic](https://absa.org/keywords/transgenic/)
- [GMO](https://absa.org/keywords/gmo/)
- [Recombinant DNA](https://absa.org/keywords/recombinant-dna/)
- [FAQ](https://absa.org/keywords/faq/)
- [hospital](https://absa.org/keywords/hospital/)
- [PPE](https://absa.org/keywords/ppe/)
- [bioRAMs](https://absa.org/keywords/biorams/)
- [biorisk](https://absa.org/keywords/biorisk/)
- [USDA](https://absa.org/keywords/usda/)
- [shipping](https://absa.org/keywords/shipping/)
- [IATA](https://absa.org/keywords/iata/)
- [handout](https://absa.org/keywords/handout/)
- [animal disease](https://absa.org/keywords/animal-disease/)
- [covid-19](https://absa.org/keywords/covid-19/)
- [transmission](https://absa.org/keywords/transmission/)
- [lab workers](https://absa.org/keywords/lab-workers/)
- [containment](https://absa.org/keywords/containment/)
- [laboratory](https://absa.org/keywords/laboratory/)
- [Resource List](https://absa.org/keywords/resource-list/)
- [serology](https://absa.org/keywords/serology/)
- [antibody](https://absa.org/keywords/antibody/)
- [vaccines](https://absa.org/keywords/vaccines/)
- [healthcare](https://absa.org/keywords/healthcare/)
- [pregnancy](https://absa.org/keywords/pregnancy/)
- [parents](https://absa.org/keywords/parents/)
- [dental](https://absa.org/keywords/dental/)
- [OB-GYN](https://absa.org/keywords/ob-gyn/)
- [correctional/detention](https://absa.org/keywords/correctional-detention/)
- [restaurants](https://absa.org/keywords/restaurants/)
- [bars](https://absa.org/keywords/bars/)
- [retirement](https://absa.org/keywords/retirement/)
- [senior living](https://absa.org/keywords/senior-living/)
- [nursing home](https://absa.org/keywords/nursing-home/)
- [respiratory surveillance](https://absa.org/keywords/respiratory-surveillance/)
- [community](https://absa.org/keywords/community/)
- [event planning](https://absa.org/keywords/event-planning/)
- [maritime](https://absa.org/keywords/maritime/)
- [workplace](https://absa.org/keywords/workplace/)
- [businesses](https://absa.org/keywords/businesses/)
- [travel](https://absa.org/keywords/travel/)
- [airlines](https://absa.org/keywords/airlines/)
- [map](https://absa.org/keywords/map/)
- [public transportation](https://absa.org/keywords/public-transportation/)
- [animals](https://absa.org/keywords/animals/)
- [cruise ships](https://absa.org/keywords/cruise-ships/)
- [standards](https://absa.org/keywords/standards/)
- [guidance](https://absa.org/keywords/guidance/)
- [variants](https://absa.org/keywords/variants/)
- [mmwr](https://absa.org/keywords/mmwr/)
- [graphs](https://absa.org/keywords/graphs/)
- [prevention](https://absa.org/keywords/prevention/)
- [research](https://absa.org/keywords/research/)
- [testing](https://absa.org/keywords/testing/)
- [manufacturing](https://absa.org/keywords/manufacturing/)
- [surfaces](https://absa.org/keywords/surfaces/)
- [blood safety](https://absa.org/keywords/blood-safety/)
- [infectious dose](https://absa.org/keywords/infectious-dose/)
- [viral shedding](https://absa.org/keywords/viral-shedding/)
- [webinar](https://absa.org/keywords/webinar/)
- [APHL](https://absa.org/keywords/aphl/)
- [ChABSA](https://absa.org/keywords/chabsa/)
- [HVAC](https://absa.org/keywords/hvac/)
- [facemask](https://absa.org/keywords/facemask/)
- [gloves](https://absa.org/keywords/gloves/)
- [inactivation](https://absa.org/keywords/inactivation/)
- [UV light](https://absa.org/keywords/uv-light/)
- [decontamination](https://absa.org/keywords/decontamination/)
- [contact tracing](https://absa.org/keywords/contact-tracing/)
- [competence](https://absa.org/keywords/competence/)
- [packaging](https://absa.org/keywords/packaging/)
- [pneumatic tube](https://absa.org/keywords/pneumatic-tube/)
- [emergency](https://absa.org/keywords/emergency/)
- [medical devices](https://absa.org/keywords/medical-devices/)
- [work from home](https://absa.org/keywords/work-from-home/)
- [HIPAA](https://absa.org/keywords/hipaa/)
- [EEO](https://absa.org/keywords/eeo/)
- [ADA](https://absa.org/keywords/ada/)
- [schools](https://absa.org/keywords/schools/)
- [childcare](https://absa.org/keywords/childcare/)
- [social distancing](https://absa.org/keywords/social-distancing/)
- [quarantine](https://absa.org/keywords/quarantine/)
- [wastewater](https://absa.org/keywords/wastewater/)
- [drinking water](https://absa.org/keywords/drinking-water/)
- [diagnosis](https://absa.org/keywords/diagnosis/)
- [flu](https://absa.org/keywords/flu/)
- [immunity](https://absa.org/keywords/immunity/)
- [clinical trials](https://absa.org/keywords/clinical-trials/)
- [gatherings](https://absa.org/keywords/gatherings/)
- [summer camps](https://absa.org/keywords/summer-camps/)
- [compliance](https://absa.org/keywords/compliance/)
- [best practices](https://absa.org/keywords/best-practices/)
- [spike protein](https://absa.org/keywords/spike-protein/)
- [cardiovascular](https://absa.org/keywords/cardiovascular/)
- [mucormycosis](https://absa.org/keywords/mucormycosis/)
- [modeling](https://absa.org/keywords/modeling/)
- [drug discovery](https://absa.org/keywords/drug-discovery/)
- [maternal](https://absa.org/keywords/maternal/)
- [infants](https://absa.org/keywords/infants/)
- [inhalation](https://absa.org/keywords/inhalation/)
- [fomite](https://absa.org/keywords/fomite/)
- [dengue](https://absa.org/keywords/dengue/)
- [detection](https://absa.org/keywords/detection/)
- [respiratory infection](https://absa.org/keywords/respiratory-infection/)
- [immunosuppression](https://absa.org/keywords/immunosuppression/)
- [transplant](https://absa.org/keywords/transplant/)
- [canine](https://absa.org/keywords/canine/)
- [zoonotic](https://absa.org/keywords/zoonotic/)
- [breakthrough case](https://absa.org/keywords/breakthrough-case/)
- [saliva](https://absa.org/keywords/saliva/)
- [breastfeeding](https://absa.org/keywords/breastfeeding/)
- [employee rights](https://absa.org/keywords/employee-rights/)
- [vaccination](https://absa.org/keywords/vaccination/)
- [adenovirus](https://absa.org/keywords/adenovirus/)
- [blood clots](https://absa.org/keywords/blood-clots/)
- [young adults](https://absa.org/keywords/young-adults/)
- [adolescents](https://absa.org/keywords/adolescents/)
- [mycocarditis](https://absa.org/keywords/mycocarditis/)
- [colleges](https://absa.org/keywords/colleges/)
- [IHEs](https://absa.org/keywords/ihes/)
- [rumors](https://absa.org/keywords/rumors/)
- [treatment](https://absa.org/keywords/treatment/)
- [drugs](https://absa.org/keywords/drugs/)
- [mental health](https://absa.org/keywords/mental-health/)
- [POC](https://absa.org/keywords/poc/)
- [Long COVID](https://absa.org/keywords/long-covid/)
- [Post-COVID](https://absa.org/keywords/post-covid/)
- [pericarditis](https://absa.org/keywords/pericarditis/)
- [unvaccinated](https://absa.org/keywords/unvaccinated/)
- [booster](https://absa.org/keywords/booster/)
- [mRNA](https://absa.org/keywords/mrna/)
- [brochoalveolar lavage](https://absa.org/keywords/brochoalveolar-lavage/)
- [non-human primates](https://absa.org/keywords/non-human-primates/)
- [Delta](https://absa.org/keywords/delta/)
- [RT-PCR](https://absa.org/keywords/rt-pcr/)
- [diagnostics](https://absa.org/keywords/diagnostics/)
- [vaccine equity](https://absa.org/keywords/vaccine-equity/)
- [isolation](https://absa.org/keywords/isolation/)
- [asymptomatic](https://absa.org/keywords/asymptomatic/)
- [ETS](https://absa.org/keywords/ets/)
- [children](https://absa.org/keywords/children/)
- [pediatric covid](https://absa.org/keywords/pediatric-covid/)
- [fraudulent vaccine](https://absa.org/keywords/fraudulent-vaccine/)
- [air filters](https://absa.org/keywords/air-filters/)
- [droplets](https://absa.org/keywords/droplets/)
- [endoscopy](https://absa.org/keywords/endoscopy/)
- [colonoscopy](https://absa.org/keywords/colonoscopy/)
- [tuberculosis](https://absa.org/keywords/tuberculosis/)
- [viral load](https://absa.org/keywords/viral-load/)
- [mouthwash](https://absa.org/keywords/mouthwash/)
- [holidays](https://absa.org/keywords/holidays/)
- [origin](https://absa.org/keywords/origin/)
- [future](https://absa.org/keywords/future/)
- [reinfection](https://absa.org/keywords/reinfection/)
- [led](https://absa.org/keywords/led/)
- [teens](https://absa.org/keywords/teens/)
- [vaccine-induced immunity](https://absa.org/keywords/vaccine-induced-immunity/)
- [pediatric vaccines](https://absa.org/keywords/pediatric-vaccines/)
- [mortality](https://absa.org/keywords/mortality/)
- [biosafety officer](https://absa.org/keywords/biosafety-officer/)
- [biosafety professional](https://absa.org/keywords/biosafety-professional/)
- [pandemic](https://absa.org/keywords/pandemic/)
- [chimeric virus](https://absa.org/keywords/chimeric-virus/)
- [response](https://absa.org/keywords/response/)
- [omicron](https://absa.org/keywords/omicron/)
- [airbourne](https://absa.org/keywords/airbourne/)
- [endemic](https://absa.org/keywords/endemic/)
- [guidelines](https://absa.org/keywords/guidelines/)
- [PCR](https://absa.org/keywords/pcr/)
- [side-effects](https://absa.org/keywords/side-effects/)
- [antivirals](https://absa.org/keywords/antivirals/)
- [monoclonal antibody](https://absa.org/keywords/monoclonal-antibody/)
- [environmental sampling](https://absa.org/keywords/environmental-sampling/)
- [zoonosis](https://absa.org/keywords/zoonosis/)
- [obesity](https://absa.org/keywords/obesity/)
- [risk factors](https://absa.org/keywords/risk-factors/)
- [symptomatic](https://absa.org/keywords/symptomatic/)
- [influenze vaccination](https://absa.org/keywords/influenze-vaccination/)
- [Varicella zoster reactivation](https://absa.org/keywords/varicella-zoster-reactivation/)
- [myocarditis](https://absa.org/keywords/myocarditis/)
- [NPI](https://absa.org/keywords/npi/)
- [precautions](https://absa.org/keywords/precautions/)
- [one-health](https://absa.org/keywords/one-health/)
- [APHIS](https://absa.org/keywords/aphis/)
- [Graves Disease](https://absa.org/keywords/graves-disease/)
- [Gain of Function](https://absa.org/keywords/gain-of-function/)
- [RNA](https://absa.org/keywords/rna/)
- [hospitalization](https://absa.org/keywords/hospitalization/)
- [remdesivir](https://absa.org/keywords/remdesivir/)
- [seroprevalence](https://absa.org/keywords/seroprevalence/)
- [breath samples](https://absa.org/keywords/breath-samples/)
- [hearing loss](https://absa.org/keywords/hearing-loss/)
- [disabilities](https://absa.org/keywords/disabilities/)
- [reuse](https://absa.org/keywords/reuse/)
- [laboratory contamination](https://absa.org/keywords/laboratory-contamination/)
- [laboratory testing](https://absa.org/keywords/laboratory-testing/)
- [restrooms](https://absa.org/keywords/restrooms/)
- [Influenza Virus](https://absa.org/keywords/influenza-virus/)
- [HPAI](https://absa.org/keywords/hpai/)
- [outbreak](https://absa.org/keywords/outbreak/)
- [persistence](https://absa.org/keywords/persistence/)
- [media](https://absa.org/keywords/media/)
- [conditions](https://absa.org/keywords/conditions/)
- [AR/AMR](https://absa.org/keywords/ar-amr/)
- [Dual Use](https://absa.org/keywords/dual-use/)
- [WHO](https://absa.org/keywords/who/)
- [self-assessment](https://absa.org/keywords/self-assessment/)
- [responsible conduct of research](https://absa.org/keywords/responsible-conduct-of-research/)
- [poxvirus](https://absa.org/keywords/poxvirus/)
- [Monkeypox](https://absa.org/keywords/monkeypox/)
- [mutations](https://absa.org/keywords/mutations/)
- [propagation](https://absa.org/keywords/propagation/)
- [waste disposal](https://absa.org/keywords/waste-disposal/)
- [disinfectants](https://absa.org/keywords/disinfectants/)
- [EPA](https://absa.org/keywords/epa/)
- [occupational health](https://absa.org/keywords/occupational-health/)
- [europe](https://absa.org/keywords/europe/)
- [autopsy](https://absa.org/keywords/autopsy/)
- [cases](https://absa.org/keywords/cases/)
- [news](https://absa.org/keywords/news/)
- [JYNNEOS](https://absa.org/keywords/jynneos/)
- [bird flu](https://absa.org/keywords/bird-flu/)
- [china](https://absa.org/keywords/china/)
- [H10N3](https://absa.org/keywords/h10n3/)
- [nomenclature](https://absa.org/keywords/nomenclature/)
- [surveillance](https://absa.org/keywords/surveillance/)
- [avian influenza](https://absa.org/keywords/avian-influenza/)
- [reagents](https://absa.org/keywords/reagents/)
- [preparedness](https://absa.org/keywords/preparedness/)
- [swine influenza](https://absa.org/keywords/swine-influenza/)
- [specimen handling](https://absa.org/keywords/specimen-handling/)
- [VHF](https://absa.org/keywords/vhf/)
- [Marburg](https://absa.org/keywords/marburg/)
- [africa](https://absa.org/keywords/africa/)
- [ebola](https://absa.org/keywords/ebola/)
- [worker fatigue](https://absa.org/keywords/worker-fatigue/)
- [EMS](https://absa.org/keywords/ems/)
- [orthopox viruses](https://absa.org/keywords/orthopox-viruses/)
- [transportation](https://absa.org/keywords/transportation/)
- [permits](https://absa.org/keywords/permits/)
- [public health](https://absa.org/keywords/public-health/)
- [sharps](https://absa.org/keywords/sharps/)
- [virology](https://absa.org/keywords/virology/)
- [haemorrhagic fevers](https://absa.org/keywords/haemorrhagic-fevers/)
- [risk communication](https://absa.org/keywords/risk-communication/)
- [zika virus](https://absa.org/keywords/zika-virus/)
- [history](https://absa.org/keywords/history/)
- [India](https://absa.org/keywords/india/)
- [updates](https://absa.org/keywords/updates/)
- [literature](https://absa.org/keywords/literature/)
- [test to treat](https://absa.org/keywords/test-to-treat/)
- [paxlovid](https://absa.org/keywords/paxlovid/)
- [respirators](https://absa.org/keywords/respirators/)
- [epidemiology](https://absa.org/keywords/epidemiology/)
- [pathogen](https://absa.org/keywords/pathogen/)
- [fecal microbiota](https://absa.org/keywords/fecal-microbiota/)
- [medical waste](https://absa.org/keywords/medical-waste/)
- [Tpoxx](https://absa.org/keywords/tpoxx/)
- [podcast](https://absa.org/keywords/podcast/)
- [symptoms](https://absa.org/keywords/symptoms/)
- [Poliovirus](https://absa.org/keywords/poliovirus/)
- [strains](https://absa.org/keywords/strains/)
- [eradication](https://absa.org/keywords/eradication/)
- [laboratory safety](https://absa.org/keywords/laboratory-safety/)
- [infectious materials](https://absa.org/keywords/infectious-materials/)
- [laboratory exposure](https://absa.org/keywords/laboratory-exposure/)
- [facility](https://absa.org/keywords/facility/)
- [exposure](https://absa.org/keywords/exposure/)
- [vaccine policy](https://absa.org/keywords/vaccine-policy/)
- [animal pathogen](https://absa.org/keywords/animal-pathogen/)
- [control](https://absa.org/keywords/control/)
- [animal health](https://absa.org/keywords/animal-health/)
- [tissues](https://absa.org/keywords/tissues/)
- [fat cells](https://absa.org/keywords/fat-cells/)
- [seasonal influenza](https://absa.org/keywords/seasonal-influenza/)
- [sudan strain](https://absa.org/keywords/sudan-strain/)
- [MPX](https://absa.org/keywords/mpx/)
- [clinical samples](https://absa.org/keywords/clinical-samples/)
- [lab-acquired infection](https://absa.org/keywords/lab-acquired-infection/)
- [needle stick](https://absa.org/keywords/needle-stick/)
- [cVDPV2](https://absa.org/keywords/cvdpv2/)
- [bivalent](https://absa.org/keywords/bivalent/)
- [pfizer](https://absa.org/keywords/pfizer/)
- [Moderna](https://absa.org/keywords/moderna/)
- [hybrid variant](https://absa.org/keywords/hybrid-variant/)
- [RSV](https://absa.org/keywords/rsv/)
- [fungal infections](https://absa.org/keywords/fungal-infections/)
- [Zaire ebolavirus](https://absa.org/keywords/zaire-ebolavirus/)
- [ocular](https://absa.org/keywords/ocular/)
- [biodefence](https://absa.org/keywords/biodefence/)
- [health security](https://absa.org/keywords/health-security/)
- [monitoring](https://absa.org/keywords/monitoring/)
- [COVID-19 impact](https://absa.org/keywords/covid-19-impact/)
- [lab network](https://absa.org/keywords/lab-network/)
- [MPOX](https://absa.org/keywords/mpox/)
- [pathology](https://absa.org/keywords/pathology/)
- [Multisystem Inflamatory Syndrom](https://absa.org/keywords/multisystem-inflamatory-syndrom/)
- [MIS-C](https://absa.org/keywords/mis-c/)
- [Covid infection](https://absa.org/keywords/covid-infection/)
- [immunocompetant adults](https://absa.org/keywords/immunocompetant-adults/)
- [older adults](https://absa.org/keywords/older-adults/)
- [routine diagnostic testing](https://absa.org/keywords/routine-diagnostic-testing/)
- [infection](https://absa.org/keywords/infection/)
- [veterinary](https://absa.org/keywords/veterinary/)
- [diagnostic lab](https://absa.org/keywords/diagnostic-lab/)
- [necropsy](https://absa.org/keywords/necropsy/)
- [immunocompromised](https://absa.org/keywords/immunocompromised/)
- [interferon](https://absa.org/keywords/interferon/)
- [Wuhan lab](https://absa.org/keywords/wuhan-lab/)
- [diabetes](https://absa.org/keywords/diabetes/)
- [anti-viral treatments](https://absa.org/keywords/anti-viral-treatments/)
- [rebound](https://absa.org/keywords/rebound/)
- [H5N1](https://absa.org/keywords/h5n1/)
- [pets](https://absa.org/keywords/pets/)
- [Shigella](https://absa.org/keywords/shigella/)
- [XDR strains](https://absa.org/keywords/xdr-strains/)
- [shigellosis](https://absa.org/keywords/shigellosis/)
- [penicillin allergy](https://absa.org/keywords/penicillin-allergy/)
- [MDR organisms](https://absa.org/keywords/mdr-organisms/)
- [clinical treatment](https://absa.org/keywords/clinical-treatment/)
- [forecasting](https://absa.org/keywords/forecasting/)
- [pathophysiology](https://absa.org/keywords/pathophysiology/)
- [histology](https://absa.org/keywords/histology/)
- [novel treatment](https://absa.org/keywords/novel-treatment/)
- [variants of interest](https://absa.org/keywords/variants-of-interest/)
- [multiple locations](https://absa.org/keywords/multiple-locations/)
- [high risk](https://absa.org/keywords/high-risk/)
- [medium risk](https://absa.org/keywords/medium-risk/)
- [return to work](https://absa.org/keywords/return-to-work/)
- [airplane surveillance](https://absa.org/keywords/airplane-surveillance/)
- [drug resistant pseudomonas](https://absa.org/keywords/drug-resistant-pseudomonas/)
- [Drug-Resistant Candida auris](https://absa.org/keywords/drug-resistant-candida-auris/)
- [drug-resistant fungi](https://absa.org/keywords/drug-resistant-fungi/)
- [Drug-Resistant Candida](https://absa.org/keywords/drug-resistant-candida/)
- [monovalent vaccine](https://absa.org/keywords/monovalent-vaccine/)
- [ACIP](https://absa.org/keywords/acip/)
- [outcomes](https://absa.org/keywords/outcomes/)
- [prosopagnosia](https://absa.org/keywords/prosopagnosia/)
- [vaccine-derived](https://absa.org/keywords/vaccine-derived/)
- [antibiotics](https://absa.org/keywords/antibiotics/)
- [emerging infectious diseases](https://absa.org/keywords/emerging-infectious-diseases/)
- [sporotrichosis](https://absa.org/keywords/sporotrichosis/)
- [fungi](https://absa.org/keywords/fungi/)
- [Valley fever](https://absa.org/keywords/valley-fever/)
- [coccidioidomycosis](https://absa.org/keywords/coccidioidomycosis/)
- [fungal meningitis](https://absa.org/keywords/fungal-meningitis/)
- [Aspergillus glactomannan](https://absa.org/keywords/aspergillus-glactomannan/)
- [Exserohilum rostratum](https://absa.org/keywords/exserohilum-rostratum/)
- [Tinea](https://absa.org/keywords/tinea/)
- [Trichophyton indotineae](https://absa.org/keywords/trichophyton-indotineae/)
- [skin infection](https://absa.org/keywords/skin-infection/)
- [Waterborne Diseases](https://absa.org/keywords/waterborne-diseases/)
- [reporting](https://absa.org/keywords/reporting/)
- [water reservoir](https://absa.org/keywords/water-reservoir/)
- [infection prevention](https://absa.org/keywords/infection-prevention/)
- [nasocomial pathogens](https://absa.org/keywords/nasocomial-pathogens/)
- [healthcare associated infections (HAIs)](https://absa.org/keywords/healthcare-associated-infections-hais/)
- [water-containing medical devices](https://absa.org/keywords/water-containing-medical-devices/)
- [recreational water](https://absa.org/keywords/recreational-water/)
- [pools](https://absa.org/keywords/pools/)
- [water playgrounds](https://absa.org/keywords/water-playgrounds/)
- [hot tubs](https://absa.org/keywords/hot-tubs/)
- [hospitality](https://absa.org/keywords/hospitality/)
- [mitigation](https://absa.org/keywords/mitigation/)
- [Hepatitis A vaccine](https://absa.org/keywords/hepatitis-a-vaccine/)
- [entamoeba](https://absa.org/keywords/entamoeba/)
- [investigation](https://absa.org/keywords/investigation/)
- [water supply](https://absa.org/keywords/water-supply/)
- [fungal PH](https://absa.org/keywords/fungal-ph/)
- [ECDC](https://absa.org/keywords/ecdc/)
- [Cryptosporidiosis](https://absa.org/keywords/cryptosporidiosis/)
- [parasites](https://absa.org/keywords/parasites/)
- [plasmodium](https://absa.org/keywords/plasmodium/)
- [locally transmitted](https://absa.org/keywords/locally-transmitted/)
- [Brazil](https://absa.org/keywords/brazil/)
- [dog](https://absa.org/keywords/dog/)
- [glove doffing](https://absa.org/keywords/glove-doffing/)
- [Beak method](https://absa.org/keywords/beak-method/)
- [Pirola](https://absa.org/keywords/pirola/)
- [BA.2.86](https://absa.org/keywords/ba-2-86/)
- [ASHRAE](https://absa.org/keywords/ashrae/)
- [aerosol transmission](https://absa.org/keywords/aerosol-transmission/)
- [aerosol spread disease](https://absa.org/keywords/aerosol-spread-disease/)
- [sporicide](https://absa.org/keywords/sporicide/)
- [quatemary-ammonium](https://absa.org/keywords/quatemary-ammonium/)
- [copper](https://absa.org/keywords/copper/)
- [hurricanes](https://absa.org/keywords/hurricanes/)
- [Vibrio vulnificus](https://absa.org/keywords/vibrio-vulnificus/)
- [malaria](https://absa.org/keywords/malaria/)
- [H1N1](https://absa.org/keywords/h1n1/)
- [novel](https://absa.org/keywords/novel/)
- [epidemiological alert](https://absa.org/keywords/epidemiological-alert/)
- [Enterobacteria](https://absa.org/keywords/enterobacteria/)
- [toxoplasmosis](https://absa.org/keywords/toxoplasmosis/)
- [T. gondii](https://absa.org/keywords/t-gondii/)
- [reference](https://absa.org/keywords/reference/)
- [pathogen safety](https://absa.org/keywords/pathogen-safety/)
- [Zoonotic Diseases](https://absa.org/keywords/zoonotic-diseases/)
- [one health](https://absa.org/keywords/one-health-2/)
- [database](https://absa.org/keywords/database/)
- [Salmonella](https://absa.org/keywords/salmonella/)
- [West Nile Virus](https://absa.org/keywords/west-nile-virus/)
- [Plague](https://absa.org/keywords/plague/)
- [SARS](https://absa.org/keywords/sars/)
- [MERS](https://absa.org/keywords/mers/)
- [coronavirus](https://absa.org/keywords/coronavirus/)
- [Rabies](https://absa.org/keywords/rabies/)
- [brucellosis](https://absa.org/keywords/brucellosis/)
- [lyme disease](https://absa.org/keywords/lyme-disease/)
- [MAB](https://absa.org/keywords/mab/)
- [therapeutics](https://absa.org/keywords/therapeutics/)
- [chikungunya](https://absa.org/keywords/chikungunya/)
- [vaccine](https://absa.org/keywords/vaccine/)
- [IXCHIQ](https://absa.org/keywords/ixchiq/)
- [Crimean-Congo](https://absa.org/keywords/crimean-congo/)
- [arenaviruses](https://absa.org/keywords/arenaviruses/)
- [Nipah virus](https://absa.org/keywords/nipah-virus/)
- [MPXV](https://absa.org/keywords/mpxv/)
- [IPV](https://absa.org/keywords/ipv/)
- [Leishmaniasis](https://absa.org/keywords/leishmaniasis/)
- [visceral leishmaniasis](https://absa.org/keywords/visceral-leishmaniasis/)
- [molecular diagnosis](https://absa.org/keywords/molecular-diagnosis/)
- [quantative PCR (qPCR)](https://absa.org/keywords/quantative-pcr-qpcr/)
- [crithidia sp.](https://absa.org/keywords/crithidia-sp/)
- [Leishmania infantum](https://absa.org/keywords/leishmania-infantum/)
- [trypanosomatid co-infection](https://absa.org/keywords/trypanosomatid-co-infection/)
- [cryptosporidium](https://absa.org/keywords/cryptosporidium/)
- [viral inactivation](https://absa.org/keywords/viral-inactivation/)
- [urine](https://absa.org/keywords/urine/)
- [plasma](https://absa.org/keywords/plasma/)
- [analytes](https://absa.org/keywords/analytes/)
- [mmr](https://absa.org/keywords/mmr/)
- [measles](https://absa.org/keywords/measles/)
- [rubella](https://absa.org/keywords/rubella/)
- [mumps](https://absa.org/keywords/mumps/)
- [attenuated measles](https://absa.org/keywords/attenuated-measles/)
- [virotherapy](https://absa.org/keywords/virotherapy/)
- [virus vectors](https://absa.org/keywords/virus-vectors/)
- [Chronic Wasting Disease](https://absa.org/keywords/chronic-wasting-disease/)
- [CWD](https://absa.org/keywords/cwd/)
- [Prion Diseases](https://absa.org/keywords/prion-diseases/)
- [prions](https://absa.org/keywords/prions/)
- [anthrax](https://absa.org/keywords/anthrax/)
- [alaskapox](https://absa.org/keywords/alaskapox/)
- [Akhmeta virus](https://absa.org/keywords/akhmeta-virus/)
- [Buffalopox](https://absa.org/keywords/buffalopox/)
- [Camelpox](https://absa.org/keywords/camelpox/)
- [Horsepox](https://absa.org/keywords/horsepox/)
- [Vaccinia virus](https://absa.org/keywords/vaccinia-virus/)
- [volunteering](https://absa.org/keywords/volunteering/)
- [flyer](https://absa.org/keywords/flyer/)
- [at-home testing](https://absa.org/keywords/at-home-testing/)
- [Arboviruses](https://absa.org/keywords/arboviruses/)
- [yellow fever](https://absa.org/keywords/yellow-fever/)
- [rVSVΔG-ZEBOV-GP](https://absa.org/keywords/rvsvδg-zebov-gp/)
- [Pneumocystis Talaromyces](https://absa.org/keywords/pneumocystis-talaromyces/)
- [Histoplasma](https://absa.org/keywords/histoplasma/)
- [Candida Cryptococcus](https://absa.org/keywords/candida-cryptococcus/)
- [Aspergillus](https://absa.org/keywords/aspergillus/)
- [Antifungal](https://absa.org/keywords/antifungal/)
- [Streptococcus suis](https://absa.org/keywords/streptococcus-suis/)
- [epidemic](https://absa.org/keywords/epidemic/)
- [water surveillance](https://absa.org/keywords/water-surveillance/)
- [long-term facilities](https://absa.org/keywords/long-term-facilities/)
- [Simian hemorhagic fever virus](https://absa.org/keywords/simian-hemorhagic-fever-virus/)
- [SHFV](https://absa.org/keywords/shfv/)
- [macaques](https://absa.org/keywords/macaques/)
- [EBOV](https://absa.org/keywords/ebov/)
- [recombinant vesicular stromatitis virus](https://absa.org/keywords/recombinant-vesicular-stromatitis-virus/)
- [pathogenicity](https://absa.org/keywords/pathogenicity/)
- [syrian hamsters](https://absa.org/keywords/syrian-hamsters/)
- [surrogate models](https://absa.org/keywords/surrogate-models/)
- [vaccine evaluation](https://absa.org/keywords/vaccine-evaluation/)
- [drug screening](https://absa.org/keywords/drug-screening/)
- [transfusion](https://absa.org/keywords/transfusion/)
- [platelet transfusion](https://absa.org/keywords/platelet-transfusion/)
- [contacts](https://absa.org/keywords/contacts/)
- [vector-borne](https://absa.org/keywords/vector-borne/)
- [global health](https://absa.org/keywords/global-health/)
- [Tripanosoma cruzi](https://absa.org/keywords/tripanosoma-cruzi/)
- [food poisioning](https://absa.org/keywords/food-poisioning/)
- [foodborne diseases](https://absa.org/keywords/foodborne-diseases/)
- [bat](https://absa.org/keywords/bat/)
- [ISKV](https://absa.org/keywords/iskv/)
- [Issyk-Kul virus](https://absa.org/keywords/issyk-kul-virus/)
- [Infectious Respiratory Particles](https://absa.org/keywords/infectious-respiratory-particles/)
- [IRP](https://absa.org/keywords/irp/)
- [direct deposition](https://absa.org/keywords/direct-deposition/)
- [highly pathogenic avian influenza](https://absa.org/keywords/highly-pathogenic-avian-influenza/)
- [a(H5N1)](https://absa.org/keywords/ah5n1/)
- [pasteuization](https://absa.org/keywords/pasteuization/)
- [enteric viruses](https://absa.org/keywords/enteric-viruses/)
- [foot and mouth disease](https://absa.org/keywords/foot-and-mouth-disease/)
- [FMD](https://absa.org/keywords/fmd/)
- [Nagoya Protocol](https://absa.org/keywords/nagoya-protocol/)
- [CJD](https://absa.org/keywords/cjd/)
- [Creutzfeldt Jakob Disease](https://absa.org/keywords/creutzfeldt-jakob-disease/)
- [sterilization](https://absa.org/keywords/sterilization/)
- [iatrogenic](https://absa.org/keywords/iatrogenic/)
- [TSE](https://absa.org/keywords/tse/)
- [Transmissible Spongiform Encephalopathies](https://absa.org/keywords/transmissible-spongiform-encephalopathies/)
- [ecology](https://absa.org/keywords/ecology/)
- [ecological epidemiology](https://absa.org/keywords/ecological-epidemiology/)
- [viral infection](https://absa.org/keywords/viral-infection/)
- [occupational exposure](https://absa.org/keywords/occupational-exposure/)
- [emergency response](https://absa.org/keywords/emergency-response/)
- [fish](https://absa.org/keywords/fish/)
- [Wildlife](https://absa.org/keywords/wildlife/)
- [case definition](https://absa.org/keywords/case-definition/)
- [ferrets](https://absa.org/keywords/ferrets/)
- [employers](https://absa.org/keywords/employers/)
- [workers](https://absa.org/keywords/workers/)
- [candida auris](https://absa.org/keywords/candida-auris/)
- [antifungal resistance](https://absa.org/keywords/antifungal-resistance/)
- [control measures](https://absa.org/keywords/control-measures/)
- [AVL](https://absa.org/keywords/avl/)
- [fomalin](https://absa.org/keywords/fomalin/)
- [heat](https://absa.org/keywords/heat/)
- [rickettsiae](https://absa.org/keywords/rickettsiae/)
- [β-propiolactone](https://absa.org/keywords/β-propiolactone/)
- [Orientia tsutsugamushi](https://absa.org/keywords/orientia-tsutsugamushi/)
- [scrub typhus](https://absa.org/keywords/scrub-typhus/)
- [Spotted fever](https://absa.org/keywords/spotted-fever/)
- [FESAP](https://absa.org/keywords/fesap/)
- [milk](https://absa.org/keywords/milk/)
- [dairy](https://absa.org/keywords/dairy/)
- [flavivirus](https://absa.org/keywords/flavivirus/)
- [cutaneous](https://absa.org/keywords/cutaneous/)
- [biological agents](https://absa.org/keywords/biological-agents/)
- [recommendations](https://absa.org/keywords/recommendations/)
- [dairy cows](https://absa.org/keywords/dairy-cows/)
- [VHFV](https://absa.org/keywords/vhfv/)
- [global case reporting](https://absa.org/keywords/global-case-reporting/)
- [laboratory worker](https://absa.org/keywords/laboratory-worker/)
- [Oropouche](https://absa.org/keywords/oropouche/)
- [overview](https://absa.org/keywords/overview/)
- [ACAM2000](https://absa.org/keywords/acam2000/)
- [Tick Borne Encephalitis](https://absa.org/keywords/tick-borne-encephalitis/)
- [immunization](https://absa.org/keywords/immunization/)
- [TBE](https://absa.org/keywords/tbe/)
- [poultry processing](https://absa.org/keywords/poultry-processing/)
- [OROV](https://absa.org/keywords/orov/)
- [blood donation](https://absa.org/keywords/blood-donation/)
- [donning/doffing](https://absa.org/keywords/donning-doffing/)
- [Lassa](https://absa.org/keywords/lassa/)
- [CCHF](https://absa.org/keywords/cchf/)
- [South American Hemorrhagic Fevers](https://absa.org/keywords/south-american-hemorrhagic-fevers/)
- [health alert](https://absa.org/keywords/health-alert/)
- [chagas](https://absa.org/keywords/chagas/)
- [trypanosoma](https://absa.org/keywords/trypanosoma/)
- [neglected disease](https://absa.org/keywords/neglected-disease/)
- [Burkholderia](https://absa.org/keywords/burkholderia/)
- [farm workers](https://absa.org/keywords/farm-workers/)
- [Orthobunyavirus](https://absa.org/keywords/orthobunyavirus/)
- [Rwanda](https://absa.org/keywords/rwanda/)
- [Clade 1](https://absa.org/keywords/clade-1/)
- [tecoviramat](https://absa.org/keywords/tecoviramat/)
- [MVA-BN](https://absa.org/keywords/mva-bn/)
- [raccoon](https://absa.org/keywords/raccoon/)
- [ringworm](https://absa.org/keywords/ringworm/)
- [trichophyton mentagrophytes](https://absa.org/keywords/trichophyton-mentagrophytes/)
- [genital tinea](https://absa.org/keywords/genital-tinea/)
- [biologicals](https://absa.org/keywords/biologicals/)
- [public health laboratories](https://absa.org/keywords/public-health-laboratories/)
- [drug-resistant Tuberculosis](https://absa.org/keywords/drug-resistant-tuberculosis/)
- [antimicrobial resistance](https://absa.org/keywords/antimicrobial-resistance/)
- [animal tissues](https://absa.org/keywords/animal-tissues/)
- [Creutzfeldt-Jakob disease (CJD)](https://absa.org/keywords/creutzfeldt-jakob-disease-cjd/)
- [infection control](https://absa.org/keywords/infection-control/)
- [animal food](https://absa.org/keywords/animal-food/)
- [unpasteurized milk](https://absa.org/keywords/unpasteurized-milk/)
- [AI](https://absa.org/keywords/ai/)
- [SDV](https://absa.org/keywords/sdv/)
- [Uganda](https://absa.org/keywords/uganda/)
- [circulatin vaccine-derived poliovirus type 2](https://absa.org/keywords/circulatin-vaccine-derived-poliovirus-type-2/)
- [Tularemia](https://absa.org/keywords/tularemia/)
- [SAT](https://absa.org/keywords/sat/)
- [cats](https://absa.org/keywords/cats/)
- [poultry workers](https://absa.org/keywords/poultry-workers/)
- [dairy workers](https://absa.org/keywords/dairy-workers/)
- [East Africa](https://absa.org/keywords/east-africa/)
- [Clade 1b](https://absa.org/keywords/clade-1b/)
- [HAV](https://absa.org/keywords/hav/)
- [hepatitis virus](https://absa.org/keywords/hepatitis-virus/)
- [Texas Outbreak](https://absa.org/keywords/texas-outbreak/)
- [beta corona virus](https://absa.org/keywords/beta-corona-virus/)
- [meningitis](https://absa.org/keywords/meningitis/)
- [parasitic](https://absa.org/keywords/parasitic/)
- [meningoencephalitis](https://absa.org/keywords/meningoencephalitis/)
- [bacterial](https://absa.org/keywords/bacterial/)
- [travel advisory](https://absa.org/keywords/travel-advisory/)
- [deaths](https://absa.org/keywords/deaths/)
- [Vitamin A](https://absa.org/keywords/vitamin-a/)
- [toxicity](https://absa.org/keywords/toxicity/)
- [hazard identification](https://absa.org/keywords/hazard-identification/)
- [pathogen assessment](https://absa.org/keywords/pathogen-assessment/)
- [risk analysis](https://absa.org/keywords/risk-analysis/)
- [risk management](https://absa.org/keywords/risk-management/)
- [biorisk evaluation](https://absa.org/keywords/biorisk-evaluation/)
- [Pneumonia](https://absa.org/keywords/pneumonia/)
- [viral](https://absa.org/keywords/viral/)
- [metapneumovirus](https://absa.org/keywords/metapneumovirus/)
- [respiratory syncytial virus](https://absa.org/keywords/respiratory-syncytial-virus/)
- [Central America](https://absa.org/keywords/central-america/)
- [South America](https://absa.org/keywords/south-america/)
- [cave](https://absa.org/keywords/cave/)
- [travelers](https://absa.org/keywords/travelers/)
- [cyclospora](https://absa.org/keywords/cyclospora/)
- [cilantro](https://absa.org/keywords/cilantro/)
- [human exposure](https://absa.org/keywords/human-exposure/)
- [venison](https://absa.org/keywords/venison/)
- [processing facility](https://absa.org/keywords/processing-facility/)
- [thimerosal](https://absa.org/keywords/thimerosal/)
- [Baylisascariasis](https://absa.org/keywords/baylisascariasis/)
- [Raccoon Roundworm](https://absa.org/keywords/raccoon-roundworm/)
- [encephalopathy](https://absa.org/keywords/encephalopathy/)
- [ocular larva migrans](https://absa.org/keywords/ocular-larva-migrans/)
- [peripheral and cerebrospinal fluid eosinophilia](https://absa.org/keywords/peripheral-and-cerebrospinal-fluid-eosinophilia/)
- [brain imaging abnormalities](https://absa.org/keywords/brain-imaging-abnormalities/)
- [covid epidemiology](https://absa.org/keywords/covid-epidemiology/)
- [new world screwworm](https://absa.org/keywords/new-world-screwworm/)
- [myiasis](https://absa.org/keywords/myiasis/)
- [Cochliomyia hominivorax](https://absa.org/keywords/cochliomyia-hominivorax/)
- [CBER-regulated Biologics](https://absa.org/keywords/cber-regulated-biologics/)
- [Legionella](https://absa.org/keywords/legionella/)
- [Other Emerging Pathogens](https://absa.org/keywords/other-emerging-pathogens/)
- [New York](https://absa.org/keywords/new-york/)
- [Pontiac fever](https://absa.org/keywords/pontiac-fever/)
- [T cruzi](https://absa.org/keywords/t-cruzi/)
- [kissing bug](https://absa.org/keywords/kissing-bug/)
- [triatomine insects](https://absa.org/keywords/triatomine-insects/)
- [trypanosoma cruzi](https://absa.org/keywords/trypanosoma-cruzi/)
- [Asian Longhorned Ticks](https://absa.org/keywords/asian-longhorned-ticks/)
- [Haemaphysalis longicornis](https://absa.org/keywords/haemaphysalis-longicornis/)
- [conjunctivitis](https://absa.org/keywords/conjunctivitis/)
- [N. meningitidis](https://absa.org/keywords/n-meningitidis/)
- [periorbital cellulitis](https://absa.org/keywords/periorbital-cellulitis/)
- [Viral conjunctivitis](https://absa.org/keywords/viral-conjunctivitis/)
- [allergic conjunctivitis](https://absa.org/keywords/allergic-conjunctivitis/)
- [Clade I](https://absa.org/keywords/clade-i/)
- [clade II](https://absa.org/keywords/clade-ii/)
- [antibiotic resistance](https://absa.org/keywords/antibiotic-resistance/)
- [Chromoblastomycosis](https://absa.org/keywords/chromoblastomycosis/)
- [CBM](https://absa.org/keywords/cbm/)
- [Fonsecaea pedrosoi](https://absa.org/keywords/fonsecaea-pedrosoi/)
- [Alternaria alternata](https://absa.org/keywords/alternaria-alternata/)
- [Francisella tularensis](https://absa.org/keywords/francisella-tularensis/)
- [F. tularensis](https://absa.org/keywords/f-tularensis/)
- [tularemia treatment](https://absa.org/keywords/tularemia-treatment/)
- [tularemia PEP](https://absa.org/keywords/tularemia-pep/)

## Topics

- [Bloodborne Pathogens](https://absa.org/topic/bloodborne-pathogens/)
- [Animal Biosafety](https://absa.org/topic/animal-biosafety/)
- [Animal and Zoonotic Pathogen References](https://absa.org/topic/animal-and-zoonotic-pathogen-references/)
- [Culture of Biosafety](https://absa.org/topic/culture-of-biosafety/)
- [Decontamination, Disinfection and Sterilization](https://absa.org/topic/decon-disinfection-and-sterilization/)
- [Exercises and Drills](https://absa.org/topic/exercises-and-drills/)
- [Facility Design and Equipment](https://absa.org/topic/facility-design-and-equipment/)
- [Biosafety Cabinets](https://absa.org/topic/biosafety-cabinets/)
- [BSL-2](https://absa.org/topic/bsl-2/)
- [BSL-3](https://absa.org/topic/bsl-3/)
- [Laboratory Biosafety](https://absa.org/topic/laboratory-biosafety/)
- [General Biosafety](https://absa.org/topic/general-biosafety/)
- [IBC](https://absa.org/topic/ibc/)
- [Incident Investigation and Reporting](https://absa.org/topic/incident-investigation-and-reporting/)
- [Regulations, Standards and Guidelines](https://absa.org/topic/regs-standards-guidelines/)
- [Select Agent/Bioterrorism](https://absa.org/topic/select-agent-bioterrorism/)
- [Risk Assessment](https://absa.org/topic/risk-assessment/)
- [Training Compliance](https://absa.org/topic/training-compliance/)
- [Transportation](https://absa.org/topic/transportation/)
- [Tools & Resources](https://absa.org/topic/ttr/)
- [SARS-CoV-2/COVID-19 Toolbox](https://absa.org/topic/covid19/)
- [Planning](https://absa.org/topic/planning/)
- [Hazard Identification](https://absa.org/topic/hazard-id/)
- [Pathogen](https://absa.org/topic/pathogen/)
- [Transmission](https://absa.org/topic/transmission/)
- [Risk Assessment](https://absa.org/topic/risk-assess/)
- [Risk Mitigation](https://absa.org/topic/risk-mitigation/)
- [Engineering Controls](https://absa.org/topic/eng-controls/)
- [Ventilation](https://absa.org/topic/ventilation/)
- [PPE](https://absa.org/topic/ppe/)
- [Donning/Doffing](https://absa.org/topic/don-doff/)
- [Face Masks](https://absa.org/topic/face-masks/)
- [Operations](https://absa.org/topic/operations/)
- [Physical Security](https://absa.org/topic/phys-security/)
- [Good microbiological technique](https://absa.org/topic/microbio-technique/)
- [Validation](https://absa.org/topic/validation/)
- [Inactivation](https://absa.org/topic/inactivation/)
- [Disinfection](https://absa.org/topic/disinfection/)
- [Decontamination](https://absa.org/topic/decon/)
- [Support](https://absa.org/topic/support/)
- [Training](https://absa.org/topic/training/)
- [Emergency Response](https://absa.org/topic/emergency-response/)
- [Clothing and PPE](https://absa.org/topic/clothing-ppe/)
- [Non-pharmacological measures](https://absa.org/topic/non-pharma/)
- [Worker health programme](https://absa.org/topic/worker-health/)
- [Contact Tracing](https://absa.org/topic/contact-tracing/)
- [Isolation, Quarantine and Return to Work](https://absa.org/topic/isolation/)
- [High risk groups](https://absa.org/topic/high-risk/)
- [Waste Surveillance](https://absa.org/topic/waste/)
- [Environmental Surveillance](https://absa.org/topic/environ/)
- [Diagnostics](https://absa.org/topic/diagnostics/)
- [Vaccines](https://absa.org/topic/vaccines/)
- [Drugs and other treatments](https://absa.org/topic/treatment/)
- [Process Improvement](https://absa.org/topic/improvement/)
- [Continual Improvement](https://absa.org/topic/continual/)
- [Healthcare](https://absa.org/topic/healthcare/)
- [Dental](https://absa.org/topic/dental/)
- [Senior Living](https://absa.org/topic/senior/)
- [Travel](https://absa.org/topic/travel/)
- [Detention Facilities](https://absa.org/topic/detention/)
- [Restaurants](https://absa.org/topic/restaurants/)
- [Community](https://absa.org/topic/community/)
- [Applied Biosafety Journal](https://absa.org/topic/abj/)
- [ABSA Webinars](https://absa.org/topic/absa-webinars/)
- [Webinars](https://absa.org/topic/webinars/)
- [Journals and Publishers](https://absa.org/topic/pub/)
- [News clips](https://absa.org/topic/news/)
- [-Organizations](https://absa.org/topic/sources/)
- [Leadership](https://absa.org/topic/leadership/)
- [Roles, responsibilities, and authorities](https://absa.org/topic/roles/)
- [Policy](https://absa.org/topic/policy/)
- [ABSA: EIDC Resources](https://absa.org/topic/eidc/)
- [Face Masks](https://absa.org/topic/face-masks-clothing-ppe/)
- [Respirators](https://absa.org/topic/respirators/)
- [Competence](https://absa.org/topic/competence/)
- [Transport/Shipping](https://absa.org/topic/transport-shipping/)
- [-United States](https://absa.org/topic/united-states/)
- [-International](https://absa.org/topic/international/)
- [Africa](https://absa.org/topic/africa/)
- [Americas](https://absa.org/topic/americas/)
- [Europe](https://absa.org/topic/europe/)
- [Canada](https://absa.org/topic/canada/)
- [NGO](https://absa.org/topic/ngo/)
- [AstraZeneca](https://absa.org/topic/astrazeneca/)
- [Janssen](https://absa.org/topic/janssen/)
- [Moderna](https://absa.org/topic/moderna/)
- [Pfizer-BioNTech](https://absa.org/topic/pfizer-biontech/)
- [Communication](https://absa.org/topic/communication/)
- [Seroprevalence](https://absa.org/topic/seroprevalence/)
- [Higher Education](https://absa.org/topic/higher-education/)
- [Testing](https://absa.org/topic/testing/)
- [Disease](https://absa.org/topic/disease/)
- [Dual Use Research of Concern](https://absa.org/topic/dual-use-research-of-concern/)
- [Animal Health](https://absa.org/topic/animal-health/)
- [Sinovac](https://absa.org/topic/sinovac/)
- [Youth Camps](https://absa.org/topic/youth-camps/)
- [K-12 Education](https://absa.org/topic/k-12-education/)
- [Treatment](https://absa.org/topic/treatment-worker-health/)
- [Regulation](https://absa.org/topic/regulation/)
- [Select Agents & Toxins](https://absa.org/topic/select-agents-toxins/)
- [Variants](https://absa.org/topic/variants/)
- [Biosecurity](https://absa.org/topic/biosecurity/)
- [Children](https://absa.org/topic/children/)
- [Influenza Virus Toolbox](https://absa.org/topic/influenza/)
- [-News](https://absa.org/topic/news-influenza/)
- [-Types of Influenza](https://absa.org/topic/types-of-influenza/)
- [Transmission & Prevention](https://absa.org/topic/transmission-prevention/)
- [Diagnostics](https://absa.org/topic/diagnostics-influenza/)
- [Surveillance](https://absa.org/topic/surveillance/)
- [Vaccines](https://absa.org/topic/vaccines-influenza/)
- [Research & Development](https://absa.org/topic/research-development/)
- [Pandemic Influenza](https://absa.org/topic/pandemic-influenza/)
- [HPAI](https://absa.org/topic/hpai/)
- [Swine Influenza](https://absa.org/topic/swine-influenza/)
- [G4 EA avian-like Influenza H1N1](https://absa.org/topic/h1n1/)
- [Pox Viruses Toolbox](https://absa.org/topic/pox/)
- [Viral Hemorrhagic Fevers Toolbox](https://absa.org/topic/vhf/)
- [Zika Virus (and other arboviruses) Toolbox](https://absa.org/topic/zika/)
- [Antibiotic / Antimicrobial Resistance (AR/AMR) Toolbox](https://absa.org/topic/aramr/)
- [Resources Archive](https://absa.org/topic/archive/)
- [Inactivation](https://absa.org/topic/inactivation-influenza/)
- [-Nature of antibiotic/antimicrobial resistance](https://absa.org/topic/aramr-nature/)
- [Transmission](https://absa.org/topic/aramr-transmission/)
- [Biosecurity](https://absa.org/topic/biosecurity-general/)
- [-US](https://absa.org/topic/biosecurity-us/)
- [-WHO](https://absa.org/topic/biosecurity-who/)
- [-International](https://absa.org/topic/biosecurity-int/)
- [-Canada](https://absa.org/topic/biosecurity-ca/)
- [Journals and Publishers](https://absa.org/topic/biosecurity-pub/)
- [-Europe](https://absa.org/topic/europe-biosecurity-general/)
- [Mpox](https://absa.org/topic/mpox/)
- [-Pathogens](https://absa.org/topic/pox-pathogens/)
- [Articles](https://absa.org/topic/articles/)
- [Laboratory Safety](https://absa.org/topic/laboratory-safety/)
- [Vaccines](https://absa.org/topic/vaccines-monkeypox/)
- [Risk Assessment](https://absa.org/topic/risk-assessment-monkeypox/)
- [Regulations](https://absa.org/topic/regulations/)
- [Testing](https://absa.org/topic/testing-monkeypox/)
- [Animal Handling Safety](https://absa.org/topic/animal-handling-safety/)
- [--What are Influenza Viruses](https://absa.org/topic/influenzaviruses/)
- [-News](https://absa.org/topic/vhf-news/)
- [-Ebola](https://absa.org/topic/ebola/)
- [Transmission & Prevention](https://absa.org/topic/vhf-trans-prev/)
- [Regulation/Guidance](https://absa.org/topic/vhf-reg/)
- [Non-Government Resources](https://absa.org/topic/vhf-ngr/)
- [Healthcare Settings](https://absa.org/topic/vhf-healthcare/)
- [Laboratories/Research](https://absa.org/topic/vhf-labs/)
- [Personal Protective Equipment (PPE)](https://absa.org/topic/vhf-ppe/)
- [Packaging, Transportation, and Shipping](https://absa.org/topic/vhf-pts/)
- [Peer Reviewed Articles](https://absa.org/topic/vhf-articles/)
- [Other Hemorrhagic Fevers](https://absa.org/topic/vhf-other/)
- [Vaccines](https://absa.org/topic/vhf-vaccines/)
- [Relevant articles from Applied Biosafety: Journal of ABSA International](https://absa.org/topic/vhf-apb/)
- [EMS](https://absa.org/topic/ems/)
- [2022](https://absa.org/topic/2022/)
- [Surveillance](https://absa.org/topic/surveillance-monkeypox/)
- [Healthcare](https://absa.org/topic/healthcare-monkeypox/)
- [Shipping](https://absa.org/topic/shipping/)
- [-What is Zika Virus?](https://absa.org/topic/what-is-zika-virus/)
- [Laboratory](https://absa.org/topic/laboratory/)
- [Transmission and Prevention](https://absa.org/topic/transmission-and-prevention/)
- [-News](https://absa.org/topic/news-zika/)
- [Regulatory/Guidance](https://absa.org/topic/regulatory-guidance/)
- [International Resources](https://absa.org/topic/international-resources/)
- [Peer Reviewed Articles](https://absa.org/topic/peer-reviewed-articles/)
- [Vaccines](https://absa.org/topic/vaccines-zika/)
- [Transmission/Prevention](https://absa.org/topic/transmission-prevention-monkeypox/)
- [Medical Waste](https://absa.org/topic/medical-waste/)
- [-News](https://absa.org/topic/news-pox/)
- [Treatment](https://absa.org/topic/treatment-monkeypox/)
- [Poliovirus Toolbox](https://absa.org/topic/polio/)
- [-Pathogens](https://absa.org/topic/pathogens/)
- [Lab Containment](https://absa.org/topic/lab-containment/)
- [Surveillance](https://absa.org/topic/surveillance-polio/)
- [Journals and Publications](https://absa.org/topic/journals-and-publications/)
- [Transmission](https://absa.org/topic/transmission-polio/)
- [Laboratory Safety](https://absa.org/topic/laboratory-safety-polio/)
- [Risk Assessment](https://absa.org/topic/risk-assessment-polio/)
- [Policy](https://absa.org/topic/policy-polio/)
- [Occupational Health](https://absa.org/topic/occupational-health/)
- [Vaccines](https://absa.org/topic/vaccines-polio/)
- [Public Health](https://absa.org/topic/public-health/)
- [Animals](https://absa.org/topic/animals/)
- [Solutions](https://absa.org/topic/solutions/)
- [Detection](https://absa.org/topic/detection/)
- [Active Outbreaks](https://absa.org/topic/active-outbreaks/)
- [SARS-CoV-2/COVID-19](https://absa.org/topic/sars-cov-2-covid-19/)
- [Resources](https://absa.org/topic/resources/)
- [Surveillance](https://absa.org/topic/surveillance-aramr/)
- [Fact Sheets](https://absa.org/topic/fact-sheets/)
- [Pathogen Origin](https://absa.org/topic/pathogen-origin/)
- [Alerts](https://absa.org/topic/alerts/)
- [Fungi Toolbox](https://absa.org/topic/fungi/)
- [Fact Sheets](https://absa.org/topic/factsheets/)
- [Drug-Resistant](https://absa.org/topic/drug-resistant/)
- [Risk Assessment](https://absa.org/topic/risk-assessment-fungi/)
- [Prevention](https://absa.org/topic/prevention/)
- [Waterborne Disease Toolbox](https://absa.org/topic/waterborne/)
- [Outcomes](https://absa.org/topic/outcomes/)
- [Community](https://absa.org/topic/community-mpox/)
- [Books](https://absa.org/topic/books/)
- [Resources](https://absa.org/topic/resources-fungi/)
- [News](https://absa.org/topic/news-fungi/)
- [Fungal Infections](https://absa.org/topic/fungal-infections/)
- [Skin Infection](https://absa.org/topic/skin-infection/)
- [Most Common Waterborne Diseases](https://absa.org/topic/common/)
- [Transmission](https://absa.org/topic/transmission-waterborne/)
- [Prevention](https://absa.org/topic/prevention-waterborne/)
- [Regulatory/Guidance](https://absa.org/topic/regulatory-guidance-waterborne/)
- [Risk Mitigation](https://absa.org/topic/risk-mitigation-waterborne/)
- [Support](https://absa.org/topic/support-waterborne/)
- [-Organizations](https://absa.org/topic/organizations/)
- [United States](https://absa.org/topic/united-states-organizations/)
- [World Health Organization](https://absa.org/topic/world-health-organization/)
- [Worker Health Program](https://absa.org/topic/worker-health-program/)
- [Diagnostics](https://absa.org/topic/diagnostics-support-waterborne/)
- [Surveillance](https://absa.org/topic/surveillance-support-waterborne/)
- [Vaccines](https://absa.org/topic/vaccines-worker-health-program/)
- [Eradication](https://absa.org/topic/eradication/)
- [ECDC](https://absa.org/topic/ecdc/)
- [Parasites Toolbox](https://absa.org/topic/parasites/)
- [Cyclosporidia](https://absa.org/topic/cyclosporidia/)
- [Malaria](https://absa.org/topic/malaria/)
- [Surveillance](https://absa.org/topic/surveillance-fungi/)
- [PPE](https://absa.org/topic/ppe-ttr/)
- [Articles](https://absa.org/topic/articles-aramr/)
- [Disinfection](https://absa.org/topic/disinfection-fungi/)
- [United States](https://absa.org/topic/united-states-parasites/)
- [Outbreaks](https://absa.org/topic/outbreaks-news-influenza/)
- [Journal Article](https://absa.org/topic/journal-article/)
- [Toxoplasmosis](https://absa.org/topic/toxoplasmosis/)
- [Other Zoonotic Agents Toolbox](https://absa.org/topic/zoonotic/)
- [-General References](https://absa.org/topic/general-references/)
- [Zoonotic Influenza](https://absa.org/topic/zoonotic-influenza/)
- [Salmonellosis](https://absa.org/topic/salmonellosis/)
- [West Nile virus](https://absa.org/topic/west-nile-virus/)
- [Emerging coronaviruses](https://absa.org/topic/coronaviruses/)
- [SARS](https://absa.org/topic/sars/)
- [MERS](https://absa.org/topic/mers/)
- [Rabies](https://absa.org/topic/rabies/)
- [Brucellosis](https://absa.org/topic/brucellosis/)
- [Lyme Disease](https://absa.org/topic/lyme-disease/)
- [Surveillance](https://absa.org/topic/surveillance-waterborne/)
- [-What is Chikungunya virus?](https://absa.org/topic/what-is-chikungunya-virus/)
- [Leishmaniasis](https://absa.org/topic/leishmaniasis/)
- [cryptosporidiosis](https://absa.org/topic/cryptosporidiosis/)
- [Travel](https://absa.org/topic/travel-polio/)
- [MMR (Measles, Mumps, Rubella) Toolbox](https://absa.org/topic/mmr/)
- [-Pathogen](https://absa.org/topic/pathogen-mmr/)
- [Measles](https://absa.org/topic/measles/)
- [Mumps](https://absa.org/topic/mumps/)
- [Laboratory safety](https://absa.org/topic/lab-safety/)
- [Prion Diseases Toolbox](https://absa.org/topic/prion/)
- [Chronic Wasting Disease (CWD)](https://absa.org/topic/cwd/)
- [Identification](https://absa.org/topic/identification/)
- [Biosafety](https://absa.org/topic/biosafety/)
- [Infection Control](https://absa.org/topic/infection-control/)
- [Anthrax Toolbox](https://absa.org/topic/anthrax/)
- [Prevention](https://absa.org/topic/prevention-anthrax/)
- [Alaskapox](https://absa.org/topic/alaskapox/)
- [-News](https://absa.org/topic/news-zoonotic/)
- [Trypanosoma cruzi](https://absa.org/topic/trypanosoma-cruzi/)
- [Airborne](https://absa.org/topic/airborne/)
- [Non-Polio enteric viruses](https://absa.org/topic/non-polio-enteric-viruses/)
- [Cruetzfeldt Jakob Disease (CJD)](https://absa.org/topic/cruetzfeldt-jakob-disease-cjd/)
- [Infection Control](https://absa.org/topic/infection-control-cruetzfeldt-jakob-disease-cjd/)
- [Disinfection](https://absa.org/topic/disinfection-cruetzfeldt-jakob-disease-cjd/)
- [General](https://absa.org/topic/general-prion/)
- [Disinfection](https://absa.org/topic/disinfection-general-prion/)
- [Inactivation](https://absa.org/topic/inactivation-general-prion/)
- [Inactivation](https://absa.org/topic/inactivation-zoonotic/)
- [Laboratory Safety](https://absa.org/topic/laboratory-safety-zoonotic/)
- [Laboratory Handling](https://absa.org/topic/laboratory-handling/)
- [-About Viral Hemorrhagic Fevers](https://absa.org/topic/about-viral-hemorrhagic-fevers/)
- [Reporting](https://absa.org/topic/reporting/)
- [-Oropouche Virus](https://absa.org/topic/oropouche-virus/)
- [Tick Borne Encephalitis](https://absa.org/topic/tick-borne-encephalitis/)
- [-Dengue Virus](https://absa.org/topic/dengue-virus/)
- [Surveillance](https://absa.org/topic/surveillance-parasites/)
- [Surveillance](https://absa.org/topic/surveillance-zoonotic/)
- [-Outbreaks](https://absa.org/topic/outbreaks-zoonotic/)
- [Worker Health](https://absa.org/topic/worker-health-influenza/)
- [Treatment](https://absa.org/topic/treatment-measles/)
- [Risk Assessment](https://absa.org/topic/risk-assessment-general-prion/)
- [Other Emerging Pathogens Toolbox](https://absa.org/topic/other/)
- [Pneumonia](https://absa.org/topic/pneumonia/)
- [RSV](https://absa.org/topic/rsv/)
- [Foodborne](https://absa.org/topic/foodborne/)
- [Raccoon Roundworm](https://absa.org/topic/raccoon-roundworm/)
- [Bats](https://absa.org/topic/bats/)
- [New World Screwworm](https://absa.org/topic/new-world-screwworm/)
- [Legionnaires' disease](https://absa.org/topic/legionnaires-disease/)
- [Asian Longhorned Ticks](https://absa.org/topic/asian-longhorned-ticks/)
- [Neisseria meningitidis conjunctivitis](https://absa.org/topic/neisseria-meningitidis-conjunctivitis/)
- [-News](https://absa.org/topic/news-aramr/)
- [Tularemia](https://absa.org/topic/tularemia/)

## Highlights

- [New](https://absa.org/highlight/new/)
- [EIDC](https://absa.org/highlight/eidc/)

## Agents

- [Bacteria Genus](https://absa.org/agent/bacteria/)
- [Abiotrophia](https://absa.org/agent/abiotrophia/)
- [Acetivibrio](https://absa.org/agent/acetivibrio/)
- [Acholeplasma](https://absa.org/agent/acholeplasma/)
- [Achromobacter](https://absa.org/agent/achromobacter/)
- [Acidaminococcus](https://absa.org/agent/acidaminococcus/)
- [Acidovorax](https://absa.org/agent/acidovorax/)
- [Acinetobacter](https://absa.org/agent/acinetobacter/)
- [Actinobacillus](https://absa.org/agent/actinobacillus/)
- [Actinobaculum](https://absa.org/agent/actinobaculum/)
- [Actinomadura](https://absa.org/agent/actinomadura/)
- [Actinomyces](https://absa.org/agent/actinomyces/)
- [Aegyptianella](https://absa.org/agent/aegyptianella/)
- [Aerococcus](https://absa.org/agent/aerococcus/)
- [Aeromonas](https://absa.org/agent/aeromonas/)
- [Afipia](https://absa.org/agent/afipia/)
- [Alcaligenes](https://absa.org/agent/alcaligenes/)
- [Alloiococcus](https://absa.org/agent/alloiococcus/)
- [Allomonas](https://absa.org/agent/allomonas/)
- [Alteromonas](https://absa.org/agent/alteromonas/)
- [Amycolata](https://absa.org/agent/amycolata/)
- [Anaerobiospirillum](https://absa.org/agent/anaerobiospirillum/)
- [Anaerorhabdus](https://absa.org/agent/anaerorhabdus/)
- [Anaplasma](https://absa.org/agent/anaplasma/)
- [Arachnia](https://absa.org/agent/arachnia/)
- [Arcanobacterium](https://absa.org/agent/arcanobacterium/)
- [Arcobacter](https://absa.org/agent/arcobacter/)
- [Arizona](https://absa.org/agent/arizona/)
- [Arsenophonus](https://absa.org/agent/arsenophonus/)
- [Arthrobacter](https://absa.org/agent/arthrobacter/)
- [Atopobium](https://absa.org/agent/atopobium/)
- [Bacillus](https://absa.org/agent/bacillus/)
- [Bacteroides](https://absa.org/agent/bacteroides/)
- [Balneatrix](https://absa.org/agent/balneatrix/)
- [Bartonella](https://absa.org/agent/bartonella/)
- [Beneckea](https://absa.org/agent/beneckea/)
- [Bergeyella](https://absa.org/agent/bergeyella/)
- [Bifidobacterium](https://absa.org/agent/bifidobacterium/)
- [Bilophila](https://absa.org/agent/bilophila/)
- [Bordetella](https://absa.org/agent/bordetella/)
- [Borrelia](https://absa.org/agent/borrelia/)
- [Brachyspira](https://absa.org/agent/brachyspira/)
- [Brevibacterium](https://absa.org/agent/brevibacterium/)
- [Brevinema](https://absa.org/agent/brevinema/)
- [Brevundimonas](https://absa.org/agent/brevundimonas/)
- [Brucella](https://absa.org/agent/brucella/)
- [Burkholderia](https://absa.org/agent/burkholderia/)
- [Calymmatobacterium](https://absa.org/agent/calymmatobacterium/)
- [Campylobacter](https://absa.org/agent/campylobacter/)
- [Capnocytophaga](https://absa.org/agent/capnocytophaga/)
- [Cardiobacterum](https://absa.org/agent/cardiobacterum/)
- [Carnobacterium](https://absa.org/agent/carnobacterium/)
- [Catonella](https://absa.org/agent/catonella/)
- [Cedecea](https://absa.org/agent/cedecea/)
- [Cellulomonas](https://absa.org/agent/cellulomonas/)
- [Centipeda](https://absa.org/agent/centipeda/)
- [Chlamydia](https://absa.org/agent/chlamydia/)
- [Chlamydophila](https://absa.org/agent/chlamydophila/)
- [Chromobacterium](https://absa.org/agent/chromobacterium/)
- [Chryseobacterium](https://absa.org/agent/chryseobacterium/)
- [Citrobacter](https://absa.org/agent/citrobacter/)
- [Clavibacter](https://absa.org/agent/clavibacter/)
- [Clostridium](https://absa.org/agent/clostridium/)
- [Comamonas](https://absa.org/agent/comamonas/)
- [Corynebacterium](https://absa.org/agent/corynebacterium/)
- [Cowdria](https://absa.org/agent/cowdria/)
- [Coxiella](https://absa.org/agent/coxiella/)
- [Curtobacterium](https://absa.org/agent/curtobacterium/)
- [Cytophaga](https://absa.org/agent/cytophaga/)
- [Dermatiphulus](https://absa.org/agent/dermatiphulus/)
- [Dermatophilus](https://absa.org/agent/dermatophilus/)
- [Dialister](https://absa.org/agent/dialister/)
- [Dichelobacter](https://absa.org/agent/dichelobacter/)
- [Dolosigranulum](https://absa.org/agent/dolosigranulum/)
- [Edwardsiella](https://absa.org/agent/edwardsiella/)
- [Ehrlichia](https://absa.org/agent/ehrlichia/)
- [Eikenella](https://absa.org/agent/eikenella/)
- [Empedobacter](https://absa.org/agent/empedobacter/)
- [Enterobacter](https://absa.org/agent/enterobacter/)
- [Enterococcus](https://absa.org/agent/enterococcus/)
- [Eperythrozoon](https://absa.org/agent/eperythrozoon/)
- [Erlichia](https://absa.org/agent/erlichia/)
- [Erwinia](https://absa.org/agent/erwinia/)
- [Erysipelothrix](https://absa.org/agent/erysipelothrix/)
- [Escherichia](https://absa.org/agent/escherichia/)
- [Eubacterium](https://absa.org/agent/eubacterium/)
- [Eurbacterium](https://absa.org/agent/eurbacterium/)
- [Ewingella](https://absa.org/agent/ewingella/)
- [Facklamia](https://absa.org/agent/facklamia/)
- [Faenia](https://absa.org/agent/faenia/)
- [Falcivibrio](https://absa.org/agent/falcivibrio/)
- [Flavobacterium](https://absa.org/agent/flavobacterium/)
- [Flexibacter](https://absa.org/agent/flexibacter/)
- [Fluoribacter](https://absa.org/agent/fluoribacter/)
- [Francisella](https://absa.org/agent/francisella/)
- [Fusobacterium](https://absa.org/agent/fusobacterium/)
- [Gardnerella](https://absa.org/agent/gardnerella/)
- [Gemella](https://absa.org/agent/gemella/)
- [Globicatella](https://absa.org/agent/globicatella/)
- [Gordonia](https://absa.org/agent/gordonia/)
- [Haemobartonella](https://absa.org/agent/haemobartonella/)
- [Haemophilus](https://absa.org/agent/haemophilus/)
- [Hafnia](https://absa.org/agent/hafnia/)
- [Hallella](https://absa.org/agent/hallella/)
- [Hartmanella](https://absa.org/agent/hartmanella/)
- [Helcococcus](https://absa.org/agent/helcococcus/)
- [Helicobacter](https://absa.org/agent/helicobacter/)
- [Herellea](https://absa.org/agent/herellea/)
- [Johnsonella](https://absa.org/agent/johnsonella/)
- [Jonesia](https://absa.org/agent/jonesia/)
- [Kingella](https://absa.org/agent/kingella/)
- [Klebsiella](https://absa.org/agent/klebsiella/)
- [Kluyvera](https://absa.org/agent/kluyvera/)
- [Koserella](https://absa.org/agent/koserella/)
- [Lactobacillus](https://absa.org/agent/lactobacillus/)
- [Lactococcus](https://absa.org/agent/lactococcus/)
- [Lawsonia](https://absa.org/agent/lawsonia/)
- [Leclercia](https://absa.org/agent/leclercia/)
- [Legionella](https://absa.org/agent/legionella/)
- [Leptospira](https://absa.org/agent/leptospira/)
- [Levinea](https://absa.org/agent/levinea/)
- [Liberobacter](https://absa.org/agent/liberobacter/)
- [Listeria](https://absa.org/agent/listeria/)
- [Listonella](https://absa.org/agent/listonella/)
- [Mannheimia](https://absa.org/agent/mannheimia/)
- [Megasphaera](https://absa.org/agent/megasphaera/)
- [Melissococcus](https://absa.org/agent/melissococcus/)
- [Microvirgula](https://absa.org/agent/microvirgula/)
- [Mitsuokella](https://absa.org/agent/mitsuokella/)
- [Mobiluncus](https://absa.org/agent/mobiluncus/)
- [Moraxella](https://absa.org/agent/moraxella/)
- [Moraxella (Branhamella)](https://absa.org/agent/moraxella-branhamella/)
- [Morganella](https://absa.org/agent/morganella/)
- [Morococcus](https://absa.org/agent/morococcus/)
- [Mycobacterium](https://absa.org/agent/mycobacterium/)
- [Mycoplasma](https://absa.org/agent/mycoplasma/)
- [Myroides](https://absa.org/agent/myroides/)
- [Neisseria](https://absa.org/agent/neisseria/)
- [Neorickettsia](https://absa.org/agent/neorickettsia/)
- [Nocardia](https://absa.org/agent/nocardia/)
- [Nocardiopsis](https://absa.org/agent/nocardiopsis/)
- [Ochrobactrum](https://absa.org/agent/ochrobactrum/)
- [Oligella](https://absa.org/agent/oligella/)
- [Ornithobacterium](https://absa.org/agent/ornithobacterium/)
- [Paenibacillus](https://absa.org/agent/paenibacillus/)
- [Pantoea](https://absa.org/agent/pantoea/)
- [Pasteurella](https://absa.org/agent/pasteurella/)
- [Peptococcus](https://absa.org/agent/peptococcus/)
- [Peptostreptococcus](https://absa.org/agent/peptostreptococcus/)
- [Photobacterium](https://absa.org/agent/photobacterium/)
- [Piscirickettsia](https://absa.org/agent/piscirickettsia/)
- [Plesiomonas](https://absa.org/agent/plesiomonas/)
- [Porphyromonas](https://absa.org/agent/porphyromonas/)
- [Prevotella](https://absa.org/agent/prevotella/)
- [Propionibacterium](https://absa.org/agent/propionibacterium/)
- [Proteus](https://absa.org/agent/proteus/)
- [Providencia](https://absa.org/agent/providencia/)
- [Pseudoalteromonas](https://absa.org/agent/pseudoalteromonas/)
- [Pseudomonas](https://absa.org/agent/pseudomonas/)
- [Pseudoramibacter](https://absa.org/agent/pseudoramibacter/)
- [Psychrobacter](https://absa.org/agent/psychrobacter/)
- [Ralstonia](https://absa.org/agent/ralstonia/)
- [Renibacterium](https://absa.org/agent/renibacterium/)
- [Rhodococcus](https://absa.org/agent/rhodococcus/)
- [Rickettsia](https://absa.org/agent/rickettsia/)
- [Riemerella](https://absa.org/agent/riemerella/)
- [Rochalimaea](https://absa.org/agent/rochalimaea/)
- [Saccharopolyspora](https://absa.org/agent/saccharopolyspora/)
- [Salmonella](https://absa.org/agent/salmonella/)
- [Sanguibacter](https://absa.org/agent/sanguibacter/)
- [Selenomonas](https://absa.org/agent/selenomonas/)
- [Serpulina](https://absa.org/agent/serpulina/)
- [Serratia](https://absa.org/agent/serratia/)
- [Shewanella](https://absa.org/agent/shewanella/)
- [Shigella](https://absa.org/agent/shigella/)
- [Sphaerophorus](https://absa.org/agent/sphaerophorus/)
- [Sphingobacterium](https://absa.org/agent/sphingobacterium/)
- [Sphingomonas](https://absa.org/agent/sphingomonas/)
- [Spiroplasma](https://absa.org/agent/spiroplasma/)
- [Sporichthya](https://absa.org/agent/sporichthya/)
- [Staphylococcus](https://absa.org/agent/staphylococcus/)
- [Stenotrophomonas](https://absa.org/agent/stenotrophomonas/)
- [Streptobacillus](https://absa.org/agent/streptobacillus/)
- [Streptococcus](https://absa.org/agent/streptococcus/)
- [Streptomyces](https://absa.org/agent/streptomyces/)
- [Sutterella](https://absa.org/agent/sutterella/)
- [Suttonella](https://absa.org/agent/suttonella/)
- [Tatlockia](https://absa.org/agent/tatlockia/)
- [Tatumella](https://absa.org/agent/tatumella/)
- [Taylorella](https://absa.org/agent/taylorella/)
- [Tissierella](https://absa.org/agent/tissierella/)
- [Treponema](https://absa.org/agent/treponema/)
- [Tsukamurella](https://absa.org/agent/tsukamurella/)
- [Turicella](https://absa.org/agent/turicella/)
- [Ureaplasma](https://absa.org/agent/ureaplasma/)
- [Vagococcus](https://absa.org/agent/vagococcus/)
- [Veillonella](https://absa.org/agent/veillonella/)
- [Vibrio](https://absa.org/agent/vibrio/)
- [Waddlia](https://absa.org/agent/waddlia/)
- [Xanthomonas](https://absa.org/agent/xanthomonas/)
- [Xylella](https://absa.org/agent/xylella/)
- [Xylophilus](https://absa.org/agent/xylophilus/)
- [Yersinia](https://absa.org/agent/yersinia/)
- [Viral Groups](https://absa.org/agent/viruses/)
- [Parasite Genus](https://absa.org/agent/parasites/)
- [Adenoviridae](https://absa.org/agent/adenoviridae/)
- [Arenaviridae](https://absa.org/agent/arenaviridae/)
- [Astroviridae](https://absa.org/agent/astroviridae/)
- [Baculoviridae](https://absa.org/agent/baculoviridae/)
- [Birnaviridae](https://absa.org/agent/birnaviridae/)
- [Bornaviridae](https://absa.org/agent/bornaviridae/)
- [Bunyaviridae](https://absa.org/agent/bunyaviridae/)
- [Caliciviridae](https://absa.org/agent/caliciviridae/)
- [Circoviridae](https://absa.org/agent/circoviridae/)
- [Coronaviridae](https://absa.org/agent/coronaviridae/)
- [Filoviridae](https://absa.org/agent/filoviridae/)
- [Flaviviridae](https://absa.org/agent/flaviviridae/)
- [Hepadnaviridae](https://absa.org/agent/hepadnaviridae/)
- [Herpesviridae](https://absa.org/agent/herpesviridae/)
- [Iridoviridae](https://absa.org/agent/iridoviridae/)
- [Orthomyxoviridae](https://absa.org/agent/orthomyxoviridae/)
- [Papovaviridae](https://absa.org/agent/papovaviridae/)
- [Paramyxoviridae](https://absa.org/agent/paramyxoviridae/)
- [Parvoviridae](https://absa.org/agent/parvoviridae/)
- [Picornaviridae](https://absa.org/agent/picornaviridae/)
- [Poxviridae](https://absa.org/agent/poxviridae/)
- [Prion](https://absa.org/agent/prion/)
- [Reoviridae](https://absa.org/agent/reoviridae/)
- [Retroviridae](https://absa.org/agent/retroviridae/)
- [Rhabdoviridae](https://absa.org/agent/rhabdoviridae/)
- [Togaviridae](https://absa.org/agent/togaviridae/)
- [Toroviridae](https://absa.org/agent/toroviridae/)
- [Unclassified](https://absa.org/agent/unclassified/)
- [Acanthamoeba](https://absa.org/agent/acanthamoeba/)
- [Ancylostoma](https://absa.org/agent/ancylostoma/)
- [Angiostrongylus](https://absa.org/agent/angiostrongylus/)
- [Anisakis](https://absa.org/agent/anisakis/)
- [Ascaris](https://absa.org/agent/ascaris/)
- [Babesia](https://absa.org/agent/babesia/)
- [Balantidium](https://absa.org/agent/balantidium/)
- [Blastocystis](https://absa.org/agent/blastocystis/)
- [Brugia](https://absa.org/agent/brugia/)
- [Capillaria](https://absa.org/agent/capillaria/)
- [Clonorchis](https://absa.org/agent/clonorchis/)
- [Coccidia](https://absa.org/agent/coccidia/)
- [Cochliomyia](https://absa.org/agent/cochliomyia/)
- [Contracaecum](https://absa.org/agent/contracaecum/)
- [Cryptosporidium](https://absa.org/agent/cryptosporidium/)
- [Custocercis](https://absa.org/agent/custocercis/)
- [Cyclospora](https://absa.org/agent/cyclospora/)
- [Cysticercus](https://absa.org/agent/cysticercus/)
- [Dicrocoelium](https://absa.org/agent/dicrocoelium/)
- [Dientamoeba](https://absa.org/agent/dientamoeba/)
- [Dipetalonema](https://absa.org/agent/dipetalonema/)
- [Diphyllobothrium](https://absa.org/agent/diphyllobothrium/)
- [Dipylidium](https://absa.org/agent/dipylidium/)
- [Dracunculus](https://absa.org/agent/dracunculus/)
- [Echinococcus](https://absa.org/agent/echinococcus/)
- [Eimeria](https://absa.org/agent/eimeria/)
- [Encephalitozoon](https://absa.org/agent/encephalitozoon/)
- [Entamoeba](https://absa.org/agent/entamoeba/)
- [Enterobius](https://absa.org/agent/enterobius/)
- [Enterocytozoon](https://absa.org/agent/enterocytozoon/)
- [Fasciola](https://absa.org/agent/fasciola/)
- [Fasciolopsis](https://absa.org/agent/fasciolopsis/)
- [Giardia](https://absa.org/agent/giardia/)
- [Gnathostoma](https://absa.org/agent/gnathostoma/)
- [Gongylonema](https://absa.org/agent/gongylonema/)
- [Haemonchus](https://absa.org/agent/haemonchus/)
- [Heterophyes](https://absa.org/agent/heterophyes/)
- [Hymenolepis](https://absa.org/agent/hymenolepis/)
- [Isopora](https://absa.org/agent/isopora/)
- [Leishmania](https://absa.org/agent/leishmania/)
- [Loa](https://absa.org/agent/loa/)
- [Mansonella](https://absa.org/agent/mansonella/)
- [Metagonimus](https://absa.org/agent/metagonimus/)
- [Microsporidium](https://absa.org/agent/microsporidium/)
- [Naegleria](https://absa.org/agent/naegleria/)
- [Necator](https://absa.org/agent/necator/)
- [Oesophagostomum](https://absa.org/agent/oesophagostomum/)
- [Onchocerca](https://absa.org/agent/onchocerca/)
- [Opisthorchis](https://absa.org/agent/opisthorchis/)
- [Paragonimus](https://absa.org/agent/paragonimus/)
- [Piroplasma](https://absa.org/agent/piroplasma/)
- [Plasmodium](https://absa.org/agent/plasmodium/)
- [Pneumocystis](https://absa.org/agent/pneumocystis/)
- [Pseudoterranova](https://absa.org/agent/pseudoterranova/)
- [Sarcocystis](https://absa.org/agent/sarcocystis/)
- [Schistosoma](https://absa.org/agent/schistosoma/)
- [Strongyloides](https://absa.org/agent/strongyloides/)
- [Taenia](https://absa.org/agent/taenia/)
- [Ternidens](https://absa.org/agent/ternidens/)
- [Theileria](https://absa.org/agent/theileria/)
- [Toxocara](https://absa.org/agent/toxocara/)
- [Toxoplasma](https://absa.org/agent/toxoplasma/)
- [Trichinella](https://absa.org/agent/trichinella/)
- [Trichomonas](https://absa.org/agent/trichomonas/)
- [Trichostrongylus](https://absa.org/agent/trichostrongylus/)
- [Trichuris](https://absa.org/agent/trichuris/)
- [Trypanosoma](https://absa.org/agent/trypanosoma/)
- [Varroa](https://absa.org/agent/varroa/)
- [Wuchereria](https://absa.org/agent/wuchereria/)
- [Methylobacterium](https://absa.org/agent/methylobacterium/)
- [Mimae](https://absa.org/agent/mimae/)
- [Orientia](https://absa.org/agent/orientia/)
- [Rathayibacter](https://absa.org/agent/rathayibacter/)
- [Schistosoma](https://absa.org/agent/schistosoma-bacteria/)
- [Virgibacillus](https://absa.org/agent/virgibacillus/)
- [Asfaviridae](https://absa.org/agent/asfaviridae/)
- [Fungus Genus](https://absa.org/agent/fungus-genus/)
- [Absidia](https://absa.org/agent/absidia-fungus-genus/)
- [Acremonium](https://absa.org/agent/acremonium-fungus-genus/)
- [Ajellomyces](https://absa.org/agent/ajellomyces-fungus-genus/)
- [Aphanomyces](https://absa.org/agent/aphanomyces-fungus-genus/)
- [Arthroderma](https://absa.org/agent/arthroderma-fungus-genus/)
- [Aspergillus](https://absa.org/agent/aspergillus-fungus-genus/)
- [Basidiobolus](https://absa.org/agent/basidiobolus-fungus-genus/)
- [Blastomyces](https://absa.org/agent/blastomyces-fungus-genus/)
- [Candida](https://absa.org/agent/candida-fungus-genus/)
- [Capronia](https://absa.org/agent/capronia-fungus-genus/)
- [Ceratocystis](https://absa.org/agent/ceratocystis-fungus-genus/)
- [Cladophialophora](https://absa.org/agent/cladophialophora-fungus-genus/)
- [Cladosporium](https://absa.org/agent/cladosporium-fungus-genus/)
- [Coccidioides](https://absa.org/agent/coccidioides-fungus-genus/)
- [Cryptococcus](https://absa.org/agent/cryptococcus-fungus-genus/)
- [Dactylaria](https://absa.org/agent/dactylaria-fungus-genus/)
- [Dermatophilus](https://absa.org/agent/dermatophilus-fungus-genus/)
- [Emmonsia](https://absa.org/agent/emmonsia-fungus-genus/)
- [Emmonsiella](https://absa.org/agent/emmonsiella-fungus-genus/)
- [Epidermophyton](https://absa.org/agent/epidermophyton-fungus-genus/)
- [Exophiala](https://absa.org/agent/exophiala-fungus-genus/)
- [Filobasidiella](https://absa.org/agent/filobasidiella-fungus-genus/)
- [Fonsecaea](https://absa.org/agent/fonsecaea-fungus-genus/)
- [Fusarium](https://absa.org/agent/fusarium-fungus-genus/)
- [Geotrichum](https://absa.org/agent/geotrichum-fungus-genus/)
- [Giberrella](https://absa.org/agent/giberrella-fungus-genus/)
- [Histoplasma](https://absa.org/agent/histoplasma-fungus-genus/)
- [Hortaea](https://absa.org/agent/hortaea-fungus-genus/)
- [Leptosphaeria](https://absa.org/agent/leptosphaeria-fungus-genus/)
- [Loboa](https://absa.org/agent/loboa-fungus-genus/)
- [Madurella](https://absa.org/agent/madurella-fungus-genus/)
- [Malassezia](https://absa.org/agent/malassezia/)
- [Microsporum](https://absa.org/agent/microsporum-fungus-genus/)
- [Monosporium](https://absa.org/agent/monosporium-fungus-genus/)
- [Mucor](https://absa.org/agent/mucor-fungus-genus/)
- [Nannizzia](https://absa.org/agent/nannizzia-fungus-genus/)
- [Nectria](https://absa.org/agent/nectria-fungus-genus/)
- [Neotestudina](https://absa.org/agent/neotestudina-fungus-genus/)
- [Ochroconis](https://absa.org/agent/ochroconis-fungus-genus/)
- [Ophiostoma](https://absa.org/agent/ophiostoma-fungus-genus/)
- [Paecilomyces](https://absa.org/agent/paecilomyces-fungus-genus/)
- [Paracoccidioides](https://absa.org/agent/paracoccidioides-fungus-genus/)
- [Penicillium](https://absa.org/agent/penicillium-fungus-genus/)
- [Peronosclerospora](https://absa.org/agent/peronosclerospora-fungus-genus/)
- [Phialophora](https://absa.org/agent/phialophora-fungus-genus/)
- [Phoma](https://absa.org/agent/phoma-fungus-genus/)
- [Phytophthora](https://absa.org/agent/phytophthora-fungus-genus/)
- [Pneumocystis](https://absa.org/agent/pneumocystis-fungus-genus/)
- [Pseudallescheria](https://absa.org/agent/pseudallescheria-fungus-genus/)
- [Ramichloridium](https://absa.org/agent/ramichloridium/)
- [Rhinocladiella](https://absa.org/agent/rhinocladiella-fungus-genus/)
- [Rhinosporidium](https://absa.org/agent/rhinosporidium-fungus-genus/)
- [Rhizomucor](https://absa.org/agent/rhizomucor/)
- [Rhizopus](https://absa.org/agent/rhizopus-fungus-genus/)
- [Rhodotorula](https://absa.org/agent/rhodotorula/)
- [Scedosporium](https://absa.org/agent/scedosporium-fungus-genus/)
- [Sclerophthora](https://absa.org/agent/sclerophthora-fungus-genus/)
- [Sporothrix](https://absa.org/agent/sporothrix-fungus-genus/)
- [Stachybotrys](https://absa.org/agent/stachybotrys-fungus-genus/)
- [Synchytrium](https://absa.org/agent/synchytrium-fungus-genus/)
- [Trichophyton](https://absa.org/agent/trichophyton-fungus-genus/)
- [Trichospora](https://absa.org/agent/trichospora/)
- [Trichosporon](https://absa.org/agent/trichosporon-fungus-genus/)
- [Xylohypha](https://absa.org/agent/xylohypha-fungus-genus/)
- [Zymonema](https://absa.org/agent/zymonema-fungus-genus/)
- [Coniothyrium](https://absa.org/agent/coniothyrium/)

## Event Categories

- [ABSA-Sponsored](https://absa.org/events/category/absa-sponsored/)
- [Principles & Practices of Biosafety](https://absa.org/events/category/absa-sponsored/ppb/)
- [Online Education](https://absa.org/events/category/absa-sponsored/online/)
- [Webinar](https://absa.org/events/category/absa-sponsored/online/webinar/)
- [Non-ABSA-Sponsored](https://absa.org/events/category/non-absa-sponsored/)
- [USDA/ARS](https://absa.org/events/category/absa-sponsored/usdaars/)
- [Affiliate](https://absa.org/events/category/affiliate/)
- [ABSA Conference](https://absa.org/events/category/absa-sponsored/conference/)
- [Featured](https://absa.org/events/category/featured/)
- [COVID-19](https://absa.org/events/category/covid-19/)
- [Biosecurity Symposium](https://absa.org/events/category/absa-sponsored/biosecurity-symposium/)
- [BBTC](https://absa.org/events/category/absa-sponsored/bbtc/)

## Portfolio Categories

- [ABSA History](https://absa.org/portfolio_category/absa-history/)
- [2007 Historical Videos](https://absa.org/portfolio_category/2007-historical-videos/)
- [Resources](https://absa.org/portfolio_category/resources/)
- [People](https://absa.org/portfolio_category/people/)
- [Council](https://absa.org/portfolio_category/council/)